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Editorial
Welcome to the TERMIS-EU 2008 Porto Meeting
Rui L. Reis 1–3
IT IS A REAL PLEASURE TO WELCOME you to Porto and to thespecial issue of Tissue Engineering: Part A that contains
all the abstracts submitted and accepted for presentation
at the 2008 Annual Tissue Engineering and Regenera-
tive Medicine International Society–European Chapter
(TERMIS-EU) Meeting.
As you might be aware, it was a tradition for Tissue
Engineering to publish the abstracts of TESI and then, after
merging with ETES, of the TERMIS World Congresses
(Shanghai, Pittsburgh) and North American meetings.
Last year in London we started doing the same with the
TERMIS-EU meetings. This year, once again, Mary Ann
Liebert and the editors of Tissue Engineering were kind
enough to decide to publish the abstracts of the Porto
meeting.
The present issue of Tissue Engineering compiles the
entire range of nearly 750 abstracts accepted for presenta-
tion for the 2008 TERMIS-EU Meeting. These abstracts
were submitted by researchers from all over the world and
from different research groups and core research fields.
This number is considered by the organizers as a great
achievement, since we have set a goal to make this the
largest ever TERMIS-EU meeting. We knew, however, that
this was quite a difficult challenge. In fact, not only was the
London meeting, as expected, a great success in attracting
abstracts, but we knew beforehand that 2008 was the year
of the World Biomaterials Congress, to be held in Europe
just three weeks before our meeting.
We also set an objective of making sure that we would
be able to organize a very international meeting, with many
more participants from North America, Asia, and third
world countries than was typical in ETES and in TERMIS-
EU. We have tried to work for that, using our network of
contacts. We are proud to conclude that it was, in fact,
possible to achieve that goal. For instance, the United
States is the fourth country, after Portugal, the United
Kingdom, and Germany, with more abstracts accepted (9%
of the total). Korea is the eighth country represented (with
5% of the total), and China and Japan, as well as Turkey,
were also quite active on submissions. This Asian repre-
sentation is particularly relevant as we are approaching the
TERMIS World Congress in Dajaeon, South Korea, next
year. Receiving abstracts from all over the world proves
that it was feasible to reach the goal of having a multi-
disciplinary conference, enriched with participants from
different cultures.
We also tried to organize the meeting agenda so that the
scientific community could build their own program of
scientific excellence. We have opened a call for submission
of proposals for the organization of 90-minute symposia,
typically with one or two organizers, a distinguished key-
note speaker (30 minutes), and four general presentations
(of 15 minutes each, either invited or selected from the
abstracts submitted to that particular symposia). In some
cases, the symposia have more than one session and/or are
composed of three keynote invited talks of 30 minutes
each. These thematic symposia, organized by the world’s
leading scientists and featuring recognized keynote speak-
ers, constitute 41 of the meeting’s sessions. All of the re-
maining parts of the program are made up of general oral
sessions, organized around state-of-the-art scientific topics
that are based on the submitted abstracts, as well as a very
well attended poster session of around 400 attendees.
In addition, the program of the TERMIS-EU 2008
Meeting includes eight plenary lectures given by some of
the very best scientists working in different cutting-edge
areas that are relevant to TERMIS. This is one of the
highlights of the meeting.
1Chair of the Tissue Engineering and Regenerative Medicine International Society (TERMIS) European Chapter (EU) Meeting of
2008 held in June 2008 in Porto, Portugal.
2Director of the 3B’s Research Group—Biomaterials, Biodegradables and Biomimetics, Dept. of Polymer Engineering, University of
Minho, Campus de Gualtar, 4710-057 Braga, Portugal, www.3bs.uminho.pt, regreis@dep.uminho.pt.
3IBB—Institute for Biotechnology and Bioengineering, PT Government Associated Laboratory, Braga, Portugal, www.ibb.pt.
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TERMIS has as its main goal to try to get together
specialized international communities in the field of tissue
engineering and regenerative medicine in a way that en-
ables it to promote education and research in this area
through regular meetings, publications, and other forms of
communication/announcement. TERMIS-EU is also an
international forum for promoting an informed discussion
toward the challenges and benefits of the therapeutic ap-
plication of the technologies developed by tissue engi-
neering and regenerative medicine. Therefore, the Porto
program assures a scientific and industrial impact and en-
courages the participation of a high number of scientists
and researchers from both academia and industry. In order
to enhance education and outreach aspects, a special ses-
sion has been organized within the conference program,
being hosted by the Pittsburgh Tissue Engineering In-
itiative (PTEI). This is specially aimed for high school
teachers in order to make them aware of significant aspects
of tissue engineering and regenerative medicine.
The conference will be held in the very hospitable World
Heritage city of Porto, Portugal, from June 22 to 26, 2008.
Besides a cutting-edge scientific program in the field of
tissue engineering and regenerative medicine, we added a
wonderful social program that will be associated with the
typical St. John (S. Joa˜o), one of the major Porto and
Portuguese festivities. The venue, Alfaˆndega (Old Customs
House) Congress Centre is located in the very heart of the
Porto historical centre on the north bank of the River
Douro, overlooking the Port Wine cellars. Porto is a city of
wonderful people, and a dream for food and wine lovers.
So, make sure you enjoy it as much as possible with your
friends and colleagues. I have been enjoying it since I was
born (not the wine in the first few years!) 41 years ago, and
I could never leave the city to live anywhere else!
Finally, the meeting will also be associated with the great
opening of the headquarters of the European Institute of
Excellence on Tissue Engineering and Regenerative Med-
icine (www.3bs.uminho.pt). This state-of-the-art facility
with 3600 m2 will also be the new home for the 3B’s Re-
search Group of the University of Minho and our spin-off
company Stemmatters. It is a unique facility, fully planned
from scratch, for research in the field of TERM. This
building and its well equipped laboratories will be available
for visits during the meeting. These facilities will allow
research ranging from synthesis, processing, and modifi-
cation of new materials to small animal testing, and of
course, all biological and stem cell work can be carried out
in rather good conditions.
The new institute results from the European Net-
work of Excellence (NoE) on Tissue Engineering—
EXPERTISSUES (http://www.expertissues.org). The NoE
was funded, in a very competitive selection process, by the
Sixth Framework program (FP6) of the European Com-
mission (EC), being the only European network of excel-
lence in the field of tissue engineering. The institute,
formed as a European Economic Interest Group (EEIG),
will be sustainable in time, with headquarters in Taipas,
Minho, Portugal, and branches in more than 20 different
locations in 13 countries all over Europe. This is, however,
an open process, and other groups of excellence may join
this European effort. Rui L. Reis, the coordinator of the
NoE, will be the initial CEO of the institute, which has as
one of its main aims to collaborate even more with groups
of excellence in Asia, North America, the Pacific, and
elsewhere.
However, the TERMIS-EU 2008 meeting and its pro-
gram are mainly made up of the conference delegates who
will present their new results and scientific approaches to
different problems. All the abstracts of these contributions
are published in this issue of Tissue Engineering, the offi-
cial journal of TERMIS.
A word of acknowledgement is owed to TERMIS and its
officers for allowing us to organize the meeting and sup-
porting us whenever necessary. We would also like to thank
all the institutions, foundations, and companies that have
sponsored us and made the meeting possible. You may visit
many of them in the exhibition area.
But I am especially grateful to all of my postdoctoral
fellows, Ph.D. students, management and informatics team
members, and staff colleagues who work daily on the 3B’s
Research Group—Biomaterials, Biodegradables and Bio-
mimetics, which I have the pleasure of directing. We now
include more than 110 people, from around 20 different
nationalities, of which only five are staff members. All of
the others are quite young, bright, and ambitious fellows
and students. The organization of this TERMIS-EU meet-
ing was mainly the result of the hard work, devotion,
commitment, ambitions, and aspirations of many of these
people. They have put a great number of hours into the
enterprise of organizing the conference and realized that
this was an important event for all of us. I cannot refer to all
the relevant names herein, but when you find one of the
members of the 3B’s–U. Minho during the meeting, please
just speak with her/him and you will see how fortunate I am
for being able to advise and direct such a wonderful group
of young and bright researchers!
Many people made rather important contributions to the
organization, but in this case I really have to give a special
word of appreciation to two individuals. They are Ariana
Santos, my event organizer within the 3B’s, and Catarina
Alves, the postdoctoral fellow who has been leading, along
with Ariana and myself, all this organization. Without them
we would never have been able to organize this meeting
and have this special issue out today. They have made this
their main daily activity for months. Thank you very much,
Ariana and Catarina.
From both a scientific and a social/cultural perspective,
we really hope that this will be a meeting to remember.
Enjoy the conference, Porto, and if possible, Minho and
other areas of Northern Portugal!
Rui L. Reis and the Organizing Team
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(OP 1) In Vivo Bone formation of 3-D Prevascularized Tissues
Consisting of Primary Osteoblasts and Outgrowth endothelial
Cells
S. Ghanaati1, S. Fuchs1, C. Orth1, C.J. Kirkpatrick1
1Institute of Pathology, Johannes Gutenberg University, Langen-
beck-Str. 1, 55101 Mainz, Germany
Introduction: Tissue engineering of complex and vascularized
tissues retaining the functional phenotype of involved cell types is
still a problematic issue. We have previously established 3-D co-
culture systems consisting of primary osteoblasts and outgrowth
endothelial cells (OEC) forming prevascular structures and re-
taining the phenotype of both endothelial and osteoblastic cells [1].
In this study we assessed the in vivo bone formation to gain further
insight into the functional stability of primary osteoblasts in these
constructs.
Materials and Methods: 3-D constructs were generated in a ro-
tating cell culture system as previously described (1). After one
week 3-D constructs were harvested and subcutaneously implanted
in nude mice, divided into 3 groups: group 1 (OECþ pOB), group
2 (pOB alone) and group 3 (sham group). The constructs were
explanted at day 14 after implantation for histological evaluation
by Movat’s Pentachrom, Alcian-PAS and Goldner-staining.
Results: Specific histochemical analysis (Movat’s Pentachrom,
Alcian-PAS as well as Goldner-staining) revealed osteoid and bone
tissue in an early mineralisation stage along the implantation
channel. In accordance with the expression of osteoblastic markers
(alkaline phosphatase, osteocalcin) shown in vitro, these results
indicate that primary osteoblasts retain their functional phenotype.
Conclusion: The present study showed the ability of the 3-D
constructs to produce a bone-like matrix in the subcutaneous im-
plantation model. The possibility that prevascular structures
formed by OEC might contribute to the vascularization of such
constructs is currently under investigation.
References:
1Fuchs et al. 2007. Tissue Engineering
(OP 2) Role of Paracrine Factors Released by Mesenchymal
Progenitors from the Umbilical Cord in Neurons/Glial Cell
Viability, Proliferation and Differentiation
A.J. Salgado1, J.S. Fraga1, N.M. Neves2,3, R.L. Reis2,3, N. Sousa1
1Life and Health Sciences Research Institute (ICVS), School of
Health Sciences, University of Minho, Braga, Portugal
23B’s Research Group–Biomaterials, Biodegradable and Biomi-
metics, Department of Polymer Engineering, University of Minho,
Braga, Portugal
3IBB, Institute of Bioengineering and Biotechnology, PT Asso-
ciated Lab, Braga, Portugal
Umbilical Cord Stem Cells are able to integrate within the CNS
upon injury and to improve the condition of animals suffering from
neurodegenerative diseases. However the mechanisms by which
such phenomena are mediated are unknown. Therefore the main
objective of the present work was to understand how a population
of umbilical cord mesenchymal progenitor cells isolated from the
Wharton Jelly (HUCPVCs), regulates viability, proliferation and
different ion of post-natal hippocampal neurons and cortical glial
cells. Hippocampal neurons and glial cells were exposed to
HUCPVCs conditioned media (CM) (obtained 24, 48, 72 and 96
after 3 days of culture of HUCPVCs) for 1 week. Cell viability
(MTS test) experiments revealed that HUCPVCs CM obtained for
all time points did not cause any deleterious effects on both cell
populations when compared to the control condition. Im-
munocytochemistry and total cell counts revealed that HUCPVCs
CM triggered an upregulation of the proliferation on astrocytes
(GFAP), oligodendrocytes (O4) and the differentiation of hippo-
campal neurons (MAP-2). For the latter this was noticed even in the
absence of neuronal supplements B27 and FGF-2. In direct contact
co-culture systems the total numbers of hippocampal neurons, as-
trocytes and oligodendrocytes increased, in spite of the fact that the
numbers of HUCPVCs were decreasing in this new environment.
We believe that the phenomena here in described are related to the
release of neuroregulatory molecules by HUCPVCs. Current work
is focused on their identification as well as the consequent cross-
talking mechanisms related to the phenomena herein presented.
(OP 3) A Bioresorbable Device in Combination with Bone
Morphogenetic Protein-2 for Anterior Lumbar Interbody
Fusion in Porcine Model
S.A. Abbah1, C.X.F. Lam2, K. Yang1, J.C.H. Goh1,2, D.W. Hut-
macher3, H.K. Wong1,4
1Department of Orthopaedic Surgery, National University of
Singapore
2Division of Bioengineering, National University of Singapore
3Division of Regenerative Medicine, Queensland University of
Technology Australia
4Corresponding author
Introduction: Spine fusion, a procedure commonly performed for
patients with debilitating back pain, often involves implantation of
metallic cages and autograft bone into intervertebral disc spaces.
Several problems are associated with the use of both metallic cages
and autograft bone including donor site morbidity and difficulties
with radiographic assessment. Allograft bone proposed as an al-
ternative also carries an inherent risk of infection and rejection.
Bioabsorbable cages (biocage) offer distinct advantages including
biological and mechanical compatibility with host bone. This study
aimed to evaluate the efficacy of a novel mPCL-TCP biocage when
used in combination with MSCs and rhBMP-2 for spine fusion.
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Material and Methods: Twelve (12) pigs underwent anterior
lumbar interbody fusion (ALIF) at L3/4 and L5/6 in four groups viz:
Biocage; BiocageþMSCs; Biocageþ rhBMP-2 (0.6 mg/level);
and Autograft bone, implanted for 3 months.
Results: After 3 months, all animals receiving rhBMP-2 showed
radiographic evidence of fusion. Autograft bone showed fusion
only in 50% cases. Biocage and biocageþMSCs did not show any
fusion. Micro-CT and histology confirmed these findings.
Discussion and Conclusion: Incorporating low dose rhBMP-2
onto mPCL-TCP promoted early fusion compared to autograft in
this model. Absence of fusion in standalone biocage was not unex-
pected due to lack of an osteoinductive component. Failure of MSCs
to stimulate early fusion is in variance with previously observed
ectopic ossification in rats and could indicate a less than optimal
environment for these cells. This is the first study reporting mPCL-
TCP application in a multi-level, weight bearing, ALIF model.
(OP 4) A Biosynthetic Bandage for Corneal Wound Repair
C. Pratoomsoot1, Q. Hou1, D.Y.S. Chau1, H. Tanioka2, K. Hori2,
S. Kawasaki2, S. Kinoshita2, P.J. Tighe1, H. Dua1, K.M. Shake-
sheff1, F.R.A.J. Rose1
1University of Nottingham
2Kyoto Prefectural University of Medicine
Ocular trauma and disorders that lead to corneal blindness account
for over 2 million new cases of monocular blindness every year. The
use of amniotic membrane to treat such wounds is a popular treat-
ment but its biological nature presents many issues for use in the
clinic. To address this, we proposed to bioengineer a novel synthetic
material that would serve as a biomimetic corneal bandage. The
base component of this bandage is a bioinert PLGA–PEG–PLGA
triblock copolymer which gels in situ at body temperature. We in-
vestigated the thermoreversible gelling properties of this polymer at
various compositions and blends. In addition, we assessed the bio-
compatible nature of this hydrogel both in vitro and in vivo. We have
also shown that the hydrogel can act as a controlled release depot for
both drug and protein molecules. In addition, controlled release
microparticles were embedded within the hydrogel, illustrating the
potential for using this system for dual release of wound healing
promoters. This bench-to-clinic research program has developed a
hydrogel drug delivery system that could provide clinicians with a
user friendly, off-the-shelf treatment for the promotion of corneal
regeneration. Such a treatment holds great potential to enhance the
quality of life for patients and ultimately save sight.
(OP 5) A Modified Erythropoietin Affects Secondary Injury
and Improves Neurological Recovery After Spinal Cord Injury
M. Brejnikow1, S. Strohbach2, K. Vorauer-Uhl2, H. Katinger2,
H. Redl1
1Ludwig Boltzmann Institute for Experimental and Clinical
Traumatology, Austrian Cluster for Tissue Regeneration, Vienna
2Institute of Applied Microbiology, University of Natural Re-
sources and Applied Life Sciences, Vienna
Introduction: Spinal cord injury (SCI) provokes a cascade of
proinflammatory cytokines and induces apoptosis and necrosis of
neurons, oligodendrocytes and endothelial cells. Erythropoietin
(EPO) is known for its neuroprotective and anti-inflammatory
functions. Because of the influence on erythropoiesis, EPO cannot
be administered in high dosage for this indication. By modifying
the EPO molecule we could prolong the half-life and abolish the
haematopoietic effect. This could reduce potential side effects, but
also affects activity. Therefore we asked the question whether the
modified EPO can be successfully administered as a neuroprotec-
tive agent after SCI in rats. METHODS In male Sprague Dawley
rats a laminectomy was carried out at TH11. A contusion trauma
was evoked using the IH400 Impactor (150 kdyn). All animals
were randomly divided into 5 groups: I: rhEPO (1000 units/kg); II:
Placebo (NaCl); III: rhEPO-FP (1000 units/kg); IV: rhEPO-cFP
(1000 units/kg), V: Methylprednisolon (30 mg/kg). Substances were
administered intravenously 1 hour after contusion injury. Loco-
motion testing was performed weekly on all animals using the BBB
locomotor rating scale and the CatWalk assisted Gait Analysis.
RESULTS During the observation period a distinct improvement of
the BBB-scoring of the animals treated with carbamylated Fusion-
Protein-EPO was observed. After 4 weeks there is a significant
difference compared to the placebo animals. An improved outcome
could also be achieved by the application of the Fusion-Protein-
EPO, whereas the treatment with methylprednisolon didn’t show
any beneficial effects.
Conclusion: Carbamylated Fusion-EPO would be a good can-
didate for exploiting EPO’s neuroprotective and anti-inflammatory
properties while avoiding the haematopoietic side-effects.
(OP 6) A Novel Animal Model for Studying the Bone Forming
Capacity of Stem Cell Loaded Biomaterials
M. Bensidhoum1, V. Viateau2, G. Guillemin3, M. Valentin3,
A. Langonne´4, L. Sense´be´4, D. Logeart-Avramoglou1, H. Petite3
1CNRS
2Ecole nationale ve´te´rinaire de Maison-Alfort
3INSERM
4Etablissement Franc¸ais du Sang
In a previously study we showed that MSCs loaded onto bioma-
terial could be used to repair large bone defects. The purpose of this
study was to develop a new in vivo model that enabled efficient
screening of different material/cell combinations at the same time.
An implant pouch model was developed for use in sheep.
Cylindrical polymethylmethacrylate spacers (25:15 mm) were
implanted into 18 paraspinal subcutaneous sites in each of 7 ani-
mals for 6 weeks. The spacers cause a reactive encapsulating
membrane that formed a pouch for subsequent implantation.
Autologous-derived bone marrow stem cells (MSCs) were ex-
panded and loaded onto each of four different particulate materials
(coral Porites, coral Acropora, b-TCP and bone graft) prior to
implantation. At surgery each spacer was removed and the pouch
was filled with one of the four biomaterials, with or without MSCs.
After 8 weeks, the entire pouch was resected and analyse, with
radiography and undecalcified histology for evidence of material
resorption and bone formation.
Results: Compared with controls, large amounts of resorption of
the different implant materials were observed to different extents.
Addition of MSCs to the biomaterials was associated with varying
degrees of new bone formation.
Conclusions: Despite the ectopic nature of the implant site, this
model was effective for studying bone formation in conjunction
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with stem cell therapy. The pouch model enables relatively inex-
pensive sampling different materials and cell combinations. It re-
mains, however, to validate the model by implanting the more
promising materials into the relevant large bone defect model we
previously described.
(OP 7) A Novel Cell Source for Urologic Tissue Recon-
struction
Y.Y. Zhang1, E. McNeill1, S. Soker1, J.J. Yoo1, A. Atala1
1Wake Forest Institute for Regenerative Medicine, Wake Forest
University Health Sciences, Winston-Salem, NC 27157
In this study we explored the possibility of isolating cells from urine
as an alternative autologous cell source for tissue engineering. We
investigated whether the cells contained in urine possess normal
cellular characteristics for their use in urologic reconstructive
procedures. To this end, human urine samples were collected from
9 healthy male donors (23 to 45 years of age). Cells were isolated,
expanded and characterized with progenitor and differentiated cell
specific surface markers. The culture expanded cells were labeled
with Lac Z, seeded on collagen based matrices and implanted
subcutaneously in athymic mice. Primary cultures of urine cells
stained positively for C-kit, SSEA-4, CD105þ, CD73þ, CD91þ,
CD133þ, and CD44þ, but not for CD31, CD34, and CD45,
indicating that the cells are progenitor cells. Two different types of
progenitor cells were identified; urothelial and smooth muscle. The
urothelial progenitor cells expressed cytokeratins 7, 13, 17, 19 and
uroplakin Ia, and the muscle progenitor cells expressed vimentin,
a-smooth muscle actin, desmin and myosin. The surviving graft
cells were verified by human X/Y chromosome detection assay
(FISH). The implanted cells formed multilayered tissue structures
on collagen based matrices in vivo, which were confirmed pheno-
typically. This study demonstrates that urothelial and smooth
muscle progenitor cells can be isolated, grown and expanded from
urine. The cells maintained their phenotypic and functional cellular
characteristics in vitro and in vivo. The use of urine derived cells
might provide an excellent additional/alternative source for cell
harvest for urinary tract tissue reconstruction.
(OP 8) A Novel Ex vivo Platform to Develop Fetoscopic Clo-
sure Techniques for Punctured Fetal Membranes
A.S. Mallik1, M. Jabareen2, G. Bilic1, D. Liekens3, R. Zimmer-
mann1, J. Deprest3, E. Mazza2, A.H. Zisch1
1Department of Obstetrics, University Hospital Zurich, 8091
Zurich, Switzerland
2Institute of Mechanical Systems (IMES), ETH Zurich, 8092
Zurich, Switzerland
3Department of Obstetrics and Gynecology, University Hospital
Leuven, 3000 Leuven, Belgium
Endoscopic fetal surgery may be a live-saving option to correct
anomalies. However, operative interventions into the uterine cavity
carry a high risk for postoperative preterm premature rupture of the
fetal membranes (PPROM). Indeed, iatrogenic PPROM (iPPROM)
presents a bottleneck for fetoscopic surgery. Prophylactic plugging
of fetoscopic entry sites with tissue sealants, optimization of the
needle penetration procedure, needle geometry and puncture lo-
cation in the fetal membranes potentially could prevent iPPROM.
To explore such routes, ex vivo model systems are necessary. Here
we introduce a new dynamic test device that permits to develop
and study fetoscopic closure techniques on experimentally woun-
ded fetal membranes ex vivo. We created a mechanical inflation
device that permits to deform fetal membranes under fluid pressure
till rupture, monitored by a CCD camera. For the characterization
of the mechanical properties of the fetal membrane, the inverse
finite element procedure and the optimization procedure will be
used. Mechanical tests and treatment tests, e.g. plugging of fetal
membrane wounds with glues, are performed in the aqueous milieu
and the physiological loading conditions of fetal membranes
membranes inside the uterus. The validation of this new experi-
mental platform is ongoing: First rounds of biomechanical testing
have been performed in order to understand the fracture behavior
of healthy or fetoscopically punctured fetal membranes.
(OP 9) A Porous Collagen Scaffold Wrapped with PLGA
Mesh for Cartilage Tissue Engineering
N. Kawazoe1, G. Chen1, T. Tateishi1
1Biomaterials Center, National Institute for Materials Science
Collagen-based scaffolds have been widely used for tissue engi-
neering because of their good biocompatibility and biodegrad-
ability. Their porous structure facilitates cell delivery, gas and
nutrient exchange, and waste removal. On the other hand, the
highly porous structure also results in leakage of cells. High effi-
ciency of cell seeding is important for tissue engineering, because
an available cell source from patients is limited. Collagen porous
scaffolds with high cell seeding efficiency are desirable. In the
present study, a hybrid porous scaffold was developed by covering
the surfaces of a collagen sponge with a poly(L-lactic acid-co-
glycolic acid) (PLGA, monomer ratio of L-lactic acid to glycolic
acid, 10:90) mesh to protect cell leakage during cell seeding.
At first, a cylinder mold was prepared with VICRYL mesh. And
then collagen aqueous solution was introduced into the cylinder
mold, frozen at 808C and freeze-dried. After that, the collagen
sponge was chemically crosslinked at 378C for 4 h with saturated
glutaraldehyde vapor and immersed in glycine solution to inacti-
vate residual aldehyde groups. After being washed with water and
freeze-dried, the leak-proof hybrid scaffold was obtained.
The hybrid scaffolds were used for culture of human mesen-
chymal stem cell and chondrocyte. The cell seeding efficiency was
higher than 85%. SEM observation demonstrated that the cells
were distributed homogeneously in the scaffolds. Besides the cell
leak-proof effect, the hybrid scaffolds showed higher mechanical
strength than the non-wrapped collagen sponge. The hybrid scaf-
fold will be useful for tissue engineering.
(OP 10) A Possible Role of Fibrin-E from Degradation of
Fibrin-Based Scaffolds for Recruitment of Endothelial Pro-
genitor Cells?
J.F. Dye1, F. Caiado2, Y. Di1, S.C. Dann1, F.C. Edwards1,
E.A. Clayton1, S.J. Dias2
1RAFT (Restoration of Appearance and Function Trust)
2CIPM, Instituto Portugueˆs de Oncologia Francisco Gentil, Centro
Regional de Oncologia de Lisboa, Portugal
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Exploitation of extracellular matrix molecules and mechanisms is
an obvious way to seek improved functionality of biomaterials for
scaffolds. We previously identified fibrinogen based matrices as
pro-angiogenic in an in-vitro 3D gel migration assay, compared to
collagen. Specifically, endothelial cells interact with fibrinogen or
fibrin-E degradation fragments via RGD motifs and alpha-v in-
tegrins. Therefore fibrinogen might be used to form a rapidly vas-
cularised scaffold material. In vivo evaluation of fibrinogen-based
scaffolds shows a rapid cellularisation and neovascularisation by
a process of vasculogenesis within the scaffold. Collagen-based
scaffold is populated more slowly and appears vascularised by
angiogenesis.
Because endothelial progenitor cells have been found to accel-
erate dermal wound healing, fibrinogen or fibrin-E covalently
coated surfaces were used as substrata for attachment and expan-
sion of EPC clones from human umbilical cord blood, in compar-
ison to gelatin. Initial results demonstrated effective attachment of
EPC to fibrin-based surfaces and subsequently showed a more rapid
rate of expansion than cultures on gelatin. By contrast, EPC fail to
attach to native collagen. A phenotypic analysis of EPC isolated
from each surface showed that cells on fibrinogen-based surfaces
had a stronger expression of MMP9, which is required for migra-
tory activity.
This is the first demonstration of specific effects of fibrinogen
molecules on EPC recruitment. This data suggests a mechanism
which could be involved in the rapid vasculogenesis within pro-
totype fibrinogen-based scaffolds, supplemental to or orchestrating
endothelial cell stimulation. Understanding and controlling EPC
function in tissue regeneration could guide scaffold design for
wound healing and tissue engineering.
(OP 11) A Tissue Engineered Osteochondral Composite: An
In Vitro Study
G.M. Peretti1,2, C. Scotti3, L. Mangiavini2, C. Sosio2, A. Pozzi2,
F. Vitari4, C. Domeneghini4, G.F. Fraschini2
1Faculty of Exercise Science, University of Milan
2Department of Orthopaedics and Traumatology, University Vita-
Salute San Raffaele Milan
3Recidency Program in Orthopaedic and Traumatology I, Uni-
versity of Milan
4Department of Veterinary Sciences and Technologies for Food
Safety, Faculty of Veterinary Medicine, University of Milan
The purpose of this work is to create an in vitro model of tissue
engineered osteochondral composite by combining a cylinder of
calcium phosphate and a neocartilaginous tissue produced by
isolated swine articular chondrocytes embedded in fibrin glue.
Swine articular chondrocytes were enzimatically isolated and
embedded in a fibrin glue gel. Immediately before gel polymeri-
zation, fibrin glue was placed in contact with the calcium phosphate
scaffold. Osteochondral composites were left in standard culture
conditions and retrieved after 1 and 5 weeks. At the end of each
experimental time, samples were macroscopically analyzed, pro-
cessed for histological (ematoxylin-eosin, safranin-o), immuno-
histochemical (collagen type I, type II) and biochemical evaluation
(DNA, GAGs).
Data showed a macroscopic integrity of the osteochondral
samples. Histology showed cartilage like tissue maturing within
the fibrin glue scaffold. GAGs seemed to penetrate microscopically
into the scaffold, determining an interface area of microscopic
integration between the porous of the scaffold and the cellular
fibrin glue. Immunohistochemical analysis demonstrated the
presence of type II collagen fibers. Biochemical assays confirmed
the presence of vital cells, and production of GAG matrix.
The results of this study demostrate that isolated chondrocytes,
seeded onto fibrin glue, produce cartilage-like matrix that inte-
grates with a cylinder of calcium phosphate. We noticed micro-
scopic penetration of the newly synthesized GAGs inside the
structure of the calcium phosphate, confirming the importance of
an in vitro maturation of the engineered tissue.
This tissue engineered osteochondral composite could represent
a valuable model for further in vivo studies on the repair of os-
teochondral lesions.
(OP 12) A Tissue-Engineered Tendon Scaffold
P.W. Whitlock1, T.L. Smith1, J.S. Shilt1, G.G. Poehling1,
M.E. Van Dyke2
1Department of Orthopaedic Surgery, Wake Forest University
Health Sciences, Winston-Salem, NC 27157
2Wake Forest Institute for Regenerative Medicine, Wake Forest
University Health Sciences, Winston-Salem, NC 27157
A tissue-engineered tendon has the potential to significantly im-
prove the treatment of tendon and ligament injuries. The goal of this
study was to employ a simple process that combines decellular-
ization and chemical oxidation to decellularize and modify the
dense architecture of the tendon allograft to produce a scaffold
capable of efficient cell seeding in vitro and more rapid remodeling
in vivo. Flexor digitorum profundus (FDP) tendons were harvested
from chickens. Tendons were trypsinized, decellularized and oxi-
dized using an aqueous solution containing Triton X-100 and
peracetic acid, then extensively rinsed. Cellularity, DNA content,
cell compatibility, mechanical properties, cell infiltration in vitro
and in vivo were determined using samples pre- and post-treatment.
Post-treated samples had less cellularity by H&E, less DNA con-
tent, and increased porosity by SEM. Cells were compatible with
the post-treated samples as measured using the MTS and neutral red
assays. The elastic modulus and maximum stress at break were
decreased in post-treated scaffolds, but statistical significance was
not reached. In vitro, cell penetration into the interfascicular re-
gions of the post-treated scaffold was observed. Host cell infiltra-
tion was also observed as early as 3 days after subcutaneous
implantation. An increase in host cell infiltration was observed at
21 days. No evidence of a gross inflammatory reaction or capsule
formation surrounding the post-treated scaffold was observed at
the time of explantation.
(OP 13) Adipose Derived Stem Cells can Enhance Bone Re-
generation in a Rabbit Skull Critical Defect
C. Di Bella1,2, P. Farlie3, A. J. Penington2
1Bone Regeneration Laboratory, Rizzoli Orthopaedic Institute,
Bologna, Italy
2Bernard O’Brien Institute of Microsurgery, Melbourne, Australia
3Murdoch Children’s Research Institute, Craniofacial Develop-
ment, Melbourne, Australia
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Repair of substantial cranial defects in adults and children may be
compromised due to limitations in donor bone stocks for autolo-
gous grafts. We evaluated the capability of autologous adipose
derived mesenchymal stem cells (ADSC) in combination with
Poly-Lactic Acid (PLA) scaffolds to regenerate bone in a critical-
sized skull defect. Thirty adult New Zealand White rabbits were
divided into 6 groups of 5 animals each consisting of: 1) PLA alone
(control); 2) Fibronectin-coated PLA; 3) PLA with ADSC;
4) Fibronectin-coated PLA with ADSC; 5) PLA with osteogeni-
cally induced ADSC (osADSC), and 6) Fibronectin coated PLA
with osADSC. All the animals were sacrificed after 6 weeks. X-
Ray, histology and histomorphometric analysis were performed in
order to evaluate the new bone formation inside the PLA scaffold.
Radiographically and histomorphopmetrically, the groups in which
the PLA was not fibronectin coated showed no bone formation in
contrast to the fibronectin coated groups; the group treated with
osteo-induced ADSC and fibronectin showed significantly more
bone formation than the group treated with undifferentiated ADSC
and the group treated without cells. These data indicate that the
surface treatment with fibronectin permits cell attachment and
survival within the scaffold, and that autologous, osteo-induced
adipose-derived stem cells can regenerate bone if seeded into a
surface-treated PLA scaffold.
(OP 14) Alginate Film as a Tissue Adhesion Barrier
W.J Cho1, S.H. Oh1, J.H. Lee1
1Hannam University
Adhesion formation is a well-known complication of abdominal
surgery, which not only renders future operations more difficult but
also is the most common cause of small bowel obstruction, female
infertility, and chronic debilitating pain. In order to reduce post-
surgical adhesion formation, physical barrier to isolate the trau-
matized tissue from surrounding organ was commonly used. It
should have adhesiveness in injured site, biodegradibility, me-
chanical strength and flexibility for handling. Various natural and
synthetic polymer sheets or membranes have been developed as
non-absorbable or absorbable physical barriers, however, their
loose contact with applied tissue needed for sutural fixation. It has
been also reported that a variety of polymer solutions or gels such
as hyaluronic acid, dextran, polyvinylpyrolidone, carboxymethyl
cellulose and polyethylene glycol were used to prevent tissue ad-
hesion. However, their easy washing out before the healing of
injured tissues are still remained as a critical limtation.In this study,
we prepared an alginate film to estimate its potential use as an
abdominal adhesion barrier. We expected that the non-crosslinked
alginate film can have good anti-tissue adhesion property, owing to
its good mucoadhesiveness with injury site (inhibition of film
migration without suturing) and low tissue affinity of slowly sol-
ubilized alginate in the body (prevention of tissue adhesion). The
in vivo animal study using a rat model was carried to evaluate the
anti-tissue adhesion effect of the prepared alginate film. It was also
compared with those of crosslinked alginate film, alginate solution,
and commercialized anti-adhesion membrane (InterceedTM).
(OP 15) Amniotic Fluid-Derived Stem Cells for Regenerative
Medicine Therapies
J.J. Yoo1
1Wake Forest Institute for Regenerative Medicine, Wake Forest
University Health Sciences, Winston-Salem, NC 27157
Cell sourcing for tissue engineering remains a major challenge for
clinical translation of regenerative medicine therapies. Stem cells
represent an alternative source of cells in instances where differen-
tiated cells can not be expanded in vitro. Human amniotic fluid has
been used in prenatal diagnosis for more than 70 years. It has been
demonstrated to be a safe, reliable, and simple screening tool for a
variety of developmental and genetic diseases. A subset of cells in
amniotic fluid has been shown to have stem cell properties and ex-
press stem cell markers. Amniotic fluid stem (AFS) cells are capable
of maintaining prolonged undifferentiated proliferation as well as of
differentiating into multiple tissue types that encompass the three
germ layers (mesenchymal, ectodermal and endodermal). These cells
show a high self renewal capacity (>300 population doublings) and
clonal growth capability, but unlike embryonic stem cells, they do
not require a feeder layer and do not form teratomas when injected
in vivo. These findings indicate that amniotic fluid may have in-
creased utility than as a diagnostic tool and may become a preferred
therapeutic cell source for a multitude of congenital and adult dis-
orders.
(OP 16) An Oscillatory, Perfused Bioreactor for Cell and
Tissue Culture
M. Moretti1,2,3, M.Y. Cheng1, J.W. Nichol1, L.E. Freed1
1Harvard-MIT Division of Health Sciences and Technology,
Massachusetts Institute of Technology, Cambridge, MA, USA
2I.R.C.C.S. Galeazzi Orthopaedic Institute, Milano, Italy
3Department of Structural Engineering, LaBS, Politecnico di
Milano, Italy
Bioreactors can: (i) maintain viability of harvested cells prior to
transplant, (ii) seed cells onto porous 3D scaffolds, and (iii) en-
hance tissue regeneration, by providing physiologic culture con-
ditions and convective-diffusive mass transport. A single device
complying with these specifications is an oscillating perfused
bioreactor wherein 1 to 12 gas-permeable chambers are stacked on
an incubator–compatible base that provides bi-directional flow
of culture medium at a controllable rate (~0.40 to 5.0 mL/min;
~0.20 to 2.7 mm/s). This bioreactor was validated for cells cultured
in suspension and on 3D scaffolds (hyaluronic acid-based non-
wovens or sponges; collagen sponges). Suspension culture was
demonstrated by inoculating primary heart cells into chambers.
Bioreactors yielded higher (48 5%) cell viabilities than orbitally
mixed or spinner flask controls on culture day 8. Perfusion seed-
ing and culture was demonstrated by inoculating chondrocytes
into chambers containing porous scaffolds. Bioreactors yielded
more spatially uniform cell distributions and higher DNA/
construct (p< 0.001) than static controls on day 4, and enchanced
cartilaginous matrix production to yield thicker contructs than
static or spinner flask controls (p< 0.001) on day 14. Perfusion
culture after seeding was demonstrated after hydrogel entrapment
of heart cells within porous scaffolds. Bioreactors yielded more
aerobic cultures (lactate produced/glucose consumed, p< 0.05),
higher cell viability (p< 0.01), and lower apoptosis (p< 0.01)
than static controls. Moreover, heart cell elongation was observed
only in bioreactors. In conclusion, an oscillatory perfused bioreactor
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preserved viability of freshly harvested cells and enhanced in vitro
regeneration of tissue engineered cartilage and myocardium in the
context of a modular, scalable, customizable system.
(OP 17) Application of an Autologous Mixture of Platelet Rich
Plasma, Endothelial Progenitor Cells and Keratinocytes Pro-
motes Matrix organisation, Neo-vascularisation and Reepithe-
lialisation in Porcine Full Thickness Wounds.
S. Dickens1, P. Vermeulen1, B. Hendrickx1, S. Van den Berge1,
J.J. Vranckx1
1Dept. of Plastic & Reconstructive Surgery—Laboratory of Plastic
Surgery and Tissue Engineering Research
In search for an autologous vascularised skin construct, we treated
full thickness wounds (FTWs) with a mixture of basal cell kera-
tinocytes (KCs) and endothelial progenitor cells (EPCs) embedded
in platelet rich plasma (PRP). This autologous gel functions as a
guiding scaffold and a source of growth stimulating factors.
We cultivated autologous basal KCs in low serum conditions
and expanded autologous EPCs from the internal jugular vein.
FTWs (n¼ 55) were created on the back of in total 4 pigs, covered
with transparent flexible wound chambers and randomly assigned
to: 1. Saline; 2. PRP; 3. PRPþKCs; 4. PRPþEPCs; 5. PRPþ
KCsþEPCs. All wounds were biopsied (day 8) to measure neo-
vascularisation (lectin BS-I, aSMA and MT1-MMP), matrix de-
position (fibronectin and collagen I/III) and reepithelialisation.
Wound fluids, aspirated daily, were analysed for protein expression.
All EPC treated wounds showed 6–8 times more vascular
structures compared to saline (p< 0.001). Addition of PRP to EPCs
further improved neo-vascularisation, confirmed by higher lectin,
aSMA and MT1-MMP. All PRP treated groups showed higher
collagen I/III deposition (p< 0.05) and a higher fibronectin content
(p<0.001). PRP treated wounds exhibited higher concentrations
of pro-angiogenic growth factors in wound fluid samples. Appli-
cation of PRPþKCs resulted in highest reepithelialisation rates
compared to saline (p< 0.001).
In this porcine FTW model, PRP acts as a supportive biomatrix,
creating a more developed vascular network, improving extracel-
lular matrix organisation and leading to accelerated reepitheliali-
sation. Addition of EPCs further enhanced the pro-angiogenic
properties of this matrix.
We currently use this template in our ‘MilleFeuille’ autologous
tissue engineering protocols to create laminated vascularised tissue
layers.
(OP 18) Application of Fluorescence Techniques to the Study
of Protein Adsorption and Packing on Biomaterial Surfaces
J. Benesch1,2, G. Hungerfod3, K. Suhling3, C. Tavares4, J.A. Le-
witt3, J.F. Mano1,2, R.L. Reis1,2
13B’s Research Group—Biomaterials, Biodegradables and Bio-
mimetics, Department of Polymer Engineering, University of
Minho, Braga, Portugal
2IBB–Institute for Biotechnology and Bioengineering, PT Gov-
ernment associated lab, Braga, Portugal
3Physics Department, King’s College, London, United Kingdom
4Physics Department, University of Minho, Guimara˜es, Portugal
The ways proteins compete for the surface of biomaterials and
change conformation are believed to be important for the host re-
sponse to implants. It is possible to elucidate information on
packing and any induced conformational change by making use of
different fluorescence techniques on fluorescently labelled proteins.
Employing probe-probe resonance energy transfer (RET) allows
inter and intra protein interactions to be distinguished. Homo res-
onance energy transfer (hRET) avoids many problems with having
two different probes and means that labelling and subsequent pu-
rification can be done in one step.
In this study we made use of both steady state and time-resolved
fluorescence techniques and imaging to study FITC (fluorescein
isothiocyanate) tagged BSA (bovine serum albumin) adsorption to
various (fluorescent) polymeric biomaterials (poly-caprolactone,
starch polycaprolactone and starch ethylenevinylalcohol) using ti-
tania coated glass as a control. With the combination of both steady
state anisotropy and lifetime methods applied on different dilutions
(labelled:unlabelled and label:protein) of FITC-BSA differences in
packing on the surfaces was determined. The anisotropy data in-
dicated inter protein hRET, more clearly on the control. Dilution of
over-labelled proteins in unlabelled seems to be easiest way to
make sure the signal is from intraprotein interactions, but polymer
autofluorescence requires addressing.
Acknowledgement: Portuguese Foundation for Science and
Technology, project PROTEOLIGHT (PTDC/FIS/68517/2006)
and J.B. grant SFRH/BPD/17584/2004. European Union NoE
EXPERTISSUES (NMP3-CT-2004-500283) and European Union
FP6 STREP project HIPPOCRATES (NMP3-CT-2003-505758).
(OP 19) Articular Chondrocytes Culturing Conditions: Opti-
mization and Drawbacks for Cartilage Resurfacing Attempts
P. Giannoni1, R. Narcisi1, S. Scaglione1, M. Parodi1, A. Mur-
aglia2, R. Cancedda3, R. Quarto1
1Stem Cell Laboratory; Advanced Biotechnology Center; Genova;
Italy
2Biorigen s.r.l.; Genova; Italy
3Laboratory of Regenerative Medicine; D.O.Bi.G.; University of
Genova; and Natl. Cancer Research Institute; Genova; Italy
Cell-based cartilage resurfacing requires the ex-vivo expansion of
autologous articular chondrocytes (ACI) and the maintenance of
cell differentiation potentials. Culture conditions have been de-
vised to minimise cellular phenotypic changes, but their clinical
applications have to cope with outcomes-undermining aspects: a)
cell-source biopsies display different physio-pathological condi-
tions; b) defined growth media composition may not be optimal to
establish cartilage repair. We hypothesized that non-frank os-
teoarthitic (OA) chondrocytes could affect ACI outcomes. To this
purpose human cartilage specimens were prepared from 65–75
year-old donors. Normal and early grade I-OA samples were ex-
amined histologically and used to derive primary cell cultures. OA
chondrocytes showed immunopositivity to MMP-3, negativity to
type II collagen and reduced matrix components in micromass
cultures. We showed that Sox9, a cartilage-specific transactivator,
is prevented from binding its responsive elements on the promoter
of the Cartilage Oligomeric Matrix Protein (COMP) gene, coding
for an extracellular protein. Clearly, a reduced Sox9 availability
minimizes the cell chondrogenic potential. To improve it, OA
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cells were cultured in a serum-free medium (SF) but COMP ex-
pression remained drastically reduced. TGFß-1 supplementation
restored COMP transcript levels, as demonstrated by micro-
array and quantitative PCR. Unfortunately it also reactivated
the chondrocytes endochondral ossification commitment. TGF-
expanded cells showed loss of matrix component; immunores-
ponsivness was evidenced for RAGE, IHH, type-X collagen, ap-
optotic cells, and mineralization, paralleling BCL-2 expression
reduction. Thus peculiar upgrading of the culturing conditions
may be successfully targeted to the rescue of specific deficiencies,
but may be detrimental to the fate of the cell culture in a clinical
situation.
(OP 20) Autologous Nasal Chondrocytes and a Cellulose-
Based Hydrogel for the Repair of Articular Cartilage
Defects.
C. Vinatier1, O. Gauthier1, C. Merceron1, M. Masson1, A. Mor-
eau2, P. Weiss1, J. Guicheux1
1INSERM U791, Laboratory for osteoarticular and dental tissue
engineering, Nantes, France
2Department of anatomo-cytopathology, university hospital,
Nantes, France
Articular cartilage has low capacities for spontaneous repair. To
promote the repair of this tissue, amplification and transfer of au-
tologous chondrocytes using a three-dimensional matrix appear
promising. In this attempt, we have developed a self-setting
and three-dimensional matrix consisting in a silanized cellulose
derivative (Si-HPMC). In previous works, we have shown that
our hydrogel enabled the proliferation of human and rabbit chon-
drocytes, the production of sulfated GAG and the expression of
chondrocytic markers during a three-dimensional culture in vitro.
In parallel, the capacity of our hydrogel to allow the formation of a
cartilaginous tissue in vivo have been determined by transplantation
of human nasal chondrocytes and Si-HPMC in subcutaneous
pockets in nude mice. Therefore, we sought to evaluate the pre-
clinical interest of autologous chondrocyte transplantation with Si-
HPMC in rabbit articular cartilage defects.
After harvesting and amplification during 4 weeks, nasal autolo-
gous rabbit chondrocytes were transplanted with Si-HPMC in
critical-size defects created in rabbit articular cartilage. Implants
were histologically characterized for the presence of sulfated GAG
(Alcian blue staining) and collagen (Masson’s trichrome staining).
The presence of type II collagen was investigated by immuno-
staining.
After a 6-week implantation, histological analysis of implants
revealed the formation of a repair tissue exhibiting a histological
organization similar to that of healthy articular cartilage with
a positive staining for sulfated GAG and total collagen. Immuno-
histological analysis of type II collagen showed that the repair
tissue was hyaline-like cartilage.
Our results indicate that Si-HPMC hydrogel appears a potential
scaffold for the cellular therapy of articular cartilage.
(OP 21) Automated Culture of Umbilical Cord Blood Derived
Progenitor Cells
P. Singh1, R.J. Thomas1, D.J. Williams1
1Healthcare Engineering, Wolfson School, Loughborough Uni-
versity
Umbilical cord blood (UCB) derived mesenchymal stem cells
(MSC) can be differentiated into multiple cell lineages, and are
potential candidates for cell based regenerative medicine ap-
proaches to mesenchymal tissue regeneration. These cells are
particularly attractive due to high proportions of immature pro-
genitors, low immunogenicity and the lack of ethical issues asso-
ciated with their source. Autologous and allogeneic applications
are already apparent for haematopoietic reconstitution and treat-
ment of cardiovascular and neurological disorders. We have
demonstrated the growth of UCB derived CD29þ and CD44þ
adherent cells on a commercial manufacturing scale automated cell
culture platform. Slow growth rates in vitro confirmed that the
development of UC progenitor based cell therapy products may be
problematic, this is exacerbated by absolute low number of pro-
genitor cells in the UCB sample. Overcoming these challenges will
require significant improvement of the cell culture environment
and development of scaleable automated cell culture processes.
The scale and reproducibility of culture on the platform will assist
application of systematic process engineering methods to optimise
UCB derived MSC culture protocols towards levels of production
that are appropriate for therapeutic aims. A further goal will be to
verify the differentiation capacity of these automatically cultured
cells to tissues of mesenchymal origin which can then be used as
a defining end point for the quality of the process.
(OP 22) Automation, Scale-up and Process Engineering: Es-
sentials for Successful Translation of Cell Based Therapies
R.J. Thomas1, A. Chandra1, P.C. Hourd1, D.J. Williams1
1Wolfson School of Mechanical and Manufacturing Engineering,
Loughborough University, UK
The translation of experimental cell based therapies to volume
produced commercially successful clinical products requires the
development of automated manufacturing processes. Automation
removes operator effects to achieve capable and scaleable pro-
cesses that are economic, able to satisfy medicinal product regu-
lators and able to meet the unpredictable demands of the market
place. The authors have successfully transferred a number of
manual human cell culture processes to a manufacturing scale
automated cell culture platform. The automation has also been
used as an experimental platform for the application of factorial
process improvement experiments underpinned by a six sigma
inspired quality engineering approach at manufacturing relevant
scale. Cell lines successfully processed on the automation include
an osteoblast cell line, embryonic carcinoma cell line, primary
bone marrow derived mesenchymal stem cells, primary umbilical
cord derived progenitor cells and human embryonic stem cells. The
human embryonic stem cell culture has been validated over mul-
tiple passages for genetic stability and a panel of surface markers.
Factorial experiments on human mesenchymal stem cells have
shown that cell culture parameters, such as seeding density and
serum concentration, are not independent in their effects on im-
portant markers of cell fate e.g. STRO-1 and ALP. The combina-
tion of systematic methodologies, established process engineering
techniques, and the enabling scale and stability of the automation
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are therefore essential to engineer optimised and cGMP compliant
manufacturing processes for the transition of cell based therapies to
industrial production.
(OP 23) Biaxial-Rotating Bioreactor for Bone Tissue En-
gineering Application—In vitro and In vivo Study
Z. Zhang1,2, C.W. Shin3, F.T. Tien3, C.Y. Cheng3, J. Chan4, S.H.
Teoh1,2,5
1Graduate Program in Bioengineering (GPBE), National Uni-
versity of Singapore, Singapore
2Centre for Biomedical Materials Applications and Technology
(BIOMAT), Department of Mechanical Engineering, Faculty of
Engineering, National University of Singapore, Singapore
3Bioengineering Laboratory, Technology Centre for Life Sci-
ences, Singapore Polytechnic, Singapore
4Department of Obstetrics & Gynaecology, Yong Loo Lin School
of Medicine, National University of Singapore and National
University Hospital, Singapore
5National University of Singapore Tissue Engineering Programme
(NUSTEP), National University of Singapore, Singapore
Aim: The generation of effective tissue engineered bone grafts
requires efficient exchange of nutrients and mechanical stimulus.
Bioreactors provide a manner in which this can be achieved. We
have recently developed a biaxial rotating reactor with improved
fluidics on in-silicon simulation. Here we investigated the perfor-
mance of this bioreactor in proliferation and osteogenic induction
of human fetal mesenchymal stem cell (hfMSC) seeded onto
polycaprolactone-tricalcium phosphate (PCL-TCP) 3D bioactive
scaffolds.
Methods: hfMSC-scaffolds were seeded to 3D scaffold and
cultured in osteogenic medium in our bioreactor or standard static
culture, with assessment of cellular viability, proliferation and
differentiation/mineralization properties. Furthermore, after two
weeks in-vitro culture, hfMSC/scaffolds were implanted subcuta-
neously into NOD/SCID mice to investigate their ectopic bone
formation capabilities.
Result: In-vitro, bioreactor induced hfMSC-scaffolds achieved
confluence within 7 days (while it took 28 days for static culture),
resulted in increased cellularity, cell viability and homogenous
cellular distribution after 28 days culture. In addition, bioreactor
induced hfMSC-scaffolds resulted in higher osteogenic differen-
tiation and mineralization as demonstrated by Von Kossa staining,
calcium deposition assay, alkaline phosphatase assay and micro-
CT analysis. Interestingly, majority of hfMSC were fully differ-
entiated into osteoblast and encapsulated inside mineralized ECM
after 28 days bioreactor culture. In-vivo, two-week bioreactor cul-
ture induced more ectopic bone formation than static culture, as
demonstrated by histological and micro CT analysis.
Conclusion: The use of biaxial rotating bioreactors allows
shorter in-vitro culture, with more efficient osteogenic differenti-
ation of bone tissue-engineered grafts compared to static culture
conditions.
(OP 24) Bio-Molecular Interaction between Fibrin and Lipo-
plexes Results in Extended Release of Plasmid DNA
M. Kulkarni*1, A. Breen1, U. Greiser2, Timothy O’ Brien2,
A. Pandit1
1National Centre for Biomedical Engineering Science, Galway,
Ireland
2Regenerative Medicine Institute, Galway, Ireland
Fibrin has many applications in the clinical field, especially as a
topical delivery system of bio-molecules. The objective of this
study was to develop an efficient, safe, non-toxic delivery system
for sustained release of DNA. The hypothesis was that fibrin will
act as a scaffold that binds to the lipoplexes and release them in a
sustained fashion. Fibrin scaffold was utilized to deliver lipoplexes
encapsulating reporter genes to fibroblasts. Fibrin scaffolds con-
taining pre-formed lipoplexes were incubated at 378C in static
conditions and the supernatant was used to transfect fibroblast cell
lines. The system released only about 1–2% of total DNA during
144 hours of incubation. The lipoplexes released from the scaffold
were successfully utilized for transfections in vitro indicating ab-
sence of degradation of plasmid DNA. In order to understand the
kinetics of this release, we investigated the interaction between the
bio-molecular components of our fibrin-based delivery system
using Surface Plasmon Resonance, a well established method to
obtain kinetic binding profiles [1]. CM3 sensor was used for im-
mobilizing the fibrin components. The binding and kinetic analyses
were carried out according to the manufacturer’s instructions. The
results revealed a sufficiently strong binding between the fibrinogen
and lipid components of the lipoplexes. In conclusion, a pro-
grammed controlled release of lipoplexes from the scaffold was
achieved. Future experiments are aimed at optimizing transfection
efficiencies.
Acknowledgements: Research Frontiers Program, Science
Foundation Ireland
Baxter Healthcare, Vienna
Reference:
1Besenicar, M., Macek, P., Lakey, J. H. and Anderluh, G. Chemistry and
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(OP 25) Bioactive Functionalised Porous Scaffolds as Supports
for Tissue Engineering
J.S. Roman1, M.R. Aguilar1, H. Kirsebom1
1Institute of Polymers, CSIC, CIBER-BBN
Scaffolds able to support and reinforce the growing cells are re-
quired for tissue engineering applications. These scaffolds are re-
quired to be biocompatible, bioactive and porous to be suitable for
cell growth. In order to obtain optimum scaffolds for tissue re-
generation we have prepared new cryogels based on chitosan.
Cryogels are macroporous gels with large interconnecting pores
prepared by polymerizarion in semifrozen state. This structure
enables rapid mass transfer ensuring efficient supply of nutrients
and removal of waste products during cell culturing
Chitosan is a polysaccharide composed of linked D-glucosamine
residues that structurally shares similarities with various GAGs
present in the extra cellular matrix of cartilage. It has a significant
potential as a material for tissue engineering due to its biode-
gradability, low immunological response and positive effect on
wound healing. The cationic nature of chitosan enables ionic in-
teractions while the amine and hydroxyl groups in its structure are
well suited for modifications in order to improve cell adhesion.
This study investigates the preparation of chitosan cryogels
crosslinked with glutaraldehyde. These chitosan cryogels will be
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modified using anionic polymers and/or RGD-containing peptides
in order to improve the properties of chitosan.
(OP 26) Bioactive Nanostructures for Regenerative Medicine
and Cancer Therapies
S.I. Stupp1,2,3,4
1Institute for BioNanotechnology in Medicine, Northwestern
University, Chicago, IL 60611, USA
2Department of Materials Science and Engineering, Northwestern
University, Evanston, IL 60208, USA
3Department of Chemistry, Northwestern University, Evanston, IL
60208, USA
4Department of Medicine, Northwestern University, Chicago, IL
60611, USA
Bioactive nanostructures molecularly crafted to signal cells in vitro
or in vivo have the potential to emerge as the elements of future
therapies to regenerate tissues and cure disease. The chemistry of
such nanostructures should allow them to interact specifically with
cell receptors or intracellular structures. Ideally, they should also
disintegrate into nutrients within an appropriate time frame. The
organization of these nanostructures at larger length scales compa-
rable to cells and large colonies of cells will also be critical to their
function. Our laboratory has developed an extensive family of am-
phiphilic molecules that self-assemble into nanofiber architectures
with capacity to display a large diversity of signals to cells1–5. This
lecture will illustrate the use of nanoscale molecular features in
these systems to regenerate axons in the central nervous system for
spinal cord injuries and other brain disorders, bone, and blood
vessels in cardiovascular therapies. With the appropriate supramo-
lecular design, these nanostructures could also be used as the func-
tional elements in cancer and gene therapies. The lecture will also
demonstrate their future potential to create niches for stem cells in
regenerative medicine as the nanostructures self-assemble across
scales forming constructs with macroscopic dimensions.
References:
1Science 2001, 294 (5527), 1684–1688
2Proc. Natl. Acad. Sci. USA 2002, 99 (8), 5133–5138
3Science 2004, 303, 1352–1355
4Nano Letters 2006, 6 (9), 2086–2090
5Biomaterials 2007, 28(31), 4608–4618
(OP 27) Bioactive Supramolecular Membranes for Tissue
Engineering of Kidney Tubules
P.Y.W. Dankers1,2, J.M. Boomker1, E. Wisse3, A. Huizinga-van
der Vlag1, A.J.H. Spiering3, F.M.M. Smedts4, E.W. Meijer3, M.C.
Harmsen1, A.W. Bosman2, M.J.A. van Luyn1
1Department of Pathology and Medical Biology, Stem Cell and
Tissue Engineering Group, University Medical Center Groningen,
Groningen, The Netherlands
2SupraPolix Research Center, Eindhoven, The Netherlands
3Laboratory of Molecular Science and Technology, Eindhoven
University of Technology, Eindhoven, The Netherlands
4Laboratory of Pathology, Foundation of Collaborating Hospitals
of Eastern Groningen, Winschoten, The Netherlands
The quality of life of patients with chronic renal failure will im-
prove by innovative therapies that can be applied as total kidney
replacement or in adjunct to conventional dialysis. Bioengineered
renal tubules may significantly ameliorate the patients’ health by
regulating removal of uremic toxins, reabsorption of water and
salts, and production of essential hormones. The basement mem-
brane provides essential cues for maintenance of epithelial cell
polarity and tubule integrity. Our major goal is to tissue engineer a
part of the kidney, the renal tubule, by mimicking the basement
membrane using a supramolecular polymer membrane and syn-
thetic extracellular matrix (ECM)-derived peptides. We propose
that a modular, self-assembly approach using ureido-pyrimidinone
(UPy) modified supramolecular building blocks is an exquisite
way to produce such bioactive filters. Supramolecular oligo-
caprolactone UPy-membranes can be easily formed by electro-
spinning from solution. After processing, the materials become
supramolecularly cross-linked by lateral association of the UPy-
dimers. Moreover, bioactive membranes can be prepared without
tedious synthetic procedures but simply by addition of UPy-
modified ECM-peptides, derived from laminin and different col-
lagens, to the UPy-polymer solution to be used for electrospinning.
Viability and function of primary tubule epithelial cells on electro-
spun UPy-membranes with and without ECM-peptides were eval-
uated under static and perfusion culture conditions. Our findings
show that these UPy-membranes provide excellent mechanical
stability, and that formation of a cellular monolayer with polarized
cells and maintenance of cell specific marker expression can be
achieved. Moreover, viability of the cells could be further improved
by incorporating the specific ECM-peptides into the material.
(OP 28) Biocompatibility of a Decellularised Ureteric Scaffold
for Tissue Engineering Small Diameter Vessels.
C. Derham1, T. Khan1,2, J. Ingram1, E. Ingham1, S. Homer-
Vanniasinkam2
1Institute of Medical and Biological Engineering, University of
Leeds
2Leeds Vascular Institute
Introduction: Allogenic vein or artery is not always available for
revascularization. This study investigated the biocompatibility of
an acellular porcine ureteric scaffold (AU) for tissue engineering
vessels.
Methods: Ureters were decellularized by sequential incubation
in PBS, hypotonic Tris buffer [10 mM plus 0.1% (w/v) EDTA,
aprotinin (10 KIU/ml) pH 8.0], 0.1%(w/v) SDS, in Tris buffer
0.1% (w/v) with proteinase inhibitors, nuclease (1 U/ml RNase &
0.5 U/ml DNase) solution and PBS.
Expression of the major xenoepitope a–gal was studied by im-
munohistochemistry and antibody absorption. The cytotoxicity of
the scaffold was determined using standard contact and extract
cytotoxicity tests with porcine endothelial (EC) and smooth muscle
cells (SMC). In order to determine the host response to the scaf-
fold, 0.5 cm2 sections of AU, fresh tissue, and AU treated with a-
galactosidase were implanted subcutaneously into GTKO mice.
Tissues were explanted and examined after one month.
Results: The AU was devoid of a–gal. In contact cytotoxic-
ity assays SMC and EC grew up to and in contact with AU with
no change in morphology. Following incubation with extracts
of AU the ATP content of SMC and EC was not significantly
different from DMEM controls whereas fresh tissue extracts were
toxic.
ORAL PRESENTATIONS 703
Explanted fresh tissues showed a typical host response with
thick capsules (242 mm), CD3þve T-cells and macrophages. The
explants were vacuolated. AU explants had thin capsules (74mm)
and only sporadic CD3þve T-cells The tissue remained intact and
was infiltrated with macrophages, endothelial cells and fibroblastic
cells.
Conclusion: This study demonstrates proof of concept for AU
scaffold in vascular tissue-engineering.
(OP 29) Biocompatible Macroporous Scaffolds can Serve
as Stem Cell Carriers for The Treatment of Spinal Cord
Injury
P. Jendelova1,2, A. Hejcl1, T. Amemori1, P. Lesny1,2, J. Micha-
lek2,3, M. Pradny2,3, E. Sykova1,2
1Institute of Experimental Medicine, ASCR, Prague, Czech Re-
public
2Center for Cell Therapy and Tissue Repair, Charles University,
Prague, Czech Republic
3Institute of Macromolecular Chemistry, ASCR, Prague, Czech
Republic
Spinal cord injury is accompanied by cell death and glial scar
formation that negatively affects regeneration in the injured region.
Extensive research is being done to prevent scarring, to bridge the
lesion and to create an environment permissive for the ingrowth
of tissue elements, e.g. axons, neurons, glia and blood vessels. We
found that biocompatible polymer hydrogels can eliminate scar-
ring and facilitate regeneration within a spinal cord injury; how-
ever, the ingrowing cells comprise mostly connective tissue. We
tested the growth of bone marrow stromal cells (BMSC) and
human or rat olfactory ensheathing glia (OEG) in vitro in bio-
compatible macroporous hydrogels based on copolymers of 2-
hydroxyethylmethacrylate (HEMA) or hydroxypropylmethacril
amide (HPMA). The BMSC or OEG containing hydrogels were
implanted into an acute spinal cord hemisection, and the extent of
tissue regeneration was evaluated after 4 weeks by histology and
immunohistochemistry. Hydrogels based on HEMA and HPMA
copolymers were biocompatible, well tolerated by the spinal cord
and permissive for the growth of both MSC and OEG in vitro. The
tissue formed within both hydrogels was comprised of connective
tissue elements; neural cell processes entered the implants from
both the cranial and caudal borders. The presence of MSC or OEG
increased the number of ingrowing neural cell processes and de-
creased the amount of connective tissue in the implants. Our results
show that seeding polymer hydrogels with cells, such as MSC or
OEG, may augment their regenerative properties within a spinal
cord lesion.
Supported by 1M0538, AVOZ503905703, 309/06/1246 and
1A8697-5.
(OP 30) Biodegradable Poly(Ester-Urethane-Urea)s Based
with Amino Acids for Tissue Engineering and Drug Release
M. Ferna´ndez1, J. Jimenez2, A. Marcos-Ferna´ndez3, A. Lo´pez-
Bravo2, J. San Roma´n3
1F. Farmacia, UCM
2SACYL-CSIC
3ICTP (CSIC)
Non-toxic biodegradable poly(ester-urethane-urea)s with differ-
ent hydrophilic and crystallinity character were synthesized from
poly(e-caprolactone) as macrodiol, L-lysine diisocyanate (LDI)
and ethyl ester L-lysine or L-ornithine as chain extenders, with
different properties. A human embrionary fibroblast primary cul-
ture is used to measure biocompatibility. Cytotoxicity, attachment
and proliferation onto materials were tested using biochemical
methods (MTT, Alamar Blue) and morphological assays (optical
and scaning electronic microscopy-SEM). Low cell citotoxicity is
found for all systems. Cell adhesion and proliferation degree were
strongly dependent of the polyurethane composition, which con-
ditioned their physical/chemical properties.
Hydrophilic/hydrophobic grade, hardness, polycaprolactone mo-
lecular weight; and different aminoacid as chain extender, or com-
ponent molar ratio, modified the cell biological parameters. The cell
adhesion and proliferation are dependent of the chemical composi-
tion, morphology and topography of the PUs membranes and in this
sense, the stiffness of hard and soft blocks, controlled by the amount
and size of PCL blocks affects the cell parameters noticeably.
In vitro biocompatibility results and physical-chemical charac-
teristics showed that these polymers are good candidates as bio-
degradable materials for soft tissue engineering and control release
applications.
The design of the polymer microstructure with the composition
and size of PCL blocks and the application of LDI or ODI diiso-
cianate and aminoacids extenders, often interesting possibilities for
modulating of stiffness of polymeric membranes and scaffolds for
tissue engineering applications in soft and hard tissues.
(OP 31) Bioerodible Polymeric Nanoconstructs for the
Administration of Hydrophobic Bioactive Agents in Tissue
Engineering
C. Errico1, M. Gazzari1, F. Chiellini1, E. Chiellini1
1Laboratory of Bioactive Polymeric Materials for Biomedical
and Environmental Applications (BIOlab)–UdR INSTM, Depart-
ment of Chemistry & Industrial Chemistry, University of Pisa, Via
Vecchia Livornese 1291 56122 S. Piero a Grado, Pisa (Italy)
Successful tissue regeneration cannot always be achieved by the
combination of cells and their scaffold alone. In this cases growth
factor or differentiating agents to promote tissues regeneration are
required.
The goal of this work was to investigate the use of bioerodible
nanoparticles as carrier of retinoic acid (RA), which is known to
induce differentiation of several cell lines into neurons. Due to its
high hydrophobicity and short half-lives in blood, RA parenteral
administration is very difficult and oral formulations are charac-
terized by uncertain drug bioavailability. An organic solvent-free
method, called ‘‘Colloidal-Coating,’’ has been developed for the
preparation of nanoparticles based on a copolymer of maleic an-
hydride and butyl vinyl ether (VAM41) loaded with RA. This
method presents numerous advantages if compared with other
nanoparticles preparation methods: does not entail the utilization
of toxic organic solvents, allows for the preparation of small na-
noparticles with narrow size distribution, it is easy to perform, it is
based on a reversible process which avoid wastes of material in
case of accidental errors during the preparation. The activity of
the encapsulated RA was evaluated on SK-N-SH human neuro-
blastoma cells which are known to undergo inhibition of prolif-
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eration and neuronal differentiation upon treatment with RA.
The activity RA was not affected by the encapsulation and pu-
rification processes. Growth inhibitory effects and morphologic
differentiation into neuronal cell was observed indicating the
suitability of the developed formulation for neuronal regeneration
purposes.
(OP 32) Biologic Scaffold Remodeling and Macrophage
Response in a Rat Model
B. N. Brown1,2, J. E. Valentin1,2, A. M. Stewart-Akers2,3,
S. F. Badylak1,2,3
1Department of Bioengineering—University of Pittsburgh
2McGowan Institute for Regnerative Medicine—University of
Pittsburgh
3Department of Surgery—University of Pittsburgh
Macrophages are characterized as having an M1 or M2 phenotype
based on receptor expression, cytokine and effector molecule
production, and function. Classically activated (M1) macrophages
produce pro-inflammatory cytokines and reactive oxygen inter-
mediates and efficiently present antigen. Alternatively activated
(M2) macrophages produce minimal pro-inflammatory cytokines
and possess the ability to facilitate tissue repair/regeneration.
Effects of macrophage phenotype upon tissue remodeling in the
context of regenerative medicine are largely unknown, but the
phenotypic profile may provide a tool by which constructive tis-
sue remodeling can be predicted/promoted.
The objectives of this study were to determine the effects of
a cellular component (autologous or xenogeneic) within an im-
planted extracellular matrix (ECM) scaffold upon macrophage
phenotype, and to determine the relationship between macrophage
phenotype and tissue remodeling.
Partial-thickness defects in the abdominal wall musculature of
Sprague-Dawley rats were repaired with cellular autologous body
wall tissue, acellular allogeneic rat body wall ECM, cellular xe-
nogeneic pig urinary bladder tissue, or acellular xenogeneic pig
urinary bladder ECM. At 3, 7, 14, and 28 days the host tissue
response was characterized using histologic, immunohistochemi-
cal, and RT-PCR methods.
Acellular test articles elicited a larger M2 response than cellular
test articles and resulted in more constructive remodeling, while
those containing a cellular component, even an autologous cellular
component, elicited a more prominent M1 response and resulted in
deposition of dense connective tissue and/or scarring.
We conclude that the presence of cells does affect macrophage
polarization following implantation of an ECM scaffold, and that
macrophage phenotype is associated with tissue-remodeling out-
come.
(OP 33) Biological Performance of Natural-Based Polymers
for Tissue Engineering Scaffolding
N.M. Neves1,2
13B’s Research Group–Biomaterials, Biodegradables and Biomi-
metics, Department of Polymer Engineering, University of Minho,
Campus de Gualtar, 4710–057–Braga, Portugal
2IBB–Institute for Biotechnology and Bioengineering, PT Gov-
ernment Associated Laboratory, Braga, Portugal
One of the open issues in the Tissue Engineering area is whether
scaffolds are needed at all to regenerate many tissue defects. This
is a fundamental question that may be answered by providing
clear evidence of success by scaffold-less tissue regeneration
strategies. In its absence, many groups within this research com-
munity are focused in the development of scaffold-dependent
strategies.
Natural-based biomaterials have been proposed and explored
to meet the requirements of many applications in the Tissue
Engineering and Regenerative Medicine. Among the important
characteristics of those biomaterials it should be highlighted the
easy biodegradation by normal metabolic pathways, the low cy-
totoxicity and low immunogenic reaction upon implantation and
the myriad of properties obtained by combination of those materials
with other biodegradable polymers. This later strategy has been
pursued in our lab in the quest to obtain scaffolds that effectively
help, assist and drive cells to regenerate connective tissues.
Many sources of cells have been considered for tissue engi-
neering. Embryonic and adult stem cells are among the most
promising to achieve the cell numbers required to have therapeutic
relevance. The ethical and political constraints surrounding em-
bryonic stem cell line derivation led most research efforts to
concentrate in adult stem cells. We have been using adult stem
cells from different sources for bone and cartilage tissue engi-
neering applications.
This presentation will review our latest developments in tissue
engineering of bone and cartilage using natural-based biodegrad-
able scaffolds with relevant cells both in-vitro and in-vivo.
(OP 34) Bioreactor Strategies in Tissue Engineering
I. Martin1, S.A. Riboldi1, D. Wendt1
1Institute for Surgical Research and Hospital Management, De-
partments of Surgery and of Biomedicine, University Hospital
Basel
Over the last decade, we have witnessed an increased recognition
of the importance of 3D culture models to study various aspects of
cell physiology and pathology, as well as to engineer implantable
tissues. Given the crucial role that bioreactors play in establishing
a comprehensive level of monitoring and control over specific
environmental factors in 3D cultures, we review herein the mani-
fold potentialities of bioreactor systems in the translational para-
digm of Tissue Engineering (TE) from bench to bedside. In
particular, we will highlight their functions as:
1) Pragmatic tools for tissue engineers, making up for limitations
of conventional manual and static techniques (e.g., seeding and
culture of cells and engineered constructs), enabling automation
and allowing physical conditioning of the developing tissues;
2) 3D culture model systems, enabling to recapitulate specific
aspects of the actual in vivo milieu and, when properly integrated
with computational modelling efforts and sensing and control tech-
niques, to address challenging scientific questions (e.g. elucidation
of cell function and tissue development mechanisms);
3) Tissue manufacturing devices, implementing bioprocesses so
as to support safe, standardized, scaleable, traceable and possibly
cost-effective production of grafts for clinical use (e.g. automating
conventional cell and tissue culture processes, streamlining graft
manufacturing within centralized and de-centralized production
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facilities, defining and facilitating ‘‘intraoperative engineering’’
approaches).
In conclusion, we will provide evidences that fundamental
knowledge gained through the use of well-defined and controlled
bioreactor systems at the research level will be essential to define,
optimize, and moreover, streamline the key processes required for
efficient manufacturing models.
(OP 35) Bioreactor Technology for Vascular Tissue En-
gineering
Prof. H. Mertsching1, J. Hausmann1
1Fraunhofer-Institut fu¨r Grenzfla¨chen und Bioverfahrenstechnik
(IGB)
Cardiovascular Tissue engineering is a fast evolving field of bio-
medical science and technology to manufacture viable blood vessels,
heart valves, myocardial substitutes and vascularised complex tis-
sues. In consideration of the specific role of the hemodynamics of
human circulation, bioreactors are a fundamental of this field. The
development of perfusion bioreactor technology is a consequence of
successes in extracorporeal circulation techniques, to provide an
in vitro environment mimicking in vivo conditions. The Bioreactor
system should enable an automatic hydrodynamic regime control.
Furthermore the systematic studies regarding the cellular responses
to various mechanical and biochemical cues, guarantee the viability,
bio-monitoring, testing, storage, and transportation of the growing
tissue.
Tissue engineering of complex tissues and organs is limited by the
need of a vascular supply to guaranty graft survival and render bio-
artificial organ function. To overcome this hurdle numerous strate-
gies and bioreactor technologies have been developed. To induce
vessel sprouting and endothelial cell differentiation in vitro and
in vivo a pulsatile hemodynamic flow pattern mimicking physio-
logical conditions are essential. We recently introduce, a unique
biological capillarized matrix (BioCaM) and a PC controlled bio-
reactor system for the generation of complex vascularised tissues.
(OP 36) BMP-12 and BMP-13 Transduced MSCs in Collagen
Type I Hydrogel for ACL Constructs
M. Weber1, J. Stehle1, L. Seefried1, J. Eulert1, U. No¨th1,
A.F. Steinert1
1Orthopedic Center for Musculoskeletal Research, Orthopedic
Clinic Koenig-Ludwig-Haus, University of Wurzburg
Introduction: The anterior cruciate ligament (ACL) ruptures in-
evitably lead to knee instability and premature osteoarthritis. The
current treatments replace the ACL with autologous tendon grafts,
but cannot restore the complex architecture and biomechanics of
the ACL. Therefore our research aims to develop biologically
augmented approaches for primary ACL repair. In this study we
investigate the ligamentogenic potential of human mesenchymal
stem cells (MSCs) transduced with BMP-12 and -13 genes in
collagen hydrogel cultures.
Materials and Methods: MSCs from bone marrow were trans-
duced at confluency with 10, 50, or 100 vp/cell of adenoviral
vectors encoding BMP-12 or -13. Afterwards, genetically-modified
hMSCs were placed in collagen I hydrogels at 3105 cells/200 mL.
After 21 days in culture histochemical, immunohistochemical, and
RT-PCR analyses of the constructs were performed. Control cul-
tures were also maintained that were transduced with equal amounts
of Ad.GFP or remained untransduced.
Results: Histochemical (H&E, Azan, Goldner) analyses of
BMP-12 and -13 transduced hMSCs in hydrogels showed elon-
gated fibroblasts embedded in a ligament-like matrix. BMP-12
overexpression resulted in weak positive stainings for collagen III,
V and elastin, but strong stainings for tenascin and vimentin.
Furthermore, RT-PCR analyses of BMP-12 and -13 cultures
showed high expression of ligament markers such as biglycan,
collagen III and V, decorin, elastin, tenascin, tenomodulin, and
vimentin compared to controls.
Discussion and Conclusion: Gene transfer of BMP-12 and -13
induced a ligament-specific matrix in MSC hydrogel cultures. This
technology might serve as an effective strategy to augment ACL
repair.
(OP 37) Bone Marrow Stromal Cells Recuperate Hepatocyte
Functions in an Acute Liver Injury Model
L.B. Jeng1, T.M. Lin2, H.Y. Chung2, H.H. Chao3, Sophia C.N.
Chang4
1Department of Surgery, China Medical University Hospital,
Taichung, Taiwan
2Department of Medical Research, China Medical University
Hospital, Taichung, Taiwan
3Department of Pediatric Surgery, China Medical University
Hospital, Taichung, Taiwan
4Department of Plastic Surgery, China Medical University Hos-
pital, Taichung, Taiwan
Humans are subject to being exposed to acrolein through the deg-
radation of a variety of compounds including cigarette smoke, auto-
mobile exhaust, and burning oils. In addition, acrolein is a metabolite
of the anticancer drug cyclophosphamide. Allyl alcohol (AA) has
been used in food flavorings and causes a periportal-specific hepa-
tocellular lesion in animal livers. Liver injury is dependent upon
AA’s metabolism to the reactive aldehyde acrolein via alcohol de-
hydrogenase. Bone marrow comprising heterogeneous cell popula-
tions contains certain progenitors with the ability to differentiate into
multiple mesenchymal cell lineages. To identify any differentiation
plasticity of adult bone marrow mesenchymal stem cells (MSCs), we
used AA treated rabbits for acute liver failure model.
The MSCs were aspired and expanded to a cellular concen-
tration of 1108 mL. The rabbits were injected AA intraperito-
neally. Three days after the injection, the MSCs were injected via
portal vein. The control group rabbits were injected with 4 ml of
normal saline under the same condition. The postoperative re-
covery was closely monitored by hepatic function markers.
Within one week, in the experimental group, the AST, A LP,
Billirubin and rGT were reduced significantly. The ALT and al-
bumin level recovered two weeks after. The BUN was better off
one week later.
Whether extracorporeal devices or the transplantation of pri-
mary hepatocytes, stem cells or cells genetically engineered to
over-express key metabolic functions, a proliferative phenotype or
cytoprotective pathways will be best suited to meeting these de-
manding challenges.
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(OP 38) Bone Morphogenetic Protein-2 Delivery Using
Poly(Lactic-Co-Glycolic Acid) Nanosphere for Bone Regen-
eration
O. Jeon1, J. M. Kang2, H. S. Yang2, S. J. Song2, S. H. Bhang2,
S. W. Kang1, B. S. Kim2
1Department of Chemical Engineering Hanyang University, Seoul
133–791, Korea
2Department of Bioengineering, Hanyang University, Seoul
133–791, Korea
Here, we tested two hypothesis; (1) a long-term delivery of bone
morphogenetic protein-2 (BMP-2) would enhance ectopic bone
formation compared to a short-term delivery at an equivalent
dose, (2) human cord blood mesenchymal stem cells (hCBMSCs)
that are not osteogenically differentiated prior to implantation
would regenerate bone extensively in vivo once exogenous BMP-2
was delivered to the implantation site. Heparin-conjugated poly(L-
lactide-co-glycolide) (PLGA) nanospheres (HCPNs) suspended in
fibrin gel (group 1) were developed for a long-term delivery of
BMP-2. Fibrin gel containing normal PLGA nanospheres (group 2)
was used for short-term delivery of BMP-2. The in vitro release of
BMP-2 from group 1 was sustained for four weeks with no initial
burst release. In contrast, 83% of BMP-2 loaded in group 2 was
released only for the first three days. Group 1 induced bone for-
mation to a much greater extent than did group 2 upon implantation
into rat hind limb muscle. On the other hand, undifferentiated
hCBMSCs on BMP-2-loaded scaffolds induce far more extensive
bone formation in mouse calvarial defects than either undifferen-
tiated hCBMSCs or osteogenically differentiated hCBMSCs. These
results show that long-term delivery of BMP-2 enhances in vivo
osteogenic efficacy of the protein compared to short-term delivery
at an equivalent dose, and the BMP-2 delivery could prove in-
valuable for in vivo regeneration of bone from undifferentiated
hCBMSCs.
Acknowledgements: This work was supported by a grant (SC
3220) from the Stem Cell Research Center of the 21st Century
Frontier Program, the Ministry of Science and Technology, Re-
public of Korea.
(OP 39) Bone, Cartilage and Osteochondral Tissue Engineer-
ing Strategies Using Natural Origin Polymers and Ceramics,
Growth Factors and Progenitor Cells
J.F. Mano1,2, J.T. Oliveira 1,2, C.M. Alves1,2, P.B. Malafaya1,2,
R.L. Reis1,2
13B’s Research Group–Biomaterials, Biodegradables and Biomi-
metics, Dept. of Polymer Engineering, University of Minho,
Campus of Gualtar, 4710–057 Braga, Portugal
2IBB–Institute for Biotechnology and Bioengineering, PT Gov-
ernment Associated Laboratory, Braga, Portugal
Tissue engineering (TE) has emerged in the last decade of the 20th
century as an alternative approach to circumvent the existent
limitations in the current therapies for organ failure or replace-
ment. The EU HIPPOCRATES project joined academic and in-
dustrial partners to develop novel products and concepts that can
be used for bone, cartilage or osteochondral TE strategies. Several
issues were addressed including i) the choice and study of adequate
human cell cultures, (ii) the development of culture technology
with which human tissues can be grown ex vivo in three dimen-
sional biodegradable matrices, (iii) the development of a mate-
rial technology with which polymeric matrices can be produced,
being suitable for cell culture (proliferation, differentiation), (iv)
to assess the in-vivo functionality and clinical relevance of
the tissue engineering strategies. In this context, we proposed the
use of a series of natural-based biomaterials, namely polysac-
charides (e.g. starch, chitin derivatives, alginate, carrageenan,
gellan gum) compounded, or not, with synthetic polymers and
ceramics, including calcium phosphates obtained from mineralized
red algae. A series of processing techniques and surface modifi-
cations were used to produce scaffolds with a wide range of po-
rosity and porous architecture and controlled surface features.
Hydrogels, including thermo-responsive injectable systems, were
produced as biodegradable supports and vehicles for cells and
growth factors. Complementary studies were performed to use the
same kind of materials in drug release systems; such information
could be integrated in tissue engineering strategies where growth
factors or differentiation agents could be delivered in a controlled
way to progenitor cells.
(OP 40) Calcium Phosphate Bioceramic Derived from Mi-
neralised Red Algae for Bone Tissue Application by Low
Temperature Exchange
P.J. Walsh1, F.J. Buchanan2, G.M. Walker2, M.J. Dring2, C.A.
Maggs2
1National University of Ireland, Galway
2Queen’s University, Belfast, N. Ireland
There is great need to design functional bioactive substitute
materials capable of surviving harsh and diverse conditions
within the body. Hydroxyapatite (HA) is a well established sub-
stitute material for orthopaedic and dental applications. The lit-
erature suggests that porous HA displays better osteoconductivity.
A recent study by Roy et al [1] concluded that meso-porous
ceramic material significantly improved the percentage of new
bone formation when compared to non-porous ceramic material.
The purpose of our research was to develop a bioceramic from
algal origins suitable for bone tissue application. Corallina offi-
cinalis was selected as the source material for two main rea-
sons (1) it has a high surface area owing to its highly porous
interconnective morphology and (2) it is a magnesium rich
calcite.
Low-temperature hydrothermal synthesis achieved the conver-
sion of Corallina to HA in a simple and cost-effective manner [2].
The resultant material contained a calcium phosphate apatite phase
of approximately 90%, with a pore size of <10 microns and spe-
cific surface area of 124.1 m2/g. This morphology provides an
additional mechanism for cellular activity and offers the potential
for use as a drug delivery system. Furthermore, cell studies show
that the material can support cell growth, thus indicating its bio-
compatibility. These physiochemical properties make this material
an ideal candidate for tissue engineering applications.
Acknowledgements: Supported by the European Union funded
STREP Project HIPPOCRATES (NMP3-CT-2003-505758).
References:
1Roy TD et al, J. Biomed Mater Res. 2003; 66(2): 283–291.
2Walsh et al, ESB, Sorrento, 2005
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(OP 41) Cardiac Commitment of Human Embryonic Stems
Cells: Genetic and Epigenetic Mechanisms
M. Puce´at,1, J. Leschik1, S. Stefanovic1
1INSERM UMR861
Human embryonic stem cells (HUESCs) are derived as their mouse
counterpart from early embryos (i.e. blastocyst stage). Recent
studies using stem cells derived from mouse epiblast suggest that
HUESC represent a slightly later stage of development than mouse
ESC, questioning the molecular mechanisms underlying both their
self-renewal and their specification towards various cell fates.
Herein, we provide evidence that the main genetic and epige-
netic mechanisms that we recently uncovered in mouse ESC and
which drive ESCs toward a cardiac lineage are fully conserved in
HUESCs.
Indeed, the BMP2-dependent canonical cardiogenic pathway is
functional in HUESCs. As one of the earliest element of the genetic
and epigenetic event of this pathway, Oct-4 level of expression is
critical to maintain selfrenewal of ESC or to drive them toward a
mesendodermal fate trough a Sox17 mediated event in both mouse
ESCs and HUESCs. BMP2 switches on a similar pattern of gene
expression in both mouse and HUESCs. A change in the methyl-
ation state of mesodermal and cardiac gene promoters, already
poised to activation, precedes this genetic program. Thus, we re-
port that most of the basic genetic and epigenetic transcriptional
events are fully conserved in HUESCs. BMP2 ensures a tune
regulation of these events to drive HUESCs toward a cardiogenic
fate. Furthermore, activation of the BMP2 pathway allows for
expression of a membrane marker, which turned out to be suitable
to sort out cardiac progenitors, a key step toward the genreration of
a cell product for a secure cell therapy of heart failure.
(OP 42) Cardiovascular Tissue Engineering: Impact of Me-
chanotransduction and Functionalised Electrospun Scaffolds
B. Glasmacher1, A. Szentivanyi1
1Institute of Multiphase Processes, Leibniz University Hannover
In the field of cardiovascular tissue engineering, the need for
functional bioartificial constructs at the time of implantation re-
mains a driving factor for further development. This is due to the
active role of a functional endothelial cell layer in mediating blood
compatibility and preventing adverse reactions. Thus designing a
scaffold to present the correct mechanical and biochemical clues to
cells and mechanically stimulating the construct after seeding are
vital factors to support physiological tissue formation and cell
activity.
Electrospinning offers a unique opportunity to process both
synthetic and biological materials, either in pure form or as a
combination, to generate nanofibrous mats as tissue engineering
scaffolds. The generated fibrous microstructure closely resembles
structures in the native extracellular matrix and can be oriented to
provide tactile clues to influence cell migration and behaviour.
Furthermore, processing different materials in parallel to finetune
the internal microstructure allows a wide range in which to mod-
ulate mechanical and biochemical properties.
To support and guide neotissue formation, mechanical stimu-
lation of the seeded construct up to the point of implantation is
required. This has been recognized by the advent of specialized
bioreactors to reproduce the mechanical stimuli in the cardiovas-
cular environment. However, the effects of individual factors (e.g.
shear rate and oxygenation level) are still not fully understood
especially with regard to their temporal kinetics. Real time mi-
croscopic imaging of cells and their response to changes in their
micromechanical stimulation may help to better define parameters
for stimulation of tissue engineering constructs.
(OP 43) Cartilage Repair with Chondrocytes and a Novel
PLGA-Based Scaffold in a Full Thickness Goat Model
C. Clausen1, M. Lind2, H. Everland3, K. Osther1
1Interface Biotech A/S, Hørsholm, Denmark
2University Hospital of Aarhus, Sportstrauma Clinica Aarhus,
Denmark
3Coloplast A/S, Humlebaek, Denmark
Introduction: Porous scaffolds in combination with cultured chon-
drocytes have demonstrated the best ability to regenerate hyaline
cartilage both experimentally and clinically. This study aims to in-
vestigate the cartilage repair response of a novel methoxypoly-
ethyleneglycol-block-co-poly(lactide-co-glycolide (MPEG-PLGA)
porous scaffold and a fibrin scaffold combined with chondrocytes in
a goat model.
Methods: MPEG-PLGA scaffold was tested in vitro with re-
spect to adhesion and gene expression. 20 adult goats were used
for the in vivo study. Defects were created in both femoral con-
dyles. Cartilage tissue was harvested for chondrocyte culturing.
At secondary open surgery, defects were randomized to four treat-
ment groups; 1. Empty defect 2. Microfracture 3. Fibrin scaffold
with chondrocytes and 4. Fibrin/chondrocyte solution in a MPEG-
PLGA scaffold. Evaluation of the cartilage regeneration in the
four groups was done after 4 months by ICRS macroscopic scor-
ing and histological analyses, using the O,Driscoll and Pinada
scores.
Results: Chondrocytes adhered within the MPEG-PLGA scaf-
fold in vitro and expressed collagen type II and aggrecan. A mi-
gration assay demonstrated the ability of chondrocytes to migrate
within the scaffold.
In vivo scores demonstrated significant difference between
groups. The cartilage regeneration in group 4 demonstrated high
defect fill and tissue characteristic close to hyaline cartilage
whereas no regeneration tissue was observed in empty defects.
Fibrin/chondrocyte and microfracture group demonstrated limited
tissue formation.
Conclusion: MPEG-PLGA scaffold containing chondrocytes
demonstrates extensive cartilage regenerative response. Fibrin
scaffold with chondrocytes and microfracture stimulated only
limited cartilage repair. MPEG-PLGA scaffold in combination
with chondrocytes seems to be a good technique for cartilage tissue
engineering.
(OP 44) Cartilage Tissue Engineering Using a Flow Perfusion
Bioreactor
M. Alves da Silva1,2, A. Martins1,2, P. Costa1,2, V. M. Correlo1,2,
P. Sol1,2, M. Battacharya3, N. Rougier4, R. L. Reis1,2,
N. M. Neves1,2
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3Department of Biosystems Engineering, University of Minnesota,
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4Research and Development Department, Biopredic International,
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Joint diseases include several conditions that have great impact on
society, such as rheumatoid arthritis or osteoarthritis. Tissue en-
gineering is one of the most promising alternatives to overcome the
low capacity of cartilage self-repair in those debilitating diseases
context.
Chitosan-polybutylene succinate (C-PBS) scaffolds have been
studied for their suitability for cartilage tissue engineering. Pre-
vious works have shown that these scaffolds support chondrocytes
primary cultures, its growth and ECM production. C-PBS fiber
meshes were produced by fiber extrusion, followed by hot com-
pression, producing a 3D non-woven mesh of variable pore size.
These fiber meshes were used for supporting human mesenchymal
stem cells (hMSCs) chondrogenic differentiation.
hMSCs isolated from human bone marrow were expanded until
passage 2. Afterwards, 1 million cells were statically seeded in
each C-PBS fiber mesh, in a total of 20. Then, constructs were
transferred to a flow perfusion bioreactor. Perfusion rate was
0,1 mL/h per scaffold. Constructs were cultured for 28 days, with
chondrogenic differentiation medium. Differentiation was evalu-
ated by SEM, histology and immunolocalisation of collagens.
Preliminary results indicate that cells are able to proliferate and to
differentiate into chondrocytes, at 14 days of culture. Results in-
dicate that C-PBS fiber meshes are able to support hMSCs chon-
drogenic differentiation and extracellular matrix production.
Acknowledgments: Portuguese Foundation for Science and
Technology (PhD Grant to M. Alves da Silva, SFRH/BD/28708/
2006). European IP Genostem (LSHB-CT-2003-503161) and Eu-
ropean NoE EXPERTISSUES (NMP3-CT-2004-500283).
(OP 45) Cartilage Tissue Engineering–Innovative Scaffold
Design and New Structural Characterization Methods
C. Brochhausen1, R. Zehbe2, S.Grad3, H. Schubert2, M. Alini3,
A. Haibel4, C. J. Kirkpatrick1
1REPAIRlab, Institut of Pathology, Johannes Gutenberg-
University Mainz, Germany
2Institute of Materials Science and Technologies, TU Berlin,
Berlin, Germany
3AO Research Institute, Davos, Switzerland
4GKSS Research Centre at DESY, Petra III, Hamburg, Germany
Aims: Modern tissue engineering solutions use scaffolds, cells and
growth factors. We present an innovative oriented scaffold con-
cept. For three dimensional characterization we used a new method
and compared the data with histomorphological techniques.
Methods: Scaffold design: Scaffolds were synthesized using a
freeze structuring procedure. Gelatine from porcine skin was dis-
solved and partly amended by previously synthesized PLGA mi-
crospheres for release of signalling molecules. The solutions were
directionally frozen, freeze-dried and chemically cross-linked in
aldehyde-saturated atmosphere followed by detoxification. Cell
culture: Bovine chondrocytes were cultivated on different scaffold
modifications. After 8 days histology and histochemistry were
performed.
Three-dimensional characterization: The three dimensional
structure as well as the cell and microsphere distribution were
analyzed by synchrotron-generated X-rays (SR-mCT) without any
metal labelling using the Berlin synchrotron facility BESSY.
Results: After 8 days the chondrocytes maintained a chon-
drocytic phenotype, with synthesis of extracellular matrix as
shown by alcian blue staining. The three dimensional character-
ization of the scaffold by SR-mCT revealed the orientation of the
scaffold fibres and the homogeneous distribution of PLGA mi-
crospheres in the scaffolds. Furthermore, the detection of single
cells and their distribution in the scaffold could be demonstrated
and was in correspondence with the histological data.
Conclusions: Our scaffold concept offers innovative opportu-
nities for chondrocyte culture in an oriented structure, imitating the
fibre arrangement in articular cartilage. SR-mCT represents a high
resolution three-dimensional imaging method showing cells, scaf-
folds and microspheres, without disturbing the structural integ-
rity of the cell-scaffold construct, and in correspondence with the
histological data.
(OP 46) Cell Encapsulation in Thermoresponsive Chitosan
Based Hydrogels for Cartilage Tissue Engineering
H. C. Lima1,2, J. V. Arau´jo1,2, N. M. Neves1,2, J. F. Mano1,2,
R. L. Reis1,2
13B’s Research Group–Biomaterials, Biodegradables, and Bio-
mimetics, University of Minho, Campus de Gualtar, 4710–057
Braga, Portugal.
2IBB—Institute for Biotechnology and Bioengineering, PT Gov-
ernment Associated Laboratory, Braga, Portugal
The repair of articular cartilage is still a challenging medical
problem and there is a need for the development of a clinically
useful cartilage tissue engineering strategies. A variety of materials
have been suggested for cartilage engineered repair, and injectable
hydrogels are among the most promising alternatives.
This work aimed the exploration of the suitability of chitosan/
glycerol-phosphate/hydroxyethyl cellulose (CGP) hydrogel as
scaffold for cell encapsulation, using ATDC5 cells (murine chon-
drogenic cell line) to produce cartilage-like tissue trough tissue
engineering approach.
A high cell density was encapsulated within the CGP hydrogel
and cultured for up 28 days. The MTS and DNA assays suggest
that CGP hydrogel neither altered cell viability nor proliferation
in three-dimensional culture. The constructs were histologicaly
characterized by H&E staining which revealed that the cells were
uniformly distributed within the hydrogel, they adopted a rounded
morphology, and formed characteristic lacunae around each cell
in the hydrogel. Toluidine Blue and Safranin O stainings also sug-
gest an abundant accumulation of GAG in the extracellular matrix
surrounding the ATDC5 cells cultured in 3D into CGP hydro-
gels, after 4 weeks of culture. The results also evidence an increase
in the synthesis of GAG observed by the DMB quantification assay.
The results confirm the potential of the CGP hydrogel as carrier
and support for chondrocyte-like cells. CGP hydrogel induces and
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supports a stable chondrocytic phenotype of ATDC5 cells in vitro,
by promoting the expression of cartilage-specific markers and the
accumulation of cartilage-specific extracellular matrix, and thus
showing promising properties for cartilage regeneration.
(OP 47) Cell Sheet Engineering for Clinical Application
T. Okano1
1Institute of Advanced Biomedical Engineering and Science,
Tokyo Women’s Medical University
Ideal tissue engineering therapy should be achieved by cell and cell
sheet manipulation engineering that would be established with the
following three core technologies: first, the noninvasive harvest
of cultured cells and cell sheets are realized with our developed
temperature-responsive culture dishes. The surfaces are hydro-
phobic at 378C, but change to hydrophilic below 328C. Various cell
lines adhere, spread and proliferate on the surfaces similarly to
those on commercial tissue culture dishes. Only by reducing tem-
perature, cells spontaneously detached from the surfaces without
the need for trypsin. Confluent cells are also recovered as a single
contiguous monolayer sheet with deposited extracellular matrix.
Second, the harvested viable cell sheets can be transferred to other
surfaces (2D cell sheet manipulation) because the extracellular
matrix associated with the basal side of cell sheets shows adhesion.
Thus, tissue regeneration with cell sheet tissue engineering can be
accomplished either by transplantation of single cell sheets, as with
skin, cornea and periodontal ligaments. Finally, the recovered cell
sheets can be stratified to reconstruct complex stratified tissue ar-
chitectures such as liver lobule, kidney glomeruli, and cardiac
patches (3D cell sheet manipulation). For example, layered cardi-
omyocyte sheets harvested from temperature responsive dishes
pulsate simultaneously and show diffuse gap junction formation.
When transplanted into the subcutaneous tissues of nude rats,
spontaneous beatings could be macroscopically observed after 3
weeks and maintained for over 1 year. We believe that these 2D and
3D cell manipulations, cell sheet tissue engineering, will become
new revolutionary tools for tissue engineering.
(OP 48) Characterization of Early Cardiac-Specific Transcripts
in Embryonic Stem Cell-Derived Multilineage Progenitors—A
Transcriptional Profiling Study
S. Schmitteckert1, H. Schulz2, N. Huebner2, A.M. Wobus3,
A. Rolletschek1,3
1Institute for Biological Interfaces, Forschungszentrum Karlsruhe
GmbH, Hermann-von-Helmholtz-Platz 1, D-76344 Eggenstein-
Leopoldshafen
2Max-Delbrueck Center for Molecular Medicine, D-13125 Berlin,
Robert-Roessle-Str.10
3In Vitro Differentiation Group, Leibniz Institute (IPK) D-06466
Gatersleben, Corrensstr. 3
During in vitro differentiation, embryonic stem (ES) cells reca-
pitulate cellular developmental processes and gene expression
patterns of early embryogenesis. Here, we characterize early stages
of cardiac differentiation of mouse ES cells. ES cells were cultured
as embryoid bodies (EBs) for 5 days (d). After plating EBs were
spontaneously differentiated for 9d into a multilineage progenitor
population representing cells of all three primary germ layers in-
cluding early cardiomyocytes. To investigate this stage of multi-
lineage progenitors and of early cardiac cell types at the transcript
level, microarray analysis was performed using Affymetrix chips
comparing undifferentiated ES cells and 5þ 9d progenitors fol-
lowed by RT-PCR analysis. Transcript levels of transcriptional
regulators (e.g. Tbx20, GATA4, Pitx2), extra-cellular matrix
components (e.g. procollagens I, III, IV, MMPs), and cytoskeletal
proteins (troponins T2 and C, cardiac alpha actin) involved in
cardiac differentiation and function were found to be up regulated.
Specifically, we detected a subset of up regulated transcripts of
genes known to be specifically expressed in the cardiac neural crest
or its derivatives. mRNA levels of transcription factors Hand1 and
Hand2, known to control cardiomyocyte-specific gene expression
through interaction with other transcription factors, and the neural
crest-specific genes Mef2c, Id2, Lbx1, Efnb1, and Sema3c were
clearly up regulated at this early stage of cardiogenesis. Also, the
presence of the signaling molecule TrkC in this population sug-
gests the involvement of neural crest-specific genes at an early
stage of cardiac differentiation. Immunocytochemistry is presently
performed to analyse the potential role of cardiac neural crest cells
in early ES-derived cardiogenesis.
(OP 49) Characterization of Novel Tissue Engineered Vas-
cular Grafts in a Murine Model
T. L. Mirensky1,2, C. K. Breuer1,2
1Yale New Haven Hospital
2Yale University School of Medicine
Cardiovascular disease is a leading cause of morbidity and mor-
tality in developed countries. Surgical options remain restricted
secondary to the limitations of prosthetic vascular grafts or inac-
cessibility of adequate autologous vessels. Although large animal
studies have greatly facilitated the development of tissue-
engineered vascular grafts, little is known about the molecular and
cellular mechanisms underlying the remodeling processes of these
grafts. Using sub-1 mm tissue engineered vascular grafts composed
of biodegradable poly-L-lactic acid scaffolds statically seeded with
human aortic smooth muscle cells and human endothelial cells
which were implanted into immunodeficient female SCID/bg
mice, we were able to characterize cellular (histologic) composi-
tion of the grafts at various time points and evaluate progression of
graft structure throughout the graft remodeling phase. Thirteen
mice received our tissue-engineered grafts as infra-renal aortic
interposition grafts. The mice were followed to early time points
(4–18 days) as well as later time points (8–30 weeks). Histologic
evaluation of the grafts using species specific cellular markers
revealed replacement of the human seeded endothelial cells with
those of murine origin. By 8 weeks, there was evidence of sub-
endothelial exracellular matrix protein deposition with active re-
modeling and layering of cellular deposits resembling those of
native mouse aorta. Additionally, all grafts remained patent and
without rupture throughout the study. Although residual polymer
scaffold was present in all samples, progressive aneurysmal dila-
tion was noted at the later time points. Further understanding of
graft remodeling may enable us to target this process and optimize
the grafts for clinical application.
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(OP 50) Chitosan-Based Hydrogels as Extracellular Matrix
for Cartilage Tissue Engineering: In vitro Biological Evalua-
tion
L. Moreira-Teixeira1, R. Jin2, P. Dijkstra2, J. Feijen2, C. van
Blitterswijk1, M. Karperien1
1Department of Tissue Regeneration, Institute for Biomedical
Technology, Faculty of Science and Technology, University of
Twente, Enschede, The Netherlands.
2Department of Polymer Chemistry and Biomaterials, Institute for
Biomedical Technology, Faculty of Science and Technology,
University of Twente, Enschede, The Netherlands.
Cartilage reconstruction demands for biocompatible materials with
controlled biodegradation. Hydrogels, based on natural polymers,
fulfil these properties. Recently we have developed an injectable
chitosan-based hydrogel and have studied its biocompatibility
in vitro.
Chitosan was made water soluble by the covalent attachment of
glycolic acid with a graft ratio of 43. Phloretic acid was covalently
attached to the chitosan (graft ratio 10) and was used as the
crosslinking moiety. The hydrogels were prepared by enzymatic
crosslinking of the phenol moieties using hydrogen peroxide and
horseradish peroxidase. To evaluate biocompatibility, the polymer
was mixed with 5106 mL bovine primary chondrocytes and ge-
lation was induced. Gelation occurred within 1 minute, under
mild conditions, and resulted in efficient encapsulation of the cells.
The reaction was not associated with cytotoxicity. The gels were
cultured for 21 days in standard chondrocyte culture medium
and cell viability was evaluated using a live-dead assay at 1,7,14
and 21 days. There was no evidence for toxicity over time. Next,
we assessed the cell morphology using SEM-analysis. Results
show the presence of round chondrocyte-like cells and the pro-
duction of extracellular matrix. Biodegradation of the constructs
was assessed by weight loss quantification, up to 28 days in culture.
Hydrogels with encapsulated chondrocytes degrade slower than
control.
In conclusion, our data show efficient encapsulation of primary
chondrocytes in a chitosan-based hydrogel. The gelation reaction
was fast and not harmful for the cells. Cells retained a chondrocyte-
like morphology and produced extracellular matrix upto 21 days in
culture. This novel chitosan-based biodegradable matrix may have
application in cartilage reconstruction.
(OP 51) Chitosan/Soy-Based Membranes Enhance Wound
Reepithelialization in Partial Thickness Skin Wounds
T. C. Santos 1,2, A. P. Marques 1,2, S. S. Silva 1,2, J. M. Oliveira 1,2,
J.F. Mano 1,2, A. G. Castro 3, M. van Griensven 4, H. Redl 4,
R. L. Reis1,2
13Bs Research Group-Biomaterials, Biodegradables and Biomi-
metics, Univ. of Minho, Campus de Gualtar, 4710-057 Braga,
Portugal
2IBB–Institute for Biotechnology and Bioengineering, PT Gov-
ernment Associated Laboratory, Braga, Portugal
3Institute of Health and Life Sciences, School of Health Sciences,
University of Minho, Campus de Gualtar, 4710-057, Braga, Por-
tugal
4Ludwig Boltzmann Institute for Experimental and Clinical
Traumatology, Donaueschingenstrasse 13, A-1200 Vienna, Aus-
tria
Chitosan-based biomaterials proved to have promising character-
istics for wound dressing and skin regeneration. In the context of
developing new natural-based biomaterials for these applications,
chitosan and soybean-based biomaterials were proposed. These
materials were shown to be non cytotoxic and to impair human
leukocytes activation in vitro. Thus the goal of this study was to
evaluate the in vivo performance of chitosan/soy-based membranes
in the regeneration of partial thickness skin wounds. Excisional
skin wounds were created on the backs of rats and the healing
capacity of chitosan/soy-based membranes was assessed after 1
and 2 weeks. To promote impaired wound healing all rats were
injected with a steroid. After one week, membrane-dressed wounds
showed less granulation tissue formation and the wounds margins
were thinner than in untreated wounds (negative control). Fur-
thermore, in comparison to the positive control (Eppigard), the
chitosan/soy-based membranes were also able to reduce the wound
size and the thickness of the wound limits. A similar trend was
observed 2 weeks after the dressing. The membrane-dressed
wounds were almost closed, although with some contraction, and
with almost no granulation tissue. For both time periods there were
no signs of infection. The observed reepithelialization and en-
graftment between the regenerated tissue and the original skin
reinforces the suitability of the proposed chitosan/soy-based
membranes to be used in skin wound dressing.
Acknowledgements: This work was partially supported by
the European Union funded STREP Project HIPPOCRATES
(NMP3-CT-2003-505758) and was carried out under the scope
of the European NoE EXPERTISSUES (NMP3-CT-2004-
500283).
(OP 52) Chondrogenic Differentiation of Human Embryonic
Stem Cells: Effects of TGF-beta and BMP-2
Y.M. Elcin1, B. Inanc1, A.E. Elcin1,2
1Ankara University, Faculty of Science and Biotechnology In-
stitute, Tissue Engineering and Biomaterials Laboratory, Ankara,
Turkey
2Gazi University, GEF, Division of Biology Education, Ankara,
Turkey
Background: Human embryonic stem cells (hESCs) have potential
to become cell source in tissue engineering applications upon
successful differentiation into specific cell types. With its limited
regenerative ability, cartilage is a particular candidate for skeletal
tissue engineering. This study investigates the differentiation of
hESCs into cartilaginous progenitors and the effects of TGF-b,
BMP-2 on the process at different time points.
Materials and Methods: Undifferentiated hESCs (HUES-9) were
characterized microscopically and by IHC. Pellet cultures were
established and differentiated for 28 days in hESC expansion
medium (ES-EM) supplemented with (1) 10 ng/ml TGF-b, (2)
50 ng/ml BMP-2, and (3) their combination. Cell pellets cultured in
ES-EM alone served as controls. At Day 1, 14 and 28, specimens
were fixed and stained with Alcian Blue to detect glycosamino-
glycans. IHC and RT-PCR were performed for Collagen I, Collagen
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II and Aggrecan expression. Resultant tissue structures were vi-
sualized by SEM. One-way ANOVA was used to determine the
expression difference for each marker between the groups.
Results and Discussion: Results demonstrate the feasibility to
direct hESCs into chondrogenic lineage based on micropellet
culture and the influence of TGF-b and BMP-2 both alone and in
combination. It appears that the two growth factors have a syner-
gistic effect on the expression of chondrogenic markers, particu-
larly when TGF-b is withdrawn from Day14 onward, but BMP-2 is
present throughout the experimental period. The successful di-
rected differentiation of hESCs into cartilaginous tissue progeni-
tors supports the notion that they could be utilized as cell source in
prospective cartilage tissue engineering applications.
(OP 53) Co-Culture System of Osteoblasts and Endothelial
Cells, an In vitro Strategy to Enhance Vascularization in Bone
Regeneration
M.I. Santos1,2, R. Unger2, R.A. Sousa1, R.L. Reis1, C.J. Kirkpatrick2
13B’s Research Group–Biomaterials, Biodegradables and Biomi-
metics, Dept. of Polymer Engineering, University of Minho,
Portugal
2Institute of Pathology, Johannes Gutenberg University Mainz,
Germany
For bone TE applications the formation of a prevascularized
structure is not only required for the survival of seeded cells on
scaffolds, but is also a fundamental process in bone formation
and repair. In this work we describe an in vitro strategy consist-
ing in the simultaneous culture of osteoblasts and endothelial
cells (ECs) onto a starch-based fiber-mesh scaffold, aiming to
accelerate the establishment of a vascular bed in the implanted
construct.
In order to distinguish between cell populations, samples were
stained after several time points for nuclei (both osteoblasts and
ECs), PECAM-1 (endothelial specific) and visualized by confocal
microscopy. After 21 days of culture the formation of tube-like
structures with PECAM-1 expression at the cell-cell junctions was
observed. The structural complexity was even higher after 35 days
with ramified tube-like structures. Immunohistochemistry of co-
culture/scaffoldcross-sections revealedthat thescaffold’svoidspaces
were filled with a dense ECM positively stained for type I collagen.
Inserted in this matrix were PECAM-stained ECs surrounding a
patent lumen. Furthermore, these tube-like structures were stained
for type IV collagen, a component of the vascular basal lamina.
Cross-talk communication between the two cell types was another
aspect under analysis. Osteoblasts in co-culture were producing
higher amounts of VEGF than in monoculture. In addition, the ex-
pression of gap junction connexin43 in the co-culture demonstrates
the heterotypic communication established between cells.
In short, the use of this co-culture system in conjunction with a
starch-based 3D scaffold holds great potential for the formation of
a prevascular network in vitro.
(OP 54) Cocultivation of Hemopoietic Stem Cells (HSCs) and
Mesechymal Stem Cells (MSCs) Derived from Umbilical Cord
Blood in Spinner Flasks
X. Fan1, T. Liu1, Z. Cui2, G. Zhao1, Y. Hao1, Y. Yin1, Y. Liu1,
X. Ma1
1Dalian R&D Center for Stem Cells and Tissue Engineering
2Oxford Centre for Tissue Engineering and Bioprocessing, Uni-
versity of Oxford
Autogenetic mesenchymal stem cells (MSCs) not only can sup-
port hematopoietic stem cells (HSCs) expansion in vitro but also
alleviate complications and lead to a speedy recovery of hemato-
poiesis during hematopoietic stem cell transplantation. In order to
achieve this destination, expansion of HSCs with autogenetic
MSCs simultaneously is required. In the present study, we inves-
tigated the feasibility of expanding umbilical cord blood (UCB)
mononuclear cells (MNCs) with appearance of autogenetic MSCs
in the 3-D dynamic system without serum support. The cells were
cultured in spinner flask with microcarriers and IMDM medium,
supported with the combination of cytokines, including SCF, TPO,
FL, IL-3, GM-CSF and G-CSF, and cocultured with allogeneic
UCB-MSCs encapsulated in the beads of calcium alginate-chitosan
(AC). With the diluted-feeding protocol, the total cell number,
CD34þCD45þ cells (HSCs) and CD34CD45 cells (MSCs)
could expand 2.7-fold, 9.1-fold and 8.4-fold respectively during
primary culture within 6 days. After coculture, HSCs and MSCs
can be easily separated by gravity sedimentation. At the same time,
by inducing differentiation and flow cytometric analysis, the fi-
broblast-like cells appeared on the surface of microcarriers could
differentiate into osteoblasts, chondrocytes and adipocytes and
expressed MSCs surface markers of CD29CD44CD105CD166
positive and CD34CD45HLA-DR negative. In conclusion we
have developed an efficient protocol to expand and harvest UCB-
HSCs and UCB-MSCs simultaneously by adding cytokines and
stromal cells together with microcarriers in the dynamic culture
system.
(OP 55) Development of an Osteochondral Repair Therapy
Utilizing BMP2-Loaded Collagen Scaffolds
M. DiMicco1, M. Philbrook1, M. Santos1, N. Moran1, D. Blasioli1,
H. Rubin1, T. Jozefiak1, G. Matthews1
1Genzyme Corporation, Framingham, MA, USA
With more than 20,000 patients treated globally, Genzyme’s
MACI (Matrix-assisted Autologous Chondrocyte Implantation)
implants and Carticel cultured chondrocytes are used by ortho-
paedic surgeons to treat patients who have clinically significant
articular cartilage lesions. These therapies employ the patient’s
own chrondrocytes to grow new cells for implantation. Genzyme
has over 20 years of clinical experience in developing and pro-
ducing autologous cell therapy products that meet the highest
standards of quality and compliance. In 2007, Genzyme announced
clinical data which demonstrated that Carticel cultured chon-
droncytes provided sustained and clinically meaningful improve-
ments in knee function and reduction in knee pain. In another
study, the MACI implant was demonstrated to have the ability to
generate hyaline-like cartilage as early as six months after im-
plantation. Despite the success of these cell-based therapies, al-
ternative therapies that rely solely on biomaterial scaffolds, in
some cases containing growth factors, would offer advantages in
simplicity and reduced patient morbidity. Cell-free biomaterial
approaches to cartilage repair have been the subject of a great deal
of work in academia and in industry, yet a successful cell-free
cartilage repair product remains an unmet goal. Beyond the dis-
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covery of the ideal scaffold and/or formulation, great challenges
must be overcome to successfully develop a product for cartilage
repair. These include ambiguities in preclinical models, the lo-
gistics of conducting controlled surgical trials, and the lack of
global harmonization. Finally, a successful business model must be
found despite significant uncertainty in market size, time to
achieve market penetration and difficulties in obtaining reim-
bursement after regulatory approval.
(OP 56) Comparative Study of the Multidifferentiation Po-
tential of Human Wharton’s Jelly and Amniotic Fluid Derived
Stem Cells
A. Costa-Pinto1,2, A.M. Frias1,2, M. Alves da Silva1,2, S. Fer-
nandes3, A. Barros3, R.L. Reis1,2, N.M. Neves1,2
13B’s Research Group–Biomaterials, Biodegradables and Biomi-
metics, Department of Polymer Engineering, University of Minho,
Campus de Gualtar, 4710-057–Braga, Portugal
2IBB–Institute for Biotechnology and Bioengineering, PT Gov-
ernment Associated Laboratory, Braga, Portugal
3Genetics Department, Faculty of Medicine, University of Porto,
Portugal
Mesenchymal stem cells (MSCs), potentially immune-privileged
cells, have been isolated from bone marrow, umbilical cord, e.g.
umbilical vein and Wharton’s Jelly, and from amniotic fluid.
Amniotic fluid cells were used for prenatal diagnosis since 1950.
Although being a well established diagnostic technique, little is
known about the origin and properties of those cells, its embryonic
or foetal origin remaining unclear.
In this study, we compared the osteogenic and chondrogenic
potential of human Wharton’s Jelly derived cells (WJCs) and am-
niotic fluid stem cells (hAFSCs). We used MSCs isolated from
around the blood vessels (perivascular zone) of umbilical cords col-
lected in caesarean surgeries of full-term pregnancies, and hAFSCs
from day 6 supernatant of the cultures of amniotic fluid were also
obtained from amniocentesis. Flow cytometry analysis was per-
formed to characterize both cell populations, by evaluating the
presence of stem cell surface markers. Osteogenic and chondrogenic
differentiation was assessed by immunocytochemistry and RT-PCR.
Acknowledgments: Portuguese Foundation for Science and
Technology (PhD Grant to Ana Costa-Pinto SFRH/BD/24735/
2005). European IP Genostem (LSHB-CT-2003-503161) and Eu-
ropean NoE EXPERTISSUES (NMP3-CT-2004-500283).
Work developed under the cooperation agreement established
between the 3B’s Research Group-UM and the Hospital de Sa˜o
Marcos, Braga.
(OP 57) Comparison of Bone and Cartilage Gene Expression
in Marrow Stromal Cells and Embryonic Stem Cells During
Osteogenic Differentiation
N. D. Evans1, E. Gentleman1, R. Swain1, M. M. Stevens1
1Imperial College London
Embryonic stem cells (ESCs) are a potential cell source for tissue
engineering applications because they have unlimited prolifera-
tive potential and the capacity to differentiate into all cells of the
adult organism, including osteoblasts. Here we sought to test the
hypothesis that ESCs follow similar patterns of gene and protein
expression as marrow stromal cells (MSCs) using qPCR, immu-
nocytochemistry (ICC) and Raman spectroscopy. ESCs and MSCs
were grown for 28 days in the presence of 280 mM ascorbate,
10 mM b-glycerophosphate, with 1mM dexamethasone added at
d14 (osteogenic medium). At various timepoints qPCR was per-
formed on extracted RNA using primers to Osteocalcin, Col1a1
and Col2a1 with normalisation using a combination of 3 different
housekeeping genes. Cells were fixed at d0, d14 and d28 and
stained with antibodies to Osteocalcin, Runx2 and Collagen type
II. Live cells were examined by Raman spectroscopy with a
785 nm laser and spectra were examined between wavenumbers
400 and 1900 cm-1. Osteocalcin expression was not significantly
different in ESCs and MSCs at d0, but had increased by 900-fold in
MSCs by d14 compared to only 3-fold in ESCs. Col1a1 expression
was 1000-fold greater in MSCs than in ESCs at d0 but by d14 had
increased 500-fold in ESCs compared to 10-fold in MSCs. Col2a1
peaked at d14 in both cell types (5-10-fold), and was detectable by
ICC and Raman spectroscopy only at this timepoint. These results
demonstrate that osteo- and chondogenic markers follow similar
patterns of expression in ESCs and MSCs but are expressed at
lower levels in ESCs.
(OP 58) Complex Tissue Engineering with a Novel Poly(Lactic
Acid-Co-Caprolactone)-Collagen Hybrid
M. Ananta1, C. Aulin2, J. Hilborn2, S. Houis3, R.A. Brown1,
V. Mudera1
1UCL Tissue Repair & Engineering Centre, Institute of Ortho-
paedics and Musculoskeletal Sciences, Middlesex, HA7 4LP,
United Kingdom
2The A˚ngstro¨m Laboratory, Department of Materials Science,
Uppsala University, Box 538, SE-751 21 Uppsala, Sweden
3Institut fu¨r Textiltechnik der RWTH Aachen, University of
Technology Aachen, Eilfschornsteinstrasse 18, D-52062 Aachen,
Germany
A biocompatible hybrid construct was fabricated by plastic com-
pressing hyperhydrated collagen gels onto the surfaces of a flat
slow degrading poly(lactic-acid-co-caprolactone) warp knitted
mesh. This resulted in natural polymer cell carrying components
supported by a synthetic polymer backbone. Fluid/weight loss was
measured to establish a standardised compaction protocol. Con-
structs were characterised for matrix density. Living interstitial,
epithelial and complex tissues were constructed by seeding hu-
man dermal fibroblasts inside and on the surface of the collagen
layers. Cell viability was determined after compression and at
various time points during a 7 day culture period using the Ala-
marBlue reduction assay. Fluorescent cell staining and confocal
microscopy were used to visualise cell death and migration. It was
found that in the range of 120 to 240 grams, and 5 to 10 minutes,
the level of fluid loss and collagen compaction was dependent on
the duration of the compression process rather than the loading
weight. No significant cell death was observed post-compaction.
After one week of static culture, the hybrid construct showed no
macroscopic contraction. Cells inside as well as layered on top
of the constructs proliferated. Cells inside the collagen matrix
were homogenously distributed and there was no evidence of
degradation.
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(OP 59) Complexing DNA with Dendrimers to Enhance Gene
Delivery from Collagen Scaffolds to Mesenchymal Stem Cells
Carolyn Holladay1,2, Mary Murphy3,2, Udo Greiser1,3,2, Timothy
O’Brien3,2, Abhay Pandit1,2
1National Centre for Biomedical Engineering Science
2National University of Ireland, Galway
3Regenerative Medicine Institute
Collagen scaffolds have been investigated as in vitro DNA reser-
voirs, which allow sustained release of genetic information. These
scaffolds have proved effective in viral gene-transfer, where viru-
ses transfer genetic material across the cell membrane. However,
collagen will not transport DNA across the cell membrane, so non-
viral vectors such as liposomes and linear polymers are commonly
used to improve transfection efficiency [1]. In this study, partially
degraded polyamidoamine dendrimers (dPAMAM) are combined
with collagen scaffolds for gene delivery. dPAMAM dendrimers,
such as those found commercially in SuperFect (Qiagen), have
found to be highly effective transfection reagents [2]. It is hy-
pothesized that the addition of these dendrimers to the DNA res-
ervoir will improve transfection efficiency as compared to collagen
scaffolds impregnated with naked DNA. Collagen scaffolds were
cross-linked with 1-ethyl-3-(3-dimethyl aminopropyl) carbodii-
mide (EDC) or a combination of EDC and dPAMAM. Plasmid
DNA encoding firefly luciferase was complexed with dPAMAM or
impregnated into the collagen scaffold in its naked form. Rat
mesenchymal stem cells were seeded on the scaffold and assayed
for luciferase after 72 hours. Transfection was seen in all samples,
with significant transfection in the scaffolds conjugated with DNA-
dPAMAM complexes. This conjugation platform may lead to an
effective method of scaffold mediated gene delivery.
Acknowledgement: Research Frontiers Program, Science
Foundation Ireland.
References:
1Dang, J.M., Leong, K.W., ‘‘Natural polymers for gene delivery and tissue
engineering.’’ Adv. Drug Delivery Reviews. 58(4) (2007) 487–499.
2Gebhart, C.L., Kabanov, A.V. ‘‘Evaluation of polyplexes as gene transfer
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(OP 60) Composite Scaffolds for Bone Tissue Regeneration
S.J. Lee1, J.W. Lee1, G. Lim1, A. Atala1, J.J. Yoo1
1Wake Forest Institute for Regenerative Medicine, Wake Forest
University Health Sciences, Winston-Salem, NC 27157
Numerous materials have been proposed for bone tissue regener-
ation. However, none has shown to be entirely satisfactory. Ideal
scaffolds for bone tissue regeneration should be biocompatible,
biodegradable, easily fabricated and configured to provide ade-
quate structural support. We have developed a scaffolding system
that meets these criteria. In this study we evaluated the biocom-
patibility and structural properties of the scaffolds for their use in
bone tissue regeneration. Poly(D,L-lactide-co-glycolide) (PLGA),
biodegradable synthetic polymer, and a naturally derived collagen
matrix derived from porcine bladder submucosa (BSM) were
fabricated into a composite scaffolding system using a solvent
casting/particulate leaching process. The structural properties were
examined by scanning electron microscopy (SEM), mercury in-
trusion porosimeter, hydrophilicity assay, and biomechanical
testing. The biological properties of the scaffolds were evaluated
by seeding with both human embryonic stem cells and bovine
osteocytes. Cell adhesion, survival, proliferation and toxicity were
assessed. The BSM-PLGA composite bone scaffolds possessed
uniform porous structures with a consistent interconnectivity
throughout the entire scaffold. The average pore size of the com-
posite bone scaffolds was 121.84 23.44 mm and had a porosity of
94.79 10.76%. The surface hydrophilicity of the BSM-PLGA
composite scaffolds was significantly enhanced, when compared to
the hydrophilicity of each material separately, resulting in uniform
cell seeding and distribution. Cells seeded on the composite bone
scaffolds readily attached, survived and proliferated, as confirmed
by histological examination, cell viability and MTT assays. There
was no evidence of toxic effects of the scaffolds.
(OP 61) Compressed Collagen-PLA Hybrids as Scaffold for
Human Bladder Cells
E.-M. Engelhardt1, M. Ananta2, F. Foroughi2, V. Mudera2, R.A.
Brown2, J. Hilborn3, J.A. Hubbell4, F.M. Wurm1, M. Adam1,4,
P. Frey4,5
1EPFL, Laboratory of Cellular Biotechnology, Lausanne, Swit-
zerland
2UCL, Institute of Orthopaedics and Musculoskeletal Sciences,
London, United Kingdom
3Department of Materials Chemistry, Polymer Chemistry, Up-
psala, Sweden
4EPFL, Laboratory for Regenerative Medicine & Pharmacology,
Lausanne, Switzerland
5Centre Hospitalier Universitaire Vaudois, Department of Pae-
diatric Surgery and Urology
Collagen gels have proven to be adequate scaffolds for tissue re-
generation as cell attachment is facilitated by the presence of cell-
adhesion domain sequences. This specific cellular interaction
could also play a role in preserving the phenotype and functional
activities of many cell types. However, collagen matrices offer
a limited mechanical strength. In this work we described a cell-
independent way to increase mechanical strength of collagen based
scaffolds and its potential for bladder tissue regeneration. Material
strength was increased by the use of hybrid materials composed of
knitted fabrics of poly(lactic acid-co-epsilon-caprolactone) (PLA)
embedded in plastic compressed collagen gels. Human smooth
muscle (SMCs) and urothelial cells (UCs), the two major cellu-
lar components of the urinary tract, were cultured on and inside
collagen-PLA hybrid materials. Cells were analysed by scanning
electron microscopy, conventional histology, immunohistochem-
istry and proliferation assay over a period of 14 days. Cellular
distribution of smooth muscle cells seeded inside the gel was also
evaluated during this time. We showed that both cell types pro-
liferated on the hybrid surface forming dense cell layers after two
weeks and that urothelial cells featured spontaneous stratification.
However for SMCs that have been seeded inside the gel, prolif-
eration rates were reduced as compared to surface seeded cells.
Conventional histology as well as immunohistochemistry will be
performed to determine cellular distribution inside the hybrid
material.
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The first data we obtained so far encourage the use of com-
pressed collagen–PLA hybrid materials as scaffolds for bladder
tissue regeneration.
(OP 62) Contrast Enhanced Micro-CT Imaging of Vascular
and Cartilaginous Tissues
R.E. Guldberg1, L. Xie1, C.L. Duvall2, A.W. Palmer1, W.R.
Taylor3, M.E. Levenston4
1Georgia Institute of Technology
2University of Washington
3Emory University
4Stanford University
Advanced imaging methods play an increasingly important role in
the rigorous evaluation of tissue regenerative strategies. Micro-
computed tomography (micro-CT) imaging offers excellent reso-
lution for quantifying 3D morphology but has typically been
restricted to analysis of x-ray attenuating tissues such as bone.
Even with this limitation, micro-CT analysis has been a valuable
evaluation technique for tissue engineering studies to monitor
mineralized matrix synthesis in vitro and quantify functional bone
regeneration in vivo. Unfortunately, soft tissues such as blood
vessels and cartilage alone are not sufficiently radiodense relative
to surrounding tissues to allow micro-CT analysis. However,
vascular ingrowth into scaffolds or regions of tissue injury may be
imaged nondestructively following perfusion of a radiodense
contrast agent. Subsequent morphological analysis can provide
quantification of 3D vascular volume, vessel thickness and density.
We have also recently established a new technique called Equili-
brium Partitioning of an Ionic Contrast agent mCT (EPIC-mCT),
that provides direct in situ analysis of both bone and cartilage
during joint development, degeneration, or repair. The high reso-
lution provided by EPIC-mCT and ability to separately analyze
both bony and cartilaginous tissues nondestructively makes it
particularly well suited for small animal studies. We have validated
and applied EPIC-mCT for assessment of 3D articular joint mor-
phology and proteoglycan composition with high precision and
accuracy in the rat model. The use of selective contrast agents has
thus extended the application of micro-CT imaging in TE/RM to
include not only bone but also non-mineralized tissues such as
blood vessels and cartilage.
(OP 63) Controlled Angiogenesis by Rapid FACS-Purification
of Transduced Progenitors Expressing Defined VEGF Levels
H. Misteli1, P. Fueglistaler1, T. Wolff1, R. Gianni-Barrera1,
U. Helmrich1, L. Gurke1, M. Heberer1, A. Banfi1
1Department of Surgery and Department of Research, Basel
University Hospital, Basel (Switzerland)
Vascular Endothelial Growth Factor (VEGF) gene delivery is
a powerful strategy to re-vascularize ischemic tissues or tissue-
engineered grafts. However, its microenvironmental dose must be
controlled, as VEGF remains bound around each producing cell
(Ozawa, JCI 2004). To achieve stable and homogeneous controlled
expression in vivo, we developed a FACS-based method to allow
the rapid purification of genetically-engineered progenitors ex-
pressing predictable levels of VEGF.
Myoblasts were transduced with a retrovirus expressing
VEGF164 transcriptionally linked to a truncated CD8a marker,
which could be quantified on individual live cells by FACS and
reflect differences in VEGF expression.
The transduced population expressed very heterogeneous
transgene levels, but VEGF and CD8 expression were tightly
correlated (R2¼ 0.897) in individual clones (range¼ 2–142 ng
VEGF/106 cells/day). A clone expressing the highest safe VEGF
level (40 ng VEGF/106 cells/day), inducing only normal angio-
genesis in vivo) was selected as reference. Cells expressing similar
CD8a levels (and therefore of VEGF) were rapidly purified from
the primary population using 2 different gate sizes. In vivo, the
heterogeneous population always caused angioma growth. How-
ever, both purified populations caused robust normal angiogenesis
and completely prevented angioma formation. The angiogenic
response was stable after 4 months, without adverse effects. Safety
in the presence of endogenous angiogenic activation was con-
firmed in a rat model of chronic hindlimb ischemia.
Therefore, rapid FACS-purification of engineered progenitors
completely prevented angioma growth, allowing safe and efficient
angiogenesis in vivo. We are currently applying this technology to
mesenchymal progenitors to stimulate controlled vascularization
of osteoinductive grafts in vivo.
(OP 64) Controlling Human Mesenchymal Stem Cell (MSC)
Differentiation on PCL Substrates Using Silane Modification
Techniques (SAMs)
J.M. Curran1, R. Chen1, J.A. Hunt1
1The University of Liverpool
Introduction: The ability to produce substrates that can trigger and
maintain a cellular response, without the need for exogenous bi-
ological stimuli is one of the ultimate aims of tissue engineers. In
this study -OH, -COOH, -NH2 and -CH3 groups were grafted onto
spun coated PCL films and their ability to influence MSC behav-
iour in vitro was analysed.
Materials and Methods: PCL films were spin-coated onto pre-
pared chromium coated glass coverslips and activated by oxygen
gas plasma. Subsequent ultraviolet (UV) induced grafting of dif-
ferent chemical groups in the monomer solution was performed to
introduce -CH3,-COOH, -OH, -NH2 groups on the surface. All
materials were characterised using contact angle, surface energy
and XPS. Phenotype defined human MSC were cultured in contact
with the surfaces in either basal, chondrogenic or osteogenic media
for up to 28 days. Analysis included cell adhesion and real time-
PCR to evaluate the expression of beta-actin, ornithine decarboxy-
lase, collagen I, collagen II, collagen X, CHOP, sox-9, osteocalcin,
osteopontin, osteonectin and cbfa1 over the 28 day time period.
Expression of STRO-1, nucleostemin, collagen I, II, X, osteocalcin
and CBFA1 was visualized using fluorescent immunohistochem-
istry and confocal microscopy.
Results: -NH2 modified surfaces were positive for osteocalcin
and cbfa1, fluorescent immunohistochemistry and RT-PCR, in both
basal and osteogenic mediums, these surfaces were osteoinductive.
Modifying PCL with -OH and -COOH groups induced chon-
drogensis as demonstrated by increased production of collagen II
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and a reduction in collagen I formation. SAMs modification en-
hanced the potential of PCL as a tissue engineering substrate.
(OP 65) Coordinated Co-Expression of VEGF164 and PDGF-
BB Prevents Aberrant Angiogenesis and Increases Blood Flow
in Ischemia
A. Banfi1,2, G. von Degenfeld1, M.J. Merchant1, R. Gianni-
Barrera2, D.M. McDonald3, H.M. Blau1
1Baxter Laboratory in Genetic Pharmacology, Departments of
Molecular Pharmacology and of Microbiology & Immunology
and Stem Cells Institute, Stanford, USA
2Departments of Surgery and of Research, Basel University
Hospital, Basel, Switzerland
3Cardiovascular Research Institute, Comprehensive Cancer Cen-
ter, and Department of Anatomy, UCSF, San Francisco, USA
VEGF regulates normal vessel growth in development and physi-
ology. However, VEGF gene delivery can have serious dose-
dependent side-effects, such as the induction of angiomas. We
have recently found that the switch between induction of stable
capillaries and angioma growth occurs at a threshold level in mi-
croenvironmental VEGF concentration and correlates with aber-
rant pericyte recruitment. Since pericytes are responsible for
nascent vessel maturation and are recruited by PDGF-BB, we in-
vestigated the role of PDGF-BB signaling in modulating VEGF-
induced angiogenesis.
Primary mouse myoblasts were retrovirally transduced to deliver
either VEGF164 or PDGF-BB to skeletal muscle. Although PDGF-
BB did not induce any angiogenesis, its co-expression significantly
increased VEGF-induced vascular density and prevented aberrant
vessels, yielding a network of homogeneous, mature capillaries.
However, both factors required precise co-localization in the mi-
croenvironment at fixed relative levels, through co-expression from
a single bicistronic retrovirus. In a model of hindlimb ischemia,
coordinated co-expression greatly improved blood flow, stimulated
collateral arteriogenesis and reduced muscle damage compared to
VEGF or PDGF-BB alone. PDGF-BB did not influence the initial
response to VEGF, but modulated subsequent remodeling, prevent-
ing circumferential enlargement and leading to capillary sprouting.
Mechanistically, we found that the VEGF level, at which the
threshold between normal and aberrant angiogenesis occurs, was
not fixed, but depended on the balance between VEGF and PDGF-
BB signaling. The induction of homogeneous normal angiogenesis,
despite heterogeneous and uncontrolled VEGF levels, suggests that
VEGF and PDGF-BB co-expression is suitable for gene therapy
with traditional vectors, whereby the distribution of microenvi-
ronmental levels cannot be controlled.
(OP 66) Cryoprotectants for Vitrification of Corneal Endo-
thelial Cell
W.-X. Fan1, X.-H. Ma1, T.-Q. Liu1, Z.-F. Cui1,2
1Dalian R&D Center for Stem Cell and Tissue Engineering, Da-
lian University of Technology, Dalian
2Department of Engineering Science, Oxford University
The objective of this work is to study the suitable cryoprotective
agents (CPAs) for vitrification of corneal endothelial cell (CECs).
Fresh bovine CECs were isolated and tested with a optimized
vitrification protocol with multi-step CPA loading and removal.
Three types of CPAs components, i.e. the pnentrating CPA com-
ponent, sugars and high molecular weight compounds were ex-
perimentally evaluated using the viability measured by trypan
blue. Dimethyl sulfoxide ((CH3)2SO), ethylene glycol (EG), 1,2-
propanediol (1, 2-PD), glycerol (Gly), 2,3-butanediol (2,3-BD),
diethylene glycol (DEG), acetamide (Ace) and ethylene glycol
monomethyl ether(EGMME) were chosen as the pnentrating CPA
components, and sugars included xylose, fructose, mannose, glu-
cose, maltose, sucrose and trehalose. Ficoll(wt. 7KD), dextran(wt.
7KD), chondroitin sulfate(CS, wt. 18~30KD), albumin bovine
V(wt. 68KD), and polyethylene glycol(PEG, wt. 6KD, 10KD and
20KD) were the high molecular weight compounds. The results
showed that EG was the most suitable penetraring CPA component
and glucose the best sugar, and CS the best high molecular weight
component. The optimized concentrations for each compoent in
the vitrification solution were 52% EG, 8% glucose and 3% CS.
The CEC survival rate of 86.4 6.1% (mean S.D.) was obtained
following the established protocol.
(OP 67) Cultivation of Human mesenchymal Cells in a
Microcarrier-Based Bioreactor System
Y. Ibold1, S. Frauenschuh2, M. Sittinger1, J. Ringe1
1Tissue Engineering Laboratory and Berlin-Brandenburg Center
for Regenerative Therapies, Department of Rheumatology and
Clinical Immunology, Charite´-Universita¨tsmedizin Berlin, Tu-
cholskystr. 2, 10117 Berlin, Germany
2Department of Bioprocess Engineering, Institute of Biotechnol-
ogy, Technical University of Berlin, Ackerstr 71-76, Sek. ACK
24, 13355 Berlin, Germany
For an effective application of primary mesenchymal cells such as
chondrocytes and mesenchymal stem cells (MSC) as cell source
for tissue engineering approaches, obstacles regarding the cost-
and labor-intensive in vitro expansion phase have to be overcome.
In order to develop a controlled, cost-effective and scalable pro-
cess, a microcarrier-based cultivation system for human bone
marrow-derived MSC and chondrocytes was established.
MSC and chondrocytes were isolated and expanded in conven-
tional monolayer culture. Passage 3 cells were seeded on Cytodex
1, 2 and 3 microcarriers and the adherence phase was investigated.
For different time points, the number of adherent cells on 60 car-
riers was counted. By comparison of the measured frequency of
cell distribution with a Poisson distribution and subsequent re-
gression analysis, the average cell count per carrier was determined
showing the best results for Cytodex 1 with over 80% adherent
cells after 3 hours of incubation. After the adherence phase,
the cells were cultivated in a spinner flask bioreactor for 28 days
and cell viability, morphology and cell distribution was ana-
lyzed revealing proliferation and cell-specific morphology. At
day 14 we added unseeded carriers and analyzed the colonization
status in the following. This way, we could show that the cells
colonize freshly added carriers by bead-to-bead transfer. Finally,
the cells were harvested and evaluated for their differentiation
potential.
After showing the applicability of microcarrier cultures for
expansion of primary mesenchymal cells, current research ap-
proaches comprise the transfer of established protocols for regu-
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lar spinnerflask bioreactors on the parallel DASGIP bioreactor
system.
(OP 68) Cyclic-Compressive Stimulation does not Alter the
Stem Cell Character of Mesenchymal Stem Cells but their
Functional Behaviour
A. Ode1,2, A. Kurtz3, U. Lehnigk1,2, S. Geissler1,2, K. Schmidt-
Bleek1, P. Kolar4, G.N. Duda1,2, G. Kasper1,2
1Julius Wolff Institut and Musculoskeletal Research Centre Ber-
lin, Charite-Universita¨tsmedizin Berlin, Germany
2Berlin-Brandenburg Centre for Regenerative Therapies, Ger-
many
3Technische Universtita¨t Berlin, Germany
4Deutsches Rheuma-Forschungszentrum, Berlin, Germany
Mesenchymal stem cells (MSCs) are involved in bone regenera-
tion, which is influenced by mechanical boundary conditions. On
the cellular level, mechanical stimulation leads to differences in
the expression profile of MSCs, e.g. an increased matrix metallo-
proteases (MMPs) secretion. Also the paracrine stimulation of
angiogenesis is elevated. Still, it remains unknown whether these
effects are mediated directly by MSCs or indirectly as a conse-
quence of differentiation processes. This study aimed to analyse
the stem cell character and behaviour of rat-MSCs after mechan-
ical stimulation.
MSC populations were homogeneous in their characteristic cell
surface marker profile (CD14 CD45, CD34, CD29þ,
CD44þ, CD73þ, CD90þ, CD105þ, CD166þ) and multipotent as
confirmed by osteogenic, adipogenic and chondrogenic differen-
tiation assays. In comparison to monolayer cultures, upregulation
of CD106 and downregulation of CD29, CD44, CD105 and CD166
were observed in 3D-cultures. Mechanical loading (10 kPa, 1 Hz,
72h) lead to an increased expression of CD166 and decreased
expression of CD44 and CD73. Determination of Alkaline Phos-
phatase activity, degree of mineralisation, fat deposition and
Collagen-II content revealed no effect of mechanical stimulation.
However, migratory capacity decreased significantly after me-
chanical stimulation.
In summary, we could show that antigen expression of MSCs
is differentially regulated by mechanical stimulation, but still
maintains the typical MSC marker profile. Furthermore, me-
chanical loading does not alter the cells multipotency. Thereby,
physiological loading does not change the stem cell character of
MSCs. However, the migratory capacity of MSCs is dependent
on mechanical conditions. Additional studies are necessary to
clarify the relevance of decreased migratory potency to bone re-
generation.
(OP 69) Delivery Strategy of Biosignaling Molecules for Tissue
Engineering
Y. Tabata1
1Department of Biomaterials, Field of Tissue Engineering, In-
stitute for Frontier Medical Sciences, Kyoto University
To realize cells-induced tissue regenerative therapy, there are two
practical methods; cell therapy and tissue engineering. For the
former approach, stem cells with the high potential of proliferation
and differentiation are directly transplanted to induce tissue re-
generation. However, only by the simple cell transplantation,
successful tissue regeneration cannot be always expected because
of the lack of oxygen and nutrients supply to cells transplanted.
Therefore, a biomedical technology and methodology are highly
required to create a local environment which enables cells to
promote their proliferation and differentiation for tissue regener-
ation. One of the practically possible strategies is to make use of
biosignaling molecules (growth factors and genes). Some mole-
cules induce angiogenesis which can supply cells oxygen and
nutrients, while others directly act on cells to maintain and activate
their biological functions. We have explored biodegradable hy-
drogels for the controlled release of bioactive growth factors or
genes and succeeded in regeneration and repairing of various tis-
sues. The growth factor delivery was a promising strategy to sig-
nificantly increase the grafting rate of cells transplanted, and
consequently enhance the efficacy of cell therapy. Some clinical
trials for the growth factor-induced regeneration of blood vessels,
bone or periodontal tissues, and skin dermis have been started to
demonstrate the superior therapeutic availability. In this paper,
several research data of growth factor and gene-induced tissue
regeneration are overviewed to emphasize scientific and clinical
significance of delivery strategy of biosignaling molecules in tissue
regenerative therapy.
(OP 70) Demonstration of the Potential of Iron Oxide Label-
ling of Chondrocytes for In Vivo Tracking
E. Farrell1, P.K. Bos1, P. Wielopolski2, P. Pavljasevic1, N. Kops1,
M. Bernsen2, G.J.V.M van Osch1,3
1Department of Orthopaedics, Erasmus MC
2Department of Radiology, Erasmus MC
3Department of Otorhinolaryngology
Autologous chondrocyte implantation is becoming a common
treatment modality for cartilage defects. To verify its safety and
efficacy it is necessary to determine the fate of these transplanted
cells. One approach is to pre label cells prior to implantation and
track them using a variety of imaging techniques. The use of
superparamagnetic iron oxide for tracking of cells with MRI is
ideal for this purpose. It is non-radioactive, does not require viral
transfection and is already approved for clinical use as a contrast
agent. The purpose of this study was to assess the effect of SPIO
labelling on the redifferentiation potential of adult human chon-
drocytes and determine the ability to track these cells by MRI.
Chondrocytes from 4 individual donors were culture expanded
and dedifferentiated for two passages, labelled with SPIO and
cultured for 21 days in alginate beads in redifferentiation medium.
Following this period, cells were analysed for expression of car-
tilage related genes, proteoglycan production and collagen protein
expression in triplicate. SPIO labelling did not significantly affect
collagen type II expression at gene or protein level (P¼ 0.6187
and P¼ 0.9491 respectively) or any of the other parameters rel-
ative to unlabelled controls. We also demonstrated SPIO retention
within the cells for the duration of the experiment and the ability
to visualise ex vivo implanted cells in a large animal cartilage
defect by MRI. This work demonstrates for the first time the
effects of SPIO labelling on chondrocyte redifferentiation ca-
pacity and its potential for in vivo tracking of implanted chon-
drocytes.
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(OP 71) Dendritic Cells and Host Reponses in Tissue
Engineering
J.E. Babensee1
1Georgia Institute of Technology
The host response to such a tissue engineered construct includes
an innate immune response (inflammatory response) towards the
biomaterial component and an adaptive immune response to-
wards an immunogenic biological component. Since biomaterials
are used as vehicles in such combination products it is important
to clarify the role of the biomaterial component in potentiating
the immune responses towards the biological component due to
the adjuvant effect of the biomaterial. Maturation of dendritic
cells (DCs) upon encountering a pathogen or ‘danger signal’ is
the central means by which adjuvants act in the enhancement of
an adaptive immune response to an associated antigen. DCs are
important in the context of biomaterials when there is a specific
immunogenic biological component present which is part of the
combination product. We have shown that poly(lactic-co-glycolic
acid) (PLGA) acts as an adjuvant in the immune response
against co-delivered antigen. As adjuvants act through the mat-
uration of DCs, we have determined a differential biomaterial
effect on DC maturation. We hypothesize that DCs use analo-
gous mechanisms to recognize and respond to biomaterials
as they use to recognize and respond to pathogens. We have
identified ‘danger signals’ associated with biomaterial implanta-
tion site and the significance of this is being evaluated using an
animal model. We are examining the pattern recognition recep-
tors which may be involved in mediating DC recognition of
and response to biomaterials, particularly focusing on toll like
receptor-4 (TLR4) and C-type lectin receptors and the biomate-
rial associated ligands, e.g. carbohydrate modifications of ad-
sorbed proteins.
(OP 72) Dependence of Cell Proliferation on the Morphology
of Starch Based Scaffolds for Tissue Engineering
S. Chung1,2, A. Martins 1,2, V.M. Correlo1,2, J.T. Oliveira1,2, A.P.
Marques1,2, N.M. Neves1,2, J.F. Mano1,2, R.A. Sousa1,2, R.L. Reis1,2
13B’s Research Group–Biomaterials, Biodegradables and Biomi-
metics, University of Minho, Campus de Gualtar, 4710-057
Braga, Portugal
2IBB–Institute for Biotechnology and Bioengineering, PT Gov-
ernment Associated Laboratory, 4710-057 Braga, Portugal
In tissue engineering (TE), several biological, mechanical and
geometrical design constraints need to be addressed in order to
create an adequate micro-environment for cells response. In this
study, the correlation between architectural features of the scaffold
construct and cellular behavior was investigated for a blend of
starch and polycaprolactone (SPCL). The aim was to determine the
effects of scaffold parameters on mechanical properties on cell
seeding efficiency and proliferation of human osteoblast-like cells
(SaOs-2) of scaffolds obtained via Rapid Prototyping (Bioplotter)
and fiber bonding. For fiber bonding, a L8 design of experiment
approach was used to produce different scaffold morphologies and
properties by systematically varying processing parameters. For
rapid prototyping, processing parameters such as filament orien-
tation, offset, and building layers were also varied to obtain dif-
ferent structural configurations.
Fiber bonding method produced randomly oriented fiber mesh
with porosity values up to 75%, whereas rapid prototyping method
produced a precise 3D architectures with similar porosity levels.
Correlation between the mechanical performance and scaffold
architecture was determined. Scaffold architecture was demon-
strated to have a profound effect on cell seeding efficiency and cell
proliferation. SEM micrographs and HE staining indicated cells’
preference during seeding towards points of geometric constraint
that resulted in higher seeding efficiencies for low values of po-
rosity. Conversely, high values of porosity revealed to be an im-
portant aspect to enhance cell proliferation for longer culture
periods. These results are an indication that scaffold architecture
can be optimized according to a specific envisaged cellular re-
sponse and period of culture.
(OP 73) Design of a Novel Bioreactor Employing the InCor
VAD for Dynamic Conditioning of Tissue Engineered Heart
Valves
A. Kaasi1,2,3, I.A. Cestari1, A.A. Leirner1, I.N. Cestari1
1University of Sa˜o Paulo
2Technical University of Denmark
3University of Copenhagen
Previous studies have shown that dynamic bioreactor conditioning
of tissue engineered (TE) heart valves is beneficial to their growth
and maturation. To the authors’ knowledge, no bioreactor system
has yet employed a ventricular assist device (VAD) to host TE
valves. In this study, the InCor paediatric VAD (30 mL blood
chamber volume) is used to this end. The pump of the VAD
system, the artificial ventricle, has two chambers: a blood and a
pneumatic chamber separated by an elastic membrane. A pneu-
matic driver provides pulsatile air-pressure to the ventricle’s
pneumatic chamber, ejecting the fluid in the blood chamber. A St.
Jude HP Mitral mechanical heart valve is placed in the inflow
position of the ventricle. The TE heart valve is placed in the
outflow position. The ventricle is coupled in series with a glass
Windkessel compliance chamber, throttle and glass reservoir,
connected by silicone tubings. The reservoir sits on a metal lab-
jack used to adjust ventricular filling pressure between 0 and 7.4
mmHg. Gaseous exchange with the reservoir interior was
achieved using a 0.2 mm filter. The system fits a standard incu-
bator, and all components which contact culture medium may be
autoclaved except for the ventricle, which is sterilized by ethylene-
oxide. Preliminary tests with a biological valve in the outflow
position achieved physiologically relevant values for pulmonary
artery pressures (med/min/max¼ 15.7/18.3/6.5 mmHg), frequency
(70 bpm) and flow output (2.1 L/min). The use of this system
may better reproduce physiological pressure and flow condi-
tions, which may improve conditioning of tissue engineered
valves.
(OP 74) Designing Silk-Based 3D Architectures with Con-
trolled Lamellar Morphology
A.L. Oliveira1,2,3, L. Sun3, H. J. Kim3, X. Hu3, W. Rice3,
J. Kluge3, R. L. Reis1,2, D. L. Kaplan3
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metics, Univ. of Minho, Campus Gualtar, Braga, Portugal
2IBB–Institute for Biotechnology and Bioengineering, PT Gov-
ernment Associated Laboratory, Braga, Portugal
3Department of Biomedical Engineering, Tufts University, Med-
ford, Massachusetts 02155, USA
The impressive mechanical properties, along with established
biocompatibility and slow degradability, render silk as an inter-
esting biomaterial for bone tissue engineering applications. New
silk-based scaffolds resembling bone lamellar structure were suc-
cessfully developed using a freeze-drying technique. The structure
could be controlled directly by the solute concentration and
freezing parameters. The lamellar scaffolds disclosed a controlled
and regular morphology (lamellar thickness: ~3.5 mm; interlamelar
distance: ~15 mm). In order to induce water stability, different post-
treatments were studied including methanol treatment, water an-
nealing and steam sterilization. The resulting structures exhibited
significant differences in terms of morphological integrity, struc-
tural details and mechanical properties. Steam sterilization pre-
served the structural integrity of the lamellar features, while
improving mechanical properties of the scaffolds. Human bone
marrow-derived mesenchymal stem cells (hMSCs) were seeded on
these silk fibroin lamellar scaffolds and grown under osteogenic
conditions to assess the effect of the microstructure on cell be-
haviour. The water annealing treatment promoted significantly
improved osteogenic outcomes based on elevated alkaline phos-
phatase (ALP) activity and the deposition of mineralized matrix.
Two-photon excited fluorescence (TPEF) was used to detect the
presence of collagen, based on Second Harmonic Generation.
Collagen was aligned along the morphology of the lamellar ar-
chitecture, demonstrating that the lamellar morphology constituted
a patterned surface onto which hMSCs cells attached, proliferated
and guided the formation of new ECM. These lamellar-based
constructs have potential for use in tissue engineering, were ap-
propriate surface environments are important in the control of
biological outcomes.
(OP 75) Detection Techniques for the Analysis of Protein
Adsorption
E. Servoli1, D. Maniglio1, M.R. Aguilar2, A. Motta1, J. San Ro-
man2, C. Migliaresi1
1Department of Materials Engineering and INSTM Research Unit,
University of Trento, Via Mesiano 77, 38100 Trento, Italy
2Institute of Polymer Chemistry and Technology, CSIC, C/Juan de
la Cierva 6, 28006 Madrid, Spain
Protein adsorption is a complex phenomenon, governed by mate-
rial surface properties, working conditions, protein nature itself,
time dependency; deep understanding of the process can provide
correlation between material properties and host tissue responses,
promoting the development of efficient biomedical devices for
tissue replacement and regeneration.
In order to investigate exhaustively protein adsorption we have
pursued two main tasks: the choice of proper system models and
suitable detection techniques.
We have modeled the process taking into account the individual
contribution of protein concentration, composition of protein so-
lution, the working conditions (time, temperature and way of in-
cubation) as well as material surface chemistry and topography.
System complexity has been increased gradually, starting from static
incubation in individual protein solutions (albumin, fibrinogen and
fibronectin); new variables as protein competition and incubation
under dynamic conditions have been introduced step by step. The
model has been tuned on Self Assembled Monolayers (SAMs)
before studying protein adsorption on silk fibroin substrates.
We have obtained qualitative and quantitative information on
the amount, conformation and distribution of proteins, along with
real time monitoring of adsorption, by immuno-modified Atomic
Force Microscopy (AFM), immunogold labeling and Surface
Plasmon Resonance (SPR).
At the end we have related adsorption isotherms (provided by
SPR) with protein activity and distribution (obtained by AFM) to
material surface chemistry and topography, in order to correlate
material properties to protein adsorption events: chemistry was
effective in controlling the amount and conformation of proteins
while topography had a major influence on protein distribution.
The authors thank Expertissues NoE
(OP 76) Determination of the Cell Viability of Primary Cul-
tures of Chondrocytes by Quantitative Electron Probe X-ray
Microanalysis
R. Rosales1, I. Garzo´n1, M. Alaminos1, M. Lobo1, A. Ferna´ndez-
Montoya1,2, C. Delgado2, A. Campos1, M.C. Sa´nchez-Quevedo1
1University of Granada, Department of Histology
2Blood and Tissue Bank of Granada, Spain
Introduction: Evaluation of the cell viability is very important
before the cells can be used for construction of artificial tissues and
organs by tissue engineering. In this study, we determined the cell
viability of isolated rat chondrocytes kept in culture at different
subcultures to identify microanalytical changes associated to each
cell subculture.
Materials and Methods: Rat chondrocytes were isolated from the
condilar surface of the temporomandibular joint of laboratory rats,
by incubating small pieces of cartilage with collagenase I at 378C
for 2 h. Primary cell cultures were cultured in DMEM medium
supplemented with 10% fetal serum and several growth factors.
Subconfluent chondrocytes were subcultured using trypsin-EDTA.
Cell viability was determined in the first 6 cell passages by quan-
titative electron probe X-ray microanalysis of cells cultured on gold
grids.
Results and Discussion: Electron probe X-ray microanalysis
revealed that the K/Na ratio rose from the first to the third passage,
and progressively decreased later on (0.07 for the first passage,
2.69 for the second, 15.61 for the third, 4.65 for the fourth, 2.46 for
the fifth and 1.48 for the sixth). Intracellular concentrations of S
and Cl tended to increase from the first passage, showing the
highest values at the sixth passage. These results show the use-
fulness of this technique to evaluate cell viability and imply that
cells at the third cell passage should be used in tissue engineering.
Supported by CTS-06-2191 from Junta de Andalucia.
(OP 77) Development and Characterization of Natural-Origin
Bilayered Scaffolds for Osteochondral Tissue Engineering
Under the Scope of Hippocrates Project
P.B. Malafaya1,2, J.T. Oliveira1,2, R.L. Reis1,2
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13B’s Research Group—Biomaterials, Biomimetic and Biode-
gradables, Department of Polymer Engineering, University of
Minho, Campus de Gualtar, 4710-057 Braga, Portugal
2IBB—Institute for Biotechnology and Bioengineering, PT Gov-
ernment Associated Laboratory, Braga, Portugal
Osteochondral tissue engineering presents a challenge to research
due to requirements’ combination of bone and cartilage tissue en-
gineering. It has been accepted that bilayered structures are more
adequate to regenerate an osteochondral defect. These should
be able to incorporate/induce different types of cells in a favourable
environment requiring different biochemical and mechanical cues,
leading to the growth of two different tissues. A potential strategy to
be discussed, also developed under the scope of HIPPOCRATES, is
based in a hydrogel and CaP coated fibres meshes. Nevertheless,
focus will be on the development of bilayered chitosan-based
scaffolds produced by particle aggregation. This methodology is
proposed to achieve an improved integrative bone and cartilage
parts’ interface, since any discontinuity is likely to cause long-term
failure. An extensive characterization was carried out. Dynamical-
mechanical analysis has demonstrated that scaffolds are me-
chanically stable in wet state under compression solicitation.
Micro-Computed Tomography was performed for accurate mor-
phometric characterization quantifying porosity, interconnectivity
and pore size. In composite scaffolds, surprisingly it was observed
an in-vitro cytotoxicity when unsintered hydroxylapatite was used.
This study reports the investigation that was conducted to overcome
and explain this behaviour. It is suggest that the uptake of divalent
cations may be inducing the cytotoxic behaviour. Sintered hy-
droxylapatite was further used showing no cytotoxicity. Attention
was paid primarily to chondrogenic differentiation of ATCD5 cells
by developing polymeric systems that provide insulin release.
Acknowledgements: FCT (SFRH/BD/11155/2002) and EU
funded projects HIPPOCRATES and EXPERTISSUES. Ana L.
Oliveira and Paula Sol for their contribution for CaP fibre meshes.
(OP 78) Development and Characterization of Osteogenic Cell
Sheets in an In vivo Model
R.P. Pirraco1,2,3, M. Yamato1, A.P. Marques2,3, R.L. Reis2,3,
T. Okano1
1Institute of Advanced Biomedical Engineering and Science,
Tokyo Women’s Medical University, Tokyo, Japan
23B’s Research Group–Biomaterials, Biodegradables and Biomi-
metics, Dept. of Polymer Engineering, University of Minho,
Campus de Gualtar, 4710-057 Braga, Portugal
3IBB–Institute for Biotechnology and Bioengineering, PT Gov-
ernment Associated Laboratory, Braga, Portugal
Despite some successes in the tissue engineering field its evolution
seems to be tampered by limitations such as cell sourcing and the
lack of adequate scaffolds to support cell growth and differentia-
tion. The use of stem cells combined with cell sheet engineering
technology seems a promising way to overcome these limitations.
In this work bone marrow cells were flushed from 3 weeks old
Wistar rat femurs and cultured in basal DMEM medium until
subconfluence. Cells were then transferred to thermo-responsive
dishes (3105 cells/dish) and cultured for 3 weeks in osteogenic
medium. Cell sheets were recovered from the dishes by tempera-
ture reduction and subcutaneously transplanted into the dorsal flap
of nude mice. The histological characterization was performed
before and after implantation using haematoxylin/eosin (HE) and
alizarin red staining. H&E staining showed that the cell sheets
before implantation were composed by a multilayer of cells em-
bedded in a collagen matrix while the alizarin red revealed ex-
tensive calcium deposition. A similar analysis of the implanted cell
sheets showed a good integration with host tissues without visible
inflammatory response. Calcium deposition was visible several cell
layers above the flap’s basal cells both after 3 and 6 weeks of
implantation suggesting the induction of mineralization by the
implanted cell sheets. The present work shows promising results
concerning the application of cell sheet engineering for bone-
related applications and future work may confirm the suitability of
this powerful technique for bone tissue engineering purposes.
(OP 79) Development of a Patient-Specific Autologous Hy-
drogel Suitable for Cellular Delivery Across a Spectrum of
Tissue Engineering Applications
N.Bryan.1, N.P. Rhodes.1, J.A. Hunt.1
1University of Liveprool
In this study an extracellular matrix hydrogel scaffold validated as
a candidate for both in vivo and in vitro cell expansion was derived
exclusively using the components of a patient’s own blood, so as to
overcome any histocompatability issues.
Blood was fractionated into platelet poor plasma and then was
gelled by the addition of either basal or bespoke cell culture media,
creating a stable hydrogel at 378C. This hydrogel was demon-
strated to be a suitable substrate for the culture of both lineage
committed cells, including articular chondrocytes and dermal fi-
broblasts, and multipotent cells such as human dental pulp pro-
genitor cells and mesenchymal stem cells derived from umbilical
cord and bone marrow. The proliferation of the cells was greater
than those cultured in Matrigel. The gel also permitted microvas-
cular formation from blood-derived endothelial cells.
Cell-loaded hydrogels were implanted in rats and NOD/SCID
mice using an injection strategy which allowed the components of
the gellation system to mix at the point of implantation, allowing
the precise delivery of the gel into a defect site using a minimally-
invasive procedure. The gel supported the expansion and pheno-
typic maintenance of primary dermal fibroblasts and osteoblasts
for extensive periods in vivo.
The hydrogel supported the proliferation of a broad range of
clinically-relevant primary human cells in vitro and demonstrated
translation into an in vivo model. This is an excellent candidate for
use as a non-immunogenic, autologous scaffold enabling the precise
localisation of cells into a defect using minimally-invasive surgery.
(OP 80) Development of Porous Scaffolds by Template
Method
Guoping Chen1, Hiroyuki Kobayashi1, Younggwang Ko1, Naoki
Kawazoe1, Tetsuya Tateishi1
1Biomaterials Center, National Institute for Materials Science, 1-1
Namiki, Tsukuba, Ibaraki 305-0044, Japan
Porous scaffold is an important factor for tissue engineering to
accommodate cells, control their functions and guide new tissue
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formation. Many methods have been developed for scaffold
preparation. However, precise control of porous structures such as
interconnectivity and open surface structure remains challenge-
able. In this study, we developed a template method for the prep-
aration of porous scaffolds by using biodegradable polymer
template and ice particulates. Two kinds of collagen scaffolds were
prepared. One is collagen mesh that was prepared by using a
synthetic poly(DL-lactic-co-glycolic acid) knitted mesh as a tem-
plate. At first a hybrid mesh of PLGA knitted and collagen was
prepared by forming web-like collagen microsponges in the
openings of a PLGA knitted mesh. And then the PLGA knitted
mesh was selectively removed. The interconnected porous struc-
ture of collagen mesh was confirmed by SEM observation. Another
collagen scaffold is collagen sponge with open surface structure
prepared by using embossing ice particulates as a template. Ice
particulates were formed on a plate and collagen aqueous solution
was poured onto them. Collagen sponge with a surface structure of
open big pores and a bulk porous structure of small pores was
prepared after freeze-drying. These collagen scaffolds were used
for cell culture of human dermal fibroblasts. The fibroblasts ad-
hered and proliferated in the collagen scaffolds. The open surface
and interconnected porous structures facilitated cell seeding and
homogeneous cell distribution. The template method is a useful
technique for the preparation of precisely controlled porous scaf-
folds for tissue engineering.
(OP 81) Development of Regenerative Therapies Using Ge-
netically Modified Cell Transplantation
T. O’Brien1
1Regenerative Medicine Institute, National University of Ireland,
Galway
Cell therapy may provide novel approaches to aid tissue regener-
ation. Genetic modification of cells may enhance the therapeutic
effect and cell therapy may be considered a form of gene delivery
given the homing characteristics of these cells. Thus combined
gene and cell therapy approaches hold great potential for future
therapeutics. A large number of vector systems exist for genetic
modification of cells. These include non-viral means such as lipo-
somes, adenovirus, adenoassociated virus and lentivirus. Me-
senchymal stem cells and endothelial progenitor cells may have
therapeutic use in a broad variety of diseases such as myocardial
infarction and peripheral vascular disease. We have demonstrated
that adenoviral vectors are a highly efficient gene delivery system
for both cell types. Lentivirus can efficiently transduce mesenchy-
mal stem cells but are randomly integrated into the host cell genome.
Autologous cell transplantation has advantages in terms of
avoidance of allogeneic immune responses but disadvantages as
the cells may be dysfunctional when harvested from diseased in-
dividuals. We explored this in the context of using endothelial
progenitor cells as an autologous therapy for diabetic vascular
disease. Endothelial progenitor cells were found to be dysfunc-
tional in patients with diabetes mellitus. We showed that genetic
modification of endothelial progenitor cells harvested from dia-
betic animals with an adenoviral vector encoding eNOS improved
the ability of these cells to enhance wound healing.
Thus genetic modification of stem cells may enhance the ther-
apeutic effect especially in the context of autologous cell trans-
plantation.
(OP 82) Dexamethasone-Loaded Carboxymethylchitosan/
Poly(Amidoamine) Dendrimer Nanoparticles Enhances Bone
Formation In Vivo
J.M. Oliveira1,2,3, R.A. Sousa1,2, N. Kotobuki3, P.B. Malafaya1,2,
M. Tadokoro3, M. Hirose3, J.F. Mano1,2, R.L. Reis1,2, H. Ohgushi 3
13B’s Research Group–Biomaterials, Biodegradables and Biomi-
metics, Department of Polymer Engineering, University of Minho,
Campus de Gualtar, 4710-057 Braga, Portugal
2IBB–Institute for Biotechnology and Bioengineering, PT Gov-
ernment Associated Laboratory, Braga, Portugal;
3Research Institute for Cell Engineering (RICE), National In-
stitute of Advanced Industrial Science and Technology (AIST),
Nakoji 3-11-46, Amagasaki, 661-0974 Hyogo, Japan
Dexamethasone-loaded carboxymethylchitosan/poly(amidoamine)
dendrimer nanoparticles, CMC/PAMAM-Dex were successfully
synthesized to find applications as a controlled system of relevant
molecules in Bone Tissue Engineering. These are aimed at modu-
lating the proliferation and differentiation of stem cells, both in vitro
and in vivo. In previous work, we have demonstrated that CMC/
PAMAM-Dex nanoparticles are internalized with high efficiency
by different cell types, namely osteoblastic-cells, SaOs-2 and rat
bone marrow stromal cells, RBMSCs. The biocompatibility of HA
and SPCL scaffolds was also assessed by means of seeding
RBMSCs onto the materials and performing a luminescent cell
viability assay, after 24 and 72 hrs.
In this work, the ability of the nanoparticles to induce the os-
teogenic differentiation of RBMSCs and bone formation was in-
vestigated by exposing the nanoparticles (dispersed in culture
media) to RBMSCs during expansion period, then cells were
trypsinized and seeded (cell number of 1106 per scaffold) over-
night onto the hydroxyapatite, HA and starch-polycaprolactone,
SPCL scaffolds. Afterwards, the constructs were implanted sub-
cutaneously on the back of F344 rats for the period of 4 weeks.
After the implantation period, the animals were sacrificed and
constructs retrieved. Micro-Computed Tomography (m-CT) anal-
ysis, ALP activity, osteocalcin content (ELISA), and calcium
content were performed to investigate new bone formation. For
routine examination of undecalcified constructs, Haematoxylin &
Eosin (H&E) and Toluidine blue staining were also carried out.
Results have shown that CMC/PAMAM-Dex nanoparticles are
biocompatible and enhanced new bone formation as compared to
controls (RBMSCs/scaffolds that were not exposed to nano-
partiles), in vivo.
(OP 83) Different Configurations of Membranes for Bioarti-
ficial Liver Application
A. Gautier1, M. Dufresne1, B. Carpentier1, P. Paullier1, C. Le-
gallais1
1University of Technology of Compiegne, UMR CNRS 6600,
Biomechanics and Bioengineering, Compiegne, France
Fulminant hepatic failure and acute episodes in chronic liver
failure are associated with high mortality due to a sudden loss of
liver functions. Organ transplantation is the only treatment avail-
able to improve patient survival but shortage of donors worldwide
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results in approximately 20% of mortality. A temporary liver
support system is thus required to bridge patients to transplantation
or to help them recover native liver functions.
BioArtificial Liver (BAL) is an extracorporeal system which
permits to exploit the potential performances of hepatocytes im-
mobilized into bioreactors to replace main liver functions. Cells
cultured in 3D environment exhibit higher activity in comparison
with monolayer culture. In addition, a mechanical barrier should be
placed between cells and host to prevent immune rejection. This
barrier can under different configurations: spherical membrane
encapsulating the cells–alginate bead- or hollow fiber membranes
where the cells are located outside.
Our goal is to compare both configurations in term of mass
transfer phenomena in order to help for the best choice for future
bioartificial liver. Several solutes with different molecular weight
are considered for transfer such as ammonia, lactate, glucose, vi-
tamin B12, albumin, alpha-foetoprotein with and without the
presence of human hepatic C3A cells.
The effects of bead diameter and the porosity are also studied.
The biological behaviours are then analyzed though mass transfer
models taking into account the synthesis or consumption rates.
(OP 84) Differential Gene Expression of Transcription Factors
During Multilineage Differentiation of Human MSC
J. Ringe1, B. Delorme2, D. Mrugala3, S. Stich1, C. Jorgensen3,
D. Noe¨l3, P. Marie4, P. Charbord2, T. Ha¨upl1
1Dept. Rheumatology, Charite´, Berlin, Germany
2Inserm-Espri/Ea-3855, Tours France
3Inserm U475, Montpellier, France
4Inserm U606, Paris, France
To characterize transcription factors involved in adipogenic, os-
teogenic or chondrogenic stimulation of MSC.
Methods: Human bone marrow MSC from 3 independent donors
were induced for adipogenic (DEX, insulin, indomethacin IBMX),
osteogenic (DEX) and chondrogenic (pellet culture with BMP2 or
TGFß3 or fibrin/PLGA 3D-culture with TGFß3) differentia-
tion. Cartilage and fat tissue was derived from hip surgery and
osteoblasts by outgrowth from squamous bone. Hybridization was
performed on HG-U133Plus2.0 GeneChips and analysis with
GCOS 1.4 and the SiPaGene database (www.bioretis.de).
Results: Selection for more than 80% change increased revealed
2154 probesets for adipogenic, 690 for osteogenic and 2422 to 2748
for each of the three chondrogenic differentiations. 147 transcription
factors according togene ontology were found involved inadipogenic
(e.g. C/EBPa, PPARg2), 40 in osteogenic (e.g. MSX2) and 171 to
220 in chondrogenic differentiation (e.g. Sox5, Sox6, Sox9, Runx3).
Comparative analysis of MSC, fat, bone and cartilage enabled to
develop a tissue specific score for each gene including transcription
factors. Differentially expressed genes as well as the signal intensity
of the best marker genes were used to scale the quality of tissue spe-
cific differentiation. For the three chondrogenic differentiation as-
says, 3D-culture with PLGA revealed the best quality with highest
levels of collagen type two expression comparable to native cartilage.
Discussion: Extensive comparative analysis is necessary to com-
prehensively describe the network of transcription factor activity in
tissue specific development. Three different assays and qualities of
chondrogenic differentiation demonstrated how to optimize gene se-
lection for the most important candidates for functional validation.
(OP 85) Donor Lymphocyte Infusion in Patients with Hae-
matological Diseases
S. Roncon1, M. Rosales1, F. Campilho2, I. Barbosa1, A. A´vila1,
S. Ferreira1, H. Leal1, S. Lopes1, C.P. Vaz2, R. Branca2,
P. Pimentel2, A. Campos2, A. Carvalhais1
1Hemotherapy Department
2Stem Cell Transplantation service
Donor lymphocyte infusion (DLI) after allogeneic haematopoietic
transplantation (alloHT) is an effective therapy for some patients
with recurrent haematological diseases; in high risk patients with
mixed chimerism it has been used to prevent relapse. Delayed
lymphocyte add-back after transplants with selection of CD34þ
cells prevent graft failure, decrease risk of relapse and graft-versus-
host disease (GVHD). The aim of this review was to study efficacy,
toxicity and long-term outcome.
We studied 54 patients(35 male/19 female) between 1994 and
2007; median age:32.5(7-59) years old. Diagnosis: Chronic Mye-
loid Leukemia(CML) 20/Acute Leukemia(AL) 20/Multiple Mye-
loma (MM) 6/others 8. Graft source: peripheral blood 46/bone
marrow 9 (one also 2 blood cords); 4 donors unrelated. Con-
ditioning regimen: myeloablative 38/reduced intensity 16. T-cell
depletion of the graft: 25. GVHD prophylaxis: single agent 20/
double 34. Median CD34þ and CD3þ cells infused with the graft:
6.71(0.62–13.43) and 0.31(0.01–596) respectively.
DLI was therapeutic in 42, pre-emptive in 5 and as T cell add-
back in 7. Median CD3þ lymphocytes infused: 1107 kg in 71%
of DLI. Median interval transplant-first DLI: 8 months (1–60).
Others therapies for relapse: imatinib-dazatinib 10/chemotherapy
9/second alloHT 6/others 3. Thirty-seven patients developed
GVHD. Patients alive: 31 (22 complete remission/9 disease);
main cause of death: disease progression. There was remission
in 16 of therapeutic DLI (12/19CML;2/2AL;1/5MM;1/2others),
5 months.
This form of adoptive cell therapy is a therapeutic option in
selected patients after alloHT, with better results in CML. Overall
survival after 1st DLI was 50.4% (8.2%) at 8 years. GVHD was
the most frequent complication, otherwise it was well tolerated.
(OP 86) Downregulation of Osteogenic BMP and Cartilage
Matrix Degrading MMP Gene Expression in Delayed Com-
pared to Standard Bone Healing
J. Lienau1, H. Schell1, K. Schmidt-Bleek1, C. Perka1, H.J. Bail1,
G.N. Duda1
1Julius Wolff Institut and Center for Musculoskeletal Surgery,
Charite´—Universita¨tsmedizin Berlin, Berlin, Germany
The aim of this study was to compare the temporal expression
pattern of factors related to cartilage and bone formation and en-
dochondral ossification during standard and delayed bone healing
for a more in-depth understanding of the molecular basis of dis-
turbed bone healing and to elucidate timely adapted substitution of
factors to stimulate the healing process.
A tibial osteotomy was performed in two groups of sheep
(n¼ 30 each) and stabilized with either a rigid external fixator
leading to standard healing or with a mechanically critical one
leading to delayed healing. Hematoma/callus tissue was harvested
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4, 7, 14, 21 and 42 days postop. qPCR was employed to determine
the expression patterns of BMPs and other molecules.
Gene expressions of BMP2, BMP4, BMP7, Nog, MMP9 and
MMP13 were distinctly lower in the delayed compared to the
standard healing group at several time points from day 14, whilst
no differential gene expression of Coll II and Coll X was found
between both groups. Among the BMPs, BMP7 showed the most
markedly differential expression. The first evident difference in
BMP7 expression between both groups was found at day 14 sug-
gesting that exogen substitution in the context of a therapeutic
approach should be postponed. The differential expression pattern
of both MMP9 and MMP13 suggests that there might be a failure in
endochondral ossification in delayed bone healing.
Downregulation in gene expression of osteogenic BMPs and
cartilage matrix degrading MMPs may account for a considerable
delay of bone healing.
(OP 87) Drug Releasing Hybrid Scaffold: New Avenue in
Cardiovascular Tissue Engineering
C. Spadaccio1,2, A. Rainer3, M. Chello2, E. Covino 2, M. Trom-
betta3, J.A. Genovese1
1Cardiac Cell & Molecular Biology Lab. McGowan Institute for
Regenerative Medicine and UPMC, Univ. of Pittsburgh
2Department of Cardiovascular Surgery. University Campus Bio
Medico, Rome
3CIR Bioengeneering Department. University Campus Bio Med-
ico, Rome
Clinical application of tissue engineered vascular graft (TEVG)
still needs to overcome several limitations. Our aim was to eval-
uate a novel hybrid device able to simultaneously provide a spe-
cific microenviroment to allow cell differentiation and to function
as a drug delivery system.
We developed a multilayer hybrid construct with a middle
pivotal fibronectin-collagen network and two functionalized Poly-
lactic acid (PLLA) layers on its inner and outer sides. The inner
side layer was realized as a drug delivery system releasing Heparin
(HEP) useful in the immediate management of the scaffold en-
graftment, and Erythropoietin (EPO), important in differentiation
and recruitment of endogenous stem cell populations.The outer one
was engrafted with TGF- for muscular differentiation.
PLLA/HEP-EPO nanocomposite scaffolds were prepared by
electrospinning. Polymer solutions containing 13% w/w PLLA
alone or 13% w/w PLLA with HEP and EPO solution were elec-
trospun (15 kV) forming a non-woven cloth. Membranes micro-
structure was evaluated by Scanning Electron Microscopy. After
sterilization scaffolds were seeded with human mesenchymal stem
cells and cell engraftment, viability, proliferation and differentia-
tion were evaluated by light and confocal microscopy.
Mean fiber diameter was 1.5 0.9 mm with a porosity favorable
to cell attachment and culture. Both HEP and EPO release showed
an initial burst within the first 24 hrs and a further smoother pattern.
Microscopy was consistent with a good cell attachment and via-
bility with changes in cell morphology resembling to endothelial
phenotype.Detection of ki67þ cells confirmed cell proliferation
and suggested the presence of a favourable mircorenviroment. A
shift towards CD31 positivity could be observed in the functio-
nalized scaffold.
(OP 88) Dynamic Mesenchymal Stem Cell Culturing for Bone
Tissue Engineering
S. Roeker1, S. Diederichs1, S. Boehm1, T. Scheper1, M. van
Griensven2, C. Kasper1
1Institut fu¨r Technische Chemie, Leibniz Universita¨t Hannover
2Ludwig Boltzmann Institut fu¨r experimentelle und klinische
Traumatologie, Wien
Mesenchymal stem cells (MSCs) are a widely used cell source in
tissue engineering and regenerative medicine because they can be
expanded and differentiated easily in vitro as well as in vivo. MSCs
can be obtained from a variety of tissues including adipose tissue.
Static cell culture with the aim of tissue engineering applications has
been proven to be disadvantageous since constructs grown in static
cell culture lack the mechanical stability native tissue exhibits.
Mechanical stimulation has therefore become a substantial tool in
tissue engineering to accustom cells to their future physically active
environment. Moreover, differentiation of stem and progenitor cells
has been proven to be supported by mechanical strain. In this work,
the effect of mechanical strain on the differentiation of a pre-
osteoblastic cell line and adipose tissue derived mesenchymal stem
cells was analysed. Nutrient supply especially on 3D scaffolds is
heterogeneous in static cell culture leading to reduced growth rates
or even death of the tissue on the scaffold. Thus, a specifically
customised bioreactor systems have been developed to control tissue
growth under dynamic culture conditions. In this work cultivation of
adMSC on 3D scaffolds under controlled and reproducible condi-
tions in a rotating bed system bioreactor is presented.
(OP 89) Dynamic Studies of Biomimetic Coated Poly-
caprolactone Nanofiber Meshes as Bone Extracellular Matrix
Analogues
J.V. Araujo1,2,3, C. Cunha-Reis3, G. Gogniat3, Y. Yang3, N.
Ashammakhi3, R.L. Reis1,2, A.J. El Haj3, N.M. Neves1,2
13B’s Research Group—Biomaterials, Biodegradables and Bio-
mimetics, Department of Polymer Engineering, University of
Minho, Campus de Gualtar, Braga, Portugal
2IBB—Institute for Biotechnology and Bioengineering, PT Gov-
ernment Associated Laboratory, Braga, Portugal
3ISTM—Institute for Science and Technology in Medicine, Keele
University, Stoke-on-Trent, UK
This work aimed at studying the effects of dynamic culture con-
ditions and biomimetic coating on bone cells grown on nanofiber
meshes. In our previous work, biomimetic calcium phosphate
coated polycaprolactone nanofibre meshes (BCP-NM) proved to
be more efficient for supporting cell attachment and proliferation
under static conditions, when compared to polycaprolactone na-
nofibre meshe (PCL-NM). However, no studies on the influence of
bioreactors on the behaviour of cells cultivated on these materials
were developed so far. In fact, in vitro cultivation of constructs
using bioreactors which support efficient nutrition of cells has ap-
peared as an important step toward the development of functional
grafts. In the current work, osteoblast-like cells were seeded on both
BCP-NM and PCL-NM. The formed constructs were cultured in a
rotating bioreactor (Synthecon, RCSS-1, USA), for different time
periods. Cell morphology and viability were assessed by confocal
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microscopy. DNA and total protein quantifications were performed
accordingly. No significant difference in cell proliferation was
observed in BCP-NM and PCL-NM constructs kept under dynamic
conditions when compared to the results obtained from static
studies. However, under dynamic conditions, total protein contents
were higher on BCP-NM constructs than in the uncoated ones.
Moreover, PCL-NM presented a higher number of dead cells than
BCP-NM. Obtained results point out that BCP-NM can support cell
growth under dynamic conditions. The vast potential of using BCP-
NM in applications related to bone tissue engineering was also
confirmed.
Marie Curie Actions ‘‘Alea Jacta Est Training Fellowship’’ and
the European NoE EXPERTISSUES (NMP3-CT-2004-500283)
supported this work.
(OP 90) Dynamics and Interactions of Hemoglobin in Red
Blood Cells
A. Stadler1,2, K. Zerlin2, I. Digel3, G. Bueldt2, G. Zaccai1,
G. Artmann3
1Institut Laue-Langevin, 38042 Grenoble, France
2Research Centre Juelich, 52425 Juelich, Germany
3University of Applied Science, 52428 Juelich, Germany
We studied molecular dynamics and interactions of hemoglobin in
whole human red blood cells with Incoherent Elastic Neutron
Scattering and Small Angle Neutron Scattering. Thermal neutron
wavelengths and energies match atomic distances and atomic
thermal motions and allow their study in biological material
without damage. Protein dynamics were measured on time scales
of around 100ps which reflects protein side chain motions and long
time self diffusion of the whole protein.
We could show that there occurs a transition of hemoglobin
dynamics at human body temperature of 378C in cells and solution.
The measurements show that there is a break in the long term self
diffusion coefficient at human body temperature. Complementary
from our interaction studies, we found that hemoglobin start
forming aggregated clusters at human body temperature.
(OP 91) Educational Aspects of Tissue Engineering: an In-
dustrial Perspective
B.M. Thomson1
1Smith and Nephew Research Center, York YO10 5DF, UK
Tissue engineering is a branch of regenerative medicine that at-
tempts to convert insights from biomedical research into novel
therapies composed of cells, growth factors and/or biocompatible
structural materials. It aims to (i) repair, rather than replace dam-
aged tissues; (ii) postpone radical surgery; and (iii) stimulate en-
dogenous healing responses.
Society’s need for these new clinical approaches, (e.g. biological
therapies for cartilage repair), is indisputable and growing in line
with the aging population. Unfortunately, the commercial and
clinical success of tissue engineering has been poor to date because
the early innovators failed to appreciate the need to resolve all the
scientific, clinical, regulatory, commercial and logistical issues
involved in bringing a complex and unfamiliar therapy from
‘bench to bedside’.
Educators should therefore emphasise the multidisciplinary na-
ture of regenerative medicine to students. They should stress that in
order to be successful a new product must simultaneously resolve all
the problems associated with its introduction (e.g. (i) definition of
clinical need; (ii) cell/molecular biology of the product; (iii) struc-
tural materials and biomechanics; (iv) scale-up and production; (v)
patents and IPR; (vi) regulatory approval and quality control; (vii)
distribution, inventory control and logistics; (viii) immunology and
graft integration; (ix) patient selection and adoption into clinical
practice; (x) proof of cost-effectiveness and re-imbursement; and
(xi) time to market and return on investors capital). Curricula,
should encompass these topics and the management approaches
(e.g. open innovation) required to build and maintain the multidis-
ciplinary teams needed to develop regenerative medicine.
(OP 92) Educational Aspects of Tissue Engineering: the Aca-
demic Perspective
D.F. Williams1,2
1Emeritus Professor, University of Liverpool, UK
2Editor-in-Chief, Biomaterials
Everyone recognises that tissue engineering is a rapidly emerging,
multidisciplinary subject that, so far, is not grounded in traditional
academic courses. A multitude of departments, institutes and
centres concerned with tissue engineering have emerged in Uni-
versities throughout the world, but almost wholly being research or
clinically oriented. This has been inevitable and, as with any
emerging subject, is has been very sensible to identify its bound-
aries before constructing educational courses. The time is now
coming, however, where there is a role for new courses, in order to
provide for this education.
The subject of biomaterials provides an example of how this
could be done since 40 years ago this subject was similarly in its
infancy. We have witnessed the introduction of courses at under-
graduate and postgraduate levels, some based in medical schools
and others in engineering schools. We cannot pretend that we have
always got this right and it is no means obvious that either the
industrial or clinical end-users of the student output have fully
benefited. The most obvious question has been whether it is pos-
sible or necessary to train ‘biomaterials scientists’ or for students to
follow a major relevant discipline, for example materials science,
cell biology or mechanical engineering, perhaps to PhD level, and
then to develop the skills and knowledge for the transition into
biomaterials science.
It is essential that the field of tissue engineering learns these
lessons; this presentation will explore the options.
(OP 93) Educational Aspects of Tissue Engineering: the Per-
spective of Students and Young Investigators
C.M. Alves1,2
13B’s Research Group–Biomaterials, Biodegradables and Biomi-
metics, Dept. of Polymer Engineering, University of Minho,
Campus of Gualtar, 4710-057 Braga, Portugal
2IBB–Institute for Biotechnology and Bioengineering, PT Gov-
ernment Associated Laboratory, Braga, Portugal; cmalves@
dep.uminho.pt
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The Students and Young Investigators Section (SYIS) of TERMIS-
EU aims to bring together an international community of students
and young investigators engaged or interested in different aspects
of science and technology of tissue engineering and regenerative
medicine.
An essential aspect to accomplish this purpose is to promote
education improving informed and current discussion on the sci-
entific challenges and therapeutic developed technologies. A plat-
form for the ‘‘next generation’’ of scientists in the field of tissue
engineering and regenerative medicine can only be generated if their
opinion, career expectations, motivations and needs are considered.
Several issues related with the multidisciplinary nature of re-
generative medicine field were assessed within the S & YI section.
This survey will give an outlook on different issues including: (i)
opinion on Master/PhD/Post-Doc programmes; (ii) most relevant
subjects/skills to include in their respective programmes; (iii) best
format to deliver this information and enhance professional de-
velopment; (iv) awareness of the students for activities, such as
short courses, currently being organized; (v) understanding of the
development of the area and the value of their contribution; and
(vi) how S & YI see their future in a tissue engineering and re-
generative medicine related area.
These issues will be explored in this presentation having in
consideration the perspectives and opinions of Students and Young
Investigators of different nationalities and from different back-
grounds.
(OP 94) Effect of Hypoxia on Vascular Endothelial Growth
Factor Expression in an Engineered 3D Cell Model
U. Cheema1, T. Alekseeva1, A. J. MacRobert2, B. Alp1, V. Mu-
dera1, R. A. Brown1
1Tissue Repair and Engineering Centre, UCL
2National Medical Laser Centre, UCL
Tissue hypoxia results in rapid angiogenesis in vivo, triggered by
angiogenic proteins, including vascular endothelial growth factor
(VEGF). We have developed an in vitro model using dense cell-
seeded collagen constructs to engineer hypoxic gradients which
can be quantified using a sensitive O2 probe in real-time.
We have used 3 cell types: human dermal fibroblasts (HDF),
bone-marrow derived stromal cells (BMSC) and pulmonary
artery-derived smooth muscle cells (PASMC) seeded in collagen
constructs at 2106 cells, constructs were compressed, spiralled
and statically cultured for up to 10 days. Levels of O2 in the core
fell from 145 mmHg at 20 mmHg for HDF’s, 10 mmHg for
PASMC’s and 8 mmHg for BMSC’s after 24 hours of static
culture. Levels of O2 in surface layers were 145 mmHg for all
constructs. Following O2 monitoring over 10 days, mRNA was
extracted from spatially distinct zones to reflect O2 gradients from
core to surface of constructs. VEGF was up-regulated 10-fold in
the core of HDF constructs after 7 days in culture, correlating
low O2 levels to increased angiogenic signalling. Further work is
underway to establish signalling in other cell types. There was
no evidence of decreased cell viability for HDF’s within all zones
of the construct, however BMSC’s and PASMC’s had lower
viability in the core, and therefore are more sensitive to low O2
levels.
This study raises the possibility of engineering naturally oc-
curring angiogenic signals for induction of vascularisation in such
3D tissue engineered constructs post-implantation by manipulating
cell density (hence O2 consumption) to control cell responsive
signalling.
(OP 95) Effect of Matrix Stiffness on Cellular Responses
V. Mudera1, D. Karamichos1, J. Skinner2, R. Brown1
1UCL, UK
2Royal National Orthopaedic Hospital, Stanmore UK
Several cell types respond to mechanical forces, key to in-vitro
remodeling. We have tested the differential response of human
dermal fibroblasts (HDFs) and human bone marrow stem cells
(HBMSCs) using increasingly stiffer collagen matrices with the
mechano-molecular regulation of specific extracellular matrix
genes, following ramp load regimes.
Strain was applied using a computer driven tensional-Culture
Force Monitor (t-CFM). Cell seeded collagen constructs were
subjected to pre-strain (0% and 5%) and kept under tension. Ramp
load applied was: a) 10% ramp over 1h, b) 10% ramp over 12 h
pre-strain level (i.e 0% and 5%). Molecular outputs from con-
structs were also investigated. Both HBMSCs and HDFs showed
no significant increase on force generation following ramp load
stimulation, with either 10 and/or 20% FCS. ECM regulatory
genes TIMP-2 and COL-3 showed up regulation, with 10% FCS,
at 5% pre strain and ramp load over 1h. In contrast, genes MMP-2
and COL-1 showed down regulation at the same groups. At
20% FCS genes showed no regulation over 1h ramp loads, in-
stead the slow ramp load 12h led to, again, MMP-2 down regu-
lation and TIMP-2 up regulation, but up regulation of COL-1.
HBMSCs showed no significant gene regulation at 10% FCS, and
only minimal though significant down regulation of COL-1 with
20% FCS and slow ramp load regimes. ECM remodeling gene-
regulation and turnover is important when stiff constructs, ramp
rate and FCS levels are combined in bioreactors. This has major
implications in TE, specifically in tissues where load bearing is
a major function.
(OP 96) Effect of Membrane Surface on Hippocampal Neu-
ronal Cell Differentiation
M. Rende1,2, S. Morelli1, G. Giusi3, S. Salerno1, A. Piscioneri1,4,
A. Gordano1, M. Canonaco3, E. Drioli1,2
1Institute on Membrane Technology, National Research Council
of Italy, ITM-CNR, via P. Bucci cubo17/C, Rende (CS) Italy
2Department of Chemical Engineering and Materials University of
Calabria, via P. Bucci, Rende (CS) Italy
3Comparative Neuroanatomy Laboratory, Department of Ecology,
University of Calabria, via P. Bucci, 87030 Rende (CS), Italy
4Department of Cell Biology, University of Calabria, via P. Bucci,
87030 Rende (CS), Italy
Biomaterials such as membranes have become of great interest,
since they offer the advantage of developing neuronal tissue that
may be used for in vitro simulation of brain function. In an attempt
to develop a membrane biohybrid system constituted of mem-
branes and neurons the behaviour of neurons isolated from the
hippocampus of the hamster Mesocricetus auratus were studied on
membranes with different morphological properties.
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Polymeric membranes in polyester (PE), modified poly-
etheretherketone (PEEK-WC), fluorocarbon (FC) and poly-
ethersulfone (PES) coated with poly-L-lysine with different
morphological surface properties (e.g., pore size, porosity and
roughness) were used as substrates for cell adhesion.
Confocal and SEM analyses demonstrated that in response to
varying the roughness of the membrane surface, hippocampal
neurons exhibited a different morphology. Indeed cells grown on
smoother membranes differentiated with a large number of neuritis
with consequent formation of bundles. As a consequence while a
very complex network was formed on FC membrane, cells tend to,
instead, form aggregates and most of the processes are developed
inside the pores of the membranes when rougher PEEK-WC sur-
faces were used. Metabolic results in terms of glucose consump-
tion, lactate production and BDNF secretion confirmed the effect
of roughness on the cell behaviour: neurons exhibited BDNF se-
cretion at high levels on FC membranes with respect to the other
membranes. Taken together these results suggest the pivotal role
played by membrane roughness in the adhesion and differentiation
of the hippocampal neurons and may thus constitute a valuable
approach for future neurobiological studies.
(OP 97) Effect of Surface Modification on Morphology,
Mechanism and Function of Human Adipose-Derived Stem
Cells
K.D. Song1, P.F. Wen1, G.Y. Mei1, T.Q. Liu1, X.H. Ma1, Z.F.
Cui2
1Dalian University of Technology, Dalian R&D Center for Stem
Cell and Tissue Engineering, Dalian, 116023, China
2Oxford University, Department of Engineering Science, Oxford
OX1 3PJ, UK
The effect of surface modification by using three materials, chit-
osan, gelatin and poly-ornithine on the morphology, mechanism
and cell adhesion function of human adipose-derived stem cells
(hADSCs) were observed under atomic force microscope (AFM),
and the chemical actions between surface coatings and hADSCs
were further investigated by using Raman spectra. The mechanism
and morphology of hADSCs were observed under AFM, the exis-
tence on the glass slides modified with above three materials with
different concentrations of 2%, 1%, 0.5% and 0.25% (w/w) re-
spectively were also qualitatively assayed. Then, the growth con-
dition and distribution of hADSCs on different coated surfaces were
surveyed under inverted microscope and by hochest/PI double
stainings. The mechanism of hADSCs and the effect of chemical
actions between these materials and cells on cellular structure and
performance were analyzed at molecular level. The results showed
that the existence of surfaces modified with different concentrtions
presented tremendous difference, the mean sizes of surface mod-
ificaitons were decreased with the degrade of concentration. The
surface modified by protein groups showed rugged and rough with
high-low protuberance, resulting in the comparative large rugosity.
But to chitosan, the surface appeared very smooth and lower ru-
gosity. The cell quantity and conditions on the surface modified by
protein groups were clearly better than that of chitosan. The cellular
structure and characteristic functional group of hADSCs were an-
alyzed and dertemined by Raman spectra. It is indicated that the
surface modification and its morphology play important roles to the
cellular structure and function of stem cells.
(OP 98) Effective Nutrient Supply through Multi-Layer
Scaffolds
Bernke Papenburg1, Jun Liu2, Ida-Jacoba de Vries1, Dimitris
Stamatialis1, Jan de Boer2, Clemens van Blitterswijk2, Matthias
Wessling1
1Membrane Science and Technology, Institute for Biomedical
Technology, University of Twente, Enschede, The Netherlands
2Department of Tissue Regeneration, Institute for Biomedical
Technology, University of Twente, Enschede, The Netherlands
Introduction and Method: In tissue engineering scaffolds, the de-
livery of nutrients to cells and removal of waste products and cell
metabolites is of outmost importance.
In previous work [1] we presented the preparation of highly
porous (porosity> 80%) micropatterned poly(l-lactic acid) (PLLA)
sheets and showed the potential of multi-layer staking these sheets
in 3-D constructs. The porous micropatterned sheets are prepared
by one-step fabrication method Phase Separation Micromolding
(PSmM) which is based on immersion precipitation on a micro-
patterned mold replicating the micropattern into the polymer sheet.
Nutrient transport can take place through the inner-porosity of
the sheets as well as via perfusion of the micropatterned channels.
This work focuses on nutrient supply through these layers.
Glucose and culture medium transport through the sheets with and
without cells is studied to investigate the effect of the cell sheet
layer on nutrient transport.
Results and Discussion: Modeling shows that nutrient diffusion
is sufficient up to a few sheet layers for static culturing and low cell
density. However, for clinical relevant constructs (1 mm thick-
ness) more sheets are needed and nutrient transport through the
sheets in static culture is not sufficient anymore. Preliminary ex-
perimental results confirm these predictions.
The preliminary experiments indicate as well that the cell sheet
layer might in fact be the limiting step in nutrient transport through
the porous sheet layers, and perfusion of the micropattern channels
is required to ensure sufficient nutrient transport through the
complete multi-layer scaffold.
Reference:
1Papenburg, B.J, et al., Biomaterials 28(2007), 1998
(OP 99) Electrospun Polymeric Meshes for Application in
Bone and Cartilage Regeneration
D. Puppi1, N. Detta1, A.. M. Piras1, F. Chiellini1, I. Fascione1,
E. Chiellini1
1Laboratory of Bioactive Polymeric Materials for Biomedical and
Environmental Applications (BIOlab)–UdR INSTM, Department
of Chemistry & Industrial Chemistry, University of Pisa, Via
Vecchia Livornese 1291 56122 S. Piero a Grado, Pisa (Italy)
A successful approach in tissue engineering practice is related to the
development of bioactive scaffolds with proper biocompatibility,
morphology and mechanical strength. In this work, the evaluation
and processing of raw polymeric materials, the characterization of
the manufactured systems and their culturing in dynamic environ-
ment are performed. Three-arm star poly(epsilon-caprolactone)
(PCL*), 88% hydrolyzed polyvinylalcohol (PVA) and poly(lactic-
co-glycolic acid) (PLGA), were processed by means of a custom-
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ized electrospinning apparatus allowing control over applied volt-
age, solution flow rate, aeration and collection shape and size.
Processing conditions were optimized and correlated to morphol-
ogy and mechanical properties of the collected meshes. Morphol-
ogy and mechanical properties of PCL* meshes were significantly
affected by flow rate (e.g. fiber diameter of 1,5 micron at 1 ml/h
and 2,75 micron at 16 ml/h). Cytocompatibility in vitro tests on
these meshes showed cell viability at 12th day. PVA meshes dis-
played fiber size ranging between 100–500 nm and strength and
strain at break comparable to those of human articular cartilage.
Mesh stabilization in aqueous environment was accomplished by
glutaraldehyde crosslinking, without affecting fibers morphology.
Regarding PLGA fibrous meshes, the fiber size depended mostly on
voltage and flow rate, varying within 1 and 5 micron. The loading of
active agents was also approached by preparing albumin-loaded
PVA meshes and retinoic acid-loaded PLGA meshes. Preliminary
testing showed encouraging results in terms of effective loading
and controlled release. Finally, in order to perform dynamic cell
culture onto the optimized meshes, a bioreactor system allowing for
the employment of either a perfusion or a rotating wall chamber
was designed.
(OP 100) Electrostatically Spun Scaffolds with Controlled
Topographies Induce Changes in Stage-Specific Schwann Cell
Development, Myelination and Functioning
K.D. Andrews1, J.A. Hunt1
1UKCTE, Division of Clinical Engineering, University of Liver-
pool, UK
A tissue engineered solution to peripheral nervous system damage
or disease is increasingly sought. The Schwann cell is vital in
maintaining, regenerating and protecting these peripheral nerve
structures and cells, and in its ability to develop lineage-specific
functionality, particularly myelination. The aim of this work was to
investigate the potential of electrostatically spun scaffolds, with
controlled topographies, to control the cellular development and
specific functioning.
A range of polyurethane scaffolds (Tecoflex SG-80A) was
electrostatically spun using different spinning parameters. Scaf-
folds were characterised using SEM, AFM, image analysis and
FTIR, for inter-fibre separation, fibre diameter, surface roughness,
void fraction, fibre orientation and surface chemistry. UV-Ozone
sterilised scaffolds were cell-seeded with human Schwann cells
(5104 cells per 1cm2 of sample), for culture periods of 1, 2, 4, 7,
14 and 28 days. Immunohistochemistry for a range of extra-
cellular matrix, adhesion, function and developmental stage-
specific markers was analysed. SEM and image analysis examined
cell coverage, number, spreading, orientation and cellular inter-
actions.
All scaffold forms were determined through the fabrication
conditions. All aspects of underlying topographical features di-
rectly induced changes in cellular behaviour, with increased to-
pography producing a ‘‘lag’’ in the cellular responses. The scaffold
properties were also significantly linked to differences in the ad-
hesion mechanisms, with high upregulation of extracellular matrix
molecules correlating with increased topographical features. To-
pography also correlated with cell development, with individual
scaffolds directly inducing stage-specific changes in myelin pro-
duction and cell functionality.
Electrostatically spun PU scaffolds showed significant potential
as controllable scaffolds for application-specific peripheral ner-
vous system tissue engineering.
(OP 101) Enabling Technologies for Tissue Engineering and
Regenerative Medicine
M. Van Dyke1
1Wake Forest Institute for Regenerative Medicine, Wake Forest
University Health Sciences, Winston-Salem, NC 27157
Tissue engineering and regenerative medicine has emerged as an
innovative scientific field that focuses on development of new
approaches to repairing cells, tissues and organs for clinical ap-
plications. Recent advances in this field have offered new thera-
peutic opportunities that facilitate the restoration and maintenance
of normal tissue function. Consistent with the goals of tissue en-
gineering and regenerative medicine, we have followed a strategy
that has shown to be effective clinically. This approach involves
the use of biocompatible matrices either with or without cells. The
matrices are either used as cell delivery vehicles or as scaffolds to
promote and enhance tissue regeneration. When cells are used,
donor tissue is dissociated into individual cells, which are ex-
panded in culture, attached to a support matrix, and re-implanted
into recipient for recovery of tissue function.
Over the past several years, research investigations have
been actively pursued in various tissue systems using a paradigm
for tissue engineering and regenerative medicine that utilizes
combinations of biomaterial scaffolds and cells. Although these
engineered tissues have shown their potential applicability ex-
perimentally, only a limited number have successfully translated
to clinical trial. This is due to various obstacles encountered in the
tissue building process. Recent advances in novel biomaterials,
new sources of cells, and scaffold fabrication strategies are being
applied to these challenges. Significant progress has already been
made in the development of the next generation of enabling
technologies.
(OP 102) Endothelial Adhesion Molecule Expression on
Electrospun Small Diameter Vascular Grafts
C. Grasl1,2, M. Stoiber1,2, H. Schmallegger1, H. Bergmeister2,3, H.
Schima1,2,4, G. Weigel2,4
1Center for Biomedical Engineering and Physics, Medical Univ.
Vienna, Austria
2Ludwig Boltzmann Cluster for Cardiovascular Research, Vienna,
Austria
3Core Unit for Biomedical Research, Medical Univ. Vienna,
Austria
4Department of Cardiothoracic Surgery, Medical Univ. Vienna,
Austria
The introduction of new vascular substitutes requires extensive pre-
clinical characterization e.g. assessment of phenotypical changes of
endothelial cells (EC) occurring after attachment to artificial scaf-
folds. In this study spontaneous attachment, proliferation, and ad-
hesion molecule expression of EC seeded onto electrospun, small
diameter polyurethane grafts was studied in vitro.
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Human EC were seeded onto the luminal surface of the pros-
theses without additional pre-coating. Cell attachment and ex-
pression patterns of the endothelial adhesion molecules E-Selectin,
ICAM-1, and VCAM-1 were studied using an immunogold label-
ing technique, scanning electron microscopy, and energy dispersive
X-ray analysis (EDX). Mechanical properties of the prostheses
were characterized by suture force measurement.
Vascular prostheses with an inner diameter of 2 mm, a uniform
wall thickness of 0.1 mm and fiber diameters ranging from 500 to
2500 nm were fabricated. Electrospun polyurethane grafts showed
a two-fold higher resistance to suture forces compared to native
arteries. EC attachment was easily achieved without pre-coating
the fiber matrix. Stimulation of EC with interleukin-1beta led to a
significant upregulation of the adhesion molecules investigated.
EDX quantitation showed no differences in the stimulatory re-
sponses of EC cultured on electrospun polyurethane in comparison
to cells grown on tissue culture-treated coverslips.
We have shown that proper adjustment of the electrospinning
parameters allows for the production of small diameter polyure-
thane grafts which are suitable for spontaneous EC attachment.
The underlying synthetic graft surface did not impair the endo-
thelial response toward IL-1 stimulation or adversely affect the
regulation of adhesion molecules known to be crucially involved in
endothelial-leukocyte interactions.
(OP 103) Endothelial Progenitor Cell Dysfunction in Patients
with Progressive Chronic Renal Failure
G. Krenning1, P.Y.W. Dankers1, W.J. Drouven1, F. Waanders2,
C.F.M. Franssen3, R.R.H. Nap3, M.J.A. van Luyn1, M.C. Harm-
sen1, E.R. Popa1
1Stem Cell & Tissue Engineering Research Group, Dept. Pathol-
ogy & Medical Biology, University Medical Center Groningen,
University of Groningen, Groningen, The Netherlands
2Dept. Nephrology, University Medical Center Groningen, Gro-
ningen, The Netherlands
3Dialysis Center Groningen, University Medical Center Gronin-
gen, Groningen, The Netherlands
Patients suffering from end-stage renal failure are plagued by
vascular complications such as thrombus formation of the he-
modialysis shunt. Regenerative medicine aims to relieve these
vascular symptoms by amongst others tissue engineering of au-
tologous vascular shunts, combining endothelial cells and biode-
gradable materials. Autologous endothelial cells can be isolated
from progenitor cells in the circulation from two distinct cell
populations; the rare CD34-positive endothelial progenitor cell
(EPC) and the more common CD14-positive EPC. However,
vascular diseases often appear to associate with impaired EPC
function. We hypothesize that patients with chronic renal failure
(CRF) also have impaired EPC function. We therefore assessed
the EPC numbers in the circulation of CRF patients during disease
progression and dialysis treatment. Furthermore, we assessed
angiogenic differentiation and endothelial cell function of these
patient-derived EPC after culture on biodegradable diureido-
pyrimidinone polycaprolactone (PCLdiUPy). The frequency of
circulating CD14-positive EPC in the circulation of CRF patients
did not differ from healthy controls. In contract, CD34-positive
EPC numbers decreased in all patient groups. In vitro, EPC of
CRF patients showed a strongly reduced adherence to PCLdiUPy
and a strongly reduced capacity for angiogenic differentiation.
This was observed for all stages of CRF. Noticeably, the
antithrombogenic behavior from EPC-derived endothelial cells
did not differ between CRF-patients and healthy controls. In
conclusion, autologous EPC from CRF patients are inappropriate
for tissue engineering of hemodialysis shunts. Further research
should reveal the causes of reduced adherence and aim at the
development of ‘smart’ biomaterials that augment adhesion and
differentiation.
(OP 104) Engineered Cartilage Generated by Nasal Chon-
drocytes is Responsive to Physical Forces Resembling Joint
Loading
A. Barbero1, C. Candrian1,2, E. Bonacina1,3,4, D. Vonwil1,
J. Farhadi1, D. Wirz5, S. Dickinson6, M. Jakob1, M. Alini7,
I. Martin1
1Departments of Surgery and of Biomedicine, University of Basel,
Switzerland
2Departments of Orthopaedic Surgery and Traumatology, Bru-
derholzspital, Basel, Switzerland
3Istituti Ortopedici Galeazzi, Milano, Italy
4LaBS, Bioingeneering Department, Politecnico di Milano, Mi-
lano, Italy
5LaBS, University of Basel, Switzerland
6Department of Cellular & Molecular Medicine University Walk,
Bristol, UK
7AO Research Institute, Davos, Switzerland
We tested whether Engineered Cartilage generated by Nasal
chondrocytes (ECN) is responsive to different regimes of loading,
associated with joint kinematics and previously shown to be
stimulatory of Engineered Cartilage generated by Articular chon-
drocytes (ECA).
Human nasal and articular chondrocytes, harvested from 5
individuals, were expanded and cultured for 2 weeks into po-
rous polymeric scaffolds. The resulting ECN and ECA were
then maintained under static conditions or exposed to the following
loading regimes. Regime1: Single application of cyclic deforma-
tion for 30 minutes. Regime2: Intermittent application of cyclic
deformation for a total of 10 days, followed by static culture for
2 weeks. Regime3: Application of surface motion for a total of
10 days.
Prior to loading, ECN constructs contained significantly hig-
her amounts of glycosaminoglycans (GAG) (1.7-fold) and type-II
collagen (1.7-fold) than ECA. ECN responded to Regime 1 by
increasing collagen (1.4-fold) and proteoglycan synthesis (1.4-
fold), to Regime 2 by increasing the accumulation of GAG (1.5-
fold) and type-II collagen (1.6-fold), as well as the dynamic
modulus (1.3-fold), and to Regime 3 by increasing the expression
of superficial zone protein, at the mRNA (32.9-fold) and protein
level (1.4-fold), as well as the release of hyaluronan (1.4-fold).
ECA constructs were overall less responsive to all loading regimes,
likely due to the lower extracellular matrix content.
Human ECN is responsive to physical forces resembling joint
loading and can upregulate molecules typically involved in joint
lubrication. The findings prompt for in vivo studies exploring the
possibility of using nasal chondrocytes as a cell source for articular
cartilage repair.
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(OP 105) Engineered Heart Tissue for Target Validation and
Cardiac Repair
T. Eschenhagen1
1Institute of Experimental and Clinical Pharmacology and Tox-
icology, University Medical Center Hamburg Eppendorf, Ham-
burg, Germany
Over the past years methods have been developed to generate 3-
dimensional, spontaneously and coherently beating engineered heart
tissues (EHT) from embryonic chick, neonatal rat and mouse cardiac
myocytes. Circular EHT may be useful as an in vitro model for
target validation and drug screening for several reasons. (i) The
system provides cardiac cells with a more physiological, 3D envi-
ronment than classical 2D cultures, (ii) allows measurement of force
of contraction, contraction kinetics and beating rate under con-
trolled, isometric conditions, (iii) is stable for weeks, and (iv) allows
efficient genetic manipulation with adeno- and lentivirus (overex-
pression, gene silencing). On the other hand, EHT have been tested
as graft material for cardiac repair and improved the function of
infarcted rat hearts. To translate the EHT approach to patients and to
develop a human heart muscle system, recent efforts concentrate on
optimizing experimental conditions for generating EHTs from hu-
man embryonic (hESC) and adult stem cells. To this end, cells from
hESC-derivedspontaneouslybeatingembryoidbodiescanbedispersed
and reassembled to generate human EHTs that contract synchro-
nously, develop force of contraction and react to pharmacological
stimulation qualitatively similar to normal human heart muscle.
(OP 106) Engineering Cartilage Like Tissue Using Polymeric
Systems Derived from 2-Ethyl-2-Pyrrolidone-Methacrylate
Combined with Hyaluronic Acid
J. Magalha˜es1, J. San Roman1, A. Crawford2, P.V. Hatton2, R.A.
Sousa3,4, R.L. Reis3,4
1Instituto de Ciencia y Tecnologı´a de Polı´meros CSIC, Juan de la
Cierva 3, 28006-Madrid, Spain
2Univ Sheffield, Sch Clin Dent, Ctr Biomat & Tissue Engn,
Claremont Crescent, Sheffield S10 2TA, S Yorkshire England
33B’s Research Group—Biomaterials, Biodegradables, and Bio-
mimetics, Department of Polymer Engineering, University of
Minho, Campus de Gualtar, 4710-057 Braga, Portugal
4IBB–Institute for Biotechnology and Bioengineering, PT Gov-
ernment Associated Laboratory, Braga, Portugal
Hydrogels are potential candidates for Tissue engineering (TE),
because of their water content, transport properties, and tissue like
physical and chemical behaviour. This project was based on the
production and characterization of implantable stimuli responsive
scaffolds made of hyaluronic acid (HA) that presents a high water
retention character, in combination with 2-ethyl (2-pyrrolidone)
methacrylate (EPM), possessing temperature-dependent solubility
in water, by bulk polymerization.
Semi-interpenetrated networks were produced with different
EPM and HA concentrations using K2S2O8 as an initiator and
triethylene glycol dimethacrylate or N,N-methylene-bisacrylamide
as crosslinkers. PEPM-HA hydrogels were washed and freeze
dried. Characterization of the systems was assessed by NMR,
ATR-FTIR and SEM techniques. The swelling degree and degra-
dation behaviour studies were conducted in a phosphate buffer
solution. Biocompatibility studies were performed by culturing
bovine chondrocytes (BC), L929, ROS and MES in the PEPM-HA
hydrogels. After evaluating the cells’ viability, BC were cultured
under agitation for a period of 6 weeks. Distribution, morphology
and extracellular matrix components deposition during the exper-
iment were analysed. The different combinations of EPM-HA and
crosslinkers led to hydrogels with different porous structures that
could be intimately related to their swelling character. When BC
where incubated for 72 h in different PEPM-HA hydrogels, cells
remained viable and therefore were cultured for a longer period of
time to predict their suitability for a cartilage TE approach. PEPM-
HA hydrogels may constitute a valid alternative for pursuing future
cartilage tissue engineering strategies.
(OP107)EngineeringofHypertrophicCartilage forBoneRepair
A.Kwarciak1, A.Crawford1, P.V.Hatton1, I. Brook1, H. Redl2,
M. van Griensven2
1Centre for Biomaterials & Tissue Engineering, University of
Sheffield, UK
2Ludwig Boltzmann Institute for Experimental and Clinical
Traumatology, Vienna, Austria
Introduction: Using a hypertrophic cartilage graft could be an al-
ternative approach to bone repair. Cartilage can survive in a rela-
tively hypoxic environment, giving time for vascularization of the
engineered graft to develop post-implantation. The aim of this
research was to utilize different culture conditions to investigate
whether nasal chondrocytes may be used to generate a cartilage
construct with characteristics of hypertrophic tissue.
Methods: Rat nasal chondrocytes (P2) were cultured as pellets
and on PGA scaffolds under conditions that could promote hy-
pertrophic differentiation and matrix mineralisation (chondro-
genic and osteogenic medium, addition of BMP-2, -7, leptin,
b-glycerophosphate). Chondrocyte differentiation was evaluated by
immunolocalisation of collagens (types I, II and X) and histo-
chemical detection of proteoglycans, calcium deposition and alka-
line phosphatase. Further investigation of phenotype (e.g. MMP13,
VEGF, annexin, Runx2 gene expression) and potential of human
nasal chondrocytes in hypetrophic cartilage formation is ongoing.
Results and Conclusion: Expanded chondrocytes successfully re-
differentiated in pellets and on PGA scaffolds. Alkaline phosphatase
activity and collagen type X expression was detected mainly in PGA
constructs, and suggested that chondrocytes were entering the hy-
pertrophic stage (however no matrix mineralisation was detected
even with b-glycerophosphate). In conclusion, nasal chondrocytes
may express a hypertrophic-like phenotype and therefore show some
potential in bone tissue engineering strategies.
Acknowledgements: This work is sponsored by the EC under the
Marie Curie EST programme (MEST-CT-2004-008104) and is
part of the activity of the EXPERTISSUES Network of Excellence
(NMP-2002-3.4.4.2).
(OP 108) Engineering Pre-Vascularized Tissue Substitutes for
Clinical Use
I. Montan˜o1, C. Schiestl2, J. Schneider1, L.Pontiggia1, T. Bie-
dermann1, S. Bo¨ttcher-Haberzeth1, E. Braziulis1, P. Groscurth3,
M. Meuli2, E. Reichmann1
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Initial take, development, and function of transplanted engineered
epithelial substitutes are crucially dependent on the vascular sup-
ply by the adjacent mesenchyme. Therefore, the development of
rapidly and efficiently vascularized (epithelio-mesenchymal) tis-
sue substitutes is vital for tissue engineering and regenerative
medicine. Here we report on the construction of highly organotypic
capillaries in engineered mesenchymal (dermal) substitutes. We
employed a 3D culture system consisting of human microvascular
endothelial cells (HuMECs) isolated at high purity and seeded into
a novel biodegradable fibrin-based hydrogel. The process of cap-
illary formation in vitro was initiated by endothelial cells arranging
into solid cords. Subsequently, these cells developed intracellular
vacuoles that fused with the plasma membrane to form an extended
intercellular lumen. Transplanted vascular structures were stabi-
lized by mural cells recruited from the recipient animal. An au-
tologous tissue substitute that can connect to existing vessels via
inosculation and differentiate its engineered vasculature according
to the tissue type it regenerates, may critically impact the emerging
field of tissue engineering.
(OP 109) Enhancement of Chondrogenesis from Mesenchymal
Stem Cells by Modulation of Signal Transduction Pathways
H.J. Kim1, S.Y. Kim1, G.I. Im1
1Dongguk university hospital
MSCs isolated from human bone marrow have pluripotential ca-
pacity to differentiate into a variety of connective tissue lineages.
However the very multipotentialities of MSCs pose drawbacks as a
source of cells for cartilage repair because MSCs may differentiate
into any tissue type depending on the milieu in which they are cul-
tured. The objective of this study is to test the hypothesis that the
modulation of signal transduction pathway promotes chondrogen-
esis and suppresses hypertrophic changes in the differentiation pro-
cess of MSCs. We employed inhibitors of ERK (PD98059;100 nM)
and p38(SB203580;100 nM) in MAPK pathway, and PTHrP
(100 nM) which maintains chondrocyte phenotypes in growth plate.
To investigate cellular proliferation, amount of DNA was measured
after administration of each drug. DNA content increased by 42%,
21%,and 75% using PD98059, SB203580 and PTHrP treatment
respectively. GAG contents per ug of DNA also increased by 67%,
16%, 46% with PD98059, SB203580 and PTHrP treatment re-
spectively. Safranin-O staining showed that metachromatic staining
and chondrogenic differentaion of cells increased by the treatment
with PD98059 or PTHrP while SB203580 did not notably change
the profile. Immunohistochemical staining for type II collagen
demonstrated that PD98059 or PTHrP enhanced type II collagen
expression in cell and matrix while SB203580 did not affected the
expression. PTHrP reduced the expression of type X collagen
compared with the control whereas SB203580 rather enhanced type
X collagen. The results from this study show that modulators of
signal transduction pathway, especially PTHrP, may be used to
enhance chondrogenesis and suppress hypertrophic changes in the
chondrogenic differentiation.
(OP 110) Enrichment of Adipose-Derived Mesenchymal Stem
Cells Using Resveratrol
C. P. Erdman1, J. Chen1, R. Olivares-Navarrete1, H. R. Moyer1,2,
J. K. Williams2, Z. Schwartz1, B. D. Boyan1
1Wallace H. Coulter Department of Biomedical Engineering,
Georgia Institute of Technology, Atlanta, GA
2Children’s Healthcare of Atlanta, Atlanta, GA
Adipose tissue has been shown to contain a supply of mesenchy-
mal stem cells (MSCs), however improved enrichment techniques
are required before these cells can be used effectively. Resveratrol
inhibits cyclooxygenase and activates Sirt1, which inhibit adipo-
genesis and induce apoptosis in adipocytes. This suggested that re-
sveratrol could reduce the number of adipocyte progenitor cells and
enrich the MSC population with osteogenic progenitors.
Adherent cells were isolated from the inguinal fat pads of
Sprague-Dawley rats, plated at 5,000 cells/cm2, and cultured in
MSC growth media (GM) or osteogenic media (OM) (Lonza)
containing 0, 12.5, or 25mM resveratrol for 7 or 14 days. Flow
cytometry was used to assess expression of MSC or osteoblast
markers in the original population as well as following growth in
GM or OM. MSCs were defined as CD73þ, CD271þ, and CD45.
Osteoprogenitors (OPC) were defined as osteocalcin positive.
Resveratrol caused a dose and time-dependent increase in cell
number and of the percentage of both MSCs and OPCs. In GM
containing 25 mM resveratrol, there was a 577-fold increase in
MSCs at 7 days (5% of population), and a 106-fold increase in
OPCs (21% of population) at 14 days. In OM, 25mM resveratrol
increased MSCs 27.8-fold (18% of population) at 7 days, and
OPCs 29.9-fold (34% of population) at 14 days. These results show
that MSCs and OPCs were present in the original adherent cell
population and that resveratrol treatment enriched both cell pop-
ulations. Moreover, effectiveness of the treatment was reduced
when the adherent cells were cultured in OM.
(OP 111) Enrichment of CD271þ Cells from Culture-
Expanded Mesenchymal Stromal Cells (MSCs) Selects Cells
with In Vivo Bone Forming Capacity
H. Prins1, H. Rozemuller1, B.A. Naaijkens1, I. Slaper-Cortenbach2,
A.C.M. Martens1
1University Medical Center Utrecht
2The Utrecht Center for Gene and Cell Therapy
MSCs are postulated as an attractive stem cell source for bone
tissue engineering (TE), but so far the amount of bone that can be
produced by cultured human MSCs appears to be limited. CD271
defines a subpopulation in bone marrow containing CFU-F with a
high proliferation capacity. We investigated the in vitro growth
kinetics as well as the in vivo bone forming capacity of the culture-
expanded CD271þ MSCs subpopulation.
Adherent cells from BM aspirates were passaged in standard
culture medium until passage 8 (P8) and monitored for CFU-F and
CD271 frequency. During culture, frequencies of CFU-F gradually
decreased from 10% at passage 3 (P3) to 0% at P8 and of the
NGFRþ fraction from 3% to 1%.
P3 CD271þ MSCs were sorted and expanded parallel to un-
sorted cells until P5. At P5, sorting resulted in a 7-fold increase in
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frequency of CD271þ and 2-fold of CFU-F. After seeding of
200,000 P5 cells on Biphasic-Calcium-Phosphate scaffolds, hybrid
constructs were implanted subcutaneously in nude mice, explanted
after 6 weeks and analyzed for bone formation using histo-
morphometry. Sorted CD271þ cells showed a 9-fold improved
bone formation compared to unsorted cells. No bone was formed in
scaffolds without cells or P8 cells.
We show that in vivo bone formation of cultured MSCs resides
in the CD271þ fraction and by selecting this population a better
bone formation was achieved. This finding has implications for
preparation of hybrid constructs in TE and for MSC therapy as a
treatment for bone related diseases.
(OP 112) Establishment of Continuously Growing Human
Adult Stem Cells from Adipose Tissue and Amnion for Cell-
Based Therapies
S. Wolbank1,2, M. Karbiener3, G. Stadler4,5,2, A. Peterbauer1,2,
A. Gillich3, H. Katinger3, J. Grillari3, M. van Griensven4,2,
H. Redl4,2, R. Voglauer3
1Red Cross Blood Transfusion Service of Upper Austria, Linz,
Austria
2Austrian Cluster for Tissue Regeneration
3Institute for Applied Microbiology, University of Natural Re-
sources and Applied Life Sciences, Vienna, Austria
4Ludwig Boltzmann Institute for Experimental and Clinical
Traumatology/AUVA research center, Linz/Vienna, Austria
5Bio-Products & Bio-Engineering AG, Vienna, Austria
Recently, stem cell sources including adipose tissue or amniotic
membrane have evolved as interesting targets for tissue regeneration
research. However, due to lack of telomerase activity, mesenchymal
stem cells cease growth after a limited number of population dou-
blings which limits long-term analysis and expansion before use in
cell-based therapies. Additionally, telomerase deficiency might
impair the cells’ differentiation potential as has been reported for
bone-marrow mesenchymal stem cells. In order to get more in-
sights into the role of telomerase in the general development of
stem cells from adipose tissue and amnion, the catalytic subunit
of human telomerase (hTERT) was overexpressed in these cells.
Subsequently, the cellular phenotype, growth characteristics, surface
marker profile, differentiation potential, immunogenic and immu-
nomodulatory properties of the resulting stem cell lines were moni-
tored. Indeed, while all of these analysed stem cell characteristics
remained unaltered, the replicative life span was largely extended
and growth characteristics were improved. Interestingly, among the
generated hTERT lines, stem cell lines with reduced and improved
differentiation and immunomodulatory potency were identified.This
study therefore emphasizes that ectopic expression of hTERT
maintains the parental phenotype of adipose and amnion derived
mesenchymal stem cells and thus will be a useful tool for studying
cell differentiation and tissue engineering approaches.
Acknowledgments: HIPPOCRATES (NMP3-CT-2003-505758),
EXPERTISSUES (NMP3-CT-2004-500283).
(OP 113) Ethical Issues in Soft Tissue Engineering for Con-
genital Birth Defects in Children–What Do Experts in the
Field Say?
A.J.M. Oerlemans1, H.C.M.L. Rodrigues2, M.A. Verkerk2, P.P.
van den Berg3, W. Dekkers1
1Department of Ethics, Philosophy and History of Medicine,
Radboud University Nijmegen Medical Centre
2Health Sciences/Medical Ethics, University of Groningen/
University Medical Centre Groningen
3Department of Obstetrics and Gynaecology, University Medical
Centre Groningen
Paediatric applications of tissue engineering are expected to raise
some unique moral questions. For instance, how should we deal
with the unpredictability of the (long-term) effects of the materials
used? And, is it morally acceptable to subject young children to
highly experimental interventions? The use of soft tissue engi-
neering for the treatment of congenital defects in children is the
focus of the EuroSTEC project, which takes a translational route
through in vitro and animal experiments to clinical trials and
(eventually) clinical practice. To be able to respond adequately and
timely to possible future moral issues, a prospective and antici-
patory ethical analysis is essential.
Review of medical and ethical literature yielded an initial idea
of the issues that might arise. To investigate what moral issues, if
any, experts in the field expect to occur during development of
tissue engineering applications for structural defects, a Delphi
study was started, targeting professionals involved in EuroSTEC.
Through a questionnaire consisting of open-ended questions, par-
ticipants were invited to express their opinion about possible
(future) ethical issues.
The first round of the Delphi study saw a response rate of 60%.
The different nationalities, institutions, educational backgrounds
and roles in the project were well represented among respondents.
A first analysis showed that content of the answers was highly
variable; ranging from no moral issues listed to a multitude for
each phase. At the conference, a thorough analysis of the results of
the first Delphi round and their conversion into topics for future
rounds will be presented.
(OP 114) European Human Embryonic Stem Cell Registry—
hESCreg
J.M. Borstlap1, A. Kurtz2, G. Stacey3, A. Elstner2, A. Da-
maschun1, B. Aran4, A. Veiga4,5
1CellNet Initiative, Berlin-Brandenburg Center for Regenera-
tive Therapies (BCRT), Charite´–Universita¨tsmedizin Berlin,
Germany
2Cell Therapy Group, Berlin-Brandenburg Center for Re-
generative Therapies (BCRT), Charite´–Universita¨tsmedizin Ber-
lin, Germany
3The UK Stem Cell Bank, National Institute for Biological
Standards and Control, London, UK
4Banc de Lı´nies Cel.lulars, Center of Regenerative Medicine
Barcelona (CRMB)
5Institut Universitari Dexeus. Barcelona. Spain
The European Human Embryonic Stem Cell Registry (hESCreg)
is a publicly accessible internet site for researchers to sub-
mit and obtain information on hESC lines, their availability,
characteristics and utilisation. The primary objective of hESCreg
is to pool comprehensive information on cell lines, starting
with those that have been derived in Europe and also non-
European lines, which are available to the scientific community
at large.
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Defined eligibility criteria guarantee a common standard for
registration of each cell line in the registry. Scientific annotations
on the cell lines include specific features, culture conditions, results
obtained with the cells, information about differentiation potential,
gene expression and application. Provided information will be
regularly updated and completed.
Furthermore, information on the regulatory framework in the
countries involved in hESC research will be provided as well as
communication and feedback mechanisms. The registry closely
co-operates with other European hESC research projects, as well as
national and international registries and aims to contribute to the
establishment of standardized evaluation parameters for human
ESC lines.
hESCreg is co-ordinated by BCRT at Charite´ Universita¨-
tsmedizin Berlin and the Stem Cell Bank of Barcelona at the CRMB.
It is supported by an international Scientific Advisory Board and an
Ethics Advisory Board to guarantee quality, reproducibility, com-
parability and transparency of the registry. The UK StemCell Bank
is a lead partner and responsible for quality assessment, code of
practice and information on listed cell lines.
hESCreg is funded by the European Commission as a Specific
Support Action within FP6.
(OP 115) Evaluating Cell Sources for Osteochondral Tissue
Engineering
A. Peterbauer1,2, S. Hennerbichler1,2, G. Stadler2,3,4, F. Hildner2,3,
H. Redl2,3, M. van Griensven2,3, C. Gabriel1,2, S. Wolbank1,2
1Red Cross Blood Transfusion Service of Upper Austria, Linz,
Austria
2Austrian Cluster for Tissue Regeneration
3Ludwig Boltzmann Insitute for Experimental and Clinical
Traumatology, AUVA Research Centre, Vienna/Linz, Austria
4Bio-Products & Bio-Engineering AG, Vienna, Austria
Finding a promising cell source to achieve a viable tissue engi-
neering construct for osteochondral transplantation was one of
the tasks in Hippocrates. Hence, we established and character-
ized primary cell cultures from different origins including amniotic
membrane, Wharton’s Jelly from umbilical cord, articular carti-
lage, adipose tissue and bone marrow. For all cell sources, isola-
tion, expansion and differentiation protocols were established and
optimized.
Human cell populations were additionally characterized re-
garding their immunomodulatory potential demonstrating contact-
and dose-dependent immunosuppression of mesenchymal and
epithelial amniotic SC populations as well as adipose-derived SC.
For testing a tissue engineered osteochondral construct in a larger
animal model cells from this species have to be applied to avoid
host-versus-graft reactions. Hence, we established also protocols for
harvesting, isolation, expansion, differentiation and scaffold seeding
for porcine bone marrow mesenchymal stem cells and porcine
adipose-derived stem cells for use in autologous in vivo models.
For small animal experiments cells from different sources were
labelled by reporter genes and assessed in vivo by bioluminescence
and in vitro by fluorescence microscopy. Cultures of human mes-
enchymal stem cells transiently transfected with a reporter gene
were able to express the trans-gene for up to 3 weeks. The intro-
duction of a reporter gene in the cells allows cell tracking over
several days also in an in vivo experiment.
Acknowledgments: HIPPOCRATES (NMP3-CT-2003-505758),
Lorenz Boehler Fonds, EXPERTISSUES (NMP3-CT-2004-
500283).
(OP 116) Evaluation of Biomaterials-Based Tissue Engineer-
ing Technology for Regeneration Therapy
Y. Tabata1
1Department of Biomaterials, Institute for Frontier Medical Sci-
ences,
To induce the natural regeneration and repairing of tissues and
organs based on the self-healing potentials of body, there are two
approaches; cell transplantation and tissue engineering. Tissue
engineering is a biomedical technology or methodology to artifi-
cially create the environment which enables cells to enhance their
proliferation and differentiation for tissue regeneration by making
use of biomaterials. When applied to a certain tissue defect, a 3-
dimensional scaffold of biomaterials with a good compatibility to
cells will function as a substrate for cell-induced tissue regenera-
tion. However, there are some cases when the mechanical property
of scaffold is too poor to expect successful regeneration of bulky
tissue. As one trial to tackle the problem, polymer fibers and ce-
ramic granules are incorporated to mechanically reinforce the
scaffold. In the body tissue, bio-signaling molecules (growth fac-
tors and genes) enable cells to enhance the proliferation and dif-
ferentiation for regeneration and repairing of tissues. To enhance
the in vivo efficacy of growth factor, the combination with drug
delivery system (DDS) is practically promising. Substantial com-
bination with DDS-modified growth factor is integrated to provide
the scaffold with a biological function. For example, a scaffold of
gelatin sponge capable for the controlled release of osteogenic
BMP-2 could facilitate bone formation more homogeneously in the
sponge at a larger volume. In this paper, some results on tissue
regeneration by the cell scaffold and controlled release technolo-
gies are presented to emphasize significance of biomaterials-based
tissue engineering in regeneration therapy.
(OP 117) Evaluation of Different Culture Conditions for Hu-
man Mesenchymal Stem Cells Derived from Second Trimester
Amniotic Fluid
N. Ochsenbein-ko¨lble 1, Y. Ozog 1, G. Verbist 1, L. Vercruysse 1,
V. Van Duppen2, K. Theunissen 2, J-P. Fryns 3, R. Lories 4,
L. Gucciardo1, J. Deprest 1
1Department of Obstetrics and Gynecology, University Hospital
Gasthuisberg, Leuven, Belgium
2Department of Hematology, University Hospital Gasthuisberg,
Leuven, Belgium
3Center for Human Genetics, University Hospital Gasthuisberg,
Leuven, Belgium
4Department of Rheumatology, University Hospital Gasthuisberg,
Leuven, Belgium
Objective: To examine growth, phenotypic characteristics and
differentiation potential of isolated mesenchymal stem cells
(MSC) from second trimester amniotic fluid (AF) under different
culture conditions.
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Study Design: MSC were co-cultured on fibronectin, gelatin and
polystyrene using three different culture media. Medium 1, 2 and 3
were earlier proposed growing human AF-derived MSC (in’t Anker
2004), amnion mesenchymal cell (Ochsenbein-Ko¨lble 2003) and
bone marrow-derived mesodermal progenitor cell (Reyes 2001).
MSC were characterized after at least 15 cell doublings by mor-
phology and FACS-analysis and differentiation potential by im-
muno- and cytochemical staining. Karyotyping was performed prior
and after> 15 cell doublings in order to show cytogenetic stability.
Results: Human MSC were isolated from second-trimester AF.
Cell doubling time ranged between 49–104 h depending on culture
conditions. Cytogenetic analysis showed normal karyotype. Med-
ium 2 containing fetal bovine serum, epithelial growth factor, in-
sulin, transferrin and tri-iodothyronine, stimulated cell growth better
than the other two media and resulted in over 36 cell doublings.
Flow cytometry of cells showed typical MSC phenotype, posi-
tive for CD166, CD105, CD73, CD44, CD29 & HLA-ABC, but
negative for CD45, CD34, CD14 & HLA-DR. The cells showed
potential of differentiation into osteoblasts.
Conclusion: We were able to identify the most potent medium
and culture conditions for AF-derived MSC. This protocol is fur-
ther being used to explore the potential of AF-MSC in perinatal
tissue engineering. Work supported by a grant of the European
Commission (6th Framework Programme www.eurostec.eu,
LSHC-CT-2006-037409).
(OP 118) Evaluation of Sterilization Procedures for Collagen-
Based Matrices
Kaeuis A. Faraj1,2, Katrien M. Brouwer1, Elly M.M. Versteeg1,
Willeke F. Daamen1, Wout F. Feitz3, Toin H. van Kuppevelt1
1Dept. of Biochemistry 280, Radboud University Nijmegen
Medical Centre, NCMLS, The Netherlands
2EMCM BV, Nijmegen, The Netherlands
3Dept. of Urology 659, Radboud University Nijmegen Medical
Centre, The Netherlands
Introduction: A challenge in the use of collagen scaffolds as bio-
medical implants is the sterilization procedure, since this biologi-
cal material collagen damages/denatures easily upon sterilization.
The objective of this work is to evaluate the current available
sterilization processes gamma-irradiation, beta-irradiation and
ethylene oxide (ETO) to find the most appropriate method for
sterilization of lyophilized collagen scaffolds. These sterilization
processes are compared with non-sterilized scaffolds.
Materials and Methods: Preparation of type I collagen scaffolds:
Type I collagen scaffolds were prepared by means of freezing
and subsequent lyophilization. Scaffolds were chemically cross-
linked with/without heparin.
Applied sterilization procedures:
- 5 kGy Gamma-irradiation
- 10 kGy Gamma-irradiation
- 20 kGy Gamma-irradiation
- Beta-irradiation
- ETO
Characterization of scaffolds after sterilization: Scanning Elec-
tron Microscopy (SEM) was used to study the ultrastructure of the
scaffolds; SDS-PAGE was used to determine degradation prod-
ucts. The extent of scaffold crosslinking and the heparin content
were determined before and after sterilization.
Results: The gamma-sterilized scaffolds showed severe mor-
phology changes, while sterilized scaffolds by ETO and beta-
irradiation remained almost unchanged.
On a SDS-PAGE gel, Gamma-irradiated scaffolds showed col-
lagen breakdown products, especially in non-crosslinked scaffolds.
The amount of amine groups showed differences after sterili-
zation; Gamma-sterilization resulted in a dose-dependent decrease
of amine groups. ETO sterilization also gave some decrease.
No differences were found in the amount of bound heparin
(~17%) after various sterilization procedures.
Conclusion: This study shows that both beta-irradiation and
ETO sterilization are promising methods to preserve the ultra-
structure of collagen scaffolds.
(OP 119) Evaluation Technology of Tissue Engineered Con-
structs for Regenerative Medicine
H. Ohgushi1, M. Hirose1, Y. Katsube1, A. Sakaguchi2, A. Iwama2,
M. Harada2, H. Yamamoto2
1National Institute of Advanced Industrial Science and Technol-
ogy (AIST)
2SANYO Electric Co., Ltd
In order to realize an early introduction of regenerative medicine
for practical use, it is necessary to ensure its safety and effec-
tiveness. At the same time, development of related technologies,
including devices to enable efficient measurement and evaluation
of various characteristics of cells to be used, is needed. Many
grants from Japanese government support the research in regen-
erative medicine. The New Energy and Industrial Technology
Development Organization (NEDO) has organized one project to
evaluate the process/products of regenerative bone, cartilage, heart
and cornea. In this symposium I will focus on the technology,
especially bone tissue engineering.
We have already treated the patients having osseous problems
by using tissue engineered constructs. The construct consists of
osteogenic differentiated cells (osteoblasta) derived from patient’s
bone marrow mesenchymal stem cells (MSCs) and bone matrix
produced by the osteoblasts on various kinds of biomaterilas. To
evaluate the constructs, we have developed in situ monitoring
system to estimate the quantity of the bone matrix. We added
calcein or tetracycline in the medium during the osteogenic culture
of patient’s mesenchymal stem cells and measured the fluores-
cence emission from the constructs by either commercial available
or our original new equipment. The measurements well paralleled
the bone matrix quantity determined by calcium contents. These
data indicate usefulness of the monitoring system for bone tissue
engineering and to be used for validation of the constructs in
clinical applications.
(OP 120) Expansion of Chondrocyte Numbers on a Thermo-
responsive-Grafted Surface.
L. R. M. Elowsson1, A. Crawford1, M. van Griensven2, S. Rim-
mer1, B. Tichy2, H. Redl2, P. V. Hatton1
1Centre for Biomaterials & Tissue Engineering, University of
Sheffield, UK
2Austrian Cluster for Tissue Regeneration, Vienna, Austria
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Introduction: Using thermoresponsive polymer grafted surfaces it
is possible to expand number of cells without the use of proteo-
lytic enzymes. It has been shown that chondrocytes gradually de-
differentiate and lose their phenotype in monolayer. The aim was
to investigate the potential use of a thermoresponsive surface for
expansion of cell numbers to generate chondrocytes for tissue
engineering.
Materials & Methods: Articular chondrocytes were cultured on
commercially available thermoresponsive culture plates (Re-
pCell) and tissue culture plastic (TCPS) in monolayer. Cells were
passaged either by decrease of temperature below lower critical
solution temperature of the thermoresponsive surface, or by enzy-
matic treatment using a trypsin/EDTA solution. After passages 2
(P2) and 5 (P5), cells were seeded on PGA-scaffolds. Differential
expression along with cell viability, proliferation rate, cell mor-
phology, and surface markers were evaluated in monolayer cultures.
3D constructs were analysed by histochemistry and immunoloca-
lisation of cartilage specific molecules.
Results & Conclusion: Chondrocytes de-differentiated on both
surfaces, but cells expanded on RepCell were metabolically more
active. Constructs engineered from P2 expanded on RepCell,
appeared to have more extensive staining for collagen-II and pro-
teoglycans, higher content of glycosaminoglycans, and weaker
staining for collagen-I compared to constructs engineered from
enzymatic-treated chondrocytes. The results indicated there was a
difference in chondrocytic phenotype, suggesting chondrocytes not
repeatedly exposed to trypsin/EDTA may be re-differentiated more
successfully to produce a hyaline cartilage-like tissue.
Acknowledgements: This work is sponsored by the EC under the
Marie Curie EST programme (MEST-CT-2004-008104) and is
part of the activity of the NoE EXPERTISSUES (NMP-2002-
3.4.4.2).
(OP 121) Expansion of Human Adipose-Derived Stem Cells in
Spinner Flasks
L.L. Jiang1, K.D. Song1, B. Jiang1, T.Q. Liu1, X.H. Ma1, Z.F. Cui2
1Dalian University of Technology, Dalian R&D Center for Stem
Cell and Tissue Engineering, Dalian, 116023, China
2Oxford University, Department of Engineering Science, Oxford
OX1 3PJ, UK
Human adipose-derived stem cells (hADSCs) are an emerging
source of stem cells, which can be easily harvested without detri-
ment to donors. Few studies have been published to date about the
efficient expansion of hADSCs in vitro to provide enough cells for
tissue construction, which play a key role in tissue engineering
applications. In this study, the hADSCs was isolated from human
adipose tissue by liposuction. The expanded conditions of hADSCs
were investigated in vitro, especially in spinner flasks where the
cells were cultured on the microcarriers. The expanded fold and
the metabolism of glucose and lactic acid were assayed. During the
whole culture process, the protein markers (CD29, CD44, CD105,
CD106, CD34, CD13, CD45, HLA-DR) of hADSCs were detected
by flow cytometry (FCM), and the multi-lineage differentiation of
the expanded hADSCs was also tested. Besides, the cell viability,
glucose and lactic acid concentration of hADSCs in spinner flasks
and culture plate were detected and compared. The results showed
that hADSCs could express specified stem cell protein markers
and differentiate into adipocytes, osteoblasts and chondroblasts.
The growth curves suggested that the viability of hADSCs cultured
in spinner flasks was stronger than that in culture plate, and the
expanded fold was also much higher than that in it. Moreover,
hADSCs could still remain stem cell characteristics after being
expanded in spinner flasks. In conclusion, these data suggest that
the spinner flask is an available and alternative tool to expand a
great number of hADSCs for tissue construction of tissue engi-
neering.
(OP 122) EXPERTISSUES—a Network of Excellence for
Tissue Engineering in the Bone, Cartilage and Osteochondral
Field
H. Redl1,2,3, M.V. Griensven1,2,3, all EXPERTISSUES Members4
1Ludwig Boltzmann Institut for experimental and clinical Trau-
matology
2AUVA Research Center, Vienna, Austria
3Austrian Cluster for Tissue Regeneration
43B’s Research Group—Inst. for Biotechnol. Bioeng. Braga,
Portugal
The main goal of EXPERTISSUES is to overcome fragmentation
of European Research in the field of tissue engineering of bone,
cartilage and osteochondral defects by applying an interdisciplin-
ary and translational approach. EXPERTISSUES joins together
academic centers and industry (* currently 22 coordinated by Rui
Reis, Portugal) with expertise in biomaterials/processing, includ-
ing bioplotting–soft/hardware, growth factor application/delayed
release, (stem) cell biology including GMP production facilities,
bioreactors and multiple preclinical models plus imaging tech-
niques as well as clinical experience (maxillofacial, trauma and
orthopedic surgery).
To achieve the objectives of the NoE, integrating activities are
established, e.g. by joint internal project grants (influence of bio-
material surfaces, biomaterial inner structure on cell mobility, gene
therapy approaches for bone regeneration, multi-center preclinical
trials and TERM knowledge networks); by mobility of personnel
including integrated PhD students, a joint training programme of
hybrid researchers in different labs of the NoE; by establishment of
a Common Quality Assurance System; by organization of work-
shops, seminars, courses and conferences; by launching the TERM
( Journal of Tissue Engineering and Regenerative Medicine)
journal and edition of scientific books as well as a shared electronic
network on TERM; by ethical and technical inputs for the devel-
opment of European Standards; by jointly submission of grants on
the European level.
The final goal is the creation of the EXPERTISSUES European
Institute of Excellence for Tissue Engineering and Regenerative
Medicine (as an EEIG).
NoE EXPERTISSUES (NMP3-CT-2004-500283).
(OP 123) Exploiting Lymphatic Transport and Complement
Activation in Nanoparticle Vaccines
S.T. Reddy1, A.J. van der Vlies1, E. Simeoni1, C.P. O’neil1,
M.A. Swartz1, J.A. Hubbell1
1E´cole Polytechnique Fe´de´rale de Lausanne (EPFL)
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The development of vaccine technologies has emerged as a fore-
front healthcare initiative, especially technologies for use in
developing countries, posing severe economic and logistic con-
straints. One must develop antigen targeting and adjuvant schemes
that respectively facilitate delivery of antigen to dendritic cells
(DCs) and elicit their activation. Here we engineered antigen-
bearing nanoparticle vaccines with two novel features: lymph
node-targeting and in situ complement activation. Following in-
tradermal injection, interstitial flow transported our ultra-small
nanoparticles (25 nm) highly efficiently into lymphatic capillaries
and their draining lymph nodes, targeting half of the DCs there,
whereas nanoparticles even 100 nm large were only 10% as effi-
cient. Furthermore, the surface chemistry of our nanoparticles ac-
tivated the complement cascade, which spontaneously generated a
danger signal in situ and potently activated DCs. With the model
antigen ovalbumin conjugated to the nanoparticles, we demon-
strated humoral and cellular immunity in mice in a highly size-
dependent and complement-dependent manner. We will also
present data where we exploit nanoparticles as synthetic pathogens
in order to elucidate molecular mechanisms of complement acti-
vation with DCs. Finally we characterized the adaptive immune
response that complement induces.
(OP 124) Expression of Cyclooxygenases and Prostaglandin
Receptors in the Growth Plate and Articular Cartilage of the
Rat–Its Possible Role for Tissue Engineering of Cartilage
C. Brochhausen1, G. Klaus2, C.J. Kirkpatrick1
1REPAIRlab, Institute of Pathology, Johannes Gutenberg-
University, Mainz, Germany
2Department of Paediatrics, Philipps-University, Marburg, Ger-
many
Background: Tissue Engineering of articular cartilage remains an
ongoing challenge. Since tissue regeneration recapitulates ontoge-
netic processes we use the growth plate as a model to target suitable
signalling molecules and growth factors for the tissue engineering
of cartilage. In previous investigations we demonstrated that in the
growth plate cyclooxygenases (COX-1 and COX-2) are involved in
the proliferation of chondrocytes. In the present study we analysed
the expression of cyclooxygenases and prostaglandin receptors in
articular cartilage and growth plates of young rats.
Methods Frozen sections from epiphyseal plates including the
articular cartilage of 4 weeks old Sprague Dawley rats were fixed
in paraformaldehyde (4 per cent) and stained by the alkaline
phosphatase–anti-alkaline phosphatase (APAAP) method using
polyclonal antibodies against COX-1, COX-2 and the prostaglan-
din receptors EP-1, EP-2, EP-3, EP-4. The tissues were counter-
stained with haemalaun according to laboratory standards.
Results: Growth plate chondrocytes and chondrocytes of the
articular cartilage showed the expression of COX-1, COX-2 EP-1,
EP-2, EP-3 and EP-4. The reserve zone of the growth plate showed
only weak expression of COX-2 with numerous negative cells. The
superficial layer of articular cartilage is negative for COX and EP-
receptors.
Conclusions: Our findings indicate a functional role of cy-
clooxygenases and prostaglandin receptors not only in the growth
plate but also in the maturation of articular chondrocytes. This
opens interesting perspectives to improve the proliferation and
maturation of chondrocytes in scaffold especially since prosta-
glandin receptor ligands are available in pharmaceutical quality.
(OP 125) Extracellular Matrix as a Biologic Scaffold for
Urinary Bladder Reconstruction: the Role of Mechanical
Loading in the Remodeling Process
A. Nieponice1,2,3, A. Boruch1,2,3, T. W Gilbert1,2,3, S. F Badylak1,2,3
1Department of Surgery
2McGowan Institute for Regenerative Medicine
3University of Pittsburgh
Extracellular matrix (ECM) scaffolds have been widely studied for
their potential role in the functional reconstruction of several tis-
sues and organs including the lower urinary tract, the gastrointes-
tinal tract, skin, and cardiovascular structures among others. ECM
derived from two layers of the porcine urinary bladder, the base-
ment membrane and subjacent tunica propria (termed urinary
bladder matrix–UBM) was used to replace a 30% resection of the
dome of the urinary bladder in eight adult female dogs. Four dogs
were catheterized for 24 hours following surgery at which time
spontaneous filling and emptying of the bladder was allowed to
occur for the remainder of the study. The catheter remained in place
for 30 days in the following four dogs. Two dogs in each group
were sacrificed after 30 days and the other two after 90 days. Dogs
that remained catheterized showed 90% contraction of the scaffold
material, incomplete urothelial coverage at 30 days, and a chronic
inflammatory response within the underlying UBM scaffold and
newly deposited host ECM. The dogs that were allowed sponta-
neous filling of the bladder showed 30% contraction of the scaffold
area, complete urothelialization at 30 days with islands of smooth
muscle in the subjacent remodeling tissue. By 90 days, these non-
catheterized dogs showed sheets of functional smooth muscle ar-
ranged in patterns that resembled the normal muscularis externa
with an adjacent submucosal layer and near normal bladder histo-
morphology. These findings indicate that mechanical signals play
an important role in the remodeling process of this hollow organ.
(OP 126) Fabricating and Testing of Flexible Microelectrode
Arrays for Neural Recordings
S. Myllymaa1, K. Myllymaa1, H. Korhonen1, K. Djupsund2,
H. Tanila2, R. Lappalainen1
1University of Kuopio, Dept. of Physics, Finland
2University of Kuopio, Dept. of Neurobiology, Finland
In this study, flexible polymer-based microelectrode arrays (MEA)
were designed, fabricated and characterized. The functionality of
these arrays was tested in different neuronal recording cases in vivo
and in vitro. Several designs of MEAs were realized varying the
layout of array and material of insulation layer. Two different
layouts were 8-channel MEA with 200 mm (circle-shaped, diame-
ter) electrode sizes and 16-channel MEA with 100 mm electrode
sizes. As insulation materials were tested polyimide Pyralin PI-
2771 and epoxy-resist SU-8. The substrate material in all MEAs
was 25 mm Kapton film coated with thin layer of polyimide PI-
2525. Metallization layer is formed by structuring UV-resist (ma-N
1420), sputter-coating of biocompatible Ti and Pt thin films
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(200 nm) and via lift-off procedure. A 3mm thick insulation layer
(PI-2771 or SU-8) was structured by UV-exposure to form elec-
trode openings and connector pads. Thin film pads were designed
to fit into 16-channel ZIF-type connector. Fabricated MEAs were
characterized by impedance spectroscopy in saline. Electrode
impedances of 100mm and 200mm electrodes measured at 1 kHz
were 98kO (SD: 18kO) and 34kO (SD: 4kO), respectively. The
preliminary biological studies showed promising results. Evoked
potentials were recorded in vivo from the rat brain when electrical
stimulus was conducted to the rat paw. We managed to record
different responses in every 8 channels. 16-channels MEAs also
gave encouraging results evoked potential recordings in rat hip-
pocampal slices. In future, this biocompatible fabrication protocol
is possible to adapt for development of different neural interfaces
with higher spatial resolution.
(OP 127) Factor Xa and Thrombin Evoke Additive Calcium
and Proinflammatory Responses in Endothelial Cells Sub-
jected to Coagulation
P. Philippart1, V. Daubie2, R. Pochet2, J. Heemskerk3
1IRIS South Brussels Public Hospital
2Fac. Medicine, Universite´ Libre de Bruxelles
3Biochemistry, Maastricht Universiteit
Endothelial cells react to factor Xa and thrombin by proin-
flammatory responses. It is unclear how these cells respond under
physiological conditions, where the serine proteases factor VIIa,
factor Xa and thrombin are all simultaneously generated, as in
tissue factor-driven blood coagulation. We studied the Ca(2þ)
signaling and downstream release of interleukins (ILs), induced by
these proteases in monolayers of human umbilical vein endothe-
lial cells. In single cells, factor Xa, but not factor VIIa, complexed
with tissue factor, evoked a greatly delayed, oscillatory Ca(2þ)
response, which relied on its catalytic activity and resembled that
of SLIGRL, a peptide specifically activating the protease-activated
receptor 2 (PAR2). Thrombin even at low concentrations evoked a
rapid, mostly non-oscillating Ca(2þ) response through activation
of PAR1, which reinforced the factor Xa response. The additive
Ca(2þ) signals persisted, when factor X and prothrombin were
activated in situ, or in the presence of plasma that was triggered to
coagulate with tissue factor. Further, thrombin reinforced the
factor Xa-induced production of IL-8, but not of IL-6. Both in-
terleukins were produced in the presence of coagulating plasma. In
conclusion, under coagulant conditions, factor Xa and thrombin
appear to contribute in different and additive ways to the Ca(2þ)-
mobilizing and proinflammatory reactions of endothelial cells.
These data provide first evidence that these serine proteases
trigger distinct signaling modules in endothelium that is acti-
vated by plasma coagulation. In conclusion these results suggest
the protease inducing clot formation might induce different bio-
logical events in downstream in platelet rich plasma clinical pro-
cedure.
(OP 128) Fetal Chorionic Villi and Amniotic Fluid Derived
Progenitors As Autologous Cell Sources for Pediatric Cardi-
ovascular Tissue Engineering
D. Schmidt1,2, J. Achermann3, B. Odermatt4, M. Genoni1,
G. Zund5, S. P. Hoerstrup2
1Clinic for Cardiovascular Surgery University Hospital Zurich,
Switzerland
2Division of Tissue Engineering and Regenerative Medicine,
University Zurich, Switzerland
3Human Genetics Laboratory, Genetica, Zurich, Switzerland
4Institute for Clinical Pathology, University Hospital Zurich,
Switzerland
5Department of Surgical Research, University Zurich, Switzerland
Due to a lack of viable autologous replacement materials with growth
and regeneration capacities current surgical treatment of cardiovas-
cular malformations requires non-autologous, non-living replace-
ments associated with disadvantages including obstructive tissue
ingrowths and calcification. This typically causes re-operations over
the patient’s lifetime. Therefore, pediatric cardiovascular tissue en-
gineering aims at the fabrication of autologous living replacements,
ideally, already being available at or shortly after birth. Thus, the tis-
sue engineering process has to be initiated prenatally as soon as the
cardiovascular defect has been detected. Here, a novel concept using
routinely prenatally obtained human fetal progenitors as autologous
cell source for cardiovascular tissue engineering is presented.
Prenatal progenitor cells were isolated from chorionic villi and
amniotic fluid. After expansion and characterization, cells were
differentiated into the cell types required for heart valve tissue
engineering: myofibroblast-like cells and endothelial-like cells.
Thereby, cell phenotypes were analyzed by immunohistochemistry
and flowcytometry. For fabrication of heart valves PGA/P4HB-
based biodegradable scaffolds were seeded with mesenchymal-like
cells derived from chorionic villi or amniotic fluid. Afterwards,
constructs were cultured in a pulse duplicator system and subse-
quently coated with endothelial-like cells. After maturation, en-
gineered heart valves demonstrated endothelialized layered tissue
formation. Analysis of extracellular matrix elements and cell
number revealed production of gycoaminoglycans and collagen
(GAG 80%, HYP 5%) and cell numbers up to native tissue values.
In conclusions, the use of fetal progenitor cells as autologous
cell source is a promising strategy enabling the fabrication of heart
valves ready to use at birth for the early repair of congenital
malformations.
(OP 129) Fibrin Delivery Systems for Elastic Tissue Re-
generation
L.R. Yang1, P. Frey2, T.H. Barker3, J.A. Hubbell1
1Institute of Bioengineering, Ecole Polytechnique Fe´de´rale de
Lausanne, Switzerland
2Department of Pediatric Surgery, Centre Hospitalier Uni-
versitaire Vaudois Lausanne, Switzerland
3Department of Biomedical Engineering, Georgia Tech and Em-
ory University, USA
Fibrinogen (Fgn), a soluble plasma protein found in all vertebrates,
is a covalent dimer composed of pairs of three polypeptide chains
called Aa-, Bb- and gamma-chains. Fgn is converted to an insoluble
fibrin network following activation by thrombin and crosslinking
by factor XIIIa following vascular injury and serves the primary
role in haemostasis. Our interest in developing fibrin-based bio-
material technology is based on fibrin’s central role in tissue bind-
ing and in the initiation of tissue repair and defence. Technologies
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have been developed with some success for incorporation of
growth factors into fibrin, ranging from simple admixing to cova-
lent incorporation using the coagulation transglutaminase factor
XIIIa. We are developing a novel platform technology where the
growth factor is incorporated into Fgn’s Aa-chain at the genetic
level. We have chosen this region since evidence suggests that the
C-terminus of Fgn’s Aa-chain is not required for bioassembly or
polymerization. The release profile and functional significance of
this novel fibrin-delivery system will be compared to current fibrin
delivery schemes. For comparison to our current fibrin delivery
system using factor XIII coupling, hIGF1 cDNA was generated by
PCR for incorporation into the expression vector where the trans-
glutaminase substrate sequence from alpha2PI (Tg) for cross-
linking into fibrin was added at the N-terminus.
(OP 130) Fibrous Scaffold for Encapsulation of Pancreatic
Islets
X. Yao, A. C. A. Wan, K. Narayanan, J.Y. Ying1
1Institute of Bioengineering and Nanotechnology
Conventional microencapsulation methods for cell-based therapies
are limited by inadequate nutritional transport and surrounding fi-
brotic overgrowth, thus rendering long-term graft survival difficult
to achieve. A fibrous scaffold is presented as an alternative en-
capsulation strategy of pancreatic islets. Fibers containing RINm5F
cells are formed by interfacial polyelectrolyte complexation be-
tween alginate and water-soluble chitin. Additional polyelectrolyte
coatings are used to reduce scaffold porosity and increase stringency
of immunoisolation. The multicomponent fibers, measuring ap-
proximately 100 um in diameter, offer a higher surface-to-volume
ratio and better diffusion dynamics than conventional alginate
beads.The fabrication process well preserves the formation of via-
ble cell aggregates as revealed by calcein staining, especially as
aggregation is desirable for islet survival and insulin secretion. Ef-
ficiency of coating is demonstrated by changes in surface zeta po-
tential with each layering at physiological pH. Functionality of
encapsulated islets was validated by rat C-peptide ELISA. A sus-
tainable release of C-peptide is observed with 20 mM of glucose
challenge, with a total of 3 ng for every 5105 cells after 100
minutes. The efficiency of immunoisolation is further assessed by
gel permeation chromatography. Protein markers ranging from
5 kDa to 300 kDa are encapsulated in the fibers and allowed to dif-
fuse out, revealing a marked decrease in the concentration of bigger
molecules in the supernatant. Potential crosslinkers are currently
being evaluated to improve the scaffold porosity and islet survival.
(OP 131) Frictional Properties of Tissue Engineered Cartilage
Generated Using Standard or Bioreactor Culture
M. Plainfosse´1, P.V. Hatton1, A. Crawford1, J. Katta2, Z.M. Jin2,
J. Fisher2
1University of Sheffield, Centre for Biomaterials and Tissue En-
gineering, United Kingdom
2University of Leeds, Institute of Medical and Biological En-
gineering, United Kingdom
Introduction: Tissue engineered (TE) cartilage may, in the future be
used to repair articular cartilage in joints and restore the low fric-
tional properties of the surfaces. Research to date suggested that the
properties of constructs cultured using standard culture conditions
(orbital shaker) were inferior to those of native articular cartilage.
Advanced culture conditions in bioreactors might therefore be es-
sential to engineer a functional tissue with low friction properties.
Objective: This study compared the fictional properties of TE
cartilage cultured under standard culture conditions and a rotating
wall vessel (RWV).
Methods: TE cartilage constructs were cultured under standard
conditions and in a RWV. Indentation and start-up friction tests
were performed with PBS as a lubricant. The presence of GAGs,
type I and II collagen were investigated.
Results: All the constructs exhibited a time-dependent increase
in deformation and friction during the tests. The friction values
were however, lower for the constructs cultured in the RWV
(m20 min¼ 0.20 0.02) than those under the semi static culture
conditions (m20 min¼ 0.25 0.06), and closer to native tissue
(m20 min¼ 0.20 0.05). The composition of the extracellular
matrix of the constructs cultured in the RWV was also superior.
Conclusion: TE constructs from the bioreactor showed func-
tional properties including low friction in common with native
tissue. By using these more advanced culture conditions, it was
possible to improve the biological quality and frictional properties
of TE cartilage.
Acknowledgement: The authors are grateful to the White Rose
University Consortium for funding, and the work was performed as
part of the EXPERTISSUES Network.
(OP 132) Functional Control of Myoblasts in a Strained Fibrin
Gel
T. Matsumoto1, J. Sasaki1, M.H. Uddin1, H. Egusa1, T. Sohmura1
1Dept. of Oromaxillofacial Regeneration, Osaka University
In vitro engineering of biomimetic skeletal muscle tissue is one of
the candidates for the future treatment of the skeletal muscle dis-
ease. To control cell functions including patterning, prolifera-
tion, and differentiation in three-dimensional (3D) matrices might
be crucial for this purpose. To address this goal, we used fibrin gel
as a 3D cell culture matrix and tried to control cell functions in this
3D gel.
When continuous tensile strain was applied to a cylindrical
shaped fibrin gel to the opposite uniaxial direction, the bundle-like
structures which aligned parallel to the strain direction were
formed in the gel. Myoblasts cultured in this fibrin gel demon-
strated a specific alignment in the gel, proliferated to the specific
one direction, and finally formed aligned cell sets in this gel. When
we applied different degrees of strain to the cells in the gel, cell
proliferation was the highest in the high-strained gels and was
attenuated in the low-strained gels. In contrast, myoblast differ-
entiation was the highest in the low-strained gel, but was inhibited
in the high-strained gel. These results indicate that this 3D fibrin
gel culture system enables one to control patterning, proliferation,
and differentiation of myoblasts.
(OP 133) Gene Expression Profiling of HYAFF-11 Cartilage
Transplants Generated by Chondrocytes from OA Donors
T. Dehne1, C. Karlsson2, J. Ringe1, A. Lindahl2, M. Sittinger1
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1Tissue Engineering Laboratory, Department of Rheumatology,
Charite´-Universitaetsmedizin Berlin, 10117 Berlin, Germany
2Institute of Biomedicine, Department of Clinical Chemistry and
Transfusion Medicine, Sahlgrenska University Hospital, SE 41345
Go¨teborg, Sweden
Osteoarthritis (OA) is the most abundant disorder of the muscu-
loskeletal system. It is characterized by the degeneration of articular
cartilage due to mechanical wear. Currently Tissue Engineering
(TE) technologies based on scaffold-supported chondrocytes are
used to treat traumatic cartilage defects but not joint lesions due to
OA as in vitro and clinical studies are lacking. Therefore, in this
study the feasibility of chondrocytes from OA donors for cartilage
TE was determined by investigating the differentiation capacity of
chondrocytes from OA donors in comparison to healthy donors on
gene expression level.
OA cartilage biopsies (Mankin Score 3-7) were taken from the
femoral condyle of patients undergoing total knee replacement.
Chondrocytes were isolated enzymatically and expanded in
monolayer cultures. Chondrocytes from normal donors (ND) were
obtained from excess samples of cells originally used for autolo-
gous chondrocyte transplantation. ND and OA chondrocytes were
seeded onto HYAFF-11 scaffolds and were maintained up to 4
weeks under chondrogenic conditions (serum free, TGFbeta-1).
Re-differentiation associated collagen type II formation was as-
sessed by fluorescence immunohistochemistry. Furthermore, gene
expression of monolayer as well as of scaffold cultured chon-
drocytes were analyzed applying Affymetrix HG-U133plus2.0
GeneChip microarrays and. A set of genes, that were differen-
tially expressed between normal donor HYAFF-11 culture and
monolayer cultures was generated and used to assess differentia-
tion of OA chondrocytes. ND and OA chondrocytes showed a
comparable formation of cartilage-associated collagen type II and
a comparable expression of a relevant set of chondrogenic mark-
ers, which indicates the feasibility of OA chondrocytes for carti-
lage TE.
(OP 134) Generation of a Bioartificial Liver Using a Decel-
lularized Whole Liver Bioscaffold
P.M. Baptista1, Van Nguyen1, A. Atala1, S. Soker1
1Wake Forest University Health Sciences, Institute for Re-
generative Medicine, North Carolina, USA
Our laboratory recently developed a decellularization method able
to generate an entire organ bioscaffold from a whole liver, pre-
serving its functional vascular network. Preliminary studies
showed the possibility to efficiently re-cellularize the bioscaffold
using a perfusion cell seeding process in a bioreactor. Nonetheless,
numerous technical issues need to be optimized to efficiently seed
by perfusion primary hepatocytes to generate functional hepatic
tissue. The purpose of this study was to investigate the feasibility
of generating bioartificial liver by re-cellularizing the decellular-
ized whole organ bioscaffold with primary hepatocytes and en-
dothelial cells.
Mouse endothelial cells and freshly isolated rat hepatocytes
were seeded through the portal vein of the bioscaffold. The seeded
bioscaffolds remained in a bioreactor with constant culture me-
dium perfusion up to one week. Microscopy was used to determine
cell density and seeding efficiency. Immunohistochemistry was
used to identify the engrafted cells and to detect hepatic tissue
associated functions.
The perfused endothelial cells attached and formed a mono-
layer on the luminal side of the vascular channels. Rat primary
hepatocytes showed homogeneous seeding and high cell density
throughout the bioscaffold (with 1–1.5 cm thickness). Immuno-
histochemistry showed progressive tissue formation with expres-
sion of albumin, alpha 1-antitrypsin and cytochrome P450.
Our results demonstrate the efficient generation of a bioartificial
liver with primary hepatocytes using a perfusion cell seeding
process in a liver bioscaffold. Hepatic tissue associated functions
were detected with three-dimensional tissue formation in vitro.
This technology may provide a new approach for bioartificial liver
engineering, critical for drug discovery and treatment of terminal
liver diseases.
(OP 135) Generation of Functional Cardiomyocytes from In-
duced Pluripotent Stem (iPS) Cells for Myocardial Tissue
Engineering
C. Mauritz1, M. Reppel2, K. Schwanke1, G. Kensah1, K. Kat-
sirntaki 1, I. Gruh1, S. Groos3, M. Wernig4, H. Zaehres5,
G. Wrobel2, W. Zimmermann6, J. Hescheler2, H. Schoeler5, R.
Jaenisch4, U. Martin1
1Leibniz Research Laboratories for Biotechnology and Artificial
Organs (LEBAO), Department of Cardiac, Thoracic-, Transplan-
tation and Vascular Surgery, REBIRTH-Cluster of Excellence,
Hannover Medical School, 30659 Hannover, Germany
2Institute of Neurophysiology, University of Cologne, Germany
3Department of Cell Biology; Hannover Medical School, Hann-
over, Germany
4Whitehead Institute for Biomedical Research, Massachusetts
Institute of Technology, Cambridge Massachusetts, USA
5Max-Planck Institute for Cell- and Developmental Biology,
Mu¨nster, Germany
6Institute for Experimental and Clinical Pharmacology and Tox-
icology, UKE, Hamburg, Germany
So far, development of autologous bioartificial cardiac tissue
(BCT) was hampered by the lack of a suitable cell source. The
recent reprogramming of fibroblasts into induced pluripotent stem
cells (iPS) for the first time offers an autologous pluripotent cell
source with theoretically unlimited expansion potential. The com-
bined overexpression of 4 transcription factors resulted in repro-
gramming of fibroblasts and generation of pluripotent cells that
largely resemble ES cells.
It was now aim of our study to characterize the cardiac differ-
entiation potential of iPS, to characterize the resulting iPS-derived
cardiomyocytes on a molecular, structural and functional level, and
to apply these cells to myocardial tissue engineering.
Differentiation of a murine iPS clone O9 resulted in sponta-
neously beating cell clusters comparable to those arising in dif-
ferentiating mESC lines. Semi-quantitative RT-PCR analyses
demonstrated expression of marker genes typical for mesoderm,
cardiac mesoderm and cardiomyocytes. Immunohistological and
ultrastructural studies showed expression of CM-typical proteins
and cross-striated muscle fibrils. Electrophysiological studies by
means of multi electrode arrays (MEAs) revealed evidence of
functionality and ß-adrenergic signaling of the generated cardio-
myocytes. Moreover, own iPS clones were generated and con-
738 ORAL PRESENTATIONS
firmed the cardiac differentiation potential of iPS cells. Finally,
pilot studies aiming the generation of iPS-based bioartificial car-
diac tissue (BCT) were performed.
This is the first study demonstrating the in vitro differentiation
of iPS cells into functional cardiomyocytes. In contrast to ES cells,
iPS cells allow for the establishment of autologous pluripotent
customized stem cell lines, showing great promises for myocar-
dial tissue engineering and other applications in regenerative
therapies.
(OP 136) Genetically Engineered KSFrt Mesenchymal Pro-
genitors Cells in Combination with Whole Body Optical
Imaging Provide an Excellent Model to Study Effects on Cell
Fate, Bone and Cartilage Formation and Biomaterials
K.E. de Rooij1, H.C.M. Sips1, G. van der Horst1,2, I. Que1, L. van
der Wee-Pals1, C.W.G.M. Lo¨wik1, M. Karperien1,3
1Dept. of Endocrinology, LUMC, The Netherlands
2Dept. of Urology, LUMC, The Netherlands
3Dept of Tissue Regeneration, University of Twente, The Neth-
erlands
Mesenchymal Stem Cells have great potential for application in
tissue engineering of bone and cartilage, especially in combina-
tion with biomaterials. Composition and structural properties of
biomaterials can considerably influence MSC differentiation. At
present, differentiation of MSCs in vitro or in vivo as well as
osteogenic properties of biomaterials are poorly understood.
Therefore, we created a model, which allows fast and reproducible
production of stable cell lines, by introducing an FRT-site into the
genome of the KS483 cell line. This site is used for the insertion of
DNA to enable gene function studies by overexpression or knock
down or by insertion of reporter genes to visualise and quantify
specific biological processes. Insertion of a luciferase2 gene en-
abled us to follow cell fate in vivo by whole body biolumines-
cent imaging after subcutaneous implantation in nude mice for 20
weeks. Immunohistochemical analysis indicated absence of bone
formation without further stimulation. However, when seeded onto
BCP scaffolds, KSFrt-Luc2 cells have formed bone after 8 weeks,
while KSFrt cells overexpressing Runx2 already generated bone
after 3 weeks, indicating that proper stimulation significantly ac-
celerated bone formation by KSFrt cells in vivo. Therefore, these
cells provide an excellent model to investigate bone-inducing
properties of biomaterials. To facilitate this, we generated an os-
teogenic reporter cell line by introducing an osteoblast-specific
collagen I promoter driving expression of the luciferase2 gene. This
cell line will be used to test drugs and biomaterials in vitro, followed
by in vivo conformation of results using whole body optical im-
aging.
(OP 137) Genomic Guided ECM Biomaterials Development
for Regenerative Medicine Applications
T. Xu1, J. Hipp1, A. Atala1, J.J. Yoo1, M.E. Van Dyke1
1Wake Forest Institute for Regenerative Medicine, Wake Forest
University Health Sciences, Winston-Salem, NC 27157
Identification of appropriate ECM surrogates for cellular dif-
ferentiation is a challenge for biomaterials development because
little is known about most of the ECM proteome. To address the
problem, effective methodologies to screen a wide range of bio-
materials candidates for stem cell differentiation applications are
needed. We have developed a novel high throughput ECM screen-
ing method which is guided by the genomic analysis of cellular
differentiation.
Methods: Human amniotic fluid derived stem cells (hAFSCs)
were used, and microarrays were performed on hAFSCs at various
timepoints following myogenic, hepatogenic, vasculogenic, &
osteogenic differentiations. RNA was isolated and hybridized to
GeneChip. Highly up-regulated genes involved in ECM formation
were identified. To demonstrate these ECM molecules could serve
as potential biomaterials targets, several were selected for further
study under osteogenic differentiation.
Results: Microarray analyses of differentiating hAFSCs provided
over 40 ECM-related genes that were universally up-regulated as
these cells reached their terminal fate. Some of the most signifi-
cantly up-regulated genes are those involved in ECM production.
4 ECM-related genes were highly up-regulated upon osteogenic
differentiation and selected for further study. The 4 selected
ECM molecules (aggrecan, decorin, osteoblast specific factor, and
thrombospondin) demonstrated significantly enhanced or inhibited
effects on hAFSCs osteogenic differentiation in several ways, in-
cluding concentration, combination, and temporal dependencies.
Conclusions: ECM biomaterials with highly up-regulated genes
identified by micro-array profiling of differentiating stem cells
demonstrated certain effects on efficiency and temporal patterning
of cellular differentiation. This new genomic-guided ECM mole-
cule screening represents a new approach for ECM mimicry in
regenerative medicine applications.
(OP 138) Growth Factor Gene Therapy for Alveolar Bone
Engineering
W. Giannobile1
1Departments of Oral Medicine and Biomedical Engineering,
Schools of Dentistry and Engineering, University of Michigan,
Ann Arbor, Michigan USA
Repair of craniofacial defects including alveolar bone lesions
caused by trauma, congenital malformations or disease is a major
goal of oral reconstructive therapy. Alveolar bone tissue engi-
neering has been achieved with limited success by the utilization of
bone replacement grafts, guiding tissue membranes and block
grafting techniques. Over the past decade investigators have begun
to utilize signaling molecules such as growth factors to restore lost
bone support due to damage to the alveolar process. This presen-
tation will review emerging therapies in the areas of materials
science, growth factor biology and cell/gene therapy. Results from
preclinical and clinical trials will be reviewed. The presentation
will conclude with a future perspective on the use of novel bio-
mimetic approaches such as gene delivery of signaling molecules
and scaffolding matrices with the potential of accelerating dental
implant osseointegration. Funded by NIH DE 13397, AO Foun-
dation Switzerland and the ITI Foundation.
(OP 139) Growth Factor Releasing Biohybrid Silk-PLGA
Scaffolds for Tendon and Ligament Tissue Engineering
S. Sahoo1, J.C.H. Goh1,2, S.L. Toh1,3
ORAL PRESENTATIONS 739
1Division of Bioengineering, National University of Singapore
2Department of Orthopaedic Surgery, National University of
Singapore
3Department of Mechanical Engineering, National University of
Singapore
One of the major challenges facing tendon and ligament tissue
engineering is the availability of suitable scaffolds. Hybrid scaf-
folds fabricated by combining knitted scaffolds with nanofibre
coatings have been shown to be effective for tissue engineering of
tendons and ligaments.
In this study, biocompatible knitted silk scaffolds were fabricated
and coated with FGF-releasing PLGA nanofibres, using silk solution
as intervening glue. Such scaffolds were optimized with terms of the
method of silk processing, cell seeding, growth factor incorporation,
and characterized subsequently for their efficacy in engineering
tendons and ligaments by a variety of assays. Silk scaffolds de-
gummed using an improved degumming method, employing ul-
trasonic agitation in the presence of a detergent, proved better by
better retaining the mechanical properties of silk (38% stronger).
Scaffolds seeded with bone marrow stem cells on both surfaces
allowed better cell proliferation (14–17% higher), as compared to
scaffolds seeded with the same total number of cells on just one
surface. Rolling up the scaffolds and continuing in vitro culture
yielded ligament analogs. When the scaffolds were coated with
FGF-releasing nanofibres, the constructs demonstrated increased
cell proliferation (24% higher), collagen production (39% higher),
upregulation of tendon/ligament specific extracellular matrix pro-
teins (collagen I, collagen III, fibronectin and biglycan), as well as
improved mechanical properties (21% stronger and 26% stiffer).
Thus, the biohybrid scaffolds developed in the study proved suit-
able for tendon/ligament tissue engineering applications.
(OP 140) Hemocompatible Membranes for Blood Oxygenators
M. Besteiro1, M. N. de Pinho2
1IBET
2Instituto Superior Te´cnico
Artificial blood oxygenation is required during surgical interven-
tions such as coronary artery bypass grafting, in which both lung and
heart functions are replaced by a heart-lung machine. In these
equipments the membrane placed between the blood and the gas
phase is object of new developments in terms of the characteris-
tics of O2 and CO2 permeability and hemocompatibility. Anderson
JM et al. (Academic Press, 1999) emphasized that the literature is
contradictory with respect to the role of interactions between arti-
ficial material surfaces and the blood components that may lead to
platelet adhesion/activation, activation of coagulation and comple-
ment, resulting in thrombus formation and systemic inflammation.
This work addresses:
 The preparation of polyurethane membranes with two soft
segments: a polypropylene oxide based one with isocyanate
terminal groups and another polyester or polyether based one
with hydroxyl terminal groups (1).
 Surface characterization through spectroscopic and micro-
scopic techniques: X-Ray Photoelectron Spectroscopy (XPS),
Atomic Force Microscopy (AFM), Transmission Electron
Microscopy (TEM) and Field Emission Scanning Electron
Microscopy (FESEM).
The correlation between bulk and/or surface characteristics of
the membranes and their gas permeation and hemocompatibility
characteristics is carried out in order to understand the mechanisms
of membrane surface/blood components interactions. The knowl-
edge of that and the versatility in casting bi-soft segments mem-
branes with a wide variety of bulk and surface morphologies allows
the tailoring of membranes with optimal gas permeation and he-
mocompatibility properties.
Reference:
1D. P. Queiroz, M. C. Gonc¸alves, M. N. de Pinho, J. Appl. Polym. Sci.,
103, 315–320 (2007).
(OP 141) Home, Sweet Home: Recreating the Native Bony
Environment In vitro Using a Novel Dynamic Cell-Culture
System for Bone-Biology Research
A. C. Allori1, A. M. Sailon1, J. L. Ricci2, S. M. Warren1
1Institute of Reconstructive Plastic Surgery, NYU Medical Center,
New York, NY
2Dept. of Biomaterials and Biomimetics, NYU College of Den-
tistry, New York, NY
Introduction: Traditional cell-culture methods are ill-suited to
study the intricacies of bone biology because they ignore the three-
dimensionality of meaningful cellular networks and the lacuno-
canalicular system. Reliance on nutrient diffusion limits scaffolds
to 2–3 mm thickness. Static culture also ignores the importance of
mechanical loading in regulating bone metabolism. A novel flow
perfusion system was developed to overcome these limitations.
Both bioreactor and osteoconductive/osteoinductive scaffolds re-
sulted from evolutionary outgrowth of the native structure/function
of bone and the design requirements crucial to successful experi-
mentation.
Methods: Eight adaptable chambers house cylindrical scaffolds,
up to 24 mm diameter 10 mm thickness. A multi-channel peri-
staltic pump draws medium from parallel reservoirs and perfuses it
through each scaffold (0.3–30 mL/min). Hermetically sealed valves
permit sampling of medium. A gas-permeable membrane permit
gas exchange. Tubing was selected to withstand continuous per-
fusion for >2 months without leakage. Porous scaffolds were
manufactured using a novel 3D bioprinting process. These scaf-
folds were composed of hydroxyapatite/tricalcium phosphate with
variable thicknesses, strut sizes, and pore sizes.
Results: Fluid shear stress ranged from 0.04–4 dyn/cm2 at the
cellular level and are described by finite element modeling. Scaf-
fold architecture is characterized by micro-CT and scanning elec-
tron microscopy. Osteoblastic networks and canalicular channels
are visualized by fluorescent confocal microscopy.
Conclusions: Unlike spinner flasks and FlexCell devices, this
novel system simulates the natural 3D lacuno-canalicular system
of native bone, ensuring chemotransportation throughout thick 3D
scaffolds and allowing for the study of bone biological and bio-
mechanical processes in vitro.
(OP 142) Host Responses in Tissue Engineering
J.A. Hunt1
1UKCTE, University of Liverpool, UK
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Therapies utilising cell delivery or accumulation to provide a
medical treatment that is functional by cellular activity requires
rapid integration and guided immediate communications with host
tissues. The many and varied tissue engineering processes to
achieve these objectives bring to the fore the critical host defence
mechanisms that require to be at least anticipated if not controlled
and utilised in providing long lived, functional cell therapies.
Historically most implanted materials have lacked an inherent
potential to trigger pathways in the specific immune response, but
have always initiated a non-specific immune response. In regen-
erative medicine by taking a biological approach to treatments and
regeneration the potential activation pathways of both the specific
and non-specific immune pathways begin to at least in theory be-
come significant areas that require further consideration and ex-
perimentation. How far does the clear potential from the theory for
increased immune activity extend to being a real functional issue or
risk for tissue engineering therapies and the patient?
A biological approach to therapies provides an abundance of the
right type (proteins) of fundamental molecules for directed cell
communication. The drive is towards providing autologous sources
or protein free solutions, should be met by the fundamental un-
derstanding of what protein interactions are important, their ki-
netics, dynamics and thresholds. Do immunity thresholds exist
for cell based therapies? An objective well characterised approach
to determining for implanted organic materials the immune thresh-
old potential is clearly required for both scientific and clinical
success but is also fundamentally required for regulatory and safety
issues.
(OP 143) How will We Repair Nerves and Bridge Nerve Gaps
in the Future?
M. Wiberg1, P. Kingham2, G. Terenghi2
1Anatomy and Hand & Plastic Surgery Depts, Umea˚ University,
Sweden
2Blond McIndoe Laboratories, University of Manchester, UK
Peripheral nerve injures are common and often result in impaired
sensory and motor function. This is true especially when there is
a nerve-defect that requies bridging. The present conventional
technique of using nerve grafts is still the only clinical applicable
one, but extensive research is ongoing to find other techniques to
avoid autologous nervous transplantation and still achieve an im-
proved functional recovery. The concept of tubulisation using
biodegradable polymeric materials, either with or without luminal
fillers, is suggested as an alternative. The naturally occurring bio-
degradable polymer Poly[(R)-3-Hydroxybuturate] (PHB), meta-
bolised to the endogenous monomer D-(-)-3-hydroxybutyric acid,
is one of the tubulisation materials that has been experimentally
tested as an alternative for peripheral nerve grafts together with
both Schwann cells and mesenchymal stem cells with good results.
In several previous experimental studies we have demonstrated
that PHB is a suitable material to be used in combination with
transplanted Schwann cells to bridge nerve gaps and to improve
regeneration. The limitation is however that transplanted Schwann
cells need to be autologous to avoid immunorejection. In some
recent studies we have, however, been able to demonstrate that
mesenchymal stem cells have the ability to differentiate to Schwann
cells morphologically but also to achieve their nerve stimulating
properties. The lecture will summarise the experimental and clin-
ical results on using PHB as a synthetic nerve implant and its
combination with Schwann and stem cells to enable bridging of
nerve gaps and to enhance nerve regeneration.
(OP 144) Human Adipose Stem Cells–From Laboratory to
Clinical Practice
S. Miettinen1, B. Lindroos1, S. Haimi1, R. Suuronen1,2,3
1Department of Eye, Ear and Oral Diseases, Tampere University
Hospital, Finland
2Department of Biomedical Engineering, Tampere University of
Technology, Finland
3REGEA, Institute for Regenerative Medicine, University of
Tampere and Tampere University Hospital, Biokatu 12, 33520
Tampere, Finland
Currently, the most reliable method of reconstructing large bony
defects involves painful harvest of bone. This causes donor site
morbidity and a higher risk of infection. The use of other biological
materials carries the risk of virus transmission.
Tissue engineered custom-made products will replace harvested
flaps in the future. This new technology will be based on stem cells
capable of self-renewal and differentiation into several cell types
in vitro. The cells can be transplanted with a biomaterial scaffold
without immunosuppression.
Adipose tissue is an appealing donor tissue for cell replacement,
since it is redundant and can easily be harvested. Furthermore,
adipose stem cells combined with osteostimulative biomaterials
provide an attractive alternative for bone tissue engineering.
Adipose tissues were subjected to cell extraction techniques and
the cells were expanded. For flow cytometry, cells were stained
with antibodies and cell surface marker expression was analysed.
Biocompatibility of biomaterials was tested by measuring cell
proliferation and osteogenic differentiation in vitro.
Our surface marker expression data is in accordance with the
results reported earlier. Furthermore, our data shows that adipose
stem cells have the capacity to undergo osteogenic differentiation.
At the moment, we have treated three patients with bony defects
using adipose stem cells. These cases show that the use of autol-
ogous adipose stem cells combined with osteostimulative bioma-
terial results in faster generation of new viable bone. Moreover, our
results show that adipose tissue stem cells can be utilized in fab-
rication of custom-made bone flaps. This will begin a new era of
reconstructive surgery.
(OP 145) Human Cultured Epithelial Allografts: an Adapted
Approach Introducing More Efficient Production Schemes
and Resulting in Extra Patient Safety
P. De Corte1, G. Verween1, G. Verbeken1, T. Rose1, S. Jennes1,
J.-P. Pirnay1
1Burn Unit/LabMCT, Queen Astrid Military Hospital, Bruynstraat
1, B-1120 Brussels, Belgium
Introduction: Since 1987 keratinocytes are grown and used in our
burn unit (> 800 patients were treated). During those two decades,
our culture system has evolved considerably with an emphasis on
safety assurance for the acceptor patients, increased quality and
overall performance, and cost-reduction.
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Methods: The major improvements consist in the introduction of
neonatal foreskin keratinocytes (NFK), a feeder layer- and animal
component free culture system, and a Quality Management System
(QMS).
Results: In contrast to the irregular and unpredictable growth
rates and end stages of normal adult human epidermal keratino-
cytes (HEKa), NFKs show a very regular and consistent growth,
comparable to that of established cell lines, which lasts for up to 50
population doublings (theoretical expansion of a 1 cm2 biopsy up
to 100 km2 of cultured epithelium, compared to 50 m2 for adult
keratinocytes). This tremendous proliferation potential allows the
use of more strict and predictable subculturing schemes. Today, all
culturing and banking procedures are performed taking into ac-
count the cGMP guidelines and ISO 9001:2000 QMS require-
ments. Recently, our lab tested of a new totally defined and animal
free culture medium. This medium supported a regular and ex-
tended growth (up to 25 population doublings). The use of a totally
defined and animal free medium is avoiding possible transmittance
of potential animal viral agents. The support for the cells is given
by a coating of recombinant human type-1 collagen instead of the
traditional bovine collagen. We also tested (safe) membranes as a
support for human epithelial grafts.
(OP 146) Human Dermal Fibroblasts, Keratinocytes and
Adipose Stem Cells Behaviour on Patterned Electrospun Na-
nofiber Meshes
M. T. Cerqueira1,2, A. Martins1,2, T. Rada1,2, M. E. Gomes1,2, A. P.
Marques1,2, N. M. Neves1,2, R. L. Reis1,2
13B’s Research Group–Biomaterials, Biodegradables and Biomi-
metics; Dept. of Polymer Engineering, University of Minho, Cam-
pus de Gualtar, 4710-057 Braga, Portugal, www.3bs.uminho.pt
2IBB–Institute for Biotechnology and Bioengineering, PT Gov-
ernment Associated Laboratory, Braga, Portugal
Natural extracellular Matrix (ECM) creates a unique cellular
microenvironment. It acts as a support to organize cells in tissues,
maintains their structure and works also as a reservoir for cytokines,
thus controlling cell growth and differentiation. A well-defined
biomaterial surface topography is believed to be adequate to mimic
native ECM for guiding cell growth or tissue regeneration. This
structure can be achieved by using an electrospinning technique,
which allows producing a non-woven nanofibrous structure with
topographic features mimicking the natural ECM.
This study evaluates the influence of micro-topography of pat-
terned Polycaprolactone (PCL) nanofiber meshes, aimed at being
used in skin regeneration approaches. The morphology, adhesion
and proliferation of primary cultures of human keratinocytes
(hKC), dermal fibroblasts (hDFs), and adipose-derived stem cells
(hASCs), isolated from the abdominal region, was evaluated after
seeding in those structures.
In vitro studies showed that the characteristic morphology of
each cell type and respective phenotype was maintained on the
patterned electrospun nanofiber meshes during the culture period.
SEM micrographs demonstrated that these cells adhered better on
the randomly distributed areas of the nanofibers than in the aligned
ones. Furthermore, DNA quantification and metabolic activity
analysis confirmed the enhanced performance of the cells adhered
on the random structures. Additionally, the patterned areas were
able to induce cell alignment along the nanofibers.
The combination of the organized and random structures into
patterned nanofiber meshes, being able to control cell distribution
and proliferation, showed promising characteristics for upcoming
studies regarding skin tissue engineering applications.
(OP 147) Human Mesenchymal Stem Cells (hMSC) Increase
the Stiffness of Collagen Meshes: Dependence of the Crosslink
Percentage
I. Ochoa1,2, C. Alcaine1,2, M. Perez-Ilzarbe3, J.E. Robles4,
J. Grasa 1,2, F. Pro´sper3, M. Doblare´1,2
1Group of Structural Mechanics and Materials Modelling; Aragon
Institute of Engineering Research; University of Zaragoza
2CIBER-BBN Networking Centre on Bioengineering, Biomater-
ials and Nanomedicine
3Cell Therapy Group; Department of Haematology and Hae-
motherapy; Clinica Universitaria, School of Medicine; University
of Navarra
4Urology Department; Clinica Universitaria, School of Medicine;
University of Navarra
Introduction: The use of graft materials in uroginecology surgery
has been promoted to compensate for the inherent weakness in
autologous tissues. The ideal graft should be inert, noncarcino-
genic, strong, nonallergenic, noninflammatory, convenient, and
affordable1. The advantages of collagen matrix laminates made
from porcine dermis as implantable xenograft products are well
known. Collagen-based meshes possess good mechanical proper-
ties, strong resistance and poorly antigenicity. Moreover, they allow
a secondary cellular colonization and can become less degradable if
modified.
Material and Methods: Porcine collagen meshes (Pelvicol,
BARD) with different crosslink degrees were tested to determine
their mechanical properties. Monotonic and cyclic uniaxial tensile
tests were carried out along the two principal directions of the
mesh. hMSC were seeded and cultured for one week at 378C in a
CO2 incubator.
Results: Significant differences in mechanical properties be-
tween samples with different crosslink percentages were observed.
The partial crosslink mesh showed higher anisotropy. The hMSC
colonized the collagen mesh and also increased the young modulus
of the collagen meshes depending on the crosslink percentage.
Damage accumulation due to cyclic load depends also on the
crosslink percentage.
Conclusions: Increasing the crosslink percentage produced a
stiffness gain with a decrease in the damage accumulation in the
collagen meshes. MSC could increase the stiffness of the collagen
meshes but not of the full crosslinked ones. This increase is in-
versely proportional to the crosslink degree.
Reference:
1W.A. Silva and M.M. Karram, Scientific basis for use of grafts during
vaginal reconstructive procedures, Curr Opin Obstet Gynecol 17 (2005),
pp. 519–529.
(OP 148) Human Wharton’s Jelly Stem Cells can be Differ-
entiated In Vitro into Endothelial Cell Lineage with the Ap-
propiated Culture Mediums
B. Pe´rez-Ko¨hler1, V. Go´mez-Gil1,2, N. Garcı´a-Honduvilla1,2,
C. Trejo3,2, J. M. Bello´n3,2, J. Buja´n1,2
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1Department of Medical Specialities. University of Alcala´, Ma-
drid, Spain
2Networking Research Center on Bioengineering, Biomaterials
and Nanomedicine (CIBER-BBN) Madrid, Spain
3Department of Surgery. University of Alcala´, Madrid, Spain
Introduction: Mesenchymal stem cells have the ability to differ-
entiate into several lineages, and they have high levels of self-
renewal. The objective of this study was to verify this potential of
differentiation in Human Wharton’s Jelly Stem Cells (HWJSC).
Material and Methods: HWJSC were isolated from fresh um-
bilical cords by mechanical and enzymatic methods. They were
separately cultured in Amniomax (Gibco) and M199 (Gibco)
supplemented with 1% EGF (Sigma) until reach the 4th passage.
Cells fixed in 10% formalin were used to analyze the specific
endothelial line markers vWF and CD31. Proliferation studies
were realized by trypan blue techniques.
Results: HWJSC showed high proliferation rate in both culture
mediums, but Amniomax cultures had a faster cellular prolifera-
tion than M199. Cells cultured in M199 did not express vWF until
the 4th passage and the marker appeared to be very light at this
time. No positive vWF cells were found in Amniomax cultures
at any passage. M199 cultures were positive to CD31 since the 1st
passage and the positive average percentage was increasing with
the passages (from 9% in the 1st to 40% in 4th). This marker
was found in 2nd to 4th passages of Amniomax cultures in less
than 1%.
Conclusion: If we are able to differentiate in vitro HWJSC into
endothelial cell lineage using M199 medium supplemented with
1% EGF in the first four passages, we could use this cells in tissue
engineering as a substitute of endothelial cells.
This work was supported by a grant from: FIS (PI-061781)
(OP 149) Imaging Techniques to Improve and Control Tissue
Engineering Strategies
R. Mu¨ller1
1Institute for Biomechanics, ETH Zurich, Wolfgang-Pauli-Strasse
10, 8093 Zurich, Switzerland
With recent advances in tissue engineering there is a strong need for
quantitative image processing of three-dimensional natural and
engineered biomaterials models to improve and control tissue en-
gineering strategies. A number of new microstructural imaging
modalities have been put forward recently allowing quantification
with high precision and accuracy. Although biomedical imaging
technology is now readily available, few attempts have been made
to expand the capabilities of these systems. Nevertheless, quanti-
tative endpoints have become an important factor for success in
basic research and the development of novel therapeutic strategies
in tissue engineering. Microtomographic imaging is key to these
developments and is expected to shed light on the relationship be-
tween cell in-growth and viability and structural features of the host
material. As part of the presentation, new strategies for advanced
imaging techniques to improve and control tissue engineering strat-
egies in skeletal applications will be presented. Results will include
the use of imaging for tissue engineering specifically in studies of
bone and cartilage repair. The focus will be on hierarchical micro-
and nano-imaging as well as image-guided biomechanics. In
conclusion, microstructural bone imaging is a nondestructive, non-
invasive, and precise procedure that allows the measurement of
natural and engineered biomaterials as well as the repetitive 3D
assessment and computation of microstructural and micromechan-
ical properties in laboratory, animal and patient studies. The pro-
cedure can help improve predictions of material failure, clarify the
pathophysiology of skeletal diseases, and define the response to
therapy.
Acknowledgment: Partial funding EU/NoE EXPERTISSUES
(NMP3-CT-2004-500283).
(OP 150) Improve Tissue-Engineered Bone Regeneration by
Introducing Endothelial Cells-Initiating Vascularization
Haiying Yu1, Li Mao1, Pamela J. Vandevord1, Howard W. Mat-
thew1, Paul H. Wooley1, Shang-You Yang1
1Wayne State University
Natural bone growth greatly depends on the precedent vascular net-
work to supply the oxygen and essential nutrients, while remove
metabolites. Likewise it is crucial for tissue engineered bone to es-
tablish a vascular network which temporally precedes the new bone
formation, and spatially originates from inside of graft. Recapitulating
the archetype of skeletal development we developed a complex bone
graft used to repair rat bone defects. Based on the cell morphology,
quantification of specific antigen molecule, matrix mineralization or
capillary-like growth, we demonstrated that the endothelial cells and
osteoblast were able to be differentiated and expanded from rat
bone marrow mononuclear cells population. Using methods of point-
injection and low pressure, the seeded endothelial cells and osteoblast
were capable of assembly into microvascular networks and form
bony matrix in grafts. In sex-mismatch implantation, Y chromosome
assay identified the exogenous origination of these cells and contri-
bution to the vascularization and osteogenesis. By pre-seeding en-
dothelial cells, endothelial cells-initiating vascularization was able to
promote osteogenesis, prevent ischemic necrosis and improve the
mechanical properties in engineered bone tissue. Taken together, the
present study integrating complex cell populations and complex
scaffold materials were an effective technique to improve osteo-
genesis in engineered bone graft and provided important perspective
for therapy of mass bone defect clinically.
(OP 151) In Situ Generated Scaffolds for Tissue Regeneration
Daniel Cohn1, Itai Pelled1, Shai Garty1
1The Hebrew University of Jerusalem, Jerusalem, ISRAEL
Injectable polymeric systems play a fundamental role in the
emerging ‘‘in situ generated implants’’ field, which aims at engi-
neering biomedical structures at their site of performance. The
water solutions of reverse thermo responsive display low viscosity
at ambient temperature and exhibit a sharp viscosity increase as
temperature rises within a narrow interval, producing semi-solid
gels at body temperature.
This contribution describes various of the strategies pursued in
our laboratory, aiming at tailoring the rheological, mechanical and
biological properties of novel reverse thermo-responsive poly-
mers, expanding, therefore, their clinical applicability. Particularly
promising are: (i) The generation of high molecular weight thermo
responsive polymers, and (ii) The use of functionalized building
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blocks that combine thermo-responsiveness and in situ cross-
linkability. Additionally, these thermo-responsive gels were also
reinforced at their site of performance.
Of special significance is the development of scaffolds for Tis-
sue Engineering based on reverse thermo responsive polymers, as
an alternative to the currently used pre-formed constructs com-
prising biodegradable polymers.
The objective of the ‘‘in situ generated implants’’ area is not
only to deploy materials, but primarily to engineer structures at a
precise body site, having specific geometric and mechanical
characteristics. This study presents, therefore, the in vitro pro-
duction of macroscopic constructs (e.g. tubular conduits), capi-
talizing on the improved mechanical properties of the reverse
thermo responsive polymers developed. Mono-layered structures
as well as conduits comprising two and three layers were en-
gineered in vitro and their mechanical response (burst strength,
compliance) wil be presented.
(OP 152) In Situ Tissue Engineering - Multilineage Potential
and Migratory Capacity of Human Periosteum Derived Cells
S. Stich1, A. Loch2, Z. Liang1, Y.X Zheng1,3, T. Haeupl1, S. Park1,
M. Sittinger1, J. Ringe1
1Charite-University Medicine Berlin,Tissue Engineering Labora-
tory and Berlin-Brandenburg Center for Regenerative Therapies
2Charite-University Medicine Berlin, Department of Otorhino-
laryngology
3Zhejiang University, Department of Surgery, The Second Af-
filiated Hospital, School of Medicine
Objective: Recently, a mesenchymal stem cell like character of
human periosteum-derived cells (PCs) was shown. The aim of our
study was to investigate their bone and cartilage formation on the
molecular level applying microarrays and their chemokine-
dependent migration potential, which is essential for in situ tissue
engineering applications.
Methods and Results: PCs isolated from periosteum covering
mastoid bone were expanded in medium containing human serum,
embedded in fibrin-PLGA fleeces and induced towards osteogenesis
(dexamethasone) and chondrogenesis (TGFbeta3). Matrix formation
was verified by von Kossa (osteogenesis) and alcian blue and col-
lagen type II staining (chondrogenesis) respectively. Gene expres-
sion profiling using Affymetrix microarrays was done on PC
samples from native tissues, expansion cultures and 3D transplants
(osteogenesis: day 7, 14, 28; chondrogenesis: day 14, 28, 42). Data
were analyzed with software tools for cluster and pathway analysis.
During differentiation culture osteogenic marker genes (e.g. Cbfa-1,
osteopontin) and chondrogenic marker genes (e.g. aggrecan, COMP,
collagen type II, Sox9) were upregulated. Hierarchical clustering of
differentially expressed genes showed a molecular relationship be-
tween native tissue and tissue-engineered bone and cartilage trans-
plants. PCs were also checked for their expression profile of
chemokine receptors on the mRNA (PCR) and protein (antibodies)
level. A chemotactic response to CCL2, CCL25, CXCL8, CXCL12,
and CXCL13 was measured in a multiwell chemotaxis assay.
Conclusion: In conclusion, PCs cultured in fibrin-PLGA con-
structs can be induced to form bone and cartilage, and they migrate
after chemokine stimulation. Therefore, they represent promising
candidates for in situ tissue engineering applications of skeletal
defects.
(OP 153) In Vitro Characterization on the Interactions
between Carboxymethyl-Chitosan/Poly(Amidoamine) Den-
drimer Nanoparticles and Neurons/Glial Cells
J.M. Oliveira2,3, A.J. Salgado1, R.P. Pirraco2,3, V.H. Pereira1, J.S.
Fraga1, A.P. Marques2,3, N.M. Neves2,3, J.F. Mano2,3, R.L.
Reis2,3, N. Sousa1
1Life and Health Sciences Research Institute (ICVS), School of
Health Sciences, University of Minho, Braga, Portugal
23B’s Research Group—Biomaterials, Biodegradables and Bio-
mimetics—Department of Polymer Engineering, University of
Minho, Braga, Portugal
3IBB, Institute for Bioengineering and Biotechnology, PT Asso-
ciated Lab, Braga, Portugal
Central nervous system associated disorders are a leading cause
of disability worldwide. In recent years targeted drug delivery
nanoparticle based systems for intracellular application have
been put forward has a possible therapeutic route to follow. In this
sense the objective of the present report was to characterize and
evaluate the possible applicability of recently developed carbox-
ymethylchitosan/poly(amidoamine) (CMC/PAMAM) dendrimer
nanoparticles in central nervous system (CNS) cell populations.
Atomic force and transmission electron microscopy observations
revealed that these nanoparticles possessed a nanosphere-like shape
and sizes between 2–123 nm. Moreover it was also possible to
confirm by UV/VIS spectrophometry that these nanoparticles could
be bound to FITC for tracing purposes. Experiments with post-natal
hippocampal neurons and cortical glial cells revealed that both cell
populations were able to internalize the CMC/PAMAM dendrimer
nanoparticles. The internalization rates changed according to the
cell populations, reaching a maximum peak after 48 hours of in-
cubation. Overal astrocytes and microglial cells disclosed higher
internalizaton rates (around 100% of the total cell sub-population)
followed by neurons and oligodendrocytes (up to 80–90% of the
observed cells). Further experiments for periods of up to 7 days
revealed that these values were maintained or even increased if
CMC/PAMAM dendrimer nanoparticles were periodically added
to the culture medium. Finally it was also observed that cell via-
bility and proliferation were not significantly affected by the
presence of the above referred nanoparticles. Further studies will be
focused on loading relevant drugs for future applications in CNS
disorders.
(OP 154) In Vitro Comparison of Cardiac-ECM and Urinary
Bladder Matrix for Cardiac Remodeling
John M. Wainwright1,2, Urvi B. Patel1,2, Donald O. Freytes1,2,
Kimimasa Tobita2,3, Stephen F. Badylak1,2,4
1University of Pittsburgh, Department of BioEngineering
2McGowan Institute for Regenerative Medicine
3University of Pittsburgh, Department of Pediactrics
4University of Pittsburgh, Department of Surgery
While cardiac surgery with synthetic materials improve heart
function, they do not form contracting tissue or grow with the
patient. One successful regenerative medicine approach for tissue
restoration has been the development of naturally occurring ex-
tracellular matrix (ECM) scaffolds. Recently, porcine urinary
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bladder matrix (UBM) was used to repair myocardial tissue that
contributed to regional function in a canine and porcine models,
but did not fully regenerate contractile tissue. Given the highly
specific composition, organization, and function of individual or-
gan ECM, a xenogeneic ECM scaffold derived from the organ that
is targeted for repair (i.e., the heart) may provide the optimal
biomechanical behavior and biological signals for site specific
remodeling. Therefore, a Cardiac ECM (C-ECM) scaffold from a
porcine heart has been developed.
C-ECM development included decellularization, chemical and
physical characterization, and cell seeding with comparison to
UBM. Decellularization of a whole porcine heart was performed
using retrograde perfusion of trypsin, Triton X-100, deoxycholatic
acid each for 2 hours and peracetic acid for 1 hour. Decellular-
ization was confirmed with H&E, DAPI, and Pico Green for cel-
lular remnants and DNA content. Movat’s Pentachrome and
GAG assays were used for chemical characterization. Physical
characterization was performed with SEM and uniaxial testing
in multiple orientations. Scaffolds were seeded with cardiomyo-
cytes, endothelial, and progenitor cells. Seeded constructs were
characterized with ATP biocompatibility assays and confocal mi-
croscopy.
C-ECM is ready to be compared to UBM and Dacron in a full
thickness right ventricle defect in a GFP bone-marrow chimera rat
model scheduled for March 2008.
(OP 155) In Vitro Culture of Human amniotic Cells: Pheno-
type and Differentiation Capacity
G. Stadler 1,2,3, S. Hennerbichler 4,3, A. Lindenmair 1,2,3, A. Pe-
terbauer 4,3, M. van Griensven 1,3, C. Gabriel 4,3, H. Redl 1,3,
S. Wolbank 4,3
1Ludwig Boltzmann Institute for Experimental and Clinical
Traumatology/AUVA Research Center, Linz/Vienna, Austria
2Bio-Products and Bio-Engineering AG, Vienna, Austria
3Austrian Cluster for Tissue Regeneration
4Red Cross Blood Transfusion Service of Upper Austria, Linz,
Austria
Amniotic membrane is a promising cell source for tissue engi-
neering. This abundantly available and uncontroversial tissue
contains epithelial and mesenchymal cells which show stem cell
and immunomodulatory characteristics. We have studied the bio-
logical variability and adipogenic and osteogenic differentiation
capacity of purified amniotic cells in various differentiation me-
dia. We further investigated the consequences of in vitro expan-
sion, comparing freshly isolated and cultivated human amniotic
epithelial cells (hAEC) regarding stem cell characteristics includ-
ing surface antigen expression profile and their differentiation ca-
pacity.
All isolations of epithelial and mesenchymal cells homo-
genously expressed typical mesenchymal and embryonic stem
cell markers. Osteogenesis could be induced in all epithelial and
75% of mesenchymal amniotic, while adipogenesis was detected
only in mesenchymal and not in epithelial amniotic cell cultures.
Differentiation capacity was strongly dependent on cell type and
differentiation protocol but only slightly on biological variation.
We demonstrate that expression of surface antigens changes
dramatically during cultivation of hAEC. The mesenchymal
markers CD13, CD44, CD49e, CD54, CD90 and CD105 are
strongly up-regulated during in vitro propagation. In contrast, ex-
pression of the embryonic markers TRA-1-60 and TRA-1-81 but
not SSEA-4 rapidly decreases upon cultivation. The phenotypic
shift is associated with reduced osteogenic differentiation. This
suggests that phenotypic alterations of hAEC during cultivation
might be associated with a functional reduction of the differentia-
tion potential, which should be considered for potential application
of these cells in cell based therapies.
Acknowledgments: HIPPOCRATES (NMP3-CT-2003-505758);
EXPERTISSUES (NMP3-CT-2004-500283).
(OP 156) In Vivo Behaviour of Injectable Polymeric/Calcium
Phosphate Cement Composites: an Experimental Study in
Rabbits.
J.G.C. Wolke1, W.J.E.M. Habraken1, H.B. Liao1,2,3, A.G. Mikos4,
J.A. Jansen1
1Radboud University Nijmegen University, dept Periodontology
and Biomaterials, Nijmegen, The Netherlands
2Guangxi Medical University, College of Stomatology, Guangxi,
China
3Sichuan University,Center for Nano-Biomaterials, Chengdu,
China
4Rice University, Dept. Bioengineering, Houston,Texas,USA
Calcium phosphate compounds are osteoconductive and can reach
to mechanical strenghts that are comparable to bone. Especially
calcium phosphate cement (CPC) is a good candidate for bone
repair since it can be shaped to the defect site after injection and
render an optimal contact between bone and material. However,
in vivo resorption and tissue ingrowth is slow. To improve these
properties, microspheres can be introduced, which will create
macroporosity into the system.
The current study focussed on the in vivo behaviour of injectable
composites consisting of CPC with PLGA and Gelatin micro-
spheres. Osteoconductive and osteoinductive behaviour were ex-
amined respectively in the femoral condyle and subcutaneous
tissue of a rabbit, with implantation periods of 4, 8 and 12 weeks.
Histological examination of the CPC/PLGA composite showed
new bone formation and almost complete degradation of the CPC
cement after 12 weeks of implantation. On the other hand, solid
CPC cement was completely surrounded by newly formed bone
and no degradation could be observed. However, CPC/gelatine
composite revealed a moderate degradation and a lower bone con-
tact. Subcutaneous implantation showed that all CPC/microsphere
composites exhibited microspheres degradation. Furthermore, all
composites showed a similar tissue response with a decreasing
capsule thickness and moderate inflammatory response over time.
In conclusion, the in vivo degradation of the CPC/microsphere
composites is dependent of the degradation pattern of the individual
microspheres. Although no clear osteoinductivity was found, the
injectable cement showed excellent biocompability as well as os-
teoconductivity.
(OP 157) In Vivo Effects of TGF-b1-Loaded Polymeric Mi-
crosphere Incorporation in Injectable Cap Cement
J.J.J.P. van den Beucken1, A.S. Plachokova1, D.P. Link1, A.G.
Mikos2, J.A. Jansen1
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Calcium phosphate cements (CPCs) represent feasible synthetic
bone substitution and regeneration materials. To facilitate degra-
dation, composites of CPC and degradable, polymeric micropar-
ticles have been developed. In addition to the creation of porosity
within the implant after microparticle degradation, these micro-
particles can be loaded with appropriate biologicals (e.g. growth
factors) to direct biological responses.
The current study focused on the in vivo effects of injectable
composites consisting of CPC with microspheres, either or not
loaded with transforming growth factor-b1 (TGF-b1). Bone aug-
mentation properties of an injectable CPC/PLGA composite were
evaluated using an in vivo rat model, in which the composite was
injected onto the skull for implantation periods of 2, 4, and 8
weeks. Histological and histomorphometrical analyses showed that
microsphere loading with TGF-b1 significantly increased initial
bone-implant contact. Moreover, TGF-b1 loading significantly
enhanced bone formation after prolonged implantation periods.
Alternatively, an injectable CPC/gelatin composite was implanted
in a cylindrical femoral condyle defect in rabbits for 4, 8, and 12
weeks. Irrespective of TGF-b1-loading, all implants showed an
increase in mechanical strength with implantation time. Further,
TGF-b1-loading significantly accelerated implant degradation,
whereas no effects on bone-implant contact or bone formation
were observed compared to composites containing non-loaded
gelatin microspheres. These results demonstrate the applicability
of CPC/microsphere composites for bone augmentation and sub-
stitution, and demonstrate that growth factor loading of the mi-
crospheres can further direct biological responses.
(OP 158) In Vivo Engraftment Potential of Human Bone
Marrow and Amniotic Fluid Stem Cells Cultured Under Os-
teogenic Conditions
A.M. Frias1,2, I.R. Dias1,2,3, C.A.A. Viegas1,2,3, S. Fernandes4,
A. Barros4, J.T. Azevedo5, N.M. Neves1,2, R.L. Reis1,2
13B’s Research Group–Biomaterials, Biodegradables and Biomi-
metics, Dept. of Polymer Engineering, University of Minho,
Campus de Gualtar, 4710-057 Braga, Portugal
2IBB–Institute for Biotechnology and Bioengineering, PT Gov-
ernment Associated Laboratory, Braga, Portugal
3Department of Veterinary Sciences, University of Tra´s-os-Montes
and Alto Douro, Vila Real, Portugal
4Genetics Department, Faculty of Medicine, University of Porto,
Porto, Portugal
5CECAV—Centre for Animal Science and Veterinary, Depart-
ment of Animal Sciences, University of Tra´s os-Montes and Alto
Douro, Vila Real, Portugal
The potential immune privilege presented by mesenchymal stem
cells (MSCs) makes them a promising population in tissue engi-
neering and regenerative medicine. In this study, we investigated the
effect of culture medium (expansion versus osteogenic media) over
the in vivo potential of adult stem cells derived from human bone
marrow (hBMMSCs) and amniotic fluid (hAFSCs).To this end, we
isolated hAFSCs from day 6 supernatant of the cultures of amniotic
fluid obtained from amniocentesis, and hBMMSCs were a kind gift
from Biopredic. Cells were maintained in culture until confluence
either in expansion or in osteogenic media (7 days), and then
transplanted into 58 to 62 day-old foetal sheep at a concentration of
1106 cells/foetus. Pregnant ewes were fasted for 24 hours. General
anaesthesia was induced with thiopental sodium and maintained by
inhalation anaesthesia with isoflurane and oxygen. After general
anaesthesia, the ewes were positioned in dorsal recumbency and
prepared in a sterile surgical environment for a ventral midline
celiotomy. The abdomen was exposed through a ventral midline
incision and the gravid uterus located. After the identification of
the foetus inside the uterus and their gentle handling contention
against the inner epithelium layer of the uterus, cells were trans-
planted into the intraperitoneal foetus cavity by injection through
the intact uterus walls. The animals were euthanized sixty days after
transplant, and samples from various tissues were collected. The
engraftment and phenotype of human-derived cells was evaluated
by flow cytometry and immunocytochemistry analysis.
(OP 159) In Vivo Evaluation of Fibrin-Based Tissue En-
gineered Heart Valves in a Sheep Model
T.C. Flanagan1, J. Frese1, J.S. Sachweh2, N. Bernstein3,
T. Schmitz-Rode1, S. Jockenhoevel1
1Department of Applied Medical Engineering, Helmholtz Institute
for Biomedical Engineering, Aachen University, Aachen, Ger-
many
2Department of Paediatric Cardiac Surgery, University Hospital,
Aachen, Germany
3Institute for Laboratory Animal Research, University Hospital,
Aachen, Germany
Objective: Our group has previously demonstrated the synthesis of
dynamically-conditioned tissue-engineered heart valves based on
an autologous fibrin scaffold. The present study aims to evaluate
the structure and mechanical stability of fibrin-based heart valves
following implantation in a sheep model.
Methods: Autologous tissue-engineered heart valves were
moulded using a fibrin scaffold, ovine carotid artery-derived
myofibroblasts and endothelial cells, before subjection to 28 days
of mechanical conditioning in a bioreactor. Following condition-
ing, tissue-engineered valves were implanted in the pulmonary
trunk of the same animals (n¼ 4) from which the cells had been
harvested; identical valves conditioned in parallel served as con-
trols. Valves were explanted after 1 and 2 months and analysed
using routine histology, immunohistochemistry, electron micros-
copy (EM) and extracellular matrix (ECM) assay.
Results: Explanted valve conduits had excellent tissue consis-
tency after 2 months in vivo. Routine histology showed excellent
tissue development and cell distribution, functional blood vessel
ingrowth in the conduit wall, with no evidence for inflammation.
Immunohistochemistry and ECM assay demonstrated almost
complete resorption of fibrin gel components and replacement with
ECM proteins. A monolayer of vWf-positive endothelial cells
lined the valve surface, and was shown to be completely confluent
using scanning EM. The resident valve tissue cells were in ex-
cellent health, as evidenced by transmission EM.
Conclusions: Preliminary results of implanted fibrin-based tis-
sue engineered heart valves are encouraging, with remarkable
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tissue remodelling and mechanical stability after 2 months in vivo.
The results suggest that it may be possible to construct truly
‘‘autologous’’ tissue-engineered heart valves on a patient-to-
patient basis.
(OP 160) In Vivo Immune Response to Allogeneic Porcine
Mesenchymal Stem Cell (MSC) Transplantation: a 12-Day
Course of FK-506 Abbrogates Humoral Response
A.J. Poncelet1,2, J. Vercruysse1, A. Saliez1, P. Gianello1
1Experimental Surgery- Catholic University of louvain
2Cardio-vascular Department-Cliniques universitaires Saint-Luc
Purpose: Several reports have highlighted the low immunogenic
profile of MSC. Therefore, we decided to test in vivo the humoral
response to allogeneic MSC transplantation and the effect of tran-
sient immunosuppression in a porcine model.
Methods/Material: MHC-controlled mini-swine SLAcd and
SLAdd were used as donor and recipients, respectively. Two sites
of transplantation were selected: subcutaneous and intracardiac. In
our control group (n¼ 5), animals received no immunosuppres-
sion. In the study group (n¼ 11), 1106 allogeneic MSC/kg were
injected. Tacrolimus was given from day 0–12. Recipient sera were
collected weekly after MSC transplantation. The presence of spe-
cific anti-donor IgM and IgG was tested by flow cytometry and by
complement-mediated cytotoxicity assay.
Results: In the control group, all animals developed humoral
responses in both IgM/G classes that persisted up to ten weeks.
A single subcutaneous injection failed to elicit a complement-
mediated cytotoxicity but subsequent re-challenge did.
In the study group, only 2 out of 11 animals developed a tran-
sient humoral response, both in IgM and IgG, whereas all others
failed to develop donor-specific antibodies. However, none of the
sera tested from those 11 animals could elicit a complement-
mediated cytotoxic response.
Conclusion: Allogeneic MSC can elicit prolonged humoral re-
sponses despite their putative low immunogenic profile. As already
shown for experimental allogeneic organ transplantation, a tran-
sient immunosuppressive regimen can overcome the initial B cell
response. Our result suggests that in vitro and in vivo character-
istics of MSC might differ and emphasizes the importance of
pursuing research on allogeneic stem cell transplantation.
(OP 161) In Vivo Tissue Engineering of Vascular Grafts Using
High Specific DNA-Aptamers as Capture Molecules for Cir-
culating Endothelial Progenitor Cells
H.P. Wendel1, J. Hoffmann1, M. Avci-Adali1, A. Paul1,
T. Walker1, A.M. Scheule1, G. Ziemer1
1Dept. of Thoracic, Cardiac and Vascular Surgery, University
Hospital Tuebingen, Germany
Objective: Due to their insufficient biocompatibility and high
thrombogenicity, small diameter artificial vascular prostheses still
do not show a satisfactory patency rate. In vitro endothelialization
of artificial grafts before implantation has been established ex-
perimentally years ago, but, has never been used for routine clin-
ical applications. This study deals with the coating of graft surfaces
with capture molecules for circulating endothelial progenitor cells
(EPCs), mimicking a pro-homing substrate to fish out EPCs from
the bloodstream after implantation.
Methods: Aptamers against EPCs were generated by systematic
evolution of ligands by exponential enrichment (SELEX), a tech-
nique from combinatorial chemistry. They can be selected from a
library of 1015 starting nucleotides. We have spotted a defined ap-
tamer onto a hydrogel coated surface, installed in a flow chamber, to
detect the attachment of EPCs from fresh human whole blood. Fi-
nally these cells were cultivated in growth factor enriched medium
and fluorescence marked antibodies against CD34, CD 31, von
Willebrand factor and VEGFR-2 were used to characterize the cell
attachment.
Results: After eight SELEX rounds 36 aptamers in total were
cloned, sequenced, synthesized and evaluated by flow cytometry.
The best binding aptamers were immobilized in a flow chamber.
The captured cells were positive for CD34, CD 31, von Willebrand
factor and VEGFR-2 and able to differentiate into a confluent
endothelial layer.
Conclusion: We hypothesize that in vivo self-endothelialization
of blood contacting implants by homing factor mimetic capture
molecules for EPCs may bring new perspectives towards future
clinical applications of stem cell and tissue engineering strategies.
(OP 162) In-Vitro Investigation of Esophageal Cell Organiza-
tion and Collagen Scaffold Interaction
A.K. Saxena1, H. Ainoedhofer1, P. Baumann1, M. Kristler1 and
M.E. Ho¨llwarth1
1Department of Pediatric Surgery, Medical University of Graz,
Austria
Esophageal tissue and organ demand is foreseen not only in the
pediatric but also in the adult population. Since the intention of
esophageal tissue engineering project is to replace the esophagus in
the thoracic esophagus, two cell types-esophageal epithelial cells
and smooth muscle cell have been identified to engineer esopha-
geal tissue. The aim of this study was to isolate, culture and seed rat
esophageal epithelial cells. Using the Sprague-Dawley-rat model,
esophagus tissue was isolated and treated with enzymatic solutions
to release the esophageal epithelial cells from the mucosal lining.
These cells were cultured to investigate the organization of these
cells under culture conditions and to evaluate there interaction with
collagen scaffolds.
Optimizing of esophageal epithelial cell protocols were neces-
sary to increase the cell yield. Microsurgical techniques were
employed to slide through the esophageal epithelial lining to
provide maximal exposure for cell extractions. Collagen coating of
tissue culture plates was necessary and was found to increase cell
attachment which was extremely low on non-coated surfaces.
Medium with serum offered better cell viability, proliferation and
differentiation when compared to serum free media.
Positive identification of esophageal epithelial cells were done
using immunofluorescent and immunohistochemical CK-14 mark-
ers which as specific for esophageal epithelial cells. Collagen
sponges were rolled into tube and sutured and viable esophageal
epithelial cells were demonstrated 4 weeks after seeding on the
collagen sponge tubes. The initial results from our investigations
are promising steps in the tissue engineering of esophagus.
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(OP 163) Influence of the EPC-BMSC Proportions Included
in a PRP Gel on Cell Differentiation
J. Denom1, S. Hoppe1, M. Alini1, S. Verrier1
1AO Research Institute, Davos, Switzerland
Bone formation highly depends on osteogenic cells presence at
the implant sites, but vascularisation is also crucial. Our aim is to
establish a precellularised bone graft containing both endothelial
and bone cells. We previously showed a strong effect of Platelet
Rich Plasma (PRP) on BMSC differentiation into osteoblast, and
that direct contact between BMSC and HUVEC enhances osteo-
blastogenesis and vessels-like formation. Willing to develop an
autologous bone grafts, we then studied the effect of endothelial
progenitor cells (EPC) on BMSC differentiation, and the influ-
ence of the cellular proportion (EPC vs BMSC) on cell differen-
tiation. BMSC were isolated by density-gradient centrifugation.
EPC (CD133þ) cells were isolated from mononuclear cell frac-
tion of bone marrow using magnetic beads (Miltenyi Biotec). PRP
was prepared from thrombocyte concentrates diluted in plasma
(2106 platelets/mL). PRP was activated using 0.5U thrombine.
EPC and BMSC were mixed in different proportions: 100%EPC,
75%-25%, 50%-50%, 25%-75%, 100%BMSC. Cell proportions
were mixed together within a PRP gel (3D). LDH analyses
showed cell viability of both cell types in 3D, after 21 days of
culture, for each proportion. In 3D, we observed an up-regulation
of runx2 and dlx5 genes for BMSC co-cultured with EPC when
compared to BMSC alone. The expression was found higher for
the proportion 25%EPC-75%BMSC compared to higher EPC
proportions. This work shows the high potential of EPC as an
autologous source of endothelial cells, and their positive effect on
BMSC differentiation.
(OP 164) Inhibition of Proteoglycan Production Influences
Cartilage Collagen Network Formation
Y.M. Bastiaansen-Jenniskens1,2, J.L.M. Koevoet1, K.M.B. Jan-
sen3, J.A.N. Verhaar1, J. DeGroot2, G.J.V.M. van Osch1
1Erasmus MC, University Medical Center Rotterdam, the Neth-
erlands
2Business Unit BioSciences, TNO Quality of Life, Leiden, the
Netherlands
3Delft University of Technology, the Netherlands
Cartilage tissue engineering is hampered by slow production of
collagen. In the present study we investigate the influence of
proteoglycans on collagen network.
Bovine chondrocytes were cultured in alginate beads with(out)
0.25 mM para-nitrophenyl-beta-d-xyloside (PNPX). PNPX is an
exogenous acceptor for galactosyl transferase I that prevents gly-
cosaminoglycans (GAGs) being incorporated in the matrix. GAG
and collagen deposition and distribution in matrix and medium,
collagen crosslinks, aggrecan and collagen II gene expression, and
mechanical properties were determined.
At day 21, 33.3 4.0 mg GAG/bead was deposited in controls
and 6.6 1.4 mg GAG/bead with PNPX. Almost no GAG was de-
tectable in culture medium of controls, this increased with PNPX.
AGCN gene expression was slightly upregulated, not reaching
statistical significance. 21.6 4.4 mg collagen/bead was deposited
in controls and 14.4 4.0 mg collagen/bead with PNPX. Collagen II
expression was not affected by addition of PNPX. PNPX addi-
tion resulted in a shift in GAG deposition from cell-associated to
Further-Removed Matrix (FRM) (64% in FRM versus 55% in
controls) and collagen (53% in FRM versus 29% in controls). The
number of collagen cross-links decreased from 0.13 0.02 HP/
collagen in controls to 0.08 0.03 HP/collagen in the presence of
PNPX. Mechanical properties, measured by stiffness and ability to
hold water, were decreased when PNPX was added.
The absence of a GAG network results in diffusion of collagen
away from the cells and probably also excretion into the culture
medium, leading to less collagen deposition. GAGs therefore seem
to contribute in the formation of a functional collagen network.
(OP 165) Injectable Gellan Gum Hydrogels as Supports for
Cartilage Tissue Engineering Applications
J. T. Oliveira1,2, R. Picciochi1,2, T. C. Santos1,2, L. Martins3, L.G.
Pinto3, P. B. Malafaya1,2, R. A. Sousa1,2, A.P.Marques1,2, A. G.
Castro3, J. F. Mano1,2, N. M. Neves1,2, R. L. Reis1,2
13B’s Research Group—Biomaterials, Biodegradables, and Bio-
mimetics, Department of Polymer Engineering, University of
Minho, Campus de Gualtar, 4710-057 Braga, Portugal
2IBB—Institute for Biotechnology and Bioengineering, PT As-
sociated Laboratory
3Life and Health Sciences Research Institute, School of Health
Sciences, University of Minho, Campus de Gualtar, 4710-057,
Braga, Portugal
Gellan gum is an extracellular microbial polysaccharide from
Sphingomonas paucimobilis that forms a firm and transparent gel
in the presence of metallic ions. This hydrogel presents some in-
teresting features that allow its use as a cell encapsulating support,
or as an in vivo injectable system. In this work, the usefulness of
gellan gum hydrogels as supports for cartilage tissue engineering
applications was shown. Processing versatility of gellan gum into
different structures such as discs, fibers, membranes, particles, and
3D porous structures using temperature and pH based technologies
was demonstrated. The characterization of these structures was
conducted using rheological analysis, dynamic mechanical analy-
sis, transmission electron microscopy and cytotoxicity assessment.
In vitro tests with human articular chondrocytes were conducted
during a 8 weeks period. The histological characterization of the
tissue engineered constructs was performed using different stain-
ings for cartilage extracellular matrix (ECM) components. At the
molecular level, real time PCR was used to quantify the expression
of cartilage ECM markers such as col I, col II, aggrecan and Sox9.
The in vivo performance of the developed structures was investi-
gated in mice. The properties of the materials revealed that gellan
gum is adequate to be used as a cell encapsulation support or as an
injectable system. The in vitro results showed that the typical
cartilage ECM components, col II and aggrecan, were being ex-
pressed throughout the culturing periods. The in vivo results ob-
tained so far are rather promising envisaging the use of gellan gum
hydrogels in the cartilage tissue engineering field.
(OP 166) Interface Integration of Rapidly Engineered Multi-
layer Collagen Scaffolds
E. Hadjipanayi1, V. Mudera1, R.A. Brown1
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The ability to engineer tissue interfaces, with the possibility of
measuring interface integration would offer an invaluable tool in
surgical tissue reconstruction and repair biology. Plastic com-
pression (PC) of collagen hydrogels has been shown to rapidly
produce dense, mechanically strong collagen sheets (100mm thick)
with high cell viability(Brown et al. 2005). In this study we in-
vestigated the interface integration of multilayer scaffolds based on
such compressed collagen constructs.
Acellular or HDF-seeded collagen gels were cast on top of each
other, in order to produce bilayer constructs. After setting, acellular
constructs were compressed and fitted onto a mechanical testing
system to measure the interface adhesive strength. Cell-seeded
constructs were either compressed at D0 and cultured for 7
days(compressed culture) or left attached to the casting well during
the culture period and compressed on D7(compliant compressed
culture). Interface adhesive strength was then measured.
After 1 week culture strength of the integration between two
collagen layers increased 6-fold (p< 0.05), compared to acellular
constructs. For compliant compressed cultures, interface break
force was higher (2282 383105N) compared to compressed
cultures (1636 145105N). Cell migration across the interface
i.e. cell translocation might play an important role in the integration
process. We tracked cell migration in both models at 24 hours and
found that cell migration was greater in the complaint-compressed
culture.
Integration of tissue engineered structures with host tissue post
implantation is critical for successful outcomes. We have devel-
oped an in vitro model which can define integration parameters and
after some refinement should be capable of predicting in vivo in-
tegration outcomes.
(OP 167) Interleukin-18 System Plays an Important Role in
Keloid Pathogenesis via Epithelial-Mesenchymal Interactions
T.T. Phan1,2, D.V. Do1, A. Khoo1, A. Carbone3, C.P. Lim4, S.G.
Wang2, A. Mukhopadhyay1, H.C. Han2, C.T. Ong1, X. Cao4,
D.H. Cho5, X.Q. Wei6, G. Bellone7, I.J. Lim1
1Department of Surgery, National University of Singapore
2Faculty of Dentistry-Centre for Craniofacial and Regenerative
Biology
3Department of Gastroenterology and Clinical Nutrition, Azienda
Ospedaliera San Giovanni Battista, Molinette, Turin, Italy
4Institue of Molecular and Cell Biology, Proteos, Singapore
5Department of Life Science, Sookmyung Women’s University,
Seoul, Republic of Korea
6Department of Dental Health and Biological Sciences, Cardiff
University, Cardiff, UK.
7Department of Clinical Physiopathology, University of Turin,
Turin, Italy
Keloid scarring is a dermal fibroproliferative disorder characterized
by increased fibroblast proliferation and excessive production of
collagen-extracellular matrix (ECM) components. To date, the role
of cytokines in the keloid pathogenesis has not been unraveled.
Interleukin-18 (IL-18) is a pro-inflammatory cytokine that plays
important roles in wound healing, fibrogenesis and carcinogenesis,
and our aim was to study the role of IL-18 sytem in keloid patho-
genesis. Results revealed that IL-18, IL-18Ra and IL-18Rb ex-
pression were elevated in keloid tissue compared with normal skin
tissue. Studies on the expression of IL-18 and its antagonist, IL-18
binding protein (IL-18BP) using a coculture model demonstrated
severe IL-18/IL-18BP imbalance in keloid keratinocyte/keloid fi-
broblast cocultures with significant elevation of bioactive IL-18
whereas IL-18BP levels which remained the same. Overproduction
of bioactive IL-18 in keloid cocultures could be due to increased
Caspase-1 and decreased Caspase-3 expression in keloid tissue, as
well as decreased soluble IL-10 levels observed in keloid cocul-
tures. The important inductive effects of IL-18 on keloid fibroblasts
(KF) was further underscored by the observation that exposure of
KF to IL-18 resulted in increased cellular proliferation, collagen-
ECM component synthesis, increased secretion of profibrotic cy-
tokines, as well as decreased production of matrix-degrading
proteases and antifibrotic cytokines. The present study has proven
that the IL-18 system plays an important role in keloid pathogenesis
via epithelial-mesenchymal interactions. It also suggests a thera-
peutic potential of PI3K, MAPK, Sp1 and mTOR inhibitors in the
treatment of keloid scarring.
(OP 168) Intervertebral Disc Regeneration Using Adipose
Stem Cells; a Large Animal Model in Goats
M.N. Helder1,2, R.J.W. Hoogendoorn1,2, R.A. Bank1,3,4,2, B.J. van
Royen1,2, V. Everts4,2, T.H. Smit5,2
1Dept. of Orthopaedic Surgery, VU University medical center,
Amsterdam, The Netherlands
2MOVE/Skeletal Tissue Engineering Group Amsterdam, The
Netherlands
3Dept. of Tissue Repair, Division of Biosciences, TNO-Quality of
Life, Leiden, The Netherlands
4Dept. of Oral Cell Biology, Academic Centre for Dentistry
Amsterdam (ACTA), Universiteit van Amsterdam and Vrije
Universiteit, Amsterdam, The Netherlands
5Dept. of Physics and Medical Technology, VU University med-
ical center, Amsterdam, The Netherlands
Introduction: Adipose stem cells (ASCs) can be obtained rapidly, in
high yields, with minimal patient discomfort. This allows stem cell
therapy concepts in which the stromal vascular fraction (SVF) con-
taining ASCs is harvested, either or not stimulated differentiation-
induced, and re-implanted within one single surgery. For preclinical
feasibility assessment, we developed a mild disc degeneration model
in goats.
Purpose: SVF still contains additional cell types apart from
ASCs (endothelial cells, monocytes, erythrocytes (RBCs)). Since
haemophilic arthropathy models showed that monocytes/RBCs
may evoke radical formation and inflammatory responses, we
evaluated whether RBC removal and/or other cell types from SVF
is mandatory for inflammation-free IVD regeneration.
Methods: Degeneration was induced in lumbar IVDs of six goats
with Chondroitinase ABC (cABC). After 12 weeks, these IVDs
were randomly injected with PBS, SVF, SVF meticulously RBC-
deprived using Optiprep, or cultured ASCs (isolated during
cABC degeneration induction surgery and cultured to homogene-
ity). After twelve weeks, goats were euthanized and analyzed using
X-ray, MRI, and histology.
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Results: PBS resulted in disc height loss, decrease in MRI Index
and mild degenerative changes on histological examination. SVF
resulted in severe inflammatory responses, resulting in severe de-
generative changes in all parameters. Histologically, round cellular
infiltration and osteoclastic activity were observed. This inflam-
matory response was observed in neither cultured nor Optiprep
‘‘treated’’ discs. The disc height and MRI index were decreased
comparable to PBS-injected discs.
Conclusion: Removal of RBCs from SVF prevented a negative,
inflammatory response in degenerated IVDs, implying that RBC
removal from SVF is crucial for IVD regeneration.
(OP 169) Intra-Individual Comparison of Human Ankle and
Knee Chondrocytes In Vitro: Relevance for Talar cartilage
Repair
C. Candrian1, E. Bonacina1, J. Frueh1, S. Dickinson2, M. He-
berer1, I. Martin1, A. Barbero1
1ICFS, Departments of Surgery and of Biomedicine, University
Hospital, Basel, Switzerland
2Avon Orthopaedic Center, University of Bristol, Southmead
Hospital, Bristol, UK
As compared to knee chondrocytes (KC), talar chondrocytes (TC)
have superior synthetic activity and increased resistance to in-
flammatory stimuli. We thus investigated whether these properties
are maintained when TC are isolated from their own environment
and de-differentiated in vitro.
TC and KC (n¼ 10) were expanded in monolayer for 2 pas-
sages and then cultured in pellets for 3 and 14 days or in hya-
luronan meshes (Hyaff-11) for 14 and 28 days. The generated
tissues were assessed biochemically [glycosamminoglycans
(GAG), DNA, collagen I and II], histologically (Safranin-O) and
by RT-PCR (collagen I and II). The proteoglycan and collagen
synthesis of the pellets were measured following or not exposure
to IL-1b.
Following 14 days of pellet culture, TC and KC expressed
similar amount of collagen I and II mRNA and produced tissues
with comparable amount of GAG and collagens. Proteoglycan and
collagen synthesis increased between 3 and 14 days of culture to a
similar extent for TC and KC. The drop in synthetic activity in
response to IL-1b was similar among TC and KC.
Following 14 days of culture in Hyaff-11, TC and KC gener-
ated tissue with similar amounts of GAG and collagens. The in-
crease in the contents of these macromolecules from 2 to 4 weeks
culture was larger (up to 2.2-fold) in tissues generated by KC.
The superior synthetic activity of TC as compared to KC is lost
when chondrocytes, isolated from their original matrices, are de-
differentiated and subsequently induced to re-differentiate, sug-
gesting a critical role of the tissue environment in determining the
properties of KC or TC.
(OP 170) Intracellular Fate Investigation of Bio-Eliminable
Polymeric Nanoparticles by Confocal Laser Scanning Micro-
scopy (CLSM)
D. Dinucci1, C. Bartoli1, F. Chiellini 1
1Laboratory of Bioactive Polymeric Materials for Biomedical and
Environmental Applications (BIOlab)–UdR INSTM, Department
of Chemistry & Industrial Chemistry, University of Pisa, Via
Vecchia Livornese 1291 56122 S. Piero a Grado, Pisa (Italy)
The present contribution is reporting on the assessment of
in vitro cytotoxicity and intracellular fate of poly[(glycylglycine
methacrylamide)x-co-N-(2-hydroxypropylmethacrylamidey)] bio-
eliminable polymer samples and relevant nanoparticles in Balb/c
3T3 cloned A31 mouse embryo fibroblasts cell line by using
Confocal Laser Scanning Microscopy (CLSM). Nanoparticles
were prepared by co-precipitating the polymers with fluorescein
labeled human serum albumin (HSA-FITC) as the fluorescent
probe and as the model protein drug. The toxicity of the polymer
samples consisting of 25, 50 and 100%, respectively, of gly-
cylglycinemethacrylamide monomeric units (GGMA), was inves-
tigated in terms of cytoskeleton morphology by exposing cell
cultures to various concentrations of polymers for 24 h. Under
normal culture conditions, fibroblast cells exhibit characteristic
spreading and shape, however, when the cell cultures were sub-
jected to chemical, metabolic or physical stress, their morphology
changed in terms of cytoskeletal architecture and reducing their
visibility. The co-polymer samples at 25% GGMA monomeric
units showed a lower toxicity even at high concentrations [8.5 mg/
mL]. The cellular uptake of polymeric nanoparticles was deter-
mined by comparing incubation of fibroblasts with HSA-FITC
loaded particles to HSA-FITC alone at three different time end-
points. The results indicate that the nanoparticles were up-taken by
the cells in a time dependent fashion. Computer assisted analysis of
nanoparticles fluorescence emission suggests a possible lysosomal
escape as intracellular fate.
(OP 171) Isolation and Characterisation of Stem Cells from
Different Human Salivary Glands
N. Rotter1, J. Oder1, U. Lindner1, P. Schlenke1, J. Kramer1,
J. Rohwedel1, S. Lang2, B. Wollenberg1
1University of Luebeck
2University of Duisburg-Essen
There is continuously growing interest in adult stem cells as a
source for regenerative medicine and tissue engineering applica-
tions. The characterisation of novel stem cell sources is therefore of
utmost concern.
Recently we reported for the first time the presence of adult stem
cells with mesenchymal characteristics in human parotid gland
tissue. In this study we isolated stem cells from human subman-
dibular glands and compared these cells to cells from parotid origin
and characterised both in more detail.
Cells were isolated from normal submandibular and parotid
glands by enzymatic digestion. Following initial proliferation
cells were characterized by flow cytometry. For differentiation
specific induction media and growth conditions were used with the
purpose to generate adipogenic, osteogenic and chondrogenic cells.
Differentiation was assessed by histochemical and immunocyto-
chemical stainings as well as by the demonstration of specific
mRNA using RT-PCR.
Cells from both gland types had surface characteristics very
similar to mesenchymal stem cells. They were e.g. positive for
CD13, CD29, CD44, and CD90 and negative for CD34 and CD45.
Cells could be induced into adipogenic, chondrogenic and osteo-
genic celltypes, demonstrating their differentiation capability.
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In this study we demonstrated that stem cells with mesenchymal
characteristics can be derived from both adult parotid and sub-
mandibular glands. Thus, human salivary gland tissue might be a
novel promising tissue source for future applications of these stem
cells in tissue engineering and regenerative medicine.
This work was supported by Novartis Foundation for Ther-
apeutic Research and the Network of Excellence EXPERTISSUES
(OP 172) Isolation and Expansion of Human Umbilical Cord
Perivascular Cells (HUCPV)
F. Feyerabend1, C. Lindner2, M. Lauke2, R. Willumeit1
1GKSS Research Centre, Institute of Materials Research, Max.
Planck-Str. 1, 21502 Geesthacht, Germany
2Frauenklinik Diakonie-Krankenhaus ELIM, Hohe Weide 17,
20259 Hamburg Germany
Adult mesenchymal stem cells from bone marrow (BMSC) rep-
resent the most commonly used cell source for applications like
cell-based therapies or bone marrow transplantations. However,
due to the limited number of BMSCs available for autogenous use
and additionally the possibility of donor site morbidity, there is a
need to identify alternative cell sources. Recently, Wharton’s Jelly
(WJ) of the human umbilical cord has been identified as a potential
new cell source. Cell populations derived from this tissue have
been shown to be major histocompatibility complex (MHC) class
I/II negative, making them a potential cell source for allogeneous
therapies, without ethical constraints.
In this study an outgrowth protocol was compared with a col-
lagenase digestion. The outgrowth of HUCPV (n¼ 6) started
around day 10. The first harvesting time point was dependent on
the amount and length of WJ surrounded vessels per flask. The time
range was between 24 days for three vessels and 45 days for one
vessel per flask. The harvests yielded an average of 5.6106 cells.
Thereafter, the outgrowth of cells was much faster, leading to an
average harvesting time of 9 days for outgrowths 2–4. The maxi-
mum cell yield summed up to 24106 cells, in average 19106
cells were isolated during the four outgrowths. In comparison to
the collagenase digestion the cell yield increases by a factor of 10.
Cell expansion was dependent on the seeding density. The highest
expansion (34-fold) was achieved at a cell density of 500 cells/cm2.
(OP 173) Isolation of Adipose Stem Cells (ASCs) Subpopula-
tions with Distinct Differentiation Potential
T. Rada1,2, M.E. Gomes1,2, N.M. Neves1,2, R.L. Reis1,2
13B’s Research Group–Biomaterials, Biodegradables and Biomi-
metics, Dept. of Polymer Engineering, University of Minho,
Braga, Portugal.
2IBB–Institute for Biotechnology and Bioengineering, PT Gov-
ernment Associated Laboratory, Braga, Portugal.
ASCs are becoming the elected cells for TE applications because
ASCs have been easily isolated and have shown good differentiation
potential. The aim of this work was to isolate the ASCs using im-
munomagnetic beads coated with different antibodies (Ab) markers
and to test the differentiation potential of the different subpopula-
tions isolated. The Ab used were CD29, CD44, CD49d, CD73,
CD105, STRO-1 and NGFr (p75). Once isolated, the cells were
cultured with Basal Medium until the confluence, then the cells were
trypsinized and divided in 3 groups. The first one was used to per-
form RT Real-Time PCR for CD44, CD105; CD73, CD90 and
STRO-1. The second group was cultured with Osteogenic Medium
for 3 weeks. The third one was used to set up a pellet culture with
chondrogenic medium and cultured for 3 weeks. After 3 weeks of
culture with osteogenic medium or chondrogenic medium the sam-
ples were retrieved. Alizarin Red Staining and RT Real-Time PCR
for Osteocalcin and Osteopontin were used to establish the osteo-
blast differentiation potential. Alcian Blue, Toluine Blue and Sa-
franin O staining and RT Real-Time PCR for Agrecan, Collagen I,
Collagen II, Collagen X and Sox 9 assess the chondrogenic differ-
entiation potential. The described method was effective to isolate
distinct subpopulations which present different gene expression
profile relative to the stem cell markers studied. The expression of
osteogenic and chondrogenic markers showed that these subpopu-
lations exhibit significantly different differentiation potentials.
Acknowledgements: Marie Curie Actions Alea Jacta Est, Project
HIPPOCRATES, NoE EXPERTISSUES.
(OP 174) Lactide-PEG Cryostructures with Stem Cells as
Tissue Engineering Scaffolds in Reconstruction of Cranial
Bone Defects in Rat Model
S. Egri1, I. Vargel2, T. Cavusoglu2, P. Korkusuz3, E. Guzel3,
D. Uckan4, E. Kilic4, E. Piskin1
1Hacettepe University, Chemical Engineering Department and
Bioengineering Division, and Biyomedtek, Ankara, Turkey
2Kirikkale University, Faculty of Medicine, Department of Plas-
tics and Reconstructive Surgery, Kirikkale, Turkey
3Hacettepe University, Faculty of Medicine, Department of His-
tology and Embryology, Ankara, Turkey
4Hacettepe University, Faculty of Medicine, Pediatric Hematol-
ogy Unit, Ankara, Turkey
Poly(L-lactide)(PLLA)-poly(ethylene glycol)(PEG) copolymers
were synthesized by ring opening polymerization of lactide dimer
with PEGs with different molecular weights, and molar ratios.
They were characterized with GPC, 1H-NMR and DSC. Cryos-
tructures were prepared from these copolymers in organic medium.
Salt crystals in the size range of 100–200 mm were used to create
macropores pores by a salt-extraction process in addition to the
relatively smaller pores that are formed during cryogelation.
Scaffolds with dimensions of 8 mm in diameter and 1 mm height
were used in a critical size cranial bone defects in rats with or
without using mesenchymal stem cells that were obtained from rat
bone marrow. Animals were sacrificed on 1, 3 and 6th months after
implantation, and the specimens were taken out from the implan-
tation site with the surrounding tissues for histological analysis.
Histological data confirmed ingrowth of connective tissue cells
with vascularization within the scaffold. Group with mesenchymal
stem cells resulted with much better scores and bone mineraliza-
tion. It has also been reported that the scaffolds were almost fully
degraded at 6th month after implantation.
(OP 175) Lessons from the Sea: Biomaterials Development
Inspired by Marine Bioadhesives
J. D. White1, C. R. Matos-Pe´rez1, J. R. Burkett1, J. L. Cloud1,
L. M. Hight1, J. L. Wojtas1, J. J. Wilker1
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1Department of Chemistry, Purdue University, West Lafayette,
Indiana 47907, USA
Biomedical engineers can easily find inspiration for exciting re-
search directions by looking to the oceans. Barnacles, starfish, sea
cucumbers, and mussels are examples of the many marine organ-
isms that generate adhesive materials. Although the details of for-
mation and bonding within these biological materials are not
completely understood, barnacle and mussel adhesives are known to
be protein-based materials. The animals apply proteins to surfaces
and then cross-link these proteins to yield the final, cured adhesive
matrix. These bioadhesives exhibit various properties appealing to
the tissue engineer: a cross-linked protein environment, the forma-
tion of strong bonds to surfaces, low toxicity, and the ability to set in
wet environments. Studies in our lab have begun by characterizing
marine adhesive materials. We are working with live mussels, ex-
tracted adhesive protein, and synthetic peptide models. Our results
indicate that mussels use iron for the key reagent to cross-link their
adhesive proteins. With this knowledge in hand, we are testing
mussel adhesive for biomaterial development. Although promising
results are being obtained, using the natural material can be some-
what limiting. Consequently we are taking advantage of our char-
acterization insights to design new synthetic biomaterials. We have
combined mussel adhesive cross-linking chemistry with the acces-
sibility and flexibility of bulk polymers. Early results show these
materials to exhibit strong adhesive properties. Ongoing efforts
are focused on developing surgical adhesives, dental cements, bone
cements, and cell growth scaffolds for organ generation.
(OP 176) Linking the Physical Environment to Cell
Behaviour–Applications for Tissue Engineering and Re-
generative Medicine
A.J. El Haj1
1Institute of Science and Technology in Medicine, Keele Uni-
versity Medical School, Guy Hilton Research Centre, Stoke on
Trent, UK
Physical cues such as the mechanical environment are well known
to influence cell behaviour and growth of tissues. Using in vivo and
in vitro models, we have been able to study the mechano-receptors
which control these interactions in a variety of cell types. We have
been studying the potential ways to activate or regulate these
mechano-receptors for tissue engineering applications using three
approaches. Firstly, we design growth environments which apply
physiological stresses similar to the ones which the implant will
experience in a patient. The stresses can vary according to the
ultimate functional tissue design. Secondly, we have extended to
create scaffolds which augment the mechanical receptors by pro-
viding targeted release agonists. In this way, we can allow me-
chanical cues to be enhanced with release strategies promoting
tissue growth in areas subjected to mechanical loads. In both ap-
proaches, mechanical environments are applied to combinations of
cell seeded biomaterials which ultimately relies on the initial
mechanical integrity of the construct. For conditioning of brittle or
soft scaffolds e.g. ceramics or injectables, we have developed a
technology for direct activation of cell membrane mechanorecep-
tors using magnetic nanoparticles coated with specific antibodies
or peptides, e.g. TREK1 or RGD. We then apply a varying mag-
netic field activating the cells remotely across a 3D construct.
Our work has shown targeted differentiation and matrix production
of MSCs in 2D and 3D tissue engineering configurations. In ad-
dition, the magnetic particle technology can be adapted for in vivo
tissue engineering where cell seeded constructs mature inside the
patient.
(OP 177) Living Biological Annuloplasty Rings with Potential
to Growth for Reconstructive Mitral Valve Surgery
J.-P. Minol1, M. Suprunov2, H. Baraki1, P. Akhyari2, E. Bagaev1,
G. Brandes3, C. Bara1, A. Haverich1, A. Hilfiker1, A. Lichtenberg2
1Medical School Hannover, Dep. of Thoracic and Cardiovascular
Surgery
2University of Heidelberg, Dep. of Cardiac Surgery
3Medical School Hannover, Dep. of Cell Biology
Introduction: Growing materials for reconstruction of cardiac
structures are of big advantage for pediatric surgery. In the present
study, we investigated the integrative capacity of viable and non-
viable allo- and xenogeneic tracheal cartilage rings, (allo-/xeno-
vTCR; allo-/xeno-nTCR), respectively, implanted for mitral valve
(MV) annuloplasty.
Methods: Ovine and porcine native vTCRs and deep-frozen
nTCRs were implanted in MV position for 3 and 9 months (n¼ 3,
each) in juvenile sheep. The size of each implanted TCR was
adapted to the MV size. MV function and TCR position were
analyzed by echocardiography. The TCR viability was analyzed by
LIVE/DEAD assay. The TCR integration was evaluated by mac-
roscopy, ring planimetry, H&E-, Movat-pentachrome-, von Kossa-
stainings, SEM.
Results: No echocardiographic differences were detected after
implantation. Before explantation in the xeno-vTCR and the xeno-
and the allo-nTCR groups a significant TCR-shrinkage with de-
velopment of MV stenoses were observed, whereas the size of all
allo-vTCRs was distinctly increased that paralleled the somatic
growth of the animals. No MV insufficiency was observed in all
groups. The laboratory analyses showed the superior integration of
allo-vTCRs with significantly lower rate of ring dehiscence, in-
flammation and calcification as compared to others. Consistently,
viable cartilage cells were found only in allo-vTCRs and also a
complete endothelialization was observed in this group only.
Conclusion: Since allo-vTCRs implanted in MV position show
excellent intracardiac tissue integration paralleled with ring size
increase according to the somatic growth, native viable TCR may
represent a well suited living material for reconstructive cardiac
surgery especially for pediatric patients.
(OP 178) Long Term In Vivo Performance of Starch-Based
Scaffolds
T. C. Santos 1,2, A. P. Marques 1,2, A. G. Castro 3, M. van
Griensven 4, H. Redl 4, R. L. Reis1,2
13Bs Research Group-Biomaterials, Biodegradables and Biomi-
metics, Univ. of Minho, Campus de Gualtar, 4710-057 Braga,
Portugal
2IBB–Institute for Biotechnology and Bioengineering, PT Gov-
ernment Associated Laboratory, Braga, Portugal
3Institute of Health and Life Sciences, School of Health Sciences,
University of Minho, Campus de Gualtar, 4710-057, Braga, Portugal
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4Ludwig Boltzmann Institute for Experimental and Clinical Trau-
matology, Donaueschingenstrasse 13, A-1200 Vienna, Austria
Natural-based biomaterials are mainly constituted by proteins or
polysaccharides which, under certain circumstances, may be rec-
ognized as natural host invaders. Starch-based scaffolds, produced
by different methodologies, have been shown to hold adequate
properties regarding mechanical performance and in vitro bio-
compatibility. This study aimed at evaluating the in vivo inflam-
matory response to starch-based scaffolds. Wet-spinning produced
starch-polycaprolactone (SPCL) scaffolds were subcutaneously
implanted in rats for 8 and 12 weeks in order to assess their long-
term in vivo behaviour. Macroscopically, the implantation area did
not show signs of inflammation. At the different time points the
implanted scaffolds and surrounding tissue were explanted, to-
gether with the neighbouring lymph nodes, and histological anal-
ysis was performed. The image analysis of the histological samples
showed good integration of the scaffold in the subcutaneous tissue,
with the presence of collagen fibres and newly formed blood ves-
sels. A mild inflammatory infiltrate was observed, although some
foreign-body giant cells were detected in the surroundings of the
scaffold’s fibres. The histological analysis of the lymph nodes
showed no signs of activation. All together, these findings allow
concluding that the wet-spinning produced starch-based scaffolds
did not elicit neither inflammatory nor immune responses after long
periods of implantation in rats and are suitable for long-term tissue
engineering approaches.
Acknowledgements: This work was partially supported by the
European Union funded STREP Project HIPPOCRATES (NMP3-
CT-2003-505758) and was carried out under the scope of the Eu-
ropean NoE EXPERTISSUES (NMP3-CT-2004-500283).
(OP 179) Marine Polysaccharide Multilayers: PH Responsive
Systems for the Surface Modification of Tissue Engineering
Scaffolds
T.H. Silva1,2, J.F. Mano1,2, R.L. Reis1,2
13B’s Research Group–Biomaterials, Biodegradables and Biomi-
metics, Dept. of Polymer Engineering, University of Minho, Campus
de Gualtar, 4710-057 Braga, Portugal, www.3bs.uminho.pt
2IBB–Institute for Biotechnology and Bioengineering, PT Gov-
ernment Associated Laboratory, Braga, Portugal
The success of some polymeric scaffolds for Tissue Engineering is
hindered by its surface chemistry, which in many cases leads to a
significant foreign body response. To overcome this, the present
project intend to explore a strategy of surface modification through
electrostatic self-assembly, first reported in the 1990s, by the con-
struction of multilayered systems by assembling a polycation and a
polyanion in an alternate fashion.
In the present work, polyelectrolyte multilayers constituted only
by marine polysaccharides are studied by Quartz Crystal Micro-
balance with Dissipation monitoring, QCM-D, focusing on the
effect of pH in their construction, properties and stability. The
results show the effectiveness of layer-by-layer assembly with the
consecutive deposition steps, with the mass of each layer being
dependent on the solution pH. Moreover, the effect of pH is also
present after the preparation of the multilayer, once the resonance
frequency of the crystal changes when it is submitted to solutions
with different pHs. This was attributed to an effect on the multi-
layer structure due to the ionization/deionization of different
groups within the macromolecules. The variation in dissipation of
energy with pH supports this, once dissipation is dependent on the
viscoelastic properties of those multilayers. In this way, these
multilayers may constitute a pH responsive smart material.
The knowledge acquired will be later transferred to 3D
substrates–porous scaffolds–with the final goal of controlling their
surface properties, maintaining the mechanical properties of the
original scaffolds.
(OP 180) Measuring Ion/Element Changes in Cells in Culture
to Monitor Cell Death
A. Warley1
1CUI King’s College London
To be successful, tissue engineering requires that cells are grown
and differentiate outside of the body for a period of time and it is
necessary to be able to determine the viability of these cultures
before re-implantation occurs. Traditional methods used for the
assessment of viability of cell culture lines such as exclusion of
vital dyes and the MTT assay have the disadvantage that they re-
flect late changes in cell physiology affecting a large number of the
cell population, and generally denote that the culture is moribund.
Cell death by either necrosis or apoptosis involves alteration in
cell volume with a concomitant change in intracellular ion/element
concentrations. The EM technique of X-ray microanalysis has a
long tradition in the measurement of element changes in cells
undergoing necrotic insult such as e.g. heavy metal poisoning,
where cell swelling is accompanied by early increases in the in-
tracellular concentrations of sodium and chloride with a decrease
in potassium only in the later stages. More recently this technique
has shown that apoptotic cell death is accompanied by a different
profile with immediate decreases in the concentrations of potas-
sium and chloride reflecting the early shrinkage that occurs in this
pathway. In both necrosis and apoptosis these changes in element
profile occur well before any of the recognised markers of cell
death, and, since very few cells are required for EPXMA, this is a
sensitive technique for monitoring cells in culture.
(OP 181) Mechanical Stimulation of Adipose-Derived Stem
Cells Embedded in a 3-Dimensional Fibrin Construct
T. Morton1,2, K. Baar3, K. Reise1,2, A. Peterbauer1,2,4, M. van
Griensven1,2, H. Redl1,2
1Ludwig Boltzmann Institute for experimental and clinical Trau-
matology in the Research Centre of the AUVA, Vienna, Austria
2Austrian Cluster for Tissue Regeneration Vienna, Austria
3Division of Molecular Physiology, Sir James Black Centre, College
of Life Sciences, University of Dundee, Dundee, United Kingdom
4Red Cross Blood Transfusion Service of Upper Austria, Linz,
Austria
The mechanical environment has the ability to alter the differen-
tiation of mesenchymal stem cells (MSC). We developed a novel
method for generating three-dimensional MSC-based constructs
using fibrin gel casting as described for myoblasts1. Adipose-
derived stem cells were seeded on top of a fibrin gel or mixed within
the gel. Over the next 8 days, cell-mediated tension contracts the
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gel around two artificial anchors, resulting in small tubular con-
structs 1–2 mm diameter and 10–12 mm length. Following forma-
tion, these constructs were connected to a stepper-motor and were
uniaxially loaded to 110% of their resting length at 0.1 Hz over 14
days. Histological analysis of the constructs after the 14 days of
stretch showed a high density of collagen between the anchors.
Since MSC cells normally don’t produce large amounts of collagen,
this indicates that the stem cells within the fibrin gel constructs had
differentiated down a tendon/ligament phenotype. These data in-
dicate that MSC/fibrin-based gels provide a novel method to en-
gineer three-dimensional functional constructs, load the cells either
in tension or compression, and rapidly determine the phenotype of
the MSCs. The fibrin MSC model may be used to drive MSC cells
towards the tendon/ligament or cartilage phenotype in vitro.
Reference:
1Huang YC, Dennis RG, Larkin L, Baar K. Rapid formation of functional
muscle in vitro using fibrin gels. J Appl Physiol. 2005;98:706–713.
(OP 182) Mechanism of Haemoglobin Sensing Body Tem-
perature
G. M. Artmann1, I. Digel1, P. Linder1, D. Porst1, P. Kayser1, A. T.
Artmann1
1Institute of Bioengineering and Centre of Competence in
Bioengineering, Dept. Cell Biophysics, Juelich, Germany
The talk works on answering the question whether hemoglobin
(protein) can ‘‘sense’’ body temperature. When human red blood
cells (RBCs) were aspirated into 1.3 mm pipettes (DP¼2.3 kPa),
a transition from blocking the pipette below Tc¼ 36.3 0.38C to
passing it above Tc occurred (passage transition). With a 1.1 mm
pipette, no passage was seen and RBC volume measurements were
possible. With increasing temperature RBCs lost volume signifi-
cantly faster below than above a Tc¼ 36.4 0.7 (RBC volume
transition). Colloid osmotic pressure (COP) measurements of
RBCs in plasma (258C  T  39.58C) showed a turning point at
Tc¼ 37.1 0.28C above which the COP rapidly decreased (COP
transition). In NMR T1 relaxation time measurements the T1 of
RBCs in plasma changed from a linear (r¼ 0.99) increment of T1
below Tc¼ 37 18C at a rate of 0.023 s/K, into a parallel to the
temperature axis above this point (RBC T1 transition). In con-
clusion: during micropipette aspiration, an amorphous gel forms in
the spherical trail of the aspirated RBC, consisting of mostly he-
moglobin and water. At Tc the gel turns fluid and Van-der-Waals
bonds brake due to thermal energy enabling cell passage. The
passage, the volume, the COP, and the RBC T1 transitions all
happen at Tcs close to body temperature suggesting a glass-like
transition as mechanism. Tc may mark the set point of a species’
core body temperature inscribed in the primary structure of a
species’ hemoglobin and possibly other proteins (cited from
‘‘Bioengineering in cell and tissue research,’’ GM. Artmann & Shu
Chien (ed.), Springer 2008)
(OP 183) Mechanobiology: Computer Simulations for Tissue
Engineering
P.J. Prendergast1
1Trinity Centre for Bioengineering, School of Engineering, Trinity
College, Dublin, Ireland
In this paper I will present research relating to how computer
simulations relating mechanical stimulation to tissue phenotype
can be performed. Issues to be addressed include: (A) stimuli
controlling cell differentiation [1], in particular mesenchymal stem
cell fate, (B) dispersal of cells within the scaffold due to crawling
and convection in the fluid (C) proliferation and apoptosis of cells,
and the relationship to mechanical stimuli in the cellular micro-
environment [2,3], (D) angiogenesis: the budding, growth, and
branching of capillaries in the granulation tissue and the differ-
entiated tissue, and possible modulation of this process by me-
chanical forces. Also the local oxygen tension and therefore the
differentiation of cartilage is affected by inhibitions on angiogen-
esis, (E) variability in outcome: this is due to either (i) environ-
mental factors such as variation in loading or diffusion of nutrients
and (ii) genetic differences between individuals and possibly inter-
individual differences in cellular mechanosensitivity.
References:
1Prendergast P.J., Huiskes R., Soballe K. Biophysical stimuli during tissue
differentiation. Journal of Biomechanics 30, 539–548, 1997
2Kelly D.J., Prendergast P.J., Prediction of optimal mechanical properties
for a scaffold used in ossteochondral defect repair, Tissue Engineering 12,
2509–2519, 2006
3Byrne D.P., Lacroix, D., Kelly, D.J., Planell J. & Prendergast P.J., Si-
mulation of tissue differentiation in a scaffold as a function of porosity,
Young’s modulus, and dissolution rate of a scaffold: application of me-
chanobiological models in tissue engineering. Biomaterials 28, 5544–
5554, 2007
(OP 184) Medtech Industry Requirements for the Cooperation
with Spin-Off Companies
J. Vienken1
1Fresenius Medical Care—BioSiences Department—Bad Homburg,
Germany
European universities currently promote the foundation of spin-off
companies to accelerate product realisation of innovative ideas. It
is an open secret that such spin-offs frequently fail. What are the
reasons for these failures which lead to a loss of investment and
personal disappointments. As large companies are seeking coop-
erations with innovative SMEs, several conditions are necessary to
be considered prior to starting a successful collaboration: 1. The
performance of an innovative product should have been proven in
in vitro or animal trials. 2. Logistics of applied biomaterials and
their quality/reproducibility should have been established. 3. Ideas
for approval and legal conditions have to be assessed before and
intelectual properties (IP) in terms of patents been fixed. 4. At best
a prototype of the innovative device should be available, whereby
considering that manufacturing of such a device might need fi-
nancial resources of up to 3–7 Mio e. Subsequent clinical trials in
cooperation with large companies might then easily add to further
15–20 Mio e. 5. The competence of an SME approaching a large
company might also be evaluated by a local audit and SMEs
should not hesitate to undergo such investigations. 6. One detail
should not be neglected: timing of contacts should be performed
rather early. Establishing cooperative programms and budgets
needs time. Large companies finish their budget-planning for
subsequent years in late summer. Being late would postpone the
whole process by a further year. These and other details will be
discussed.
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(OP 185) Membrane Biohybrid Systems for Liver Tissue En-
gineering
S. Salerno1, A. Piscioneri1,2, S. Morelli1, M. Rende1,3, C. Cam-
pana1,3, A. Bader4, E. Drioli1,3, L. De Bartolo1
1Institute on Membrane Technology, National Research Council
of Italy, ITM-CNR, c/o University of Calabria, via P. Bucci cubo
17/C, I-87030 Rende (CS) Italy
2Department of Cell Biology, via P. Bucci, University of Calabria,
Italy
3Department of Chemical Engineering and Materials of Uni-
versity of Calabria, via P. Bucci cubo 45/A 87030 Rende (CS)
Italy
4Biomedical-Biotechnological Center, BBZ, University of Liep-
zig, Germany
The reconstruction of human organ functions has proved to be an
important challenge besides for reducing the need for organ re-
placement also as model system for studying disease, drug, in-
fection and molecular therapeutics. Polymeric membranes can be
used in engineering of the liver tissue for the construction of in vitro
liver functions and modulation of cell behaviour.
In this study we report on the synthesis of novel semipermeable
membranes able to support the long-term maintenance and dif-
ferentiation of human liver cells and on the strategies to optimise
cell-biomaterial interactions in biohybrid systems.
We developed membrane biohybrid system constituted by
membranes made from a polymeric blend of modified polyether-
etherketone and polyurethane (PEEK-WC-PU) and human hepa-
tocytes.
Human hepatocytes organize in a 3D structure in the membrane
biohybrid system maintaining a polygonal shape, which would
lead to better functional maintenance, so many of the features of
the liver in vivo are reconstituted. Liver specific functions inves-
tigated in terms of urea synthesis, albumin production and total
protein secretion are maintained at high levels. Hepatocytes are
able to biotransform diazepam, which is an anti anxiety agent
(benzodiazepines), through the formation of its typical metabolites
including temazepam, N-desmethyl-diazepam and oxazepam. This
engineered liver construct is able to promote adhesion and to
provide a microenvironment able to elicit specific cellular re-
sponses.
Acknowledgments: The Authors acknowledge European
Commission through the Livebiomat project, Contract No. NMP3-
CT-2005-013653 and European Network of Excellence on
Nanoscale-based membrane technologies (‘‘NanoMemPro 500623-
2-26-7-2004).
(OP 186) Membranes for Bioartificial Organs and Tissue
Engineering
D.F. Stamatialis1, B.J Papenburg1, M.S Bettahalli1, M. Girones1,
J. de Boer2, C. van Blitterswijk2, M. Wessling1
1Membrane Technology Group, Institute for Biomedical Tech-
nology, University of Twente, Faculty of Science and Technol-
ogy, P.O. Box 217, 7500 AE Enschede, The Netherlands
2Tissue Regeneration Group, Institute for Biomedical Technol-
ogy, Faculty of Science and Technology, University of Twente,
P.O. Box 217, 7500 AE Enschede, The Netherlands
Membrane technology is of major importance in medical appli-
cations. Membranes are used in drug delivery, artificial organs,
tissue regeneration, diagnostic devices, as coatings for medical
devices etc. In fiscal terms, the value of medical membrane
products is far larger than all other membrane applications com-
bined. Only in the US, the medical membrane market approaches
1.5 billion dollars per year and grows steadily.
In this keynote lecture, a description of European Network of
Excellence: ‘‘NanoMemPro’’ and the research activities of the
partners on ‘‘membranes for bio-rtificial organs and tissue engi-
neering’’ will be initially presented. Furthermore, examples of
application of membranes in bio-artificial organs will be discussed;
including bio-artificial kidney, liver, pancreas etc [1]. In tissue
engineering, membrane science can play an important role in the
design and construction of better scaffolds for cell culture [1, 2].
The optimum design of cell culture bioreactors for delivery of
nutrients and oxygen, using flat sheet and hollow fiber membranes
is an important challenge and will also be discussed in detail.
References:
1D. F Stamatialis, B. J. Papenburg, M. Girone´s, S. Saiful, N.M.S. Betta-
halli, S. Schmitmeier and M. Wessling. J. Membr. Sci., 308 (2008) 1.
2B. J. Papenburg, L. Vogelaar, L. Bolhuis–Versteeg, R.G.H. Lammertink,
D. F. Stamatialis and M. Wessling, Biomaterials 28 (2007) 1998.
(OP 187) Mesenchimal Stem Cell Improved Bone Regenera-
tion Around a Hip Prosthetic Uncemented Stem
C. Di Bella1,2, E. Lucarelli1, B. Dozza1, C. Divieto1, L. Martini3,
G. Giavaresi3, M. Fini3, D. Donati1,2
1Bone Regeneration Laboratory, Rizzoli Orthopaedic Institute,
Bologna, Bologna, Italy
2Musculoskeletal Oncology Department, Rizzoli Orthopaedic In-
stitute, Bologna, Bologna, Italy
3Experimental Surgery, Rizzoli Orthopaedic Institute, Bologna,
Bologna, Italy.
Non cemented prosthetic stem is the gold standard for hip re-
placement. In presence of poor quality bone, cementation is nec-
essary. To avoid the use of cement, we tested the ability of a cell
based composite to enhance bone ingrowth around a hip prosthetic
uncemented stem.
Twelve adult sheep were divided into 2 groups. Group I received
unilateral uncemented hip emiarthroplasty. In Group II a com-
posite material made of type I collagen, autologous platelet-rich
plasma and mesenchymal stem cells, was injected into the femoral
canal followed by a press-fit insertion of the stem. X-Ray, histol-
ogy and histomorphometry were performed.
The roentgenograms in group I showed 2 cases of peri-prosthetic
fracture and one case of incorrect positioning of the stem. In group
II we had one case of dislocation and one case of subsidence of the
prosthesis. These animals were not evaluated histologically.
Histomorphometry showed a higher percentage of newly formed
bone inside the medullary canal in group II (18,72%) in compar-
ison to group I (4,61%). Inside the cortex there were no differences
between the 2 groups. The bone contact to the titanium femoral
stem was higher in group II (7,3%) than in group I, where no bone
contact was detected.
The cell-based substance is able to improve bone remodelling in
a two months sheep model and the contact between newly formed
bone and the titanium stem.
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The addition of a composite material based on collagen, PRP
and mesenchymal stem cells can improve the secondary fixation of
a hip uncemented femoral stem.
(OP 188) Mesenchymal stem Cells Differentiate Towards
Endothelial Cells in a Prevascularized Bone Tissue En-
gineering Setting
J. Rouwkema1, N.C. Rivron1, N.M.S. Bettahalli2, D. Stamatialis2,
M. Wessling2, C.A. van Blitterswijk1
1Department of Tissue Regeneration, Twente University, En-
schede, The Netherlands
2Department of Membrane Technology, Twente University, En-
schede, The Netherlands
Introduction: One of the current limitations of tissue engineering
is the inability to provide sufficient blood supply in the initial
phase after implantation. A strategy to overcome this limitation is
prevascularization. We previously developed a spheroidal system
to co-culture human mesenchymal stem cells (MSC) with human
endothelial cells (HUVEC), resulting in the formation of a 3D
prevascular network. Here we study the role of the different cell
types in the network formation in this system using BrdU labeling
combined with immunostaining.
Results and Discussion: After 10 days of co-culture, CD31
positive and vWF positive prevascular structures could be seen
throughout the entire spheroid. BrdU staining revealed that these
structures consisted of both HUVEC and MSC. Although MSC that
stained positive for CD31 were already seen after 3 days, positive
vWF staining of MSC was only seen after 5 days of co-culture.
The mechanism of endothelial differentiation of MSC in this
system remains largely unknown, although experiments using anti-
VEGF antibodies and indirect cocultures indicate that both secreted
factors and direct cell contact are important for the endothelial
differentiation and organization of MSC. Future research will focus
on unraveling the mechanism and trying to replicate the results
without the addition of endothelial cells.
Conclusions: This study indicates that human mesenchymal stem
cells have the potential to differentiate towards endothelial cells and
can be incorporated in prevascular structures in a bone tissue engi-
neering setting. This is an important finding, since this might enable
prevascularized bone tissue engineering from a single cell source.
(OP 189) Mesenchymal Stem Cells: a Novel Cell Therapy
Based Approach for the Treatment of Autoimmune Diseases
A. Uccelli1
1Department of Neurosciences, Ophthalmology and Genetics,
University of Genoa, Italy
Mesenchymal stem cells (MSCs) represent a heterogeneous subset
of stromal stem cells that can be isolated and expanded ex vivo from
many adult tissues and can differentiate into mesodermal tissues
such as fat, bone and cartilage. Under some experimental condi-
tions, MSCs have been reported also to transdifferentiate into cells
from the other two germinal lineages. Recent data suggest that
MSCs can interact with cells of both the innate and the adaptive
immunity and modulate their function. Based on these findings, we
have shown that i.v. injected MSC can ameliorate both relapsing-
remitting (PLP-induced) and chronic progressive (MOG-induced)
experimental autoimmune encephalomyelitis (EAE) through the
induction of peripheral tolerance. Upon i.v injection, GFP labeled
MSCs home inside the lymph nodes and the inflamed CNS where
they engraft without evidence of transdifferentiation into neural
cells. However, MSCs may promote survival of damaged neural
cells through paracrine mechanisms sustained by striking anti-
inflammatory, trophic and anti-apoptotic activities. Due to the
relative simplicity of growing them in vitro, MSCs currently rep-
resent the ideal source for adult stem cells amenable to therapeutic
development in immune-mediated diseases.
(OP 190) Mimicking Interstitial Microenvironments for
Lymphatic Capillary Tissue
J.A. Overney1, D. Foretay1, C.E. Helm2, M.A. Swartz1
1Institute of Bioengineering, Ecole Polytechnique Fe´de´ral de
Lausanne, Switzerland
2Department of Chemical and Biological Engineering, North-
western University, Evanston, USA
Lymphangiogenesis depends mainly on three factors: interstitial
flow, the extracellular matrix, and the matrix environment (che-
mical and physical factors). We have previously shown in vivo as
well as in vitro that the organization of lymphatic endothelial cells
(LEC) is guided by slow interstitial flow. Additionally, it is known
that vascular endothelial growth factor (VEGF)-C is important for
lymphatic proliferation and migration via signaling through its re-
ceptor VEGFR-3. We have engineered a VEGF-C protein that can
covalently bind to fibrin such that it can be liberated by cellular
proteolytic activity. Using a novel 3D radial flow chamber devel-
oped in our lab, we studied the effects of subtle flow on cells cul-
tured in this VEGF-C linked matrix. These studies showed that
liberation of the bound VEGF-C protein from the fibrin gel sy-
nergizes with slow flow to promote the formation of small capillary
networks, presumably by preferentially cleaving VEGF-C in the
direction of flow thereby biasing the free morphogen gradient and
inducing subsequent morphogenesis. We also show that fibro-
blasts co-cultured with LECs strongly promote lymphangiogenesis
and give them more relevant morphologies and possibly stabilize
them. These new models of the lymphatic microenvironment can
thus be used both to better understand the biology governing
lymphangiogenesis as well as provide engineering design criteria
for creating functional lymphatic vessels in vitro and for regener-
ative medicine.
(OP 191) Molecular Mechanisms in Schwann Cells that Con-
trol Axon Growth and Nerve Repair
Kristjan R. Jessen1, R. Mirsky1, P. Arthur-Farraj 1, A. Woodhoo1
1Department of Anatomy and Developmental Biology, University
College London
In comparison to nerve fibre tracts in the central nervous sys-
tem, peripheral nerves have a remarkable ability to re-grow
following injury. This difference is largely due to the different
reaction to injury shown by the glial cells in the two locations,
and to the particular properties of Schwann cells, the glial cells
of peripheral nerves. Normally, Schwann cells are highly dif-
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ferentiated, tightly ensheathing all axons and forming insulating
myelin sheaths around the larger ones. Nerve injury triggers a
radical change in these cells: They start to proliferate, the myelin
sheaths collapse and are phagocytosed and digested by Schwann
cells and macrophages and Schwann cells start expressing a
range of molecules that promote neuronal survival and axon
growth. Overall this represents a process of de-differentiation,
because this injury-response takes the differentiated cells of
normal nerves back to a phenotype that is very similar to that of
immature Schwann cells found in developing nerves prior to
myelination. Remarkably, this de-differentiation process is the
basis for the ability of axons to regenerate after injury, and when
it is prevented axon re-growth is blocked or severely impaired.
The molecular processes responsible for the de-differentiation are
therefore fundamental for nerve repair. This talk will discuss
some of the molecules that control the de-differentiation pro-
gramme, in particular the transcription factor c-Jun and the sig-
nalling receptor Notch. It will describe how molecular failures
within this programme result in failure of axon regeneration and
functional nerve recovery.
(OP 192) Monitoring Cell Based Therapy by Magnetic Re-
sonance Imaging
A. Crabbe1, C. Vandeputte1, T. Dresselaers1, C. Verfaillie1,
U. Himmelreich1
1Biomedical NMR Unit/MoSAIC and Stem Cell Institute Leuven,
Faculty of Medicine, Katholieke Universiteit Leuven
Magnetic Resonance Imaging (MRI) is one of the most powerful
tools for high-resolution, non-invasive imaging. Apart from mon-
itoring anatomical changes and functional recovery, the location
and potentially functional changes of cells can be followed by
MRI. It has recently been demonstrated that the migration of low
cell numbers can be monitored in rodents after cell labeling with
MRI contrast agents and subsequent implantation.
We have focused on methodological aspects of cell labelling
strategies for robust and sensitive visualisation of multipotent adult
progenitor cells, mesenchymal stem cells and embryonic stem
cells. The sensitivity, stability, toxicity and adverse effects on the
cell biology by the labelling procedure was studied for ultrasmall,
small and micron-sized iron oxide particles. In vivo imaging was
performed in control animals and a stroke animal model.
Although, the actual labelling procedure can be straight forward,
there are several issues that require careful consideration for (stem)
cell labelling and their in vivo applications. Among these issues
are:
(1) Generation of highly sensitive contrast for the visualization
of small cell numbers
(2) Generation of unambiguous contrast that distinguishes cells
from other sources of hypo- or hyperintensity in MR images
(3) Stable binding or incorporation to avoid contrast agent
leakage or transfer to cells of the host
(4) Prevention of toxicity or harmful alterations of cellular
processes by the contrast agent
(5) Minimal influence on the physiological behavior of the cells
in the host (for example migration of differentiation potential)
(6) Generation of contrast even after continued cell proliferation
(dilution)
(OP 193) Morphometric and Mechanical Characterization,
Insulin Loading and In-Vivo Biocompatibility of Chitosan
Particles Aggregated Scaffolds for Tissue Engineering
P.B. Malafaya1,2, J.T. Oliveira1,2, T.C. Santos1,2, M. van Griens-
ven3, R.L. Reis1,2
13B’s Research Group—Biomaterials, Biomimetic and Biode-
gradables, Department of Polymer Engineering, University of
Minho, Campus de Gualtar, 4710-057 Braga, Portugal
2IBB—Institute for Biotechnology and Bioengineering, PT Gov-
ernment Associated Laboratory, Braga, Portugal
3Ludwig Boltzmann Institute for Experimental and Clinical
Traumatology, Austrian Cluster for Tissue Regeneration, Do-
naueschingenstrasse 13, A-1200 Vienna, Austria
In tissue engineering, scaffolds development presents, among
others, 3 key requirements: adequate morphological characteristics,
mechanical performance and in-vivo biocompatibility. The aim of
the present study was to evaluate chitosan-based scaffolds produced
by particle aggregation in these key issues. Furthermore, chitosan
scaffolds were loaded with insulin to promote chondrogenic dif-
ferentiation. Micro-Computed Tomography (m-CT) was carried out
for accurate morphometric characterization quantifying porosity,
interconnectivity, particles and pores size that shown to be ade-
quate. Dynamical Mechanical Analysis (DMA) showed that scaf-
folds are mechanically stable in wet state with a storage modulus
of 4.21 1.04 MPa at 1 Hz frequency. Insulin-loaded scaffolds
were characterized and studied with a pre-chondrogenic cell line
(ATDC-5). The in-vitro release was carried out mimicking cell
culture conditions quantified by micro-BCA. When seeded with
ATDC-5, insulin-loaded scaffolds promoted the chondrogenic dif-
ferentiation as assessed by SEM, DNA and GAG content, histology
and real time-PCR. Furthermore, chitosan scaffolds were evaluated
in-vivo using a rat muscle-pockets defect model for different
implantation periods (1, 2 and 12 weeks). The histological and im-
munohistochemistry results have demonstrated that chitosan scaf-
folds are biocompatible. In addition, scaffolds interconnectivity
shown to be favourable to the connective tissues ingrowth into the
scaffolds and to promote the neo-vascularization even in early stages
of implantation. It is concluded that chitosan scaffolds produced by
particle aggregation could serve as alternative, biocompatible, and
safe biodegradable scaffolds for tissue engineering applications.
Acknowledgements: FCT (SFRH/BD/11155/2002) and EU
funded projects HIPPOCRATES and EXPERTISSUES.
(OP 194) Mouse Embryonic Stem Cell Expansion in a
Microcarrier-Based Stirred Culture System
A.M. Fernandes1, M.M. Diogo1, C. Lobato da Silva1, D. Henri-
que2, J.M.S. Cabral1
1IBB-Institute for Biotechnology and Bioengineering, Centre for
Biological and Chemical Engineering, Instituto Superior Te´cnico
2IMM-Institute of Molecular Medicine, Faculdade de Medicina de
Lisboa
The aim of this study was the scaling-up of mouse embryonic stem
(mES) cell expansion in a microcarrier-based stirred culture system
while maintaining their pluripotency and neural commitment po-
tential. The 46C mES cell line was used as a model system. The
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scale-up of 46C mES cell expansion was studied in spinner flasks
(30–50 mL), in serum-containing (DMEM/FBS) or serum-free (SF)
media, both supplemented with LIF. In order to immobilize mES
cells, two different microcarriers were evaluated: a microporous
gelatin-covered microcarrier (Cytodex 3) and a porous gelatin
microcarrier (Cultispher S). The expansion of mES cells (5104
cells/ml) was firstly performed using DMEM/FBS medium on
Cytodex 3 microcarriers (0.5 mg/ml) for 8 days. The maximum cell
concentration achieved was (1.9 0.1)106 cells/ml on day 6,
which represented a 38 2-fold increase. In the next step, the ex-
pansion of mES cells was performed in the spinner flask on the
Cultispher S microcarriers (1 mg/ml) both in DMEM/FBS and
SF medium. Maximal cell densities achieved during 8 days in
culture were (2.6 0.7)106 and 3.5106 cells/ml, which corre-
sponds to fold increases of 50 15 and 70 for DMEM/FBS and
SF, respectively. After 8 days of culture under stirred conditions
in SF medium, approximately 90% of the expanded cells were
viable. More importantly, the cells maintained their ability to dif-
ferentiate into neural progenitors with more than 90% of Sox1-
GFPþ cells obtained upon the neural commitment protocol. In
addition, after expansion, cells stained positively for alkaline
phosphatase, indicating that a high percentage of cells remained
pluripotent.
(OP 195) MRI Evaluation of Deformation Fields and Glyco-
saminoglycan Concentrations in Tissue-Engineered Articular
Cartilage
C.P. Neu1, H. Arastu1, S. Curtiss1, A.H. Reddi1
1University of California at Davis
Noninvasive magnetic resonance imaging (MRI) is a technology
that enables the characterization multiple physical phenomena in
biological tissues. Mechanical function of engineered tissue is a
primary endpoint for the successful regeneration of many biological
tissues such as articular cartilage, spine, and heart. Here, we dem-
onstrate the application of MRI to characterize mechanical func-
tion of tissue-engineered articular cartilage (agarose) constructs.
The mechanical function of an articular cartilage defect model was
evaluated in terms of displacement and glycosaminoglycan (GAG)
concentration fields computed throughout the tissue construct. Two
techniques were demonstrated using the articular cartilage defect
model: (1) phase contrast-based methods (i.e. displacement encod-
ing by stimulated echoes with a fast spin echo readout) to charac-
terize deformation fields of the tissue under compressive loading
and (2) gadolinium-enhanced imaging to determine GAG concen-
trations. Using these two techniques, displacement and GAG con-
centrations fields were found to vary nonuniformly depending on
spatial position. Displacements were highest at the articular surface
and in the tissue constructs compared to surrounding cartilage.
Tissue surface geometry corresponded to observed displacement
fields. GAG concentrations were lowest in the tissue constructs
compared to the surrounding cartilage. GAG content was increased
in agarose constructs but not restored to that of surrounding cartilage
following treatment with serum-free, or BMP-7 or 10% FBS sup-
plemented media. The use of multiple MRI techniques to assess tis-
sue mechanical function suggest that deformation is related
to tissue geometry and underlying biomolecular tissue constituents,
and highlight the need for successful tissue integration following
repair.
(OP 196) Multi-Tiered Sequential Processing and Analysis
of 3D Tissue-Engineered Constructs
A. C. Allori1, T. G. Bromage2, J. L. Ricci2, S. M. Warren1
1Institute of Reconstructive Plastic Surgery, NYU Medical Center,
New York, NY
2Dept. of Biomaterials and Biomimetics, NYU College of Den-
tistry, New York, NY
Introduction: Many analytical tools are relevant to the study of
tissue-engineered constructs, but some are destructive and preclude
further testing of the same sample. Here, we describe a streamlined
process that allows multiple analytical modalities to be applied,
sequentially, to the same sample.
Methods: A flow-perfusion bioreactor was used for dynamic
cell culture of various cell types (MC3T3-E1 pre-osteoblastic
cells, primary murine osteoblasts, NHOst cells, and human osteo-
progenitor and mesenchymal stem cells) seeded in porous
hydroxyapatite/tricalciumphosphate scaffolds. Following dynamic
cell culture, samples were sectioned along the median plane. One
half was imaged by environmental scanning electron micros-
copy (SEM) for cellular morphometry along the top, bottom, and
median cut surfaces. Following SEM, mechanical testing was
performed. The second half of the sample was fixed in glutaralde-
hyde, dehydrated in ethanol, progressed through graded acetone-
polymethylmethacrylate cycles under vacuum, and cured at 478C in
the dark. Cured blocks were sequentially sectioned and ground/
polished to desired thicknesses (50 nm-25mm) on semi-automated
processing equipment. Cells labeled with fluorescent tags prior to
experimentation were viewable by laser confocal microscopy im-
mediately, without any additional processing. SEM or transmission
electron microscopy (TEM) of non-sequential sections allowed
detailed imaging at various depths within the scaffold. Slides were
also processed by standard histological (e.g., trichrome) and im-
munohistological (e.g., osteocalcin) staining for light or laser con-
focal microscopy.
Conclusions: With advances in tissue engineering, a uniform
method of processing is needed. This processing algorithm is ca-
pable of extracting a large amount of data from the same samples
by non-destructive sequential analysis.
(OP 197) Multilineage Progenitors of the Enteric Nervous
System: Interesting and Useful?
V. Pachnis1
1National Institute for Medical Research, The Ridgeway, Mill
Hill, London NW7 1AA, UK
The enteric nervous system (ENS) is composed of a complex
network of interconnected ganglia distributed throughout the
length of the gastrointestinal tract. Most enteric neurons and glia
are derived from a small population of progenitors which origi-
nate in the vagal neural crest and invade the foregut from where
they migrate to colonise the entire organ. Mutations in genes
encoding extracellular signals and their intracellular mediators
often lead to partial colonization of the gut by ENS progenitors
and failure of gangliogenesis in the distal colon (congenital co-
lonic aganglionosis¼Hirschsprung’s disease-HSCR). We have
generated mice expressing only one of the two Ret receptor ty-
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rosine kinase isoforms (Ret51) and they are characterized by a
‘‘HSCR-like’’ phenotype. In parallel studies, we have developed
protocols to culture ENS Progenitor Cells (EPCs) from the fetal
and postnatal mouse gut. Clonal analysis of such EPCs has
established that they represent self-renewing multilineage pro-
genitors capable of generating both neurons and glial cells. In-
terestingly, EPCs can also be generated from Ret51 mutant mice,
raising the possibility that they can be used in an autotrans-
plantation assay to replenish the agagnlionic gut segments with
ENS progenitors. To examine these possibilities we have been
transplanting EPCs into the wall of gut maintained in organotypic
cultures or in vivo. I will describe our efforts to maximize the
efficiency with which we obtain EPCs from embryonic and
postnatal gut and report on our preliminary studies on the trans-
plantation of EPCs into the gut wall with the ultimate aim of
restoring a functional ENS.
(OP 198) Myocardial Tissue Engineering Using ES Cell-
Derived Cardiomyocytes and Elastomeric Polymers
H. Jawad1, S.E. Harding2, A. Piegat3, M. El Fray3, A. R. Boc-
caccini1, N.N. Ali2
1Department of Materials, Imperial College London
2National and Lung Institute, Imperial College London
3Polymer Institute, Szczecin University of Technology, Poland
Heart failure (HF) results from heart tissue having limited regen-
erative capacity following a heart attack. At end stage of HF, heart
transplantation is the only option. However, donor shortages leave
cell therapy, including tissue engineering solutions, as alternative
strategies. In our approach preformed patches of myocardial cells
are attached to a biodegradable engineered biomaterial support
using embryonic stem cell (ESC)-derived cardiomyocytes (ESC-
CM). We report on the characterisation of a series of biodegrad-
able elastomeric materials describing also tests carried out to
demonstrate their biocompatibility with cells, including ESC-CM.
Multiblock copolymers containing 30 wt% hard segments of
poly(ethylene terephthalate) (PET) or poly(butylene terephthalate)
and 70 wt% soft segments composed of dilinoleic acid (DLA) or
poly(ethylene glycol) were selected. Additionally, PET/DLA co-
polymers were used for preparation of composites containing
0.2 wt% of titania nanopowder with the aim to induce nanotopo-
graphic features. D3 mouse ESC line (from ATCC) and human
ESC H7 (from Geron Corp) that were induced to differentiate via
embryoid body formation started to beat spontaneously from day
7 and day 9–12 onwards, respectively. All materials tested were
biocompatible with differentiating cardiac cells, which did not
show any signs of cytotoxicity or adverse effects. This was evi-
denced by the continuous beating of the cardiomyocyte clusters
for more than 35 days on these materials. It was noted that iso-
lated cells adhered and spread well on all materials tested even in
the absence of gelatin, and the presence of TiO2 nanoparticles was
not toxic to the cells but encouraged their adhesion, spread and
proliferation.
(OP 199) Nano/Microparticle Incorporated Chitosan Fibers as
Tissue Engineering Scaffolds
P. Yilgor1,2, K. Tuzlakoglu3,4, R.L. Reis3,4, N. Hasirci2,5, V. Ha-
sirci1,5
1METU, BIOMAT, Department of Biological Sciences, Bio-
technology Research Unit, 06531 Ankara, Turkey
2METU, BIOMAT, Department of Chemistry, 06531 Ankara,
Turkey
33B’s Research Group—Biomaterials, Biodegradables and Bio-
mimetics, Univ. Minho, 4710-057 Braga, Portugal
4IBB—Institute for Biotechnology and Bioengineering, PT As-
sociated Laboratory
5METU, Graduate Department of Biomedical Engineering, 06531
Ankara, Turkey
The aim of this study was to develop a bone tissue engineering
scaffold with an inherent bone morphogenetic proteins BMP-2
and BMP-7 sequential delivery system. BMPs were encapsulated
in poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) and
poly(lactic acid-co-glycolic acid) (PLGA) nano/microparticules
which are then introduced to a chitosan matrix by two methods:
embedding in the chitosan fibers and then forming the scaffold or
by forming the chitosan scaffold and then introducing the nano/
microparticules.
Nano/microparticles loaded with BSA (model protein) or BMPs
were prepared by double emulsion/solvent evaporation technique.
The structure, encapsulation efficiency and BSA release were
studied. Chitosan-based fiber mesh scaffolds were prepared by wet
spinning. Incorporation of nano/microparticles into fiber mesh
scaffolds was achieved by two methods: incorporation within the
fibers and by post-seeding. For incorporation within the fibers,
particles were mixed with chitosan solution and wet spun as pre-
sented above. Post-seeding was obtained by adding a particle
suspension in dH2O onto the scaffold followed by the application
of vacuum-pressure cycle.
Among the particles prepared, 20% PLGA nano/micro spheres
and 20% PHBV nano/micro capsules were chosen as the rapid and
slow release components of the sequential delivery system, re-
spectively. Wet spun chitosan scaffolds produced from 4% chit-
osan (w/v) revealed smooth surfaces and used for further studies.
Presence of particles within the fibers was shown by SEM analysis
for the first incorporation method. Post-seeding did not influence
the final release pattern, but suppressed the burst release. In-
corporation of BMP-2 and BMP-7 carrying particles and the effect
of GF release on MSCs are being studied.
(OP 200) Nanoscale Organization of Biomimetic Peptide Mo-
tifs on Polymer Surfaces: a Molecular Printing Approach
F. Rypacek1, E. Chanova1, S. Popelka1, L. Machova1, V. Proks1,
L. Bacakova2
1Institute of Macromolecular Chemistry AS CR, v.v.i., Heyrovsky
Sq. 2, 162 06 Prague, Czech Republic
2Institute of Physiology AS CR, v.v.i., Prague, Czech Republic
The cells in tissues receive key solid-phase signals from ex-
tracellular matrix (ECM) through interactions of their trans-
membrane recognition proteins with specific domains on ECM
molecules. Therefore, biomaterials to be used as scaffolds for
guided tissue regeneration should exhibit corresponding recog-
nizable structures, either as whole ECM molecules or their frag-
ments, typically peptides, on their surfaces. A number of evidence
shows that not only the presence but also, and most importantly,
the molecular organization of peptide ligands on the surface
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represents a key factor in creation of functional biomimetic cell/
biomaterial interfaces. The importance of spacing of fibronectin-
peptide mimics on a tens-of-nanometers scale to produce
functional integrin clustering into focal adhesions has been dem-
onstrated on planar model substrates. The presented work focuses
on creation of nanoscale organized surfaces of biodegradable
polymer materials, such as polyesters (e.g., PLA, PLGA), appli-
cable to real 3D scaffolds. To achieve distribution of peptide
motifs on a scale comparable with the size of individual trans-
membrane macromolecules, e.g., integrins, a ‘‘molecular print-
ing’’ technique, based on deposition of a molecular layer formed
by well-defined functional block copolymers was developed.
The molecular characteristics of copolymer films and the sur-
face topology of biomimetic groups obtained through molecular
assemblies of copolymers were characterized. The applicability
of the technique to polyester surfaces is discussed. The posi-
tive effect of clustering of fibronectin-derived peptides through
association of functionalized copolymer molecules on the cell
adhesion and phenotype differentiation in cell cultures was
demonstrated.
Acknowledgment: The support by Academy of Science of CR
(Grant No.: 1QS500110564) is acknowledged.
(OP 201) Neural Driven Angiogenesis through Local Secretion
of Neurotrophic Factors
M. Blais1, S. Belmonte1, P. Le´vesque1, M. Grenier1, M. Gingras1,
F. Berthod1
1Universite´ Laval
Nerves and blood vessels are closely associated. Moreover, sen-
sory nerves were shown to determine the branching pattern of the
vascular network in skin, and to promote the arterial differentia-
tion of blood vessels. We developed a unique in vitro model
featuring a pre-formed three-dimensional neurites network on
which a capillary-like network was allowed to organize and ma-
ture. Sensory neurons and glial cells were cultured with fibro-
blasts in a collagen-chitosan sponge to reconstruct the neural
network for 14 days and human endothelial cells were then see-
ded on the tissue to build a capillary-like network for 17 addi-
tional days. Neural cells induced a 27% increase in the number of
capillary-like tubes (CLT) formed in the tissue. This effect was
abolished when K252a, an inhibitor of the TrkA, B and C re-
ceptors for the NGF, BDNF and NT-3 neurotrophins respectively
was added to the culture medium. Moreover, we demonstrated
that when 10 ng/ml of NGF, 0.1 ng/ml of BDNF, 15 ng/ml of NT3
and 50 ng/ml of GDNF were added to our endothelialized re-
constructed connective tissue model, a major increase from 40 to
80% in the number of CLT was observed. This is the first in vitro
demonstration of a direct angiogenic effect of peripheral neural
cells on human endothelial cells through the release of neuro-
trophic factors and of the angiogenic potential of NT-3 and
GDNF, the later belonging to an other family of neurotrophic
factors.
(OP 202) Neurogeneic and Osteogeneic Potential of Placental-
Derived Cells: Why Should We Use Placenta?
D. Surbek1, S. Mohr1, A. Schoeberlein1, P. Rollini1, B. Portmann-
Lanz1
1Laboratory for Prenatal Medicine, University Women’s Hospital
Bern, and Department of Research, University of Bern, Switzer-
land
Objective: To determine the osteogeneic and neurogeneic differ-
entiation potential of placental-derived mesenchymal stem cells
(MSC)
Study Design: Fetal MSCs from first trimester placental chor-
ionic villi and term gestation chorion were isolated and grown in
the presence of EGF and FGF-2 as floating spheric clusters. After
plating on collagen, neural differentiation was initiated with re-
tinoic acid and growth factors. Differentiation into neurons, oli-
godendrocytes and astrocytes and their progenitors was monitored
immunohistochemically and by RT-PCR of neural genes. 2D-
PAGE followed by high performance liquid chromatography
(HPLC) with subsequent tandem mass spectrometry (MS/MS) was
used for protein identification.
Results: Placental-derived MSC’s differentiated into osteo-
geneic, chondrogeneic and adipogeneic cell lines. After 5–7 days
in the neurogeneic medium, placental MSC formed rapidly pro-
liferating neurosphere-like structures which stained strongly pos-
itive for nestin. 60–80% of the cells outgrowing from stimulated
neuropheres were positive for Tuj-1 and TUC-4, both markers
specific for immediately postmitotic neurons (untreated controls:
4%), also confirmed in the Proteomics analyses.10% of the neurons
expressed markers for more mature postmitotic neurons (NeuN;
MAP1B; NF-M; NSE). Mature (MAP2þ/TAU1þ/NF200þ) neu-
rons were rarely found (1%). A part of the neurons had dopami-
nergic, another serotonergic or glutamatergic (but not GAGAergic)
character. A fraction of 5–10% of the neurally differentiated cells
had oligodendrocytic character:
Conclusion: Placental MSCs can differentiate into early neural
progenitors and might be an ideal source for autologous stem cell
graft for peripartum neuroregeneration
(OP 203) New Biosynthetic Bacillus-Derived Hyaluronic Acid
as an Attractive Potential Biomaterial for Tissue Engineering
Applications
F. Longin1, K. Schwach-Abdellaoui1
1Novozymes Biopolymer A/S, Krogshoejvej 36, DK-2880 Bags-
vaerd, Denmark
Hyaluronic acid (also referred to as HA or hyaluronan) is a natural
linear and unbranched polysaccharide. It is a major constituent of
the extracellular matrix of soft connective tissues and the synovial
fluid of articular joints. HA is ubiquitous in human and animal
tissues, where it exhibits significant structural, rheological, phys-
iological, and biological functions. Its distinctive moisturizing and
visco-elastic properties, coupled with its lack of immunogenicity
and toxicity, have led to a wide range of proven and marketed
applications within the cosmetic, biomedical and pharmaceutical
industries. These include skin moisturizers, osteoarthritis treat-
ment, ophthalmic surgery, adhesion prevention, dermal fillers, and
wound healing. Recent studies also report the use of HA-based
materials for tissue engineering.
Hyaluronic acid is currently obtained commercially from rooster
combs and certain strains of Streptococcus. However, the rooster
comb extraction process is faced by growing concern over the use of
animal-derived products and requires extensive purification to re-
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move antigenic avian proteins. In addition, Streptococci are fastid-
ious microorganisms to grow and can potentially produce exotoxins.
Finally, in both industrial processes, large amounts of organic sol-
vents are used during the purification of hyaluronic acid. To avoid
these complications, an alternative and safe fermentation strain,
namely Bacillus subtilis, has recently been used to produce HA. This
improved process, during which no animal-derived materials are
employed, relies on defined and aqueous-based recovery steps.
In this work, we introduce Bacillus-derived hyaluronic acid as a
new biosynthetic material. We also highlight its advantageous
properties which make this biopolymer particularly attractive for
tissue engineering applications.
(OP 204) New Developments in Neural Tissue Engineering
E. Snyder1
1Institute for Medical Research, La Jolla, CA, USA
During phases of active neurodegeneration, factors seem to be
transiently elaborated to which neural stem cells (NSCs)–a proto-
type for most stem cells—may respond by migrating (even long
distances) to degenerating regions where they attempt to restore
homeostasis by a variety of mechanisms. This may include, (but is
not limited to) differentiating, towards the replacement of degen-
erating neural cells of multiple types, not only neurons but also
requisite non-neuronal ‘‘chaperone’’ cells, all of which are essential
for the proper development and reconstitution of function. NSC’s
are drawn to inflammatory niches, where they then exert anti-
inflammatory actions. These ‘‘repair mechanism’’ may also reflect
the re-expression of basic developmental programs (particularly
during temporal ‘‘windows’’ following injury). There is an enor-
mous amount of ‘‘programmed’’ cross-talk between stem cells
and the milieu that add complexity but also enrich therapeutic
promise to the system. In addition, NSCs in their native state (as
well as following genetic-engineering) may serve as vehicles for
protein delivery allowing for the possibility of simultaneous cell
replacement & gene therapy (e.g., with factors that might enhance
differentiation, neurite outgrowth, connectivity, neuroprotection,
anti-inflammation, anti-scarring, and angiogenesis). Cell-cell con-
tact with communication through gap junctions appears to repre-
sent another mode of cross-talk. Multi-model approaches to most
neurological conditions are likely required. The stem cell may
serve as the ‘‘glue’’ for these. When combined with certain syn-
thetic biomaterials, NSCs may be even more effective in ‘‘engi-
neering’’ the damaged CNS towards reconstitution.
(OP 205) New Materials for 3D-Scaffolds for Tissue En-
gineering Applications
C. Heller1,2, M. Schuster2, S. Baudis2, C. Turecek3, F. Varga3,
H. Bergmeister4, G. Weigel4,5, J. Stampfl1, R. Liska2
1Intitute of Materials Science and Technology, Vienna University
of Technology, Vienna, Austria
2Institute of Applied Synthetic Chemistry, Vienna University of
Technology, Vienna, Austria
3Ludwig Boltzmann-Institute of Osteology, Hanusch Hospital,
Vienna, Austria
4Ludwig Boltzmann Cluster for Cardiovascular Research, Vienna,
Austria
5Dept. of Cardiothoracic Surgery, Medical University of Vienna,
Austria
Stereolithography has become a very appealing method for the
production of three-dimensional scaffolds for several tissue engi-
neering applications, e.g. for bone and blood vessel replacement.
This layer-by-layer technique is based on the photopolymerization
of commonly acrylate-containing resin formulations and allows
the fabrication of cellular structures with defined pore sizes and
attainable wall thicknesses down to 100mm. Nevertheless, resid-
ual, unreacted acrylate groups have shown to be highly cyto-
toxic toward endothelial and osteoblast-like cells and a high
local concentration of poly(acrylic acid), formed by in vivo deg-
radation, may impair cell function. Therefore, a new class of vinyl
ester-based monomers, forming harmless poly(vinyl alcohol)
upon in-vivo degradation, has been synthesized. In-vitro biocom-
patibility assays revealed that the concentrations leading to cyto-
toxic cell damage are about two orders of magnitude higher
compared to similar acrylate systems. This finding is corroborated
by excellent cell adhesion and proliferation observed on the surface
of vinyl ester-based polymer specimens. High reactivity for pho-
topolymerization and good mechanical properties of the polymers
further indicate the suitability of these monomers for rapid proto-
typing of 3D-scaffolds in the field of tissue engineering.
(OP 206) New Monitoring Parameters and Increased Effi-
ciency in Bone Tissue Engineering Using Longitudinal Micro-
Computed Tomography in a Novel Bioreactor
H. Hagenmu¨ller1,2, H.P. Merkle2, L. Meinel2, R. Mu¨ller1
1Institute for Biomechanics, ETH Zurich
2Institute of Pharmaceutical Sciences, ETH Zurich
Mechanical stimulation of in vitro engineered bone tissue con-
structs is believed to have strong osteogenic effects, if applied
appropriately. Nevertheless, because of its inherent complexity,
further advancement is needed to improve efficiency and control of
this approach. In order to shed light onto the dynamics of miner-
alization under cyclic loading, we recently introduced a concept
combining direct mechanical compression of 3-dimensional tis-
sue engineered constructs and longitudinal monitoring by micro-
computed tomography (mCT). Here we demonstrate the application
of this approach by studying the osteogenicity of cyclic mechanical
loading. Bone marrow-derived mesenchymal stem cells were see-
ded onto porous silk scaffolds and cultured under osteogenic con-
ditions. Mechanical loading of the scaffolds using different loading
regimens was applied five times per week and non-destructive
imaging bymCT once a week. Differences in tissue quality were
monitored longitudinally by using novel tissue quality parameters
(such as ‘‘mineralization rate’’ and ‘‘surface growth activity’’ but
also ‘‘tissue stiffness’’). Efficiency of tissue culture was optimized
by individualized termination of each culture, either when reaching
a previously defined target bone volume density of 2%, or when the
mineralization performance of a specimen was too low to reach this
target within a reasonable period of time. We expect that the in-
troduced monitoring parameters offer new insights into the min-
eralization dynamics under different mechanical loading regimens.
Furthermore, we envisage this approach not only to rationally allow
the termination of the culture of mal-performing specimens but also
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to make use of variable mechanical loading regimens to bring such
specimens back on track.
(OP 207) NGF Release from Functionalised Collagen-
Thermosensitive Polymer Networks Supports Neuronal Cell
Growth and Differentiation
S. Doleski1,2, L. Yao1, A. Pandit1, C. Elvira1,3
1National Centre for Biomedical Engineering Science, National
University of Ireland, Galway, Ireland
2University of Applied Sciences, Weihenstephan, Germany
3Dept. of Biomaterials, Institute of Polymer Science & Technol-
ogy, CSIC, Juan de la Cierva, 3, 28006 Madrid, Spain
Smart polymeric gels constitute a new generation of biomateri-
als that are being developed for their use as biomedical devices,
scaffolds for tissue engineering and biosensors. The combination of
biodegradable materials as collagen type I, with stimuli thermo-
sensitive polymers (such as poly-(N-isopropylacrylamide), PNI-
PAam, or poly (ethylpyrrolidone methacrylate), PEPM) ushers new
possibilities to develop hydrogels that exhibit properties of both
components. For the purpose of demonstrating this concept, semi-
interpenetrated networks (semi-IPNs) of collagen and crosslinked
PNIPAam or PEPM, and IPNs of collagen crosslinked with PA-
MAM dendrimers and crosslinked PNIPAam or PEPM were pre-
pared. NIPAam or EPM, and a trifunctional acrylic crosslinker,
were polymerized in the presence of non- and crosslinked collagen.
Scaffolds were characterized by FTIR spectroscopy, DSC, swelling
and rheological studies, and by collagenase assay. Formulations
were loaded with neural growth factor (NGF) and subsequently
neural cellular behaviour and drug release studies at different
temperatures was investigated. The prepared semi-IPNs and IPNs
exhibited temperature sensitivity in the swelling studies from
unswollen (378C) to swollen (R.T.) with swelling degrees that in-
crease with the collagen content. Transition temperature modula-
tion was detected by DSC increasing from 278C to 328C when
increasing the collagen content. In addition, the rheological studies
performed from 458 to 58C at constant frequency and oscillating
stress also showed a clear transition in both storage and loss moduli
that were also dependent on the network composition. The release
of NGF from NGF pre-loaded collagen-thermosensitive polymer
scaffolds supported the differentiation of neuronal cells on the
scaffold.
(OP 208) Nonmelanoma Skin Cancer In Vitro Reconstructed
R. Cortivo1
1Dept. Histology, University of Padova, Italy
The identification of genetic changes has led to an increased un-
derstanding of tumorigenesis, identifying the involvement of pu-
tative oncogenes and tumor-suppressor genes. These genes and
their protein products have further potential as targets for disease
management and, ultimately, therapy. Such approaches are equally
applicable to nonmelanoma skin cancer (NMSC), such as basal cell
carcinoma (BCC) and squamous cell carcinoma (SCC). Up to now,
many studies on tumor cells have been performed under standard
in vitro cultures. In standard culture conditions, neoplastic cells, as
expected, can grow only in a two-dimensional array that differs
from their native three-dimensional organization in nodules or
masses and although interesting results have been obtained, three-
dimensional scaffolds would better allow the tumor cells to orga-
nize into nodules or masses. With the present work we cultured
keratinocytes isolated from skin cancer in 3D conditions by using
scaffolds made with hyaluronic acid derivatives. (benzyl ester of
hyaluronic acid- Hyaff materials) These three-dimensional tumor
cell cultures were be used to study genetic changes and in partic-
ular to define genetic profile, cell spatial organization, cell/cell and
cell/extracellular matrix interactions of skin cancer keratinocytes.
(OP 209) Not All Fibrin Matrices are Equally Suitable for
Tissue Regeneration
H. Redl1, M. van Griensven1, T. Morton1, R. Mittermayr1
1Ludwig Boltzmann Institute for Experimental and Clinical
Traumatology, Austrian Cluster of Tissue Regeneration, Do-
naueschingenstrasse 13, A-1200 Vienna, Austria
Fibrin is both an attractive matrix for drug or cell delivery because
it consists of biologic components of the natural clotting cascade,
which is the basis for tissue regeneration. There are different
commercial fibrin products, which all have a different composition
regarding salts and excipients. There is also a clear difference in
biochemical properties between the commercial fibrin preparations
and autologous fibrin sealants.
Fibrinogen is a molecule that is very sensitive to small changes in
the solvent composition, resulting in different fibrin clot. There are
two different kinds of fibrin clots: white, non transparent ‘‘coarse
clots’’ formed at an ionic strength and pH value within the physio-
logical range, and transparent ‘‘fine clots’’ produced at a higher ionic
strength and/or pH value, which are less cell friendly. There are
frozen and lyophilized versions of commercial fibrin products
available on the market as well as those with fast or slow clotting
properties. The stability of fibrin clots is an important quality crite-
rion for fibrin sealants since premature clot lysis could cause post-
surgical bleedings or dissociation of glued tissues. To a variable
extent, fibrin persistence in vivo can be controlled by adding
antifibrinolytic agents, of which some synthetic can have adverse
effects.
Such due to differences in composition, different fibrin products
have different mechanical and cellular properties, which can dra-
matically change the applicability for tissue engineering and re-
generative medicine.
(OP 210) Novel Biodegradable Polymeric Microparticles for
the Localized Delivery of Differentiation Agents in Bone Tissue
Engineering Applications
E. R. Balmayor1,2, P. C. Bessa1,2, K. Tuzlakoglu1,2, H. S. Aze-
vedo1,2, M. Casal3, R. L. Reis1,2
13B’s Research Group—Biomaterials, Biodegradables and Biomi-
metics, Dept. of Polymer Engineering, University of Minho, Cam-
pus de Gualtar, 4710-057 Braga, Portugal, www.3bs.uminho.pt,
erosado@dep.uminho.pt
2IBB–Institute for Biotechnology and Bioengineering, PT Gov-
ernment Associated Laboratory, Braga, Portugal.
3CBMA–Molecular and Environmental Biology Centre/Biology
Department, University of Minho, Braga, Portugal
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Growth and differentiation factors can be used to guide the biology
in tissue engineering, ranging from promoting cell proliferation, to
morphogenic activities initiating a cascade of events leading to
tissue formation in vivo. Synthetic glucocorticoids (e.g. dexa-
methasone, DEX) and bone morphogenetic proteins (BMPs) are
particularly relevant in bone tissue engineering, as they are able to
induce osteoblastic differentiation.
In this work, starch-poly-e-caprolactone (SPCL) microparticles
were developed as a matrix for the controlled release of DEX and
BMP-2. The developed system was characterized in terms of
morphology and size distribution. DEX and BMP-2 were en-
trapped into SPCL microparticles at different percentages. The
loading and encapsulation efficiency, as well as their release pro-
file, were evaluated by HPLC and ELISA quantification.
Particles with a spherical morphology and size distribution be-
tween 10 and 150mm were obtained, which indicates their poten-
tial to be used as an injectable system for the localized delivery of
differentiation factors in vivo. The release behaviour of the en-
trapped molecules seems to be governed by diffusion and degra-
dation of the polymeric matrix allowing their sustained release for
controlled stem cell differentiation.
To investigate the potential of the developed carrier system for
delivering factors for stem cell differentiation, adipose stem cells
(ADSC) will be cultured in contact with the carrier systems. The
release of entrapped molecules on the differentiation of ADSC
towards the osteoblastic lineage will be studied by assaying the
expression of phenotypic markers, such as high ALP activity, and
genes (osteocalcin, osteopontin, Runx2) using real-time PCR.
(OP 211) Novel Genipin Cross-linked Chitosan-Silk Based
Sponges for the Regeneration and Repair of Cartilage Using
a Tissue Engineering Approach
S.S. Silva1,2, M.T. Rodrigues1,2, A. Motta3, M.E. Gomes1,2, J.F.
Mano1,2, C. Migliaresi3, R.L. Reis1,2
13B’s Research Group—Biomaterials, Biodegradables and Bio-
mimetics, Dept. of Polymer Engineering, Campus de Gualtar,
Braga, Portugal
2IBB–Institute for Biotechnology and Bioengineering, PT Gov-
ernment Associate Laboratory, Braga, Portugal
3Departament of Materials Engineering and Industrial Technolo-
gies, University of Trento, Trento, Italy
Development of materials that can interact positively with tissues is
important to regenerative medicine strategies success. Cartilage
tissue engineering (TE) scaffolding is a field of continuous evolu-
tion, and sponges derived from the combination of polysaccharides
and proteins are expected to mimic the naturally occurring envi-
ronment in the articular cartilage matrix, providing an optimum
environment for tissue growth and regeneration. Chitosan (Cht) and
Bombyx mori silk fibroin (SF) are excellent candidates for sponges
design due to their intrinsic characteristics. The present work aimed
to improve the chitosan biocompatibility through blending with
Cht-SF and genipin-cross-linking. Hydrogels, produced by cross-
linking of Cht-SF, were freeze-dryed to obtain the cross-linked
chitosan/silk (CSG) sponges. Rheological and mechanical proper-
ties, structural aspects and morphological features of CSG sponges
were evaluated. CSG sponges possess stable and ordered struc-
tures due to protein conformation changes from alpha-helix/
random coil to beta-sheet structure, porous and globular-like sur-
face morphologies, and pH/swelling dependence at pH 3, 7.4 and 9.
To evaluate sponges’ suitability for cell studies, ATDC5 chon-
drocyte-like cells were seeded onto CSG sponges and ATDC5 vi-
ability (MTS assay), proliferation (DNA test), morphology (SEM
analysis) and matrix production (GAGs quantification) were as-
sessed after 14, 21 and 28 days of culture. ATDC5-sponge con-
structs showed a significant higher adhesion, proliferation and
matrix production with the time of culture when compared to Cht,
suggesting CSG sponges as potential candidates for cartilage TE
strategies. Acknowledgements. Thanks to Portuguese Foundation
for Science and Technology, STREP Project HIPPOCRATES
(NMP3-CT-2003-505758) and European NoE EXPERTISSUES
(NMP3-CT-2004-500283)
(OP 212) Novel Injectable Gel Encapsulating Human Articular
Chondrocytes for Cartilage Tissue Repair and Regeneration
R.C. Pereira1,2, M. Scaranari3,4, H.S. Azevedo1,2, R.L. Reis1,2,
R. Cancedda3,4, C. Gentili4
13B’s Research Group–Biomaterials, Biodegradables and Biomi-
metics, University of Minho, Campus de Gualtar, 4710-057
Braga, Portugal
2Department of Polymer Engineering, University of Minho,
Campus de Azure´m, 4800-058 Guimara˜es, Portugal
3Dipartimento di Biologia, Oncologia e Genetica, Universita‘ di
Genova, Genova, Italy
4Instituto Nazionale per la Ricerca sul Cancro, Genova, Italy
Cartilage tissue loss, as a result of trauma, congenital disorders and
diseases of joints, involving structural damage of articular cartilage
surface, is a substantial clinical problem representing a major
challenge for cartilage tissue engineering. The aim of our study
was to evaluate the in vitro and in vivo behavior of human articular
chondrocytes encapsulated within a novel carrageenan in situ in-
jectable hydrogel for cartilage tissue engineering and regeneration.
Human articular chondrocytes (Hac) were expanded using a well
defined serum free medium able to support cell proliferation and
differentiation with high cell chondrogenicity. Specifically, Hac
were encapsulated within the hydrogels and cultured in vitro for 28
days. Results showed that there was a statistically significant in-
crease of cellular viability, with deposition of extracellular matrix
(ECM) and subsequent maintenance of chondrocyte differentiated
phenotype, as revealed by expression of chondrogenic markers
and reinforced by histological analysis. Optical sections acquired
by APOTOME (Zeiss) of Hac hydrogel labelled with Hoechst
(viable cell dye) allowed the construction of 3D models images
demonstrating an homogenous viable cell dispersion as well as
a increasing cell number over the time. Bovine full-thickness
articular cartilage defects were injected with the biodegradable
hydrogel loaded with Hac and implanted subcutaneously in nude
mice. Histological results documented the formation of a new
human origin cartilaginous repair tissue, clearly indicating the
potential of this novel cell delivery system for cartilage tissue
engineering.
(OP 213) Novel Micro-Nanofibrous Multilayer Scaffold for
Bone Tissue Engineering Applications
A. Martins1,2, S. Chung1,2, A.J. Pedro1,2, R.A. Sousa1,2,3, A.P.
Marques1,2, R.L. Reis1,2,3, N.M. Neves1,2
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13B’s Research Group–Biomaterials, Biodegradables and Biomi-
metics, University of Minho, Campus de Gualtar, 4710-057
Braga, Portugal
2IBB—Institute for Biotechnology and Bioengineering, Braga,
Portugal.
3Stemmatters, Biotechnology and Regenerative Medicine LTD,
AVEPARK—Parque de Cieˆncia e Tecnologia S.A., Zona Indus-
trial da Gandra, S. Cla´udio do Barco, APARTADO 4152—4805
Caldas das Taipas, Portugal
Fibrous structures mimicking the natural extracellular matrix
(ECM) morphology are considered promising scaffolds for Tissue
Engineering (TE). Scaffold architecture determines its structural
integrity, mechanical strength, transport properties and the micro-
environment for cell adhesion and proliferation. Therefore, several
scaffold processing techniques were developed to control the
scaffold architecture. Rapid prototyping (RP) allows the production
of scaffolds with precise control of porosity and internal pore ar-
chitecture; while electrospinning (ES) technique has become very
popular in the TE community due to the production of submicron
ECM-like fiber meshes.
This work aims to evaluate a novel starch-based scaffold ob-
tained by the combination of starch-polycaprolactone micro- and
polycaprolactone nano-motifs, produced by RP and ES, respec-
tively. Scanning Electron Microscopy (SEM) and micro-Computed
Tomography micrographs showed a multilayer scaffold composed
by parallel aligned microfibers, in a grid-like arrangement, inter-
calated by randomly distributed nanofibers forming a mesh-like
structure.
Human osteoblast-like cells (Saos-2) were dynamically seeded
on the multilayer scaffolds using spinner flasks to improve cell
seeding efficiency within the scaffold, and the constructs were
subsequently cultured under static conditions for 1 and 7 days. SEM
micrographs and Hematoxylin-Eosin staining showed the pre-
dominant cell attachment and spreading on the nanofiber meshes,
which enhanced cell retention at the bulk of the RP scaffold. Cell
viability (MTS assay) and proliferation (DNA quantification) re-
sults demonstrated the advantageous effect of the combined micro-
nano architecture, as compared to the micro structure on cellular
performance. These results demonstrated the high potential of the
innovative multilayer scaffolds for improving cellular response
when pursuing bone TE strategies.
(OP 214) Novel Nano-Composite Biomaterial for Osteochon-
dral Tissue Engineering:Pilot Clinical Study
M. Marcacci1, E. Kon1, S. Zaffagnini1, G. Filardo1, D. Pressato2,
E. Arcangeli2, R. Quarto3, Bruna Parma4, A Tampieri5, M. Del-
cogliano1
1Istituti Ortopedici Rizzoli, Bologna, Italy
2Fin-ceramica S.p.a. Faenza, Italy
3Stem Cells Laboratory, Advanced Biotechnology Center, Uni-
versity of Genova–Italy.
4Opocrin S.p.A. Corlo di Formigine (Modena)
5I.S.T.E.C- National Council of Research Faenza, Italy
Introduction: Osteochondral articular defects represent a key con-
cern in orthopedic surgery. The objective of this pilot clinical study
was to test safety and performance of a newly developed type-I
collagen-hydroxyapatite (HA) nanostructural bio-mimetic osteo-
chondral (O.C.) scaffold which reproduces cartilage-subchondral
bone morphology.
Methods: A gradient composite O.C. scaffold, based on type-I
collagen-HA, was obtained by nucleating collagen fibrils with
hydroxyapatite nanoparticles at physiological conditions.
30 cases (9F, 21M, mean age 29,3 years) with knee os-
teochondral lesions (8 medial femoral condyle, 5 lateral condyle,
12 patella, 8 femoral troclea) were treated with scaffold implan-
tation from January 2007 to July 2007. The lesions size went from
2 cm2 to 6 cm2. All patients achieved minimum 1 year follow up
and were clinically evaluated using the International Repair Car-
tilage Society score.
Results: IKDC objective score improved after 1 year showing a
normal or nearly normal knee in 80% of patients at 1 year of follow
up. Similar results were obtained with the IKDC subjective score
and with Tegner score. Cases with previous surgery had the worst
results, while associated surgery doesn’t influenced significantly
the clinical outcome. 1 case failed and were reoperated.
MRI evaluation demonstrated good bone and cartilage forma-
tion and only in the failed case no integration of the graft was
found.
Conclusions: This open one-step surgery was used for treatment
of big osteochondral defects. The results of this technique at short
follow-up are encouraging. Better results can be obtained in young
patients with no previous surgery.
(OP 215) Novel Smart Cryogels for Drug Delivery
N. Bo¨lgen1, M.R. Aguilar2, M. Fernandez3, S. Villar-Rodil2, J. San
Roman2, E. Piskin1
1Hacettepe University, Chemical Engineering Department and
Bioengineering Division, Beytepe, Ankara, Turkey
2Institute of Polymer Science and Technology (CSIC), Juan de la
Cierva, 3. 28006 Madrid, Spain
3Facultad de Farmacia, Universidad Complutense de Madrid
(UCM). Ciudad Universitaria s/n, 28040 Madrid, Spain
Biodegradable thermoresponsive cryogels were prepared by free
radical polymerization of N-isopropylacrylamide monomer and a
macromer composed of hydrolytically degradable oligolactate-2-
hydroxyethyl methacrylate and dextran by cryogelation protocol.
They were characterized by several techniques, i.e., FTIR, 1H-NMR
and SEM. Thermoresponsive behaviour of the cryogels with differ-
ent chemical compositions was determined by swelling experiments
and imaging NMR. These novel smart cryogels exhibited ‘‘volu-
metric phase change temperatures, VPCT’’ between 208–378C
depending on the composition. The composition of cryogels and the
medium temperature were found key parameters affecting in vitro
degradation rate and profile. Two forms of simvastatin, hydrophobic
and hydrophilic, were loaded into the cryogels following two dif-
ferent protocols: (i) embedding the drug after cryogelation, and (ii)
incorporating simvastatin during cryogelation. FTIR and 1H-NMR
confirmed the drug loading. SEM micrographs demonstrated that
hydrophobic simvastatin molecules were deposited on the walls of
the pores of the cryogels, while hydrophilic simvastatin molecules
were distributed within the solid polymer phase. In vitro release of
simvastatin from the cryogels was investigated for possible appli-
cation as Simvastatin delivering scaffolds for regeneration of bone
defects. Different release profiles were observed in the in vitro re-
lease experiments, which were varied significantly depending on the
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type of simvastatin, the composition of the cryogel and the medium
temperature.
(OP 216) Organized Kidney Tissue Structures for the Treat-
ment of End Stage Renal Disease
A. Joraku1, A. Atala1, J.J. Yoo1
1Wake Forest Institute for Regenerative Medicine, Wake Forest
University Health Sciences, Winston-Salem, NC 27157
Introduction: While dialysis can prolong survival for many pa-
tients with end stage renal disease (ESRD), only renal trans-
plantation can restore normal function, and renal transplantation
is severely limited by a critical donor shortage. Previous work
showed that cultured renal cells seeded on artificial renal de-
vices can form functional renal structures producing urine-like
fluid. In this study we investigated the feasibility of creating 3D
renal structures for in situ implantation within the native kidney
tissue.
Methods: Primary renal cells from 4 week old mice were grown
and expanded in culture. Cells were placed in a collagen-based 3D
culture environment. Cells were labeled with fluorescent markers
and injected into mouse kidneys for in vivo formation of renal
tissues. Collagen injection without cells and sham operated ani-
mals served as controls.
Results: Culture expanded single renal cells formed tubular
structures after 4 days in the collagen-based 3D culture condi-
tions. The tubules, lined with renal epithelial cells, progressively
increased in length and divided to form branching structures. Im-
planted renal cells formed tubular and glomerular structures within
the kidney tissue, as confirmed by the fluorescent markers. There
was no evidence of renal tissue formation in control and sham op-
erated groups.
Conclusion: These results demonstrate that cultured renal cells
can reconstitute into organized kidney structures in a collagen-
based 3D culture system. The implanted cells self assemble into
tubular and glomerular structures within the kidney tissue. The data
suggest that this may be the preferred approach to engineer func-
tional kidney tissues for the treatment of ESRD.
(OP 217) Osteoblast and Osteoclast Differentiation in an
In Vitro Three-Dimensional Model of Bone Turnover
F. Tortelli1, N. Pujic1, Y. Liu1, R. Cancedda1
1Universita` di Genova and Istituto Nazionale per la Ricerca sul
Cancro, Genoa, Italy
There is an increasing interest in developing innovative in vitro
tissue models using typical tissue-engineering approaches. The
expansion of models based on integration between cells and bio-
materials could help to better understand basic mechanism of hu-
man diseases and could be also used for the screening of new drugs,
by testing their efficacy and safety before clinical trials. This study
was designed to develop a novel 3D in vitro model of bone turnover
using Skelite (67% Si-TCP and 33% HA/B-TCP) scaffolds in order
to investigate osteoblast-osteoclast interactions in a 3D environ-
ment and to compare it to traditional two-dimensional Petri-dish
cultures. Murine primary osteoblasts from C57Bl6/J mice and os-
teoclast precursors from GFP transgenic mice (C57Bl/6-Tg(ACTB-
EGFP)1Osb/J) were co-cultured on 3D Skelite scaffolds and on
standard plastic culture dishes. We compared the growth and the
differentiation of these cells in both culture conditions by prolif-
eration assay (3H-Thymidine incorporation) and histology. Os-
teoblast and osteoclast differentiation were then monitored by Real
Time PCR for Runx2, Osterix, Osteocalcin, Cathepsin K, TRAP
after co-culture in normal medium and following an osteogenic
stimulation. The GFP expression was examined to monitor the cell
type ratio during the cultures. The expression of each gene was
normalized to GAPDH and calibrated to the percentage of GFPþ or
GFP- cells if expressed by osteoclasts precursors or osteoblasts re-
spectively. In conclusion, our data show that the three-dimensional
mineralized environment induces osteoblast and osteoclast differ-
entiation and that the osteoclastogenic inductive properties of
murine osteoblasts are strongly dependent on their stage of matu-
ration.
(OP 218) Osteoconductive Scaffolds Obtained by Means of
In Situ Surface Functionalization of Wet-Spun Fibre Meshes
for Bone Regeneration Applications
M.T. Rodrigues1,2, I.B. Leonor1,2, C.A. Viegas1,2,3,4, I.R.
Dias1,2,3,4, M.E. Gomes1,2, R.L. Reis1,2
13B’s Research Group–Biomaterials, Biodegradables and Biomi-
metics, Dept. of Polymer Engineering, University of Minho,
Braga, Portugal
2IBB–Institute for Biotechnology and Bioengineering, PT Gov-
ernment Associated Laboratory, Braga, Portugal
3Dept of Veterinary Sciences, Univ. de Tra´s-os-Montes e Alto
Douro, Quinta dos Prados, 5000-911 Vila Real, Portugal
4Department of Animal Science, Univ. de Tra´s-os-Montes e Alto
Douro, Quinta dos Prados, 5000-911 Vila Real, Portugal
The success of bone tissue engineering (TE) strategies is strongly
dependent on the development of new synthetic materials com-
bining osteoconductive, osteoinductive and osteogenic properties.
Recent studies suggest that biomaterials incorporating silanol
groups promote and maintain osteogenesis with or without bio-
logical stimuli. This study aims to evaluate the osteoconductivity
and osteogenic properties of novel wet-spun fibre mesh scaffolds of
SPCL (blend of starch with polycaprolactone) with or without su-
perficial functionalized silanol (Si-OH) groups by seeding/culturing
them with goat marrow stromal cells (GBMCs). A calcium silicate
solution was used as a non-solvent to precipitate the SPCL solution
by wet-spinning and to develop an in situ functionalization meth-
odology of the SPCL fiber mesh with silanol groups. GBMCs were
seeded onto SPCL scaffolds with or without Si-OH groups (control)
for 7 or 14 days in different culture medium; shifting osteogenic
growth (beta-glycerophosphate, ascorbic acid) or differentiation
(dexamethasone) factors. The fiber meshes-GBMCs constructs
were characterized analyzing cellular viability, proliferation, early
differentiation as well as matrix mineralization. The bioactive 3D
fibre meshes with superficial Si-OH functional groups produced by
a one-step wet-spinning technique not only sustained cell prolifer-
ation and viability, which increased with the culturing time, but
also the higher ALP activity levels and matrix production in the
Si-OH fiber meshes indicated that Si-OH groups improve cellu-
lar functionality towards the osteoblastic phenotype, which we
believe to have an enormous potential for bone regeneration ap-
plications.
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(OP 219) Osteogenic Differentiation of Human Bone Marrow
Cells Cultivated in Single Cell 3D Microenvironments
M. Rottmar1, A.-K. Born1, M. Pleskova1, K. Maniura-Weber1
1Lab for Materials-Biology Interactions, Empa (Materials Science
and Technology), Lerchenfeldstrasse 5, 9014 St. Gallen, Swit-
zerland
Cell shape and regulation of biological processes such as prolif-
eration and differentiation are to a large degree connected. Chan-
ges in cell shape correlate with changes in gene expression such as
up- or down-regulation of proteins involved in proliferation, ECM
production, cellular signalling or differentiation. This possible
relationship is therefore of great interest for tissue engineering
strategies as well as for the development of cell based sensors. For
such studies we use a technology where single cells can be studied
in engineered quasi three-dimensional (3D) microenvironments.
Osteogenic differentiation encompasses a well organized series
of events including expression of various regulatory factors. This
gradual process can be followed by different marker proteins being
expressed at various time points, comprising early and late genes.
The aim of our project is to live monitor osteogenic differentiation
of single cells in quasi 3D microenvironments.
Gene constructs reporting for osteogenesis were created by
fusing fluorescent proteins to promoters of specific marker proteins
for nucleofection of human cells, which allows to live monitor
osteogenesis on a single cell level. In addition cells were im-
munohistochemically stained against bone-specific proteins to de-
tect differentiation. The 3D microwells were produced by standard
microfabrication techniques in silicon followed by thin film replica
molding in PDMS. Passivation of the surface was followed by
functionalization of the wells with fibronectin.
Cells adhere and grow inside the functionalized microwells,
avoiding the passivated surface. Immunohistochemical staining as
well as the GFP reporter strategy allow single cell monitoring of
osteogenic differentiation in 3D microenvironments.
(OP 220) Osteogenic Differentiation of Human Dental Neural
Crest-Derived Progenitor Cells: a Model for Developing Bone
O¨. Degistirici1, F. Grabellus2, S. Irsen1, K. W. Schmid2, M. Thie1
1Center of Advanced European Studies and Research (caesar),
Bonn (Germany)
2Institute of Pathology and Neuropathology, University Hospital
of Essen, University of Duisburg-Essen (Germany)
Human tooth contains a distinct population of neural crest-derived
progenitor cells (dNC-PCs) which give rise to specialized daugh-
ter cells like neurogenic, chondrogenic and osteogenic lineages
(Degistirici et al., 2008). Here, the ability of dNC-PCs to develop
engineered bone in a self-propagating culture system was studied.
For preparation of monolayers, a defined number of dNC-PCs in
growth medium was seeded in plastic dishes. After some days of
osteogenic stimulation, dNC-PCs had formed a multilayer. Flat
cells covering the surface (outer cells) as well as cuboidal cells
trapped within the layer (inner cells) were found. With prolonged
culture time, an organic matrix that is not mineralized initially was
secreted by the inner cells, which showed an osteoblast-like phe-
notype. When further cultured, the multilayer detached from the
substrate and started to contract. As an active process, a three-
dimensional structure was formed which subsequently calcified. For
example, collagen fibrils which are produced by the inner cells
formed ordered arrays and small and large calcified/calcifying ma-
trix vesicles containing amorphous deposits were present. The Ca/P
ratio was examined within this tissue. Indeed, electron dispersive
X-ray analysis showed that the collagen fibrils were mineralized to a
certain extent. The experiments so far show that long-term culti-
vation of dNC-PCs in osteogenic medium leads to formation of a
hard tissue that can serve as an in vitro model for developing bone.
These results suggest that dNC-PCs could also be used for tissue
engineering for the bone defects of the craniofacial region.
(OP 221) Particularities of Tissue Engineering in Pediatric
Applications: EuroSTEC
W.F.J. Feitz1
1Radboud University Nijmegen MC
EuroSTEC: European program on Soft Tissue Engineering for
Children. The aim of this project is to use modern tissue engineering
approaches to treat children with structural disorders present at birth,
such as spina bifida, urogenital defects, gastroschisis, diaphragmatic
hernia and esophageal atresia. The project strives to take a trans-
lational route through in vitro and animal experiments to early
clinical trials. Tailor-made ‘‘smart’’ biomatrices (scaffolds) will be
prepared using natural scaffold molecules (collagen, elastin) and/
or manmade polymers (poly lactic/glycolic acid), and will be
substituted with regulatory molecules such as growth factors and
glycosaminoglycans. A variety of cells, including stem cells, fi-
broblasts, muscle cells and urothelial/epithelial cells will be cultured
in vitro and seeded into biomatrices. Biomatrices thus prepared, will
be implanted using novel animal models for major congenital birth
defects, and evaluated for their capacity to regenerate the correct
tissues. Clinical trials for diaphragmatic hernias will form the start
of the patient registry and protocol development for future clinical
studies. Ethical and regulatory issues will be fully addressed before
final clinical application, and parents and children will have to be
able to understand these new treatment options. A dialogue with
society, including patient’s associations, will be sought. Demon-
stration activities will be undertaken to increase the awareness of
new treatment modalities based on new soft tissue engineering
techniques.
(OP 222) Perfusion and Tissue Engineering Scaffolds: Micro
versus Nano Pores
R. A. Brown1, U. Cheema1, B. Alp1, Z. Rong2, V. Mudera1, A. J.
MacRobert1
1University College London, Tissue Repair & Engineering Centre,
Institute of Orthopaedics Stanmore Campus, London HA7 4LP
2Queen Mary University of London, IRC in Biomedical Materials.
Mile End Rd., London.UK
A bedrock concept in tissue engineering (TE) holds that synthetic
cell-support scaffolds (e.g. polymer or ceramic) should be highly
porous; range 20–200mm diameter. Pore walls, consequently, tend
to be dense for mechanical strength. This is partly (i) for rapid
nutrient exchange and (ii) to give space for cell growth. However,
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recent characterisation, of real time (RT) O2/glucose gradients
in biomimetic collagen scaffolds indicates a major flaw, as these
factors eventually oppose each other. In contrast to such tradi-
tional synthetic scaffolds, biomimetic matrices (eg collagen, fibrin)
commonly comprise cell-seeded nano-fibrillar meshes with corre-
sponding nano-porosity. Precise RT core O2/glucose monitoring
in controlled, graded-density collagen constructs has shown, sur-
prisingly, that cell density-dependent consumption, not matrix
density, dominates.1 The present analysis compares the traditional
polymer TE scaffold model with biomimetic, nano-fibrillar matrices.
The critical factor is that small nutrients diffuse so effectively across
these nano-matrices, that multi-mm pores are unlikely to improve
exchange. However, since cell consumption/density dictates deep
perfusion, the very cell in-growth needed for successful culture
generates the steepest, most damaging gradients for core cells. This
will be exaggerated by the minimal matrix accumulation in early cell
aggregates and the dense polymer pore walls. We suggest, then, that
biomimetic nano-fibril scaffolds may hold the key to effective deep-
cell perfusion, since the logic of traditional multi-mm pore design is
eroded by its own success: rapid, 3D cell in-growth.
Reference:
1Cheema U., Rong Z., MacRobert AJ., Vadgama P. Brown RA. 2008.
Oxygen diffusion through plastic compressed collagen constructs. In Prep.
(OP 223) Phenotypic Comparison of Intervertebral Disc Cells
with Articular and Nasal Chondrocytes: Towards a Phenotypic
Signature for Annulus Fibrosus and Nucleus Pulposus Cells.
J. Clouet1, C. Vinatier1, M. Masson1, J. Lesoeur1, Y. Che´rel2,
L. Guigand2, F. Rannou3, M.T. Corvol3, E. Bord4, G. Grimandi1,
J. Guicheux1
1INSERM U791, Physiopathology of skeletal tissues, University
hospital, Nantes, France
2INRA UMR703, National School Veterinary, Nantes, France
3INSERM U747, university Paris Descartes, Paris, France
4University hospital, Department of Neurosurgery, Nantes, France
There is a surge of interest in applying tissue engineering princi-
ples to treat spinal disorders associated with the intervertebral disc
(IVD). However, the cellular and molecular characteristics of IVD,
an essential prerequisite for the development of tissue engineering,
are poorly defined. We aimed at characterizing intervertebral disc
by comparing the phenotype of Annulus fibrosus (AF) and Nucleus
pulposus (NP) cells with articular (AC) and nasal chondrocytes
(NC). Rabbit IVD were immunohistologically characterized and
the level of transcripts from the freshly isolated cells was assessed
by real-time PCR. Alcian Blue staining reveals an increasing
content of sulfated glycosaminoglycans from the outer to the inner
part of the AF. Conversely, Masson’s Trichrome staining evi-
dences an inverse distribution for total collagen that was abundant
in the outer AF and decreased towards the inner AF and NP. Fi-
nally, whereas the immunostaining for type II collagen was neg-
ative in the outer AF, it appeared strongly positive in the inner AF
and NP. Differential expressions of the transcripts were observed.
Type II collagen (COL2A1)/Type I collagen (COL1A1) and
COL2A1/aggrecan (AGC1) ratios in IVD cells were significantly
different from those in AC and NC. Interestingly, type V collagen,
COL1A1 and Matrix Gla Protein (MGP) were strongly expressed
in AF but barely detectable in NP cells. As expected AC and NC
expressed COL2A1, AGC1 and MGP. In view of a stem cell-based
tissue engineering approach for IVD regeneration, the differential
expression of these markers could become instrumental in moni-
toring and, eventually, triggering stem cell differentiation towards
IVD cells.
(OP 224) Poly(Ether Imide) Membranes as a Matrix for Cell-
Polymer Interactions
K. Luetzow1, W. Albrecht1, T. Weigel1, B. Seifert1, N. Ma1,2, A.
Lendlein1
1Research Center Geesthacht GmbH, Institute of Polymer Re-
search
2Department of Cardiac Surgery, University of Rostock
Aim of this work are polymeric membranes prepared from poly
(ether imide) (PEI)to meet the demands of Regenerative Medi-
cine concerning (selective) separation, bio/hemocompatibility, and
sufficient stability of the matrix. Poly(ether imide) was chosen
because it can be steam-sterilized, its membrane forming proper-
ties, and because it can be modified covalently with nucleophiles
in order to bind biofunctional ligands. The talk gives an overview
on scaffolds prepared from poly(ether imide) for biomedical ap-
plications. The ease of surface functionalization of PEI can be used
to create tailor-made surfaces for specific medical applications or
for further modification of the pore structure. The promising re-
sults concerning cell interactions (e.g. fibroblasts, endothelial cells,
platelets, keratinocytes) make PEI scaffolds a promising matrix for
many applications such as biohybrid organs, apheresis, wound
healing, or implants.
Support by the EU(NoE NanoMemPro) and the Helmholtz
Gemeinschaft and Mecklenburg-Vorpommern (Nachwuchsgruppe
0402710) is gratefully acknowledged.
(OP 225) Polyelectrolyte Complex Fibrous Scaffold for Liver
Tissue Engineering
B.C.U. Tai1, S. Gao1, C. Du1, A.C.A. Wan1, J.Y. Ying1
1Institute of Bioengineering and Nanotechnology
Liver transplantation as a therapy for liver failure is often hampered
by a shortage of donor tissue. The delivery of liver-differentiated
human mesenchymal stem cells (hMSCs) is a potential therapy to
aid in liver regeneration. In this study, a polyelectrolyte complex
(PEC) fibrous non-woven scaffold is employed to deliver differ-
entiated hMSCs in vivo. The PEC fibres are synthesized by a pro-
cess of interfacial polyelectrolyte complexation, which has its
benefits in being a room-temperature, aqueous-based reaction. The
fibres used in this experiment are mainly composed of natural
biopolymers, chitosan and alginate, and are crosslinked by silica.
The alginate component of the fibre has been chemically modified
to present an integrin-binding peptide, RGD, which enhances at-
tachment of the cells to be delivered. Bone marrow-derived hMSCs
are differentiated in vitro by a combination of extracellular matrix
and conditioned medium. The differentiated cells are seeded onto
the RGD-modified chitosan/alginate fibrous scaffolds and allowed
to attach overnight. The cell/scaffold construct is then implanted
into the livers of Wistar rats, from which 70% of the liver has been
removed. Immunolabeling of histological sections reveals minimal
capsule formation and hMSC expression of a subset of hepatocyte
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markers after two weeks. Hence, we have demonstrated that the
RGD-modified chitosan/alginate fibrous scaffold is useful for de-
livering pre-differentiated hMSCs in vivo.
(OP 226) Polyethylene–Mediated Gene Delivery into Rat Bone
Marrow Stem Cells
J.H. Lee1,2, H.H. Ahn1,3, M.S. Kim1, B. Lee2, G.S. Khang4, I.W.
Lee3, H.B. Lee1
1Fusion Biotechnology Research Center, Korea Research Institute
of Chemical Technology
2Department of Polymer engineering, Pukyung National Uni-
versity
3Department of Neurosurgery, Catholic University of Korea
4BK21 Polymer BIN Fusion Research Team, Chonbuk National
Stem cells possess the inherent capability of transforming and dif-
ferentiating into many cell types and specific cell type. Based on this
potential, stem cell-based gene therapy is promising for the recon-
struction of injured tissues or organs. Thus, the aim of this study is to
evaluate transfection efficiency in rat bone marrow stem cells
(rBMSCs) using DNA/polyethyleneimine (PEI) complexes.
The formation of complexes from DNA and PEI was performed
by the adding of the PEI solution to the DNA solution. Gel retar-
dation assay showed the optimal N/P charge ratio where PEI com-
pletely binds DNA. The particle size of DNA/PEI complexes
measured by dynamic light scattering (DLS) showed diameters of up
to 500 nm. From AFM measurement, DNA/PEI complexes showed
round-shape. These results indicated that DNA was sufficiently
condensed by PEI to give DNA/PEI complexes. The viability of
rBMSCs in the presence of DNA/PEI complexes was evaluated by
the MTT assay. As the relative amount of PEI was increased, its
cytotoxicity to rBMSCs increased. The DNA/PEI complexes were
transfected into rBMSCs. After gene transfection, enhanced green
fluorescence protein (EGFP) was monitored by flow cytometry.
Naked DNA showed no EGFP expression, whereas delivery of
DNA/PEI complexes to rBMSCs showed EGFP expression and
resulted in 2–10% transfection. Transfection efficiencies of DNA/
PEI complexes increased with increasing N/P charge ratio.
In conclusion, we have shown that PEI acts as an effective gene
carrier for rBMSCs.
(OP 227) Polymer–ECM Hybrids Combining Engineered
Shape with Cell Produced Matrix Components
J. Hilborn1
1Polymer Chemistry, Materials Chemistry Department, Uppsala
University, 751 21 Uppsala, Sweden
Synthetic biodegradable polymers are a current class of safe bio-
materials and they combine mechanical strength with processa-
bility and reproducibility. Their biodegradability and tuneable
degradation rate allow them to offer temporary mechanical support
for cells. However, they suffer from poor acceptance by cells and
almost complete absence of biological activity. Conversely, scaf-
folds made from extracellular matrix components like collagen
often exhibit excellent adhesion, adequate cell growth and can be
remodelled in-vivo. However, they suffer from limited processa-
bility, poor strength, source variability and low biological activity.
The objective of the 3G-SCAFF project is to develop the
‘‘third generation’’ bioresorbable intelligent polymer-ECM com-
posite materials that have a bioactive information built into them
using engineered cells and thus can activate specific tissue regen-
eration.
This approach for developing materials for Tissue Engineering
and Regenerative Medicine ranges from synthesis and processing of
synthetic polymers over cell engineering and culture systems to
in-vivo tests in relevant animal models. The partners involved in
this project with complimentarily competences and expertise in
polymer synthesis (Uppsala University), biomedical textiles
(RWTH Aachen University), cell- and tissue engineering (Swiss
Federal Institute Lausanne), mechanotransduction and bioreactor
(University College London) and clinical applications in urology
(Lausanne Research Hospital, CHUV) and skin (Karocell AB,
Sweden) will present the way from molecules to engineered cell
constructs.
(OP 228) Polymer/ECM Composite Biomatrix for Regenera-
tion of Soft Tissues
S.Piskounova1, J. Mindemark1, W.F. Daamen 2, A. van Koppe-
velt2, B. Harbage3, H. Chajra3, I. Heschel4, K. Faraj2,5, J. Hilborn1
1Uppsala University
2Radboud University Nijmegen Medical Center
3Symatese
4Matricel
5EMCM
A three dimensional scaffold is a common but challenging tool in
modern soft tissue engineering. On one hand it needs be porous to
allow cell penetration and resorbable. On the other hand, the
scaffold has to have mechanical properties allowing for suturing
and giving compliance similar to the surrounding tissue.
Collagen is the most abundant natural polymer in the body and
possesses important characteristics needed for attachment and
proliferation of cells, which makes it an interesting candidate for
preparing scaffolds. However, such biomatrices lack mechanical
strength, making them fragile and difficult to use for more me-
chanically demanding applications.
To overcome this problem we designed a construct that consists
of a biodegradable synthetic polymer knitting, incorporated in a
collagen sponge. The polymer fabric acts as a mechanical rein-
forcement, while the collagen provides the necessary three di-
mensional cues for cell integration and proliferation. Several
preparation methods are being explored in order to control the
orientation and the porosity of the collagen.
This composite system will be evaluated for soft-tissue regen-
eration e.g. for repairing large congenital defects in children within
the frames of the European program on Soft Tissue Engineering for
Children (EuroSTEC).
(OP 229) Polyureyhane/BMP-4 for Periodontal Tissue En-
gineering in an Osteoporotic Rabbit Model
M.K. Marei1, S. Agrawal2, M.M. Saad1, R.M. El-Backly1, D.K.
Ahmed1, N.E. El-Feshawy1, Y.M. El-Mokhtar1, R.H. AbdelAty1
1Tissue Engineering Laboratories, Alexandria University
2Oral biology, Ohio State University
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Introduction: Osteoporosis is a global problem and is the under-
lying cause of more than 1.5 million fractures annually. Presumed
correlations between age, systemic osteoporosis and periodontal
disease, tooth loss and changes in the quantity and quality of jaw
bone have been reported. Biomaterials for tissue engineering are
continuously developing for enhancement of tissue regeneration
and as delivery systems for BMP gene therapy. The present work
evaluated the regenerative potential of polyurethane/BMP-4 gene
encoded scaffold for periodontal tissue engineering in an osteo-
porotic rabbit model.
Materials and Methods: The first stage included synthesis of
biodegradable polyurethane matrix containing plasmid DNA vec-
tors encoding Bone Morphogenetic Protein–4 (BMP-4) as a ther-
apeutic transfectant. In the second phase, an osteoporotic rabbit
model was established by ovarectomizing 6 female New Zealand
white rabbits aged 5–7 months old. Animals were sacrificed 2 and 4
months post-ovarectomy and histological and histomorphometric
analyses were performed. The third phase involved the use of 6
normal and 6 osteoporotic rabbits to induce periodontal defects on
the distal surface of the 2 lower central incisors. For all the animals,
the left defects were left empty and the right defects received the
polyurethane/BMP-4 scaffolds. Animals were sacrificed 2, 4, and 6
weeks after the periodontal surgery.
Results & Conclusions: The New Zealand white rabbit was a
suitable model for osteoporosis as confirmed by histological ana-
lyses of bone status. The implanted polyurethane/BMP-4 matrix
was capable of regeneration of periodontal structures; alveolar
bone, highly organized periodontal ligament attachment in defects
in normal and osteoporotic rabbits.
(OP 230) Preferential Cellular Behaviour is Seen with a
Collagen-Elastin-Like Polypeptide Scaffold
Y. Garcia1, H. Naik2, R. Collighan3, M. Griffin3, J.C. Rodriguez-
Cabello4, A. Pandit2
1Department of Anatomy, NUI Galway, Galway, Ireland
2NCBES (National Centre for Biomedical Engineering Science),
NUI Galway, Galway, Ireland
3School of Life and Health Sciences, Aston University, Aston
Triangle, Birmingham, UK
4G.I.R. Bioforge, Universidad de Valladolid, 47011–Valladolid,
Spain
Collagen scaffolds cross-linked with microbial transglutaminase
have shown to enhance angiogenesis and resist wound contrac-
tion in in-vivo models [1]. Using this scaffold as the structural
foundation; it is hypothesised that the introduction of a functio-
nalised elastin-like polymer can be fully integrated, providing
enhanced mechanical and programmed cell viability. In addition,
this elastic component, designed using recombinant methodol-
ogy, will provide inherent proteolytic resistance to the scaffolds
as well as increased functionality by carrying specific sequences
for endothelial cell adhesion and enzyme substrate. The objec-
tive of this study was to study physico-chemical properties and
preferential cellular behaviour of a tethered ELP-collagen scaf-
fold. The effect of ELP introduction on collagen fibrillogenesis,
thermal behaviour, porosity and mechanical properties was
evaluated using atomic force microscopy, differential scanning
calorimetry and rheology respectively. In addition, cell viability
and morphology were assessed using different cells lines (fibro-
blasts, human umbilical vein endothelial cells and smooth muscle
cells) using AlamarBlue reduction assay in conjunction with
confocal and bright filed microscopy. The analysis of these pa-
rameters allowed us to conclude, that the introduction of ELP in
enzymatically cross-linked collagen scaffolds significantly en-
hances mechanical properties without significantly affecting other
physico-chemical properties. In addition, enzymatically cross-
linked collagen-ELP scaffolds favoured endothelial and smooth
muscle cells over fibroblasts. This preferential attribute could be
used to modulate cellular responses not only in wound healing
models but in cardiovascular and reconstructive tissue engineer-
ing fields.
(OP 231) Preparation of Macroporous 3D Bonelike Struc-
tures Through 3D Machining Techniques
M.S. Laranjeira1, A.G. Dias1, J.D. Santos1,2, M.H. Fernandes3
1INEB
2FEUP
3FMDUP
Bioactive and bioresorbable materials can be used in bone regen-
erative surgery, avoiding bone grafts.Using these biomaterials it is
possible to construct three-dimensional (3D) structures, which can
be used in regenerative bone surgery, as well as scaffolds, for
tissue engineering applications. This work reports a 3D machining
technique that allows the preparation of scaffolds with a repro-
ducible pore size, pore distribution and pore interconnections in
opposite to some conventional techniques used to prepare porous
materials. This technique also allows the preparation of scaffolds
with a defined architecture with the right shape to a specific im-
plant site. This work reports the use of 3D machining techniques in
the preparation of 3D macroporous Bonelike, a glass reinforced
hydroxyapatite. A virtual 3D structure model was created and a
CNC milling device machined the Bonelike dense structure.
In vitro testing using human bone marrow showed that cells were
able to adhere and proliferate on 3D structures surface and migrate
into all macropores channels. Moreover, these cells were able to
differentiate, since mineralized globular structures associated with
the cell layer were identified. The results obtained showed that 3D
structures of Bonelike allow with success cell migration into all
macropores, as well as the human bone marrow stroma cells pro-
liferation and differentiation.
Acknowledgments: The authors would like to thanks to the FCT
for their support in this work through the project POCI/CTM/
59091/2004.
(OP 232) Preparing Bone Using an Injectable Hydrogel
Scaffold
J. Hilborn1, D. Ossipov1, K. Bergman1, T. Bowden1, T. En-
gstrand1, S. Piskonova1
1Polymer Chemistry, Department of Materials Chemistry, Uppsala
University, 751 21 Uppsala, Sweden
Autologous bone grafts are routinely used to heal large bone defects
but has the disadvantages limited graft quantity, donor site mor-
bidity, pain for the patient, and cost of harvesting. A promising
alternative to this autografting is the delivery of osteoinductive
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growth factors, such as members of the bone morphogenetic protein
(BMP) family. It is, however, estimated that less than 20% of the
more than 1 million patients in US and Europe who develop non-
healing bone fractures can today be treated by bone growth stim-
ulation to heal. One reason for this is that the clinical efficiency
of BMP is critically dependent on the delivery strategy: when de-
livered in solution, BMPs will be rapidly cleared, resulting in
suboptimal healing. When employing carriers that can retain and
sequester BMPs greatly enhances efficacy and reduces protein dose
by localizing the morphogenetic stimulus.
To address this problem we have developed a new hydrogel
carrier that has demonstrated the desired features of an injectable
replacement for bone grafts: with BMP-2 it induces bone formation
in animals, it induces vascularisation, it is sterilizable, forms a gel
upon injection, shows little or no inflammatory reaction and is
based on naturally occurring hyaluronic acid which has a firmly
established biocompatibility.
(OP 233) Processing Biodegradable Thermoplastic Elastomers
for Applications in Soft Tissue Replacement and Augmentation
Y. Hong1,2, J. Guan1,2, K. Fujimoto1,2, P. Ramaswami1,2, J.J.
Stankus1,2, L. Soletti1,2, A. Nieponice1,2, D.A. Vorp1,2, W.R.
Wagner1,2
1University of Pittsburgh
2McGowan Institute for Regenerative Medicine
A poly(ester urethane urea) (PEUU) with hydrolytically labile soft
segments has been shown to act as a thermoplastic elastomer and
has been processed into a variety of formats to meet clinical needs
in the treatment of cardiovascular disease and soft tissue replace-
ment. Early pre-clinical testing has demonstrated the promise of
this platform in several settings. For pediatric cardiac surgery, a
full-wall thickness right ventricular outflow tract reconstruction
was performed in rats with a porous PEUU patch and lead to
complete functional scaffold replacement without complications.
For adult disease, placement of an epicardial patch onto a sub-
acute myocardial infarct in rats resulted in positively altered ven-
tricle wall remodeling and improved cardiac function. A tissue
engineered blood vessel generated by a combination of thermally
induced phase separation and electrospinning, followed by seeding
with muscle-derived stem cells, was successfully implanted in rat
(aortic) and porcine (carotid) models. Abdominal wall replace-
ment was achieved in an infected, trauma model with controlled
antibiotic release. Processing methods could yield structural and
mechanical anisotropy by electrospinning or thermally induced
phase separation with thermal gradients and composites could
be made by blending with collagen or extracellular matrix di-
gests. For controlled release, growth factors (e.g. bFGF, VEGF)
could be blended into the polymers as could a small molecule
ligand for a rheostatic ligand/gene promoter system. Electrostatic
coprocessing of polymer and cells allowed formation of tissue
constructs with microintegrated cells and fibers. This platform
offers attractive features for numerous applications in regenerative
medicine.
(OP 234) Production of Bone Substitutes Within Bioreactor-
Based Systems: Modeling and Culture of Preosteoblastic Cells
B. Carpentier1,2, J. Sohier2, P. Layrolle2, C. Legallais1
1UMR CNRS 6600, University of Technology of Compie`gne,
Biomechanics and Bioengineering, France
2Inserm U791, Laboratory for Osteoarticular and Dental Tissue
Engineering, University of Nantes, France
Aim: Our project aims at developing a bioreactor-based de-
vice dedicated to the production of bone substitutes ex vivo, by
combining bone marrow stem cells and biomaterials. The goal of
this study is to better characterize the flow and the mechanical
stimuli to which the cells are exposed within such systems by
means of computational fluid dynamics software, and to identify
the appropriate configuration for culturing bone cells on micro-
particles.
Methods: Modeling software (Gambit, TGrid and Fluent) was
used to determine fluid velocity, static pressure and shear stresses,
parameters that may greatly impact cell proliferation and differ-
entiation. In parallel, preosteoblastic cells (MC3T3-E1) were
seeded and cultured dynamically on glass microbeads. Three bio-
reactor configurations were investigated: vertically and horizon-
tally positioned packed beds, fluidized beds as well as monolayers
of beads within plane-parallel chambers. Cell survival and prolif-
eration rates were determined by cell counting. Cell distribution
and morphology were evaluated using ESEM and methylene blue
staining. The experimental data were subsequently correlated to
the numerical simulations.
Results: The fluidic environment could be investigated. A patent
effect of bioreactor configuration was observed on both survival
and proliferation of preosteoblastic cells. Horizontally positioned
packed beds and monolayers of beads lead to the best results in
terms of cell survival and proliferation.
Conclusion: Computational fluid dynamics is a valuable tool to
better comprehend the effect of dynamic culture on cells and to
determine the optimal experimental conditions required to produce
bone substitutes. Monolayers seem to represent an appropriate
configuration for culturing bone cells on micro-particles.
(OP 235) Production of Cytokines and Response to IL-1b by
Human Articular Chondrocytes at Different Stages of Tissue
Maturation
S. Francioli1, S. Miot1, J. Frueh1, C. Cavallo2, M. Jakob1,
B. Grigolo2, I. Martin1, A. Barbero1
1ICFS, Departments of Surgery and of Biomedicine, University
Hospital, Basel, Switzerland
2Laboratorio di Immunologia e Genetica, Istituti Ortopedici Riz-
zoli, Bologna, Italy
Implantation of engineered cartilaginous tissues represents a
promising strategy for the repair of cartilage defects. In the injured
joints, proinflammatory/catabolic mediators can impair the im-
planted engineered tissue. We aimed at investigating whether an
increased extent of tissue maturation in vitro would reduce the
production of pro-inflammatory chemokines and the IL-1b-medi-
ated catabolic effects by human articular chondrocytes (HAC).
HAC isolated from knee cartilage biopsies of 6 individuals were
expanded in monolayer for 2 passages and then cultured in pellets
for 3 or 15 days in chondrogenic medium. Tissue maturation was
assessed biochemically [glycosaminoglycans (GAG), DNA] and
histologically (Safranin-O). MCP-1, IL-8 and TGFb-1 were
quantified in culture surnatants or in tissues by real time RT-PCR.
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At 3 or 15 days of culture some tissues were exposed to IL-1b and
specific metalloproteases (MMPs) were quantified in the culture
media.
By increasing culture time, HAC accumulated more GAG
(4.3-fold), released lower amounts of IL-8 (12.0-fold) and MCP-1
(10.0-fold) and higher amount of TGFb-1 (5.4-fold). PCR analysis
confirmed respectively lower and higher expressions of IL-8 and
TGFb-1 mRNA in more mature tissues. As compared to HAC cul-
tured for 3 days, those cultured for 15 days responded to IL-1b re-
leasing lower MMP-1 (12.6-fold) and MMP-13 (1.8-fold) amounts.
Quantification of cytokines in response to IL-1b is in progress.
We showed that chondrocytes embedded within a more aboun-
dant cartilaginous matrix release lower levels of pro-inflammatory
chemokines and exhibite less IL-1b-mediated catabolic effects. The
implantation of more mature cartilaginous tissues could therefore
guarantee superior graft survival and functional outcome.
(OP 236) Production of PDLA and PLGA Scaffolds by Mi-
crofabrication and Electrospinning Techniques
E. Carletti1, T. Endogan2, A. Motta1, D. Maniglio1, V. Hasirci2,3,4,
N. Hasirci2,5,4, C. Migliaresi1
1University of Trento, Department of Materials Engineering and
Industrial Technologies and INSTM Research Unit, 38050 Trento,
Italy
2METU, BIOMAT, Dept. Polymer Science and Technology,
06531 Ankara, Turkey
3METU, BIOMAT, Dept. Biological Sciences, 06531 Ankara,
Turkey
4METU, Dept. Chemistry, 06531 Ankara, Turkey
5METU, Graduate Dept. Biomedical Engineering, 06531 Ankara,
Turkey
Properties, structure and morphology of scaffolds have a key role
in determining seeded cells behavior and scaffold fate once im-
planted. Among the various methods of scaffold production used
for polymer based materials are microfabrication and electro-
spinning techniques which can produce scaffolds with different
geometry and order. Microfabrication permits the production of
3-D scaffolds with tailored regular porosity and micro-resolution,
while non-ordered or less-ordered nanostructures are obtained by
the electrospinning process.
In this study we compare properties and in vitro behavior of
scaffolds produced by electrospinning and by a home-made mi-
crofabrication apparatus.
The microfabrication apparatus consists of three computer
controlled slides and an automatic pumping device connected to a
syringe. Slides can move independently with micrometric resolu-
tion in three orthogonal directions while the syringe extrudes a thin
filament of polymer solution through a 60 mm stainless steel cap-
illary needle at constant flow rate. The electrospinning system
makes use of a high voltage between the needle and a target to form
a mat of fine fibers. By changing the electrospinning process pa-
rameters such as voltage, distance and flow rate nets with different
morphology can be obtained.
In this study, poly(D,L-lactic acid) (PDLA) and poly(D,L-
lactide-co-glycolide) (PLGA) (50:50) scaffolds were prepared by
the microfabrication and electrospinning techniques. Rheological
tests were performed to characterize polymer solutions. The
properties of the prepared scaffolds were investigated by DSC,
ATR-FTIR, SEM. Cell culture tests were performed with MG63
osteoblast and MRC5 fibroblast cell lines on the scaffolds.
(OP 237) Programming Cells In Situ
D. Mooney1
1Harvard University, Cambridge, MA 02138 USA
There are hundreds of clinical trials of cell therapy currently un-
derway, with the goal of curing a variety of diseases. Simple cell
infusions lead to large-scale cell death (>90%), and little control
over cell fate. Typical tissue engineering approaches do not regen-
erate host tissues, but instead lead to the formation of a new tissue
mass that replaces the original tissue and must be integrated with the
host. We propose a new approach, in which material systems are first
used either as cell carriers or attractors of host cell populations, and in
either case the material then programs the cells in vivo and ultimately
disperses the cells to surrounding host tissues or organs to participate
in tissue regeneration or destruction. We have first addressed this
possibility in the context of skeletal muscle regeneration and vas-
cularization, as materials were designed to transplant progenitor
cells, promote their proliferation, and ultimately release the cells in a
controlled manner over time to repopulate host tissue. Further, this
concept has also been examined in the context of cancer vaccines, in
which antigen-presenting cells were recruited to the material, ma-
tured, and then dispersed to lymph nodes to activate an immune
response. These examples demonstrate the broad potential for this
approach to cell therapies, and suggest one may ultimately be able to
bypass most or all ex vivo manipulations in cell therapies.
(OP 238) Prostaglandin E2 as an Innovative Signalling Mo-
lecule for the Tissue Engineering of Cartilage
C. Brochhausen1, S. Halstenberg1, N. Sanchez1, R. Zehbe2,
B. Watzer3, A. Meurer4, H. Schubert2, C. J. Kirkpatrick1
1REPAIR-Lab, Institute of Pathology, Johannes Gutenberg Uni-
versity, Mainz, Germany
2Institute of Materials Science and Technologies, TU Berlin,
Berlin, Germany
3Mother-Child Center, Philipps University, Marburg, Germany
4Clinic of Orthopedic Surgery, Johannes Gutenberg University,
Mainz, Germany
Background: Prostaglandin E2 (PGE2) is involved in physiologi-
cal homeostasis and plays a role in cartilage metabolism. Thus,
PGE2 could serve as a candidate for tissue engineering strategies.
We investigated the incorporation of PGE2 into biodegradable
poly-L-lactide-co-glycolide (PLGA) microspheres and its release
over 154 h. Furthermore, we analysed the effect of PGE2 on human
articular chondrocytes seeded in a gelatine-based, oriented scaffold.
Methods: PGE2-modified microspheres were produced by a co-
solvent emulsification method. Upon incubation in 1.0 ml serum-
free medium at 378C, the supernatants were removed at defined
time points up to 154 hours. PGE2 concentrations were analyzed
by gas chromatography tandem mass spectrometry (GC/MS/
MS). The effect of this PGE2-release system was analysed in
freshly isolated primary human chondrocytes cultivated on ori-
ented, collagen I-coated gelatin scaffolds with and without PGE2-
containing microspheres. Cell morphology was visualized after
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2 weeks by Calcein-AM staining and laser-scanning confocal
microscopy.
Results: Microspheres showed a prolonged release of PGE2 with
a linear concentration increase over the first 12 hours, followed by
a plateau phase and a slow decrease until 154 h. Cell culture and
Calcein-AM staining of chondrocytes revealed that cells cultured
on the collagen scaffolds with PGE2 microspheres preserved a
rounded form resembling native articular chondrocytes, whereas
those cultured in the absence of PGE2 attained an elongated,
fibroblast-like morphology.
Conclusions: We demonstrated the prolonged release of PGE2
from PLGA-microspheres. Furthermore, our results from chon-
drocyte cultures suggest that PGE2 enhances the preservation of
the chondrocyte phenotype. Thus, PGE2 is an interesting candidate
for tissue engineering of cartilage.
(OP 239) Rapid Engineering of a Biomimetic Skin Substitute
E. Hadjipanayi1, C. Fredriksson2, R.A. Porter1, R.A. Brown1
1University College London (UCL), Tissue Repair and En-
gineering Centre, Institute of Orthopaedics, Stanmore Campus,
London, HA7 4LP, UK
2Institute of Biomedicine and Surgery, Department of Experi-
mental Plastic Surgery, Faculty of Health Science, University of
Linkoping, Sweden
Skin substitutes should promote recovery of function by reprodu-
cing the anatomy, physiology and biologic stability of uninjured
skin. Plastic compression(PC) of collagen hydrogels is promising
as it rapidly produces dense, mechanically strong and biomimetic
scaffolds. We studied the possibility of further developing this into
a skin substitute.
Collagen constructs were prepared as two layer mimics of native
skin. A dense ‘dermal’ layer was developed by PC of collagen gels,
seeded with human dermal fibroblasts. Human keratinocytes were
seeded onto the surface and constructs were submerged in media
for 2 days before being raised to the air-liquid interface and cul-
tured for an additional 12 days. One set of constructs was embossed
with 3D micro-ridges into the dermal-epidermal interface during
the PC process, by embossing the putative interface of the initial
collagen gel with a template pattern of 40um diameter glass fibres,
parallel and 100um apart.
The skin-like ECM construct formed rapidly, taking a max of
1 hour to fabricate and up to 14 days to culture keratinocytes
to a multilayer. Histological analysis and immunofluorescence
staining(anti-cytokeratin) indicated that a stratified and differen-
tiated epidermis was formed. SEM showed a pattern of deep ridges
on the collagen surface which induced the formation of invagina-
tions of the epidermal layer as shown by histological analysis.
Epidermal thickness was 14 6 mm for ridged interfaces compared
to 40 14mm for smooth interfaces, indicating that the topography
of the microtextured interface influenced the stratification rate of
keratinocytes.
These findings support ongoing research for developing com-
pressed collagen scaffolds into biomimetic skin substitutes.
(OP 240) Recent Advances of Term in Korea: Commerciali-
zation and Academic Research
J.K. Park1
1Department of Chemical and Biochemical Engineering, Dongguk
University, Seoul 100-715, Korea
In Korea, basic researches on tissue engineering and regenerative
medicine (TERM) have grown rapidly last decade in the academic
and industry fields. A lot of basic researches have been supported
by national research grants. Based on these basic researches,
commercialization of TERM products has continued. Now, about
10 products are being launched in market. These products include
8 cell therapy products and 1 scaffold product and 1 tissue en-
gineered product. Also, some products are under investigational
new drug (IND) application. By recent outstanding results from the
stem cell research, a major cell source of the above products is
mesenchymal stem cell derived from bone marrow or umbilical
cord blood for the treatment of ischemic stroke etc. Some com-
bined products such as bioartificial liver system are under pre-
clinical study. Despite of this breakthrough in commercialization,
it is strongly suggested to secure a lot of the original and core
technology for TERM in Korea now.
(OP 241) Redifferentiation Mechanisms of Human Articular
Chondrocytes in Three-Dimensional Scaffolds
C. Albrecht1, W. Schlegel2, S. Zechbauer1, P. Eckl3, T. Ja-
gersberger1, B. Tichy1, V. Ve´csei1, S. Marlovits1
1Department of Traumatology, Medical University of Vienna,
Austrian Cluster for Tissue Regeneration
2Department of Paediatrics, Medical University of Vienna
3Department of Cell Biology, University of Salzburg
In order to obtain a sufficient number of cells for matrix-associated
autologous chondrocytes transplantation (MACT), human articular
chondrocytes are expanded in monolayer culture. During this cul-
tivation time, the chondrocytes undergo a dedifferentiation process,
which is partially reversed, when the cells are seeded on three-
dimensional scaffolds. The aim of this study was to enlighten some
molecular aspects of the redifferentiation process on the basis of
two different scaffolds, which are already used for MACT. Human
articular chondrocytes were seeded on a colllagen I/III membrane
(Biogide) and a hyalruonic acid fleece (Hyaff). Expression levels
of collagens, BMPs, BMPRIb, Noggin, Connexin43 and CD44s
were determined by real-time PCR at different time points. Fur-
thermore the samples were analysed histochemically and im-
munhistochemically. Gene expression of Col1, Gdf5, CD44s and
Connexin 43 was upregulated during monolayer culture in com-
parison with native cartilage and was partially downregulated in the
scaffolds. BmprIb expression was increased in monolayer culture,
but in Hyaff and Biogide the expression completely returned to
levels of native cartilage. Col2 and Noggin expression was dra-
matically diminished in monolayer culture. After 5 weeks three-
dimensional culture we found Col2 and Noggin expression slightly
increased in comparison with monolayer culture. Expression of
Bmp6 was decreased in monolayer culture and in the scaffolds.
Bmp7 expression was not detected in any sample. Although the two
scaffolds highly differed in composition, they showed a very similar
influence on chondrocyte redifferentiation. Our data indicate that
major changes in the expression of differentiation/proliferation
factors caused by three-dimensional scaffolds may induce re-
differentiation.
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(OP 242) Regeneration of Muscular Defects by a Composite
Graft Made of Mesenchymal Stem Cells and Human Acellular
Collagen Matrix
M. van Steenberghe1, R.M. Goebbels1, C. Lecuivre1, C. Galli2,
P. Gianello1, D. Dufrane1
1Experimental surgery laboratory
2Laboratorio di Tecnologie della riproduzione
Purpose: This work investigates, in 2 animal models, the recon-
struction of muscular defect by a composite graft made of ‘‘Me-
senchymal Stem cells (MSc) and human acellular collagen
matrix.’’
Methods: MSc cells were isolated from transgenic ‘‘Green
Fluorescent Protein’’ pigs and seeded on human acellular collagen
matrix (incubation time: 2–3 weeks). Two experimental models of
muscular defects were tested on nude rats (n¼ 16): (i) abdominal
wall defect and (ii) muscular necrosis induced by electrocoagula-
tion (4 necrosis areas of 16mm2/animal). Three experimental
groups were designed to cure muscular defect: 1) composite ‘‘MSc/
collagen matrix,’’ 2) Collagen matrix alone and 3) No repair.
Histomorphometry were performed, at 2, 4 and 8 weeks post-
implantation, to assess pig MSc cells detection (anti-GFP anti-
body), matrix remodelling (Masson’s Trichrom/dystrophin) and
revascularization (von Willebrandt factor).
Results: No significant difference of muscular defect remodel-
ling was observed at 2 weeks for each experimental group. In both
animal models, human acellular collagen matrix remained non-
recolonized up to 8 weeks post-transplantation. In contrast, a sig-
nificant higher area of composite implants was recovered by
muscular cells and vascular structures between 4 and 8 weeks for
composite grafts in comparison to collagen matrix alone (p< 0.05
for Group 1 vs. Group 2).
In both models, pig MSc remained undifferentiated and tissue
recolonization was performed by native nude rat endothelial and
muscular cells up to 8 weeks post-implantation.
Conclusion: A composite graft of MSc/human acellular collagen
matrix can promote the remodelling of muscular cell defect by
paracrine effect of MSc cells on the native environment.
(OP 243) Regional Expression of Articular Cartilage Surface
Lubricants following Mechanical Loading: Implications for
Tissue Engineering
C.P. Neu1, A. Khalafi1, K. Komvopoulos2, T.M. Schmid3, A.H.
Reddi1
1University of California at Davis
2University of California at Berkeley
3Rush University
Mechanical signals are critical for restoration strategies in tissue
engineering and regenerative medicine. The objective of this study
was to investigate the role of mechanical signals in the expression
of superficial zone protein (SZP), a lubricating biomolecule in
articular cartilage. Regional expression of SZP was first quantified
in cartilage obtained from the femoral condyles of immature bo-
vines using immunoblotting and visualized by immunohisto-
chemistry. Contact pressure mapping in whole joints was
accomplished using pressure sensitive film and a load application
system for joint testing. Friction measurements on cartilage plugs
were acquired in using a pin-on-disk tribometer modified for re-
ciprocating sliding. Direct mechanical stimulation by shear loading
of articular cartilage explants was performed with and without
inhibition of TGF-beta signaling, and SZP content in media was
quantified by enzyme-linked immunosorbent assay. SZP locali-
zation in femoral cartilage was initially identified, with anterior
regions exhibiting high SZP expression. Regional SZP patterns
were regulated by mechanical signals and correlated to tribological
behavior. Direct relationships were demonstrated between highest
SZP expression, maximum contact pressures, and lowest fric-
tion coefficient. SZP expression and accumulation was increased
by applying a shear stress, depending upon location within the
knee, and was decreased to control levels with the use of a spe-
cific inhibitor of TGF-beta type I receptor kinase and subse-
quent phospho-Smad2/3 activity. The regional localization of
SZP may be a critical design endpoint for tissue engineering
and regenerative medicine strategies aimed at functional restora-
tion of the articular cartilage surface with optimal tribological
properties.
(OP 244) Rheological Characterization of Pathological Blood
Alterations and Possible Effects on EC Blood Treatment
Processes Based on TE Constructs
D. Gabriele1, R. Hackel1, B. de Cindio1, R. Bonofiglio2, G. Cat-
apano1
1Department of Chemical Engineering and Materials
2Nephrology Unit, Annunziata Hospital, Cosenza, Italy
TE constructs are often used in bioreactors coupled to artificial
organs to treat blood, or plasma continuously pheresed from it, of
patients with metabolic disorders that, also through administered
drugs, alter blood composition and rheological properties. Never-
theless, these devices are designed as if blood were Newtonian
with standard viscosity. In this work, we report on a technique to
characterize both viscous and elastic blood behavior based on
deformation measurements under low constant stress (creep), and
blood rheological characterization of nephropatic and transplant
patients.
Blood collected with EDTA from healthy individuals, nephro-
patic and renal transplant patients of both genders was tested in a
Rheometrics DSR200 with parallel plates (D¼ 40 mm, gap¼
1.5 mm) at 0.09 Pa. From deformation-to-stress ratio (compliance)
vs. time curves it was estimated the shear viscosity, as the re-
ciprocal slope at long times, blood elasticity, as the hysteresis
area between Newtonian and experimental compliance, and a
specific blood elasticity, as the differential-to-total hysteresis area
ratio.
The technique yielded reproducible sound parameter values with
viscosity consistent with literature values at the given shear rate,
blood elasticity decreasing with hematocrit, and specific blood
elasticity independent of hematocrit and gender. Viscosity and
specific elasticity of nephropatic and transplant patients was lower
than the controls, decreasing with progression of renal damage of
the former, and were correlated with altered blood structure.
During EC treatment lower viscosity may cause lower pressure
drop and transmembrane pressure for given permeate flux. Re-
duced cell deformability may favor clotting in narrow channels,
and in membrane manifolds in the device headers.
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(OP 245) Role of Austrian Cluster for Tissue Regeneration in
the Hippocrates Project
M. v. Griensven1, A. Peterbauer2, S. Wolbank2, G. Feichtinger1,
G. Schu¨ller1, T. Morton1, H.Redl1
1LBI -Austrian Cluster for Tissue Regeneration
2RC-Austrian Cluster for Tissue Regeneration
The Cluster was mainly responsible for three areas, growth factors
and its monitoring, (stem) cells (see the Linz Branch) and in vivo
models including imaging. BMPs play an impotant role in bone of
critical size defects, therefore different Bmps were expressed and
purified in different expression systems in addition to FGFs or
derivates thereof.
Non viral gene therapy is another focus within our growth factor
research. For this reason, cDNAs of the most important BMPs
(BMP-2, BMP-4 and BMP-7) were cloned by RT-PCR and sub-
cloned into an eukaryotic expression plasmid and used, partly also
in bicistronic vector systems.
To establish a fluorescent based system to evaluate osteogenic
differentiation of human ASC, human CollagenIa1 as well as os-
teocalcin promoter-reporter vector systems were used. The pro-
moter activity was monitored by fluorescence microscopy and
semi-quantitative RT-PCR.
Different cell/growth factor combinations in different scaffolds
were tested in different spezialised osteochondral models (mice,
rats, rabbits, pigs).
The process of degradation and the removal of scaffold material
was shown using fluorescently labelled hydrogel in combination
with a real time in vivo imaging system (Maestro)
Transfection with a luciferase reporter gene allowed both de-
tection and quantification of implanted cells via a highly sensitive
CCD camera for at least 20 days in nude mice.
The mobility of the cells can further be influenced by choosing
different modes of application. The real time tracking of implanted
cells provides a valuable tool to detect processes of integra-
tion,homing or healing in defect model experiments
(OP 246) Self-Assembling Peptide Amphiphiles for Articular
Cartilage Regeneration
R.M. Capito1, N.A. Shah2, S.I. Stupp1,3
1Institute for Bionanotechnology in Medicine, Northwestern
University
2Department of Orthopaedic Surgery, Northwestern University
Feinberg School of Medicine
3Department of Materials Science & Engineering, Chemistry, and
Medicine, Northwestern University
Despite significant surgical advances and other therapies, treat-
ment of damaged articular cartilage due to injury or degenerative
disease remains a major medical challenge. This is largely due to
the limited capacity for self-regeneration of mature cartilaginous
tissues. The goal of these studies was to develop injectable peptide
amphiphile (PA) gels to enhance articular cartilage regeneration.
These aqueous gels consist of small peptide-based molecules that
self-assemble to form nanofibers of similar dimension and archi-
tecture to collagen fibrils.
In vitro experiments were completed to determine the viability
and chondrogenic differentiation of human mesenchymal stem
cells (hMSCs) within PA scaffolds. Cells were cultured within PA
gels with or without the incorporation of varying amounts of the
chondrogenic-inducing transforming growth factor (TGF)-b1 for
up to 4 weeks. Live/dead assays and gene expression of aggrecan
and type II collagen demonstrated good cell viability and suc-
cessful chondrogenic differentiation within the PA scaffolds with
the addition of TGF-b1.
PA gels were then evaluated for their ability to enhance tis-
sue formation in an in vivo rabbit model. Full thickness articu-
lar cartilage defects were created in the trochlea of rabbit knees
followed by microfracture. TGF-b1 alone or PA gel containing
TGF-b1 were subsequently injected within the defects. Four weeks
post-op, histological evaluation revealed a 2-fold increase in the
amount of tissue fill within defects containing the PA gels and TGF-
b1 compared to defects with TGF-b1 alone. These results dem-
onstrate the capability of using less invasive injectable PA gels to
augment current clinical practice for regenerating cartilage tissue.
(OP 247) Self-Assembling Peptides for Scaffolds in Re-
generative Medicine: Production Using Recombinant DNA
Technology
S. Kyle1, J. M. Riley1, A. Aggeli2, E. Ingham1,3, M. J. McPherson1
1Institute of Molecular & Cellular Biology, University of Leeds,
Leeds, West Yorkshire, LS2 9JT, UK
2Centre for Self-Organising Molecular Systems, University of
Leeds, Leeds, West Yorkshire, LS2 9JT, UK
3Institute of Medical & Biological Engineering, University of
Leeds, Leeds, West Yorkshire, LS2 9JT, UK
Peptides have been rationally designed which spontaneously
self-assemble into hierarchical structures in solution in response
to specific physico-chemical triggers to provide a new genera-
tion of well-defined biopolymers. An 11 mer peptide, P11-4
(n-QQRFEWEFEQQ-c) that forms a self-supporting isotropic hy-
drogel at concentrations of 10–30 mg/ml in physiological medium
has utility in regenerative medicine applications. Production of the
peptide using solid-state chemical synthesis is not cost effective for
biomedical applications and so our aim is to generate the peptide at
high yield and purity using a recombinant DNA approach.
The pET31b(þ) E. coli expression system was used for high
level expression of P11-4, generating approximately 0.6 g peptide/L.
The coding sequence for P11-4 was fused in tandem repeats to the
fusion protein ketosteroid isomerase (KSI) to allow high yield,
insoluble expression. Plasmids containing the KSI-His-(P11-4)3
construct carrying three P11-4 tandem repeats were transformed into
BL21 (DE3) and expressed for 42 hours in an autoinduction system.
Subsequent inclusion bodies that formed were harvested by cen-
trifugation after cell lysis. A hexahistidine tag on the construct was
used to purify the protein by nickel affinity chromatography. Re-
combinant P11-4 was obtained by cyanogen bromide cleavage of
internal methionine residues at the end of the KSI and between each
individual peptide.
Recombinant P11-4 was shown to spontaneously self assem-
ble into hydrogels in physiological tissue culture medium. Re-
combinant P11-4 was not toxic to cells and was shown to support
three-dimensional proliferation of L929 cells and primary human
dermal fibroblasts over 28 days of culture.
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(OP 248) Senescence-Related Myocardial Differentiation of
Human Bone Marrow Mesenchymal Stem Cells Induced by
Polystyrene Niche and its Reversal/Prevention by Extra Cel-
lular Matrix Culture
S.H. Shin1,2, H.H. Cho1,2,3, D.H. Choi2,3, H. Suh1,2
1Department of Medical Engineering
2National BK21 Project Team of Nanobiomaterial for Cell-based
Implants
3Cardiology Division, Yonsei Cardiovascular Center and Cardi-
ovascular Research Institute, Yonsei University College of Med-
icine, 250 Seongsanno, Seodaemun-gu, Seoul, Korea
In the present study, it was revealed that human bone marrow
mesenchymal stem cells (MSCs) undergo senescence-related dif-
ferentiation into myocardial lineage during in vitro culture without
any induction treatment. This phenomenon occurred over the whole
population of MCSs, much different from conventional differen-
tiation with limited frequency of occurrence, and was accompanied
by change of morphology into large, flat cells with impeded pro-
liferation which are the representative indications of MSC senes-
cence. By culturing MSCs under several culture conditions, it
was determined that medium type used and induction treatment
with 5-azacytidine were not associated with the phenomenon, but
serum starvation condition, under which proliferation is most se-
verely hampered, caused senescence progression and up-regulation
of cardiac markers. Nevertheless, MSCs gradually developed into
myocardial phenotype under normal culture conditions over pro-
longed culture period and heterogeneous populations were formed.
In perspectives of research and clinical applications, this must be
prevented for fair and consistent outcomes. Hence, a more biomi-
metic niche environment was constituted for hBM-MSCs by cul-
turing on a conventionally available ECM, as this phenomenon
seemed to have derived from the diverse nature of polystyrene
niche from that of in vivo environment. Consequently, cells cul-
tured on ECM regained spindle-shape morphology, increased in
their proliferation rate by two folds, and showed decreased ex-
pression of cardiac markers at both mRNA and protein levels. In
conclusion, these results indicate that progression of MSC senes-
cence may occur via myocardial differentiation during in vitro
polystyrene culture and this can be overcome by employing ap-
propriate ECM culture techniques.
(OP 249) Silicon—Hydroxyapatite Bioactive Coatings (Si-HA)
from Diatomaceous Earth and SiO2. Study of Adhesion and
Proliferation of Osteoblast-Like Cells
M. Lo´pez-A´lvarez1, E.L. Solla1, P. Gonza´lez1, J. Serra1, B. Leo´n1,
A.P. Marques2,3, R.L. Reis2,3
1Department of Applied Physics. E.T.S.I. Industriales. University
of Vigo. Spain
23B’s Research Group—Biomaterials, Biodegradables and Bio-
mimetics. University of Minho, Campus de Gualtar, 4710-057,
Braga. Portugal.
3IBB—Institute for Biotechnology and Bioengineering, Braga.
Portugal
The aim of this study consisted of investigating the influence of
bioactive ceramic coatings of silicon substituted hydroxyapatite
(Si-HA) over the behaviour of the human osteoblast-like cell
(SaOS-2) line. Pulsed laser deposition (PLD) was the selected
technique to deposit the coatings over titanium substrates. Diato-
maceous earth and SiO2, together with commercial hydroxyapatite
were respectively the silicon and HA sources used to produce the
Si-HA coatings. HA coatings with 0% of silicon were used as
control of the experiment. The Si-HA thin films were characterized
by Fourier Transform Infrared Spectroscopy (FTIR) demonstrating
the efficient transfer of Si to the HA structure in the form of SiO4
4-
groups. The in vitro cell culture was established with three-
dimensional titanium discs covered with Si-HA bioactive ceramic
coatings. Cell attachment, proliferation and their osteoblastic ac-
tivity was followed up to 7 days respectively by, Scanning Electron
Microscopy (SEM), DNA and alkaline phosphatase (ALP) quan-
tification. The SEM analysis demonstrated the similar adhesion
behaviour of the cells on the tested materials and the mainte-
nance of the typical osteoblastic morphology along the time of
culture. The Si-HA coatings did not evidence any type of cyto-
toxic behaviour when compared with commercial HA coatings,
although the proliferation rate was enhanced on the commercial
HA from day 3 to day 7 of culture. In what concerns the osteo-
blastic activity no significant changes were observed for the tested
culture times.
This work was supported by the UE-Interreg IIIA (SP1.P151/03)
Proteus Project and Ministerio de Educacio´n y Ciencia (MAT
2004-0291).
(OP 250) Silk Fibroin Based Strategies for Bone and Cartilage
Repair
C. Migliaresi1, A. Motta1
1Department of materials engineering and industrial technologies,
University of Trento, Italy
Silk fibroin is receiving large attention for possible application in
medicine and namely in tissue engineering. Different processes
can lead to the fabrication of gels, sponges or nets that have been
already tested in vitro and sometimes confirmed in animal tests
the attractive properties of this protein. Looking at bone and car-
tilage repair, fibroin can provide injectable gels, able to promote
fast repair of bone defects, sponges that could be implanted or
inserted in the damaged cartilage site, nets that can be used in
hybrid formulae for more complex needs such as osteochondral
defects.
For instance, fibroin water solution can gel after acidic, thermal
treatments or other treatments, these resulting in gels with different
rheological properties; sponges can be prepared by freeze-drying
and salt leaching with the formation of materials with various ar-
chitecture and mechanical behavior; nets can be formed by solvent
induced fibres bonding or electrospinning, providing materials
able to induce ‘‘in volume’’ or ‘‘on the surface’’ tissue engineering
processes. In all these formulations, fibroin preserves its ability to
induce cell adhesion and proliferation, and to guide tissue forma-
tion when implanted.
The lecture will overview some of the results achieved by this
research group also together with Expertissues partners as part of
the strategies of the NoE Expertissues addressed to the develop-
ment of natural polymers based solution for bone and cartilage
repair.
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(OP 251) Silk Fibroin Processing and Thrombogenic Re-
sponses
A. Motta1, D. Maniglio1, C. Migliaresi1, H.J. Kim2, X. Wang2,
X. Hu2, D.L. Kaplan2
1Department of Materials Engineering and Industrial Technolo-
gies, University of Trento, Trento, Italy
2Tufts University, Bioengineering Centre, Medford, MA, USA
Silkworm fibroin, the core of the silk filament, is an attractive
protein-polymer for biomedical applications due to its biocom-
patibility, ability to promote tissue regeneration and slow bio-
degradation. Fibroin can also be processed into a variety of 2-D
and 3-D formats to match morphological and structural features
to specific applications. Depending on the method of preparation
and the source of the silk (e.g, Bombyx mori race) with different
amino acid chemistries, the polymer can assume different struc-
tures, which lead to different mechanical and biological proper-
ties. Of particular interest in the field of biomaterials and
associated biocompatibility is the interaction of material surfaces
with biological defense systems, such as blood coagulation and
inflammation. The complement interactions are mediated by a
combination of biomaterial structure and chemistry, as well as
serum protein modifications of surfaces. The focus of the pres-
ent research was to correlate the structure of the silk fibroin-
derived biomaterials with plasma protein adsorption, platelet
activation and inflammatory cell (THP-1 cell line) adhesion and
activation.
The chemistry of the two types of silk studied influenced the
crystallinity of the films, hydrophobicity, surface roughness and
biological interactions. Protein adsorption was lower on samples
with the higher crystallinity and hydrophobicity, mainly the che-
motactic factors (C3a, C5a, C3b), while other protein adsorption
such as fibrinogen were comparable. As a consequence, platelets
and immune cells used in the present work responded to the dif-
ferent chemical and physical patterns among the various films in
terms of their adherence, activation, and the secretion of inflam-
matory mediators by monocytes.
(OP 252) Silk Fibroin-Based 3-D Porous Scaffolds for Carti-
lage Tissue Engineering
A. Motta1, Y. Wang2, E. Bella1, C.S.D. Lee2, C. Migliaresi1,
Z. Schwartz2, B.D. Boyan2
1Dept. of Materials Engineering and Industrial Technologies,
University of Trento, Trento, Italy
2Dept. of Biomedical Engineering and Institute of Bioengineering
and Bioscience, Georgia Institute of Technology, Atlanta, Geor-
gia, USA
Tissue-engineering scaffolds require chemical, structural and me-
chanical properties to provide templates that enable cells to adhere
and produce their extracellular environment. Previously, we showed
that chondrocytes prefer PLGA-scaffolds with mechanical proper-
ties similar to native cartilage, but cell-loading problems limit their
use for cartilage production in-vitro. Here we investigated chon-
drocyte growth on scaffolds produced using a natural extracellular-
matrix (ECM) protein, silkworm derived fibroin as the model
biopolymer.
Scaffolds were prepared from 7% fibroin/water (w/v) using
the salt leaching method and were characterized in terms of
morphology, amino acid composition, molecular weight, confor-
mation, thermal behaviour, porosity size, water absorption capa-
bility and mechanical properties. Sponges with a 500–1180 mm
pore size were used to assess chondrocyte growth. Confluent cul-
tures of rat costochondral chondrocytes were released from their
native ECM by trypsin-digestion, suspended in medium, and loa-
ded onto 3 mm6 mm cylindrical sponges (104 cells/mm3) by
static gravity-dependent filtration and by dynamic perfusion via an
orbital shaker, resulting in 87.1% and 81.8% loading efficiency,
respectively. Cell/scaffold constructs were cultured in DMEM
containing 10%FBS, ascorbate and antibiotics for 28-days.
At harvest, live/dead staining showed >90% cell viability re-
gardless of loading technique. Cell number, determined as a func-
tion of DNA content, increased 3.3-fold in the static-loading group
but decreased 50% for the dynamic-loading group. The chondro-
cytes on the scaffold retained their capacity to synthesis cartilage-
ECM, producing 2 mg sulfated-glycosaminoglycan/mgDNA, based
on DMMB-staining. Thus, natural silk fibroin scaffolds permit ef-
ficient gravity-dependent cell loading and support cell proliferation
and ECM production in-vitro, suggesting they are good alternatives
to synthetic polymeric scaffolds in-vivo.
(OP 253) Silk Nanoparticles for Delivery of Human BMP-2 in
Bone Regenerative Medicine Applications
P.C. Bessa1,2,3, E.R. Balmayor1,2, M.T. Cerqueira1,2, T. Rada1,2,
M.E. Gomes1,2, N.M. Neves1,2, H.S Azevedo1,2, M. Casal3, R.L.
Reis1,2
13B’s Research Group–Biomaterials, Biodegradables and Biomi-
metics, University of Minho, Braga, Portugal
2IBB–Institute for Biotechnology and Bioengineering, PT Gov-
ernment Associated Laboratory, Braga, Portugal
3CBMA–Molecular and Environmental Biology Centre/Biology
Department, University of Minho, Braga, Portugal
A tissue engineering approach combines the use of scaffold bio-
materials, stem cells and growth factors. Bone morphogenetic
proteins (BMPs) are growth factors that have sparked a great in-
terest in tissue engineering due to their strong ability to promote
new bone formation. Herein, we report the use of silk derived
nanoparticles as carriers for delivery of human BMP-2. Silks are
attractive biomaterials for tissue engineering due to its biocom-
patibility, slow biodegradability and excellent mechanical proper-
ties. Recombinant human BMP-2 was expressed in Escherichia coli
and purified by affinity chromatography, showing bioactivity in
human adipose stem cells. BMP2-containing silk particles were
then prepared by a water-in-oil emulsion method. Scanning elec-
tron microscopy (SEM) revealed that silk formed nanoparticles of
100–200 nm in absence of BMP-2 and of 300–350 nm when BMP-2
was incorporated. Western-blot using an antibody against human
BMP-2 allowed to detect that the growth factor loaded into the
particles, and that it could be slowly released, maintaining the
original BMP-2 conformation. In human adult adipose stem cells,
the particles showed no significant cytotoxicity and an increase in
alkaline phosphate activity. Ongoing research includes the study of
particle size by Dynamic Light Scattering (DLS), release assays
using FITC-labeled BMP-2 and FTIR analysis. Silk nanoparticles
showed to be a promising option as biomaterials for the delivery
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of bone growth factors such as BMPs for regenerative medicine
purposes.
(OP 254) Single Integrin Detection on the Surface of Osteo-
sarcoma Derived Cells by means of Functionalized AFM
Probes
F. Caneva Soumetz1, L. Pastorino1, R. Raiteri2, C. Ruggiero1
1Department of Communication, Computer and System Sciences,
Via All’Opera Pia 13, 16145 Genova, Italy
2Biophysical and Electronic Engineering Department, Via Al-
l’Opera Pia 11a, 16145 Genova, Italy
Integrins are transmembrane glycoproteins made of non-covalently
bonded alfa- and beta-chains. They are involved in cell-extracellular
matrix and cell-cell interaction and then in fundamental processes
such as cell adhesion, growth, and differentiation [1]. During tis-
sues development, the presence of environmental conditions per-
missive to cell differentiation is associated with the expression of
proper cell surface receptors [2]. To this regards, the possibility to
investigate cell membrane at the single molecule level is of high
potential in the field of tissue engineering. In this work AFM probes
have been successfully functionalised and tested for the detection
of integrins expressed on the surface of a line of osteosarcoma-
derived osteoblasts named MG-63. To this purpose, monoclonal
antibodies specific to the b1 subunit of the integrins expressed by
this cell line have been covalently immobilized on the tip of sili-
con nitride AFM cantilevers by means of a bifunctional linker (PEG)
[3]. Force curves have been collected in culture medium over the
surface of both fixed and living cells obtaining maps of the inter-
action between the immobilized antibodies and the respective cell
membrane receptors. The obtained results demonstrate the possi-
bility to detect specific receptors on the surface of living cells and
then the high potential of the AFM technique in the field of tissue
engineering to investigate cell response to external environmental
conditions.
References:
1Hynes R. O. (1987), Cell, 48:549–554.
2Rosso F. et al. (2004), J. Cell. Phys., 199:174–180.
3Hinterdorfer P. et al. (1996), Proc. Natl. Acad. Sci. U.S.A., 93:3477–
3481.
(OP 255) Site-Specific Patterned Differentiation of Embryonic
Stem Cells to Vascular Cells
M. F. Chowdhury1, W. L. Stanford1,2, M. Radisic1,2,3
1Department of Chemical Engineering and Applied Chemistry,
University of Toronto, Toronto, ON, Canada
2Institute of Biomaterials and Biomedical Engineering, University
of Toronto, Toronto, ON, Canada
3Heart & Stroke Richard Lewar Centre of Excellence
Due to oxygen diffusion limitations, engineering of cardiac tissues
of physiologically relevant thicknesses (>1 cm) requires engineer-
ing blood vessels. Blood vessels are primarily comprised of endo-
thelial cells (ECs) and smooth muscle cells (SMCs). ECs line the
lumen whereas SMCs surround the ECs and provide vascular in-
tegrity. We and others previously demonstrated that primitive me-
sodermal progenitors derived from embryonic stem cells (ESCs)
express the receptor, Flk1, for vascular endothelial growth factor
(VEGF). When grown on collagen IV (ColIV), Flk1þ cells pref-
erentially differentiate further into ECs or SMCs in the presence or
absence of soluble VEGF-A, respectively. Previously, we demon-
strated that azidobenzoic acid-modified chitosan (Az-chitosan), a
cell-repellent cationic hydrogel, can be used to pattern cells. We
hypothesize that blood vessels can be engineered by differentiat-
ing ESCs on micropatterned ColIV with or without VEGF-A. We
immobilized VEGF-A onto negatively-charged ColIV and micro-
patterned this solution onto Az-chitosan coated coverslips. Flk1þ
ESCs differentiated in embryoid bodies for 3 days were FACS
sorted and seeded onto patterned surfaces to induce site-specific
differentiation into vascular cells. Immunostaining analyses dem-
onstrated that approximately 70% of sorted cells differentiated
into vascular cells. Using immobilized VEGF, 52 14% of cells
differentiated to ECs and 19% to SMCs. While in the absence
of immobilized or soluble VEGF, ECs and SMCs accounted
for 19 14% and 49% of the differentiated cells, respectively.
Therefore, ESCs are capable of differentiating into vascular cells
in a site-specific manner. Future work will examine the signalling
pathways of the immobilized VEGF and extend this system to 3D
structures.
(OP 256) Six Month Control of Diabetes by Transplantation of
Encapsulated Pig Islets in Diabetic Primates Without Im-
munosupppression.
D. Dufrane1, R.M. Goebbels1, G. Beaurin1, P. Gianello1
1Experimental surgery laboratory
Objective: This study assessed the capacity of alginate encapsu-
lated islets to reverse diabetes in ‘‘pig to primate’’ model.
Methods: Adult pig islets were encapsulated in microcapsules
and implanted under the kidney capsula of 4 Streptozotocin-treated
primates or in subcutaneous macrodevice in 5 additional diabetic
animals. As controls, primates received non-encapsulated pig is-
lets (n¼ 2) or empty capsules (n¼ 2). Body weight, fasting blood
glucose (FBG), insulin, porcine C-peptide, HbA1C (glycosylated
haemoglobin) and anti-pig antibodies were evaluated in sera. Im-
munostaining for CD3,CD68,C3,C9 and insulin were performed
on explanted grafts.
Results: Non-encapsulated pig islets were rejected within 7 days.
Although a significant reduction of FBG and a transient increase of
insulin/porcine C-peptide levels were observed during 2 weeks
after microencapsulated pig islets implantation, a gradual decline
of function was observed after 6 weeks. After subcutaneous trans-
plantation of a macrodevice, diabetes was corrected up to 6 months:
normal FBG (52–107 mg/dl) and HbA1C (after 16 weeks) reached
8 1.4%. Two animals were retransplanted with a new macro-
device between 25 and 35 weeks after the first graft whereas the
latter clearly dysfunctioned. Diabetes was completely controlled
again (HbA1C¼ 7.4 9.8%) ten weeks after retransplantation.
Although anti-pig IgG antibodies were evidenced in primates sera,
immunohistology demonstrated insulin positive cells inside the
graft and no sign of graft rejection. Permeability testing by lectin-
FITC revealed no permeablity to molecules over 150 KDa for al-
ginate used in macrodevice.
Conclusions: Adult pig islets encapsulated in a subcutaneous
Macrodevice can completely reverse STZ-induced diabetes up to 6
months without immunosuppression.
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(OP 257) Skeletal Myogenic Differentiation of Mesenchymal
Stem Cells Isolated from Human Umbilical Cord for Skeletal
Muscle Tissue Engineering
F.R. Pu1, J.A. Hunt1, N.P. Rhodes1
1UK Centre for Tissue Engineering, Department of Clinical En-
gineering, University of Liverpool, Daulby Street, Liverpool L69
3GA, United Kingdom
We have investigated the phenotype of mesenchymal stem cells
(MSCs) from human umbilical cord (UC) and their potential to
differentiate into a skeletal muscle phenotype as a new approach to
skeletal muscle tissue engineering. Furthermore, we investigated
whether UC MSCs were capable of differentiation into multiple
lineages, such as osteoblasts, adipocytes and neural cells.
Human UCs were harvested from full term deliveries. Each UC
was cut into 1mm2 pieces and then cultured in DMEM-LG con-
taining 15% FCS for 7–10 days. The pieces were removed and the
phenotype of the adherent cells investigated using FACS. During
cell population expansion, UC MSCs gave rise to adherent layers
of fibroblast-like cells expressing MSC-related antigens SH2, SH3,
CD90, CD29 and CD117 and negative for CD34, CD45, CD133,
CD106, HLA-ABC and HLA-DR. More importantly, when these
UC-derived MSCs were incubated in myogenic conditions for up
to 6 weeks, they expressed myogenic markers in accordance with a
typical myogenic differentiation pattern. Both RT-PCR analyses
and immunohistological staining showed that two early myogenic
markers, MyoD and myogenin were expressed after 3 days of in-
cubation but not after 2 weeks. At week 6, most of the UC MSCs
expressed myosin heavy chain, a late myogenic marker. Our re-
sults demonstrated that UC MSCs possess a potential of skeletal
myogenic differentiation and also imply that these cells could be a
suitable source for skeletal muscle repair and a useful tool of
muscle-related tissue engineering. Finally, osteoblastic, adipocytic
and neural differentiation was demonstrated when cultured in
typical differentiation media.
(OP 258) Smart ‘‘Temperature Responsive’’ Self-Assembled
Monolayers
E. Piskin1, G. Demirel1, Z. Rzaev1, S. Patır1
1Hacettepe University, Chemical Engineering Department and
Bioengineering Division and Biyomedtek, Ankara, Turkey
Self-assembled monolayers (SAMs) are a class of molecular as-
semblies that are prepared by spontaneous adsorption of molecules
from solution onto a solid substrate. The process of SAMs and more
recently, self-assembly of multilayer systems have attracted a great
deal of interest. SAMs technology provides a powerful tool for
generating monolayers of biological molecules on various solid
substrates. The orientation of monolayers offers great versatility in
terms of the complex bio-recognition, which might provide a
method for the in vitro development of biosurfaces that are able to
mimic naturally occurring molecular recognition process. Recently
we were able to form smart (i.e., temperature responsive) poly(N-
isopropylacrylamide) (Poly(NIPA)) based SAMs on model sub-
strate surfaces. We have investigated the effects of dipping time and
solution concentration on the formation of SAMs with 3-amino-
propyltrimethoxysilane (APTS) molecules on the Si(001) surfaces.
Poly(NIPA) was synthesized by reversible addition-fragmentation
chain transfer (RAFT) polymerization to contain two different
functional groups at two ends (i.e., -SH and -COOH), then was
covalently attached to the surfaces via surface APTS molecules via
the–COOH terminal groups. 5’-thiolated oligodeoxynucleotides
(ODNs) were immobilized onto these thiol-terminated poly(NIPA)
molecules on the surface by disulfide bond formation. It was pos-
sible to control the hybridizations of these immobilized ODNs with
the target ‘‘complementary’’ ODNs within the medium by changing
the temperatures (from 258C to 458C) which was monitored by an
ellipsometer
(OP 259) Smooth Muscle Cell Seeding of Decellularized
Scaffolds: Further development Toward a More Native Ar-
chitecture for Tissue Engineered Blood Vessels
S.K. Yazdani1, B. Watts1, M. Machingal1, Y.P.R. Jarajapu1, M.E.
Van Dyke1, G.J. Christ1
1Wake Forest Institute for Regenerative Medicine, Wake Forest
University Health Sciences, Winston-Salem, NC 27157
Vascular Smooth muscle cells (VSMCs) impart important func-
tional characteristics in the native artery, and therefore, should
logically be incorporated in the development of tissue engineered
blood vessels designed for vascular repair or replacement. However,
the native architecture and low porosity of naturally derived bio-
materials (i.e., decellularized vessels) has impeded efforts to in-
corporate VSMCs into the wall of tissue engineered blood vessels.
To this end, the goal of this study was to develop improved methods
for seeding VSMCs onto decellularized porcine carotid arteries.
Decellularized vessels were prepared in the absence and presence of
the adventitial layer, and statically seeded with a pipette containing
a suspension of rat aortic VSMCs. Following cell seeding, re-
cellularized engineered vessels were place in a custom bioreactor
system for 1–2 weeks to enhance cellular proliferation, alignment
and maturation. Seeding of SMCs was dramatically enhanced by
removing the adventitial layer of the decellularized porcine artery.
Moreover, cyclic bioreactor conditioning (i.e., flow and pressure)
augmented SMC proliferation and accelerated formation of a
muscularized medial layer. Fura-2 based digital imaging micros-
copy revealed marked and reproducible depolarization-induced
calcium mobilization following bioreactor preconditioning in the
absence, but not in the presence of the adventitia. The major finding
of this investigation is that following 2 weeks of bioreactor pre-
conditioning, re-cellularized, adventitia denuded, native scaffolds
possessed a relatively thick layer of VSMCs capable of mobilizing
calcium in response to depolarization. These findings represent an
important first step toward the development of tissue engineered
vascular grafts that more closely mimic native vasculature.
(OP 260) Starch/Ethylene-Co-Vinyl Alcohol Fiber Mesh
Scaffolds: Production, Characterization and Surface Mod-
ification
I. Pashkuleva1,2,3, H. S. Azevedo1,2,3, P. M. Lo´pez-Pe´rez1,2, R. L.
Reis1,2
13B’s Research Group–Biomaterials, Biodegradables and Biomi-
metics, Dept. of Polymer Engineering, University of Minho,
Campus de Gualtar, 4710-057 Braga, Portugal
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2IBB–Institute for Biotechnology and Bioengineering, PT Gov-
ernment Associated Laboratory, Braga, Portugal
3These authors contributed equally to this work.
Tissue engineering scaffolds must provide cell anchorage sites,
mechanical stability and structural guidance. Fiber mesh structures
have been considered as adequate scaffolds for tissue engineering
due their high surface area available for the adhesion and prolif-
eration of different cell types. In addition, they present a good
degree of interconnectivity between pores, which is essential for
the migration of cells and diffusion of nutrients.
Herein, we propose a new route to produce fiber mesh scaffolds
from a starch/poly(ethylene-co-vinyl alcohol) (50/50-%wt) blend.
Scaffolds with porosity up to 80% were obtained by a simple wet
spinning technique based on solution/precipitation of a polymeric
blend and subsequent fiber sintering to stabilize the produced 3D
structures. The proposed wet spinning procedure avoids thermal
degradation, typical for the conventional melt spinning techniques,
as shown by thermal gravimetric analysis.
The high surface area and the presence of –OH groups in the
blend components caused relatively high values of water uptake
(about 110%). On the other hand, the samples presented very low
percentages of weight loss in buffer solution, which reveals their
stability in aqueous media.
To enhance cell attachment and proliferation, plasma treatment
was applied to the produced scaffolds. The untreated and treated
scaffolds were examined using SaOs-2 human osteoblastic cell line.
The results showed that SaOs-2 were able to attach and proliferate
on the studied materials. However, double concentration of DNA
was measured for the modified scaffolds after 2 weeks of culture.
Moreover, the cells seeded onto the treated samples showed more
spread morphology with extended filopodia.
(OP 261) Starch/Gellan Gum Hybrid 3D Guidance Systems
for Spinal Cord Injury Regeneration: Scaffolds Processing,
Characterization and Biological Evaluation
N.A. Silva1,2, A.J. Salgado3, R.A. Sousa1,2, J.T. Oliveira1,2, N.M.
Neves1,2, J.F. Mano1,2, N. Sousa3, R.L. Reis1,2
13B’s Research Group–Biomaterials, Biodegradables and Biomi-
metics, Department of polymer Engineering, University of Minho,
Braga, Portugal
2Institute for Biotechnology and Bioengeneering, PT Government
Associated Lab, Braga, Portugal
3Life and Health Sciences Research Institute, School of Health
Sciences, University of Minho, Braga, Portugal
Spinal cord injury (SCI) represents a significant health and social
problem and therefore it is urgent to find strategies that can spe-
cifically target this problem. In this sense the objective of the
present work was to develop a new range of 3D tubular structures
aimed at inducing the regeneration within SCI sites. Up to six
different 3D tubular structures were initially developed by rapid
prototyping-3D bioplotting–based on a biodegradable blend of
starch. The mechanical properties of these structures were assessed
by DMA, in both dry and wet conditions, and their morphologies/
porosities analysed by micro-CT and SEM. Afterwards, gellan gum
hydrogel was injected in the central area of structures. Biological
evaluation was then carried out by determining their cytotoxicity,
using MEM extraction and MTS test, as well as by encapsulation of
oligodendrocytes (M0III cell line) within the hydrogel phase. The
histomorphometric analysis showed a fully interconnected network
of pores with porosity ranging from 70%–85%. Scaffolds presented
compressive modulus ranging from 17.4 to 62.0 MPa and 4.42 to
27.4 MPa in dry conditions and wet conditions respectively. Cy-
totoxicity assays revealed that the hybrid SPCL/Gellan Gum
scaffolds were non cytotoxic as they did not cause major alterations
on cell morphology, proliferation and metabolic activity. Finally,
preliminary direct contact assays showed that the hybrid scaffolds
could support the in vitro culture of oligodendrocyte like cells.
Further work will focus on the behaviour of these scaffolds when
implanted in SCI animal models.
(OP 262) Stem Cell Sheet Engineering on Polyelectrolyte
Multilayer Films
O.V. Semenov1,2, A. Malek1, J. Voros2, A.H. Zisch1
1Department of Obstetrics, University Hospital Zurich, Switzer-
land
2Laboratory of Biosensors and Bioelectronics, ETH-Zurich,
Switzerland
Cell sheet engineering has emerged as a novel method for creation
of three dimensional tissue models without the need for biode-
gradable scaffolds. We aim to develop a new methodology that
builds on the use of electric charge to accomplish non-enzymatic
harvest of stem cell sheets. We arranged charge-sensitive poly-
electrolyte multilayer films (PEMs) by stacking of 9 alternating
layer pairs of poly-L-lysine and hyaluronic acid. These ‘‘soft’’
stacks were either functionalized with fibronectin or additionally
stiffed by crosslinking with [EDC/NHS]. We have established a
new protocol for isolation of Placenta-derived mesenchymal stem
cells (PD-MSC), that we tested here for creation of cell sheets. PD-
MSC were cultured on experimental stacks and examined for
morphology (phase microscopy), viability (life/death stain) and
vitality (WST-1 assay) 48 hours post-seeding. The principal find-
ings are: (1) Native ‘‘soft’’ PEM films do not support stem cell
adhesion even after functionalization with fibronectin. (2) Only
‘‘tuned’’ PEM films stiffed by crosslinking support stem cell ad-
hesion and outgrowth of dense stem cell sheets. (3) PD-MSCs
expressed mesenchymal stem cell and adult cell markers. (4) On
tissue plastic polystyrene, PD-MSCs could be successfully differ-
entiated towards three mesodermal lineages. (5) PD-MSCs main-
tained as dense cell sheets during differentiation. Crosslinked
charge-sensitive PEM films are functional substrates for sheets of
human mesenchymal stem cells. PD-MSC can successfully ad-
here on such PEM films and form viable dense sheets. Ongoing
steps of research concern whether stem cell sheets grown on PEMs
can be successfully differentiated and harvested by applying of
electricity.
(OP 263) Stem Cells and Biomaterials for the Treatment of
Spinal Cord Injury
E. Sykova1
1Institute of Experimental Medicine ASCR
Mesenchymal stem cells (MSCs) have the capacity to migrate
towards lesions and induce regeneration. MSCs labeled with
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iron-oxide nanoparticles were transplanted into rats with a spinal
cord compression lesion (SCI). In vivo MRI, used to track their
migration and fate, proved that MSCs migrated into the SCI. To
bridge the cavities we implanted blocks of hydrogel or nanofiber
scaffolds, either alone or seeded with MSCs. We compared the
effects of implanted rat MSCs with the implantation of a freshly
prepared mononuclear fraction of bone marrow cells (BMCs) or the
injection of granulocyte colony-stimulating factor (G-CSF). Seven
days after SCI, rats received either MSCs, BMCs or G-CSF intra-
venously. Animals grafted with MSCs, BMCs or treated with G-
CSF had significantly smaller lesions and higher BBB scores than
did control rats. Autologous BMC implantation was therefore used
in a Phase I/II clinical trial in patients with acute and chronic SCI
(n¼ 34). In other studies, hydrogels (degradable and nondegrad-
able) or nanofiber scaffolds were implanted into rats with a SCI.
In both acute and chronic SCI, the implants reduced scar forma-
tion and bridged the lesion, providing a scaffold to reform the
tissue structure. Furthermore, hydrogel or nanofiber scaffolds see-
ded with stem cells can bridge a lesion site in acute as well as in
chronic SCI and increase functional recovery. We conclude that
scaffolds in combination with stem cells can improve regeneration
by bridging gaps after SCI, by mechanically supporting ingrowing
cells and axons and by the rescue and replacement of local neural
cells.
(OP 264) Stem Cells Derived from Placenta: Where do We
Stand?
O. Parolini1
1Centro di Ricerca E.Menni, Fondazione Poliambulanza, Brescia,
Italy
The immunological characteristics and early embryological ori-
gin of human placenta suggest that it could be a source of cells for
allo-transplantation. Additionally, cell recovery from placenta is
non-invasive and its use is ethically sound.
Human amniotic epithelial cells (hAEC) express embryonic
stem cell markers, and differentiate in vitro toward lineages of all
three germ layers. Meanwhile, human amniotic and chorionic
mesenchymal stromal cells (hAMSC and hCMSC) display phe-
notypic and functional characteristics similar to mesenchymal
stromal cells of other origins, particularly, differentiation toward
mesodermal, but also ectodermal and endodermal lineages.
In vitro studies show that amnion- and chorion-derived cells are
non-immunogenic and can induce immunomodulation. Interest-
ingly, it has recently been shown that amnion-derived cells harbour
T-cell suppressive or stimulatory subpopulations. Long-term en-
graftment was observed after xenotransplantation of human am-
niochorionic derived cells into different animal models.
Preclinical studies show that amnion-derived cells show promise
for restoring various tissue functions. hAEC transplanted into im-
munodeficient mice gave rise to cells with hepatocyte morphology
expressing human albumin or a-1 antitrypsin, with circulating hu-
man a-1 antitrypsin detected. hAEC xeno-transplanted into lesioned
areas of spinal cord-injured animal models survived for up to 120
days, and improved performance in locomotor tests was observed.
Meanwhile, hAMSC transplanted into rat myocardial infarcts sur-
vived for 2 months and differentiated into cardiomyocyte-like cells,
reducing infarct size and improving infarct border capillary density
and left ventricular function.
The in vitro differentiation potential, immunomodulatory
characteristics and promising preclinical data suggest that pla-
centa cells hold great promise for application in regenerative
medicine.
(OP 265) Stereological Methods in the Assessment of Func-
tionalised Scaffolds In Vivo
R. Ni Ghriallais1, A. Breen1,2, M. Kulkarni2, P. Dockery3, T.
O’Brien4, A. Pandit1,2
1Department of Mechanical and Biomedical Engineering, Na-
tional University of Ireland, Galway
2National Centre for Biomedical Engineering Science, National
University of Ireland, Galway
3Department of Anatomy, National University of Ireland, Galway
4Department of Medicine and Regenerative Medicine Institute,
National University of Ireland, Galway
Animal wound healing models provide an important platform to
evaluate tissue engineering strategies that aim to reverse chronic
healing. However, there is no standard method of analysis to assess
the healing response in a functionalised scaffold; aspects such as
trangene expression, cellular and tissue response need to be
quantified. Stereology is an engineering tool used to make quan-
titative estimates of the ‘amount’ of a geometrical feature within an
object (1), based upon observations made on two-dimensional (2D)
sections. The aim of this study was to develop stereological
methods to quantify the tissue response in a standardised rabbit ear
ulcer model. Four 6 mm punch biopsy wounds were created on the
rabbit ear and the following treatments administered randomly:
scaffold containing therapeutic gene, scaffold alone, therapeutic
gene alone and no treatment. At 7 days, tissue was harvested, cut
across the midline of the wound, and prepared for histology. Six
random fields of view were captured from each section at 400
magnification. A 192 point grid was used to quantify volume
fraction of cells. A cycloidal grid of known radius was used to
assess surface density, length and radial diffusion distance of blood
vessels. Epithelial gap was measured at low magnification. Results
showed that the methods of stereology used were successful in
describing differences in total volume of cells involved in in-
flammation, proliferation and angiogenesis, providing unbiased
information on the stage of healing.
Acknowledgements: Baxter Healthcare, Vienna, Health Re-
search Board, Faculty of Engineering
(1) Unbiased Stereology 2nd Edition - Howard and Reed
(OP 266) Stimuli-Responsive Biomineralization onto Biode-
gradable Substrates
N. M. Alves1,2, J. Shi1,2, C. I. Dias1,2, J. F. Mano1,2
13B’s Research Group–Biomaterials, Biodegradables and Biomi-
metics, University of Minho, Polymer Engineering Department,
Campus de Gualtar, Braga, Portugal
2IBB - Institute for Biotechnology and Bioengineering, Portu-
guese Government Associated Laboratory, Braga, Portugal
Bioactive composites that enable the formation of an apatite layer
onto the surface are important in field of tissue engineering and
regenerative medicine, namely in the development of osteo-
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conductive biomaterials for orthopaedic applications. The aim of
this work was to control the biomineralization event by triggering
external stimuli, namely, temperature and pH. Poly (L-lactic acid)
(PLLA) reinforced with Bioglass, was modified by grafting either
poly(N-isopropylacrylamide) (PNIPAAm) or chitosan to the sur-
face, by using plasma activation methodologies.
Regarding the PNIPAAM-grafted surfaces, it was found that
temperature could trigger the formation of apatite upon immersion
in SBF above the LCST of PNIPAAm, but no apatite could be
formed at 258C.
For the chitosan-grafted substrates the apatite formation upon
immersion in SBF was analysed. It was found that the formation of
apatite could be blocked when the pH was 5.4. On the other hand, a
dense apatite layer was formed at pH 7.4.
These results suggest that the formation of apatite or possibly
other kinds of minerals could be controlled by such ‘‘smart,’’ in
these case pH- and thermo-responsive, surfaces. For the smart
surfaces analysed in this work, the apatite formation was always
blocked when the grafted chains adopted an extended conforma-
tional state.
(OP 267) Stromal Cells from the Infrapatellar Fat Pad Allow
One-Step Surgical Procedure for Regeneration of Cartilage
Tissue In Vitro
W.J.F.M. Jurgens1, Z. Lu2, A. van Dijk3, F.J. van Milligen3, M.N.
Helder2, M.J.P.F. Ritt1
1VU University Medical Center, Dept. Plastic Surgery
2VU University Medical Center, Dept. Orthopedics
3VU University Medical Center, Dept. Pathology
Current therapies for osteoarthritis lack regenerative capacity.
Therefore stem cell therapies are being developed as a promising
alternative. Adipose tissue is an attractive source of stem cells for
these therapies since they provide a rich source of adipose tissue-
derived mesenchymal stem cells (ASCs). If sufficient ASCs can be
harvested, a one-step surgical procedure could be devised in which
harvesting of adipose tissue and the treatment of the osteoarthritic
defect with these ASCs are performed within a single surgical
procedure. Therefore we investigated whether ASC quantity and
quality in the stroma of the infrapatellar fat pad allows for appli-
cation in a one-step surgical procedure for the regeneration of
osteoarthritic cartilage.
Infrapatellar fat pads were harvested from 20 patients under-
going knee arthroplasty. The frequency of Colony-Forming Units
in the stromal vascular fraction (SVF) of the infrapatellar fat pad
was 3.4 0.8%. These units showed bilineage differentiation
along the osteogenic and adipogenic pathway. When cultured (P3),
a homogeneous cell population was obtained with a population
doubling time of approximately two days and a surface marker
expression profile matching that of ASC. When cultured in a poly
(D,L-lactide-co-caprolactone) scaffold, both cultured ASCs and
freshly isolated stromal cells showed chondrogenic differentiation
potential in vitro using RT-PCR analysis and (immuno) histo-
chemistry.
In conclusion, due to the high ASC-frequency in the stroma of
the infrapatellar fat pad, the favorable proliferation rate and the
chondrogenic differentiation potential, this stroma is a suitable
candidate for a one-step surgical procedure for the regeneration of
cartilage tissue.
(OP 268) Study of Growth and Differentiation of BMSC on
Synthetic Polymeric Matrices.
M. S. Molinuevo1, J. M. Ferna´ndez2,1, M. S. Cortizo2, A. M.
Cortizo1
1Bioquimica Patologica, Facultad de Ciencias Exactas, Uni-
versidad Nacional de La Plata.
2INIFTA, Facultad de Ciencias Exactas, Universidad Nacional de
La Plata.
Bone tissue has the ability to repair minor injuries through re-
modeling. However, when the host source of osteoprogenitors is
compromised at the defect site, one effective treatment may be cell-
based therapy. These cells may be supported in a synthetic biode-
gradable scaffold to regenerate bone lesion. In this work we study
poly-ester- and polyfumarate-scaffolds and their biocompatibility
with bone marrow mesenchymal stem cells (BMSC). Surface
properties and matrix porosity were evaluated by scanning electron
microscopy (SEM), and hidrophilicity (water contact angle) of poly-
e-caprolactone (PCL) and poly-diisopropyl-fumarate (PFIP) scaf-
folds obtained by solvent casting and lyophilization. PFIP showed a
smooth surface while PCL presented some rugosities on its surface.
Scaffolds obtained by lyophilization presented well distributed and
homogeneous porosity compatible with bone microarchitechture.
PCL presented higher hydrophylicity than PFIP. However, neither
PCL nor PFIP were degraded after 21 days of incubation at 378C in
phosphate saline buffer. Biocompatibility was evaluated by cultur-
ing BMSC on plastic (control) or polymeric matrices and incubated
at 378C for different periods of time. Cell morphology, adhesion
(1 h), cell proliferation (24 h) or osteoblastic differentiation (15
days) was evaluated. BMSC growing on the matrices developed a
well defined stress fibers network without cytotoxicity signs. Cells
attached and grew well on the scaffolds and expressed the osteo-
blastic marker alkaline phosphatase after 15 days in culture, at a
similar rate that the cells growing in the control dishes.
In conclusion, our results suggest that these polymeric scaffolds
are suitable for bone tissue engineering purpose.
(OP 269) Study of Protein Adsorption onto Biodegradable
Marine Origin Polyelectrolyte Multilayer Films Followed
In-Situ with QCM-D
G.V. Martins1,2, E.G. Merino1,2, C.M. Alves1,2, R.L. Reis1,2, N.M.
Alves1,2, J.F. Mano1,2
13B’s Research Group - Biomaterials, Biodegradables and Bio-
mimetics, Dept. of Polymer Engineering, University of Minho,
Braga, Portugal
2IBB—Institute for Biotechnology and Bioengineering, PT Gov-
ernment Associated Laboratory, Braga, Portugal
The development of new coatings and surface modification strate-
gies for biomaterial is of prime importance for understanding and
controlling cell-material interactions. In this context, protein ad-
hesion plays a major role in determining the biocompatibility of
materials and scaffolds. Here, it is described the use of a Quartz
Crystal Microbalance with Dissipation Monitoring (QCM-D) to
follow in-situ the adsorption of Bovine Serum Albumin (BSA) onto
a polyelectrolyte multilayer film composed by chitosan (CHI) and
alginate (ALG), previously prepared by electrostatically driven
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Layer-by-Layer (LbL) assembly. The interaction between BSA and
CHI/ALG multilayers was assessed, manipulating multiple vari-
ables like terminating charge layer, pH, number of polyelectrolyte
layers and chemical crosslinking, to study the rate and amount of
protein adsorbed. Furthermore, the use of a QCM-D allows us to
understand the viscoelastic properties and the hydration state for the
multilayer build-up. The results evidence the influence of the out-
ermost layer and the pH conditions in the attachment of the protein
to the CHI/ALG system. This study highlights the ability to in-
corporate biomolecules into complex multilayer films as being
potentially valuable for biomedical applications, including tissue
engineering and regenerative medicine.
(OP 270) Substrate Surface Chemistry Effects on Human
Mesenchymal Stem Cell Differentiation in 3-D Culture
R. Chen1, J.M. Curran1, J.A. Hunt1
1UKCTE, Clinical Engineering, UKBioTEC, University of Li-
verpool, Ground Floor Duncan Building, Daulby Street, Liver-
pool, U.K. L69 3GA
Different functional surface chemistries control not only initial
protein adsorption and production, but also the differentiation po-
tential of human mesenchymal stem cells (hMSCs) in 2-D culture
[1,2]. In this study, the different functional chemical groups of
methyl (-CH3), amino (-NH2), thiol (-SH), hydroxyl (-OH) and
carboxyl (-COOH) have been grafted on to the surface of 3-D porous
ceramic materials. hMSCs were cultured in vitro in contact with
unmodified and modified 3-D scaffolds with -CH3, -NH2, -SH, -OH
and -COOH groups in basal, chondrogenic and osteogenic media for
time periods up to 28 days in vitro. The 3-D scaffolds were char-
acterized by scanning electron microscopy (SEM), mercury intrusion
porosimetry (MIP), attenuated total reflection FTIR (ATR-FTIR)
and X-ray photoelectron spectroscopy (XPS). Differentiation of vi-
able cells at the mRNA level was determined by targeting beta-actin,
ornithine decarboxylase, collagen I, collagen II, sox-9, osteopontin,
osteocalcin, osteonectin and CBFA using real time PCR. Fluor-
escent immunohistochemistry was used to evaluate the production
of collagen I and II, osteocalcin and CBFA1. The results indicated
that the functional chemical groups had been successfully grafted
on to 3-D scaffolds with no distinct changes in morphology. Both the
3-D structure and chemical properties of these materials had effects
on controlling hMSC differentiation with/without additional bio-
logical stimulation.
References:
1Curran J. M., Chen R. and Hunt J. A., Biomaterials, 2006, 27,4783–
V4793.
2Curran J. M., Chen R. and Hunt J. A., Biomaterials, 2006, 26,7057–
V7067.
(OP 271) Supercritical Fluids: an Emerging Technology for
the Preparation of Scaffolds for Tissue Engineering
A.R.C. Duarte1,2, J.F. Mano1,2, R.L. Reis1,2
13B’s Research Group—Biomaterials, Biodegradables and Bio-
mimetics, University of Minho,Campus de Gualtar, 4710-057
Braga, Portugal
2Department of Polymer Engineering, University of Minho,
Campus de Azure´m, 4810-058 Guimara˜es, Portugal
The field of tissue engineering has evolved greatly since the idea
of combining active compounds and scaffolds to create artificial
tissues. Small molecular weight drugs that control proliferation
differentiation of cells can be incorporated into biodegradable
scaffolds to induce cellular differentiation and tissue remodeling.
The scaffold plays, therefore an important role not only as a physical
support but also in the cell proliferation and differentiation.
One of the most important stages of tissue engineering is the
design and processing of a porous 3D structure, with high porosity,
high interconnectivity between the porous and uniform distribu-
tion. A variety of processing techniques have been developed and
include solvent casting and particles leaching, compression
moulding and particle leaching, thermally induced phase separa-
tion, gas-foaming processes, among others. The main disadvan-
tages of these methods are the use of organic solvents and the high
temperatures required. The presence of residual organic solvents is
being rigorously controlled by international safety regulations, it is
necessary to warrant the complete removal and absence of these
substances, without exposing bioactive compounds to high tem-
peratures, which may degrade them. Supercritical fluid technology
appears, therefore as an interesting alternative to the traditional
processing methods.
The unique properties of supercritical fluids have been explored
and have led to the development of a number of polymer proces-
sing techniques. Regarding tissue engineering and scaffold prep-
aration the most interesting techniques available are impregnation,
foaming, phase inversion and foam injection moulding. In this
contribution theses techniques will be presented and discussed
along with some examples.
(OP 272) Supra-Molecular Nanodevices for Gene and Drug
Delivery
K. Kataoka1
1Department of Materials Engineering, Center for NanoBio In-
tegration and Center for Disease Biology and Integrative Medi-
cine, University of Tokyo
Polymeric micelle, the self-assembly of block copolymers with
core-shell architecture, is a promising nanodevice for drug and
gene delivery. There are several relevant properties in polymeric
micelle as nanodevice systems, such as longevity in blood circu-
lation, tissue-penetrating ability, spatial and temporal controlled
drug release, and reduced inherent toxicity. Also, engineering of
the block copolymer structure allows the preparation of polymeric
micelles with integrated smart functions, such as targetability as
well as stimuli-sensitivity. This presentation overviews the recent
achievements of polymeric micelles as smart nanodevices for drug
and nucleic acid delivery to solid tumors. Then, the focus will be
placed to the application of gene-loaded polymeric micelles as
non-viral vectors in the field of regenerative medicine. Further, the
future perspective will be addressed in the last part of this pre-
sentation, directing to the new medical paradigm of smart na-
notheranostic systems controlled by external physical stimuli.
(OP 273) Supramolecular Peptide Nanofibers for Tissue En-
gineering Applications
P.Y.W. Dankers1,2, E. Wisse3, D.T.A. Ploeger1, J.M. Boomker1,
M.C. Harmsen1, A.W. Bosman2, M.J.A. van Luyn1, E.W. Meijer3
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1Department of Pathology and Medical Biology, Stem Cell and
Tissue Engineering Group, University Medical Center Groningen,
Groningen, The Netherlands
2SupraPolix Research Center, Eindhoven, The Netherlands
3Laboratory of Molecular Science and Technology, Eindhoven
University of Technology, Eindhoven, The Netherlands
Conventional polymers are extensively studied as biomaterials
for tissue engineering. Recently, we have shown an innovation
in biomaterials design by means of directed non-covalent inter-
actions based on four-fold hydrogen-bonding 2-ureido-4[1H]-
pyrimidinone (UPy) dimers. Both passive and active scaffolds
could be produced by introducing a modular approach using these
dynamic UPy-UPy interactions. This approach has shown great
benefits in processability, mechanical tunability and most impor-
tantly biofunctionalization. The creation of a toolbox with different
UPy-modified polymers, bioactive molecules and imaging probes
allowed for the off-the-shelf assembly of bioactive biomaterials
by easy mixing without the need for additional elaborated syn-
thesis steps. Investigation of this UPy-polymer system in great
detail revealed that besides UPy-UPy dimerization also addi-
tional hydrogen-bonding takes places when prepolymers are end-
functionalized with UPy-moieties via a urethane or urea group;
resulting in formation of nanofibers. UPy-modified peptides were
easily extracted from UPy-polymers lacking the lateral interac-
tions. However, when prepolymers were UPy-functionalized via a
urethane or urea group, UPy-peptides could be incorporated into
the nanofiber stacks. The nanofiber containing UPy-polymers were
mixed with several UPy-modified extracellular matrix (ECM)-
peptides, derived from laminin, fibronectin and different collagens,
to mimic the natural ECM. In-vitro studies showed that renal ep-
ithelial cells behave differently on the various supramolecular
peptide nanofiber films, with respect to their phenotype and ECM
production. The association constants of the bioactives with the
material can be regulated by using these different supramolecular
interactions which allows for the design of biomedical materials
that can be tuned on the axis between non-covalent and covalent
modification.
(OP 274) Surface Interactions Between Materials and Biology
A. Motta1
1Dept. of Materials Engineering and Industrial Technologies,
University of Trento, Trento, Italy
The role of surfaces of matrices for regenerative medicine is to
induce specific cellular responses that will guide tissue regenera-
tion. For this reason, strategies for tissue engineering materials are
also directed to surface modification methods able to overcome
surface limitations or to improve the surface crosstalk between
implant and biological environment. Surface designed scaffolds
could specifically control the biological events occurring at the
material-tissue interface. Adsorption and desorption of proteins
from biological fluids will form on the scaffold dynamic surfaces
with proteins at different conformations, eventually exposing spe-
cific sites able to dialogue with cells membrane receptors. Cell
response to scaffolds surfaces will be determined by a signalling
cascade as a consequence of ligand-receptor interactions.
In the past, surface modification strategies have been mainly
aimed at decreasing almost randomly protein adsorption; nowa-
days, strategies are aimed at minimizing non specific interactions
while controlling the protein adsorption process, to promote spe-
cific cellular activation and tissue regeneration. Surface modifi-
cation can be morphological or/and chemical, designed at nano- or
micro-level. Model surfaces can be used for in vitro evaluations,
for a biological tuning of surface properties and adsorbed protein
types and distribution, as well as adsorption kinetics. For instance,
proteins can be visualized by using functionalized immunogold
nano-particles or quantum dots marked with fluorescence, and by
using Atomic Force Microscopy with specifically functionalized
tips. Adsorbed protein characterization, i.e. type, quantity but also
distribution on the surface, can help to understand the following
cell response events. Examples will be illustrated.
(OP 275) Survival and Remodelling of Endothelialized Col-
lagen Modules in Animal Models
R. Gupta1, M. D. Chamberlain1, T. Cooper1, M. V. Sefton1
1IBBME, University of Toronto
Modular tissue engineering is intended to result in vascularised
constructs. Functional cells are embedded in sub-millimetre sized
collagen rods (modules), and the outside surface is covered with
endothelial cells (EC). Upon implantation, the transplanted EC are
expected to connect with the host vasculature, enabling blood flow
through the assemblage of modules. However the inflammatory
response encountered upon implantation drives a remodelling
process that limits the survival of the transplanted EC. Here, we
evaluate the viability of transplanted EC in different animal models
with a view to understanding the optimum implantation strategy
for maximizing EC viability. Collagen modules (without embed-
ded cells) were seeded with human umbilical vein endothelial cells
(HUVEC) or rat aortic endothelial cells (RAEC). HUVEC sur-
vived for 7 days and formed primitive vascular structures in an
omental pouch in nude rats treated with clodronate liposomes to
temporarily deplete peritoneal macrophages. Alternatively, in SCID
mice, some HUVEC on modules injected minimally invasively in
subcutaneous sites were found to form vessel-like structures for up
to 21 days. Allogeneic RAEC covered modules did not survive
when implanted in an omental pouch of rats without immunesup-
pressive treatment. However treating animals with tacrolimus
(Prograf) and atorvastatin (Lipitor, to support EC survival) ex-
tended survival to 7 days (longest time point checked) and pro-
vided some preliminary evidence for new vessel formation. Further
analysis is parsing the relative roles of apoptosis and innate im-
mune responses in EC survival.
(OP 276) Synthesis and Characterization of Matrix Metalo-
protease-Sensitive Elastin-Like Based Bioactive Hydrogels
A. Girotti1,2, F.J. Arias Vallejo1,2, M. Alonso1,2, A.M. Testera 1,2,
J.C. Rodrı´guez Cabello1,2
1G.I.R. BIOFORGE, University of Valladolid, Spain
2Networking Research Center on Bioengineering, Biomaterials
and Nanomedicine (CIBER-BBN), Valladolid, Spain
One of the main challenges in tissue engineering is the obtaining
of advanced materials acting as artificial extracellular matrices
(aECM). Alternative candidates to actual employed synthetic
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materials are represented by biopolymers with a rich complexity of
structure and function as advanced scaffolds for tissue engineering.
Among the different families of protein-based polymers (PBPs)
one has proven an enormous potential, the Elastin-like polymers
(ELPs), which are based on repeating sequences, ‘‘building
blocks,’’ found in the natural elastin. These polymers show an
unmatched biocompatibility joint with a remarkable combination
of excellent properties that are difficulty found together in other
polymer family: a strong tendency to self-assemble into elastic
fibrillar structures; the formation different topological structures in
the nanometer scale; an acute smart behavior depending to poly-
mer architecture and environment conditions. Additionally, spe-
cific functionalities as cell adhesion sequences and bioactive
functions can be included in their structure adding especially
peptide by the use of genetic engineering tools in developing re-
combinant protein-based polymers. This communication shows the
achievement of recombinant elastin-like protein polymers that
have been designed and bioproduced in E. coli. They can be easily
cross-linked to obtain elastomeric hydrogels. All of them contain,
cell adhesion domains for extracellular ligand binding. Moreover
specific protease target domains are employed to improve the
biopolymers bio-processability. The insertion of proteases recog-
nition site of human elastases allows us to achieve definite degra-
dation of the biopolymer in the same natural way of elastin during
the ECM rearrangement. The mechanical, physical-chemical and
in vitro analysis confirm their excellent behaviour.
(OP 277) Synthesis of Extracellular Matrix Components By
Tissue-Engineered Human Oral Mucosa Subtitutes
I. Garzo´n1, M. Alaminos1, S. San Martı´n2, P.V. Crespo1, M.
Gonza´lez-Jaranay3, I. Cabello1, A. Campos1, M.C. Sa´nchez-
Quevedo1
1University of Granada, Department of Histology
2University of Valparaı´so, Chile
3University of Granada, Department of Stomatology
Introduction: The extracellular matrix is one of the main compo-
nents of all kinds of connective tissues. However, in vitro repro-
duction of all proteins that are normally present in the native
extracellular matrix is very difficult. In this work, we have carried
out a gene expression analysis of the major components of the
extracellular matrix in both human native controls and bioengi-
neered oral mucosa samples.
Materials and Methods: Human oral mucosa substitutes were
generated by using fibrin-agarose scaffolds with fibroblasts en-
trapped within and keratinocytes seeded on top. To analyze the gene
expression profile of controls and artificial oral mucosa samples,
total RNA was analyzed by using Affymetrix U133-plus 2.0 mi-
croarray chips. Genes with a role in extracellular matrix were se-
lected, and genes with at least 2-fold increased expression in the
group of controls or in the group of bioengineered samples were
considered overexpressed.
Results and Discussion: Oral mucosa substitutes showed over-
expression of genes encoding for several metallopeptidases,
biglycan, several collagens, decorin, elastin, fibronectin, laminins
beta1 and gamma1, for example. In contrast, native oral mucosa
expressed high amounts of RNA of ADAMTS18, ADAMTS20,
ADAMTS6, ADAMTSL1, collagen 14, fibrillin 3, laminin beta4
and matrilin. Expression of more than 100 genes was similar for
native and artificial tissues. These results suggest that our artificial
stroma is able to induce the cells to initiate an active process of
remodeling by synthesizing several extracellular products that
normally exist in native oral mucosa controls.
Supported by CTS-06-2191 and CM2005/011 from Junta de
Andalucia.
(OP 278) Synthetic Fibrin-Like Matrix for Bone Tissue En-
gineering
F.E. Weber1, M.P. Lutolf2, S. Rizzi3, J.A. Hubbell2, M. Ehrbar1
1Section Bioengineering, Center for Dental and Oral Medicine
and Cranio-Maxillofacial Surgery, University Zurich and De-
partment of Cranio-Maxillofacial Surgery, University Hospital
Zurich, Zurich Switzerland
2Institute of Bioengineering, Ecole Polytechnique Fe´de´ral de
Lausanne (EPFL), Switzerland
3School of Life Sciences, University of Technology (QUT),
Brisbane, Australia
Materials from natural sources were successfully used as cell de-
livery or tissue regeneration devices in medical applications due
to their innate biological properties. Synthetic extracellular matri-
ces (ECM) represent interesting alternatives for biopolymers as
they can be specifically designed with respect to their mechanical
properties, susceptibility to proteolytic activity and presentation of
cell adhesion ligands or morphogens. Here we present modularly
designed poly(ethylene glycol) (PEG)-based hydrogels that are
formed by Factor XIII (FXIII) catalysis. The new class of bio-
materials enables the formation of matrices containing multiple
tethered bioactive molecules and cell-responsive enzymatic sub-
strates in a simple one step reaction. In the context of bone tissue
engineering we have designed the system to contain building blocks
that include enzymatically coupled cell adhesion ligands, the os-
teogenic growth factor BMP-2 and slow released VEGF. In this
growth factor combination vascular and bone formation should be
improved. In contrast to materials from natural sources these novel
artificial ECMs allow the nearly independent control of properties
including matrix stiffness, protease susceptibility and presentation
of biological cues. The tailoring of these properties in a wide range
enables us to rationally control cell behavior in both in vitro and
in vivo contexts. These matrices could be useful tools for experi-
mental cell biology as well as for in vivo applications such as bone
tissue regeneration.
We thank for support by SNF Switzerland, Inion OY, Tampere,
Finland, and microcomputed tomography by Prof. R. Mu¨ller, In-
stitute for Biomedical Engineering, ETH Zu¨rich
(OP 279) Tendon Regeneration with Fat Derived Stem Cells
A. Janousek1, C. Keibl1, G. Schueller1, A. Peterbauer1, T. Mor-
ton1, M. van Griensven1, H. Redl1
1Ludwig Boltzmann Institute for Experimental and Clinical
Traumatology and Austrian Cluster for Tissue Regeneration
This study investigates the treatment of tendon defects with
the help of autologous fat derived stem cells. In an in vivo rabbit
model the central third patella tendon defect was created. A single
step procedure, harvesting, preparation and implantation of stem
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cells, was chosen. Fatty tissue was separated from the surrounding
tissue and collagenase digestion was performed to isolate stem
cells. There were three treatment groups. The defect was filled with
a blood clot in group A, fibrin in group B and fibrin and adipose
derived stem cells in group C (n¼ 6 per group, per time point). A
three to seven millimeter defect in the central third of the rabbit
patella tendon was filled with one of the three solutions. After
three, five and eight weeks the experiment was terminated. Gene
expression profiling was performed with reversed transcriptase
PCR for collagen type I, aP2, Tenascin X and GAPDH. Probes
were taken in the surrounding tissue as well as in the defect.
Our results showed significant increase in gene expression of
collagen type I, aP2 and Tenascin X after five weeks in group C in
comparison to group A and B.
We conclude that implanted fat stem cells lead to high cell
activity in the tendon defect. Fat related marker PCR shows also a
significant increase. In further studies stem cells should get some
tendon specific predifferentiation. Grants: Expertissues, Lorenz
Boehler Funds.
(OP 280) The Biocompatibility and Immunogenicity of Self-
Assembling Peptides for Use in Tissue Engineering and Re-
generative Applications
S.P. Wilshaw1, A. Aggeli2, J. Fisher1, E. Ingham1
1Institute of Medical and Biological Engineering, University of
Leeds, Leeds, West Yorkshire, UK.
2Centre for Self-Assembling Systems, University of Leeds, Leeds,
West Yorkshire, UK.
Introduction: Previous work has established criteria for the for-
mation of hydro gels from chemically synthesised self-assembling
beta-sheet peptides under physiological conditions. This enabled
the design of peptides that spontaneously self-assemble into scaf-
folds of potential utility in tissue engineering and regenerative
applications.
The aim of this study was to determine biocompatibility and
immunogenicity of two rationally designed self-assembling pep-
tides.
Methods: Biocompatibility was determined using primary hu-
man fibroblasts and L929 cells in vitro. Immunogenicity of P11-4
or P11-8 was determined in a) naive BALBC mice b) mice im-
munised with peptide c) mice immunised with keyhole limpet
hemocyanin (KLH) -conjugated peptide. Antibodies levels against
the peptides were determined by ELISA. Lymphocyte respon-
siveness was determined in lymphocyte proliferation assays. Ser-
um antibody titre to the peptides and peripheral blood lymphocyte
proliferation in response to the peptides was determined in six
human volunteers.
Results and Conclusions: Following culture with human and
murine cells P11-4 or P11-8 demonstrated no cytotoxicity. Naive
mice possessed no antibodies against P11-4 or P11-8 and no lym-
phocyte response was demonstrated. Mice immunised with peptide
alone did not demonstrate a lymphocyte response and antibodies
against P11-4 or P11-8 could not be detected in serum. Mice im-
munised with KLH conjugated peptide did not demonstrate a
lymphocyte response but an antibody titre of 1/64 was measured
against P11-4 and P11-8. Human volunteers demonstrated no prior
sensitisation to the peptides.
(OP 281) The Development of Biomimicking Silk Scaffold for
Ligament Tissue Engineering
Fan Hongbin1, Liu Haifeng1, Goh James1,2, Toh Siew Lok2,3
1Department of Orthopaedic Surgery, National University of
Singapore
2Division of Bioengineering, National University of Singapore
3Department of Mechanical Engineering, National University of
Singapore
Although most in vitro studies indicate that silk is a suitable bio-
material for ligament tissue engineering, in vivo studies of implanted
silk scaffolds for ligament reconstruction are still lacking. The ob-
jective of this study is to investigate anterior cruciate ligament
(ACL) regeneration using mesenchymal stem cells (MSCs) and silk
scaffold. The scaffold was fabricated by incorporating microporous
silk sponges into knitted silk mesh, which mimicked the structures of
ligament extracellular matrix (ECM). In vitro culture demonstrated
that MSCs on scaffolds proliferated vigorously and produced
abundant collagen. The transcription levels of ligament-specific
genes also increased with time. Then MSCs/scaffolds were im-
planted to regenerate ACL in vivo. After 24 weeks, histology ob-
servation showed that MSCs were distributed throughout the
regenerated ligament and exhibited fibroblast morphology. The key
ligament ECM components including collagen I, collagen III, and
tenascin-C were produced prominently. Furthermore, direct liga-
ment-bone insertion with typical four zones (bone, mineralized
fibrocartilage, fibrocartilage, ligament) was reconstructed, which
resembled the native structures of ACL-bone insertion. The tensile
strength of regenerated ligament also met the mechanical require-
ments. Moreover, its histological grading score was significantly
higher than that of control. In conclusion, the results imply that silk
scaffold has great potentials in future clinical applications.
(OP 282) The Development of Urinary Bladder Matrix-Fibrin
Hybrid Scaffolds and the Effects of Cyclical Hydrostatic
Pressure.
F. M. Shaikh 1,2, A. Callanan 2, E. G. Kavanagh 1,2, P. E. Burke 1,2,
P. A. Grace 1,2, T. M McGloughlin2
1Department of Surgery, Mid-Western Regional Hospital, Lim-
erick, Ireland
2Centre for Applied Biomedical Engineering Research, MSSI,
University of Limerick, Limerick, Ireland
Designing an artificial scaffold that can successfully control three
dimensional cellular remodelling and tissue growth is still a pre-
dominant challenge in tissue engineering. We have previously
shown that hybrid scaffolds prepared from porcine urinary bladder
matrix (UBM) and fibrin has potential as vascular scaffolds.
However, it is unclear if our novel scaffold will withstand the
mechanical forces in the circulatory system. Here we examined the
effects of cyclical hydrostatic pressure on endothelial cells co-
cultured on hybrid UBM-fibrin scaffolds and attachment of fibrin
on UBM scaffolds.
Human Umbilical Vein Endothelial Cells (HUVECs) were
grown on hybrid UBM and fibrin scaffolds. Seeded hybrid co-
constructs were exposed to either atmospheric or pulsatile pressure
(50/110 mmHg) inside bioreactor for 24 hours. Various aspects of
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cellular growth were analyzed using immuno-florescence and
MTT based cell count kit 8. Attachment tests were carried out
using a tensile testing machine.
Experiments show that cell survival in this system is comparable
with that seen in the controls. After application of cyclical physi-
ological pressure, cell morphology appeared to change, with cells
appearing more organized. There was no significant difference in
the growth of cells in the two groups of experiments. The attach-
ment test showed that the failure load of 0.08 N was required to
dislodge the fibrin material. This is below the levels of wall shear
stress present in an arterial wall.
The successful development of UBM- fibrin hybrid scaffold
cultured with endothelial cells under physiological pressures es-
tablishes a stable platform for in-vivo investigations of this novel
hybrid scaffold.
(OP 283) The Effect of Donor Antigen-Pulsed Dendritic Cells
on Survival of Skin Allograft in a Rat Model
S.C. Eun1, J.H. Kim1, C.Y. Heo1, R.M. Baek1, H. Chang1, K.Y.
Minn1
1Department of Plastic and Reconstructive Surgery, College of
Medicine Seoul National University, Korea
Prevention of acute rejection in skin allografts without continu-
ous immunosuppression lacks reports in worldwide literature. Need
for chronic immunosuppression precludes the use of tissue allo-
graft as a routine surgical reconstructive option. Recently dendritic
cells(DC) gained considerble attention as antigen presenting cells
that are also capable of immunologic tolerance induction. This
study assesses the effect of alloantigen-pulsed dendritic cells in
induction of survival increase in a rat skin allograft model.
Recipient derived dendritic cells were harvested from rat whole
blood and cultured with GM-CSF and IL-4 for 2 weeks. Then
donor-specific alloantigen pulsed dendritic cells were reinjected
into tail vein before skin graft. Rat dorsal skin allografts were
transplanted in 5 subgroups. Groups: I) untreated, II) anti-lym-
phocyte serum (ALS, 0.5 ml), III) FK-506(2 mg/Kg), IV) DCp, VI)
DCp and FK-506. Graft appearance challenges were assessed
postoperatively. The group V(DC and FK-506 treated) showed
longest graft survival rate(23.5 days) than other groups; untreat-
ed(5.8 days), ALS(7.2 days), FK-506(17.5 days), DCp(12.2 days).
Donor antigen pulsed host dendritic cell combined with short-term
immunosuppression prolong skin allograft survival and has po-
tential therapeutic application for induction of donor antigen spe-
cific tolerance.
(OP 284) The Effect of Surface Mechanics on Cell Function
and Dynamics
Miriam Rafailovich1, Zhi Pan1, Ying Liu1, Kaustabh Ghosh2,
Richard Clark1, Glenn Prestwich3, Victoria Huang2
1Stony Brook University
2Harvard University
3University of Utah
Surface mechanics can play a pivotal role in cell function, prolif-
eration, and migration. In order to understand this role, we per-
formed a comprehensive study on the effects of substrate mechanics
on dermal fibroblasts cultured on functionalized HA hydrogels,
where the mechanics are controlled by cross linking density. We
studied both flat surfaces, as well as electropsun hydrogel fibers.
Using Scanning Force Modulation Microscopy we measured the
relative modulii of live cells on these substrates and found that they
scale with surface rigidity. Confocal microscopy indicated that the
cells on the harder substrates were far better extended with large
actin fibrils and surface area, while those on softer substrates were
rounded with thinner actin fibrils and smaller surface area. Cell
migration studies showed that while individual cell velocities were
larger, mass migration was severely hindered on softer surfaces.
These results can be correlated with finite element analysis cou-
pled with digital image scanning correlation microscopy which
was able to measure the traction forces exerted by the cells on
the different substrates. The results showed that while cells on
the softer substrates exerted the smallest traction forces, the force
gradients on the surfaces with intermediate mechanical response
produced the optimal conditions for single cell migration. Based on
these findings, we were able to model the migration velocity as
the sum of two opposing terms; one is a function of the substrate
mechanics, while the second is an inverse function of the distance
between adjacent cells. Implications to oriented fibers will be
presented.
(OP 285) The Effects of Human Adipose-Derived Stem Cells
on T-Cell Mediated Immune Response
I.W. Lee1, H.K. Cho1, H.S. Kim1, H.H. Ahn1, J.H.Yang1, J.S.
Lee1, H.J. Lee1, H.B.Lee2, G.S. Khang3
1Catholic University of Korea
2Korea Research Institue of Chemical Technology
3Chonbuk National University
Mesenchymal stem cells derived from adult bone marrow or adi-
pose tissue are known to be less immunogenic and immunosup-
pressive. But the detail of immunologic effect of adipose-derived
stem cells (ADSCs) is not revealed yet. This study is aimed to
investigate the effect of ADSCs on lymphocytes proliferation and
the production of cytokines in vitro. The ADSCs extracted from
omental or subcutaneous fat were expanded and the phenotype of
the ADSCs was identified by cell surface markers using flow cy-
tometry: positive for CD29 and CD44, but negative for CD34,
CD45, CD117 and HLA-DR. The ADSCs were able to differen-
tiate into osteoblast or adipocytes with induction media. Third-
party ADSCs added to mixed lymphocyte reactions(MLR) induced
overall suppressive effect on lymphocytes proliferation, but in part
stimulated, whereas the suppressive effect of ADSCs on the non-
specific lymphocyte proliferation provoked by PHA-A was to-
tally profound. The Stimulated Index was 11.69% to 156.5% in
MLR and 0.99% to 14.44% in PHA-A assay. The changes of cy-
tokines production were analyzed from the supernatant collected
during the lymphocyte proliferation reactions using ELISA. The
production of TNF-a, IL2, IFN-g was increased during the MLR
and PHA-A stimulation. Adding ADSCs, only the level of TNF-a
was decreased in MLR, whereas all of three cytokines was
decreased in PHA-A stimulation. The level of Th1 cytokines
such as IL-2 and IFN-g in MLR was significantly increased dur-
ing co-culture with ADSCs regardless of suppressive or stimu-
lated response.The effects of ADSCs on immunologic or
nonspecific lymphocyte stimulation different in extent and cyto-
kine regulation.
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(OP 286) The Impact of Tissue Engineering on Laboratory
Animals–an Ethical Assessment
R.B.M. de Vries1, B. Gordijn1
1Department of Ethics, Philosophy & History of Medicine, Rad-
boud University Nijmegen Medical Centre
Animal experiments play an essential role in the development of
the field of tissue engineering. Laboratory animals are used to
study the fundamental processes involved in tissue engineering and
they function as models of human disease and injury for testing
new products. Furthermore, some of these products contain xe-
nogeneic cells or materials. Significant from an animal-ethical
point of view, however, is that these uses further the in-
strumentalisation of animals and can cause them considerable
discomfort. Moreover, doubts can be and are raised about the ad-
equacy of the current animal models and therefore about the use-
fulness of the experiments.
On the other hand, human cells and human engineered tissue like
artificial skin are already applied as alternative methods to animal
use. If the promises of tissue engineering were to come to fruition,
the field might yield ever more refined products, maybe even whole
organs, that potentially could replace laboratory animals and
thereby would drastically decrease the need for them.
In my paper, I will try to assess both types of impacts of tissue
engineering on laboratory animals and discuss whether the latter
might be used as an argument to justify the former.
(OP 287) The Influence of RGD-Containing Peptides on Bone
Marrow Stromal Cell Phenotype
P. Kalia1, G. Perrett1, M.J. Coathup1, G.W. Blunn1
1Centre for Biomedical Engineering, Institute of Orthopaedics and
Musculo-Skeletal Science, UCL, Royal National Orthopaedic
Hospital, Stanmore, Middlesex, United Kingdom
It has been previously suggested that the cell culture substrate can
influence the maintenance of BMSC characteristics. We hypothe-
sized that human BMSC (hBMSC) attachment, cell surface marker
and integrin expression could be influenced by culture on a RGD-
bound cell culture substrate. Two RGD peptides (cyclic and linear),
as well as vitronectin (VN) and denatured collagen 1 (dC1) were
tested. For covalent bonding, two types of tissue culture plastic were
activated, and the peptides then attached at varying concentrations.
To assess cell attachment, hBMSCs were cultured on the surfaces
for 4 hours and then their adhesion plaques stained using an anti-
human vinculin antibody. A peptide dose was then selected based
upon vinculin plaque-forming ability and surfaces were treated at
this concentration. After 15 days of hBMSC culture, cells were then
stained for integrin subunit b1, integrins aVb3 and aVb5, as well as
the hBMSC surface markers CD73, CD105, and CD164. Marker
expression was analysed using flow cytometry. CB surfaces cova-
lently bound to either of the two peptides significantly improved
vinculin plaque formation ( p 0.05). Covalently attached peptides
performed better than when adsorbed ( p¼ 0.046 for the linear
peptide, and p¼ 0.035 for the cyclic peptide). There was no sig-
nificant difference between attachment methods in the VN and
dC1 groups. At 1000 and 1104 ng of peptide the highest levels of
vinculin plaques were observed. This dose of linear peptide in-
creased the expression of b1, integrins aVb3 and aVb5. Both the
peptide and dC1 reduced the the expression of CD73, CD105, and
CD164.
(OP 288) The Interaction Between Demineralized Bone Ma-
trix Scaffolds with Human Umbilical Cord Mesenchymal Stem
Cells for Bone Tissue Engineering
S. Honsawek1, D. Dhitiseith1, V. Phupong1, V. Parkpian1,
P. Yuktanandana1
1Faculty of Medicine, Chulalongkorn University
Mesenchymal stem cells are multipotential cells capable of dif-
ferentiating into osteoblasts, chondrocytes, adipocytes, tenocytes,
and myoblasts. Human umbilical cord contains stem cells that are a
rich source of primitive multipotent mesenchymal cells. Demi-
neralized bone matrix (DBM) has been widely used in orthopedic,
periodontal, and maxillofacial applications and extensively inves-
tigated as a material to induce new bone formation. The purposes of
this study were to characterize human umbilical cord mesenchymal
stem cells (UCMS) and to examine the interaction between DBM
scaffolds with UCMS. The altered gene expression during osteo-
genesis of UCMS was also investigated. UCMS were studied using
in vitro functional mesenchymal stem cell assay and were deter-
mined their cell surface antigen expression. Osteoblast differenti-
ation of UCMS was determined using alkaline phosphatase assay,
osteocalcin, and Von Kossa staining assay. Total RNA was iso-
lated from UCMS in the absence or presence of DBM scaffolds
and analyzed using osteogenesis cDNA gene expression array.
The selected genes were verified using reversed transcriptase-
polymerase chain reaction (RT-PCR). Analysis by flow cytometry
demonstrated that UCMS express cell surface antigens used to
define MSCs isolated from umbilical cord such as CD29, CD44,
CD90 and CD105. DBM-treated UCMS were differentiated into
osteoblasts that stained positive for alkaline phosphatase, miner-
alization (calcification) and expressed osteocalcin. When analyzed
by cDNA array and RT-PCR analyses, we found that the highly
upregulated genes were runx2, vdr, tgfb2, flt1 and smad2 whereas
the highly downregulated genes were smad7. These results indi-
cated that UCMS with DBM scaffolds could provide an alternative
approach for bone tissue engineering.
(OP 289) TheMillefeuille Principle: a New Approach to Tissue-
engineered Skin Reconstruction.
S. Van den Berge1, S. Dickens1, B. Hendrickx1, P. Vermeulen1,
J.J. Vranckx1
1Dept. of Plastic and Reconstructive Surgery—Laboratory of
Plastic Surgery and Tissue Engineering Research (LOPSTER)
Introduction: We previously presented our Millefeuille skin con-
struct, as a possible future tool for replacing lost or severely
damaged skin. We believe that focusing on constructs that come
with a potential for vascularisation, and are made up entirely of the
host’s own expanded cells, will diminish infection and rejection
rates in skin substitutes.
We tested the Millefeuilles more extensively in our porcine
model, and gathered some more insight in the construct’s ultra-
structure.
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Materials & Methods: Porcine fibroblasts and keratinocytes were
isolated from small skin fragments, expanded in vitro and grown
into sheets. In the meantime, blood outgrowth endothelial cells
(BOECs), a subset of endothelial progenitor cells (EPCs) were
harvested from peripheral blood samples, isolated and cultured.
In the next step, the Millefeuilles were prepared: multi-layered
fibroblast and keratinocyte sheets were superimposed, with BOECs
sandwiched between them.
The Millefeuille skin constructs were applied to full thickness
skin wounds in a pig model, and compared to various conditions,
with and without fibroblast sheets and/or EPCs.
Results: Reepithelialization rates in our Millefeuille-treated
wounds reached 100%, versus 41% in control wounds, in addition
to a lower contraction rate (19% vs 68%). Our Millefeuilles fur-
thermore increased the total lectin content in the wounds 3-fold,
compared to salines. Fibronectin content (and therefore a more
pronounced proangiogenic extracellular matrix) was even 4 times
higher than controls. Wounds treated with the laminated sheets
showed MT1-MMP levels up to 2.6 times higher than saline. The
EPC treated wounds displayed more regularly arranged vessel-like
structures.
(OP 290) The Role of Integrin Alpha5beta1 as Mechan-
otransducer in Chondrocytes Embedded in Agarose
L.M. Kock1,2, R.M. Schulz2, C.C. van Donkelaar1, A. Bader2,
K. Ito1
1Department of Biomedical Engineering, Eindhoven University of
Technology, The Netherlands
2Department of Cell Techniques and Applied Stem Cell Biology,
University of Leipzig, Germany
Recent studies have shown that integrins act as mechanoreceptors
in articular cartilage. In this study, we examined the role of integrin
a5b1 in the mechanoregulation of both ECM gene expression in
the short term and ECM protein synthesis in the long term.
Chondrocytes were isolated from full-depth porcine cartilage and
seeded in 3% agarose constructs. These constructs were loaded in
semi-confined compression with 15% strain at 0.33 Hz for 12 hours,
in the presence or absence of GRGDSP, which blocks integrin
a5b1 function, or GRADSP oligopeptide, as control. The levels of
mRNA for aggrecan, collagen-2 and MMP-3 were determined by
semi-quantitative PCR at several time points up to 24 hours post-
stimulation. Cell viability, dsDNA and sGAG content were deter-
mined at several time points up to 28 days post-stimulation.
The applied loading induced different temporal responses on
gene expression and ECM protein biosynthesis. The mRNA levels
for aggrecan and MMP-3 were increased immediately and 1 hour
after loading and GRGDSP counteracted these effects. In contrary,
the loaded groups demonstrated a significantly lower amount of
GAG over the entire culture duration, compared to the unstrained
control. Blocking the a5b1 integrin had no effect on the long-term
biosynthetic response.
The combined results confirmed the role of integrin a5b1 as
mechanotransducer in the regulation of GAG mRNA expression
for chondrocytes seeded in agarose under the applied loading
regime. However, this did not translate into more GAG rich
ECM matrix in the mechanically stimulated tissue engineered
constructs.
(OP 291) The Role of the Primary Cilia in Mediating Me-
chanically Induced Increases in Matrix Production During
Bone Tissue Engineering.
A. Sittichokechaiwut1, P. Tummala2, G. Reilly1, C. Jacobs2
1Tissue Engineering group, Department of Engineering materials,
University of Sheffield, U.K.
2Cells and Molecular Biomechanics Labolatory, Stanford Uni-
versity. U.S.A.
Dynamic mechanical loading is used to enhance matrix formation
in bioreactor culture of tissue engineered bone. When a cell seeded
porous scaffold is compressed in a bioreactor, substrate strain and
fluid flows are generated. Previously we have shown that dynamic
cyclic compression applied for 2 hours every 5 days induces matrix
formation by MLO-A5 osteoblastic cells. Primary cilia are sensory
organelles which translate extracellular mechanical cues into a
biochemical response, recently shown to be active in bone cells
(Malone, PNAS, 2007). We investigated the effects of fluid shear
stress on bone matrix production by osteoblasts with intact and
defective primary cilia. MLO-A5s were seeded on fibronectin
coated slides with 5104 cells per slide and subjected to dynamic
fluid flow at 2 Pa for 2 hours on day 3 of culture. Cilia function was
inhibited by knockdown of polaris, which is required for cilia
biogenesis and maintenance. Collagen content, assessed by Sirius
red on day 8, increased in flow groups compared with nonflow
groups, but the difference was eliminated in the absence of primary
cilia. Gene expression of osteopontin and type 1 collagen was
upregulated 2 fold by cells exposed to flow but there was no effect
of flow in the knockdown group. In conclusion, fluid flow induced
shear stress mediates bone matrix production by osteoblasts and
the primary cilium is involved in mechanotransduction of the flow
signal. Therefore, primary cilia may play an important role in
mechanically induced matrix formation during bioreactor culture
of tissue engineered bone.
(OP 292) The Synthetic Growth Surface Topography of Ultra-
Web Enhances Cell Culture Performance
Michael W. Briggs 1, Marie Bryhan2, Fawad Faruqi2, James
J. Cali3, Margareta Sutija4, Mary Sobol3, Jeffrey Ross5, Todd
Upton1
1Technical Applications, Corning Life Sciences
2Science and Technology, Incorporated
3Promega Corporation
4Corning Life Sciences, Corning BV, Europe
5In Vitro Technologies, SurModics, Inc
The extracellular matrix (ECM) is involved in modulating cellular
growth, development, and function through a complex array of
biochemical and physical cues.
The novel cell culture surfaces from Corning, Ultra-Web
Synthetic Surfaces are composed of randomly orientated electro-
spun polyamide nanofibers, and functionally mimic the architec-
ture of the ECM. In size Ultra-Web nanofibres (~280 nm) are
similar to collagen and other ECM fibers, this functional charac-
teristic provides nanotopography for cell attachment and growth,
which promotes in vivo -like cell responses. Ultra-Web Synthetic
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Surface is available with two surface chemistries:
1. Untreated electrospun polyamide nanofibers with an un-
charged slightly hydrophilic surface,
2. Polyamine treated electrospun polyamide nanofibers with a
positively charged surface for enhanced cell attachment, and co-
valently linking biomolecules.
In this study, we examined neurite outgrowth of neurons, dome
formation of kidney epithelial cells, spheroid formation of hepa-
tocytes, and, maintenance and differentiation of primary human
mesenchymal stem cells (hMSCs) on Ultra-Web surfaces. Speci-
fically, we compared the performance of synthetic nanofibrillar
surfaces to several other types of synthetic and biological sur-
faces. Each system demonstrated significant morphological or
functional improvements over traditional two-dimensional plastic
and coated alternatives. Additionally, the nanofibrillar surface was
compatible with several assay formats, including luminescence,
fluorescence-based calcium flux and cellular imaging. Together,
our data suggest that this new synthetic surface may provide a
unique means to achieve more physiologically relevant cell culture
results.
(OP 293) Therapeutic and Research Potential of Human Stem
Cells
S.L Minger1
1King’s College London
Stem cells offer great therapeutic potential for human disease
conditions where the loss of specific cell types is the major path-
ophysiological feature of individual disorders. Embryonic stem
(ES) cells derived from 6–8 day old human embryos offer the most
therapeutic potential as these cells are capable of generating every
cell and tissue type in the human body. If we can control the dif-
ferentiation of ES cells, then cell replacement for profound human
disorders such as Parkinson’s disease, insulin-dependent diabetes,
heart disease, stroke, multiple sclerosis, rheumatoid arthritis, spinal
cord damage, and macular degeneration could become standard
new therapies. This presentation will examine the state of the art in
the development of stem cell therapies and outline some of the
technical and ethical considerations as we progress toward clinical
and research application of human ES cells.
(OP 294) Time-Course Study of Cell-Cell Junctions Develop-
ment in Bioengineered Human Corneas
M. Gonza´lez-Andrades1, I. Garzo´n1, J.I. Mun˜oz-A´vila2, M.C.
Sa´nchez-Quevedo1, D. Serrano2, M. Alaminos1,2, A. Campos1
1University of Granada, Department of Histology
2Univ. Hospital San Cecilio, Granada, Spain
Introduction: One of the main challenges of corneal tissue engi-
neering is the development of an efficient substitute of the human
cornea. In this work, we have carried out a sequential study of
development and differentiation of intercellular junctions in partial
substitutes of the human cornea generated by tissue engineering.
Materials and Methods: Cultured human cornea epithelial cells
were cultured on top of artificial corneal stromas created by cul-
turing human keratocytes in fibrin-agarose hydrogels. Immuno-
fluorescence and scanning electron microscopy analyses of the
artificial corneal epithelium were carried out ex vivo at different
stages of development.
Results and Discussion: Sequential analysis of desmosome for-
mation revealed that immature corneas with one or two epithelial
cell layers did not show any cell-cell junctions. In contrast, mature
artificial corneas displayed a multilayered epithelium with a high
number of desmosomal junctions and a high expression of the
desmosomal proteins plakoglobin 3, desmoglein 3 and desmopla-
kin. Nevertheless, samples that had been incubated fully submerged
in culture medium preferentially expressed desmosomal proteins
in the most apical cell layers, whereas corneas cultured using
air-liquid culture techniques showed higher desmosomal protein
expression in intermediate cell layers, similar to normal human
control corneas. These results suggest that desmosomal forma-
tion and maturation was very similar for normal human control
corneas and partial corneal substitutes submitted to air-liquid cul-
ture techniques. Consequently, corneal substitutes developed in this
work could possibly be used as efficient partial human cornea
substitutes.
Supported by CTS-06-2191 from Junta de Andalucia.
(OP 295) Tissue Engineered Lung Using Somatic Lung Pro-
genitor Cells: a Potential Regenerative Lung Therapy
J. Cortiella 1,2, J.A. Niles1,3, S. Bynam 1, A. Cantu 1, M. McClure 1,
C. Fung 1, J.E. Nichols 1,3
1University of Texas Medical Branch Laboratory of Regenerative
and Nano-Medicine
2Department of Anesthesiology
3Department of Internal Medicine
The theory behind regenerative therapy is to obtain the ideal cell or
mixture of cells that will integrate itself within the existing lung
structure. One method of identifying the ideal cell is to create an
ex vivo system capable of recreating the native organ on a spe-
cialized matrix. Within the lung a specific cell type that is capable
of regenerating the lung has not been identified. Our research
shows that murine or human engineered bronchiole-alveolar tissue
developed from a mixture of somatic lung progenitor cells (SLPCs)
is self-sustaining in culture within a rotary bioreactor for 8 weeks.
Engineered tissues were examined using quantitative flow cy-
tometry to determine cell phenotypes and qRTPCR to show ex-
pression of TTF-1, SPC, PECAM-1. Expression of protein
products was evaluated by immunocytochemistry and western
blotting and included surfactant proteins A, B, C and D, Clara Cell
Protein 10 (CC10), alpha-actin and CD31. Cell types included but
were not restricted to Type I and Type II pneumocytes, Clara cells,
endothelial cells, neuroendocrine cells, smooth muscle and mucin
secreting cells cells. Engineered tissue constructs derived from
human SLPCs when engrafted onto the backs of nude mice pro-
duced type I and type II pneumocytes as well as endothelial
cells. SLPC derived tissue constructs produced from strain mat-
ched (C57Bl6) mice that were implanted into the pleural space
survived and retained the presence of type I and II pneumocytes
after 10 days. Autologous SLPC derived sheep tissue constructs
after implantation also developed into cell types found in the distal
lung.
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(OP 296) Tissue Engineered Vascular Prostheses
B.H. Walpoth1, M. Cikirikcioglu1, D. Mugnai1, J.C. Tille1,
R. Pfister1, A. Kalangos1, G.L. Bowlin2
1Cardiovascular Surgery, Pathology, University of Geneva,
Switzerland
2Biomedical Engineering, Virginia Commonwealth University,
Richmond, USA
Objectives: Patency of shelf-ready small calibre vascular pros-
theses is still sub-optimal. Vascular tissue engineering may be a
new approach for improving vascular prostheses, however, bio-
degradable scaffolds are needed. The purpose of our study was to
evaluate biocompatibility and thrombogenicity of the following
electro-spun nanofibre polymer grafts: poly-dioxanone(PDS) co-
polymer with polylactic-acid(PDS-PLA) or co-polymer with
polycaprolactone(PDS-PCL) and to assess their in vivo vascular
remodelling.
Methods: These medical grade polymers were selected because
of biomechanical strength, surgeon’s handling, degradation, cel-
lular ingrowth and tissue reaction in subcutaneous and vascular
implantation models. In 27 Sprague Dawley rats, 2 mm-ePTFE
grafts (n¼9 controls), 2 mm-PDS-PLA grafts (n¼ 9) and 2 mm-
PDS-PCL grafts (n¼ 9) were interposed in the infrarenal abdom-
inal aorta for 3, 6 and 12 weeks. Digital substraction angiography
was performed for patency assessment before euthanasia and grafts
were harvested for morphologic and scanning electron microscopic
examination.
Results: Patency rates were excellent for all types of grafts
(100%). Angiography at follow-up showed aneurysmal formation
in one of three PDS-PLA grafts and none in PDS-PCL grafts. The
neoendothelialization measured by morphometry was significantly
increased in PDS-PLA and PDS-PCL compared to ePTFE grafts at
3-weeks (p< 0.01).
Conclusions: Patency of small calibre electrospun PDS-PLA and
PDS-PCL grafts is excellent. Despite timely cellular ingrowth and
neo-matrix formation, aneurysm formation still represents a major
problem for degradable synthetic vascular grafts. Therefore, com-
binations or wrapping of the grafts with slower degrading polymers
or new co-polymer combination, such as PDS-PCL are showing
promising results. In conclusion, biodegradable, electrospun PDS-
based polymer prostheses may represent a good alternative for
future tissue-engineered vascular grafts.
(OP 297) Tissue Engineering of Peripheral Nerves: Guidance
of Axons on Pre-Aligned Schwann Cells on Polymer Filaments
B. Schlosshauer1, B. Koenig1, L. Dreesmann1, M. Hoss2,
M. Dauner2, M. Doser2
1NMI Natural and Medical Sciences Institute, Reutlingen, Ger-
many
2ITV, Denkendorf, Germany
The peripheral nervous system is capable to regenerate lesioned
nerves because most cells of the nerve tissue remain viable. De-
teriorated axons can regenerate if the continuity of the nerve tissue
is preserved. Within the nerve axonal regrowth occurs along
thousands of aligned Schwann cell (SC), so called bands of
Buengner. To improve the therapeutic performance of synthetic
implants used to bridge nerve gaps we have developed biohybrid
bands of Bu¨ngner inside nerve guides.
30mm thick micro-structured poly-caprolactone (PCL) filaments
were produced by a melt extrusion process. Each endless fila-
ment had six longitudinal micro grooves. To overcome the non-
permissiveness of the polymer filament surface, different plasma
treatments and subsequent coatings with a synthetic polyamine and
an extracellular matrix protein were investigated. Seeding of pre-
treated PCL filaments with SCs resulted in longitudinal cell
alignment. A metabolic labeling techniques revealed that SCs re-
tained their proliferation potential. When dorsal root ganglions
were explanted onto SC-seeded filaments, a highly oriented axonal
outgrowth could be induced.
Implantation of cell-free-PCL filaments into lesioned sciatic rat
nerves resulted in complete coverage of the implant by invading
cells. In order to foster SC immigration we analyzed SCs in vitro
and found that recombinant neuregulin-1 (NRG-1) accelerated cell
migration. Therefore, the future addition of NRG-1 to nerve guide
tubes with PCL filaments might accelerate SC recruitment from
both neighboring nerve endings and in turn aid axonal regeneration.
Funded by BMBF 0313728 A,B
Biotech. Bioeng. (2006) 93, 99–109; Biomaterials (2007) 27,
1425–36; Neurosurgery (2006) 59, 740–748.
(OP 298) Tissue Engineering Strategies for Vascularization
D. Kaplan1
1Tufts University, Department of Biomedical Engineering, Med-
ford, Massachusetts 02155, USA
One of the major challenges in the field of tissue engineering re-
mains ‘size’. How to engineer sufficiently large tissue systems
in vitro for utility in vivo, where scale and integration in vivo are
meaningful. This challenge is due to metabolic oxygen demands by
the cells used in the process coupled with diffusion limitations of
oxygen and nutrients within tissue constructs. With advances in
biomaterials designs and control, cell biology, cell signaling and
bioreactor features, we have been probing these issues with a variety
of approaches to improve the scaling and size of tissues grown
in vitro. Further, an Improved understanding of matrix-cell inter-
actions has provided new direction to the design and study of bio-
material scaffolds to direct cell and tissue outcomes in vitro and
in vivo. The ability to deliver appropriate topography, structure and
chemistry to cells to direct their fate is emerging as a useful strategy
relevant to functional tissue formation. Toward the goal of tissue
vascularization in vitro, we utilize fibrous protein scaffold systems
(e.g., collagens, silks) and control material processing to generate
options for tissues. Our specific areas of interest include novel bio-
degradable microfluidic systems to house vascular networks, new
modes to form mechanically robust vascular tubing for co-culture
studies, and new modes to use co-culture to generate vasculature
networks. Some of these examples will be described to highlight
the importance of matrix design, cell interactions and bioreactor
considerations in the context of functional tissue engineering.
(OP 299) Tissue Engineering with Primary Cultures and Cell
Lines on Different Scaffold and Implant Materials
H.F. Hildebrand1, F. Chai1, J.C. Hornez2, F. Monchau2, M. Des-
camps2
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1Lab of Biomaterial Research, UPRES EA 1049, Faculte´ de
Me´decine, 59045 Lille–France
2Laboratoire des Mate´riaux et Proce´de´s (LMP), EA 2443, UVHC,
59600 Maubeuge - France
Most implant materials can often also be used as scaffolds for
tissue engineering. The present work considers Hydroxyapatite
(HA) for bone substitutes and bone engineering scaffolds activated
by cold plasma treatment for further drug/bioactive molecule
loading.
In this study, HAs with specific internal pore sizes and porosities
were elaborated by varying the sinter temperature and/or adding
graphite and PMMA as porogenous agents. The micro-, meso- and
macro-porous HA samples were obtained with internal pore size of
1–10 mm, 10–50mm and 400 mm respectively. The biological tests,
concerning cell viability, proliferation and morphology (SEM), and
the cytochemical staining of actin and vinculin, were conducted
with MC3T3-E1 osteoblasts. An applying example of above ma-
terial was given by the study on the different antibiotics (ATBs)
loading directly or after cold plasma treatment under different
conditions. ATB loading amount and their kinetic antibacterial
effectiveness have been assessed by UV spectrophotometry and
bacteria inhibition tests.
The biological tests confirmed the excellent cyto-compatibility of
HA fabricated by our technique. All samples, in particular micro-
porous HA, showed a higher proliferation than the TCPS controls.
Cytochemical staining revealed a well-developed cytoskeleton and
organized focal adhesion contacts. By direct impreganating with
ATBs (vancomycine, ciprofloxacine or gentamycine), micro-porous
HA showed significantly higher ATB adsorption capacity, and pro-
longed ATB release time with anti-bacterial effects under physio-
logical conditions, comparing with dense and meso-porous HA.
Moreover, these efficiencies of bioactive molecules loading could
be further improved by physical or chemical treatments such as
cold plasma under 50%O2–50%He/NH3 atmosphere prior to im-
pregnation.
(OP 300) Towards an Intraoperative Engineering of Osteo-
genic and Vasculogenic Grafts with Freshly Isolated Human
Adipose Tissue-Derived Cells
A.M. Mu¨ller1, D.J. Scha¨fer1, M. Jakob1, M. Heberer1, M. Leh-
micke2, A. Scherberich1, I. Martin1
1ICFS, Department of Biomedicine, University Hospital, Basel,
Switzerland
2Synthes Biomaterials, West Chester, PA, USA
We recently demonstrated that perfusion of human adipose-
derived cells (ADCs) for 5 days through ceramic scaffolds estab-
lishes a three-dimensional culture system of osteoprogenitor and
endothelial cells and generates osteogenic-vasculogenic constructs.
We here investigated the principle of an intraoperative approach,
with cell harvesting, their seeding in scaffolds and subsequent
grafting of constructs within the same surgical procedure.
ADCs were enzymatically isolated from adipose samples of 7
healthy donors, yielding 2105 1.5105 nucleated cells per ml
of tissue, of which 8% 6.5% were clonogenic as determined by
CFU-f assays. 27 4% of freshly isolated ADCs expressed mes-
enchymal (CD105 and CD90) and 43 34% endothelial (CD31
and CD34) markers, as determined by cytofluorimetry. Freshly
isolated ADC were embedded in fibrin (Baxter, Vienna, Austria)
and wrapped around tricalciumphosphate (ChronOs, Synthes) or
hydroxyapatite (Engipore, Finceramica, Faenza, Italy) cylinders.
ADC-fibrin-scaffold constructs were then immediately implanted
subcutaneously in nude mice for eight weeks. In vivo, human
CD34þ endothelial progenitors formed functional, irrigated blood
vessels inside the construct. The human mesenchymal progenitors
formed a dense matrix positive for BSP with some morphological
similarity to osteoid tissue in areas initially loaded with human
clonogenic cells. However, obvious bone formation was not ob-
served in hematoxylin/eosin staining of tissue sections.
Here we provide evidences that intraoperative engineering of
autologous cell-based vasculogenic bone graft substitutes could be
achieved by wrapping an ADC-fibrin gel around ceramic-based
scaffolds. Further studies are necessary to determine whether the
engineered constructs, implanted in a relevant orthotopic model,
would be able to induce de novo formation of bone tissue.
(OP 301) Towards Prosthetic Replacement of Bruch’s Mem-
brane: Comparison of Polyester and Electrospun Nanofiber
Substrates.
B.V. Stanzel1,2,3, M. Englander 1, D.J. Strick 4, M.S. Blumenkranz 1,
S. Binder 2, M.F. Marmor1
1Department of Ophthalmology, Stanford University, Stanford,
CA, USA
2L. Boltzmann Institute for Retinology and Biomicroscopic La-
sersurgery, Vienna, Austria
3University Eye Hospital Bonn, Bonn, Germany
4Department of Genetics, Stanford University, Stanford, CA, USA
Purpose: Replacement of the Retinal Pigment Epithelium (RPE)
could be beneficial in Age-related macular degeneration (AMD),
but may not be effective if Bruch’s membrane (BM) is damaged.
We explore two biocompatible substrates that simulate properties
of BM.
Methods: Polyester culture inserts (PET) are 10mm thick and
permeable (Corning). Commercial electrospun polyamide nanofiber
(EPN) inserts are adherent to impermeable plastic (Donaldson). The
EPN can be detached from the plastic with ethanol to obtain free and
thus permeable EPN. Scanning electron microscopy (SEM) studies
were performed on all growth substrates. Fetal and aged adult human
RPE cells were cultured on above substrates. RPE marker proteins
were studied using immunofluorescence and immunoblotting.
Results: PET is a smooth surface with widely-spaced small
pores: in contrast, EPN is a fibrillar meshwork with potential fluid
transit everywhere. The EPN surface can show either flattened or
rounded nanofibers, depending on whether that side had been at-
tached to plastic or free. On PET, fetal cells remelanized and
maintained a hexagonal monolayer over 3 months. Fetal cells grown
on commercial (impermeable) EPN also showed typical RPE char-
acteristics. In preliminary experiments, aged RPE showed better
differentiation on commercial EPN than PET. Free (permeable)
EPN was less supportive. Confluent fetal RPE monolayers broke up
into a lattice pattern at days 5–7, but showed somewhat better
attachment on flattened (as opposed to rounded) fibers
Conclusion: Permeable PET and impermeable EPN support
differentiation of RPE cells. An increased flat surface for cellular
attachment improves maintenance of an RPE layer on a permeable
substrate.
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(OP 302) Transcriptional Regulation of Regenerative Gene
Expression by Biomechanical Activation of Chondrocytes-
PCL Constructs
S. Agarwal1, J. Nam1, B. Rath1, P. Perera1
1The Ohio State University, Columbus, OH USA
Biomechanical activation of tissue engineered grafts is important
for musculoskeletal tissue that are dynamically loaded in vivo.
However, the intracellular mechanisms that are activated by bio-
mechanical signals are little understood. We hypothesized that
biomechanical forces act on cell-scaffolds in two ways, (i) induce
expression of regenerative genes associated with cell proliferation
and differentiation, and (ii) suppress transcriptional activation of
proinflammatory genes expressed at the site of injury. To prove
this hypothesis, chondrocytes were cultured on 3-D microfiber
polycaprolactone scaffolds for 6 days, and subjected to dynamic
compression (15% strain, 0.5 Hz). To depict the injured tissue en-
vironment, constructs were exposed to interleukin-1beta (IL-1).
Examination of gene expression demonstrated that compressive
forces significantly upregulate SOX-9, aggrecan, collagen type II,
and BMP-2 mRNA. Simultaneously, compressive forces suppress
IL-1b-induced expression of cyclooxygenase, IL-1, MMP-1 and
MMP-13, suggesting that these signals are also antiinflammatory.
More importantly, compressive forces upregulated reparative genes
in the presence of IL-1b. Further examination of the intracellular
signaling showed that compressive forces inhibit IL-1b-induced
nuclear translocation of NF-kappaB by suppressing I-kappaB ki-
nase phosphorylation by its upstream kinases. Simultaneously, these
signals activate RAS GTPase activity, to activate C-myc and ELK-1
transcriptional activity via phosphorylation of ERK 1/2 to upregulate
cell proliferation and aggrecan expression. Thus, our findings pro-
vide the evidence that of biomechanical signals are critical in up-
regulating regenerative potential of chondrocyte in PCL scaffolds
despite the inflammatory environment surrounding the implant in
the injured tissue. Acknowledgements: Grants AR04878, DE15399,
HD40939.
(OP 303) Translating Novel Scientific Findings into Re-
generative Therapies
J. Borstlap1, A. Lendlein2, G. Duda3, S. Mundlos4, M. Sittinger5,
U. Dirnagl6, J. Gerlach7, P. Reinke8, H.-D. Volk9
1Central Administration and Communication, Berlin-Brandenburg
Center for Regenerative Therapies
2Research Field Bio-Engineering, GKSS Research Center within
the Helmholtz Association
3Research Field Musculoskeletal System, Musculoskeletal
Research Center Berlin at the Charite´—Universita¨tsmedizin
Berlin
4Research Field Basic Research, Institute for Medical Genetics,
Charite´ and Max Planck Institute for Molecular Genetics, Berlin
5Translational Research, Tissue Engineering Laboratory at the
Charite´—Universita¨tsmedizin Berlin
6Research Field Nervous System, Clinic for Experimental Neu-
rology at the Charite´—Universita¨tsmedizin Berlin
7Research Field Liver Therapy, Clinic for Experimental Surgery
at the Charite´—Universita¨tsmedizin Berlin, Germany and Mc
Gowan Institute for Regenerative Medicine Pittsburgh, USA
8Research Field Immune System, Clinic for Nephrology and in-
ternistical Intensive Medicine, Berlin
9Director, Institute of Medical Immunology at the Charite´–
Universita¨tsmedizin Berlin
The Berlin-Brandenburg Center for Regenerative Therapies—
BCRT—is located at the Charite´—Universita¨tsmedizin Berlin and
is a joint initiative with Germany’s largest research organisation,
the Helmholtz association. This Center for Translational medicine
is funded by the Federal Ministry of Science and Education and is
supported by over 15 Regional research organisations.
The research program of the BCRT comprises work in five
medical research fields linked to overlapping platforms on basic
research, bio-engineering, and translational research. Initially, the
Center will put particular emphasis on research and clinical pro-
grams related to musculoskeletal and immunological applications,
since aspects of regenerative medicine are most advanced in these
areas at the Charite´ and are closest to clinical translation. In addi-
tion, the Center will also explore additional opportunities for re-
generative therapies in the cardiovascular system, nervous system,
and liver-related applications.
The BCRT is located in a newly reconstructed building at the
Charite´ Campus Virchow Clinic and will host 23 newly im-
plemented research groups (16 professorships), supplemented with
established groups from the respective research fields.
To advance novel therapeutic concepts from the lab bench into
the clinic, BCRT offers selected industry partners options for in-
teracting at different levels:
 EARLY ACCESS: Sponsors will receive early access to re-
search results and product candidates employing various
communication instruments.
 JOINT PROJECTS: Will be conducted as fee for service as
well as codevelopment projects with outcome sharing.
 STRATEGIC ALLIANCES:
Long-term exclusive co-developments in selected research
fields.
(OP 304) Transplanted Human Amniotic Stem Cells Survive
in the Rat Vascular Wall Following Endothelial Injury
Z. Lacza1, E. Kovacs1, G. Vacz1, A. Cselenyak1, Z. Cserep1,
R. Benko1, H. Redl2, M. Kollai1
1Semmelweis University Dep. Human Physiology and Clinical
Experimental Research
2Ludvig Boltzmann Institute for Traumatology, Vienna, Austria
Human amniotic epithelial stem cells (HAESCs) are newly dis-
covered sources of multipotent implantable cells which may be
harvested without ethical concerns. We hypothesized that these
epithelial cells can survive and inhibit neointima formation fol-
lowing acute endothelial injury. Adult male Wistar rats were an-
esthesized with Halothane and a balloon catheter was inserted into
the common carotid artery through the external carotid. The bal-
loon was inflated and deflated three times in order to induce en-
dothelial injury. Brome-deoxy uridine (BrDU) labeled HAESCs
were injected into the arterial lumen immediately after the removal
of the balloon. Forty eight hours after implantation HAESCs were
located at the luminal side of the damaged but not the intact artery.
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Three weeks after the injury constrictive neointima formation was
observed at a comparable level in transplanted and sham animals.
BrDU positive cells were found in the intact arterial wall but not at
the injured side. Moreover, acetilcholine-induced vasodilation was
preserved in the sham-transplanted injured arteries, but it was re-
duced in the transplanted vessels. We conclude that amniotic stem
cells are capable of surviving in another species without any im-
munosuppression, however, functional improvement is not related
to the presence of grafted cells.
Supported by OTKA D45933, T049621, TET A4/04, Bolyai and
Oveges Fellowships.
(OP 305) Ulvan: a New Natural Derived Biomaterial Obtained
from Renewable Marine Resources
A. Alves1,2, E.D. Pinho1,2, N.M. Neves1,2, J.M. Mano1,2, R.A.
Sousa1,2, R.L. Reis1,2
13B’s Research Group–Biomaterials, Biodegradables and Biomi-
metics, University of Minho, Campus de Gualtar, 4710-057
Braga, Portugal
2IBB—Institute for Biotechnology and Bioengineering, Braga,
Portugal
It is not hard to understand the commitment set in tissue engi-
neering research and the effort to find better performing materials.
The ultimate goal: an ideal scaffold with cell and tissue com-
pliant mechanical properties that supports cellular attachment,
growth and differentiation. In this study, a new natural derived
polysaccharide–ulvan–found at the cell wall of green algae Ulva,
the common sea lettuce, was investigated. The aim of this research
work is to study and develop novel biomedical applications based
on this polysaccharide, with special emphasis to tissue engineering.
The polysaccharide ulvan, composed of sulphated rhamnose, xy-
lose, glucoronic and iduronic acids, was isolated from Ulva batch
by step extraction using hot water and precipitation with organic
solvents. The obtained polysaccharide was then used to produce
polymeric films by solvent casting. As ulvan is soluble in water, a
crosslinking step was necessary to render the membrane insoluble
in water and more chemically stable at physiological conditions.
Membranes produced were characterized by SEM and FTIR-ATR;
swelling behavior and bioactivity was investigated and the me-
chanical performance assessed by both quasi-static tensile testing
and dynamical mechanical analysis. The properties of ulvan
structures studied in this work suggest a great potential of this
natural sulphated polysaccharide for the herein envisaged appli-
cations. The knowledge generated during this work about the
properties of this readily available polymer is a necessary and
important step to uncover innovative biomedical applications.
(OP 306) Upregulation of Mesenchymal Stem Cells Differ-
entiation and Proliferation in Coculture with Endothelial Cells
S.J. Bidarra. 1,2, C.C. Barrias1, M.A. Barbosa1,2, R. Soares3, P.L.
Granja1,2
1Instituto de Engenharia Biome´dica, Biomaterials Laboratory,
Porto, Portugal
2Faculty of Engineering, Universidade do Porto, Portugal
3Faculty of Medicine, Universidade do Porto, Laborato´rio de
Bioquı´mica, Portugal
Human mesenchymal stem cells (hMSCs) have been widely used in
bone tissue engineering due to their high proliferative potential,
their default osteogenic differentiation pathway, and their major role
in endochondral and intramembranous bone formation in vivo.
Studies with MSCs have demonstrated that these cells, growing in a
monolayer culture, differentiate into osteogenic pathway under
chemical stimulation. Also hMSCs osteogenic potential has shown
to be conserved through several subcultures and even after cryo-
genic preservation. The induction of MSC osteogenesis is a highly
programmed process that involves soluble factors as well as cell-cell
and cell-matrix contacts. This work aims to study the influence of
endothelial cells in the proliferation and differentiation of MSCs.
For this purpose hMSCs (Cambrex) were culture in direct contact
with human umbilical vein endothelial cells (HUVEC, ScienCell).
The cells were cocultured in 24 well plates during 4 weeks and at
several time points the hMSCs proliferation and differentiation were
evaluated. hMSCs number in the coculture was assessed by FACS.
Their differentiation was evaluated by alkaline phosphatase (ALP)
activity quantification and by ALP staining, as well by the expres-
sion of osteogenic gene markers. It was possible to observe a higher
proliferation in hMSCs in coculture than in monoculture. In co-
culture the ALP activity values were also higher and accompanied
by the increase of intensity in ALP staining. The gene expression of
the transcriptional factor Cbfa1 and of ALP was also upregulated in
coculture. These data seems to indicate that HUVECs stimulate
proliferation and enhance differentiation of hMSCs.
(OP 307) Using Native and Denatured Collagen Nanosurfaces
to Control the Attachment and Subsequent Mineralization of
Primary Cells and Cell Lines
A. Taubenberger1, M. Woodruff2, H. Bai2, D.J. Muller1, D.W.
Hutmacher3
1Cellular Machines, Biotechnology Center, Technical University
Dresden, Germany
2National University of Singapore, Republic of Singapore
3Institute of Health and Biomedical Innovation, Queensland
University of Technology, Australia
In bone tissue, collagen I is the major constituent of the extracel-
lular matrix and serves as an organic scaffold for the osteocytes,
mineral plates and non-collageneous proteins. It has further been
shown that the ex vivo expansion of bone marrow mesenchymal
stem cells on denatured collagen (gelatin) appears to preserve the
potential for osteogenic differentiation.
The present study characterizes the effect of two substrates,
namely collagen type I and gelatin, on the in vitro culture and
osteogenic differentiation of mouse calvaria pre-osteoblasts and
human adipose derived precursor cells. The main factors examined
are cell attachment, cell morphology and the extent of minerali-
zation by the cells.
The influence of the nano-structured substrates on the miner-
alization of the cultures after 28 days of osteogenic induction
was also studied. Similar levels of mineralization are observed
of pre-osteoblasts that are plated on collagen type I and tissue
culture plastic, which is used as a control. In comparison, there is a
greater extent of mineralization of both cell types that are plated on
gelatin.
These findings demonstrate that although the cells display a larger
spread area upon plating on collagen I, gelatin results in a stronger
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adhesion at very short contact times and enhance the mineralization
of the pre-osteoblasts after of osteogenic induction in vitro. There-
fore, it is suggested that the mechanisms of cellular adhesion to
collagen and gelatin are inherently different and consequently, in-
fluence the attachment, morphology and mineralization of the cells
to varying extents.
(OP 308) Validation of Transplantable Epithelial Cell Sheets
for Regeneretive Medicine
M. Yamato1, K. Nishida2, D. Murakami3, R. Takagi1, H. Namiki3,
T. Okano1
1Tokyo Women’s Medical University
2Tohoku University Medical School
3Waseda University
As we reported (Nishida et al. NEJM 2004), we have clinically ap-
plied transplantable epithelial cell sheets fabricated on temperature-
responsive culture surfaces to treat limbal stem cell deficiency. In
order to achieve the safe and reliable treatment, we have developed a
number of validations of fabricated cell sheets performed one day
prior to the transplantation including the maintenance of epithelial
stem/progenitor cells, differentiation exhibiting barrier functions as
well as mucosal properties, stratification and so on. Now, we are
going to propose the established validation protocols as domestic
and international standards to evaluate transplantable epithelial cell
constructs for the treatment. In the presentation, we’d like to show
the details of the validation protocols and discuss the utility and
expected roles in regenerative medicine.
(OP 309) Vascular Tissue Engineering: a Clinician-Scientist’s
Perspective
S. Homer-Vanniasinkam 1,2,3
1Professor of Translational Vascular Medicine, University of
Bradford
2Consultant Vascular Surgeon, Leeds General Infirmary
3Clinical Sub-Dean, Leeds Medical School
Atherosclerotic and congenital vascular disease has made it neces-
sary for surgeons to replace/bypass segments of diseased or dys-
functional vessels. Whilst the gold standard for bypass remains
autologous vein, increasingly this is not always available due to
either previous use or the vein being unsuitable due to disease eg
varicose veins. Hence, there has been a concerted effort by the
scientific community to develop a tissue engineered alternative with
properties similar to autologous vein. The first tissue engineered
blood vessel was produced over 20 years ago and since then, several
groups, including ours, have been working in this area using a
number of different techniques.
Recently, with the emergence of sophisticated tools such as
bioreactors, engineered scaffolds, cell sourcing techniques and
imaging methods, novel vascular products have been developed.
This talk will cover the different approaches to vascular tis-
sue engineering with emphasis on the integration of vascular bi-
ology into the design of these novel products. A clinical perspective
of the current status and future directions in this field will also be
given.
(OP 310) Vascularization Strategies in the Context of Tissue
Engineering
C. J. Kirkpatrick1
1REPAIR-lab, Institute of Pathology, The Johannes Gutenberg
University, Mainz, Germany
One of the essential determining factors for the success of tis-
sue engineering approaches is the ability to provide a rapid and
fully integrated vascular system to supply oxygen and nutrients to
the regenerating cells. Various solutions include the use of pre-
vascularized tissue flaps, incorporation of pro-angiogenic drug- or
gene-delivery systems into the biomaterial, pre-seeding with au-
tologous endothelial cells (EC) and, increasingly, adult stem cell
strategies. In all of these knowledge of the nature and control
mechanisms of the regenerative niche in the tissue of interest is
essential. Our research is focussed on employing in vitro tech-
niques with human cells to characterize the biology of endothelial
progenitor cells (EPC) and how circulating EPC could be recruited
to the regenerative niche in bone. It is still unclear what contri-
bution to the vasculature comes from EPC and from the in situ
microcirculation. Our recent data indicate that both EPC and mi-
crovascular EC can self-assemble to form vessel-like structures in
interaction with osteoblasts, also in the presence of porous bio-
materials of various classes (polymers, metals, ceramics) (1,2). As
yet unpublished work concerns in vivo studies in the nude rat
and mouse to investigate the survival capacity of pre-seeded EPC
on biomaterial scaffolds (silk fibroin) and hydrogel matrices
(Matrigel) and their possible integration into the pre-existing
microvasculature. Future work will study the possible role played
by circulating EPC.
The authors acknowledge EU support via the NoE EX-
PERTISSUES.
References:
1Fuchs S et al. Tissue Engineering 2007; 13: 2577
2Unger RE et al. Biomaterials 2007; 28: 3965
(OP 311) Versatile Polyurethane Scaffold Material for Tissue
Engineering
D. H. Wiese1, G. Maier1, U. Deisinger2, S. Hamisch2, T. Blunk3,
D. Tausendpfund3, J. Baumer3
1Polymaterials AG, Innovapark 20, D-87600 Kaufbeuren, Ger-
many
2Friedrich-Baur-Institut fu¨r Biomaterialien, Ludwig-Thoma-Str
36c, D-95447 Bayreuth, Germany
3Institute for Pharmaceutical Technology, University of Regens-
burg, Universtita¨tsstr. 31, D-93040 Regensburg
A set of 2K-polyurethane-systems as scaffolds for regenerative
medicine has been developed. Its properties can be customized in a
broad range to address different tissues. For the regeneration of soft
tissues (ranging from fat to cartilage) formulations have been chosen
that can be cast to an open-pore foam without a skin. The polymers
are made from aliphatic diisocyanates and different polyester-
polyols. The porosity and the surface properties can be adjusted by
biocompatible additives. If hard tissues like bone shall be re-
constructed, the material can be filled with up to 75% of ceramic
particles (preferably HAP or TCP). Scaffolds are built up by dis-
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pensor techniques. The mechanical properties of these scaffolds can
be varied by means of the ceramic content. The Young’s modulus is
between 900 and 1600 MPa, the flexural strength between 5 and
10 MPa. These values are comparable with those of trabecular bone.
Steam sterilization of both materials is possible.
The degradation time of the polyurethanes can be adjusted from
several months up to two years by variation of the polyol com-
position, the diisocyanate and fillers. A key factor is the hydro-
philicity of the building blocks. The pH during the degradation is
within a narrow range, even if the medium is not changed. No toxic
degradation products are observed.
The compatibility with differents cells (cartilage, bone, fat,
nucleus pulposus) and tissues has been proven. The constructs are
well integrated into the surrounding tissues at different implanta-
tions sites and induced the ingrowth of bloodvessels.
(OP 312) Visualization of Structural Evolution in Tissue En-
gineering Tendon
Y. Yang1, M. Ahearne1, P.O.Bagnaninchi1, A.J. El Haj1
1Institute for Science and Technology in Medicine, Keele Uni-
versity Medical School
Introduction: Birefringence, the main polarization property in
some biological tissues, is caused by a difference in index of re-
fraction, and is often exhibited by fibrous structures. We use the
level of birefringence as a mark to assess the structural evolution
of tissue engineering tendon during a prolonged culture period in
response to external cues by polarization optical coherence to-
mography.
Materials and Methods: Primary rat tenocytes were extracted
from young rats. A Flexcell Tissue Train Culture system was
used to mechanically stimulate tissue engineered tendon with
the aim of improving the production and alignment of collagen
within the tendon. The tenocytes (passage 2) were suspended
throughout the collagen solution prior to gelation. Four different
cell seeding density from 1106 cells/ml to 105 cells/ml were
examined. The tendon constructs were loaded cyclically for one
hour per day for 11 days or 14 days at 1% or 1.5% strain level and
1 Hz.
Results and Discussion: A progressive change in the ordered
matrix structure of the tendon constructs has been visualized by
PSOCT. Birefringence was detected when the tendon constructs
were subjected to the stretching where the loading was in the di-
rection of the collagen alignment. The level of birefringence in-
creased over time and with higher cell seeding density. It was also
noticeable that the constructs became thinner over time and that
there was a relationship between seeding density and structure of
the engineered tendons. PSOCT demonstrates a powerful on-line
tool for monitoring tissue growth and structural development in
tissue engineering.
(OP 313) ‘‘Smart’’ and Stimulus Responsive Chitosan-Based
Scaffolds/Cells for Bone Tissue Engineering: Influence of Ly-
sozyme Upon Scaffold Degradation and Osteogenic Differ-
entiation of Cultured Marrow Stromal Cells Induced by Cap
Coatings
A. M. Martins1,2,3, Q. P. Pham3, P. B. Malafaya1,2, R. M. Ra-
phael3, F. K. Kasper3, R. L. Reis1,2, A. G. Mikos3
13B’s Research Group—Biomaterials, Biodegradables and Bio-
mimetics, Department of Polymer Engineering, University of
Minho, Campus de Gualtar, 4710-057 Braga, Portugal
2IBB–Institute for Biotechnology and Bioengineering, PT Gov-
ernment Associated Laboratory, Braga, Portugal
3Department of Bioengineering, Rice University, 6100 Main
Street, Houston, Texas 77005-1892
The present study reports the use of non-porous, ‘‘smart’’ and
stimulus responsive chitosan-based scaffolds with the capability of
gradual in situ pore formation for bone tissue engineering appli-
cations. Biomimetic calcium phosphate (CaP) coatings were used
as a strategy to incorporate lysozyme at the surface of chitosan-
based materials the main objective of controlling their degradation
profile as a function of immersion time. In order to confirm the
concept, degradation tests with concentration similar to those in-
corporated into CaP chitosan-based scaffolds were used to study the
degradation of the scaffolds and the formation of pores as function
of immersion time. Degradation studies with lysozyme (1.5 g/L)
showed the formation of pores, indicating an increase of porosity
(~5% - 55% up to 21 days) resulting in porous 3-D structures with
interconnected pores. Additional studies investigated the influence
of CaP biomimetic coating on osteogenic differentiation of rat
marrow stromal cells (MSCs) and showed enhanced proliferation
and differentiation of rat MSCs seeded on the CaP coated chitosan-
based scaffolds with lysozyme incorporated with bone matrix pro-
duction and mineralization as demonstrated by calcium deposition
measurements. The ability of these CaP coated chitosan-based
scaffolds with incorporated lysozyme to create an interconnected
pore network in situ coupled with demonstrated positive effect of
these scaffolds upon osteoblastic differentiation of MSCs and min-
eralized matrix production illustrate the strong potential of these
scaffolds for application in bone tissue engineering strategies.
(OP 314) Adipose Tissue as a Reservoir of Regenerative Cells
L. Casteilla1, B. Cousin1, V. Planat1, P. Laharrague1, Ph. Bourin2
1UMR 5241 CNRS/UPS, IFR109, Toulouse, France
2EFS-MP, Toulouse, France
Beside the classic role of adipose tissue in plastic and recon-
structive surgery, the importance and the role of adipose tissues in
energy balance have been greatly expanded to endocrine tissue.
Some years ago, by analogy with mesenchymal stromal cells from
bone marrow (MSC), the discovery that various phenotypes can be
obtained from stroma cells of adipose tissue raises great hope in
cell therapy and regenerative medicine. Indeed and as well known,
such tissue can be easily harvested in adults and could represent an
abundant reservoir of regenerative cells. Although MSC and ASC
share common features, genomic, proteomic and functional studies
revealed clear differences and that both cells are distinct. ASC can
differentiate towards osteoblast, chondrocytes, skeletal muscles
but are also strongly angiogenic via paracrine effects and a true
endothelial potential. To go further in this way, we set-up GMP
conditions for ASC culture and gathered many pre-clinical data in
order to perform a clinical trial. However, many studies including
ours reveal the existence of rare cells among ASC with features
similar to true stem cells. One of the next challenges will be to be
able to sort these cells a priori. Altogether, these promising results
are attracting increasing groups and investigators and in the future
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could lead to consider adipose tissue as one of the referent tissues
for regenerative medicine.
(OP 315) Materiomics: Dealing with Complexity in Tissue
Engineering
C.A. van Blitterswijk1, D. Stamatialis1, H. Unandhar1, B. Papen-
burg1, J. Rouwkema1, R. Truckenmuller1, A. van Apeldoorn1,
M. Wessling1, J. de Boer1
1Departments of Tissue Regeneration and Membrane Technology,
University of Twente, The Netherlands
As the human body holds some 200 cell types that synthesize a
multitude of both soluble and solid actives in addition to a variety
of components that provide various means of mechanical support it
will be clear that extremely complex interactions stand at the basis
of the proper functioning of all tissues.With the increase of com-
plexity, certainly when this is associated with a, at best, only partial
understanding of the underlying mechanisms, special strategies
need to be applied to unravel or direct processes that result from
such complex interactions. Rather than striving for a full under-
standing of the underlying mechanisms upon which to base ones
actions, it might be more productive to rapidly screen a multitude
of approaches and select the one with the most optimal result.
Surprisingly, in tissue engineering this approach is still largely
unexplored.In this presentation, apart from a selective overview of
the current state of high throughput in tissue engineering, we will
discuss the production of large libraries of material geometries that
will allow us to screen thousands to millions of substrates. We
propose the name MATERIOMICS for the discipline of high
throughput methods in biomaterials and tissue engineering science.
(OP 316) Tailoring ‘‘Smart’’ Polymeric Surfaces
D. Cohn1, M. Malal1 and R. Malal1
1Casali Institute of Applied Chemistry, The Institute of Chemistry
The Hebrew University of Jerusalem, Jerusalem 91904, ISRAEL
The interface generated between all biomedical systems and their
physiological environment largely affects their biological perfor-
mance. In the Tissue Engineering field, the surface properties of
the scaffold play a crucial role in determining the outcome of the
tissue regeneration process.The temperature-triggered reversible
coiling and uncoiling of water-soluble polymeric chains grafted on
the surface of a substrate, represents a promising strategy to en-
gineer ‘‘switchable’’ surfaces. Following a concept initially set
forward by Okano et al using poly(NiPAAm) chains, this study
capitalizes on the temperature-triggered ability of poly(ethylene
oxide)-poly(propylene oxide)-poly(ethylene oxide) (PEO-PPO-
PEO) triblocks, to produce surfaces that can cause cells to gently
detach at unison, generating functional cell sheets to optimize
tissue regeneration.A diversity of reactive moieties can be gener-
ated on polymeric surfaces, by exposing them to different plasma
treatments and use them as anchoring sites for further derivatization
of the substrate.The PEO-PPO-PEO triblocks were grafted onto
the surface via diisocyanate spacers, after exposing the substrate
to plasma of ammonia, whereby amine groups were generated.
The present study describes the generation of these ‘‘switch-
able’’ surfaces, and investigates their composition and thermo-
responsiveness using various analytical techniques, such as XPS,
contact angle measurements and HR-SEM. Dendrimer-like surface
structures were built by exposing the substrate to multi-stage pro-
cesses comprising alternative plasma polymerization and deriva-
tization steps. The ability of these surfaces to allow cell grow at
37 degrees, while triggering the fast and efficient detachment of
organic cell sheets, was demonstrated.
(OP 317) Regenerative Medicine Perspectives and Possibilities
in the Technological and Clinical Area
A. Bader1, G. John1, J.-C. Ionita2, W. Brehm2, C. Weber3
1University of Leipzig, Cell Techniques and Applied Stem Cell
Biology
2University of Leipzig, Veterinary Faculty, Surgical Animal
Clinic
3Asklepios Clinic Hohwald
Regenerative medicine has led to completely new approaches and
possibilities in the treatment of illnesses and bodily damage. Re-
generative medicine makes use of the recovery potential already
available in the individual for example in the form of organ spe-
cific stem cells. There are various techniques and approaches
for generating tissue. They enable an adaptation to the individual’s
particular needs. As a result we are on the way to developing a
tailor-made therapy for some important symptoms. At the same
time technical systems come into use such as bioreactors, hybrid
systems (combination systems from two origins, e.g. for the liver
outside the body; autologous liver cells in synthetic balls) as well
as complete biological implants. Since autologous tissue is im-
munologically better tolerated than exogenous tissue, the main aim
remains of regenerating tissue in the living organism. Our research
area covers among other things the search for a biological bone or
rather cartilage replacement with autologous stem cells and mi-
neralising structures, for a biological liver replacement, for a
complete biological implant for a damaged heart, e.g. heart valves,
which will also grow in children as they grow. In addition medi-
cines and new types of growth factors have provided new forms of
therapies which can initiate regeneration in living tissue. Culti-
vating the tissue e.g. ex vivo, requires a sort of extracellular scaf-
fold of synthetic or of animal material. Living cells of the patient
are then cultivated in this so-called matrix. This cultivation is
carried out in a bioreactor which we specially designed for this
purpose. The restructure and replacement of the matrix in the
bioreactor with autologous tissue is then continued after the im-
plantation in the living organism.
(OP 318) Derivation of Chemically Defined, Serum-Free Cul-
ture Parameters for the Expansion and Phenotypic Main-
tenance of Clinically Important Lineage Committed and
Pluripotent Cell Types
N. Bryan1, N.P. Rhodes1, J.A. Hunt1
1University of Liverpool
Currently cell culture techniques rely on the presence of animal-
derived products as media supplements for the expansion of cell
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populations destined for implantation. This study replaced the re-
quirement for fetal calf serum during in vitro cell culture using an
array of chemically-derived or recombinantly synthesised products
to generate a media suitable for the growth of a range of cells rel-
evant for current clinical applications. This included bone marrow-
derived mesenchymal stem cells (MSC), a proven multipotent cell.
Media combinations were synthesised de novo using raw com-
ponents. Cells of primary human origin were seeded and passaged
in these media. Cell phenotype was characterised using a combi-
nation of flow cytometry and immunohistochemistry, visualised by
laser scanning confocal microscopy.
Defined media supported the expansion of cells including der-
mal fibroblasts, smooth muscle cells, osteoblasts and articular
chondrocytes up to 50 passages with proliferation rates comparable
to commercially available bespoke media. The defined media also
supported the proliferation and undifferentiated phenotype main-
tenance of several multipotent cells including MSCs and dental
pulp progenitor cells whose undifferentiated phenotype was char-
acterised by the presence of the intracellular markers Nucleostemin
and STRO1 and the putative extracellular marker subset CD29þ,
CD34, CD44þ, CD45, CD90þ and CD105þ.
The findings in this study have established the critical founda-
tions for overcoming the major regulatory requirements for the
progression of cellular therapies from flask to clinic by optimising
chemically defined pharmacopeia grade media, entirely devoid of
animal-derived components for the ex vivo expansion of cells
destined for therapeutic intervention.
(OP 319) Test and Validation of a Bioreactor for the Stimu-
lation of Engineered Cartilage Constructs with Combined
Regimens of Hydrostatic Pressure and Interstitial Perfusion
M. Moretti1,2,3, L.E. Freed2, R.F. Padera4, K. Lagana`3, M.T.
Raimondi1,3
1I.R.C.C.S. Galeazzi Orthopedic Institute, Milano, Italy
2Harvard-MIT Division of Health Sciences & Technology, Mas-
sachusetts Institute of Technology, Cambridge, MA, USA
3LaBS, Department of Structural Engineering, Politecnico di
Milano, Milano, Italy
4Department of Pathology, Brigham and Women’s Hospital,
Boston, MA, USA
During joint physiological loading in vivo, the complex mechani-
cal stimuli which act simultaneously on chondrocytes include
hydrodynamic shear stress, cell deformation and increased inter-
stitial pressure. Bioreactor systems represent valuable instruments
to investigate the roles of several culture parameters, although
single rather than combined stimuli have often been studied. The
present study tested and validated a bioreactor developed for cul-
turing tissue engineered cartilage in the presence of different levels
of hydrodynamic shear stresses and hydrostatic pressures. Primary
bovine chondrocytes were seeded on non-woven scaffolds. Con-
structs were cultured for 5 days in Petri dishes and then for 5
additional days as follows: Group-1 with interstitial perfusion (0.4
mL/min) combined with hydrostatic pressure (10 MPa, 1 Hz for 4
h/day), Group-2 with interstitial perfusion (0.4 mL/min) without
hydrostatic pressure, and Group-3 in static Petri dishes. A total of
112 cartilage constructs were studied in four independent experi-
ments. Cell viability, assessed as MTT/DNA, was significantly
higher (p< 0.01) in Group-1 than all other groups. Sulfated gly-
cosaminoglycans (sGAG) content was significantly higher in
Group-1 than Group-3 (p< 0.01, 626 85mg vs. 326 46mg);
sGAG content in Group-2 (425 59 mg) tended to be higher than
Group-3, but with no statistical significance. Histological analyses
were consistent with the performed biochemical analyses. After
only 5 days of stimulation, application of diverse mechanical sti-
muli successfully elicited different responses and resulted in higher
quality cartilaginous constructs than static culture. We successfully
validated a bioreactor for controlled application of different me-
chanical stimuli, which can lead to a more accurate definition of
tissue-forming environments and mechano-transdcution mechan-
isms.
(OP 320) Tisseel Fibrin Glue use in Spinal Surgery: Effects on
Bone Morphogenetic Protein Diffusion, Bone Morphogenetic
Protein-Stimulated Bone Growth, and Soft Tissue Swelling
V.V. Patel1, E. Burger1, E.M. Lindley1, L. Zhao2, P. Wong2,
B.B. Pradhan2, H.W. Bae2, L. Kanim2, R.B. Delamarter2
1The Spine Center at the University of Colorado Health Sciences,
Denver, CO
2The Spine Institute at St. John’s Hospital, Santa Monica, CA
Fibrin glue is used as a carrier of osteoinductive materials, in-
cluding recombinant human bone morphogenetic protein-2
(rhBMP-2), which has become an increasingly popular method for
augmenting fusion in the lumbar and cervical spine. However,
rhBMP-2 may ‘‘leak’’ from the placement site and stimulate un-
desirable bone growth in the spinal canal and neural foramina. In
addition, there have been some reports of soft tissue swelling after
rhBMP-2 use in cervical procedures. Thus, we conducted a series
of experiments to evaluate whether fibrin glue can limit rhBMP-2
diffusion in vitro and protect spinal nerves from rhBMP-2 stimu-
lated bone growth in vivo. Lastly, we also evaluated the edematous
effects of rhBMP-2 and fibrin glue in rabbit muscle tissue. For the
in vitro studies, rhBMP-2 soaked collagen sponges were encap-
sulated in Tisseel fibrin glue (Baxter Healthcare) and immediately
incubated in saline. Subsequent measures of saline rhBMP-2
concentrations showed that fibrin glue significantly limits, but does
not completely block, rhBMP-2 diffusion. To determine whether
fibrin glue can protect against detrimental bone growth, rats were
given laminectomies and fibrin glue was placed over the dura
and transverse processes/intertransverse space prior to rhBMP-2
placement. The results of this study showed that fibrin glue can
control rhBMP-2 stimulated bone growth and thus prevent unde-
sirable bone formation. Lastly, in a preliminary study, MRI ana-
lyses of rabbit muscle tissue implanted with rhBMP-2 soaked
collagen sponges and fibrin glue suggest that individually these
materials are not associated with increased edema. These findings
should be further investigated in human clinical studies.
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(P 1) Exploration of Transglutaminase 2 As a Biological Tissue
Glue
P.P. Paul1, Z. Dimitrios1, M. Raghunath1,2
1Tissue Modulation Laboratory, Division of Bioengineering, Fa-
culty of Engineering, NUS.
2Department of Biochemistry, Yong Loo Lin School of Medicine,
NUS.
Aim: The clinical caseload of surgical wounds is very high and
physicians have long sought an efficient biological method of
wound repair that requires little time and minimizes discomfort for
their patients, yet produces a good cosmetic outcome. Our aim is to
develop a biological tissue glue based on the extracellular matrix
stabilizing enzyme transglutaminase to covalently bond tissue
layers to promote suture-less closure of surgical wounds.
Methodology: Human skin samples were cryosectioned and
assayed for native transglutaminase activity using standardized
histochemical procedures. Availability of substrate sites in human
skin, with different brands of exogenous transglutaminases 2, was
assayed with a set of substrate peptides. Tissue adhesive properties
of the enzyme were studied and optimized on human skin speci-
mens in vitro by tissue bonding experiments.
Results: Histochemical studies proved that human skin naturally
express localized transglutaminase activity. The assay of exoge-
nous transglutaminase activity revealed that skin has abundant
substrate sites for the enzyme in all the histological layers and an
efficient commercial brand of the enzyme was identified. Results
from tissue bonding experiments indicated efficient tissue adhesive
property of transglutaminase without causing any surrounding
histological tissue damage.
Conclusion: We have shown the strong potential of extracellular
matrix cross linking enzyme—transglutaminase 2 as a biological
tissue glue to achieve rapid and efficient tissue repair.
(P 2) 3d Durotaxis Within a Collagen Matrix
E. Hadjipanayi1, V. Mudera1, R.A. Brown1
1University College London (UCL), Tissue Repair and En-
gineering Centre, Institute of Orthopaedics, Stanmore Campus,
London, HA7 4LP, UK.
While matrix stiffness has been implicated in cell adhesion and
migration, most studies have focused on the effects of substrate
stiffness in 2D. This work describes a novel continuous stiffness
gradient model for studying such processes in 3D.
Wedge-shaped collagen scaffolds were compressed to produce
sheets of a desired (0.25mm) uniform thickness, but with in-
creasing collagen density along the length of the sheet. Dynamic
mechanical analysis, carried out on 1mm wide strips obtained
from the two ends and the middle of each sheet, showed that
the elastic modulus increased from 1057 487KPa to 2305
693KPa at the soft and stiff end respectively and was 1835
31KPa in the middle. In constructs seeded with sepharose marker
beads prior to compression, mean sepharose bead density rose from
10 1 to 71 12 at the soft and stiff end respectively and was
19 5 in the middle, indicating successful engineering of a density
gradient corresponding to the measured stiffness gradient. Growth-
arrested human dermal fibroblasts cultured within such constructs
for 3 and 6 days, accumulated preferentially towards the stiff part
of the gradient. Durotactic migration was significant after 6 days.
This model provides a new means for studying cellular mechan-
otaxis and patterning cells in three dimensions.
(P 3) A Bioactive Biodegradable Guided Bone Regeneration
Membrane
F.E. Weber1,2, G. McKenzie2, B. Hardwick2, M. Ehrbar1
1Bioengineering, Dept. Cranio-maxillofacial Surgery, University
Hospital Zurich, Switzerland.
2Inion Ltd, Cambridge, UK.
Medical devices derived from biomaterials of the 3rd generation are
biocompatible, biodegradable and bioactive. Recently we devel-
oped and characterized a 3rd generation guided bone regeneration
membrane and showed that the plasticizer N-methyl-pyrrolidone
(NMP) is bioactive, since it acts synergistically with bone mor-
phogenetic protein and enhances bone maturation and regeneration
in several in vitro and in vivomodels. In order to get a broader view
on the bioactivity of NMP we performed micro array experiments
which revealed that irrespective of BMP, NMP targets the tran-
scription of several genes; two of those belonging to the natriuretic
peptide hormone system.
The influence of the natriuretic peptide hormone system on bone
growth is manifested in the human disease: Acromesomelic dys-
plasia Maroteaux type where mutations in the natriuretic peptide
receptor 2 induce dwarfism. Over-expression and knock-out ex-
periments in mice showed that also other elements of this system
can affect the skeleton. The knock-down of npr-3 in mice, which
serves as scavenger receptor and the over-expression of natriuretic
peptide B lead to gigantism. Our results in the micro array exper-
iments show that the plasticizer NMP decreases npr-3 expression
and increases BNP expression in C2C12 cells, mimicking the
knock-out and over-expression of those genes in mice. Therefore,
the direct effect of NMP on the transcription of 2 elements of the
natriuretic peptide hormone system in a pro osteogenic way could
at least partially account for the accelerated bone healing seen
under the influence of NMP in vivo.
Acknowledgment: SNF; AO-Biotechnology Fund, Inion OY.
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(P 4) A Bioscaffold Enhances the Fibrillogenesis in Healing
Medial Collateral Ligament
R. Liang1, T. Nguyen2, S.L.Y. Woo1
1MSRC, Dept. of Bioengineering, University of Pittsburgh.
2Dept. of Orthopedic Surgery, University of Amsterdam.
Porcine small intestine submucosa (SIS) has been successfully
used to improve the healing of ligaments and tendons. In the
current study, our objective was to examine the organization of the
extracellular matrix, measure the collagen fibril diameter, and
analyze the gene expressions of the fibrillogenesis-related mole-
cules, specifically, collagen types I, III, V and small leucine-rich
proteoglycans including decorin, biglycan, lumican and fi-
bromodulin, in the healing rabbit MCL treated with SIS at 6 weeks
post-injury. Twenty rabbits were equally divided into two groups.
In the SIS-treated group, a 6mm gap was surgically created in the
right MCL and a layer of SIS was sutured covering the gap. For
the non-treated group, the gap-injured MCLs remained untreated.
The results revealed that in the SIS-treated group the collagen
fibers were more regularly aligned as well as the cell nuclei than
that for the non-treated group. Additionally, in the SIS-treated
group larger collagen fibrils (90–120 nm) appeared around the fi-
broblasts and the range of the fibril diameter distribution was from
24 to 120 nm while the collagen fibrils in the non-treated group
were uniformly small and the distribution of fibril diameter was
limited from 26 to 87 nm. Simultaneously, the gene expressions of
collagen type V, decorin, biglycan and lumican were down-
regulated by 41%, 58%, 43% and 51%, respectively ( p< 0.05).
The present results suggested that the significant reduction in the
gene expressions of fibrillogenesis-related molecules in the healing
MCLs following SIS treatment are closely related to the improved
morphological characteristics.
(P 5) A Cartilage Ecm-Derived 3-D Porous Acellular Matrix
Scaffold for In Vivo Cartilage Tissue Engineering with Pkh26-
Labeled Chondrogenic Bone Marrow-Derived Mesenchymal
Stem Cells
Q. Yang1, J. Peng1, S. Lu1, J. Huang1, J. Yao1, F. Yang2, S. Wang2,
A. Wang1, W. Xu1, Q. Guo1, L. Zhang1
1Key Laboratory of People Liberation Army, Institute of Ortho-
pedics, Chinese PLA General Hospital, Beijing 100853, China.
2BNLMS State Key Laboratory of Polymer Physics & Chemistry,
Institute of Chemistry, Chinese Academy of Sciences, Beijing
100080, China.
We developed a natural, 3-D interconnected porous scaffold de-
rived from cartilage extracellular matrix (ECM). Human cartilage
was physically shattered, and cartilage matrix microfilaments were
prepared after differential centrifugation, then decellularized se-
quentially with use of hypotonic buffer, TritonX-100, and a nu-
clease solution and made into a 3% (w/v) suspension. The scaffold
was fabricated by simple freeze drying, then cross-linked by de-
hydrothermal treatment and immersed in a carbodiimide solution
(1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride
and N-hydroxysucinimide). On histology, scaffolds showed most
of the ECM components after removal of the cell fragments, and
scanning electron microscopy revealed a 3-D interconnected po-
rous structure. Cellular viability assay revealed no cytotoxic ef-
fects. In vitro study showed that the novel scaffold could provide a
suitable 3-D environment to support the proliferation and differ-
entiationofbonemarrow-derivedmesenchymal stemcells (BMSCs)
to chondrocytes. BMSCs were induced along the chondrogenic
lineages for 21 days in medium containing transforming growth
factor beta-3 (TGF-b1), then labeled with fluorescent dye PKH26
and seeded onto scaffolds at 2107 cells/ml. Cell-scaffold con-
structs were implanted subcutaneously into nude mice. Four weeks
later, cartilage-like tissue formed, with positive staining for Sa-
franin O, tuoluidine blue and collagen II. Cells in the samples
seemed to confirm that they originated from the labeled BMSCs, as
confirmed by in vivo fluorescent imaging and immunofluorescence
examination. In conclusion, the cartilage ECM-derived porous
scaffold shows potential as biomaterial for cartilage tissue engi-
neering, and PKH26 fluorescent labeling and in vivo fluorescent
imaging can be useful for cell tracking and analyzing cell-scaffold
constructs in vivo.
(P 6) A Comparative Study on the Effects of Adipose Tissue
Derived and Bone Marrow Mesenchymal Stem Cells on
Neurons/Glial Cells Viability, Proliferation and Differentiation
C.A. Ribeiro1, A.J. Salgado1, J.S. Fraga1, N.M. Neves2,3, J.M.
Gimble4, R.L. Reis2,3, N. Sousa1
1Life and Health Sciences Research Institute (ICVS), School of
Health Sciences, University of Minho, Braga, Portugal.
23B’s Research Group—Biomaterials, Biodegradable and Bio-
mimetics, Department of Polymer Engineering, University of
Minho, Braga, Portugal.
3IBB, Institute of Bioengineering and Biotechnology, PT Asso-
ciated Lab, Braga, Portugal.
4Stem Cell Laboratory, Pennington Biomedical Research Center,
Louisiana State University System, Baton Rouge, LA 70808,
USA.
It isknown thatbothMesenchymalStemCells (MSCs)andAdipose-
derived Stem Cells (ASCs) are able to ameliorate the CNS con-
dition upon injury. However it is still not clear whether they have
the similar or opposite effects on the different CNS derived cell
populations. In this sense the objective of the present work was to
understand if ASCs and MSCs preferentially act on different CNS
derived cell populations. Hippocampal neurons and glial cells were
exposed to MSCs and ASCs conditioned media (CM) (obtained 24,
48, 72 and 96 after 3 days of culture of HUCPVCs) for 1week. Cell
viability experiments (MTS test) revealed that CM obtained for
both cell populations at all time points did not cause any delete-
rious effects on neurons and glial cells. Immunocytochemistry and
total cell counts revealed that hippocampal cultures incubated with
CM displayed higher numbers of neurons (MAP-2 positive cells)
when compared to the control. However this effect was higher for
ASCs CM (up to 6 fold) when compared to MSCs CM (up to 2
fold). Furthermore it was also observed in glial cell cultures that
MSCs CM preferentially stimulated oligodendrocytes (O4) pro-
liferation. Similar effects on hippocampal neurons populations
were observed whenever direct contact co-culture systems were
used. The work here in presented suggests that ASCs and MSCs
release different growth factors. Moreover it was also observed that
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ASCs secrete neuroregulary molecules that preferentially promote
neuronal differentiation/survival, while MSCs mainly act upon
glial cell populations, namely oligodendrocytes.
(P 7) A Fibroblast-Collagen Membrane Composite for Tendon
Repair: an In Vitro Study
L. Mangiavini1, C. Sosio1, M. Buragas1, C. Scotti2, A. Di Gian-
camillo3, C. Domeneghini3, G.F. Fraschini1, G.M. Peretti1,4
1Department of Orthopaedics and Traumatology, University Vita-
Salute San Raffaele, Milan.
2Recidency Program in Orthopaedic and Traumatology I, Uni-
versity of Milan.
3Department of Veterinary Sciences and Technologies for Food
Safety, Faculty of Veterinary Medicine, Universita` degli Studi di
Milano.
4Faculty of Exercise Science, University of Milan.
Tendon repair is a current challenging clinical problem, as tendons
have a poor intrinsic healing potential. The aim of this study was to
identify an in vitro model of collagen membrane seeded with fi-
broblasts, as a potential tool for improving the biological and
biomechanical properties of the repair tissue.
Achilles tendons’ specimens were taken from young pigs.
Specimens were cut in small pieces, cultured in vitro, in order to
allow cells to leave the specimens and to reach the confluence.
Fibroblasts were then enzymatically isolated, resuspended and ex-
panded since confluence was reached again. The cells were see-
ded onto membranes of collagen type I and III of 6mm of
diameter at 3 different concentrations. Membranes were cultured
in vitro at standard culture conditions for 2 and 5 additional weeks,
then retrieved from culture for macroscopic, histological and SEM
analysis.
Macroscopically, seeded membranes showed shrinkage and re-
duced biomechanical integrity compared to unseeded membranes.
Histological examination demonstrated the presence of vital cells
within the membranes with matrix production.
The results from this study demonstrate that swine fibroblasts
can be seeded onto a collagen scaffold. These cells remain vital
during in vitro culture. The shrinkage of the experimental samples
was probably due to a enzyme produced by the fibroblasts. Further
studies will demonstrate the survival of the cells and the reparative
potential of fibroblast transplantation in an orthotopic in vivomodel.
We believe this model could be a valuable tool for tendon lesions,
working either as a cell-carrier and a as patch augmentation.
(P 8) A Model for Studying the In Situ Lens Epithelial Cell
Response To Artificial Lens Replacement
T.G. van Kooten1, S.A. Koopmans2, P.K. Sharma1, T. Terwee3
1Biomedical Engineering, UMCG.
2Ophthalmology, UMCG.
3AMO B.V., Groningen.
Lens implantation is a routine procedure in elderly people. The
opacified lens is replaced by a non-accommodating artificial lens.
New approaches to replace the lens include the use of injectable gels
that allow accommodation in presbyopic people. Surgical inter-
vention in the lens capsule and application of gel materials invoke a
strong response in lens epithelial cells (LEC). In vivo, they prolif-
erate and trans-differentiate towards a cell type with fibrotic prop-
erties. This reduces accommodation amplitude and visual clarity.
Models exist in vivo and in vitro to study effects of treatment of
the capsular bag to prevent the LEC response. The aim of this study
was to develop a model in which the (prevention of) fibrosis can be
studied in the intact lens ex vivo.
Pig eyes were operated upon. The natural lens material was
removed, the capsular bag was treated and a silicone-based gel was
injected as lens replacement. The entire lens was taken out and
incubated in medium for 6weeks. Then mechanical properties
were measured relatively to freshly implanted lenses. The entire
lens was fluorescently stained and visualized with CLSM.
Results indicate the formation of fibrotic tissue in untreated
lenses. Fibrosis could be reduced by treatment of the capsular bag.
Mechanical properties were influenced by the presence of fibrotic
tissue. The model therewith serves as an ideal interpolation be-
tween in vitro and in vivo data. It can be used to evaluate new
concepts of lens replacements that allow accommodation.
(P 9) A New Scaffold Based on Globular Proteins of Plasma
E. Garcia-Perez1, V. Garcia2, S. Llames1,3, M. Pevida1,M. Alvarez-
Viejo4, A. Holguin5, B. Duarte5, M. Del Rio3,5, A. Meana1,3
1Centro de Sangre y Tejidos.
2Fundacion Inclinica.
3Ciberer U714.
4Hospital Central Asturias.
5Ciemat.
Introduction: Several different materials have been employed as
scaffolds in Tissue Engineering. In this work we describe the de-
velopment, in vitro studies and preliminary results of grafting a
new scaffold based on globular proteins of plasma.
Material and Methods: The scaffold was based on the mixture
of plasma globular proteins (albumin) and a crosslinking agent
(glutaraldehyde). Albumin was obtained from concentrates and di-
rectly from plasma or serum. The resulting mixture was frozen,
lyophilised and hydrated. The behaviour of this new scaffold was
studied in vitro by culturing several mesenchymal cell lines and
in vivo by experimental grafting.
Results: The structure obtained after lyophilization and hy-
dratation was porous and flexible with pores and septa of differ-
ent thickness depending on albumin concentration. The scaffold was
not toxic for the cells, which were able to take on the surface and
express differentiation markers (type II collagen, oil red, Von
Kossa…). In vitro, the scaffold was not degraded by the cultured
cells. After grafting the scaffold without cells, a progressive deg-
radation without inflammatory reaction was observed. After 3–
4months, the scaffold was completely degraded. When the scaffold
was grafted with differentiated chondrocytes, a complete cartilage
structure was observed. When the scaffold was grafted with adi-
pocytes, a fat tissue surrounding the scaffold was observed.
Conclusions: Albumin based scaffolds are non-toxic and well-
tolerated. Cells are able to adhere and differentiate. This scaffold is
easy to obtain, can be used to regenerate mesenchymal tissues and
represent a new alternative to other materials for tissue engineering
techniques.
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(P 10) A Novel Approach for Combining Advanced Optical
and Afm Nano Imaging—the Biomaterialsworkstation
G. Behme1, H. Haschke1, R. Owen1, J. Barner1
1JPK Instruments AG.
Optical microscopy and atomic force microscopy (AFM) make
a powerful combination for the investigation of bio-materials, be-
cause the optical overview, fluorescence or spectroscopy informa-
tion can be combined with the nano-imaging and nano-manipulation
capabilities of the AFM. Previously this combination was mainly
limited to transparent samples, where the AFM could measure from
above simultaneously with an inverted optical microscope from
below the sample.
JPK has developed a novel approach to allow the combination of
upright microsocpy with AFM on the same sample region, so that
non-transparent samples, including ceramic or metallic materials,
can be used. A patented calibration procedure ensures that the
region of interest can be found and re-imaged with micron preci-
sion, so now exactly the same area can be sequentially measured
optically and with AFM. The JPK BioMaterialsWorkstation en-
ables the full capabilities of advanced upright optical microscopy,
including fluorescence techniques, immersion lenses and confocal
laser scanning. This is combined with the AFM for high resolution
nano-imaging, elasticity and adhesion measurements, as well as
nano-manipulation and lithography. In particular, measurements
with high resolution dipping lenses and AFM measurements in
liquid become possible on the same sample area.
These capabilities open new possibilities for the investigation of
bio-film formation, biocompatible materials, cell growth on scaf-
folds and many more biomaterials measurements.
(P 11) A Novel Bioreactor Design for Enhanced Stem Cells
Proliferation and Differentiation in Tissue Engineered Con-
structs
P.F. Costa1,2, A. Martins1,2, N.M. Neves1,2, M.E. Gomes1,2,
R.L. Reis1,2
13B’s Research Group—Biomaterials, Biodegradables and Bio-
mimetics, University of Minho, Campus de Gualtar, 4710-057
Braga, Portugal.
2IBB—Institute for Biotechnology and Bioengineering, Braga,
Portugal.
Recent studies have shown that culturing undifferentiated stem
cells in appropriate biochemical environments and under me-
chanical stimulation could provide the correct signals for cellular
proliferation, differentiation and subsequent extracellular matrix
production. This triggered a growing interest about in vitro bio-
mechanically-stimulating culture environments.
Themain goal of this work was to evaluate the efficacy of a newly
developed bidirectional perfusion bioreactor. This apparatus en-
ables implementing complex culturing programmes. Both perfusion
flow rate and direction can be varied along the culturing period. This
compact and user-friendly system is made of autoclavable materi-
als enabling to culture up to 20 samples simultaneously. This study
aimed at determining the most effective programmes for enhance-
ment of cellular proliferation and differentiation. Fiber-bonded
starch polycaprolactone (SPCL) meshes were statically seeded with
goat bone marrow cells (GBMCs). These meshes were cultured ei-
ther statically or under several dynamic culturing programmes for 7
and 14 days. Collected samples were characterized by DNA and
alkaline phosphatase (ALP) quantification and scanning electronic
microscopy (SEM). DNA quantification results showed a tendency
for greater cellular proliferation under static and unidirectional per-
fusion conditions. ALP activity results revealed an enhanced cellular
differentiation rate under cyclic flow direction inversion. SEM re-
sults also showed greater cellular adherence and spreading in cell-
scaffold hybrid constructs cultured under those conditions. In
conclusion, this culture system can be used for enhancing cellular
proliferation and differentiation by optimizing the combination of
fluid flow rate and flow inversion frequency during culturing periods.
Acknowledgments: European NoE EXPERTISSUES (NMP3-
CT-2004-500283), STREP HIPPOCRATES (NMP3-CT-2003-
505758) and FCT CellStrain (POCI/V.5/A0059/2005).
(P 12) A Novel Plasma-Based Scaffold for Subcutaneous Islet
Transplantation
M. Perez-Basterrechea1,2, R.M. Briones1, M. Alvarez-Viejo1,
E. Garcia-Perez3, S. Perez1, A. Ferrero-Gutierrez1, Y. Menendez-
Menendez1, V. Garcia3, M.M. Esteban2, A. Meana3, J. Otero1
1Unidad de Trasplantes y Terapia Celular. Hospital Universitario
Central de Asturias.
2Departamento de Biologia Funcional. Universidad de Oviedo.
3Unidad de Ingenieria Tisular. Centro de Sangre y Tejidos de
Asturias.
Several studies in the last years have shown the insulin indepen-
dence achieved by intraportal islet transplantation in patients with
type I diabetes. However, long-term results have indicated that the
site and method of transplantation still need to be optimized to
improve islet engraftment. The subcutaneous space has been
widely assessed as a simple and safe alternative to the liver.
Nevertheless, the sparse vascularization of this space is the main
limitation for its use as an islet transplantation site. To overcome
this drawback, new strategies have focused on the use of pro-
angiogenic growth factors to enhance vascularization and on the
use of different biomaterials as islet scaffolds. In this study we used
plasma, obtained by directly centrifuging donor’s blood, as scaf-
fold, and fibroblasts, isolated from donor’s skin biopsies, as the
source of pro-angiogenic factors. Cultured fibroblasts were re-
suspended in plasma containing tranexamid acid. Next, fresh iso-
lated islets were added to the mixture and coagulation was induced
by CaCl2, such that pro-coagulant factors such as thrombin were
not necessary. Islets embedded in this ‘‘plasma-fibroblast gel’’ were
transplanted subcutaneously in STZ-induced diabetic mice and
compared with diabetic mice transplanted with free islets beneath
the kidney capsule (control) and with normal mice. Our findings
indicate that subcutaneous transplantation of pancreatic islets em-
bedded in a plasma-fibroblast gel reverts type I diabetes in mice
similarly to the standard procedure. This approach could be a useful
and safe option to treat this disease in human clinical practice.
(P 13) A Novel Polysaccharide-Based Porous Scaffold for Cell
Delivery Into the Infarcted Heart
C. Le Visage1, O. Gournay1,2, J. Flanders2, N. Mougenot2,
F. Norol3, R. Isnard2, J-B. Michel1, S. Hatem2, D. Letourneur1
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1Inserm, U698, Bio-Engineering, CHU X. Bichat, 46 Rue Henri
Huchard, F-75877 Paris Cedex 18, France.
2Inserm, Institut de Cardiologie/UPMC621/IFR14, 91 Bd de
l’Hoˆpital, F-75634 Paris Cedex 13, France.
3Laboratoire de Biothe´rapie, CHU Pitie´ Salpeˆtrie`re, 83 Boulevard
de l’Hoˆpital, F-75651 Paris Cedex 13, France.
Introduction: Cell therapy is one therapeutic option for ischemic
infarcts. However, direct injection into the heart leads to a major
loss of cells. We hypothesized that an implantable porous scaffold
could improve cell survival and enhance the cell engraftment into
the target tissue.
Materials and Methods: Porous polysaccharide-based scaffolds
were prepared according to a patented method by cross-linking
pullulan and dextran followed by a salt-leaching technique. Bone
marrow-derived fluorescent rat mesenchymal stem cells (rMSC)
were seeded on 6mm diameter-scaffolds (106 cells) the day before
implantation. In 17 adult rats (Wistar or Lewis), myocardial in-
farction was induced by ligation of the left coronary artery. Seeded
scaffolds were then grafted on top of the infarcted area. Animals
were sacrificed at 1week (n¼ 3) and at 1month (n¼ 14). Cell
distribution was evaluated on tissue sections with fluorescence
microscopy.
Results and discussion: After seeding of fluorescently labeled
rMSC on porous scaffolds, homogeneous cell distribution within
the 3D structure was demonstrated by confocal microscopy. Seeded
scaffoldswere successfully applied locally onto rat infarcted tissues.
Cell transfer from the scaffold into the injured tissue was clearly
evidenced with numerous fluorescently labeled cells throughout
the infarcted area in both rat autologous and syngenic models.
Conclusion: We described the feasibility of preparing porous
polysaccharide-based scaffolds and of implanting the seeded scaf-
folds on a rat infarcted heart model. This technique of cell delivery
resulted in an excellent engraftment of the cells. Future studies will
evaluate the therapeutic effects for myocardial infarction of this
type of cell therapy.
(P 14) A Novel Rat Mandibular Bone Regeneration Model
using Hap/Gemosil for Rhbmp-2 Delivery
J. N. Ferreira1, M. Kaku1, L. Chi1, A. Ma1, P. Miguez1,2,
M. Yamauchi1,2, C.C. Ko1,3
1Dental Research Center, University of North Carolina at Chapel
Hill.
2Department of Periodontology, University of North Carolina at
Chapel Hill.
3Department of Orthodontics, University of North Carolina at
Chapel Hill.
A new rat mandibular defect model was designed for bone re-
generation. Preliminary studies were conducted to determine the
effects on bone formation when using a poly(D,L-lactide-co-
glycolide) (PLGA) and the hydroxyapatite carrier HAP/Gemosil
(HAPG) loaded with bone morphogenetic protein 2 (rhBMP-2) and
biglycan (BGN), an important small leucine-rich repeat proteo-
glycan. The main goal was to analyze the usefulness of HAP/
Gemosil and these signaling cues in this model of bone regener-
ation.
Methods: A surgical defect was made in each rat hemimandible.
Each defect (n¼ 12) was assigned to one of these groups con-
taining: (1) water (Control); (2) rhBMP-2; (3) BGN; (4) rhBMP-2
and BGN; (5) PLGA; (6) PLGA loaded with rhBMP-2; (7) PLGA
with BGN; (8) PLGA with rhBMP-2 and BGN; (9) HAPG; (10)
HAPG loaded with rhBMP-2; (11) HAPG with BGN; (12) HAPG
with rhBMP-2 and BGN. A double labeling technique was used for
epifluorescence microscopy. Specimens were analyzed by micro-
tomography and processed for histology to evaluate bone forma-
tion. Results: Defects were filled by more than 37% of their initial
volume after 3 weeks, except for carriers only and control groups.
HAPG carriers appear to have a more uniform and compact min-
eralization compared to groups with PLGA. Groups loaded with
rhBMP-2 and BGN have an additive effect on the volume of newly
formed bone. Conclusions: The use of HAP/Gemosil loaded with
rhBMP-2 and biglycan can potentially constitute a good strategy
for bone regeneration, but further increase in sample size is man-
datory. This defect model was found practical although needs re-
finements.
(P 15) A Novel Thermoresponsive Copolymer As a Suitable
Substrate for Tissue Reconstruction
M.V. Viji1,2, N. Vidya2, A. Hopkinson1, K. Sreenivasan2, H.S.
Dua1, T.V. Kumari2
1Division of Ophthalmology and Visual sciences, University of
Nottingham, United Kingdom.
2Sree Chitra Tirunal Institute for Medical Sciences and Technol-
ogy, Trivandrum, India.
Introduction: For the reconstruction of tissues and organs, thermo-
responsive polymers like Poly(N-isopropylacrylamide(NIPAAm))
play an important role in the detachment of cell layers with un-
damaged cell-cell and cell-ECM interactions. PIPAAm coated
surfaces were usually prepared using electron beam irradiation or
plasma polymerisation, both of which are not usually available for
every researcher. We aimed to prepare a thermoresponsive co-
polymer that is easy to prepare and favours cell growth. In this
study, a copolymer of NIPAAm and Methyl Methacrylate was
prepared and its cytocompatibility was assessed.
Methods: Cytotoxicity and cytocompatibility of the copolymer
was analysed in comparison to tissue culture polystyrene using cell
lines. To demonstrate thermoresponsiveness, both primary and
continuous cell lines were detached from copolymer under its lower
critical solution temperature. To analyse specific cytocompatibility
at molecular level, secretome of a corneal cell line cultured on both
substrates is being studied.
Results: Copolymerisation and hydrophilic/hydrophobic tran-
sition at different temperatures was confirmed using fourier trans-
form infrared spectroscopy and differential scanning calorimetry,
respectively. Tritiated thymidine uptake assay and MTT assay
results showed that copolymer favoured cell attachment, growth
and proliferation. Actin staining demonstrated good cytoskele-
tal organisation and subsequent cell spreading on copolymer.
The cell sheet detachment from the copolymer confirmed its
thermoresponsiveness and its use in creating tissue structures. Se-
cretome analysis revealed unique protein expressions on both
substrates.
Conclusion: Our study proved that a copolymer of NIPAAM can
be easily prepared with minimum facilities and the good cyto-
compatibility along with thermoresponsiveness make the copoly-
mer a suitable candidate as a tissue engineering substrate.
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(P 16) A Novel Tissue Prefabrication Model in Rabbit using
Polyacrylamide Cryogel Scaffolds
N. Ozturk1, Y. Demirtas1, O. Karayigit2, S. Egri3, G. Kibar3,
T. Guvenc2, E. Piskin3, A. Karacalar1
1Ondokuz Mayis University, Medical Faculty, Department of
Plastic, Reconstructive and Aesthetic Surgery, Samsun, Turkey.
2Ondokuz Mayis University, Veterinary Faculty, Department of
Pathology, Samsun, Turkey.
3Hacettepe University, Chemical Engineering Department and
Bioengineering Division, and Biyomedtek, Ankara, Turkey.
The purpose of this study is to develop a new, productive and
reproducible prefabrication model in rabbit and to test the effi-
ciency of this model with a non-degradable polyacrylamide based
cryogel scaffold for studying vascularization and new tissue for-
mation. Twelve rabbits were used for this study. Bilateral thor-
acodorsal and deep circumflex iliac vascular pedicles of the
animals were prepared to simulate prefabrication and sandwiched
between two hemispheres of the scaffolds with a radius of 1 cm
forming a sphere. In each animal, four spheres were implanted on
pedicles as study groups and one sphere per animal was implanted
at the back as control. The implants were elevated at 2 (group 1), 4
(group 2) and 6 (group 3) weeks on corresponding pedicles and
replaced again. After two weeks, vascularization of the constructs,
composite of the new tissue formed and inflammatory responses
were evaluated by means of direct observation, microangiography,
and histology. Four implants in three animals were rejected due to
inflammatory response. All other constructs maintained their initial
shape and dimensions. Angiogenesis was evident in 4 weeks and 6
weeks groups of experimental constructs with intense neocapillary
formation within the scaffolds. 2 week groups of experimental
constructs were less vascularized while control constructs remained
relatively non-vascularized. The newly formed tissue was mainly
composed of granulation tissue with inflammatory components.
This study, offering a new prefabrication model with an econom-
ical non-biodegradable scaffold, may accelerate and facilitate the
future work on vascularization of in-vivo engineered tissues.
(P 17) A Surface-Modified Electrospun Elastomeric Scaffold
As a Small Diameter Vascular Graft in a Rat Model
A. Nieponice1,2,3, L. Soletti1,2,3, Y. Hong1,2,3, Sang-Ho Ye1,3,
J. Stankus1,3, J. Guan1,3, W.R. Wagner1,2,3, D.A. Vorp1,2,3
1Mc Gowan Institute For Regenerative Medicine.
2Center for Vascular Remodeling and Regeneration.
3University of Pittsburgh.
There remains a great need for vascular substitutes for coronary
artery bypass and peripheral vascular applications. Synthetic ma-
terials have proven unsuccessful to replace small diameter vessels.
The use of an elastomeric biodegradable material that enables in-
vivo remodeling could be beneficial to this purpose.
Tubular grafts (1.3mm internal diameter) were obtained by
electrospinning a polyester urethane urea (ePEUU) solution onto
a rotating mandrel. The inner surface was modified with poly
(2-methacryloyloxyethylphosphorylcholine-co-methacryl acid)
(PMA). Non-coated conduits were used as controls. The conduits
were implanted as interposition grafts in the abdominal aorta in a
rat model (Coated n¼ 12, Non-coated n¼ 25).
Angiograms at 8 weeks showed 91% patency rate in the coated
group vs. 40% in the non-coated.No signs of dilationwere evidenced
in any group up to 24 weeks. Dynamic compliance testing was
performed within the physiological range (Day 0: 2.23 0.40
104 mmHg1; 4wks: 1.34 0.54104mmHg1; 8 wks: 2.22
104mmHg1;Native aorta: 1.36 0.33103mmHg1).Ultimate
tensile stress (Day 0: 1.74 0.72107 Pa; 4 wks: 5.70 3.66106
Pa; 8 wks: 3.60106 Pa; Native aorta¼ 4.58 0.63106 Pa) and the
elastic modulus (Day 0: 2.75 0.64MPa; 4 wks: 0.44 0.17MPa;
8 wks: 0.54MPa; Native aorta: 0.24 0.1MPa) were measured by
uniaxial tensile testing. Histology showed formation of an external
collagen capsule and an endothelial-like layer at 8 weeks.
Mechanical properties following implantation suggests partial
degradation of the polymer resembling the aorta in strength and elas-
ticity. Surface modification with PMA copolymers significantly in-
creasespatencyrate.Theseconstructs suggestagoodbalancebetween
strength, biocompatibility and degradability of this vascular graft.
(P 18) A Tissue Engineered Strategy for Meniscus Bonding: an
In Vivo Study
C. Scotti1, L. Mangiavini2, C. Sosio2, A. Pozzi2, F. Vitari3,
C. Domeneghini3, G.F. Fraschini2, G.M. Peretti4,2
1Recidency Program in Orthopaedic and Traumatology I, Uni-
versity of Milan.
2Department of Orthopaedics and Traumatology, University Vita-
Salute San Raffaele Milan.
3Department of Veterinary Sciences and Technologies for Food
Safety, Faculty of Veterinary Medicine, University of Milan.
4Faculty of Exercise Science, University of Milan.
The purpose of this work is to create an in vivo tissue engineered
model for meniscus bonding by using a neocartilaginous tissue
produced by isolated swine articular chondrocytes embedded in
fibrin glue as biological glue between two meniscal explants.
Swine menisci were harvested under sterile conditions. Samples
were devitalized by freeze/thaw cycles and dissected by radial
transections. Swine articular chondrocytes were enzimatically
isolated and suspended in fibrinogen. The solution was placed onto
the flat cross-section of a meniscus specimen. Then, thrombin was
added in order to form fibrin glue embedding chondrocytes.
Immediately before gel polymerization, a second meniscus speci-
men was placed atop. The composites were then wrapped in
acellular fibrin glue and transplanted in the back of nude mice for
4weeks. Similar control samples were prepared using acellular
fibrin glue also between the meniscal samples. At the end of the
experimental time, samples were macroscopically analyzed for
bonding and processed for histological evaluation.
Data showed a macroscopic integration of the experimental
samples, while the controls did not achieve any bonding. Histology
showed cartilage like tissue maturing within the fibrin glue scaf-
fold, able to bond the devitalized meniscal tissues.
The results of this study demostrate that isolated chondrocytes,
seeded onto fibrin glue, produce a cartilage-like matrix that inte-
grates with meniscal tissues. This tissue engineered approach could
represent a valuable model for further studies on the repair of
meniscus lesions.
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(P 19) Acceleration of Spinal Fusion with Adipose Tissue De-
rived Adult Stem Cells
M.J. Lopez1, N.D. Spencer1, K.R. McIntosh2, J.N. Borneman2,
G. Yu3, J.M. Gimble3
1Laboratory for Equine and Comparative Orthopedic Research,
Department of Veterinary Clinical Sciences, School of Veterinary
Medicine, Louisiana State University, Baton Rouge, LA 70803.
2Cognate BioServices, Inc., 1448 S Rolling Road, Baltimore, MD
21227.
3Stem Cell Laboratory, Pennington Biomedical Research Center,
Louisiana State University, Baton Rouge, LA 70808.
Posterolateral spinal fusion is a standard treatment for spinal sta-
bilization. This study was designed to test the hypothesis that
syngeneic and allogeneic adult adipose tissue-derived stem cells
(ASCs) on a biomaterial scaffold accelerate spinal fusion in a rat
model. ASCs from male Fischer and ACI rats were loaded onto
collagen/tricalcium phosphate blocks and cultured in stromal me-
dia for 48 hours. Male Fisher rats were assigned to 4 cohorts
(n¼ 16/cohort): 1) No treatment; 2) Scaffold only; 3) Scaffold þ
syngeneic ASCs; or 4) Scaffoldþ allogeneic ASCs. Bilateral L4,
L5 transverse processes were decorticated. Scaffold blocks with or
without ASCs were placed at the L4-L5 intervertebral space in
scaffold treatment groups while none were placed in the no treat-
ment cohort. Half of each cohort was harvested 4 or 8 weeks after
surgery. Spinal fusion was evaluated with radiographs, micro-
computed tomography, and light microscopy. Spines without scaf-
folds did not develop callus during the study period. There were no
significant differences between scaffold cohorts with or without
cells 4 weeks after surgery. Callus formation was more highly
organized in the ASC cohorts compared to the scaffold alone co-
hort 8 weeks after surgery. Callus calcification was evident in ASC
cohorts but minimal in the scaffold alone cohort 8 weeks after
surgery. These results support ASC acceleration of posterior
lumbar spinal fusion in a rat model. Both syngeneic and allogeneic
ASCs appeared to accelerate the spinal fusion process equally. The
use of ASCs to accelerate spinal fusion has potential to signifi-
cantly reduce morbidity and complications.
(P 20) Acellular Collagen Matrix for Fascial Tissue Recon-
struction
D. Eberli1, J. Yoo1, A. Atala1
1Wake Forest Institute for Regenerative Medicine, Wake Forest
University Health Sciences, Winston-Salem, NC 27157.
Various synthetic and naturally derived materials have been pro-
posed as possible materials for fascial reconstruction. Acellular
collagen matrices have been used experimentally and clinically for
several applications, including urethra and bladder reconstruction.
We investigated the feasibility of using a naturally derived, non-
immunogenic, biodegradable, collagen-based matrix derived from
porcine bladders as an off-the-shelf biomaterial for fascial tissue
repair in 3 different tissue systems. To demonstrate the biocom-
patibility of the biomaterial, cell viability, mitochondrial metabolic
activity, and apoptosis assays were performed. In addition, the acel-
lular collagen matrices were used as a sling material for the treat-
ment of incontinence, for the treatment of abdominal hernias, and as
penile tunica reconstruction in 24 rabbits. Retrieved tissues were
assessed grossly and histologically. The direct cytotoxicity and
mitochondrial metabolic activity assays showed that the acellular
matrix did not induce significant changes in cell viability when
compared with the controls. The apoptotic activity was also mini-
mal. After implantation, the acellular matrices remained intact at
their respective implantation sites and demonstrated maintenance of
fascial tissue function. At the time of retrieval there was no evidence
of inflammation or infection and minimal adhesion was noted. The
biomechanical properties of the collagen matrices were similar to
the normal controls. Histologically, the matrix structure was intact,
demonstrating the longitudinal collagen bundles. There was only a
minimal inflammatory response which gradually decreased over
time. The cell density decreased over time and a shift from domi-
nance of lymphocytes to dominance of fibroblasts was observed.
(P 21) Adhesion Strength of Human Mesenchymal Stem Cells
on Biodegradable Polymers for Tissue Regeneration
S.J. Krizan1,2, K.D. Hankenson2
1University of Michigan.
2University of Pennsylvania.
Current tissue engineering approaches utilize mesenchymal stem
cells grown on biomaterials to promote bone regeneration, how-
ever it is unknown how the strength of MSC-substrate interactions
influences osteoblast differentiation. In this study, we have corre-
lated polymer surface properties with MSC adhesion and differ-
entiation. Methods: Immortalized humanMSCwere seeded for 1 hr
on polymer-cast glass slides. The slides were then inserted into
a parallel plate fluid shear device and subjected to a shear stress of
0-25 Pa for 30 cycles. Cell numbers were quantified and the shear
required for 50% cellular detachment (tau 50) was determined. To
create films, poly-lactide-co-glycolide and polycaprolactone were
dissolved in chloroform and cast on glass plates. Alginate wasmade
by crosslinking alginic acid with a CaCO3-GDL acid combination
and cast into cell assemblies. PLGA and PCL films were cut and fit
into assemblies. Contact angles of polymers were measured using a
sessile drop method and bulk elastic modulus was determined using
confined compression force measurements.
Results: Shear loading cells on the various polymer films re-
sulted in tau 50 of <1 to 25Pa, where cells on high-molecular
weight PLGA demonstrated the greatest adhesion strength. A po-
sitive correlation was found comparing elastic modulus and con-
tact angle with adhesion strength of MSC. Both material stiffness
and surface chemistry affect the adhesion strength of MSC to the
polymers. Preliminary studies suggest an inverse relationship be-
tween osteogenic differentiation and adhesion strength.
(P 22) Adipose Tissue Engineering using Adipose-Derived
Stem Cells and Fibrin
A. Peterbauer1,2, S. Neußl1,2, K. Schauer2,3, K. Hofer1, S. Gu¨ven3,
C. Gabriel1,2, H. Redl2,3, M. van Griensven2,3, S. Wolbank1,2
1Red Cross Blood Transfusion Service of Upper Austria, Linz,
Austria.
2Austrian Cluster for Tissue Regeneration.
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3Ludwig Boltzmann Institute for Experimental and Clinical
Traumatology, AUVA Research Centre, Linz/Vienna, Austria.
The treatment of soft tissue defects still poses a clinical problem in
reconstructive medicine e.g. after surgical trauma. Adipose-
derived stem cells have already been used for several tissue
engineering approaches including adipose tissue engineering. Fi-
brin has already been reported to be a suitable matrix to support
several cell types. This study evaluates the influence of fibrin
composition on the formation of an adipose tissue-equivalent
in vitro using adipose-derived stem cells (ASC). Undifferentiated
ASC were mixed with thrombin and added to the fibrinogen com-
ponent. Subsequently, fibrin constructs were either cultivated in
control or adipogenic induction medium and weekly analyzed. The
influence of fibrinogen concentration on fibrin structure was eval-
uated by scanning electronmicroscopy, its influence on cell viability
was demonstrated by CalceinAM/DAPI staining and quantified
by lactate-dehydrogenase (LDH) measurement. Adipogenic con-
version was demonstrated by Oil Red O staining after cryo-
sectioning, by leptin ELISA and by quantitative RT-PCR for the
adipogenic markers PPAR-a, FABP-4 and leptin. Fibrin propagates
ASC growth and adipogenic differentiation. The highest cell density
was observed when 50 mg/mL fibrinogen were used whereas adi-
pogenic conversion was more pronounced when lower fibrinogen
concentrations were applied. Interestingly, adding ASC to the fibrin
matrix led to a stabilization of the construct by influencing the
structure. Combining fibrin and ASC is a suitable approach for soft
tissue regeneration. The fibrinogen concentration has an influence
on matrix structure, cell morphology and density. However, adi-
pogenic differentiation is also affected by donor variability.
Acknowledgments: HIPPOCRATES (NMP3-CT-2003-505758),
Lorenz Boehler Fonds, EXPERTISSUES (NMP3-CT-2004-
500283).
(P 23) All-Trans Retinoic Acid Release From Biodegradable
Polyester Microcapsules
C.T. Brunner1,2, E.T. Baran1,2, R.L. Reis1,2, N.M. Neves1,2
13B’s Research Group—Biomaterials, Biodegradables and Bio-
mimetics, Department of Polymer Engineering, University of
Minho, Campus de Gualtar, 4710-057 Braga, Portugal.
2IBB—Institute for Biotechnology and Bioengineering, PT As-
sociated Laboratory (Laborato´rio Associado).
Tissue engineering strategies frequently include a scaffold, living
cells and bioactive substances to promote cell growth and guide
cell differentiation. The encapsulation in carriers enables protects
the bioactivity of those substances upon implantation, avoids being
transported by the body fluids and also allows controlling the re-
lease rate. Encapsulation materials are preferably biodegradable
polymers. In this work, all-trans retinoic acid (atRA) was used as a
model bioactive agent; since it was shown that atRA enhances the
expression of osteocalcin, a specific osteogenic marker.
atRA was encapsulated into polyester microcapsules by a water/
oil/water double emulsion/solvent evaporation technique. The
polyesters used in this study are poly(butylene succinate) (PBS),
poly(butylene succinate-co-adipate) (PBSA) and poly(butylene
terephthalate-co-adipate) (PBTA). The kinetics of atRA release
was studied in phosphate buffered saline solution of pH 7.4 at 378C
under orbital shaking.
Encapsulation efficiencies (EE) of 94.0%, 95.4% and 95.8%
were obtained for PBS, PBSA and PBTA, respectively. The high
EE is probably due to the low water solubility of atRA which is
entrapped in the organic phase and does not dissolve into the
aqueous phase.
atRA was released from PBS and PBSA steadily with an aver-
age release of 12.6% and 9.9%, respectively, after 4weeks. Release
from PBTA showed a burst of 12.8% within the first 24 hours, fol-
lowed by a slower release stage, reaching 34.0% after 4weeks.
The results obtained in this study demonstrate the interest of this
strategy and show the potential of the proposed microcapsules as
carriers for the controlled release of bioactive agents.
(P 24) Altered Neural Function on the Muscle Growth: Im-
plication for the Muscle Generation
Y.J. Choi1, S.Y. Kong1, H.W. Kim1
1Brain Korea 21 Project of Nanobiomaterials for Cell-Based Im-
plants, Department of Orthopaedic Surgery College of Medicine
Yonsei University.
Changes in muscular ubiquitin gene and protein expression in ac-
cordance with nerve injury and regeneration process were evaluated.
Sciatic nerve of 12week old SD rat was induced nerve paralysis.
Gastrocnemius muscle of both intact and injured lower extremity
were harvested at 5, 10, 20 and 40 days post injury. Contractility
and wet weight of the gastrocnemius muscle was measured and
compared with the normal muscle. RT-PCR was done for ubiquitin
gene detection, and ubiqutin protein expression in the harvested
tissue was also checked by immunohistochemisty for the evalua-
tion of expression pattern as the time sequence.
The muscle weight decreased starting the 10th day and was at the
lowest at 20th day. A recovery in weight was evident starting 40th
day. Pre-harvest degree of muscle contraction showed no changes in
the first 5 days. At 10th day, partial recovery was noted and at 20th
day, same degree of contraction was noted compared to the normal
muscle. Degree of ubiquitin expression from the extracted mRNA
showed most activity at the 10th day. At 40th day, the degree of
expression was about the same as the normal muscle. The degree in-
creased starting the 10th day and at 20th day, much ubiquitin stained
myofibers emerged and the recovery was noted at the 40th day.
Ubiquitin proteolysis seems to be involved in muscle wasting in
the reversible nerve injury. It was observed that this particular gene
and protein increased in expression during a muscle wasting process.
(P 25) Alveolar Bone Regeneration in a Gingivoperiosteoplasty
Model
P.D. Nguyen1, C.D. Lin1, A.C. Allori1, T. Reisler1, J.P. Levine1,
P.B. Saadeh1, S.M. Warren1
1NYU Medical Center, Institute of Reconstructive Plastic Surgery.
Introduction: Primary alveolar cleft repair treating congenital al-
veolar clefts with gingivoperiosteoplasty (GPP) has a 60% success
rate. The remaining 40% have persistent alveolar defects requiring
secondary grafting, potentially complicated by donor-site morbid-
ity, graft resorption, and infection. Herein, we describe a novel
critical-size defect GPP model using tissue-engineered scaffolds to
improve bone healing and circumvent secondary grafting.
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Methods: A 743-mm complete alveolar defect was surgi-
cally created in sixty 8-week old rats. Four scaffolds were tested
within the defect: absorbable collagen sponge (ACS), ACSþBMP,
hydroxyapatite-tricalcium phosphate (HA-TCP), HA-TCPþBMP,
and no scaffold as control. Animals were sacrificed at post-operative
weeks 4, 8, and 12. New bone was assessed histmorphometrically
via micro CT. Decalcified sections were processed for histology.
Results: Negative control groups grew to 43 10% at 4 weeks,
but plateaued to 53 17% at 8 weeks. ACS groups showed
50 12% at 4 weeks and 79 19% at 8 weeks. ACSþBMP
showed 49 4% and 71 13%, respectively. HA-TCP displayed
69 20% bone growth at 4 wks and plateaued to 86 6%
(p< 0.05) at 8 wks, while adding BMP yielded 55 29% and
91 5% (p< 0.05) at 4 and 8 weeks. 12-week samples were si-
milar to 8-weeks preliminarily. Histologically, HA-TCP groups
stimulated appositional bone growth around scaffold granules.
Conclusions: HA-TCP shows greater osteogenic capability than
ACS. BMP did not affect significant bone growth increases, per-
haps due to lack of a sustained release system. Inherent osteo-
conductive properties of HA-TCP and its ability to provide for
tissue guided regeneration (as opposed to an absorbable matrix)
may have contributed to defect healing.
(P 26) Amniotic Epithelial Cells Have Liver-Specific Function
of Ammonia Removal and Urea Synthesis
B.Y. Jung1, H.H. Yoon1, K.Y. Song2, Y.J. Kim3, J.K. Park1
1Dongguk University.
2Chung-Ang University.
3Lifecord Inc.
Recently, under hepatogenic condition, they expressed most of the
liver-specific proteins including HNF3-gamma, albumin, alpha-
fetoprotein, alpha1-antitrypsin, transthyretin, glutamine synthase,
CYP2C9, CYP2D6, CYP3A4, CK18, PEPCK. However, they did
not express important genes involved in the urea cycle and glu-
coneogenesis despite of the presence of stimulating factors such as
hepatocyte growth factor, fibroblast growth factor-2, oncostatin M,
dexamethasone.
In this study, we tried to differentiate them into hepatocyte-like
cells with urea synthesis activity using media modification. During
culture, AECs could synthesize urea and the quantity increased
with culture time. Also, urea synthesis significantly increased after
treatment of 1mM ammnonia. So that, they had ammonia removal
activity. They also expressed cytochrome P1A1/2 activity in the
presence of its inducer, 3-MC. This pattern in cell culture was
similar to that in tissue culture.
This result shows that their liver-specific functions deeply cor-
relate to the in vitro culture condition, and this fact can explain the
uncertainty of their hepatogenic differentiation capacity arising
from previous results.
(P 27) An Emulsion Preparation for Novel Micro-Porous
Polymeric Hemi-Shells for Use in Tissue Engineering and
Drug Delivery
K. Naidoo1, H. Rolfes2, K. Easton1, S. Moolman1, W. Richter1,
R. Nilen1
1CSIR, Pretoria, South Africa.
2University of Pretoria, Pretoria, South Africa.
A modified oil-in-water (O/W) emulsion process was developed to
produce novel micro-porous hemi-spherical polycaprolactone
(PCL) micro-particles called ‘‘hemi-shells’’. By addition of a
porogen such as sodium bicarbonate (NaHCO3) into the PCL-
dichloromethane (DCM) oil phase and emulsification in an acidic
polyvinyl alcohol (PVA) aqueous phase, micro-porous hemi-shells
formed as solvent evaporated. CO2 gas evolution from the porogen
created particles with an externally micro-porous shell containing
a central opening with a large internal cavity. The hemi-shells
were characterized by SEM and optical microscopy. The number-
average particle yield in the 50-200mm range was 84%. The
number-average hemi-shell yield in the same size range was 41%.
These novel hemi-shells could potentially be applied in tissue
bulking and regeneration of sphincter muscles in the treatment of
reflux, and incontinence. Other potential applications include cos-
metic dermatology and drug delivery.
(P 28) An Innovative Vibrating System To Increase the Muscle
Growth in Newborn Mice
G. Ceccarelli1,2, D. Pre`3,2, M.G. Cusella De Angelis1,2,
G. Magenes3,2, F. Benazzo4,2
1Dept. of Experimental Medicine, University of Pavia.
2C.I.T. Tissue Engineering Centre, Pavia.
3Dept. Informatic and Systemistic, University of Pavia.
4S.Matteo Hospital, Pavia.
The aim of our study is to investigate the relationship between high
frequency, low amplitude vibrations on the growth of muscolar
fibers in newborn mice. From our previous studies on in vitro cells,
we observed that the frequency of 30Hz increases proliferation and
differentiation of the cells. So we designed and realized an ad-hoc
bioreactor, that can produce vibrations between 1 and 120Hz and
with a sensoring system composed by an accelerometer in order to
control the stability of the imposed signals. We treated 10 newborn
mice and we used other 10 newborn mice as a control. We divided
the ten treated mice in 5 groups and we treated them one hour a day
for 1, 2, 3, 4 and 5weeks, respectively. We sacrificed two mice a
week from the control group and other two from the treated group.
We took a sample of tibial muscle and one from quadricep muscle
from every group. We analyzed the morphometry of all the sam-
ples and we compared the perimeter and the area of the muscolar
fibers get from the treated groups and the ones get from the control
group. We used the statistical test ANOVA-2 to evaluate the
confidence of our data. The results showed a strong differences
between treated and controls. For instance the mice that received
two weeks of treatment showed a higher number of muscolar fibers
(48% more than the controls, with a p< 0.001) and their fibers
have an area 40% less than the control.
(P 29) Angiogenic Potential of the Early Fracture Haematoma
Is Increased By Mechanical Stimulation
A. Groothuis1,2, G. Kasper1,2, U. Lehnigk1,2, H. Bail1, K. van
Scherpenzeel1, G. Duda1,2
1CMSC, Charite´—Universita¨tsmedizin Berlin, Germany.
2JWI, Charite´—Universita¨tsmedizin Berlin, Germany.
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Mechanical stimulation and angiogenesis play important roles in
the bone healing process. The increased secretion of matrix me-
talloproteases (MMPs) and paracrine stimulation of angiogenesis
by mechanical loading of mesenchymal stem cells have been de-
scribed earlier. However, the exact interaction of angiogenesis and
mechanical loading remains unclear. This study aimed to investi-
gate the angiogenic potential of the human fracture haematoma
itself and how this changes with mechanical stimulation, as well as
identify molecules potentially involved.
Fracture haematomas were isolated during surgery max. 24
hours post-trauma. They were embedded in a fibrin matrix and
mechanically stimulated in a bioreactor simulating the in vivo-
conditions in the early phase of bone healing (3 days, 1Hz, 10 kPa).
Both MMP-2 active and proform and MMP-9 proform were
detected in haematomas by gelatine zymography. In vitro angio-
genesis assays of endothelial cells (HMEC-1) showed increased
tube formation when stimulated with conditioned medium from
mechanically stimulated haematoma. Proliferation of HMEC-1
cells stimulated by haematoma suggests the presence of stimula-
tory molecules.
In summary, extracellular, pro-angiogenic MMPs are present in
the early human fracture haematoma and mechanical loading ap-
pears to enhance its pro-angiogenic potential. Their regulation
could be a bridge between mechanical stimulation and angiogen-
esis. Such link would open new therapeutic strategies in bone
healing process by stimulating blood vessels formation.
(P 30) Apoptotic Induction in Primary Cell Cultures of
Human Umbilical Vein Endothelial Cells (Huvec)
A. Rodrı´guez-Morata1, I. Garzo´n2, M. Alaminos2, M.C. Sa´nchez-
Quevedo2, N. Garcı´a-Honduvilla3, J.M. Garcı´a2, J. Buja´n3,
A. Campos2
1Hospital Clı´nico Virgen de la Victoria, Division of Vascular
Surgery, Ma´laga, Spain.
2University of Granada, Department of Histology.
3University of Alcala´, Department of Medical Specialties.
Introduction: Previous studies carried out by our research group
demonstrated that primary cells cultures of human umbilical vein
endothelial cells (HUVEC) could display lower cell viability than
cells corresponding to the second and third cell passages. However,
the mechanisms associated to these findings are unknown. In this
work, we carried out a comprehensive gene expression analysis in
primary cultures of HUVEC to quantify the expression of genes
associated to apoptosis induction or inhibition.
Materials and Methods: Primary HUVEC cultures were isolated
from human umbilical cords using collagenase I and cultured in
M-199 medium with 10% fetal calf serum and endothelial growth
factor. Total RNA was isolated from 3 different subconfluent pri-
mary cell cultures and hybridized to Affymetrix U133 plus oli-
gonucleotide microarrays. Genes with a role in apoptosis were
selected, and genes whose expression was present in all samples
analyzed were considered overexpressed.
Results and Discussion: Primary HUVEC cultures showed high
expression of a number of genes related to cell apoptosis, including
BCL2A1, BCL2L12, BNIP2, CASP1, CASP6, CASP7, CASP9,
CASP12, FIS1, IER3, NCKAP1, PDCD10, PDCD5, PHLDA1,
TNFAIP8, TNFRSF1 and TNFRSF21, for example. Expression of
several genes with a role in inhibition of apoptosis were expressed
in HUVEC cells, including, among others, API5, AVEN, BIRC4,
CIAPIN1, FAIM, FKSG2, RTKN, TEGT. These results imply that
decreased cell viability found in primary HUVEC could be related
to a balance between apoptosis inductor and inhibitor gene path-
ways.
Supported by FIS PI061784.
(P 31) Application of Confocal Laser Scanning Microscopy to
Estimate Spatial Cell Distribution in Cultured Tissues
M. Kino-oka1, M. Taya1
1Osaka Univeristy.
This clinical advantage of cultured tissues should be ensured by its
quality control (QC) in manufacturing. Many techniques for the
QC were developed mainly for safety of cultured tissues. From a
viewpoint of engineering, therefore, the strategic construction to
estimate the QC for efficacy is inevitable. We have focused on the
tool development for spatial estimation of cells in cultured tissues.
The cultured cartilages of chondrocytes embedded in collagen
gel were prepared to estimate the spatial cell densities as well as
size of cell aggregation by double staining of whole nuclei and
living cells. The stained cultured cartilages were set on a confocal
laser scanning microscope to capture three-dimensional images.
The data analysis based on the image processing revealed that the
spatial heterogeneity in cell distribution occurred due to cell ag-
gregation in the gel during culture.
This imaging technique was applied to estimate the proliferative
cells in myoblast sheets. The multilayer sheets of human myoblast
cells were prepared to estimate the densities of total and prolifer-
ative cells by staining of whole nuclei and proliferative nuclei,
respectively. We tried to obtain the time profile of myoblast sheet
properties. The frequency of proliferative cells decreased sharply,
being less than 20% within 1 day. However, the frequency was
maintained to be about 10% up to 2weeks, while keeping a steady
state of sheets. This suggests that the frequency of proliferative
cells is one of the important indicators to evaluate the QC for
efficacy of cultured sheets.
(P 32) Application of Plasma Treatment in the Optimisation of
Tissue Engineering using Ceramic Scaffolds
R. Ackbar1, S. Forster1, K. Hurrell-Gillingham1, A. Crawford1,
S.L. McArthur1, P.V. Hatton1
1University of Sheffield.
Introduction: The aim of this study was to determine whether or
not plasma treatments increased the wettability of porous ceramic
scaffolds, and then to investigate seeding with mesenchymal stem
cells.
Materials and Methods: Hydroxyapatite (HA) scaffolds were
placed into 3 groups; non-treated, H2O plasma treated and O2 plasma
treated.Water contact angles (n¼ 4), dye penetration (n¼ 5) and cell
penetration (n¼ 3) were all investigated, and X-ray photoelectron
spectroscopy (XPS) was used to detect surface changes.
Results and Discussion: Plasma treatment of dense hydroxyap-
atite reduced contact angles from 168 to a value too low to be
detected. Likewise, plasma treatment of porous hydroxyapatite
dramatically increased the rate of dye penetration. Studies of the
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effects of plasma treatment on mesenchymal stem cell penetration
were inconclusive. XPS analysis showed that there was little dif-
ference between treated and non-treated materials.
Conclusion: It was concluded that plasma treatment, using both
H2O and O2 sources, clearly improves the wettability of both dense
and porous hydroxyapatite. This was demonstrated by the reduc-
tion of contact angles and the increase in dye penetration in treated
vs. non-treated HA.
Acknowledgements: The author gratefully acknowledges fund-
ing of a CASE studentship from EPSRC and Ceramisys Ltd.
(P 33) Application of PLGA/Keratin Scaffold for Tissue
Engineered Articular Cartilage
S.H. Jung1, S.H. Kim1, J.Y. Lim1, H.H. Hong1, J.W. So1,
M.O. Baek1, J.M. Rhee1, G. Khang1, M.S. Kim2, H.B. Lee2
1BK-21 Polymer BIN Fusion Research Team, Chonbuk Nat’l
Univ.
2Nanobiomaterial Lab., KRICT.
Articular cartilage that is difficult to recovery when damaged needs
to tissue engineering. Keratins are the intermediate filament proteins
that form a dense meshwork of filaments throughout the cytoplasm
of epithelial cells. Keratins are generally expressed in particular
pairs of type I and type II keratin proteins in a tissue-specific and
cellular differentiation-specific manner. In this study, we are de-
veloping an alternative approach that consists of generating chon-
drocytes anchored to poly(L-lactide-co-glycolide) (PLGA) scaffolds
impregnated keratin(PLGA/Keratin) using tissue-engineering prin-
ciples.
We prepared PLGA and PLGA/Keratin scaffolds using sol-
vent casting/salt leaching method. Chondrocytes were isolated from
the articular cartilage of New Zealand white rabbit and cultured with
DMEM/Ham’s F-12 supplemented with 10 % FBS, 1 % penicillin
streptomycin, 200mM L-glutamin, 50mg/ml of ascorbic acid and
15mM HEPES buffer 1M. Cell proliferation activity was measured
at 1, 3, 7, 14 and 21 days byMTT assay. Morphological observation,
histology, biological assay for collagen and sGAG, and PCR were
performed at each time point 1, 2 and 3 weeks.
The cell viability and the quantity of collagen and sGAG were
better PLGA/Keratin scaffolds than PLGA scaffolds. Specific
mRNA, collagen type II and aggrecan, for chondrocyte expressed
significantly highly in PLGA/keratin scaffold while dedifferenti-
ation marker, collagen type X, did not appear.
PLGA/Keratin scaffold promotes in vitro chondrocyte of rabbit
articular chondrocytes. This study suggests that PLGA/Keratin
scaffold may serve as a potential cell delivery vehicle and a
structural basis for in vitro tissue engineered articular cartilage.
Acknowledgements: This research was supported by KMOHW
(0405-BO01-0204-0006) and SCRC(SC3100).
(P 34) Articular Rehabilitation Controlled By Image
Processing-Study on Animals
M. Dreucean1, G. Tanasie2, M. Toth-Tascau1, H. Boss2, B. Hoi-
noiu2, D. Poenaru2
1POLITEHNICA University of Timisoara, Faculty of Mechanical
Engineering.
2University of Medicine and Pharmacy Victor Babes Timisoara.
The paper presents the investigation strategy in a study developed
on rabbits, aimed towards the rehabilitation of the knee joint us-
ing bone marrow derived mesenchymal stem cells (MSCs)
combined to a scaffold made from resorbable polyglycolic acid
felt and sodium-hyaluronat. The cells were previously in vitro
expanded. After two passages MSCs were seeded on to the scaf-
fold.
A set of 10 rabbits were scanned in two cases: healthy and
having an induced joint trauma. The engineering approach was
directed to the 3D reconstruction of the articulation area starting
from a set of slides taken on a CT. The 3D reconstructed area was
generated with special software. The reconstruction software can
separate different tissues and build separate masks for the inves-
tigated area. The investigation revealed the implant area and de-
fined the shape of the scaffold. It also defined the cutting planes for
the implantation process. After the CT investigations and the 3D
reconstructions the subjects were submitted to surgery and im-
planted the scaffolds having pre-determined shape. The actual
study will continue with the observation of the subjects during the
rehabilitation process.
(P 35) Artificial Vascular Grafts Out of Flexible, Biocompa-
tible Photopolymers
S. Baudis1, C. Heller1,2, C. Turecek3, J. Stampfl2, F. Varga3,
R. Liska1, G. Weigel4,5, H. Bergmeister4
1Institute of Applied Synthetic Chemistry, Vienna University of
Technology, Vienna, Austria.
2Institute of Materials Science and Technology, Vienna University
of Technology, Vienna, Austria.
3Ludwig Boltzmann Institute of Osteology, Vienna, Austria.
4Ludwig Boltzmann Cluster for Cardiovascular Research, Vienna,
Austria.
5Department of Cardiothoracic Surgery, Medical University
Vienna, Vienna Austria.
Cardiovascular disease is one of the leading causes of mortality in
the western hemisphere. Autologous vessels are the preferred
material to reconstruct vessel segments with diameters less than
5mm but the number of appropriate grafts is limited due to in-
sufficient native vessels or previous harvest. So the demand for
prosthetic substitutes is a continuing concern in coronary and pe-
ripheral vascular surgery. Currently available synthetic conduits,
like Dacron or ePTFE show generally excellent long-term results
for large-caliber arterial reconstruction (aorta, iliac vessels) but
when used for small diameter.
We aim at developing suitable blood vessel substitutes out of
biocompatible photopolymers which can be printed by rapid pro-
totyping that permits the production of compliant scaffolds that
mimic the structure of the extracellular matrix.
A typical resin formulation consists of reactive diluents, special
co-monomers and cross-linkers that determine the degradation
behaviour. Test specimens were produced by UV-curing and bio-
compatibility was evaluated by in-vitro cell culture tests using
human endothelial cells.
By using appropriate reactive diluents and crosslinkers photo-
polymerizable biopolymers with elastomer-like behaviour similar
to natural blood vessels (E-modulus 0.5MPa; strain at break 130%)
were developed. Endothelial cell attachment and growth was easily
achieved without pre-coating the elastomer surface.
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The resin systems developed are highly reactive and thus suit-
able for rapid prototyping of small diameter vascular grafts. The
newly developed graft materials show excellent mechanical
properties and favor both spontaneous attachment and proliferation
of human endothelial cells.
(P 36) Autologous MSCS and Osteoprogenitor Cells for
Treatment of Non-Unions
A. Peters1, K. Kaspar1, H. Schell1, L. Lienau1, D. Toben1,
H.J. Bail1, G.N. Duda1
1Julius Wolff Institut and Center for Musculoskeletal Surgery
Berlin, Berlin.
Non-unions are one of the most severe complications in bone
healing. The aim of this study was to examine the therapeutic po-
tential of locally transplanted MSCs or osteoprogenitor cells
(OPCs) in non-unions. 76 rats were investigated histologically at
day 14, except the control group (C-group), and biomechanically at
day 56. Autologous MSCs were cultured in DMEM or osteogenic
medium.A femoral osteotomywas stabilizedwith an external fixator.
Except for the C group, a non-union was induced by cauterization of
the periosteum and bone marrow removal. Two days later, these
animals received an injection of DMEM in the gap containing
MSCs (MSC-group), OPCs (OPC-group) or no cells (NU-group).
Histology at day 14 demonstrated no bony bridging of the gap. The
MSC- and OPC-group showed a significantly larger cartilage area
(p 0.03) compared to the NU-group. Immunostaining revealed the
greatest collagen type II area in the OPC-group. At day 56 the OPC-
group showed a higher torsional stiffness than the NU-group
(p¼ 0.02). Compared to the C-group the torsional stiffness of the
NU-and both cell-groups was significantly lower (p< 0.01). Locally
appliedMSCs and OPCs slightly improved the healing in this model.
The MSCs were less effective compared to the OPCs. The less than
expected healing improvement of both cell treatmentsmay be related
to an unfavourable microenvironment at the application time. An
explanation for the superior outcome of the OPCs might be that the
OPCs may be protected by macroscopically visible matrix at the
transplantation time point.
(P 37) Behaviour of Encapsulated Vascular Smooth Muscle
Cells and Endothelial Cell
N.E. Vrana1,2, P. Cahill2, G. McGuinness1
1Dublin City University Materials Processing and Research Centre.
2Dublin City University Vascular Health Research Centre.
PVA hydrogels are good candidates for vascular tissue engineering
because of their soft tissue-like mechanical properties. However,
they are highly hydrophilic which hinders cell attachment. In this
study, PVA-based composite hydrogels which contain cell adhe-
sion promoting macromolecules (Chitosan, Starch, Gelatin) were
produced via a two step gelation technique composed of a freeze/
thaw cycle and coagulation bath treatment. Physical character-
ization of the hydrogels were done by, water content, contact angle,
percentage shrinkage, protein adsorption measurements, degrada-
tion and tensile strength tests, SEM and phase contrast microscopy.
Hydrogels were seeded with Bovine vascular endothelial and
smooth muscle cells and cell attachment and proliferation was
assessed by DAPI, FITC-Phalloidin staining and Alamar Blue
assay. Also smooth muscle cells were encapsulated within the
hydrogels during one step freeze-thaw gelation in the presence of
cryopreservatives and encapsulation parameters (Viscosity, cryo-
preservative concentration, gel stability) were determined. Pre-
sence of the additives did not compromise the mechanical
properties. Coagulation bath treatment signifincatly improved
tensile strength and resistance to degradation. Both endothelial and
smooth muscle cells attached and proliferated on the hydrogels,
with slightly better results on PVA/Gelatin hydrogels. En-
capsulation was more successful in PVA/Gelatin hydrogels too.
Our results showed that, PVA based hydrogels can be utilized for
co-culturing of endothelial and smooth muscle cells for imitation
of thin arteries (500 mm).
(P 38) Behaviour of Osteoblastic-Like MG-63 Cells Cultured
with Hydroxyapatite and Biphasic (Hap/b-Tcp) Porous
Granules
C. Santos1,2, R.P. Franke2,3, M. M. Almeida1, M.E.V. Costa1,
M.H. Fernandes4
1Department of Ceramic and Glass Engineering, CICECO, Uni-
versity of Aveiro, 3810-193 Aveiro, Portugal.
2Centre for Biomaterial Development, Institute of Polymer Re-
search GKSS/BCRT Teltow, 14513 Teltow, Germany.
3Department of Biomaterials, University of Ulm, 89081 Ulm,
Germany.
4Pharmacological and Cell Biocompatibity Laboratory, Faculty of
Dental Medicine, University of Porto, Portugal.
Hydroxyapatite (HAP) and b-tricalcium phosphate (b-TCP) have
high potential for bone replacement, particularly HAP and b-TCP
composites which combine the bioactivity of HAP with b-TCP
reabsorbability. The main motivation of the present study was to
investigate the possible impact of newly developed biphasic gran-
ules as compared to HAP granules on osteoblastic cell viability and
proliferation.
Porous granules with a donut shape were obtained by spray
drying hydroxyapatite suspensions. Heat treatment at 8008C of
spray dried granules (SGD) produced biphasic granules (HSDG)
composed by b-TCP and HAP. MG-63 osteoblastic cells were
cultured in the presence of the two types of granules (50m/ml
5mg/ml) for 3 and 6 days, and the system was evaluated for
cell viability/proliferation, cell morphology, particle internalisation
and cell-induced alterations on the granules. MTS assay showed a
dose-dependent effect of the granules on cell viability/proliferation,
with a stimulatory effect at low concentrations and deleterious ef-
fects at higher levels. Optical microscopy, SEM and EDS X-ray
mapping showed a significant internalisation of the particles and at
high particle concentration, a trend for increased cytoplasmic
volume. Compared to SDG, HSDG caused higher positive effects
on cell growth, at 50 m/ml, and presented lower cytotoxicity at high
levels. In addition, at 6 days of culture, the HSDG granules ex-
hibited a new morphology. In conclusion, SDG and HSDG are
internalised by growing MG-63 cells, while promoting cell pro-
liferation at selected concentrations. The two materials exhibit
differences regarding cell growth rate and, also, culture-induced
alterations on the granules morphology.
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(P 39) Behaviour of SAOS-2 Cells and Human Periosteum
Derived Progenitor Cells in Fibrin Gels
J. Demol1, J. Eyckmans2, F.P. Luyten2, H. Van Oosterwyck1
1Division of Biomechanics and Engineering Design, Department
of Mechanical Engineering, K.U.Leuven, Leuven, Belgium.
2Laboratory for Skeletal Development and Joint Disorders,
K.U.Leuven, Leuven, Belgium.
Both in vitro and in vivo studies have shown that fibrin sealants
provide a promising carrier for bone engineering. The present study
compares viability, proliferation and osteogenic differentiation of
human osteoblast-like cells (SaOS-2) and Human Periosteum
Derived Progenitor Cells (HPDCs) within a fibrin hydrogel.
Fibrin carriers (17mg/ml fibrinogen, 1U/ml thrombin; Tisseel
VH SD) were prepared with a cell density of 1million cells/ml.
One or two days after construct preparation, growth medium was
replaced with osteogenic medium supplemented with/without an-
tifibrinolytic agents. Subsequently, cell-gel constructs were cul-
tured in vitro. Cell behaviour was characterized by live/dead
staining, DNA quantification, RT-qPCR and histology.
HPDCs seeded fibrin gels degraded faster compared to SaOS-2
seeded gels. Initially, cells were distributed homogeneously
throughout the carrier. After 28 days, proliferating SaOS-2 cells
had formed a thick cell layer on the surface of the gels. In the center
of the carrier substantial cell death was observed, while surviving
cells clustered. In contrast, HPDCs remained viable throughout
the whole scaffold (average viability of 76%) and formed a thin
cell layer on the gel surface. Their total number per gel remained
unchanged. Interestingly, HPDCs secreted extracellular matrix
and remodeled the inner fibrin matrix in the absence of antifi-
brinolytics. However, HPDCs did not differentiate into the osteo-
blastic lineage as indicated by gene expression and histology.
This study illustrates that SaOS-2 cells and primary HPDCs
behave differently in a fibrin gel. The use of fibrin gels to support
in vitro osteogenic differentiation of HPDCs remains to be dem-
onstrated.
(P 40) Behind Functional Scaffold: Biomimetic Concept
C. Z. Liu1,2, J. T. Czernuszka2
1Wolfson School of Mechanical & Manufacturing Engineering,
Loughborough University, Loughborough LE11 3TU, UK.
2Department of Materials, University of Oxford, Oxford OX1
3PH, UK.
Many tissues are anatomically separated from neighboring tissues/
organs often by means of non-specific tissue such as fascia, and
other tissues merge into neighbouring tissues. Attachment of the
two tissues/organs by such "connector" tissues in the form of gra-
dient property could generates a new physiological function that is
lost when the connection between the two tissues/organs is severed.
This paper report a biomimetic diffusion method for the fabri-
cation of compositionally and structurally graded collagen/nano-
hydroxyapatite (HA) composite scaffold. The method is diffusion
based and produce the precipitation of nano-HA crystallites in situ.
A collagen scaffold acts as a membrane through which calcium
ions (Ca2þ) and phosphate ions (PO34 ) diffusion and precipitate
a non-stoichiometric hydroxyapatite. It was observed that prism
needle-like nano-HA crystallites (about 2220 nm) precipitated
in the interior of collagen scaffold onto the fibrils. Chemical and
microstructure analysis revealed a gradient of the Ca to P ratio
across the width the scaffold membrane. This lead to the forma-
tion of a Ca-rich side and a Ca-depleted side of scaffold. The
Ca-rich side featured low porosity and agglomerates of the nano-
HA crystallites; while Ca-depleted side featured higher poros-
ity and nano-HA crystallites integrated with collagen fibrils to form
a porous network structure. The reported graded scaffold has po-
tential applications in co-culture of tissues and would lead to better
understanding of cellular requirements for regeneration of bone.
(P 41) Bioactive Poly(ethylene Glycol) Hydrogels for Mod-
ulation of the Smooth Muscle Cell Phenotype
C. Adelo¨w1, T. Segura1,2, J.A. Hubbell1,3, P. Frey1,4
1Institute of Bioengineering, Ecole Polytechnique Fe´de´rale de
Lausanne, Switzerland.
2Department of Chemical and Biomolecular Engineering, Uni-
versity of California, Los Angeles, CA, USA.
3Institute of Chemical Sciences and Engineering, Ecole Poly-
technique Fe´de´rale de Lausanne, Switzerland.
4Department of Pediatric Surgery and Urology, Centre Hospitalier
Universitaire Vaudois, Lausanne, Switzerland.
The formation of scar tissue due to dedifferentiation of smooth
muscle cells (SMCs) is one of the major issues faced when engi-
neering bladder tissue. Furthermore, cell sources for regenerating
the SMC layer are limiting. Here we explore whether human mes-
enchymal stem cells (MCSs), cultured in enzymatically degradable
poly(ethylene glycol) (PEG) hydrogel scaffolds can be differ-
entiated into SMC-like cells. Synthetic hydrogels are formed by
the reaction of cystein-containing adhesion peptides and matrix
metallo-proteinase (MMP) sensitive peptides to four-armed PEG-
Vinyl Sulfone. Cells are mixed within the gel, attach and are able to
migrate within the scaffolds by degrading the matrix via secreted
MMPs. As opposed to cultures on traditional tissue culture plastic,
we found that MSCs cultured within the PEG hydrogel scaffolds up-
regulate SMC specific markers, such as a-smooth muscle actin and
myosin. MSCs also down-regulate a5 integrin and THY-1, that are
associated with a synthetic SMC phenotype. Furthermore, we show
that MSCs cultured in the PEG hydrogels are able to proliferate and
express matrix metalloproteinases for up to 21 d in culture, the full
duration of the study. This study addresses the importance of the
cellular microenvironment on cell fate, and proposes synthetic in-
structive biomaterials as a means to direct cell differentiation and
circumvent scar tissue formation during bladder reconstruction.
(P 42) Bioactive Polymeric Scaffolds and Nanoformulates in
Pain Management and Tissue Engineering
M. Gazzarri1, A.M. Piras1, F. Chiellini1
1Laboratory of Bioactive Polymeric Mateirals for Biomedical
and Environmental Applications (BIOlab)—UdR INSTM, De-
partment of Chemistry & Industrial Chemistry, University of
Pisa, Via Vecchia Livornese 1291 56122 S. Piero a Grado, Pisa
(Italy).
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Today pain management and tissue engineering are two impor-
tant medical issues. Pain control problems include inefficacy
of conventional drugs, serious side effects and tolerance. Naturally
derived hydrogels have frequently been used in drug delivery
technology and tissue engineering, due to their good biocompati-
bility and similarity to the natural extracellular matrix.
In this work commercial alginate and ulvan, an alginic type
material obtained from renewable resources, were investigated for
applications in pain management and neural/hepatic tissue engi-
neering. The undertaken strategy consists in the set up of a poly-
meric system able to sustain viable and metabolically active
PC-12 cell line, which retains chromaffin cell characteristic such
as the synthesis and secrection of endogenous opioids, in order to
combine a good pain control with reduced side effects.
Alginate beads, loaded with PC-12 were prepared using micro-
precipitation technique. Cells loaded into alginate beads showed a
higher proliferation in respect to controls, representing a goodmodel
of bioactive scaffolds. Ongoing investigations are devoted to the
identification and quantification of secreted morphine, by means of
HPLC.
However, ionically crosslinked alginate has limited mechanical
stability under physiological conditions. For this reason, both
polymers were functionalized with phenol moieties and success-
fully processed into enzymatically crosslinked hydrogels by a
peroxidase-catalyzed oxidative coupling, obtaining an enhanced
stability in physiological environment.
Preliminary results indicate that these promising hydrogels can
be employed for both neural tissue regeneration, using SK-N-SH
neuroblastoma cell line, opportunely induced to differentiate to-
ward a neuronal phenotype, and for bio-artificial liver support
systems, using HepG2 hepatoblastoma cell line.
(P 43) Biocompatibility and Degradation of Elastomeric
Nanomaterials for Soft Tissue Engineering
M. El Fray1, P. Prowans2, A. Piegat1, P. Zdebiak1
1Szczecin University of Technology, Polymer Institute, Division
of Biomaterials and Microbiological Technologies, Pulaskiego 10,
70-322 Szczecin, Poland.
2Pomeranian Medical University in Szczecin, Clinic of General
and Hand Surgery, ul. Unii Lubelskiej 1, 71-344 Szczecin, Poland.
Nanometric constructs, containing inorganic fillers in different
polymer matrices are becoming an emerging type of biomaterials
for soft tissue regeneration. On the other hand, elastomeric poly-
mers derived from monomers from renewable resources are be-
coming very important class of materials. Recently, we produced
an elastomeric polymer matrices, which combined with nanometer-
size ceramic particles showed various interesting mechanical prop-
erties and degradation profile. In this work, we present the results of
evaluation of the degradation process in vitro and tissue response
after implantation of polymer/ceramic materials into soft tissue.
Material composed of poly(ethylene terephthalate) hard seg-
ments and dilinoleic acid sequences in soft segments was synthe-
sized in a presence of TiO2 nanoparticles. Polymer/ceramic
materials were implanted into muscles of Wistar rats weighing
200–250 g. After implantation cellular detail, morphology was
investigated by light microscopy. Observations were compared
with those obtained from polymer without TiO2. Medical grade
poly(dimethylsiloxane) was used as a control.
In vitro degradation studies showed that TiO2 nanoparticles
demonstrated a strong influence on water absorption, crystallinity
and molecular weight of nanocomposites. The decrease in Mn after
6 months was 69% for the neat copolymer, whereas 41% was found
for the nanocomposite, thus suggesting that nanoparticles indeed
contributes to the nanoreinforcing effect. The predominant cell type
found after long term implantation were fibroblasts. Lymphocytes
were in smaller amount as compared to silicone control.
This work has been financed from the research project DWM/
18/POL/2005.
(P 44) Biocompatibility of an Acellular Porcine Meniscal
Scaffold
T.W. Stapleton1, J. Ingram1, J. Fisher1, E. Ingham1
1University of Leeds.
Background: Meniscal damage is associated with detrimental
changes in the knee which may lead to osteoarthritis. There is a
need for meniscal replacements which can provide long-term
chondroprotection. An acellular porcine meniscal scaffold (APMS)
has been previously developed which has the potential to provide
an acceptable solution. The aims of this study were to further assess
the biocompatibility of the APMS through studies of cell attach-
ment in vitro and implantation of APMS tissue in mice.
Methods: Decellularization was performed by subjecting tissue
to freeze thaw cycles in combination with sequential incubation in
hypotonic buffer/0.1% (w/v) sodium dodecyl sulphate. Cell at-
tachment was investigated in vitro using primary porcine meniscal
cells (PMMCs) and primary human dermal fibroblasts (PHDFs)
cultured on APMS. Cell attachment and morphology was deter-
mined by SEM and histology following 7 day culture. The APMS
and fresh tissue were implanted subcutaneously in GTKOmice and
explanted at 3 months for histological and immunohistochemical
analysis to determine any immunological reaction.
Results and conclusion: Both cell types readily attached to the
APMS following 7 day culture. Cells showed no signs of cytotoxity
and took on a flattened appearance. In the case of PHDFs, cells
were shown to infiltrate the scaffold. Analysis of mouse explants
revealed a thin capsule surrounding the APMS tissue. Cell phe-
notyping showed no evidence of a specific immune response.
Macrophages, endothelial and fibroblast-like cell infiltrated the
tissue indicating a possible remodelling response. This study
confirmed the excellent potential of the APMS for use as a tissue
engineered meniscal replacement.
(P 45) Biocompatibility, Osteo-Compatibility and Mechanical
Evaluations of Novel PLDLLA/TcP Scaffolds
R. Olkowski1, C. X. F. Lam2, W. Swieszkowski3, K. C. Tan4,
M. M. Savalani2, I. Gibson5, M. Lewandowska-Szumiel1, D. W.
Hutmacher2,6,7
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Composites comprising of biopolymers and bioceramics are useful
as scaffolds for bone tissue engineering, because of they could
functionally mimic native bone, hold potential osteoinductivity, as
well as relativeeaseof controlingmechanical properties, degradation
and resorption rates, through composition variations. The aim of our
work was to design and fabricate a novel composite scaffolds for
bone tissue engineering in medium/high load bearing applications.
Novel composite scaffolds were fabricated by blending Poly
(L-lactide-co-D,L-lactide) (PLDLLA) a copolymer with a ceramic-
tricalcium phosphate (TCP). The extrusion deposition method was
used to fabricate the scaffold with high open porosity. Scaffold
architecture and porosity was analysed by scanning electron mi-
croscopy and nano-computed tomography. Mechanical properties
were analysed by compressive tests of dry and wet composite
scaffolds. Porcine bone marrow stromal cells (BMSC) were seeded
onto the scaffolds and cultured in vitro for up to 8 weeks. BMSC
cultured on 2D polystyrene served as positive control. Cell prolif-
eration was studied by microscopic observations and DNA quan-
tification. To assess cell viability, Alamar Blue metabolic assay and
FDA/PI fluorescent staining with confocal observation were per-
formed. Osteogenic differentiation of BMSC was analysed by
Western blot of osteopontin.
Mechanical tests showed encouraging features of composite
scaffolds. BMSC expressed intensive proliferation, metabolic ac-
tivity and osteogenic differentiation capability on the PLDLLA/
TCP scaffolds in vitro. From these results composite PLDLLA/
TCP scaffolds exhibit potential for bone tissue engineering.
(P 46) Biocompatible Polyurethane Films Incorporation with
Antibacterial Silver Loaded Zeolites
E. A. Aksoy1,2, K. Kamıs¸og˘lu3, B. Akata2,4, N. Bac¸5, N. Hasırcı6,7
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2METU, Central Laboratory, 06531 Ankara, Turkey.
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4METU, Grad. Dept. Micro-Nano Technology, 06531 Ankara,
Turkey.
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Polyurethanes are polymers which are commonly used in blood
contacting devices since they have inherent antithrombogenic and
excellent mechanical properties. It is important that, devices like
catheters should not cause infections because of adherence of
bacteria on the surfaces. There are some techniques for surface
modifications such as addition of antibiotics or antibacterial sub-
stances. In this study, micron size nanoporous crystalline alumi-
nosilicate zeolites are synthesized and modified with silver ions in
molecular level, and combined with polyurethane forming anti-
bacterial composite films. Polyurethane films were synthesized in a
closed vacuum system in medical purity by using toluene diiso-
cynate and polypropylene ethylene glycol without adding any other
ingredients such as solvent or chain extender. Micron size zeolites
were synthesized hydrothermally from gel solutions in three
composition; as zeolites; A, X and Beta with low, intermediate and
high SiO2/Al2O3 ratios, respectively, and loaded with silver ions by
cation exchange process. Then prepared zeolite crystals were added
on prepolymer of polyurethane and cured. The composite films
were examined by SEM and tensile tester instrument. Addition of
zeolite particles into the structure improved the mechanical prop-
erties of the composite films compared to the unloaded polyure-
thane films. Antibacterial zeolite-PU composite films were placed
on agar plates containing Escherichia coli and the bacterial growth
inhibition zones were examined for all types of composite films.
About 1-2mm clear inhibition zones which show the presence of
antibacterial activity were observed around composite films.
Acknowledgements: This project was supported by METU-BAP
and European NoE EXPERTISSUES Projects.
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gineering and Other Biological Applications: Unexpected
Findings From a Mouse Model
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1Department of Orthopaedics and Traumatology, 9/F Laboratory
Block, LKS Faculty of Medicine, Sassoon Road, The University
of Hong Kong, Hong Kong SAR of China.
2GKSS-Forschungszentrum Geesthacht GmbH, MagIC—
Magnesium Innovation Centre, Max-Planck-Str. 1, D-21502
Geesthacht, Germany.
3Department of Orthopaedics and Traumatology, 5/F Professional
Block, Queen Mary Hospital, Pokfuklam, Hong Kong SAR of
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Magnesium and its alloys had been investigated for use as an ab-
sorbable implant since the beginning of the 20th century. However,
rapid gaseous evolution hindered its further use. Renewed interest
of it as biomaterial has re-emerged recently on orthopedic and
cardiovascular applications, but the use on tissue engineering was
rarely explored despite its good biocompatibility. Degradation
properties and host response of AM50A, AM60B, AZ91 alloys and
99.95% Mg are investigated in this paper. Polished Mg and Mg
alloys treated with concentrated NaOH and DMEM were im-
planted subcutaneously into a mouse for 6 months. X-ray investi-
gations were conducted twice a week for the first two weeks and
weekly thereafter, but there was no significant gas formation ob-
served for AM50A, AM60B and AZ91D. After implant retrieval,
some gas bubbles were detected under the fibrous layer covering
the implants. This implies that a lack of gas pocket on an X-ray
image is insufficient for the declaration of a lack of gaseous ac-
cumulation. Moreover it could be observed that the Mg alloys
under investigation did not degrade fast in the body. In fact there
was nearly no observable dimensional change for the alloys (ex-
cept the 99.95% Mg) after implantation. AZ91, a commonly used
alloy on literatures, was found with much more pitting corrosion
than commercially available AM50A and AM60B alloys. This
suggests that the use of AZ91 to illustrate the relatively better
corrosion profile of another alloy may be misleading.
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Poly(L-lactic acid), a synthetic biodegradable polyester, is widely
accepted for many tissue engineering applications. Hyaluronic acid
(HA), as a polysaccharide of the extra cellular matrix (ECM),
besides exhibiting an excellent biocompatibility, influences cell
signaling, growth and differentiation. A combination between
these materials might be interesting for tissue engineering studies.
However, HA must be chemically modified for this use because
of its easy dissolution in water and quick degradation in biological
environments. Glutaraldehyde, GA, has been proposed as cross-
linking agent to produce HA hydrogels. However, accordingly to
the literature, there are contradictory results about the experimental
protocol to be used, and relating to the cytotoxicity caused by glu-
taraldehyde remaining in the sample after crosslinking reactions.
In this study, crosslinking was performed by immersion of HA in
water-acetone mixtures containing GA. Reaction was performed in
several steps with increasing water/acetone ratios. Higher GA
concentrations and higher crosslinking reaction times than the
literature were necessary in the addition to the multistep procedure
to obtain HA samples that do not dissolve in water within in vitro
culture times. Poly(L-lactic acid) tridimensional scaffolds were
made by compression moulding followed by particulate leaching,
and after the scaffolds’ impregnation with soluble HA and drying,
there was a subsequent crosslinking reaction with glutaraldehyde
with the procedure described above.
A morphological study and physical characterization of the
hybrid scaffolds, and preliminary results with human fibroblasts
and human dental pulp mesenchymal cells show the ability of these
scaffolds for tissue engineering applications.
(P 49) Biological Evaluation of Macroporous Scaffolds with
Different Surface Energies for Regeneration of the Central
Nervous System
D. Dias Veiga1,2, I. Nebot3, J.F. Mano2,4, J.L. Go´mez Ribelles1,5,
J.M. Soria5,3
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Central nervous system trauma and neurodegenerative diseases
involve massive neuronal and glial cell death and loss of the three-
dimensional spatial organization and connectivity of the neuronal
networks. In this work we employ a biostable model system to
study differentiation and viability of neural precursors in 3D
scaffolds.
Polymer scaffolds with interconnected porous with 90 microns
of pore size were produced varying the hydrophobic-hydrophilic
monomeric units ratio along the polymer chain. The materials
studied, biocompatible and biostable, were polymer or copolymer
networks based on the hydrophobic homopolymer poly(ethyl ac-
rylate), PEA, and its copolymers with hydroxyethyl acrylate,
p(EA-co-HEA) and methacrylic acid, p(EA-co-MAAc). In these
biomaterials, the survival of differentiated functional neurons de-
rived from cultured subventricular zone (SVZ) postnatal neural
stem cells was investigated.
The tissues obtained from the SVZ of postnatal rats were plated
in DMEM/F12 basal medium, with EGF and FGF as single sus-
pensions. The formed spheres (neurospheres) were then collected
and dissociated mechanically, the new microspheres formed were
dissociated again and the process was repeated two times. After
dissociation at the third passage, cells were seeded onto the dif-
ferent biomaterials with a differentiation medium of neurospheres.
The neuronal cells were identified by immunocytochemical
labeling for the neuronal marker TUJ1, and for the glial marker
GFAP. The results with DAPI showed that in all the materials,
but mainly in p(EA-co-MAAc) scaffolds, cells survived inside
the pores of the biomaterial. These are promising results that prove
that these constructs have great potential in neuronal tissue engi-
neering.
(P 50) Biomechanical Stimulation of Hl-1 Cardiomyocytes
Cultured in Poly-(1,8-Octanediol-Co-Citric Acid) [Poc] Scaf-
folds
L.A. Hidalgo-Bastida1, J.H. Ingram2, R. Majani1, F.H. Falcone3,
L.D. Buttery1, F.R.A.J. Rose1, E. Ingham2, W.C. Claycomb4,
K.M. Shakesheff1
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Cardiac diseases are the main cause of death in Western countries
and one of the most expensive diseases to treat for the health
services. Current therapies do not offer a complete cure, with the
exception of heart transplantations; however, the shortage of do-
nors limits the number of patients who can benefit from this
treatment. Cardiac tissue engineering works towards the creation
of an engineered muscle by providing cardiomyocytes with
physical support and biochemical factors. This approach aims to
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ensure the survival, proliferation and differentiation in vitro as
well as a fully integration into the prospective host by offering
high cellular retention within the implantation. The possible ap-
plications of such construct would not only be in clinical therapies
but also as a substitute of animal models for drug screening and
tests.
It has been shown that constructs seeded with cardiac cells and
cultured under mechanical stress have an increased protein ex-
pression, differentiation and survival time compared to those cul-
tured without mechanical stimuli. TENCELL is a mechanical
bioreactor which allows applying either compressive or stretching
load in a controlled environment. Poly-(1,8-octanediol-co-citric
acid) [POC] has been reported previously as a flexible biomaterial
suitable for cardiomyocyte culture. In this study HL-1 cells were
seeded in POC scaffolds and mechanically stimulated to assess
whether there was any effect caused by the uni-axial stretching
load applied to the constructs. Variations in the seeding conditions
as well as in the stretching regimen were also explored.
(P 51) Bioreactor System for Bioengineered Cartilage Grafts
R.M. Schulz1, N. Wu¨stneck1, A. Bader1
1University of Leipzig, Center for Biotechnology and Biomedi-
cine, Cell Techniques and Applied Stem Cell Biology.
It has become evident that complex culture systems are necessary
for the cultivation of appropriate articular cartilage equivalents
with acceptable biological and mechanical properties. It is appar-
ent that the first requirement—the application of mechanical
loading to chondrocytes—is essential for the tissue engineering of
cartilage substitutes. Perfusion has been identified as the second
requirement when designing a bioreactor system for cartilage
grafts since a fluid environment ensures a supply of nutrients and
waste products are removed efficiently. Finally, there is a third
requirement—compliant to cGMP regulations—which any system
used commercially for the cultivation and stimulation of tissue
engineered cartilage would have to satisfy. With these key re-
quirements in mind, we set out to develop a completely new system
for the tissue engineering of matrix-coupled autologous chon-
drocyte transplants (MACTs) intended for both research and
clinical applications.
The designed bioreactor station for simultaneous loading and
perfusion of MACTs in a sealed, autoclavable, twin chamber cul-
ture device with a magnet-driven actuator for the cyclical
mechanical compression of substitutes reflects a novel biotechno-
logical outcome. Uniaxial construct deformations are guided by
external magnetic fields that were feedback-controlled in real time
by the established innovative sensing concept that is based on ac-
curate, reliable measurements of a platform load cell and an in-
ductive proximity sensor. Those devices also allow for contact-less
monitoring of the tissue development or rather the elastic property of
the grafts. Additionally, the system enables dynamic medium sup-
plementation, sterile sample removal, and incorporates online mea-
surement of relevant biochemical and biomechanical parameters.
(P 52) Bioresorbable Polymer Scaffolds Reinforced with In-
Situ Generated Hydroxyapatite for Tissue Engineering Ap-
plications.
F. Bondioli1, P. Fabbri1, M. Messori1, A.M. Ferrari2
1University of Modena and Reggio Emilia, Dept. Materials and
Environmental Engineering, Modena (Italy).
2University of Modena and Reggio Emilia, Dept. of Science and
Methods for Engineering, Reggio Emilia (Italy).
In this work biodegradable polymer scaffolds, for potential appli-
cation in the reconstruction of damaged bone tissues, were prepared
with policaprolactone (PCL) reinforced with hydroxyapatite (HA)
generated in-situ thruogh a sol-gel method. This preparation method
is proposed as a possible solution to issues related with the intrinsic
composite nature of these organic-inorganic scaffolds, since it al-
lows the preparation of a continuous inorganic network of HA
having a controlled porosity, directly inside the polymer matrix.
The synthetic route is presented for the obtainment of a pure HA
porous crystalline phase by a mild solution process, alone or in the
presence of the polymer matrix. HA was proven to be obtained in a
completely pure crystalline phase by means of XRD analysis, and
results are reported. The morphology of the polymer scaffolds
reinforced with different amounts of HA was investigated through
scanning electron microscopy, and was demonstrated to be highly
tunable by changing the experimental conditions for the sol-gel
reaction.
(P 53) Bone Marrow Stem Cells on Different Wettability
Surfaces
J.Y. Lee1, H.H. Ahn1, B.S. Kim1, M.S. Kim1, G.S. Khang2, H.B.
Lee1
1Fusion Biotechnology Research Center, Korea Research Institute
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The effect of surface wettability in the view of the cell-surface
interaction has been extensively studied because of its importance
in the design of implant scaffolds. Therefore, the cell-surface in-
teraction is one of the most important factors in the development of
implantable scaffolds. The objective of this study was to investi-
gate the adhesion and proliferation behavior of human bone mar-
row stem cells (hBMSCs) on gradient wettable polyethylene (PE)
surfaces prepared by corona discharge treatment.
Corona discharge treatment was applied to modify the surface of
PE. The wettability of PE surface was gradually increased by
power increase of a corona treatment along the PE length, indi-
cating that the hydrophilicity of PE surface increased gradually.
The adhesion and proliferation behavior of hBMSCs on the gra-
dient PE surface was evaluated. We found that hBMSCs were
adhered to and proliferated on better highly hydrophilic than hy-
drophobic surfaces. The plot of proliferation rate vs. the water
contact angles was parabolic.
In conclusion, we found that the adhesion and proliferation
behavior of hBMSCs depends strongly on surface wettability in
agreement with previous reports.
(P 54) Bone Marrow Stromal Cells Differentated into Cardi-
omyocytes within Three-Dimensional Collagen Scaffolds
J.M. Wang1, T.Q. Liu1, K.D. Song1, X.H. Ma1, Bo. wang2,
Z.F. Cui3
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Bone marrow stromal cells (MSCs) have been thought to be an
attractive candidate for treatment and application of cardiac dis-
eases. However, they are limited in the clinical application be-
cause of their poor differentiated ability into cardiomyocytes in two-
dimensional culture conditions. As the cells are more viable in the
appropriate microenvironment, we hypothesized that MSCs might
be easy to differentiate into cardiomyocytes within three-dimen-
sional collagen scaffolds. In this study, the primary MSCs were
isolated from Sprague-Dawley rats and expanded in proliferated
medium. Their phenotypes were identified with flow cytometer. For
subsequent three-dimensional study in vitro, MSCs seeded into
three-dimensional collagen scaffolds and treated with 5-azacitidine
for 24 hours were regarded as experiment group, while those cul-
tured in T-flask were regarded as control group 1, and the MSCs/
Collagen scaffolds without treatment with 5-azacitidine were the
control group 2. After 2 weeks, immunofluorescence staining
against connexin-43, myosin heavy chain(MHC), and cardiac tro-
ponin-T(cTn-T) for cardiomyocyte were performed to the section of
scaffolds. The results showed that immunostainings were positive
against connexin-43, MHC, and cTn-T on the experiment group
section and control group 1; as contrast, no connexin-43, MHC, and
cTn-T expression was observed in the control group 2. The positive
expression of experiment group is stronger than that in control group
1. It is concluded that after being treated with 5-azacitidine, MSCs
could differentiate into cardiomyocytes, and MSCs within three-
dimensional collagen scaffolds have higher differentiated ratio than
that in T-flasks.
(P 55) Bridging Critical Size Defects Applying Tissue En-
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Critical size defects of bone cannot be expected to heal by de novo
bone formation within the physiological bone healing mechanisms.
Here we applied macro porous polylactid glycolid/CaP (PLGA/
CaP) composite foam matrices (Osteo Scaf TM) additionally
coated with nano particulate CaP using a modified biomimetic
method. Geometry and pore size of the scaffolds mimicked the
architecture of human trabecular bone.
The animal study was licensed (license number 35/9185.81-3)
by the regional council Tu¨bingen according to EU ISO 10993-6.
The strain chinchilla bastard was used because these animals are
known to be less stress susceptible and have more stable bones.
Non seeded scaffolds and scaffolds seeded with allogenic rabbit
bone marrow cells (aspired from iliac crest) were implanted in
18mm defects of chinchilla diaphyseal femur. The scaffolds were
seeded with bone marrow cells using a recently developed biore-
actor technology.
The cell seeded scaffolds effectively enabled the bridging of the
neighbouring bone parts in this critical defect.
This project was supported by the EU-Project G5RD-CT-2000-
00282.
(P 56) C-Terminal Epitope Tagging of Bone Morphogenetic
Proteins Interferes with Bioactivity
G. A. Feichtinger1,2, D. Dopler1,2, A. Banerjee1,2, H. Redl1,2,
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Terminal epitope tags are widely used in protein expression
and purification approaches due to their unique properties for de-
tection and affinity purification. The aim of this study was to
generate C-terminal tagged versions of human BMP2 and BMP7
for purification after expression in eukaryotic cell lines (C2C12,
CHO).
BMP2 was tagged with a FLAG-tag (-DYKDDDDKG) and
BMP7 was tagged with a 6HIS-tag (-HHHHHH). C2C12 cells
were transfected with plasmids harboring the full length cDNAs of
either tagged or untagged BMPs by lipofection. Osteogenic dif-
ferentiation of C2C12 cells was analyzed after expression-culture
in DMEM containing only 1% fetal calf serum to reduce back-
ground signals potentially generated by osteogenic factors present
in the added serum. We employed alkaline phosphatase assays,
RT-PCR, morphology and von Kossa staining as criteria for os-
teogenic differentiation to compare the bioactivity of the produced
growth factors. Positive over-expression was confirmed by RT-
PCR for human BMP2 and BMP7 as well as by immunological
detection methods for the tagged variants (Western-blotting and
Immunocytochemistry).
Our results indicate that C-terminal FLAG- or HIS-tagging of
human BMPs reduces or even abolishes their bioactivity in vitro
compared to untagged variants probably by interfering with
secondary or quaternary structure. Nevertheless, non-reducing
Western-blotting for FLAG-tagged hBMP2 confirmed successful
dimer formation. These findings support the use of protease cleav-
age-sites for removal of C-terminal protein tags in eukaryotic or
prokaryotic expression-systems.
This work was supported by the European projects
Hippocrates (NMP3-CT-2003-505758) and Expertissues (NMP-
CT-2004-500283).
(P 57) Calcium Phosphate Formation Causes an Inflammatory
Response To a Prototype Biomaterial Scaffold
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Calcium ions are used for cross-bridging in a variety of bioma-
terials and have been incorporated into a dermal replacement
scaffold under development in our laboratory. In vivo evaluations
of these scaffolds in a porcine full thickness wound model re-
vealed a degree of inflammatory response. The aim of this study
was to identify and characterise the cause of this inflammation.
Endotoxin assay ruled this out as a contributory factor. In-
flammatory potential of individual scaffold components and su-
pernatants from whole scaffolds soaked for 24 hours in buffered
saline solutions were assayed in vitro using neutrophil CD18 ac-
tivation. Inflammatory response in vivo was measured using a
histological scoring system. In vitro studies established that of all
the components and degradation products of the scaffolds, only
calcium chloride in PBS resulted in significant CD18 activa-
tion, suggesting a potential source of inflammatory stimulus.
Further studies showed this effect depends on phosphate and could
be reduced by centrifugation. PBS solutions containing calcium
also stimulated release of neutrophil elastase, and the cytokines
IL-8 and TNF-alpha in whole blood cultures, suggesting a self-
stimulating mechanism driving the inflammatory response. In vivo
histology showed progressive inflammation in scaffolds was de-
pendent on the concentration of calcium used to make them.
Calcium phosphate precipitation and deposition may cause in-
flammation and should be carefully monitored and controlled in
biomaterials. We were unable to demonstrate marked effects
in supernatants but these data suggest that noxious effects of
calcium localised to the cell-biomaterial interface could drive an
inflammatory response.
(P 58) Can Functional Epidermal Keratinocytes be Derived
From Eccrine Sweat Glands?
S. Bo¨ttcher-Haberzeth1, T. Biedermann1, L. Pontiggia1, C.M.
Schiestl2, M. Meuli2, E. Reichmann1
1Tissue Biology Research Unit, University Children’s Hospital
Zurich.
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Our previous research shows that human eccrine sweat gland cells
can form a functional epidermis in vivo (1). Expression of various
keratinocyte-specific markers is similar in epidermal constructs of
both keratinocytes and sweat gland cells. We wanted to see, if
sweat gland cell-derived keratinocytes could also adopt a more
specific task of human keratinocytes, namely the uptake of mela-
nosomes into their cytoplasm.
We compared engineered skin substitutes derived from human
epidermal cells to substitutes derived from human eccrine sweat
gland cells. Human melanocytes were added to both cell types in a
ratio of 1:5 and were then grown on collagen hydrogels containing
human dermal fibroblasts. These constructs were transplanted onto
full-thickness skin defects created on immuno-incompetent rats
and were examined after 3 weeks.
This demonstrated that sweat gland cells can transform into a
stratified epidermis with melanocytes scattered in the basal layer.
However, early after transplantation these cells do not show an
interaction with melanocytes, as keratinocytes would.
We conclude that sweat gland cells cannot fully act like natu-
rally born keratinocytes in every perspective, at least not after a
time period of 3 weeks. We hypothesize that sweat gland cells may
need more time to be able to adapt to this new function, which is to
differentiate into true keratinocytes and incorporate melanosomes.
Studies to prove this are now being undertaken.
References:
(1) T.Biedermann et al., 2008
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for the Delivery of PDGF in Bone Tissue Regeneration Stra-
tegies
V. Espı´rito Santo1,2, A.M. Frias1,2, M.E. Gomes1,2, J.F. Mano1,2,
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One of the major drawbacks found in most bone tissue engineering
(TE) approaches developed so far consists in the lack of strategies
to promote vascularization. Some studies have addressed different
issues that may enhance vascularization in TE constructs, most of
them involving the use of growth factors that are involved in the
restitution of the vascularity in a damaged zone. The use of sus-
tained delivery systems might also play an important role in the re-
establishment of angiogenesis. In this study, k-carrageenan, a
natural polymer was used to develop hydrogel beads with the
ability to incorporate growth factors with the purpose of estab-
lishing an effective angiogenesis mechanism. Some processing
parameters were studied and their influence on the final beads
properties was evaluated. A model protein—ovalbumin (OVA)—
was encapsulated in the beads to optimize the procedure before
using the growth factor of interest, i.e., the Platelet Derived
Growth Factor (PDGF), selected as the angiogenic factor. The
results demonstrate that the developed system is mild and ade-
quate for protein incorporation and that an efficient encapsula-
tion and protein loading were achieved, as well as release profiles
matching those usually described for a typical hydrogel behav-
iour. Moreover, carrageenan shows a huge potential for applica-
tion in the biomedical field, namely in the development of
injectable systems, due to its gelling abilities. In general, the ob-
tained results demonstrate the potential of this system for bone TE
applications.
Acknowledgments: This work was supported by the European
NoE EXPERTISSUES (NMP3-CT-2004-500283) and the Euro-
pean STREP HIPPOCRATES (NMP3-CT-2003-505758).
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Introduction: While scaffolds employed in skeletal repair today
have excellent osteoconductivity, their porous structure permits
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soft-tissue ingrowth. To address these problems, a novel hy-
droxyapatite (HA) and tri-calcium phosphate (TCP) scaffold was
designed with filled internal porosity for in vitro and in vivo testing.
Methods: A 3D microprinting process was used to create mi-
crostructural lattices (11mm diameter, 3mm thickness, 250 mm
struts, 200mm pore size, HA:TCP ratio 60/40 or 15/85) that were
either left porous or filled with calcium sulfate/chitosan. To assess
for scaffold dissolution over time, porous and solid scaffolds were
placed in DMEMþ 10%FBS and weighed daily for 64 days.
In vivo, porous and solid scafffolds were implanted in a rabbit
critical-size calvarial defect model for 8 and 16 weeks and ana-
lyzed by micro-CT, histology, and SEM.
Results: Porous scaffolds retained 97 2% of their weight at 64
days. When filled by calcium sulfate, mass decreased linearly
(0.44%/day, R2¼ 0.92), correlating with gradual centripetal ex-
posure of the internal porosity at 1mm/wk. In contrast, chitosan
filling of the scaffolds was irregular in its dissolution. By 8 weeks
in vivo, scaffolds conducted bone across critical defects (85 18%)
compared to non-healed controls (p< 0.05). Bony ingrowth cor-
responded to the degradation rate of the calcium sulfate. Scaffold
filling also prevented ingrowth of soft tissue. Sixteen week samples
are being processed.
Conclusions: Filling with calcium sulfate successfully limited
bloody infiltration and soft tissue ingrowth but retained osteo-
conductivity. Present work is focused on improving scaffold os-
teoinductivity by using these fillers to encase bioactive molecules
for rate-controlled release.
(P 61) Cartilage Tissue Engineering using Native and Re-
combinant Spider Silk Scaffolds.
P. V. Hatton1, A. C. MacIntosh1, V. Kearns1, A. Crawford1
1Centre for Biomaterials & Tissue Engineering, School of Clinical
Dentistry, University of Sheffield, Sheffield S10 2TA, UK.
There is evidence that biological or biomimetic polymers may
prove superior to traditional biomaterials for fabrication of tissue
engineering scaffolds. The aim of this study was to evaluate the
suitability of silk produced by Nephila edulis and a recombinant
spider silk for use in cartilage tissue engineering. Cylindriform silk
was used to form 3D scaffolds which were evaluated for chon-
drocyte adhesion and cartilage tissue engineering using published
methods (Hatton & Hollander 2003, Biopolymer Methods in Tis-
sue Engineering. Humana Methods in Molecular Biology Series).
Untreated spider silk scaffolds provided excellent substrates for
cell adhesion, but appeared not to support differentiation. Simple
pre-treatments resulted in scaffolds that supported tissue engi-
neering of a hyaline-like cartilage, and the results were improved
further by separating the scaffold into inner and outer portions.
Recombinant silk was not available in sufficient quantities to
fabricate a full scaffold, but chondrocyte pellet culture on fibres
suggested that they had comparable properties to the native ma-
terials. Overall, the results showed that relatively crude spider silk
scaffolds were capable of supporting the formation of a hyaline-
like cartilage with similar histological appearance and biochem-
istry to that formed on commercially available PGA scaffolds. All
spider silks provided comparable data to the PGA reference bio-
materials, and we therefore concluded that they have potential for
use as scaffolds in tissue engineering.
Acknowledgements: We acknowledge the EC for FP5 funding
(GRD1-2001-40464, SPIDERMAN) and contributions of our part-
ners including Vollrath (Oxford, UK), Engstro¨m and Johansson
(Uppsala, Sweden). The authors are members of EXPERTISSUES
(NMP3-CT-2004-500283).
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From Natural Origin Polymers for Cartilage Tissue En-
gineering Applications
E. G. Popa1,2, M. T. Rodrigues1,2, M. E. Gomes1,2, R. L. Reis1,2
13B’s Research Group—Biomaterials, Biodegradables and Bio-
mimetics; Dept. of Polymer Engineering, University of Minho,
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The ideal cell-carrier material for cartilage regeneration should
closely mimic the natural environment in a living articular carti-
lage matrix.
Natural based hydrogel like alginate-carrageenan and chitosan
(Alg-Car-Ch) can provide excellent supports for chondrocyte en-
capsulation due to their adequate mechanical strength to maintain
the initial shape of the implanted scaffold and sustain cells pro-
liferation and differentiation. To test this hypothesis, we investi-
gated the encapsulation behavior of a chondrocyte cell line ATCD5
into Alg-Car and Alg-Car coated with chitosan polymer. Alginate
beads and fibres were used as controls.
Spherical beads have been prepared by an extrusion technique
and the fibres were prepared using a coagulation bath. Different
formulations of beads and fibers, and different coagulation bath
were considered in order to determine the best conditions.
The formulations used in this study were characterized by dy-
namic mechanical analysis (DMA) and rheometer measurements.
Preliminary biological tests were performed by encapsulating
ATCD5 (1106 cells/ml) onto the developed beads and fibres for 1,
3, 7, 14 day of culturing. Cells-beads/fibres were characterized in
terms of viability (MTS assay), proliferation (DNA) and specific
markers for cartilage. The obtained results indicated that the dif-
ferent formulations showed good cellular viability and proliferation
after 14 days both in beads and fibres. On the basis of these results,
we conclude that alginate-carrageenan chitosan polymer formula-
tions both in spherical beads and fibers have a considerable potential
as a cell-carrier material for cartilage tissue engineering application.
(P 63) Cell Transplantation from Bench to Bedside: Implant
Evaluation for Clinical Tissue Engineering
C. Eder1, E. Falkner2, M. Mickel1, M. Ogon1
1Orthopaedic Hospital Vienna-Speising.
2Ludwig Boltzmann Institute of Health Technology Assessment.
Tissue engineering has emerged as a promising perspective in
orthopaedic surgery. In contrast to mechanical prosthesis, tissue
engineered products represent living implants interacting with the
recipient tissue. Careful assessment of biocompatibility is there-
fore crucial for transplantation success. Parts of these assessments
can be performed in a model as simple as a chicken egg.
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Various biomaterials (collagen sponge, Chondro-Gide, Chon-
drocell A, Bio-Gide) seeded with fibrochondrocytes were
transplanted onto the chorionallantoic membrane. Tissue compat-
ibility, angiogenesis and early degradation were evaluated. Cell
loss during transplantation, cell migration and tissue formation at
the implantation site were studied.
The highest biocompatibility ranking was achieved by Chondro-
Gide and Bio-Gide followed by Chondrocell A. The collagen
sponge showed significantly poorer biocompatibility patterns.
Average angiogenesis was 10 vessels per mm2 for Chondro-Gide,
8 vessels per mm2 for Bio-Gide, 7 for the collagen sponge and 3
for Chondrocell A. High cell seeding densities and short in vitro
incubation led to instable constructs and increased cell migration.
Even the colonisation of blood vessels was observed. Increasing
the in vitro incubation period led to stable constructs and sufficient
tissue formation at the transplantation site.
Sufficient cell delivery to the transplantation site is dependant on
the preliminary incubation period rather than the initial cell load.
High cell seeding densities lead to increased cell migration and
carry a risk of blood vessel colonisation with subsequent vessel
thrombosis. Construct stability as well as tissue compatibility and
angiogenetic patterns can be evaluated using the chick chor-
ionallantoic membrane as a rapid and cost efficient testing envi-
ronment.
(P 64) Channel-Like Pores in Hap-Containing Scaffolds for
Bone Engineering: Hydrogels Vs. Ceramics
F. Despang1, R. Dittrich2, A. Bernhardt1, Th. Hanke1, G. To-
mandl2, M. Gelinsky1
1Max-Bergmann-Center of Biomaterials, Institute of Materials
Science, Technische Universita¨t Dresden.
2Institut fu¨r Keramische Werkstoffe, TU Bergakademie Freiberg.
Micro-structured scaffolds with channel-like pores were produced
by ionotropic gelation of alginate, using a well-known sol-gel-
transition mechanism. Adapting the processing to biomedicine,
suitable scaffolds for bone regeneration could be obtained by
adding hydroxyapatite (HAP) [1]. Three types of constructs were
obtained ordered by increasing energy impact by heat treatment:
þ As prepared—composite of hydrogel reinforced by HAP [1], þ
Brown body (HAP after thermic polymer removal at 6508C) or þ
HAP ceramic sintered at 12008C.
Finding in all three cases very stable constructs with compres-
sion strength in lower MPa-range even for brown bodies, we can
freely choose between hydrogel and ceramic by heat treatment.
The pore structure and channels surface were characterized by
SEM. Temperature exposer led to shrinkage of the pore diameter
and grain coarsening seen as surface smoothening. Crystallites
were growing from 22 nm to 41 nm or 238 nm, respectivly, which
was proven by XRD becoming maybe important for resorption
of scaffolds by osteoclasts. Biocompatibility was evaluated by
in vitro cultivation of human mesenchymal stem cells (hMSC) on
the materials. Cell proliferation was monitored by DNA quantifi-
cation at different time points of cultivations showing 2.5 times
increase after three weeks for all material types. Osteogenic dif-
ferentiation of hMSC was confirmed via measurement of specific
alkaline phosphatase (ALP) activity. Maximum was reached at day
14 for brown body and ceramic but only at day 21 for the hydrogel
composite. Cell distribution and morphology were studied by
cLSM.
1J. Amer. Ceram. Soc. 2007, 90, 1703.
(P 65) Characteristics of Human Adipose-Derived Stem Cells
Submitted To Short-, Medium- and Long-Term Cultivation.
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The adipose tissue contains a stromal population composed of mi-
crovascular endothelial cells, smooth muscle cells and stem cells,
which can be enzymatically isolated. The adherent, mesenchymal-
like cells that establish under appropriate culture conditions, termed
adipose tissue-derived stem cells (ADSCs), have extensive prolif-
erative potential and may undergo multilineage differentiation.
They are currently considered as one of the most promising type of
adult stem cell for therapeutic applications. In this study, we char-
acterized human ADSCs submitted to different periods of culture:
short-term (1-9 passages), medium-term (10-19 passages) and long-
term (>20 passages) (n¼ 5 cultures each). The oldest culture ana-
lyzed had been maintained for 35 passages. Doubling population
indices were significantly higher for long-term and particularly for
medium-term cultures when compared to short-term cultures. The
clonogenic potential of the cultures, analyzed by limiting dilution,
was lower in older cultures. Cell plasticity was analyzed by inducing
adipogenic, chondrogenic and osteogenic differentiation of cultures.
The differentiation potential was similar in short- and medium-term
cultures, but showed a decrease in cultures older than 22 passages.
The immunophenotype, typical of ADSCs, was the same in the three
types of culture. The DNA content was analyzed by flow cytometry,
and was also unaltered (2n) in all cultures. These results show that
human ADSCs can be maintained in culture for prolonged periods
of time, but that long-term cultures loose some of the potential for
therapeutic applications, as shown by decreased plasticity and clo-
nogenic potential.
(P 66) Characterization of a Bioactive Scaffold for Cartilage
Repair
C. Clausen1, H. Everland2, K. Osther1
1Interface Biotech A/S.
2Coloplast A/S.
Introduction: The aim of this study was to determine the matrix-
synthesis, gene-expression and growth characteristics of human
articular chondrocytes (hACs) loaded on bioactive MPEG-PLGA
(metoxypolyethyleneglycol-block-co-poly(lactide-co-glycolide)
scaffolds. A variety of glycosaminoglycans (GAGs) were incor-
porated into the scaffold structure leading to a proposed chon-
drogenic bioactivity.
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Methods: hACs (passage 1) were loaded on bioactive MPEG-
PLGA scaffolds and after 1, 2, and 4 weeks, RT-PCR, histology and
ELISA analyses were performed. Furthermore immunohistochem-
istry (IHC) was performed using monoclonal antibodies against
Col2, Ag and Collagen Type 1. hAC monolayer cultures and
MPEG-PLGA without GAG incorporation were used as controls.
Results: hACs adhered to the scaffold and proliferated at a rate
similar to the control cultures. RT-PCR analysis demonstrated an
upregulation of the chondrogenic markers, S0X9, Col2 and Ag,
compared to control cultures. The presence of Col2 and Ag was
further verified on the protein-level by IHC. Toluidine Blue O -and
Safranin O staining demonstrated an elevated synthesis of pro-
teoglycans.
Discussion: Using the novel scaffold platform, MPEG-PLGA,
with a variety of GAGs incorporated, we analyzed the ability of
hACs to synthesis a cartilage matrix, by using gene expression
analysis, IHC, histology, and ELISA. Significant differences in the
analysis results were found, depending on the actual types of in-
corporated GAG. We conclude that this novel bioactive scaffold is
a powerful in vitro environment for culturing hACs for tissue en-
gineering. A goat study is now in progress to study this system
under in vivo conditions.
(P 67) Characterization of Human Pterygium As Source of
Mesenchymal Indifferentiated Cells
V. Go´mez-Gil1,2, G. Pascual1,2, C. Pe´rez-Rico3, M.A. Montes3, M.
Rodrı´guez3,2, J. Buja´n1,2
1Department of Medical Specialities. University of Alcala´, Alcala
de Henares, Madrid, Spain.
2Networking Research Center on Bioengineering, Biomaterials
and Nanomedicine. CIBER-BBN, Madrid, Spain.
3Department of Surgery. University of Alcala´, Alcala de Henares,
Madrid, Spain.
Background: Destruction of the limbal epithelium barrier is the
most important mechanism of pterygium formation (conjunctiva
proliferation, encroaching onto the cornea). It is thought to arise
from activated and proliferating limbal epithelial stem cells. The
objective of this study is to study cells extracted from human
pterygium to evaluate their potential as mesenquimal indiffer-
entiated cells.
Material andmethods: Cells fromhuman pterygiumwere isolated
by explantation and placed in culture with Amniomax medium.
Once the monolayer was reached the cells were seeded onto 24 well
microplates. The cells were studied in the second passage. The
immunohistochemical expression of the different embryonic stem
cell markers: SSEA-1, SSEA-4, PODXL, CD-9, Nanog and SOX2,
was analyzed.
The differentiated phenotypes were characterized with the
monoclonal antibodies anti-CD31, alfa-actin and vimentin.
Results: All the cells were positives for SOX-2 at a cytoplasm
level, but only around 1% was also positive at a nuclear level.
Nanog marker was present in all the population in the nucleus of
the cells. The majority of the cell population was positive for vi-
mentin, and CD-9. About 50% of the pterygium cells showed the
SSEA-4 mesenchymal stem cell marker. There were no positive
cells for the SSEA-1 marker. PODXL marker was only present in
10% of the total population. Less of the 1% of the cells were
positive for CD31 and alfa-actin markers.
Conclusions: The pleomorphic cell population obtained from
pterygium at the second passage expressed markers for an undif-
ferentiated phenotype compatible to mesenquimal indifferentiated
cells.
(P 68) Characterization of NGFRþ and CD34þ Hasc Sub-
populations: Comparison with Unselected Hascs (Pa-Hascs)
N. Quirici1, L. de Girolamo2,3, M.F. Sartori2, C. Scavullo1,
G. Lambertenghi Deliliers4, A.T. Brini2
1Fondazione Matarelli, University of Milan.
2Medical Pharmacology Department, Faculty of Medicine, Uni-
versity of Milan.
3IRCCS Galeazzi Orthopaedic Institute.
4Ematologia I, Ospedale Maggiore Policlinico IRCCS, University
of Milan.
Human plastic-adherent adipose-derived stem cells (PA-hASCs)
have been extensively characterized for their functional potentials
in vitro. In this study, we compared positive-selected CD34þ and
L-NGFRþ (low-affinity Nerve Growth Factor Receptor) subpop-
ulations with the whole PA-hASCs. In bone marrow, NGFR an-
tigen defines a subset of early MSC with a high proliferative
potential, a high degree of clonogenic efficiency and able to dif-
ferentiate into multiple mesodermal tissues. Phenotypic profile of
freshly purified subpopulations was assessed for CD45, CD133,
CD34, NGFR, CD117, GlyA, KDR, P1h12 and CD105 expression.
Most of the NGFRþ-hASCs is CD34þ, whereas selected CD34þ-
hASCs only partially coexpress NGFR. Proliferation and clono-
genic efficiency of these three hASCs fractions were tested, and
MSC specific markers expression was monitored over time during
culture. NGFRþ- and CD34þ-cells show a culture-dependent mild
decrease of NGFR and CD34 expression. In addition, the NGFRþ
and CD34þ subpopulations showed a higher proliferation rate
compared to the PA one. Testing their differentiation potential,
preliminary data indicate that NGFRþ-hASCs differentiate more
efficiently into adipocyte- and endothelial-like cells; in contrast
CD34þ-hASCs appear to better differentiate into osteoblast-
and chondrocytes-like cells. Indeed, osteogenic differentiated
CD34þ and NGFRþ hASCs produce a more abundant extracel-
lular calcified matrix, respect to the PA cells. Pellet-culture of
chondrogenic differentiated CD34þ and NGFRþ-hASC show a
glycosaminoglycan production which is significantly greater than
in PA pellet-culture differentiated cells. We suggest that the
NGFRþ and CD34þ purified hASCs are two purified homoge-
neous populations, with a mild different differentiation poten-
tial, which is more efficient than the PA unselected cell
population one.
(P 69) Characterization of PLGA/Demineralized Bone Particle
Composites as Scaffolds
H.H. Hong1, M.O. Baek1, S.H. Kim1, J.W. So1, J.Y. Lim1, M.S.
Kim2, H.B. Lee2, G. Khang1
1BK-21 Polymer BIN Fusion Research Team, Chonbuk National
University.
2Nanobiomaterials Lab, Korea Research Institute of Chemical
Technology.
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Intervertebral discs (IVD) are fibrocartilaginous tissues put be-
tween vertebral bodies in the spine. In this study, we developed that
composites scaffolds by combining poly (lactide-co-glycolide)
(PLGA) and demineralized bone particle (DBP). We evaluated
pore structure, porosity, water absorption ability of scaffolds for
the application of IVD.
PLGA scaffolds were prepared by solvent casting/salt leaching
method and were immersed in DBP acidic solution under a vacuum
so that the scaffold pores filled with DBP solution. The structure
morphology of scaffolds was observed by SEM. Porosity were
analyzed by mercury intrusion. We performed FTIR to confirm
whether DBP solution impregnated into PLGA scaffolds. Water
absorption ability was determined by measuring the weight of
scaffolds for 12 days.
We confirmed that DBP solution was impregnated into the pores
of PLGA scaffold. FTIR peaks appeared weakly in PLGA/DBP
scaffold because the amount of DBP solution put into PLGA
scaffold was limited. Water wettability test showed DBP solution
permeated into PLGA scaffold, thus the surface of DBP enriched
PLGA scaffold was easily wetted due to hydrophilicity of DBP.
The ability to absorb water was increased in PLGA/DBP scaffold
than in PLGA scaffold. This result suggested that high water ab-
sorption ability of PLGA/DBP scaffold would help interaction with
cells seeded in scaffolds.
We developed DBP sponge and PLGA/DBP composite scaf-
folds manufactured by mixing of PLGA solution and DBP powder.
A novel scaffold was manufactured to ensure the possibility of
application of degenerated IVD.
Acknowledgements: This research was supported by KMOHW
(0405-BO01-0204-0006) and SCRC (SC3100).
(P 70) Chitosan Gel as an In situ-forming Scaffold for Rat
Bone Marrow Stem Cells In vivo
K.S. Kim1,2, H.H. Ahn1, J.H. Lee1,2, J.Y. Lee1,2, M.S. Kim1, G.S.
Khang3, B. Lee2, H.B. Lee1
1Fusion Biotechnology Research Center, Korea Research Institute
of Chemical Technology.
2Department of Polymer Engineering, Pukyong National Uni-
versity.
3BK-21 Polymer BIN Fusion Research Team, Chonbuk National
University.
In situ forming gel scaffold is attractive because it can trap the
various growth factors, genes, and cells within the gel for the repair
and regeneration of damaged tissues. Chitosan-based matrixes are
widely used in the biomedical field such as cell encapsulation, drug
delivery, cell culture, and wound healing. In this study, we describe
an injectable gel carrier which consists of chitosan and glycerol
phosphate (GP) as an in vivo scaffold for rat muscle derived stem
cells (rBMSCs).
First, the phase transition behaviors of chitosan solutions for-
mulated with and without GP were characterized as a function
of temperature. Chitosan solutions containing > 20 wt% GP be-
came a gel at 37 8C and maintained this form for 28 days in vitro
and in vivo. Next, we examined whether the chitosan gel could act
as a suitable biocompatible substrate for the attachment and pro-
liferation of rBMSCs. Immunohistochemistry clearly demon-
strated that rBMSCs survived well on the scaffold created by
in situ-forming chitosan gel in rats. Injection of chitosan gel alone
induced macrophage accumulation in the host tissue and at the
edge of the chitosan, whereas injection of chitosan gel containing
rBMSCs was associated with decreased macrophage accumula-
tion, indicating immunosuppression by the transplanted rBMSCs.
We herein prepared an in situ-forming chitosan gel and showed
that it could be used as a biocompatible in vivo scaffold for
rBMSCs in Fisher rats.
(P 71) Chitosan Microparticles as Injectable Scaffolds for
Tissue Engineering Applications
D.M. Garcı´a Cruz1,2, J.L. Escobar Ivirico1,2, M. Gomes2, J.L.
Go´mez Ribelles1,3, M. Salmero´n Sa´nchez1,3, R.L. Reis2, J.F.Mano2
1Center for Biomaterials, Universidad Polite´cnica de Valencia,
46022 Valencia, Spain.
23B’s Research Group—Biomaterials, Biodegradables and Bio-
mimetics, Department of Polymer Engineering, University of
Minho, 4710-057 Braga, Portugal.
3Regenerative Medicine Unit, Centro de Investigacio´n Prı´ncipe
Felipe, Autopista del Saler 16, 46013 Valencia, Spain.
Microparticles may be used as a support for the adhesion and
proliferation of cells. Therefore, the combination of isolated par-
ticles and previously incubated cells on their surface may have
potential to be used, in the form of a suspension with media, as an
injectable scaffold in the context of tissue regeneration: on expects
that the particles might agglomerate after the implantation as a
consequence of cells proliferation and extracellular matrix pro-
duction. With this aim, chitosan microspheres were prepared by an
emulsion procedure involving cross-linking with natural chemi-
cals. Aqueous chitosan solution was added to mineral oil, con-
taining a surfactant to form the w/o emulsion. Then, genipin
solution was added as crosslinking agent. Varying the concentra-
tions of the different solutions involved in the process, genipin-
chitosan crosslinked microparticles with diameters ranging be-
tween 150 and 200mm were obtained. A 3D construct of these
microparticles and GBMCs (goat bone marrow stromal cells) were
used for ‘‘in vitro’’ cell culture. Viability, growth, adhesion, and
morphology of GBMCs were evaluated. The obtained results
demonstrated that the microparticles are a suitable support for cell
proliferation. The best results were obtained with microparticles
crosslinked with 20mM genipin.
(P 72) Chitosan Scaffold as a Structural Base Material for
Tissue Engineering
C.H. Kim1, H.J. Chun2, S.J. Park1, G.W. Kim1, Y.J. Gin1
1Korea Institute of Radiological and Medical Sciences.
2College of Medicine, The Catholic University of Korea.
This study is to develop a novel method for fabrication of the
chitosan scaffold improved their biocompatibility, based on a
thermally induced phase separation technique. The porous scaf-
folds were basically fabricated by solid-liquid separation and
subsequent sublimation of solvent. The effects of addition of n-
butanol, as non-solvent, into aqueous chitosan solution on pore
formation of chitosan scaffold were estimated. The pore diameters
of chitosan scaffolds could be controlled within the range 4*100
mm, with adjusting to ratio of n-butanol concentration. The inter-
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connectivity between pores over resulting chitosan scaffolds was
improved without any surface skin layer, compared to control
scaffold. We performed further examination of the changes in the
biocompatibility of the chitosan scaffold on human dermal fibro-
blasts (HDFs) after the addition of non-solvent by evaluating the
initial cell binding capacity and cell growth rate. The initial cell
adhesion on the new prepared chitosan scaffold was 190% higher
than control chitosan scaffold. The proliferation rate of HDFs in
the new prepared scaffold was 1.82-fold increase than that of
control chitosan scaffold, after 3 days culture. The new prepared
chitosan scaffold had the specific surface area enough for cell at-
tachment and tissue ingrowth.
(P 73) Chitosan Scaffold for Bile Duct Reconstructive Surgery
R. Tozzi1, A. Romani2, P. Soliani3, A. Borghetti2, R. Bettini1
1Department of Pharmacy, University of Parma, Italy.
2Department of Experimental Medicine, University of Parma,
Parma, Italy.
3Department of Surgical Science, University of Parma, Parma,
Italy.
This work aims at the preparation of a novel biodegradable chit-
osan tube-shaped scaffold intended for bile duct reconstruction.
The scope implies the development of a structure, with low perme-
ability to bile, possessing suitable mechanical resistance and poten-
tially able to act as drug delivery system for antimicrobial agents.
The goal is pursued by setting up a multilayer tube where
one layer is a crosslinked chitosan hydrogel, imposing mechan-
ical resistance and low permeability to bile, while the second layer
is a soft biomaterial acting as optimal cell substrate. The latter is
constituted by chitosan and excipients (such as sugars and/or
phosphate salts) added to a chitosan solutions. These excipients are
not recovered in the scaffold upon solidification, however, they
interact with chitosan during the hydrogel formation process. For
comparative purpose, monolayer scaffolds were prepared as well.
The physical properties and the biological features of the prepared
scaffolds have been investigated. The new scaffold shows marked
different structure and higher biocompatibility in comparison to
that obtained from the sole chitosan solution.
Multilayer scaffolds are less permeable to bile than monolayer
ones. This is due to the more compact structure of the multilayer
scaffolds as indicated by their lower porosity.
This last characteristic positively influences also the mechanical
properties in particular the resistance to surgical suture.
The novel material shows beneficial effects on cell culturing:
higher rate of cell attachment and doubling, lower cell detachment
even 15 days after seeding, a higher cell yield, and an adequate
differentiation morphology.
(P 74) Chondrocyte Redifferentiation in Alginate-Agarose
Hydrogel is not Enhanced by Rotating-Wall Bioreactor
A. Barlic1, E. Malicev2, N. Kregar-Velikonja1
1Educell d.o.o., Ljubljana, Slovenia.
2Blood Transfusion Centre of Slovenia, Ljubljana, Slovenia.
Autologous Chondrocyte Implantation method (ACI) has been
introduced for healing focal articular cartilage defects in the knee.
To obtain the necessary cell number for construct preparation,
harvested chondrocytes are expanded in vitro in a monolayer
culture system and subsequently seeded into alginate-agarose hy-
drogel. Three-dimensional environment of the hydrogel enables
redifferentiation of previously dedifferentiated chondrocytes. As
rotating-wall-vessel (RWV) bioreactor has been shown to stimu-
late chondrogenesis, we wanted to examine its effect on gene ex-
pression of chondrocytes assigned for ACI.
Four samples of human articular chondrocytes were cultured in
parallel in RWV bioreactor and static culture. After 14 days, ex-
pression of collagen type I, II, aggrecan and versican was assayed
by qPCR.
Results showed no significant differences in gene expression
between tested culture systems.
(P 75) Chondrogenesis Begins with Condensation: Tissue En-
gineering Recapitulates Embryonic Development
C.A. Hellingman1, W. Koevoet1, N. Kops2, R.J. Baatenburg de
Jong1, D.A. Frenz3, G.J.V.M. van Osch1,2
1Dept. Otorhinolaryngology, Erasmus MC, University Medical
Center Rotterdam, Netherlands.
2Dept. Orthopaedics, Erasmus MC, University Medical Center
Rotterdam, Netherlands.
3Dept. Otorhinolaryngology, Albert Einstein College of Medicine,
New York, USA.
In embryonic development the first stage of chondrogenesis is the
formation of a mesenchymal condensation, expressing N-cadherin.
To tissue engineer cartilage-like constructs of Mesenchymal Stem
Cells (MSCs), in-vitro culture models are used with a high cell
density, such as pellet cultures. The aimof the presented studywas to
study whether in-vitro chondrogenesis in the pellet culture is pre-
ceded by a condensation stage such as embryonic chondrogenesis.
Therefore, we differentiated Mesenchymal Stem Cells (MSCs)
from 4 different donors on chondrogenic medium, with and with-
out dexamethasone, which is known to accelerate chondrogenesis.
Pellets were cultured for 5 weeks and harvested on different culture
days and processed for immunohistochemistry on collagen II, as a
marker for chondrogenic differentiation, and N-cadherin.
Pellets cultured with dexamethasone produced a collagen II rich
matrix. In these pellets, N-cadherin expression increased in the first
7-10 days of culture in the centre of the pellets and decreased
before collagen type II production in week 2-3. On the other hand,
pellets cultured without dexamethasone did not produce any col-
lagen II within 5 weeks. In these pellets, N-cadherin expression was
high in weeks 2-3, and did not decrease until the end of culture.
In conclusion, chondrogenic differentiation in in-vitro pellet
cultures is preceded by a condensation stage, characterized by
N-cadherin. Time of onset of collagen II production seems to be
related to the duration of this condensation stage. Therefore,
N-cadherin seems to be a good marker to monitor progression
during chondrogenesis before collagen II production.
(P 76) Chondrogenesis of Human Mesenchymal Stem Cells
(hMSCs) Affected by 17ß-Estradiol
Zs. Jenei-Lanzl1, T. Dienstknecht1, R. Kujat1, M. Nerlich1,
P. Angele1
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Introduction: Tissue engineering (TE) using bone marrow derived
hMSCs is a potent strategy to repair defects of articular cartilage,
which have been shown to be a sex hormone sensitive tissue. We
investigate the effects of 17b-estradiol on the chondrogenic dif-
ferentiation of hMSCs in vitro.
Methods: Male hMSCs proliferated as a monolayer in serum-
containing medium. Using the harvested cells we created aggre-
gates and cultured them under serum-free conditions. First we
added Dehydroepiandosterone (DHEA), testosterone (T) and 17b-
estradiol (E2) in different concentrations in addition to the standard
medium containing dexamethasone. Afterwards we tested the E2
effects in several periods of differentiation. After 21 days we ex-
amined the aggregates macroscopically, by histology and im-
munhistology. Type II collagen content (RT-PCR, ELISA), DNA
and sulphated-glycosaminoglycan (sGAG) concentrations were
measured.
Results: Aggregates treated with DHEA and T did not show
significant differences in the size and extracellular matrix pro-
duction compared to the standard group, however we found sig-
nificant smaller aggregates, lower type II collagen and sGAG
content after E2-addition. The DNA content, which was equivalent
to the cell count, did not vary between the groups. The sequential
addition of E2 showed that the inhibitory effects of E2 occur during
the first 7 days of differentiation.
Conclusions: We found that chondrogenesis of hMSCs was re-
pressed by E2. Our results may provide important approaches for
the improvement of TE-construct quality for cartilage replacement.
Elucidating the detailed processes of E2-inhibition influencing the
initial phase of chondrogenic differentiation of hMSCs is the aim
of our current and future studies.
(P 77) Chondrogenesis using Mesenchymal Stem Cells and
PCL Scaffolds
S.Y. Kim1, G.I. Im1
1Dongguk university hospital.
Mesenchymal stem cells are considered as candidate cells for
cartilage tissue engineering by virtue of their ability to undergo
chondrogenesis in vitro. The purpose of this study is to test the
feasibility of PCL scaffold manufactured from melt-molding par-
ticulate-leaching method as a suitable material for cartilage tissue
engineering from MSCs. Porous polycaprolactone scaffolds were
fabricated by a melt-molding particulate-leaching method. Pluro-
nic F127 was blended with PCL to promote cell attachment by
enhancing hydrophilic property of scaffold. Collagen was also
added to PCL scaffold to enhance cell attachment in other samples.
MSCs at passage 3 were seeded into scaffolds and cultivated for 1
week under chondrogenic medium containing 10mg/ml of TGF-
b2. Then the cell-scaffold complex was prepared for histological
examination by paraffin block. Chondrogenesis of bone marrow-
derived cells can be reliably induced with TGF-b2 treatments, for
cultures seeded in all groups. The proliferation of DNA content
increased with PCL/collagen and PCL/F127/collagen scaffolds.
These scaffolds were effective in inducing cell proliferation. GAG
analysis showed enhanced level with PCL/collagen and PCL/F127/
collagen scaffolds. The findings from Safranin-O and type II col-
lagen staining closely paralleled the finding from GAG analysis.
We have shown by DNA contents, GAG analysis, histology and
immunohistochemistry that chondrogenesis of bone marrow-
derived cells can be reliably induced with PCL/collagen and PCL/
F127/collagen scaffolds. These findings suggest that the three-
dimensional PCL/collagen and PCL/F127/collagen scaffolds are a
potential candidate bioactive scaffold for cartilage tissue engi-
neering applications.
(P 78) Chondrogenic Differentiation of Adipose Derived Stem
Cells—a Bumpy Road
F. Hildner1,2, A. Peterbauer3,2, S. Concaro4, S. Wolbank3,2,
S. Marlovits2,5, C. Gabriel3,2, H. Redl1,2, M. van Griensven1,2
1Ludwig Boltzmann Institute for Experimental and Clinical
Traumatology, AUVA Research Center, Linz/ Vienna, Austria.
2Austrian Cluster for Tissue Regeneration.
3Red Cross Blood Transfusion Service of Upper Austria, Linz,
Austria.
4ECTEC—European Connective Tissue Engineering Center at
Chalmers University of Technology and Sahlgrenska Academy,
Gothenburg—Sweden.
5Dept. Trauma Surgery, General Hospital, Vienna, Austria.
Adipose derived stem cells (ASC) show multilineage differentia-
tion potential, however chondrogenic differentiation is challeng-
ing. Aiming to substitute chondrocytes in autologous chondrocyte
transplantation (ACT) this study focuses on optimization of
chondrogenic differentiation of ASC.
We evaluated the influence of 3 approaches (growth factors, co-
cultures, scaffolds) to improve chondrogenic differentiation of
ASC. First, media containing the growth factors TGF-b3, BMP-6
or FGF-2 were tested for their differentiation inducing capacity in
ASC pellet cultures. In the second approach we investigated syn-
ergic effects between cell types by co-culturing ASC with native
chondrocytes at different ratios. Finally, the role of different bio-
materials was studied and cells were seeded in fibrin or a collagen I
scaffold. Results were evaluated histologically, biochemically and
by qRT-PCR.
Glycosaminoglycan expression of pellet cultures could be in-
duced by TGF-b3/BMP-6/FGF-2. However, quantitative RT-PCR
data demonstrate a strong inhibitory effect on chondrogenic mar-
ker gene expression in presence of FGF-2, whereas TGF-b3 and
BMP-6 act as an inducer. Although TGF-b3 led to high COL2A1
expression on the mRNA level, BMP-6 was necessary to detect
collagen II immunohistologically. Interestingly, collagen X ex-
pression exceeded all other markers. So far, chondrogenic differ-
entiation was not enhanced in co-culture with chondrocytes. When
comparing fibrin and collagen I scaffolds the results were quite
controversial between different marker genes.
With a special growth factor repertoire ASC are able to differ-
entiate towards a chondrogenic phenotype. After optimizing the
combination of growth factors and cell density both matrices
should be suitable for cartilage regeneration using ASC.
(P 79) Chondrogenic Differentiations of Adipose Tissue- De-
rived Mesenchymal Stem Cells: the Effects of Higher Doses of
Growth Factors
H.J. Kim1, S.Y. Kim1, G.I. Im1
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There has been a controversy on the chondrogenic potentials of
adipose tissue- derived mesenchymal stem cells (ATMSCs) as
compared to bone marrow derived mesenchymal stem cells
(BMMSCs). This study examined the combination of growth fac-
tors that would induce effective chondrogenesis from adipose tis-
sue- derived mesenchymal stem cells (ATMSCs). Chondrogenesis
was induced by culturing the ATMSCs in pellets with the following
growth factors: #1, without growth factors (negative control) : #2, 5
ng/ml of TGF-b2; #3, 15 ng/ml of TGF-b2; #4, 25 ng/ml of TGF-b2;
#5, 5 ng/ml of TGF-b2 and 100 ng/ml of IGF-I ; #6, 15 ng/ml of
TGF-b2 and 300 ng/ml of IGF-I ; #7, 25 ng/ml of TGF-b2 and 500
ng/ml of IGF-I. The BMMSCs cultured under 5 ng/ml of TGF-b2
was used the positive control. The proliferation of DNA content
increased with higher doses of TGF-b2 and IGF-I combinations.
Higher doses of TGF-b2 and IGF-I combinations were effective in
inducing cell proliferation. GAG analysis showed enhanced level
with the combination of higher doses of TGF-b2 and IGF-I com-
binations. We confirmed the effects of these growth factor through
quantitative RT-PCR after inducing chondrogenesis. Adding higher
doses of TGF-b2 and IGF-I combinations made the expression of
type II and sox-9, maker of Chondrogenesis increase.The findings
from Safranin-O and immunohistochemical staining closely par-
alleled the finding fromGAG analysis. Higher doses of TGF-b2 and
IGF-I combinations, may be used to enhance chondrogenesis in the
chondrogenic differntiation from MSCs.
(P 80) Circulating Progenitor Cells Obtained from Valvular
Disease Patients: Potential Applications for Engineering Heart
Valves
D.J. Lee1,2, S. Tsangaris1, P. Baptista1, Y. Jarajapu1,2, E. Kincaid1,
N. Kon1, J. Berry1,2, S. Soker1, J.J. Yoo1, A. Atala1
1Wake Forest Institute for Regenerative Medicine, Wake Forest
University Health Sciences, Winston-Salem, NC 27157.
2Departments of Biomedical Engineering and Cardiothoracic
Surgery, Wake Forest University Health Sciences, Winston-
Salem, NC 27157.
One of the persistent problems with commercially available bio-
prosthetic cardiac valves is the formation of thrombosis and cal-
cification. This is mainly caused by deficiency of endothelial cell
coverage on the valve surface. We previously have shown that it is
possible to isolate a population of progenitor cells from circulating
blood that give rise to endothelial and muscle cells. However, the
use of progenitor cells for tissue engineering has not been studied
extensively. In this study, circulating progenitor cells were isolated
and expanded from blood samples of patients with valvular disease.
Progenitor populations were analyzed by fluorescent-activated cell
sorter (FACS) with endothelial cell (EC) and smooth muscle cell
(SMC) specific markers before and after differentiation. The ex-
panded cells were induced into endothelial and smooth muscle cell
lineages followed by immunohistochemical, biochemical, and
physiological analyses. Populations of circulating progenitor cells
were successfully isolated using Anti-CD133 and Anti-KDR anti-
bodies. CD133þ/KDRþ cells were grown and expanded in vitro.
After EC differentiation, cells stained positively for CD31, VE-
Cadherine and vonWillebrand factor (vWf). After muscle cell
differentiation, cells stained positively for SM a -actin and cal-
desmon. EC also formed capillaries inMatrigel. The proliferation
of EC was higher than that of tissue derived EC. EC cells seeded on
these matrices attached, proliferated and formed defined cell layers.
These engineered valve tissues possessed similar biomechanical
properties as normal valve tissues. The degree of coagulation was
minimal in cell seeded valve surfaces when compared to unseeded
decellularized valve matrices.
(P 81) Clonally Expanded Sca-1pos& Mesenchymal Stem Cells
Spontaneously Generate Heterogeneous Phenotypes In vitro
S. Pagliari1, G. Forte1, O. Franzese2, F. Pagliari1, P. Cossa1,
R. Fiaccavento1, F. Carotenuto1, A. Di Francesco3, M. Minieri1,
E. Traversa2, P. Di Nardo1
1Dept. Internal Medicine, Univ. of Rome.
2Dept. Neuroscience, Univ. of Rome.
3Div. Pediatric Oncology, Catholic University of Rome.
Mesenchymal stem cells represent a population of multipotent
progenitors residing within the bone marrow, whose ability to
generate different phenotypes in vitro and in vivo has been com-
pellingly demonstrated. Despite the great interest they raise as
possible candidates for cell therapy, the understanding of the
mechanisms controlling mesenchymal stem cell homeostasis re-
mains poor. In fact, several lines of evidence showed that among
MSC population, Sca-1þ, c-kitþ, Islet-1þ cells are present, but the
interactions between these subsets of progenitors are currently un-
known. To improve the knowledge on stem cell behaviour, a stable
murine Sca-1þ MSC stem cell line (Sca-1 mTERT-MSC) was
generated by mTERT ectopic transduction and single cell cloning.
This cell line displayed typical stem cell morphology, phenotype
and multipotency and preserved these features until at least the 150
passage in culture. When the immortalized Sca-1 mTERT-MSC
line was subjected to single cell cloning, few clones grew in culture.
The analysis of clone morphology, phenotype and differentia-
tion ability clearly demonstrated that they had distinct features: in
particular, while clone 1 and 3 continuously expressed Sca-1 and
preserved their multipotency, clone 4 spontaneously lost Sca-1
expression and multipotential capacity. Finally, clone 10 sponta-
neously proceeded to adipogenic differentiation in standard culture
conditions. These data strongly suggest that mesenchymal stem cell
compartment is intrinsically heterogeneous. These conditions are
likely to constantly occur in stem cell niches. These evidences imply
that very accurate protocols must be set up to envisage a factual use
of stem cells in the fabrication of engineered bio-substitutes.
(P 82) Co-Culture of Endothelial and Smooth Muscle Cells for
the Development of Blood Vessel Constructs
W. Szymczyk1,2, J.V. Arau´jo1,2, A. Martins1,2, E. Pinho1,2,
N. Neves1,2, A.P. Marques1,2, R.L. Reis1,2
13B’s Research Group—Biomaterials, Biodegradables and Bio-
mimetics, U. Minho, Campus de Gualtar, Braga, Portugal.
2IBB—Institute for Biotechnology and Bioengineering, PT Gov-
ernment Associated Laboratory, Braga, Portugal.
Diseases of the blood vessels, particularly of small diameter ar-
teries are responsible for most of deaths in developing and
developed countries. The number of operations using arterial
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prostheses and of small calibre vascular bypass reaches enormous
values every year. With the limited availability of functional au-
tologous vessels the need for new strategies to develop artificial
blood vessels is increasing. The aim of this work is to develop
constructs composed of a polymeric support with two different
surfaces, displaying distinct surface properties, to seed endothelial
(ECs) and smooth muscle cells (SMCs) with the purpose of ob-
taining an artificial blood vessel substitute.
Novel polycaprolactone (PCL) 2D bi-layer membranes fabri-
cated by means of electrospinning and solvent casting, were de-
veloped. ECs and SMCs were isolated from human umbilical cord
vein. After confirmation of the phenotype of the isolated cells
by immunocytochemistry, static co-cultures were established by
seeding ECs and SMCs respectively on the electrospinning and
solvent cast layer. Cell proliferation and collagen and glycosami-
noglycans (GAGs) production were assessed on the co-cultures
and on the isolated cultures established as controls.
The results revealed that the bi-layer structure enhanced the
proliferation rate and the collagen production in the co-culture
while no differences in GAGs deposition were observed. Moreover
the established co-culture system permitted to conclude that one
cell type was not negatively influencing the other. In this context,
the proposed structure constitutes an interesting strategy for as-
sembling a blood vessel substitute.
(P 83) Coating Human Bone Allograft Surfaces Markedly
Increases Mesenchymal Stem Cell Attachment and Prolifera-
tion In vitro
Z. Lacza1, M. Weszl1, A. Cselenyak1, G. Skaliczki2, C. Forster-
Horvath2, M. Szendroi2, M. Kollai1
1Semmelweis University, Dept. Human Physiology and Clinical
Experimental Research.
2Semmelweis University, Dept. of Orthopedics.
Lyophilized human bone allograft is regularly used for providing
mechanical stability and a scaffold for bone re-growth in cases of
bone loss. Several reasons are responsible for the very slow re-
building of the allografts, one of these is the low rate of mesen-
chymal stem cell recruitment. We designed a novel coating
technique which is able to increase the attachment and proliferation
capacity of stem cells. Human lyophilized bone chips were pre-
incubated with fibronectin, albumin, fetal calf serum or collagen I
solutions and used immediately or lyophilized before use. Me-
senchymal stem cells were cultured from human bone marrow and
seeded onto the constructs. Cell attachment and proliferation was
evaluated by confocal microscopy 3, 10 and 18 days after seeding.
The un-treated allograft barely attracted any cells and the con-
structs were devoid of cells after 18 days. Coating the bone with
fibronectin increased the attachment, however, proliferation and
long-term survival was still not achievable. Pre-incubating the bone
with human albumin, especially when it was lyophilized onto the
bone resulted in very good stem cell attachment and proliferation.
Collagen I and fetal calf serum were also effective. In vivo bio-
compatibility assays in rats showed survival of the graft after 4
weeks of implantation. This novel coating technique markedly
increased the number and proliferation potential of stem cells on
allograft matrices. This procedure may be applied to create im-
plantable bone substitutes which have a faster rebuilding time
in vivo.
Supported by OTKA T049621, AO¨U 66o¨u5, Bolyai and Oveges
Fellowships.
(P 84) Collagen-Chitosan Polymeric Scaffolds for 3D Culture
of Adipose Tissue-Derived Stem Cells
Y.X. Zhu1, T.Q. Liu1, K.D. Song1, X.H. Ma1, Z.F. Cui2
1Dalian R&D Center for Stem Cell and Tissue Engineering, Da-
lian University of Technology.
2Oxford Centre for Tissue Engineering and Bioprocessing, De-
partment of Engineering Science.
Introduction: To culture cells in a three-dimensional fashion,
scaffolding architecture and biomaterial used are vital. We have
proved that adipose tissue-derived stem cell (ADSC) had limited
proliferation ability in plate and our developed collagen/chitosan
scaffold had good biocompatibility with ADSC. Thus it is neces-
sary to investigate the proliferation ability of ADSC in collagen/
chitosan scaffold.
Methods: hADSCs were isolated and cultivated in plates and in
collagen/chitosan scaffolds for 14 days respectively. During the
culture period, the growth dynamic parameters and viability of
ADSCs were examined by CCK-8 kit every other day; the meta-
bolic rates of glucose and lactic acid were analyzed every day.
After 14 days, the cells in scaffolds were evaluated with scanning
electron microscope (SEM) for histological examination of the
aggregates. The surface markers (CD13, CD29, CD34, CD44,
CD45, CD105, CD166 and HLA-DR), the specific transcription
factors (Oct-4, Sox-2, Rex-1) and the multi-differentiation poten-
tial (adipogenic, osteogenic and chondrogenic) were also assayed
to identify the stemness of proliferated cells.
Results: The results showed that hADSCs in scaffolds could be
expanded by more than twenty times, and they presented better
morphology and vitality and stronger differentiation ability than
the cells cultivated in plates. All cells maintained stem cell char-
acteristics after expansion.
Discussion and Conclusions: Our developed collage/chitosan
scaffolds can promote ADSCs adhesion, template to organize and
direct the expansion of cells, and maintenance of differentiated
function. So it is a favorable scaffold for the proliferation and
differentiation of adipose tissue-derived stem cells.
(P 85) Combined Bioimplants for Articular Defects Healing
G. Tanasie1, M. Toth-Tascau2, F. Mirea1, M. Dreucean2, S. An-
ghel1, L.Schluszer3, C. Igna3
1University of Medicine and Pharmacy Victor Babes Timisoara.
2Politechnica University, Faculty of Mechanical Engineering.
3University of Agronomical Sciences and Veterinary Medicine
Banatul Timisoara.
The aim of the present study was the optimization of the in vitro
seeding procedures for mesenchymal stem cells (MSCs) culture on
3D matrices and evaluation of the in vivo behavior of these com-
bined implants.
MSCs were isolated from bone marrow of 15 dogs and seeded
on to collagen- polyglycolic and collagen- polylactic matrices.
The in vitro adherence of MSCs was evaluated. For the in vivo
study, the cartilage defects on the femoral condyls were surgically
POSTER PRESENTATIONS 825
induced. The defect shape and size was assessed by CT scan and
3D reconstruction. The healing process after 110 days was inves-
tigated by clinical, radiology (CT) and arthroscopic examination.
The results indicated good cells viability without significant
differences between scaffold types or seeding procedure. Regarding
the adherence the better results were noticed in case of collagen-
polyglycolic matrices. After 24 h incubation period, the cell at-
tachment rate was 70 5.86%, but after only 2h of cell-material
contact was noticed a percentage of 63 7.54% attached cells,
suggesting that the main interaction were developed in the first
hours. In 75% subjects of the experimental groups, the cartilage
was partially restored in the area of implant, compared with control
group in which was noticed lack of cartilage healing, only a slight
beginning of this process from the periphery. Histological aspects
are concordant with the clinical and imaging data.
(P 86) Combining Engineered Growth Factors, Adult Stem
Cells and Bioabsorbable Materials for Skeletal Repair and
Regeneration
L. Santos-Ruiz1, P.M. Arrabal1, R. Visser1, M. Cifuentes1, J.A.
Andrades1, S. Claros1,M.D. Cuenca1, A. Dı´az-Cuenca2, J. Becerra1
1Laboratorio de Bioingenierı´a y Regeneracio´n Tisular (LABRET);
Departamento de Biologı´a Celular, Gene´tica y Fisiologı´a; Uni-
versidad de Ma´laga; Facultad de Ciencias; Campus de Teatinos;
29071-Ma´laga; Spain.
2Instituto de Ciencia de Materiales de Sevilla (CSIC-USE); Centro
de Investigaciones Cientı´ficas Isla de la Cartuja; Avda. Ame´rico
Vespucio 49; 41092-Sevilla; Spain.
Due to the limited regenerating ability of human skeletal tissues,
severe injuries to the bones often leave life-lasting sequels. Tissue
Engineering has emerged as a promising alternative to the tradi-
tional inert orthopedic devices. Engineered bones are being de-
veloped by combining biomaterials with osteogenic cells and/or
osteoinductive factors. Our group is dedicated to the study of
skeletal regeneration, with a focus on stem cell-based skeletal
tissue engineering.
PSCs: Our work on bone marrow progenitor stem cells (BM-
PSCs) focuses on a patented methodology that combines a 3D-
collagen scaffold with home-engineered growth factors to isolate,
propagate and differentiate BM-PSCs into de chondrogenic and
osteogenic pathways (Patent PCT/ES2005/000287). We are cur-
rently characterizing this method.
Engineered growth factors: The TGFß superfamily (espe-
cially BMPs) have proven to be the most powerful osteogenic
molecules among growth factors, but their low affinity for colla-
gen and short half-life hamper them for therapeutic use. For this
reason we are engineering specific growth factors of the TGFß-
superfamily to carry a collagen binding domain (CBD). The re-
sulting molecules should get trapped in the tissues extracellular
matrix and be slowly released from there. We have engineered
two growth factors in this way: rhBMP2-CBD and rhBMP6-CBD.
Their stability and osteoinductive properties are currently being
tested.
Biomaterials: We are testing the performance of composites
made up of our chondro/osteoinduced cells and specific biomate-
rials. Preliminary results show that our cells can be successfully
combined with hidroxiapatite. We are presently testing a novel
biomaterial based on the SBA-15 ternary system (patent number
P200702694).
(P 87) Comparative Characterization of Cultured Human
Term Amnion Epithelial and Mesenchymal Stromal Cells for
Application in Cell Therapy
G. Bilic1, S.M. Zeisberger1, A.S. Mallik1,2, R. Zimmermann1,
A.H. Zisch1,2
1Department of Obstetrics, University Hospital Zurich, Switzer-
land.
2Zurich Center for Integrative Human Physiology, Switzerland.
Emerging evidence suggests human amnion as a source of two
types of pluripotent cells, amnion epithelial cells (hAECs) and
mesenchymal stromal cells (hAMSCs), for applications in cell
therapy. We focused on first side-by-side characterization of
hAECs versus hAMSCs regarding their expansion and stemness
after isolation and culture. We looked at amnion cell isolates from
27 term placentas. Primary yields were 6.3106 hAECs and
1.7106 hAMSCs per gram amnion. All 27 cases gave vital cul-
tures of hAMSCs, while one third of cases (9 of 27) failed to give
adherent cultures of hAECs. Primary cultures contained signifi-
cantly more proliferating than apoptotic cells. Neither hAECs nor
hAMSCs were clonogenic. They showed slow proliferation that
almost stopped beyond passage 5. hAEC morphology changed
towards mesenchymal phenotype over several passages. Primary
and secondary cultures of hAECs and hAMSCs showed expression
of mesenchymal progenitor markers CD73, CD90, CD105 and
CD166, and the embryonic stem cell markers SSEA-3 and -4.
Transcripts of Oct-3/4 and stem cell factor were detected in pri-
mary and secondary cultures, but no of telomerase reverse tran-
scriptase. Immunocytochemistry confirmed translation into Oct-3/
4 protein in part of hAEC cultures, but not in hAMSCs. Both
amnion cell types stained for CD90 and SSEA-4. Osteogenic in-
duction studies showed significantly stronger differentiation of
hAECs than hAMSCs; this capacity to differentiate varied among
cases. In conclusion, hAECs and hAMSCs in culture exhibit and
maintain a similar marker profile of mesenchymal progenitors.
hAECs were found as less reliable source than hAMSCs and al-
tered morphology during subculture.
(P 88) Comparative Study of Cell Seeding and Bioreactor
Culture Methods for Bone Engineering Scaffolds
Y. Chen1, F.P. Luyten1, J. Schrooten2
1Laboratory for Skeletal Development and Joint Disorders, Ka-
tholieke Universiteit Leuven.
2Department of Metallurgy and Materials Engineering, Katholieke
Universiteit Leuven.
Bone tissue engineering (TE) offers a promising strategy to heal
severe bone injuries by using cell-seeded scaffolds. In order to
evolve towards clinical practice it is essential to firstly guarantee a
high, consistent and uniform cell-seeding and secondly culture
these cell-seeded scaffolds in controlled bioreactors. Because
most static seeding techniques do not meet these requirements
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this study evaluated various cell seeding methods in bone TE
Titanium scaffolds (diameter 5mm, height 3mm). Two Million
Human Saos-2 Osteoblasts were seeded using different ratios of
cell suspension volume versus scaffold volume (0.68, 1.01, 1.69)
with different pre-seeding times (30min, 2h, 4h) for static culture,
and different dynamic culture conditions (rotatory, perfusion,
oscillatory perfusion). The total DNA in the scaffolds, in the
media and in the vessels was quantified to determine the cell
number and distribution. The samples were stained with LIVE/
DEAD viability kit and analysed using fluorescence stereomi-
croscope. It was shown that the 0.68 ratio group resulted in the
highest cell proportion adhering to the scaffold. The dynamic
method had a lower seeding efficiency (~38%) compared with
static methods (~64%). However the cell distribution in static
group is less homogeneous. It was concluded, when aiming at
consistent cell-seeding, that for static seeding a small volume ratio
is required followed by culturing in an initial 2h pre-seeding pe-
riod. For dynamic seeding, a precise controlled oscillatory seeding
strategy is preferred. Further optimisation of these different
methods is required in order to obtain sufficiently high seeding
efficiencies that would allow a future transfer towards clinical
practice.
(P 89) Comparative Study of Slow Freezing and Vitrification
of Mouse Osteoblasts in Suspension and in Monolayer
Y. Liu1, X. Ma1, Z.-F. Cui2, T.-Q. Liu1
1Dalian R & D Center for Stem Cell & Tissue Engineering, Dalian
University of Technology, Dalian 116024.
2Department of Engineering Science, Oxford University, Parks
Road, Oxford OX1 3PJ, UK.
The influence of two cryopreservation methods, slow freezing and
vitrification, on the survival of osteoblasts cryopreserved as single
cells in suspension and adherent cells in monolayer was investi-
gated. Cells suspension and cell monolayer were exposed to 10%
Me2SO with or without 10% FBS in DMEM at 48C, and then the
cells were cooled to -808C at controlled rate of 18C/min for
overnight and stored in liquid nitrogen. A vitrification cocktail of
Me2SO, formamide and 1,2-propanediol was loaded stepwise into
single cells in suspension and adherent cells in monolayer and then
quenched into the liquid nitrogen. After rapid thawing in a 378C
water bath and serial removal of cryoprotectants, cell survival rate
was judged by trypan blue and Ho/PI staining. Cell morphology,
alkaline phosphatase (ALP) activity was also determined. The vi-
ability of single cells in suspension after slow freezing was 92%,
but after vitrification no single cell was recovered. Surviving cells
after slow freezing quickly recovered and exhibited a morphology
and alkaline phosphatase (ALP) activity indistinguishable from
noncryopreserved cells. The survival rate of the adherent cells in
monolayer after the slow-freezing and vitrification was very low.
The results showed that the viability of osteoblasts in monolayer
decreased significantly compared with the viability of cells in
suspension under the slow-freezing cryopreservation procedure.
Cell-cell, cell-matrix interaction may alter the cryobiological
properties of cells. It is indicated that adherent cells were subject to
more severe damage than single cells. The conventional slow-
freezing method of cryopreservation of cells in suspension is re-
liable and effective.
(P 90) Comparison of Different Stem Cell Sources and Bio-
mimetic Scaffolds for Bone Tissue Engineering
V.S. Melikhova1, I.N. Saburina1, A.A. Orlov2, A.A. Pulin1, V.S.
Repin1
1Institute of General Pathology and Pathophysiology, Moscow.
2Dentistry Clinics Dental Academy, Moscow.
Properties of stem cells together with tissue engineering ap-
proaches can be used to overcome bone degeneration and its loss
in dentistry, plastic surgery and orthopedics. We have compared
the seeding of progenitor cells from 3 different sources (adult
periosteum, adult subcutaneous fat tissue and fetal stem cells) on
2 types of scaffolds, traditionally used in bone tissue engineering:
b-tricalcium phosphate (ChronOs, Synthes GmbH, Switzerland)
and hydroxyapatite. Human adult fibroblasts were used as control
cell type in all experiments. The highly porous matrices support the
induction of osteogenic differentiation of stem cells, confirmed by
positive staining with monoclonal antibodies to osteocalcin. These
scaffolds also create and maintain a space that facilitates progen-
itor cell survival, proliferation, and migration, shown on scanning
electron microscopy pictures. All of the cell types were success-
fully seeded on both types of matrices, though, showed different
proliferation and migration results. The best result on seeding,
proliferation and survival was reached with the use of cells from
adult periosteum and b-tricalcium phosphate porous blocks. Thus,
we suggest to use periosteal cells as the appropriate source of cells-
progenitors for autologous bone tissue engineering techniques.
This approach will help to solve problems in regenerative medi-
cine, associated with such areas as wound healing and the
(P 91) Comparison of Flow Cytometry vs Haematology Ana-
lyzers in Cell Enumeration for Haematopoietic Transplanta-
tion
C. Carvalho1, I.L. Barbosa1, M.J. Pires1, S.M. Lopes1, S. Roncon1,
T. Sousa2, C. Mendes2, A. Campos3, A. Carvalhais1
1Servic¸o de Terapia Celular.
2Servic¸o de Hematologia Laboratorial.
3STMO.
Over the last two decades peripheral blood progenitor cells (PBPC)
have replaced bone marrow (BM) as the preferred source of hae-
matopoietic stem cells (HSC) for both autologous and allogeneic
transplants. It is known that the number of infused CD34þ cells in
patients determines the success of transplants. This quantification
is routinely measured by flow cytometry, but it is known that both
CD34þ and CD34- haematopoietic progenitor cells (HPC) cells
are essential to transplants’ success. Last generation haematology
analyzers such as the Sysmex XE-2100 with the ‘‘immature in-
formation’’ (IMI) channel offer an alternative method to count
HPC present in a sample. Several studies have proved the corre-
lation between CD34þ counted by flow cytometry and HPC
counted by automated haematology analyzer. From January to the
end of July 2007, 21 healthy donors and 30 patients with haema-
tologic malignancies underwent G-CSF mobilization for collection
of PBPC. On the 5th day of mobilization total leucocyte and HPC
counts were assessed by the Sysmex XE-2100 analyzer in EDTA
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peripheral blood (PB) samples and PBPC grafts. CD34þ cell
enumeration was performed in the same samples by standard flow
cytometric assay. Our data showed that for both healthy donors and
patients, PB HPC counts correlated with CD34þ cell counts pre-
dicting the PBPC yield and that HPC counts were significantly
higher than CD34þ counts (2.0 fold for PB and 2.6 fold for PBPC).
In summary, it remains to be determined the role of HPC content of
the graft on the haematopoietic recovery of patients.
(P 92) Comparison of Grafting with Buccal Mucosa Versus
Bladder Submucosa (BSM) in Patients with Complex Urethral
Structures
A. ElKassaby1,2, T. AbouShwareb1,2, A. Atala1
1Department of Urology and Institute for Regenerative Medicine,
Wake Forest University Health Sciences.
2Ain shams university, Cairo, Egypt.
Urethral strictures represent a longstanding reconstructive di-
lemma due to the limited availability of tissue substitutes and
incidence of recurrence. The goal of this study was to compare
bladder derived collagen-based matrices (bladder submucosa;
BSM) to another commonly used tissue substitute, buccal mucosa,
in patients with complex urethral strictures. To this end, BSM was
obtained from cadaveric donors and prepared as an ‘‘off the shelf’’
material for use in 30 stricture patients (age ranging from 21–59
years (ave: 36.2)). Patients were randomized into two groups and
treated with an onlay procedure (avg. stricture length of 6.9 cm).
All patients were followed for 18–36months (mean: 25months). In
patients with a healthy urethral bed (< 2 prior op), the success rate
of buccal mucosa grafts (10/10) was similar to the BSM grafts (8/9)
in terms of patency. In patients with an unhealthy urethral bed (> 2
prior op), 2/6 patients with a BSM graft were successful, whereas
5/5 patients with a buccal mucosa graft had a patent urethra. Post-
operative uroflowmetry showed a significant voiding improvement
in both groups. Histology of graft biopsies showed normal urethral
tissue characteristics. These findings show that BSM can be used
for urethral repair in stricture patients with a healthy urethral bed (2
or less prior surgeries), and furthermore, as an ‘‘off the shelf’’
material it eliminates the problems associated with donor site
morbidity. Nonetheless, the buccal mucosa remains a preferable
graft material for patients with 3 or more prior surgeries (i.e.,
unhealthy urethral beds).
(P 93) Comparison of Mesenchymal Stem Cells Derived from
Bone Marrow and Adipose Tissue of Minipigs
A. Peterbauer1,2, K. Schauer3,2, S. Neußl1,2, A. Schultz3,2,
C. Gabriel 1,2, H. Redl3,2, M. van Griensven3,2, S. Wolbank1,2
1Red Cross Blood Transfusion Service of Upper Austria, Linz,
Austria.
2Austrian Cluster for Tissue Regeneration.
3Ludwig Boltzmann Institute for Experimental and Clinical
Traumatology, AUVA Research Centre, Linz/Vienna, Austria.
For testing the reconstruction of osteochondral defects in vivo by
tissue engineering approaches large animal models like pig have to
be used to ensure that similar physical forces as in humans act on the
constructs. To circumvent the need of immunosuppressive agents for
future in vivo studies autologous cells should be used. Hence, bone
marrow and adipose tissue from Go¨ttinger minipigs were compared
as mesenchymal stem cell sources regarding cell yield, proliferation
capacity, surface marker expression and differentiation ability to the
adipogenic, osteogenic and chondrogenic lineage.
Proliferation capacity was examined by calculating population
doubling time (PDT). FACS analysis was performed for typical
MSC surface markers. Differentiation experiments were done as
described for human MSC and lineage conversion was checked by
Oil Red O staining (adipogenic), alkaline phosphatase activity
(osteogenic), Alcian blue staining and GAG quantification (both
chondrogenic).
PDT of ASC during the first 8 passages was 57 hours whereas
BMSC needed 108.4 hours for doubling. This could be decreased
to 58 hours by supplementing the culture medium with 1 ng/mL
bFGF. Adipogenic and osteogenic differentiation was observed in
90% of BMSC and ASC experiments performed whereas chon-
drogenic differentiation was found in all BMSC but only in 1 of 5
ASC approaches.
Porcine BMSC were found to be superior to ASC regarding
their chondrogenic differentiation potential in vitro. If this is due to
in vitro conditions or inherent characteristics that can also be ob-
served in vivo has to be elucidated.
Acknowledgments: HIPPOCRATES (NMP3-CT-2003-505758),
Lorenz Boehler Fonds, EXPERTISSUES (NMP3-CT-2004-
500283).
(P 94) Comparison of Schwann Cell and Olfactory En-
sheathing Cell Influence in Peripheral Nerve Regeneration
V. Penna1, K. Wewetzer2, G.B. Stark1, E.M. Lang1,3
1University Medical Center, Dept. Plastic and Hand Surgery,
Freiburg, Germany.
2University Medical Center, Dept. Neuroanatomy, Hannover.
3Evangelistic Hospital, Dept. Plastic and Hand Surgery, Zwei-
bru¨cken, Germany.
Introduction: The use of cell filled conduits in bridging nerve de-
fects has become one of the most promising alternatives in the
reconstruction of complex nerve injuries. Our group used a bio-
genically created conduit filled with Schwann Cells (SC), Olfac-
tory Enesheathing Cells (OEC) and Fibrin alone to bridge a 15mm
gap in the sciatic nerve of the rat.
Materials and Methods: We obtained biogenic conduits in a
two-step operation. The following groups were investigated: au-
tologous nerve transplantation NT, biogenic conduit filled with a
three-dimensional fibrin matrix BC, F, biogenic conduit and OEC
in fibrin matrix BC, F, OEC, biogenic conduit and SC in fibrin
matrix BC, F, SC. Survival time was 4 and 16 weeks. Regeneration
was clinically tested using the sciatic functional index. The number
of axons per cross section and the axon myelin ratio were deter-
mined on semi thin sections.
Results: The axon myelin ratio of the operated sides of all groups
showed significant worse myelinisation than the healthy control
group after 4 and 16 weeks. The SCmyelinisation was significantly
better than the OEC myelinisation. The axons in the fibrin filled
conduit showed better myelinisation than the SC and OEC groups.
Clinical function after 16 weeks showed identical results for the
fibrin filled and cell filled conduits.
828 POSTER PRESENTATIONS
Conclusion: Biogenic conduits for gap bridging are a suitable
alternative to artifical conduits. Paradoxically the results demon-
strate an advantage of only fibrin filled conduits compared to cell
filled conduits, while the use of OEC showed no advantage to the
use of SC.
(P 95) Comparisons Between Sources of Mesenchymal Stem
Cells in the Wharton’s Jelly of the Human Umbilical Cord and
Bone Marrow
Sophia C.N. Chang1, H.H. Chao2, T.M. Lin3, H.Y. Chung3, L.B.
Jeng4
1Department of Plastic Surgery, China Medical University Hos-
pital, Taichung, Taiwan.
2Department of Pediatric Surgery, China Medical University
Hospital, Taichung, Taiwan.
3Department of Medical Research, China Medical University
Hospital, Taichung, Taiwan.
4Department of Surgery, China Medical University Hospital,
Taichung, Taiwan.
The Wharton’s jelly of the umbilical cord contains mucoid con-
nective tissue surrounding two arteries and one vein. The phenotypic
stromal cells in the Wharton’s jelly are fibroblast-like ones. The
differentiationmay bemanipulated by the culturemedium.However
the potential of umbilical stromal cells (UMSC) is required to be
compared with bone marrow mesenchymal stem cells (BMSC).
Initiation of Wharton’s Jelly Matrix Cell Cultures to obtain
human UMSC from the umbilical cord, when expanded under
suitable culture conditions, the differentiation ability will be
compared with human BMSC. The cellular markers were studied
by flowcytometry, western blotting and immunocytochemistry.
Wharton’s jelly matrix has very little collagen, and there are
multiple mesenchymal cells. Using flow cytometric analysis, we
found that UMSC express matrix receptors (CD44, CD105) and
integrin markers (CD29, CD51) but not hematopoietic lineage
markers (CD34, CD45). Interestingly, these cells also express
significant amounts of mesenchymal stem cell marker (CD73). We
therefore investigated the potential of these cells to differentiate
into multilineage potential under suitable culture conditions, are
able to differentiate into cells of the hepatogenic, adipogenic,
chondrogenic and osteogenic lineages.
We reasoned that umbilical cord matrix could be an affluent
source of UMSC based on the primitive cell types seen in
Wharton’s jelly. There are no major differences between UMSC
and BMSC. These findings may have a noteworthy impact on
studies of stem cell plasticity, multi-lineage differentiation, func-
tional genomics, pharmacological testing, cell therapy, cell bank
and tissue engineering by assisting to get rid of troubled ethical and
technical issues.
(P 96) Complexity of Approach and Demand for Esophagus
Tissue Engineering
A.K. Saxena1, K. Kofler1, H. Ainoedhofer1, A. Kuess1 and M.E.
Ho¨llwarth1
1Department of Pediatric Surgery, Medical University of Graz,
Austria.
There is an enormous demand for esophageal tissue not only in the
pediatric population but also the adult population. Since esophagus
is an organ that transverses 3 anatomic planes, the neck, thorax and
the abdomen its anatomy varies according to the type of function.
The three main broad functions of the esophagus involve active
swallowing, transportation of the swallowed food bolus and re-
sisting the gastric reflux. Although the esophagus in geometric
terms is a tube the histology of the organ and the tissue organi-
zation vary along its entire length.
The aim of this literature based review is to identify pathologies
and pathological states that require esophageal tissue replacement.
Furthermore, an estimation of the population affected by esopha-
geal pathologies was calculated and to evaluation the morbidity
due to esophageal tissue loss was categorized. Also, the surgical
techniques such as gastric transposition, ileal conduit and colon
transposition presently used to treat esophageal pathlogies have
been evaluated and their morbidities estimated.
The major demand for esophageal tissue replacement in the field
of pediatric surgeryis in the area of the thoracic esophagus.
Technical difficulties in the repair of esophageal atresia according
to the classification identifies the demand for this malformation.
The results show the spectrum of esophageal loss and requirement
from the clinical perspective inorder to provide objective guide-
lines for tissue engineering research in esophagus.
(P 97) Composite Calcium Phosphate Scaffolds for Bone Tis-
sue Engineering
J.R. Popp1, B.J. Love2, K.E. Laflin3, A.S. Goldstein1,3
1Virginia Tech—Wake Forest School of Biomedical Engineering
and Sciences.
2Department of Materials Science and Engineering, University of
Michigan.
3Department of Chemical Engineering, Virginia Tech.
Tissue grafts engineered to facilitate healing of bone defects re-
quire scaffolds capable of bearing load and supporting the growth
of osteoprogenitor cells. Hydroxyapatite (HAP) is a calcium
phosphate that has been widely used as a scaffold for bone grafts
due to its osteoconductivity and biocompatibility. However, HAP
lacks osteoinductive properties to stimulate osteogenesis and is
resistant to biodegradation.
In contrast, amorphous calcium phosphate (ACP) is a mineral
that solubilizes under aqueous conditions, releasing calcium and
phosphate ions. We propose that the immobilization of ACP par-
ticles within a biodegradable PLGA scaffold will enhance the
stiffness and osteoconductivity of the scaffold while providing
calcium and phosphate ions to stimulate osteogenic differentiation.
PLGA microspheres were fabricated using an oil-in-water
emulsion technique. Microspheres were then fused with 0.5% (w/v)
HAP or ACP particles at 708C. Scanning electron microscopy
(SEM) and energy dispersive X-ray spectroscopy (EDS) were used
to determine pore size and calcium phosphate distribution on the
scaffold surface. Scaffolds were tested in compression to determine
the effects of calcium phosphate addition on scaffold stiffness.
Osteogenic differentiation on the scaffolds was assessed by
culturing pre-osteoblasts on the surface of HAP and ACP scaf-
folds. Cell number and alkaline phosphatase activity were mea-
sured at days 7 and 10. Late stage osteogenic markers were
measured by quantitative PCR after 14 days of culture.
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Preliminary SEM and EDS have confirmed the presence of
minerals on the scaffold surface. In addition, cells cultured on
scaffolds containing ACP demonstrated increased ALP activity.
(P 98) Comprehensive In vitro Model for the Engineering of
Microvasculature—Evaluation of Morphological and Func-
tional Data
K.Winter1, U. Wehrmeister1, A. Ko¨rner2, J.-P. Kuska3, B. Frerich4
1Translational Centre for Regenerative Medicine (TRM-Leipzig),
University of Leipzig.
2Childrens Hospital, University of Leipzig.
3Interdisciplinary Centre for Bioinformatics (IZBI), University of
Leipzig.
4Department of Oral and Maxillofacial Surgery, University of
Leipzig.
Objectives: The engineering of functional microvasculature has
special impact for voluminous and metabolically active tissues. In
order to quantify formation of coherent vascular networks, ap-
propriate 3D imaging and image processing is needed. We present
a model for in vitro engineering, imaging and comprehensive
analysis of microvessel-like structures.
Material and methods: Small-diameter vessel equivalents were
fabricated from collagenous scaffolds, ATSC and endothelial cells.
Specimens were compared after 16 days of rotation or pulsatile
perfusion with regard to ‘‘capillary’’ density, recruitment of a-
actin-positive cells and branching from the central lumen. Algo-
rithms were developed for 3D measurement of characteristic
quantities of capillary-like structures and for pericytal recruitment
from CLSM (confocal laser scanning microscopy) data.
Results: The aggregates were imaged and measured three-
dimensionally by use of CLSM and image analysis. Capillary
density and the maturation of capillary-like structures ascertained
by the recruitment of a´-actin-positive cells reached the highest
degree in the luminal portion of the perfused specimens. Manually
acquired histomorphometrical data were compared with computed
CLSM derived data and agree with results from automated 3D
measurement.
Conclusion: Application of hydrodynamic forces (flow and
pressure) is essential for microvascular engineering in vitro and has
impact for the engineering of ‘‘feeder donor vessel’’ with the
ability to supply surrounding tissues for the purposes of plastic and
reconstructive surgery.
(P 99) Conjugation of Fibroin and Starch to Chitosan for In-
creasing Cell Proliferation Capacity
E.T. Baran1, K. Tuzlakoglu1, J.M. Mano1, R.L. Reis1
13B’s Research Group-Biomaterials, Biodegradables and Biomi-
metics. Dept. of Polymer Engineering, University of Minho,
Campus de Gualtar, 4710-057 Braga, Portugal, 2IBB-Institute for
Biotechnology and Bioengineering, PT Government Associated
Laboratory, Braga, Portugal.
In this study, chitosan conjugates with starch and fibroin were
produced for increasing degradability in the presence of physio-
logical enzymes and cell proliferation capacities of biomaterials.
The degradation profile was monitored over prolonged time peri-
ods and characterization of chemical changes during degradation
periods were investigated by spectroscopic methods. Various ratios
of starch, fibroin and chitosan (%, (weight/weight)) were prepared.
The in vitro cell culture studies were conducted to evaluate bio-
compatibility and proliferation capacities of conjugate materials.
The DNA content of cells at certain time points of cell culture was
measured for their proliferation potentials. The cell morphologies
such as cell area and maximum cell length were measured over a
large cell population. The spectrum traces suggest that the weight
loss was primarily from starch degradation by a-amylase. The
absorption bands after protease degradation showed no significant
changes and this result can indicate that the enzyme activity was
impaired or inhibited by extensive crosslinking between oxidized
starch and fibroin or chitosan (a natural substrate of protease)
biopolymers. The DNA quantities of conjugate materials after cell
culture were increased linearly with higher fibroin ratios. This
result proves that fibroin incorporation into chitosan and starch
matrix is improving adsorption and proliferation properties of
conjugate materials. The unique cell features were detected for
each type of conjugate material. In general, the cells on pure fibroin
and chitosan had a higher cell area than conjugates. Higher fibroin
content steadily increased the cell area and cell length.
(P 100) Construction and Characterisation of a New Vascular
Composite Bioscaffold
M. Koens1, W. Daamen1, T. van Kuppevelt1
1Department of Biochemistry 280, NCMLS, Radboud University
Nijmegen Medical Centre, P.O. Box 9101, Nijmegen 6500 HB,
the Netherlands.
Introduction: Atherosclerotic disease is the leading cause of death
in Western society. Most patients do not have suitable/sufficient
autologous tissue as bypass material. The main natural materials
constituting the arterial wall are type I collagen (for strength)
and elastin (for elasticity). Therefore, the goal of this study is to
use highly-purified type I collagen and elastin to create tubular
grafts.
Materials & Methods: Elastin fibres in diluted acetic acid were
moulded around a mandrel, frozen and lyophilised. Subsequently,
type I collagen in diluted acetic acid was moulded around the
elastin sleeve and mandrel, frozen and lyophilised. Mono- and
dual-layered scaffolds were chemically crosslinked (EDC/NHS),
with or without heparin. The growth factors VEGF and FGF-2
were bound to heparin by dipping techniques. The morphology and
ultrastructure were studied with SEM and TEM. The degree of
crosslinking and the amount of covalently bound heparin were
measured. Proteins and growth factors within the scaffold were
examined by (immuno) histology.
Results: Tubular mono- and dual-layered constructs were made.
Histology and TEM clearly showed attachment of the collagen
layer to the elastin layer. Crosslinking efficiency was 60%. Up to
20% of heparin was covalently attached to the scaffolds. Im-
munohistology demonstrated that heparin, VEGF and FGF-2 were
present throughout the scaffold.
Conclusion: These preliminary results are encouraging for the
construction of completely natural grafts, as (1) type I collagen and
elastin are the main components of the arterial wall, (2) this graft is
molecularly-defined and (3) glycosaminoglycans and growth fac-
tors can be added easily.
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(P 101) Construction of Dendric Structure Carrying RGDS
and PHSRN Peptide Cell-Adhesion Motifs
V. Proks1, F. Rypacek1
1Institute of Macromolecular Chemistry AS CR, v.v.i.,
Solid-phase signals from biomaterial surface to adhering cells can
be provided by adsorbed adhesion proteins of extracellular matrix
or their fragments or even simple peptide motifs, capable of in-
teraction with the cell transmembrane proteins—integrins. Not
only the presence of the adhesion structures but also their proper
distance and orientation at nanometer scale is important for the
signal transfer efficiency. The work presents the design and syn-
thesis of a dendron construct that can carry finbronectin-derived
peptide sequences, such as RGDS and PHSRN peptide motifs of the
10th type III repeat of fibronectin and to present them in an optimum
distance and orientation for effective synergic binding to the al-
pha5beta1 cell integrin1. Series of constructs was designed based
on lysine-core dendron structures with oligo 2-amino(ethoxy-
acetic) acid2 (AEAA) arms, containing an orthogonally protected
reactive groups, allowing selective dendron modification by fi-
bronectin based peptides. The dendrons with variable length of the
oligo-AEAA arms were prepared using solid-phase peptide syn-
thesis technique. Average distance between N-terminals of the
dendron arms was studied using nonradiative excitation energy
transfer (NRET) fluorescence spectroscopy with tryptophane (Try)
and 4-dimethylamino-1-naftalenesulfonyl (Dns) as donor and ac-
ceptor, respectively.
Acknowledgement: Support by Academy of Sciences CR (No.:
1QS00110564) and Center for Cell Therapy and Tissue Repair
(Ministry of EducationCR,No.: 1M0021620803) is acknowledged.
1T.A. Petrie, J.R. Capadona, C.D.Reyes, A.J. Garcı´a:, Biomaterials 27
5459–5470 (2006).
2V. Proks, L. Machova´, F. Rypa´e`ek: J. Pept.Sci., 2006, 12, 240 Suppl. S
(P 102) Controlling the Architecture and Mechanical Prop-
erties of Supercritical Fluid Foamed Poly D,L-Lactic Acid
Scaffolds
L.J. White1, S.M. Howdle2, K.M. Shakesheff1
1School of Pharmacy, University of Nottingham.
2School of Chemistry, University of Nottingham.
Supercritical CO2 (scCO2) scaffold formation is a solvent free, low
temperature process which produces open cell, inter-connected
foamed structures. Successful applications of this technique in-
clude controlled release of proteins (Howdle et al., 2001), pro-
motion of bone formation in vitro and in vivo (Yang et al., 2004)
and the induction of angiogenesis in vitro (Kanczler et al., 2007).
Scaffolds of divergent pore size and structure can be produced and
hence this study sought to elucidate the effects of processing
conditions on the architecture and mechanical properties of the
scaffolds.
Three molecular weights of poly(D,L-lactic acid (15 kDa,
24 kDa and 57 kDa) were used to form scaffolds under different
depressurisation rates. Scaffold morphology was characterized by
micro X-ray computed tomography and mechanical properties
were tested using a TA.HD Texture Analyser.
57 kDa PDLLA scaffolds displayed a typical stress-strain curve
for elastomeric open cell foams. The Young’s modulus, elastic
collapse and ultimate stresses were increased by using shorter de-
pressurisation rates during fabrication; the ultimate stress ranged
from 5.1MPa using a 10minute vent to 2.8MPa for a 45minute
vent.
The failure behaviour of 15 kDa and 24 kDa PDLLA scaffolds
was more typical of porous brittle materials (Gibson, 2005). The
porosity of the scaffolds increased with decreased depressurization
rates; the maximum stress for the 15 kDa and 24 kDa scaffolds
(0.29MPa and 0.60MPa respectively) occurred with a 10minute
vent.
The architecture and mechanical properties of PDLLA scaffolds
can be tailored by adjusting the processing conditions and the
molecular weight of the polymer.
(P 103) Conversion of Corallina Officinalis into Calcium
Phosphates by using Hydrothermal Treatment and their Po-
tential for Bone Tissue Engineering Application
S. Gomes1,2, M.T. Rodrigues1,2, I.B. Leonor1,2, M.E. Gomes1,2,
J.F. Mano1,2, R.L. Reis1,2
13B’s Research Group—Biomaterials, Biodegradables and Bio-
mimetics, Dept. of Polymer Engineering, University of Minho,
Campus de Gualtar, 4710-057 Braga, Portugal, www.3bs
.uminho.pt
2IBB—Institute for Biotechnology and Bioengineering, PT Gov-
ernment Associated Laboratory, Braga, Portugal
Calcium phosphates (CaP) such as hydroxyapatite (HA) and tri-
calcium phosphate are widely used in bone Tissue Engineering,
due to their biocompatibility, osteoinductive and/or osteoconduc-
tive properties. The aim of this work is to obtain CaP through the
hydrothermal conversion of the calcite (HCC) present in the alga
C. officinalis. To promote the HCC into CaP, the alga was im-
mersed in a phosphate solution (Ps) and subjected to a hydro-
thermal treatment. Different Ps concentrations were used to test the
influence of this parameter on the HCC into CaP and on the type of
CaP formed. FTIR, EDS and XRD analyses demonstrated the
successful conversion of the C. officinalis calcite into HA, after
treatment with a 0.1M Ps, and into a mixture of HA and whi-
tlockite, after treatment with a 0.5M Ps. Moreover, the SEM
analysis showed that this treatment allowed the preservation of the
original porous structure of this alga. A cellular study was also
performed in order to evaluate the capacity of these CaPs to sup-
port the proliferation and differentiation of goat bone marrow cells
(GBMCs) into osteoblasts. GBMCs were seeded onto PCL mem-
branes with the CaP granules obtained by HCC. Cells were cul-
tured under static conditions in osteogenic medium for 7, 14 and 21
days. GBMCs seeded on C. officinalis-PCL membranes showed a
higher cell viability and proliferation when compared with
GBMCs seeded onto PCL (polycaprolactone) membranes without
CaPs, the positive control, indicating that the obtained CaPs are
suitable for bone tissue engineering applications.
(P 104) Cryogel Scaffolds with Stem Cells for Bone Tissue
Engineering: an Animal Model
N. Bo¨lgen1, I. Vargel2, T. C¸avusoglu2, P. Korkusuz3, E. Gu¨zel3,
E. Piskin1
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1Hacettepe University, Chemical Engineering Department and
Bioengineering Division, Ankara, Turkey.
2Kirikkale University, Faculty of Medicine, Department of Plas-
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3Hacettepe University, Faculty of Medicine, Department of His-
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Lactide-dextran based swellable cross-linked cryogels with super-
macro porosities were produced by cryogelation. Mesencyhmal
stem cells were derived from rat bone marrow. 8-mm-diameter
critical size cranial defects were created in rat cranium as animal
model for bone tissue engineering. Cryogel scaffolds (8mm in
diameter and 1mm in thickness) were implanted in the cranial
defects with or without stem cells. In a parallel group of study,
stem cells were injected into the defects without scaffold. Samples
from the implant sites were removed after 1, 3 and 6months post-
implantation and bone regeneration and tissue response were fol-
lowed by histological tests. The in vivo results exhibited osseous
tissue integration within the implant and mineralized functionally
stable bone restoration of the cranial defects. Tissue formation
started in the macrospores of the scaffold starting from periphery to
the center. A significant ingrowth of connective tissue cells and
new blood vessels allowed new bone formation. Histological data
clearly demonstrated that the more successful results were ob-
served in the group that we have used cryogel scaffolds with
mesenchymal stem cells.
(P 105) Cryopreservation of Neural Stem Cells Encapsulated
in Rat Tail Collagen Type I
D. Ge1, Z. Gao1, X. Ma1, Z. Cui2
1Dalian R&D Center for Stem Cell and Tissue Engineering, Da-
lian University of Technology, Environmental and Life Science
Building 3-403, No.2 Linggong Road, Ganjingzi District, Dalian
116024, China.
2Oxford Centre for Tissue Engineering and Bioprocessing, De-
partment of Engineering Science, Oxford University, Oxford OX1
3PJ, UK.
The cryopreservation of neural stem cells (NSCs) for clinical
medicine transplantation and the establishment of stem cell bank
are of important significance. This study followed the traditional
slow-cooling method with the NSCs encapsulated in rat tail col-
lagen type I to develop a new cryopreservation protocol. DMSO is
the cryoprotectants. The concentration of rat tail collagen type I is
0.5mg/ml,1.0 mg/ml and 1.5 mg/ml respectively, and the con-
centration of DMSO is 10%(v/v), 15%(v/v), 20%(v/v) and 25%
(v/v). From the variation of the concentration of DMSO at the
external system after loading, the average concentration of
DMSO solution within the collagen system can be calculated. And
then the average internal concentrations of 8% to 15% were se-
lected for the cryopreservation experiments and the mechanical
function of collagen was tested. The NSCs are assayed by flow
cytometry for the apoptosis of 0h and 72h after freeze-thawing and
the ATP enzyme activity. The NSCs stem cells after freeze-
thawing were assayed by immunofluorescence. The results
show that neural stem cells in the collagen keeps their good shape,
six groups of experimental conditions were tested for the slow-
cooling cryopreservition of NSCs. The survival rate of the en-
capsulated NSCs after freezing and thawing operations could be
about 85%, which is higher than that of cryopreservation of cell
suspension. Its ATP enzyme activity is also higher than that of the
traditional method. The NSCs are assayed by immunofluorescence
after freeze-thawing, the Nestin-positive cells were found. The
cultured NSCs could be differentiated into neuron (atubulinIII-
positive), astrocyte (GFAP-positive) and oligodendrocyte (RIP-
positive).
(P 106) CT-Assisted Virtual Endoscopy: an Innovative Ima-
ging Tool for the Assessment of Engineered Tissue
H.O. Orabi1, J. Tan1, A. Atala1, J.J. Yoo1
1Wake Forest Institute for Regenerative Medicine, Wake Forest
University Health Sciences, Winston-Salem, NC 27157.
Introduction: Computerized Tomography (CT) has available for
many decades. Although the capabilities of conventional CT
scanners is limited by visualizing anatomical structures, techno-
logical advances in hardware improvement and sophisticated
software development have allowed for expanded utilization. We
examined the capabilities of a three-dimensional CT scanner and
enabling software to provide a virtual endoscopic tool for assess-
ment of tabularized engineered tissue in vivo.
Methods: We used a Toshiba 32-Slice Aquilion scanner, capable
of imaging 0.5mm-thick tissue slices. Double imaging could
provide visualization every 0.25mm. The scanned images were
processed with the TeraRecon Aquarius Work station, which
provides 2–4 dimensional viewing capabilities. CT-guided ure-
throcystographic examinations were performed in 12 male beagles
that underwent urethral surgery using a 6 cm-long tabularized en-
gineered construct. Pre and post-operative scanning was performed
in conjunction with retrograde urethrograms and voiding cystour-
ethrography for comparison, and animals were sacrificed at pre-
determined time points. Urethral diameter, length and area of
lumen were measured.
Results: Scanned images were converted into movie files, which
allowed for accurate analyses from various angles. The pre and
post-operative scans of each animal correlated with retrograde
urethrograms and cystourethrography. The surgical sites were
readily identified in detail. Gross examination of the retrieved
urethras confirmed all the anatomical details visualized by virtual
urethroscopy.
Conclusions: These findings show that CT-assisted virtual ure-
throscopy allows for accurate visualization of the urethral lumen,
and provides an accurate assessment of tissue integrity. This
technological non-invasive tool may play an important role in the
evaluation of tabularized engineered tissues in vivo.
(P 107) Culture Substrate Geometry Influences Chondrogenic
Phenotype In Vitro
R. Das1, J. Malda2, G.J.V. van Osch1,3, H. Weinans1, H. Jahr1
1Dept. of Orthopaedics, Erasmus MC, Rotterdam.
2Dept. of Orthopaedics, UMC Utrecht.
3Dept. of Otorhinolaryngology, Erasmus MC, Rotterdam; The
Netherlands.
Availability of a sufficient number of cells with an appropriate
phenotype is a major challenge especially for cartilage regenera-
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tion. Microcarrier culture systems usually employ dynamic seeding
on round-shaped support materials and seem to preserve the
chondrogenic phenotype or even improve it (re-differentiation).
Interestingly, this holds as long as the microcarrier is approxi-
mately round, regardless of its diameter and substrate composition.
Therefore, we aimed to investigate the effect of substrate curvature
(flat vs. round) on cells in static (regular culture wells) or dynamic
(spinner flask) cultures.
We cultured primary chondrocytes from different passages in a
spinner-flask. Using microcarriers of identical chemical composi-
tion, but with two different surface geometries, either round or
cubic (flat), we showed that not seeding or culturing dynamics (i.e.
‘‘shear’’) prevents chondrogenic de-differentiation in bioreactor
systems.
Same cells were kept in regular static 2D culture on custom-
made, fibronection-coated silicon rubber scaffolds with different
surface curvatures. Chondrocytes spontaneously stretched out once
the arc of the surface (i.e. the radius of the curved semisphere)
became too long. Based on marker gene expression (aggrecan;
versican; collagen types I, II, and IX; and SOX9), biochemical
GAG and collagen analyses and cytoskeletal stainings, we showed
that the curvature radius (or arc length) of the culture surface is the
crucial driving force preserving a proper chondrogenic cell shape
and phenotype.
Currently, we are investigating the optimal radius for serum- and
growth factor-free cultures in order to maximize proliferation and
re-differentiation capacity. Our insights might lead to innovative
culture methods for cartilage tissue regeneration.
(P 108) Cytokeratin Expression Profiling as a Quality Control
of Oral Mucosa Substitutes Generated by Tissue Engineering
I. Garzo´n1, M. Alaminos1,2, M.C. Sa´nchez-Quevedo1, M. Gonza´lez-
Andrades1, A. Montalvo1,2, G. Moreu3, G. Ceballos2, A. Campos1
1University of Granada, Department of Histology.
2Univ. Hospital San Cecilio, Granada, Spain.
3University of Granada, Department of Stomatology.
Introduction: Different techniques have been used to evaluate the
quality and efficiency of oral tissues developed by tissue engi-
neering. In this work, we have assessed the usefulness of our model
of artificial human oral mucosa by in vivo grafting and evaluation
of cytokeratin expression at both in vitro and in vivo levels.
Materials and Methods: Human oral mucosa substitutes were
generated from primary cell cultures of human oral fibroblasts and
keratinocytes using fibrin-agarose scaffolds. Air-liquid culture
technique was used to induce stratification and differentiation
of the epithelial layer. In vivo evaluation was carried out by im-
plantation of the oral mucosa substitutes at the back of nine
Fox1nu/nu immunodeficient athymic mice for 4 weeks. Expres-
sion of several cytokeratins and proliferating cell nuclear antigen
(PCNA) was determined by microarray and immunohistochem-
istry.
Results and Discussion: Our results showed that the oral mucosa
substitutes kept in vitro developed a multilayered epithelium that
expressed PCNA and some markers of simple epithelia (cytoker-
atins 7, 8 and 18) and stratified epithelia (cytokeratins 5 and 13).
Then, bioengineered tissues grafted onto nude mice exhibited
complete biointegration, showing a cytokeratin expression pattern
that was very similar to normal native oral mucosa controls, with
the formation of rete ridges and neovascularization. Our results
suggest that in vitro and in vivo cytokeratin profiling is a good
quality control for human tissue substitutes generated by tissue
engineering and imply that our model of fibrin-agarose oral mu-
cosa substitute could have potential clinical value.
Supported by CTS-06-2191 and CM2005/011 from Junta de
Andalucia.
(P 109) DC, NK and NKT Cells Present in PBPC Allografts
Influence the Onset of Acute GVHD and the Immune Re-
covery
S.M. Lopes1, I.L. Barbosa1, E. Moreira1, C. Carvalho1, S. Ron-
con1, F. Campilho2, C. Pinho Vaz2, R.B. Ferreira2, P. Pimentel2,
A. Campos2, A. Carvalhais1
1Servic¸o de Terapia Celular.
2STMO.
Allogeneic haematopoietic stem cell transplant (HSCT) has
evolved from a tool to rescue patients from the pancytopenia
caused by aggressive chemotherapy regimes to a form of anti-
neoplasic immunotherapy. Peripheral blood progenitor cells
(PBPC) grafts are composed of not only CD34þ progenitor cells,
but also of large number of immunocompetent cells, namely nat-
ural killer cells (NK), natural killer T lymphocytes (NKT) and
dendritic cells (DC), which can exert a potent anti-tumour effect.
We studied the composition of the PBPC allografts, from HLA
matched relatives, used to transplant 25 patients with haematolo-
gical diseases between August 2004 and August 2006. The time to
engraftment and incidence of acute Graft versus Host Disease
(aGVHD) in the patients were evaluated in order to investigate DC
(both DC1 and DC2 subpopulations), NK and NKT influence on
the clinical outcome.
Of the populations and ratios studied, only the DC population, in
particular the DC1 subpopulation, correlated with the onset of
aGVHD. We also found that the CD34þ and NKT cell number in
the graft, as well as the NKT/DC ratio, correlated with the pe-
ripheral blood (PB) lymphocyte count at day 15 post transplant,
and the NK/DC ratio correlated with the time to a PB lymphocyte
count of 500/uL, both important parameters in immune recovery.
From this ongoing work we have evidence that the composition
and dose of the PBPC graft affects the outcome of allogeneic
HSCT. Understanding how each population and their interaction
affect the outcome of HSCT will hopefully allow for future tailor
made PBPC grafts.
(P 110) Defined Biomatrix with Growth Factors for Bladder
Wall Regeneration
J. Nuininga1, M. Bol2, H. van Moerkerk3, W. Daamen3, E. Oos-
terwijk4, J. Schalken4, T. van Kuppevelt3, W. Feitz1
1Radboud University Nijmegen Medical Center, Dept. of Pediatric
Urology.
2Radboud University Nijmegen Medical Center, Dept. of Pathol-
ogy.
3Radboud University Nijmegen Medical Center, Dept. of Bio-
chemistry.
4Radboud University Nijmegen Medical Center, Dept. of Ex-
perimental Urology.
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Introduction: Bladder augmentation through tissue engineering
currently involves autologous tissue transplantation, e.g. insertion
of small intestinal tissue. We evaluated four acellular collagen
biomatrices for bladder wall regeneration in a rabbit model.
Material & Methods: Rabbits underwent bladder wall augmen-
tation with a circular biochemically defined single (SL) or dual
layer (DL) collagen biomatrix. The SL or DL matrices were com-
posed of collagen (COL)þ heparin (HEP) or COLþHEPþ
Growth Factors (GF). The following GF were used: Epithelial
Growth Factor (EGF), Vascular Epithelial Growth Factor (VEGF)
and b-Fibroblast Growth Factor (b-FGF). The regenerated bladder
walls were harvested at 2, 4 and 12 weeks after implantation.
Tissue regeneration was evaluated using routine histology.
Results: Biomatrix encrustation was observed in 30/48 (63%)
of animals. All biomatrices showed considerable influx of in-
flammatory cells in the first 4 weeks, gradual decreasing in time.
At all time points, we found collagen remnants in the regenerated
bladder. The SL-HEP-GF, DL-HEP and DL-HEP-GF matrices
showed earlier epithelialization and neovascularization in com-
parison with the SL-HEP biomatrix at 2 weeks. In the biomatrices
with growth factors, only single muscle cells were present at the
peripheral area of the regenerated graft material at 12 weeks.
Conclusions: Tissue regeneration velocity was higher with
the use of dual layer or Growth Factors-modified biomatrices.
This clearly shows that bioactive modifications with the use of
special coatings and growth factors improves bladder wall regen-
eration for tissue engineering. The dual-layer biomatrix containing
heparin and growth factors have a high capacity for bladder re-
generation.
(P 111) Defining Physiological Parameters for Engineering a
Vascular Media Model
U. Cheema1, E. Hadjipanayi1, N. Tamimi1, B. Alp1, V. Mudera1,
R.A. Brown1
1University College London (UCL), Tissue Repair and En-
gineering Centre, Institute of Orthopaedics, Stanmore Campus,
London, HA7 4LP, UK.
Engineering a blood vessel requires an understanding of the pa-
rameters governing the survival of resident vascular smooth
muscle cells. We have developed an in vitro collagen-based vas-
cular media model to test the correlation between cell density, O2
requirements and cell viability.
Collagen type I constructs seeded with porcine Pulmonary Ar-
tery Smooth Muscle Cells (PASMCs) at different densities, low
(11106 cells/ml) and high (23106 cells/ml) were compressed to
produce 100 mm thick, dense collagen sheets. These were subse-
quently spiraled around a mandrel to mimic tubular structures and
cultured for up to 72 hrs in vitro under static conditions. O2 levels
were quantified in the core of these constructs and correlated to cell
viability.
The starting O2 level was 140mmHg.Within 24 hours O2 levels
in the core of constructs with low cell density dropped to
80mmHg. For the high cell density, levels dropped to 10mmHg
and remained at this level for up to 3 days. Cell viability in high
density constructs was 99% at 24 hrs both in the core and on the
surface. This decreased to 80% ( p< 0.05) in the core after 3 days,
but remained high (95%) on the surface, indicating that physio-
logical hypoxia might reduce cell viability. At low cell density,
increasing diffusion distance by 33% (increasing collagen layers)
resulted in a significant reduction of core O2 levels to 50mmHg
within 24 hrs (p< 0.05).
This study provides a useful model for examining physiological
parameters dictating vascular smooth muscle cell survival and
behaviour in engineered vascular structures.
(P 112) Degradable Particulate Composite Reinforced with
Nanofibre Meshes for Biomedical Applications
E.D. Pinho1,2, A. Martins1,2, J.V. Arau´jo1,2, R.L. Reis1,2, N.M.
Neves1,2
13B’s Research Group—Biomaterials, Biodegradables and Bio-
mimetics, Department of Polymer Engineering, University of
Minho, Campus de Gualtar, 4710-057 Braga, Portugal;
2IBB—Institute for Biotechnology and Bioengineering, PT Gov-
ernment Associated Laboratory, Braga, Portugal.
In the biomaterials field, nanofibre based structures and its com-
posites are promising materials to produce scaffolds mimicking
the architecture of the extracellular matrix (ECM). The main
purpose of this work was to develop a novel composite structure
which combines polymeric microfibres reinforced by nanofibres.
This combination was obtained by melting extrusion of a com-
posite with a natural polymer, Chitosan particles, and a biode-
gradable polymer, poly(butylene succinate) (50:50 wt), reinforced
with chitosan nanofibre meshes (0.05% wt). The chitosan meshes
were produced by electrospinning. The nanofibre reinforced mi-
crofibres were analysed by SEM demonstrated a considerable
alignment of the nanofibres along the longitudinal axis of the mi-
crofibres.
Tensile mechanical properties revealed that the introduction of
the reinforcement in the microfibres composite increased the ten-
sile modulus until 295.7 16.2MPa. This improvement is around
70% since the tensile modulus of microfibres without the nanofibre
reinforcement was 175.6 32.7MPa. Various structures were
subjected to swelling and degradation tests, in an isotonic saline
solution at 378C. The presence of chitosan nanofibres in the mi-
crofibres enhanced the water uptake in up to 24%. The weight loss
was also increased, reaching a maximum of 7.4% at the third day of
the degradation tests.
The combination of good mechanical properties and enhanced
degradability of the developed fibres may have a great potential to
produce 3D fiber meshes scaffolds.
Human bone marrow-derived stromal cells (hBMSCs) were
seeded on those 3D fiber meshes scaffolds reinforced by nanofibers
and sustain osteogenic differentiation, are adequate for bone tissue
engineering.
(P 113) Development and Plasticity in Networks of Neurons
Grown onto Micropatterned Substrates
E. Marconi1, M. Messa1, A. Fassio2, P. Baldelli1,2, F. Benfenati1,2
1Dep. of Neuroscience and Brain Technologies, The Italian In-
stitute of Technology, Genova, Italy.
2Dep. of Experimental Medicine, University of Genova, Genova,
Italy.
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Various molecules, during development of the central nervous
system, act on axons as guidance factors involved in the dynamic
rearrangements of actin cytoskeleton and promoting the formation
of neuronal networks. In order to characterize aspects of synaptic
transmission and plasticity, we generated artificial networks of
primary neurons onto substrates patterned with adhesion and
guidance molecules by using micro-contact printing (microCP).
We used poly-dimethylsiloxane stamps to pattern poly-D-lysine in
various geometries, with the aim to optimize adhesion conditions
for neurons on substrates. We evaluated different specific markers
for structure and synaptic function to assess how different pat-
terning geometries influence neuronal growth and network devel-
opment. The structural organization of the network was analyzed
by using immunofluorescence and atomic force microscopy. The
functional parameters of synaptic transmission of micropatterned
neuronal networks was assessed by patch-clamp techniques. Since
the drying step in conventional microCP could induce protein
denaturation and loss of function, we applied an indirect microCP
by which the surface was patterned with an intermediate drying
resistant molecule (protein A) that binds with high affinity and
specificity to appropriate chimeras of the guidance cues, expressed
as recombinant proteins (i.e. L1-Fc, NCAM-Fc). We found that
glutathione and streptavidin could be used as bridging molecules
because of their ability to resist to the drying step and bind with
high affinity Glutathione-S-Transferase and biotin. This approach
makes it possible to pattern more than one factor on the same
surface and to study the simultaneous effects of multiple molecules
on the differentiation of the neuronal network.
(P 114) Development and Validation of Bioactive Surfaces to
Modulate Micro-Vessel Formation
G. Sabra1,2, P. Vermette1,2
1Laboratoire de Bioinge´nierie et de Biophysique de l’Universite´
de Sherbrooke, Department of Chemical Engineering, Universite´
de Sherbrooke, 2500, blvd de l’Universite´, Sherbrooke, QC,
Canada, J1K 2R1.
2Research Centre on Aging, Institut universitaire de ge´riatrie de
Sherbrooke, 1036, rue Belve´de`re Sud, Sherbrooke, QC, Canada,
J1H 4C4.
Introduction: The reconstitution of damaged tissues or organs
represents a challenge for our aging society. Tissue engineering, at
present, is facing as a major limitation to construct viable tissues,
the lack of suitable vascular network to support its nutrient ex-
changes, growth and functionality.
In the present work, we propose the use of cross-linked gelatin to
study HUVEC specific adhesion to bioactive niches immobilized on
a low-fouling surface, aiming to stimulate and to control the forma-
tion of a vascular network in an adequate three dimensional system.
Materials and Methods: Glass substrates were surface-
modified by plasma polymerization of n-heptylamine, in a custom-
built plasma reactor. The exposed amine groups, resulted from
n-heptylamine plasma polymer (HApp) layers, were used to co-
valently graft carboxy-methyl-dextran (CMD) layers by carboii-
mide chemistry.
Afterwards, synthetic Arg-Gly-Asp (RGD) peptides, were dis-
pensed on activated CMD surfaces by using the Biochip Arrayer, a
non-contact dispensing robot, with arraying capabilities such as
those used to produce DNA and proteins chips.
These surfaces bearing RGD arrays were thereafter exposed to
HUVEC in a gel, prepared through cross linking of acid porcine
skin gelatin with transglutaminase (TGase).
Cells responses toward these spots will be presented.
Results: Based on this study, we found that the optimal condi-
tions for gelatin gel preparation were 5% gelatin and 2U/mL of
TGase, avoiding cells proliferation all over the gel, excepting those
who selectively attached to bioactive niches. The results show a
good perspective to produce controlled and directed micro-vessel
networks.
(P 115) Development of a Growth Factor-Embedded Scaffold
with Controllable Pore Size and Distribution using Micro-
Stereolithography
J.W. Lee1, T.A. Nguyen1, K.S. Kang1, Y.-J. Seol1, D.-W. Cho1
1Department of Mechanical Engineering, POSTECH
Introduction: Conventional scaffold fabrication methods have the
demerit that they cannot control the inner/outer shapes of struc-
tures. By contrast, SFF(solid free-form fabrication) can control
structure shapes freely. Therefore, the interest in SFF has increased.
Among SFF technologies, MSTL(micro-stereolithography) does
not use a heat source during fabrication and has the highest reso-
lution. In addition, many researchers have reported on the effect
of growth factors in cell differentiation. Therefore, we fabricated
3D (three-dimensional) scaffolds containing PLGA(polylactide
glycolic acid) microspheres incorporating the growth factor BMP-2
(bone morphogenetic protein-2) using MSTL and observed the
effects on cell differentiation.
Methods: Poly(propylene fumarate) (PPF) was synthesized via a
condensation reaction. Then, diethyl fumarate(DEF) was added
to reduce the viscosity. Finally, a photoinitiator was mixed with
the synthesized photopolymer. BMP-2 was encapsulated in the
PLGA using a double emulsion technique and the fabricated mi-
crospheres were centrifuged and freeze dried. Then, a MSTL
system consisting of an Ar ion laser, an x–y–z stage, and optical
components was used to fabricate 3D scaffolds by solidifying it in
layers.
Results/Discussion: A scaffold containing PLGA microspheres
that incorporated the growth factor BMP-2 was fabricated using
the MSTL system and PPF/DEF photopolymer. The pores and lines
of the fabricated scaffold were regular and all of the pores were
connected. PLGA microspheres were located both within and on
the surface of the scaffold. After scaffold fabrication, MC3T3-E1
cells were seeded on the scaffold and cell adhesion and differen-
tiation were observed. This growth factor-embedded scaffold will
be a good candidate as a bone scaffold in tissue engineering.
(P 116) Development of a Strategy to Functionalize Dextrin-
Based Hydrogel for Animal Cell Cultures
S. Moreira1,2, L. Domingues1, M. Casal2, M. Gama1
1IBB—Institute for Biotechnology and Bioengineering, Centre of
Biological Engineering, Universidade do Minho, 4710-057 Braga,
Portugal.
2Centre of Biology, Universidade do Minho, 4710-057 Braga,
Portugal.
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Several approaches can be used to functionalize biomaterials for
biomedical applications, such as hydrogels. One of the molecules
mostly used to improve cells adhesion to the biomaterials is the Arg-
Gly-Asp (RGD). The RGD sequence is the ligand for integrin-
mediator cell adhesion, which is present in several proteins from the
extracellular matrix (ECM); in many cases, this sequence was de-
scribed as being the major functional group responsible for cellular
adhesion. The covalent binding and incorporation of this molecule
during biomaterial production are the procedures mostly used. An-
other approach is to bind RGD molecules on the biomaterials sur-
face by fusing proteins with affinity to the biomaterial. The present
work shows the successful functionalization of a dextrin-based hy-
drogel using a fusion protein, containing a C-terminal starch binding
domain (SBD) and an N-terminal RGD sequence. The SBD belongs
to an a-amylase from Bacillus sp TS-23. The recombinant proteins
were cloned, expressed, purified and tested in in vitro assays. The
evaluation of cell attachment, spreading and proliferation were
performed on the polystyrene and dextrin-based hydrogel, using
mouse embryo fibroblasts 3T3. The results show that, in both cases,
the presence of RGD-SBD protein highly improves cells adhesion
and spreading. In fact, cell differentiation on the hydrogel surface
was observed to occur only in the presence of the RGD-SBD.
(P 117) Development of Bio-Nanocomposite Hydrogels Based
on Silicate Cross-Linked Peo for Tissue Engineering
P. J. Schexnailder1, Q. Jin1, A. Gaharwar1, C-J. Wu 1, G. Schmidt1
1Department of Biomedical Engineering, Purdue University, West
Lafayette, Indiana 47907, USA.
The goal of our work is to develop and refine engineered syn-
thetic hydrogels with appropriate structural and mechanical prop-
erties that can be readily applied to the creation of replacement
tissues. Our approach is predicated upon the development of a
silicate cross-linked polyethylene oxide (PEO) hydrogel contain-
ing polysaccharides. We have developed a new technology to
produce hydrogels that can be both viscoelastic and injectable or
elastomeric-like tough and compliant. Although PEO-based ma-
terials have gained recognition for good biocompatibility, the use
of these materials remains limited due to their relatively inferior
mechanical properties. Our approach overcomes this major defi-
ciency by using silicate nanoparticles to cross-link the PEO. In
addition, these silicate cross-linkers provide exfoliated, dissolution,
and degradation properties. By the addition of polysaccharides, we
can create a host of interpenetrating hydrogel networks with syn-
thetic variations in structure and mechanical strength. Most impor-
tantly, the reversible cross-linking of the interpenetrating polymer
networks allows for the ability to tune mechanical properties to
those of cartilage or other tissues. We will present preliminary
results that show how to synthesize and formulate optimal nano-
composite hydrogels that maintain mechanical strength, biocom-
patibility and degradability. We will show how the physical
properties of scaffolding materials will be optimized to provide a
suitable extracellular matrix (ECM) for cell growth and how the
biological properties will be developed for repair of cartilage.
(P 118) Development of Bioactive and Biodegradable Chit-
osan-Based Thermo-Responsive Hydrogels
D.S. Couto1,2, J.F.Mano1,2
13B’s Research Group—Biomaterials, Biodegradables and Bio-
mimetics.
2IBB - Institute for Biotechnology and Bioengineering.
There is increasing interest on the development of new tissue en-
gineering strategies to deliver cells and bioactive agents encapsu-
lated in a biodegradable matrix through minimally invasive
procedures. The present work proposes to develop a combination of
chitosan—b-glycerophosphate salt formulationwith bioactive glass
(BG) nanoparticles in order to conceive novel injectable thermo-
responsive hydrogels to be employed in different orthopedic ap-
plications. This work is inspired on natural biomineralization
process and bone structure to create injectable bionanocomposites
that combine thermal inducing gelation, biocompatibility, biode-
gradability and bioactivity.
The BG particles presented a spherical shape with nanometric
scale diameters, which guarantee its efficient injection through
small diameter needles into bone defects. The rheological proper-
ties and gelation points of the developed nanocomposite systems
revealed to be adequate for intra-corporal injection. In vitro bio-
activity tests, using incubation protocols in a simulated body fluid,
SBF, with ion concentration approximately equal to those of human
blood plasma, allowed the observation of bone-like apatite depo-
sition in the hydrogel formulations containing bioactive nano-
particles. The density of apatite formed increased when increasing
BG content and soaking time in SBF. These results suggest that
such smart hydrogels could be used as temporary injectable scaf-
folds in bone tissue engineering applications. Besides, they can also
be combined with more robust tri-dimensional scaffolds in bone
tissue engineering strategies to guarantee adequate bone’s me-
chanical features. Finally, the proposed osteoconductive injectable
biodegradable materials have potential to be used in different or-
thopedic reconstructive and regenerative applications and stimulate
the development of other biocompatible formulations.
(P 119) Development of Bioartificial Hair Papilla Tissue Em-
ploying Mesenchymal Stem Cells
B.Y. Yoo1, H.H. Yoon2, Y.H. Shin2, Y.J. Kim2, K.Y. Song3, J.K.
Park1
1Dept. Chemical and Biochemical Engineering, Dongguk Uni-
versity, Dongguk University.
2Biomedical Research Center, Lifecord. Co.
3Dept. Pathology, College of Medicine, Chung-ang University.
The hair follicle is small, but complex and a dynamic organ. In
humans, it plays an important role from the esthetic aspect of social
life. In the past,alopecia was treated typically by various methods
of implanting artificial hair into hair follicle root bulbs of the scalp,
but such artificial hair implant methods had led to some serious
problems, and such methods are now banned. Currently, there are
two methods employed to treat alopecia: drug or natural substance
therapy, and human hair transplantation. Although the transplanted
hair settles at the transplant area as a complete hair follicle and
becomes a permanent hair that undergoes a normal growth cycle,
the number of hair to be transplanted is severely limited, and in
case of transplanting about 2,000 hair strands per one operation, it
is generally not possible to perform more than three such opera-
tions. Thus, the methods currently used for treating alopecia have a
number of limitations, and to overcome such problems, many re-
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searchers have attempted to revive hair follicles by in vitro
culturing hair follicle cells and implanting them in the treatment
area. In our study, by utilizing culture-expanded mesenchymal
stem cells (MSCs) which don’t have aggregative activity, cell-
aggregated spheroidal DP tissues were produced by a special cul-
ture condition in vitro, and hair follicle inductive capacity pertinent
to the aggregative activity was evaluated.
(P 120) Development of Biomimetic and Smart Coatings Based
on Elastin-Like Polymers Containing RGD Cell Attachment
Sequences
R.R. Costa1,2,3, A.M. Testera1, F.J. Arias1, J.F. Mano2,3, J.C.
Rodrı´guez-Cabello1
1G.I.R. Bioforge, Univ. Valladolid, Edificio IþD, Paseo de Bele´n,
1, 47011 Valladolid.
23B’s Research Group—Biomaterials, Biodegradables and Bio-
mimetics, Dept. of Polymer Engineering, University of Minho,
Campus de Gualtar, 4710-057 Braga, Portugal.
3IBB—Institute for Biotechnology and Bioengineering, PT Gov-
ernment Associated Laboratory, Braga, Portugal.
Elastin-like polymers (ELPs) are based on repeating sequences
found in the natural elastin. They show remarkable combination of
properties, such as a large range of mechanical properties, excel-
lent biocompatibility, and smart behaviour and self-assembly
towards temperature, pH and often different stimuli. Around a cer-
tain temperature, known as inverse transition temperature (ITT)
these polymers show phase transitions aqueous solutions: under the
ITT, the polymer chains are disordered and in a relatively extended
state, remaining soluble; above the ITT, the chains suffer a tran-
sition to a helical ordered state and aggregate. Nowadays, through
recombinant genetic engineering it is possible to construct and
produce recombinant ELPs with specific cell attachment sequences
from human fibronectin and elastin.
In this study, an ELP containing six monomers of RGD se-
quence was obtained by fermentation of a genetically modified
Escherichi coli (E. coli) stock. After purification, the final bio-
production yield was over 120 mg/L. Electrophoreris and mass
spectroscopy were performed for assessment of RGD purity. Mo-
lecular weight was of about 60 kDa as expected. Differential
scanning calorimetry (DSC) tests were done to evaluate the vari-
ations of ITT as a function of pH.
The objective is to use the properties of recombinant ELPs
containing RGD in the development of coatings for medical im-
plants with improved biocompatibility and biomimetic behaviour
regarding cell attachment, through technologies such as layer-by-
layer and spin-coating.
(P 121) Development of Enhanced Low Serum Culture Stra-
tegies for Human Amniotic Fluid Stem Cells
A.M. Frias1,2, S. Fernandes3, A. Barros3, N.M. Neves1,2, R.L.
Reis1,2
13B’s Research Group—Biomaterials, Biodegradables and Bio-
mimetics, Dept. of Polymer Engineering, Univ. of Minho, Campus
de Gualtar, 4710-057 Braga, Portugal.
2IBB—Institute for Biotechnology and Bioengineering, PT Gov-
ernment Associated Laboratory, Braga, Portugal.
3Genetics Department, Faculty of Medicine, University of Porto,
Portugal.
The role of stem cells in tissue engineering and regenerative
medicine is evolving rapidly, namely the use of mesenchymal stem
cells (MSCs) due to their potentially immune privilege. These cells
can be isolated from different sources such as bone marrow, adi-
pose tissue, umbilical cord and more recently amniotic fluid. Al-
though the amniotic fluid cells have been used for prenatal
diagnosis since 1950s in a well established routine technique, little
is known about the origin and properties of these cells. In this
study, we aimed at developing a method of isolation and expansion
of purified cultures of adult stem cells from amniotic fluid to be
used as a tool for regenerative medicine. We isolated hAFSCs
(Human Amniotic Fluid Stem Cells) from day 6 supernatant of the
cultures of amniotic fluid obtained from amniocentesis. The cell
pellet was reseeded in expansion medium and cultured until con-
fluence. The effect of cell density plating, basic fibroblast growth
factor (bFGF) and foetal bovine serum (FBS) concentrations, in the
culture medium were tested and the proliferative potential was
evaluated by cell counts at various time points. The osteogenic and
chondrogenic differentiative potential were also evaluated. Para-
meters as cell surface markers of ‘‘stemness’’, telomerase activity
and stem cells transcripts expression of specific lineages were
evaluated by flow cytometry and RT-PCR techniques. With this
work we intended to contribute to unfold the potential of stem cells
populations from amniotic fluid by decreasing FBS concentration,
number of cell-passages and culture time needed to obtain a
homogeneous stem cell culture.
(P 122) Development of Novel Carrageenan Scaffolds for
Tissue Engineering using Rapid Prototyping
B.M. Ferreira1,2, R.A. Sousa1,2, R.L. Reis1,2
13B’s Research Group—Biomaterials, Biodegradables and Bio-
mimetics, Dept. of Polymer Engineering, University of Minho.
2IBB—Institute for Biotechnology and Bioengineering, PT Gov-
ernment Associated Laboratory, Braga, Portugal.
In the Tissue Engineering (TE) field, great attention has been given
devoted to the use of rapid prototyping (RP). The combined use of
Computer Assisted Design (CAD) with advanced RP techniques
enables the design and fabrication in a reproducible way of patient
adapted scaffolds featuring complex 3D architectures. In this
context, Carrageenan is a natural polymer that exhibits a very high
biomedical potential. Carrageenan is a sulphated hydrocolloid
capable of forming hydrogels with very different behaviours and
properties depending on the experimental conditions.
In this preliminary work, novel 3D porous structures of carra-
geenan were for the first time prepared using RP, by using a 3D
bioplotting (Bioplotter). The study aimed to establish a rela-
tionship between the scaffold architectural and crosslinking pa-
rameters and the subsequent physicochemical properties. In this
perspective, the conjugation of diverse architectural arrangements
and post-processing methods, including chemical crosslinking
techniques, were explored in order to obtain a diverse range of
scaffold architectures.
The properties of the developed scaffolds were assessed by both
dynamic and quasi-static characterization tools. The relationships
between mechanical properties and architectural parameters and
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degree/type of crosslinking were established. Furthermore, cyto-
toxicity testing using fibroblasts (L929) and direct contact assays
using osteoblast-like cells (SaOs-2) were performed in order to
assess the effect of crosslinking on cell behavior. Preliminary re-
sults confirm the potential of carrageenan scaffolds to be used in
bone TE.
(P 123) Development of PLA and PCL Based Textile Struc-
tures as Scaffolds for Tissue Engineering
B. Gupta1, S. Saxena1, Geeta1, A.R. Ray1, J. Hilborn2
1Indian Institute of Technology, New Delhi-110016, India.
2University of Uppsala, Uppsala, Sweden.
Textile structures are particularly attractive to tissue engineering
because of their ability to tailor a broad spectrum of scaffolds with
a wide range of properties. Our initial efforts have been successful
in designing textile based biostable polyester scaffolds for urinary
bladder reconstruction. We have been working on the development
of biodegradable scaffolds for the development of blood vessels in
our laboratory. The inherent problems of PLA in terms of rigid
structure and high crystallinity were overcome by using a blended
composition. The PLA was blended with the poly(lactic acid-co-
glycolic acid) (PLCL) and was subsequently spun into filaments of
40–60 microns diameter. Alternatively, PCL filaments were pro-
duced by the melt spinning process. The spun filaments were
subjected to the drawing and heat setting operations so that re-
quired strength in filaments is achieved. The blending leads to
significant alteration in the inherent PLA structures. The filaments
thus produced have good tensile strength and high elongation. It is
important to mention here that the blending leads to significant
reduction in the crystallinity of the filaments. The PLA and PCL
filaments are being made into the textile structures so that the
tubular structures of 5–6mmmay be produced. Characterization of
these filaments and structures is being carried out.
(P 124) Development of Textile Scaffolds for Bone Tissue
Engineering
M. Moczulska1,2, M. Bitar2, S. Lischer2, W. Swieszkowski1,
A. Bruinink2
1Warsaw University of Technology.
2Swiss Federal Laboratories for Materials Testing and Research.
Introduction: The development of textile scaffolds for bone re-
generation should take into consideration the effect of its compo-
sition and structure on cell function. The ideal scaffold should be
biocompatible, biodegradable, and promote cellular interactions
and bone tissue development. The scaffolds architecture should
initially permit, and promote, cell colonization and subsequently
drive the population towards osteoblastic differentiation.
This study aims at defining of optimal physical character of
fibrous mesh scaffolds mesh for bone tissue engineering. This is
conducted by elucidating the influence of fibre diameter, mesh size,
and fibre crossing angle on cell migration and proliferation.
Materials andMethods: Reaggregates of primary adult trabecular
bone derived human osteoblasts, and of human skin fibro-blasts,
were used to assess the capacity of the cell population in covering
the textile scaffold as function of fibre diameter and mesh gap size.
PET and PA textile scaffolds of various fibre diameters, mesh size
and fibre crossing angle were used. Cell reaggregates were seeded
onto the scaffolds and samples were examined using light micro-
scope. Subsequently, cell spreading was monitored by assessing
the evolution of the total textile area covered by cells.
Results and Discussion: The results obtained in this study
strongly suggested that fibre diameter, and mesh gap size, signif-
icantly influenced cell outgrowth out of the reaggregate. Further-
more, the cell population response to the physical characteristic of
the scaffolds appeared to be cell type dependent. Further work is
undergoing to substantiate these results by quantifying cell mi-
gration and proliferation rate on these scaffolds.
(P 125) Development of Three Dimensional Culture Systems
for Embryonic Stem Cells
K.A. Meade1, R.V. Ulijn1, S. Downes1, C.L.R. Merry1
1School of Materials, The University of Manchester
The capacity of pluripotent, self-renewing embryonic stem (ES)
cells to differentiate into any cell type of the adult body holds great
potential for their use in tissue engineering and cellular therapy.
However, current two dimensional (2D) culture techniques are
hindering their large scale culture and efficient differentiation.
Three dimensional (3D) scaffolds can mimic the in vivo micro-
environment of ES cells, leading to sustained pluripotency and
enhanced differentiation into mature cell phenotypes.
We are focusing on the development and application of elec-
trospun poly(lactic-co-glycolic acid) (PLGA) scaffolds and self
assembling Fluorenylmethoxycarbonyl (Fmoc) peptide hydrogels
to the culture of ES cells. Parameters for electrospinning 20%
PLGA in Hexafluoroisopropanol (HFIP) have been established.
The resulting non woven meshes were comprised of fibres rang-
ing between 0.2 and 1.5 mm in diameter. Mouse ES cells cultured
on the surface of RGD functionalised dipeptide hydrogels formed
colonies reminiscent of those observed in standard 2D culture
conditions. Cells seeded within the gels remained viable after
24 hours.
Future work will focus on assessing the survival of ES cells
within the Fmoc-dipeptide hydrogels over a longer time period,
and the successful application of electrospun PLGA to ES cell
culture. Long term aims include modification of both 3D culture
environments with oligosaccharides or extracellular matrix pro-
teins in order to better replicate the environment stem cells expe-
rience in vivo.
(P 126) Differentiation and Proliferation of T17b Murine
Embryonal Endothelial Progenitor Cells with Angiogenic Po-
tential in a Fibrin Matrix
O. Bleiziffer1, M. Hammon1, A. Arkudas1, E. Naschberger2,
S. Rath1, J. Beier1, M. Sturzl2, U. Kneser1, R.E. Horch1
1Plastic and Hand Surgery, Erlangen University Medical Center.
2Experimental Surgery, Erlangen University Medical Center.
Introduction: Vascularisation of bioartificial matrices is an
important goal in tissue engineering. T17b murine embryonal en-
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dothelial progenitor cells (EPC) (Hatzopoulos, 1998) can differ-
entiate and support formation of new blood vessels in vivo.
Therefore, the aim of our study was to investigate their properties
in a fibrin matrix in vitro.
Materials and Methods: EPC were cultured in a fibrin matrix
or on chamber slides and overlayed with basal medium (BM) or
differentiation medium (DM). Constructs were harvested after 3 or
8 days and immunohistochemically assessed for EPC proliferation
(Ki-67) and differentiation (von Willebrand Factor (vWF)). VWF
gene expression was investigated by PCR. VEGF secretion in
chamber slides supernatants was quantified by ELISA.
Results: Under BM incubation EPC formed multicellular clus-
ters containing lumen-like structures and displayed positive Ki-67
staining in the fibrin matrix. Addition of DM resulted in a reduced
cell number, absence of Ki-67 expression and upregulated vWF
gene expression, indicating successful differentiation of EPC. In
chamber slide cultures, hypoxia/BM induced significant increases
in proliferation and vWF gene expression as well as a 6-fold in-
crease in VEGF secretion compared normoxia/BM where vWF
staining was negative and cell proliferation less pronounced.
Normoxia/DM resulted in the highest levels of vWF gene ex-
pression but no proliferation.
Conclusion: EPC exhibited proliferation and differentiation
and formed multicellular lumen-containing clusters in fibrin ma-
trices. Hypoxia stimulated cell proliferation more than normoxia
and induced differentiation and VEGF secretion. Taken together,
these findings indicate that T17b EPC may deserve further in-
vestigation as a tool to enhance vascularisation of bioartificial
matrices.
(P 127) Differentiation of Bone Marrow-Derived Stromal Cells
using Co-Culture System with Annulus Fibrosus Cells
J.Y. Lim1, S.H. Kim1, J.W. So1, M.O. Back1, H.H. Hong1, S.H.
Jung1, J.M. Rhee1, G.S. Khang1, M.S. Kim2, H.B. Lee2
1BK-21 Polymer BIN Fusion Research Team Chonbuk Nat’l Univ.
2Nanobiomaterial Lab., KRICT.
Healing damage of intervertebral disc(IVD) dose not naturally
occur and degenerative processes may lead to herniation of the
annulus fibrosus(AF), resulting in pain. One major aim is the
identification of suitable cell populations with the capacity to re-
generate IVD tissue. So, we have focused bone marrow stromal
cells (BMSCs) as an alternative cell source. In this study, we
evaluated the possibility of differentiation of BMSC into AF-like
cell by the co-culture system of BMSC and AF cells.
We isolated AF cells from the spine of New Zealand white
rabbit and cultured cells using DMEM/Ham’s F-12 supplemented
with 10% FBS and 1% penicillin streptomycin. For BMSCs iso-
lation, it was aspirated from femoral region of rabbit and cultured
using a-MEM contained 10% FBS and 1% PS. We established
three experimental group; (A)BMSCs, (B)AF and (C)BMSCs co-
cultured with AF cells. The gene expression of type I collagen was
examined by RT-PCR. We assayed DNA and sGAG contents. And
safranin-O staining and immunohistochemistry for type I collagen
were performed.
We could observe the typical morphologies of fibroblast-like
BMSCs and polygonal AF cell in group (A) and (B), respectively.
In group (C), it was observed that BMSC morphology changed into
polygonal AF-like cell. The RT-PCR result showed significant up-
regulation of type I collagen gene expression.
These results revealed that BMSCs were differentiated to
AF-like cell showing character of AF cell. We concluded the dif-
ferentiation of BMSCs into AF-like cells is possible through co-
culture system.
Acknowledgements: This research was supported by KMOHW
(0405-BO01-0204-0006) and SCRC (SC3100).
(P 128) Differentiation of Umbilical Cord Lining Membrane
Stem Cells into Hepatic-Like Cells
T.T. Phan1,2,3,4, D.V. Do4, I.J. Lim1,4, J. Masilamani1,4
1Department of Surgery, National University of Singapore, Sin-
gapore.
2Centre for Craniofacial & Regenerative Biology, Faculty of
Dentistry, National University of Singapore, Singapore.
3NUS Tissue Engineering and Stem Cell Research Program, Na-
tional University of Singapore, Singapore.
4CellResearch Corp Pte Ltd, Singapore.
We have successfully isolated both epithelial and mesenchymal
stem cells from the outer amniotic lining membrane of the um-
bilical cord with easily accessibility and significantly high yield.
Interestingly, these cells possess embryonic stem cell characteris-
tics, and could be differentiated into specific cells such as skin,
bone, and fat. In the present study, we examined the in-vitro he-
patic differentiation of umbilical cord lining derived epithelial
stem cells (CLECs) and mesenchymal stem cells (CLMCs). These
cells were cultured under 2-step protocol with the use of hepato-
cyte culture medium (HCM) and hepatocyte maturation medium
(HMM). Expression of a variety of hepatic makers was analyzed
by RT-PCR, Western blot, and immunocytochemistry. The func-
tionality of differentiated cells was assessed by their ability to
produce albumin, secrete urea, store glycogen, and uptake low-
density lipoprotein. After 7 days of induction, the cells were
morphologically transformed into hepatocyte-like cells with in-
creased mRNA expression of most hepatic markers. Moreover,
increased protein expression of Albumin and cytokeratin-18, as
well as decreased protein expression of alpha-fetoprotein and
cytokeratin-19 was also observed. Differentiated cells further
demonstrated in vitro functions characteristic of liver cells, in-
cluding albumin production, glycogen storage, urea secretion,
uptake of low-density lipoprotein. In conclusion, CLECs and
CLMCs will be good cell sources for hepatocyte transplantation for
the treatment of metabolic disorder or bioartificial liver system.
(P 129) Direct Laser Writing of Cad-Designed 3D Scaffolds for
Tissue Engineering
A. Ovsianikov1, S. Schlie1, A. Ngezahayo2, B. Chichkov1
1Laser Zentrum Hannover e.V.
2University of Hannover.
Currently, there is a great demand in the ability to mimic the in vivo
cellular tissue environment in the laboratory conditions. The
systematic study of cell interaction and tissue growth in 3D relies
on the ability to fabricate scaffolds, supporting the cell growth, in a
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reproducible manner. In this contribution, our recent ad-
vances on laser microfabrication of three-dimensional (3D) scaf-
folds are presented.
By applying multi-photon illumination technique, arbitrary
CAD-designed 3D objects can be fabricated in a single step.
Taking its origin in multiphoton microscopy, two-photon poly-
merization technology is now becoming an important rapid pro-
totyping tool. In our work, near-infrared femtosecond laser pulses
are applied for 3D material processing. When tightly focused into
the volume of a UV-photosensitive material, they interact with
material through two-photon absorption. As a result a highly lo-
calized material modification appears. This can be, for example,
polymerization process, transferring liquid into the solid state. By
moving the laser focus in 3D a trace of modified material is pro-
duced, resulting in a fabrication computer generated 3D structure
by direct laser ‘‘recording’’ into the volume of photosensitive
material. After the illumination, the unmodified material is re-
moved by an appropriate developer, and the fabricated structure is
revealed. Such scaffold structures are used to support cell growth,
in order to artificially produce tissue of a desired shape. Applica-
tion of 2PP for fabrication of 3D scaffolds directly targets such
common issues as vascularization of large in vitro grown tissues,
and demand for patient specific scaffold production.
(P 130) Does Administration of Immunosuppressive Drugs
Impact on the Immunomodulatory Properties of Mesenchy-
mal Stem Cells (MSC): Insights from an In vitro Study
A.J. Poncelet1,2, Y. Nizet1, C. Lecuivre1, J. Vercruysse1, P. Gia-
nello1
1Experimental Surgery- Catholic University of louvain.
2Cardio-vascular Department-Cliniques universitaires Saint-Luc.
Background: Mesenchymal stem cells (MSC) down-modulate
immune responses in vitro and clinical studies currently test the
role of allogeneic MSC in immunosuppressed patients suffering
from graft versus host disease (GVHD). We tested in vitro the
interaction of different immunosuppressive drugs (IS) on the
immuno-modulatory properties of MSC.
Methods: Both calcineurin inhibitors: cyclosporine (CsA) and
tacrolimus (Tac), and mTOR inhibitors : sirolimus (Si) and ever-
olimus (Ev) were tested.
MSC proliferation was assessed on day 5 & 7. For in vitro
experiments, the effect of IS drugs on the immune modulation by
MSC was measured in proliferation assays of modified mixed
lymphocyte reaction where MSC were added (ratio 1:2) with de-
creasing concentration of IS drugs (C100 to C0).
Results: On day 5, no significant difference in proliferation was
noticed among IS drugs. On day 7 of culture, all IS drugs except
tacrolimus significantly decreased cell proliferation compared to
IS-free culture medium (CsA, -43.6%; Si, -14%, Ev, -17%).
In dose-dependant PBMC-MSC co-cultures, the immuno-
modulatory properties of allogeneic MSC were maintained in-
dependantly of the concentration of IS drug used.
At C50 for Tac (5 ng/ml) and Si (0.3 ng/ml), the down-
modulation by MSC was still present since the degree of inhibition,
for a 1:2 MSC/PBMC ratio, was 96% and 94%, respectively.
Conclusions: The concomitant use of immunosuppressive drugs
significantly interacts on the proliferation of MSC in vitro.
Among their class, Tacrolimus and Sirolimus were the drugs
with the least interaction and at C50 neither had detrimental effect
on the immuno-modulatory properties of MSC.
(P 131) Dose-Dependent Effect of Plasma-Rich in Growth
Factors (PRGF) in the Proliferation of Rat Bone Marrow
Stromal Cells
A.G. Dias1, M.H. Fernandes1
1Faculdade de Medicina Denta´ria da Universidade do Porto.
Plasma-rich in growth factors (PRGF) is a blood derived fraction
containing high concentrations of autologous growth factors.
PRGF application as been reported as an effective way to accel-
erate and stimulate hard and soft tissue repair. The main goal of
this work is to evaluate the effect of autologous PRGF on the
behavior of rat bone marrow stromal cells. Cell behavior in the
presence of fetal bovine serum (FBS) was also assessed.
PRGF was obtained by cardiac puncture from Wistar rats using
a centrifugationmethodology. Bonemarrow cells were isolated from
the femurs of the same animals and cultured in?-MEM, 10% SBF,
in standard conditions. At 70–80% confluence, cells were released
and the cell suspension was cultured (104 cell/cm2) for 10 days in the
presence of (i) 0.5 and 5% PRGF and (ii) 0.5 and 5% FBS. Cultures
were characterized for cell morphology and proliferation.
PRGF treated cultures presented a higher cell growth rate
throughout the incubation time. FBS treated cultures showed a
similar proliferation pattern. Despite the similar profile, both
conditions caused a dose-dependent effect on cell growth, an effect
more marked in condition (i). Differences regarding cell morphol-
ogy were also apparent, with FBS treated cells presenting more
pronounced cytoplasmic extensions.
In conclusion, results showed that the cultures supplemented with
autologous PRGF presented a high proliferation rate at very low
PRGF concentrations, compared to FBS. Thus, combination of au-
tologous stem cells and PRGF might provide an optimized system
for ex vivo cell expansion regarding bone tissue engineering appli-
cations.
(P 132) Dynamic Cell Culture Prevents Core Necrosis
and Creates Meaningful Osteoblastic Networks in Thick 3D
Tissue-Engineered Constructs
A.C. Allori1, A.M. Sailon1, E. Clark2, C. Cretiu-Vasiliu3, J. Smay3,
J. L. Ricci2, S. M. Warren1
1Institute of Reconstructive Plastic Surgery, NYU Medical Center,
New York, NY.
2Dept. of Biomaterials and Biomimetics, NYU College of Den-
tistry, New York, NY.
3Oklahoma State University, Stillwater, OK.
Introduction: Bone lacuno-canalicular fluid flow ensures chemo-
transportation and provides a mechanical stimulus to cells. A novel
flow-perfusion bioreactor was used to provide chemotranspor-
tation through a thick 3D scaffold in vitro. We hypothesize that
flow perfusion will improve cellular distribution and viability
throughout the construct and that osteoblasts will form meaningful
osteoblastic networks.
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Methods: 3D bioprinted cylindrical hydroxyapatite-tricalcium-
phosphate scaffolds (246mm, 200200mm pore size) were
seeded with MC3T3-E1 cells (4106 cells/cm3) and subjected to
dynamic cell culture (0.4 dyn/cm2) in osteogenic medium. Control
scaffolds remained in static culture. A dye-transfer technique using
diI and calcein AMwas used to label cells to check for gap junction
formation. Samples were harvested at 2, 4, 6, 10, 14, and 21 days,
plastic-embedded, and analyzed by confocal microscopy and
scanning electron microscopy.
Results: Histologic analysis confirmed uniform cell distribution
after seeding and that >90% of cells survived the time allotted for
cellular adherence. By 6 days in static culture, 80% of cells in the
core of the scaffolds were non-viable, while 90% of those at the
peripheral crust survived. In contrast, scaffolds subjected to flow
perfusion demonstrated uniform cell density and 95% viability
throughout the construct at all time points. Osteoblasts assumed
characteristic dendritic phenotype and extended podocytes toward
other cells, with evidence of gap junction formation.
Conclusion: Flow perfusion ensured adequate chemo-
transportation to all regions of a thick 3D scaffold, such that cel-
lular viability and distribution were preserved. The 3D environment
was conducive to the formation of meaningful osteoblastic net-
works.
(P 133) Dynamic Seeding and Culture of Urothelial Cells on
Tubular Type I Collagen Scaffolds for Urogenital Tissue En-
gineering Applications
M.A. Milczarek1, P.J. Geutjes2, D.M. Tiemessen2, E. Oosterwijk2,
M.J.W. Koens3, W.F. Daamen3, T.H. van Kuppevelt3, W.F.J.
Feitz2, R.M.H. Wijnen1
1Pediatric Surgery 816, Radboud University Nijmegen Medical
Centre, The Netherlands.
2Urology 659, Radboud University Nijmegen Medical Centre,
The Netherlands.
3Biochemistry 280, Radboud University Nijmegen Medical Cen-
tre, The Netherlands.
Purpose: Urethral reconstruction still leads to significant compli-
cation rates and remains a challenge within the Urology. Tissue
engineering raised our expectations of changing this situation. Our
study aims to evaluate different cell seeding methods on collagen
based tubular scaffolds for urethra reconstruction.
Methods: Three different urothelial cell seeding procedures
were compared on highly porous type I collagen tubular scaffolds.
In the static method, cells were suspended into the lumen of the
scaffold and cultured for one or seven days. This method was
compared with two dynamic cell seeding procedures; the open
method (Xo) in which the flow was directed through the lumen of
the construct, and the sealed method (Xs) in which the flow was
perfused through the wall of the tubular scaffold. In the Xs method
we also compared two different flow-rates (1 ml/min and 1 ml/h).
After one or seven days culture the constructs were evaluated with
histology and electron microscope.
Results: With the Xo method and the static method, cells were
seen in the lumen of the tubular scaffold. However, with the static
method, cells were also observed on the outside of the scaffold.
Interestingly, the Xo method resulted in cell distribution through-
out the wall of the scaffold. No cells could be observed with the
1 ml/min Xs method. No distinctive differences between 1 and 7
days time-points were observed.
Conclusion: Although cells were not always evenly distributed,
both dynamic methods resulted in a localized cell growth (lumen
versus wall) with a high density.
(P 134) Effect of Keratin/PLGA Scaffold on the Neural Dif-
ferentiation of Rat BMSCs
A.Y. Oh1, S.H. Kim1, S.M. Kim1, M.S. Kim2, J.H. Kim 3, J.M.
Rhee1, H.B. Lee2, G. Khang1
1BK-21 Polymer BIN Fusion Research Team, Chonbuk National
University, Korea.
2Fusion Bio Research Center (KRICT), Korea.
3Department of Biochemistry and Molecular Biology, Yeungnam
University, Korea.
Bone marrow stromal cells(BMSCs) exhibit multiple traits of a
stem cell population, and they can expand many times in vitro and
be induced to differentiate into multiple cell types. Keratin is the
major structural fibrous protein providing outer covering such as
wool, hair, and nail. Keratin is useful as natural biomaterial. We
examined the effect of Keratin/PLGA scaffold on the neural dif-
ferentiation of rat BMSCs.
We developed the keratin loaded poly(L-lactide-co-glycolide)
(PLGA) scaffold (Keratin/PLGA). Keratin/PLGA (Keratin con-
tents: 0%, 10% and 20% of PLGA weight) scaffolds were prepared
by solvent casting/salt leaching method. BMSCs were harvested
from the femurs of adult female Fischer rat (rBMSC). These cells
were seeded in Keratin/PLGA scaffold and cultured with Medium
1(50ml DMEM , 2% DMSO, 200 mM BHA, 25 mM valproic acid,
10 mM forskolin, 1 mM hydrocotisone, 5 mg/ml insulin)and Med-
ium 2 (50ml DMEM, 10% FBS, 1% PS) for 14 days. rBMSC
viability in keratin/PLGA were assessed using the MTT assay.
mRNA expression using RT-PCR to neural maker such as NF and
NSE was conducted to confirm the effect of Keratin/PLGA scaf-
fold on the neural differentiation of rBMSCs. In addition, we
evaluated NF and NSE protein on Keratin/PLGA scaffold seeded
rBMSC by immunohistochemisty.
We confirmed that effect of Keratin/PLGA scaffold on the neural
differentiation of rat BMSCs. According to our results, 10 % and 20
% keratin/PLGA scaffold have good cell compatibility and the
expression of neural markers was higher. In conclusion, Neural
differentiation of rat BMSCs is possible on Keratin/PLGA scaffold.
This research was supported by SCRC(SC3100).
(P 135) Effect of Mechanical Stimulation on the Differentia-
tion of Human Dental Pulp Cells
M.J. Han1, Y.K. Seo1, K.Y. Song2, J.K. Park1
1Department of Chemical and Biochemical Engineering, Dongguk
University, Seoul, Korea.
2Department of Pathology, Chung-Ang University, Seoul, Korea.
Recently, there are lots of periodontal diseases and one of them is a
defect of alveolar bone considered as a serious problem. Hence,
researchers have studied to treat these problems using tissue en-
gineering technique. Periodontal tissues are exposed to mechanical
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stress caused by occlusion and mastication, and both the cells and
extracellular matrix in these tissues undergo architectural modifi-
cation to equilibrate the applied stress. Therefore, in this study we
are willing to recognize the effect of the mechanical tension on the
osteogenesis of human periodontal dental pulp cells.
To identify the osteogenesis by mechanical stress in the dental
pulp, we examined the effects of the tension on human periodontal
dental pulp cells (HDPCs). We evaluated the effects of mechanical
stimuli for the osteogenesis of human dental pulp cells on the silk
scaffold using a bioreactor with 10% tension. The tension was
applied with 0.2Hz during 5 days and continuously applied during
10 days. We evaluated the differentiation of cells by RT-PCR,
Western blot and immunohistochemistry. Application of 10%
tension culture reported in increases in collagen type I, Fibronectin,
osteoprotegerin, bone sialoprotein, and decreases in alpha-smooth
muscle actin. These data suggest that mechanical stimulation can
promote osteogenesis of human dental pulp cells.
(P 136) Effect of Radiation on Tissue-Engineered Mucosa
W.M.W. Tra1, H.A. Rakhorst1, S.O.P. Hofer2, S.G. Perez-
Amodio1
1Dept of Plastic Surgery, Erasmus MC, Rotterdam, The Nether-
lands.
2Department of Surgery and Department of Surgical Oncology,
University of Toronto, Ontario, Canada.
Tissue-engineered mucosa (TEM) can be used to reconstruct de-
fects that remain after oncological resection. After resection, most
patients receive radiotherapy. Radiation primarily affects prolif-
erating cells. Therefore, mucosa, in particular the basal layer of the
epidermis, is susceptible to radiation damage due to its physio-
logical high cell turnover rate. Radiation damage results in DNA
double strand breaks (DSBs).Our goal was to determine the effect
of various radiation doses on TEM.
Human keratinocytes and fibroblasts were isolated from buccal
mucosa. Keratinocytes were seeded onto a scaffold of acellular
human donor skin and fibroblasts were seeded onto a polyester
membrane insert. TEM irradiated with 0, 0.5, 1, 2, 4, 6 and 12Gy
and harvested after 6 hours. Radiation damage and repair was quan-
tified by determining the number and size of ionizing radiation-
induced foci (IRIF) for damage marker 53BP1, and repair markers
Mre11 and Rad51. Cell proliferation was determined by immuno-
localization of Ki-67.
Overall morphology did not change significantly up to 4Gy. At
6Gy the TEM showed picnotic cells. At 12Gy the epidermis was
severely damaged, resulting in vast destruction of the morphology.
A significant increase of 53BP1 positive cells was observed as
the rediation dose increased.The size of IRIF of both Mre11 and
Rad51 gradually expanded with increasing radiation dose. In-
creasing radiation dose resulted in a decrease in cell proliferation.
To our knowledge, this is the first study to use a 3-dimensional
mucosal construct to study radiation damage. Our results strongly
indicate that TEM can repair DNA DSBs caused by radiation.
(P 137) Effect of Solvent-Dependent Viscoelastic Properties of
Chitosan Membranes on the Permeation of Low Molecular
Weight Drugs
S.G. Caridade1,2, R.M.P. da Silva1,2, R.L. Reis1,2, J.F. Mano1,2
13B’s Research Group—Biomaterials, Biodegradables and Bio-
mimetics, Dept. of Polymer Engineering, University of Minho,
Braga, Portugal.
2IBB—Institute for Biotechnology and Bioengineering, PT Gov-
ernment Associated Laboratory, Braga, Portugal.
Chitosan (CTS), a widely used biopolymer in different biomedical
applications, is a derivative of chitin, the most abundant polysac-
charide found in the marine world.
This work aimed at providing relevant information about the use
of CTS membranes in separation applications or in sustained re-
lease systems of therapeutic molecules. Moreover, the mechanical
characterization may be also very important in such kind of ap-
plications, especially if the materials are tested in adequate phys-
iological conditions.
Chitosan membranes, both non-crosslinked and crosslinked with
genipin, were characterized by dynamic mechanical analysis,
swelling and permeability experiments using a model molecule.
The membranes were tested immersed in different mixtures of
water/ethanol. The swelling equilibrium varied linearly with the
volumetric composition of the solvent mixture. The mechanical
properties of CTS increased with the enhancement of the cross-
linking density. A peak of the loss factor appeared at 24.5% of
water attributed to the a-relaxation of chitosan and simultaneously
a reduction of the storage modulus was observed. This was the first
time that the glass transition (Tg) dynamics was monitored in a
polymer in immersion conditions, where the plasticizer composi-
tion in the bath changed in a controlled way. Permeability de-
creased sharply until it reached very small values around the Tg.
We hypothesise that conformational mobility of the polymeric
chains may play an important role in the diffusion properties of
molecules through polymer matrices. Results may elucidate some
aspects regarding to relationships between glass transition and
transport properties that may be important in the use of CTS in TE
strategies.
(P 138) Effective Action Distance Between Umbilical Cord
Blood-Derived Hematopoietic Stem Cells and Human Adipose
Derived Stem Cells
H. Yongjie1, F. Xiubo1, L. Tianqing1
1Stem Cell and Tissue Engineering Laboratory, Dalian University
of Technology, Dalian 116024, China.
Abstract: In order to investigate the optimal communication dis-
tance between umbilical cord blood (UCB) derived hematopoietic
stem cells (HSCs) and human adipose derived stem cells (ADSCs),
transwell co-culture protocol was applied and the distance between
the two culture chambers was adjusted. UCB mononuclear cells
(MNCs) were isolated by density gradient centrifugation over Fi-
coll (1.077 g/ml, proportion of 1:1~2 between the Ficoll and UCB)
and centrifuged horizontally at 2500 r/min for 30minutes at room
temperature. The HSCs were cultured in the transwell with the
inoculated density of 5105 cells/ml supported with the ADSCs of
1105 cells/ml inoculated density in the 6 well-plate for 7 days.
IMDM medium was used supplemented with 12.5% horse serum
(GIBCO) and 12.5% fetal calf serum (GIBCO). The total cell
number was counted and the cell morphology was viewed every
24 h by the hemacytometer and inverted microscope. The results
show that there exists an optimal communication distance about
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370 mm between these two kinds of stem cells during their co-
culture. At this distance the expansion fold of the UCB MNCs
becomes the maximum of 27.29 1.62, and the CD34þ cells can
be expanded by 10.92 0.65.
Keywords: Adipocyte derived stem cells, hematopoietic stem
cells, transwell, co-culture, umbilical cord blood.
(P 139) Effective Expansion of Umbilical Cord Blood HSPCs
by Regulating of Microencapsulated Osteoblasts Under Hy-
poxia Condition
G.F. Zhao1, K.D. Song1, T.Q. Liu1, L. Zhang1, Z.F. Cui2
1Dalian R&D Center for Stem Cell and Tissue Engineering, Da-
lian University of Technology.
2Department of Engineering Science, Oxford University, Parks
Road, Oxford OX1 3PJ, UK.
This study was aimed to construct a three-dimensional static hyp-
oxic culture system by using encapsulated osteoblasts (OBs) and to
investigate its support effect on ex vivo expansion of hematopoietic
stem/progenior cells (HSPCs) from umbilical cord blood. The rat
osteoblasts were isolated by tissue culture method and were cul-
tured in HG-DMEM containing 10% newborn bovine serum. The
osteoblasts were encapsulated in gelatin-alginate-chitosan (GAC)
microcapsules by the polyelectrolyte-complexation method to cre-
ate the special culture environment. Hematopoietic mononuclear
cells (hMNCs) were isolated from fresh umbilical cord blood by
density gradient centrifugation and seeded into the 6 well plates
together with the encapsulated OBs for a co-culture ex vivo in CO2
incubator under 5% and 20% oxygen tension respectively. The
expansion of HSPCs was evaluated by counting the hMNC number
and by using colony-forming assay and CD34þ flow cytometric
analysis. Meanwhile the pH value, the glucose and lactic acid
concentrations were detected everyday. After 7 days’ culture, the
expansion of hMNCs co-cultured with encapsuled osteoblasts un-
der hypoxia condition was 18.7 folds, the percentage of CD34þ
cells increased from 2.0% to 2.5%, and the CD34þ cells was ex-
panded by 23.4 folds. The co-culture system with low oxygen
level displayed more significant support effect compared with
other culture systems, especially on long-term HSPCs survival
ex vivo. It is concluded that the supporting capacities of micro-
encapsuled osteoblasts in ex vivo expansion of umbilical cord blood
HSPCs is notable under hypoxia condition. Hypoxia and osteo-
blasts play a crucial synergistic role in regulation of HSPCs pro-
liferation.
(P 140) Effects of Common Sterilization Methods on the
Structure and Properties of 3D Silk Fibroin Scaffolds
S. Hofmann1,2, A.J. Wandrey2, H.P. Merkle2, R. Mu¨ller1
1Institute for Biomechanics, ETH Zu¨rich, Zu¨rich, Switzerland.
2Institute of Pharmaceutical Sciences, ETH Zu¨rich, Zu¨rich,
Switzerland.
Scaffold development for tissue engineering applications requires
careful choice of macroscale properties, such as porosity, inter-
connectivity and biodegradation. The micro- and nanoscale prop-
erties of a scaffold are another important design criterion as these
influence cell adhesion, proliferation and differentiation. Standard
sterilization methods such as autoclaving, ethylene oxide treatment
or gamma irradiation have been shown to be unsuitable for many
polymer scaffolds because of deformation from elevated temper-
atures, lengthy degassing, and deterioration due to decreased mo-
lecular weights. Apart from being autoclavable, 3D silk fibroin
scaffolds have previously been demonstrated to offer exceptional
benefits over conventional synthetic and natural biomaterials in
generating functional tissue replacements. It would be interesting
to investigate whether topographical changes on the scaffold sur-
face caused by sterilization methods could be used as a tool to
influence cellular behaviour. This study sought to determine the
effects of sterilization with different autoclaving protocols (dry,
humid, wet), ethanol, ethylene oxide treatment or aseptic prepa-
ration on the structure of silk fibroin scaffolds. All methods re-
sulted in scaffold sterilization, and scanning electron microscopy
revealed deformations on the scaffold surface. The extent of to-
pographical alterations was various, including flattened structures,
increased roughness, indentation or a mixture of those structures on
the microscale level, depending on the sterilization method used.
None of the methods had an influence on the crystalline structure or
the degree of crystallinity of the silk fibroin after treatment with
90% methanol as verified by FTIR. Future studies will show to
what extent those topographical differences influence cell adhe-
sion, proliferation and differentiation.
(P 141) Effects of Fibrin Component Compositions on Fibrin
Structure and Cell Viability
E. Potier1, J. Noailly1, C.M. Sprecher1, K. Ito2
1AO Research Institute, Switzerland.
2Department of Biomedical Engineering, Eindhoven University of
Technology, Netherlands.
Introduction: Fibrin is a natural polymer proposed as a cell scaffold
for numerous tissue engineering purposes. Studies on fibrin opti-
misation for cell scaffolds have mainly focused on fibrinogen and
thrombin content. However, other factors, such as factor XIII
(FXIII), calcium, and chloride ions contained in fibrinogen and
thrombin formulations, are also known to affect fibrin structure.
In this study, such effects on cell viability during culturing were
assessed.
Materials and Methods: Different FXIII, calcium, and chloride
concentration combinations were used to polymerize fibrin re-
sulting in various amounts of cross-linking. The relative amounts
of cross-links were estimated by gel transparency measurements
(n¼ 3/conditions). Two compositions resulting in high and low
amounts of cross-linking were then tested for cell viability. These
carriers were seeded with C3H10T1/2 cell line (0.6 million cells/
ml) and cultured for 7 days (mediumþ 5%FBS). Cell number,
morphology and distribution on histological sections were assessed
at day0 (D0) and day7 (D7), (n¼ 3/carrier-type/time/test). All fi-
brin carriers were synthesized as cylinder (8mm diameter, 4mm
height) containing 20mg/ml fibrinogen and 13.5U/ml thrombin.
Results: Chloride increased gel cross-links, as well as FXIII
(133þ/-1U, high transparency). Calcium decreased cross-links
(60þ/-6U, low transparency) and countered the effect of FXIII.
Cell proliferation at D7 was higher for lower (227þ/26% of
initial cell number) than for higher cross-linking (120þ/1%).
Cell spreading was observed in both types of carrier, but clusters
were only seen for lower cross-linking.
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Conclusion: These results showed that FXIII, calcium and
chloride affects fibrin structure and that less cross-linked fibrin
carriers allowed better proliferation of mesenchymal cells.
(P 142) Effects of Frequency and Loading Duration on Me-
chanically Modulated Collagen Production by Osteoblasts in
Bone Tissue Engineering
I.M. Sebastine1, A. Sittichokechaiwut2, D.A. Clarke2, C. Wil-
liams3, G.C. Reilly2, D.J. Williams1
1The Wolfson School of Mechanical and Manufacturing En-
gineering, Loughborough University, Loughborough, England,
United Kingdom.
2Department of Engineering Materials, University of Sheffield,
Sheffield, England, UK.
3ElectroForce Systems Group, Bose Corporation, Eden Prairie,
Minneapolis, MN, USA.
Bone cells are known to respond to mechanical stimulation, there-
fore mechanical conditioning is used to modulate matrix formation
in bone tissue engineering. Mechanotransduction is the signalling
process where external an mechanical signal is translated into a
controlled cascade of biological events. In this study we compared
the effects of different loading regimens on cell proliferation and
matrix production. MLO-A5, late stage osteoblast-like cells were
seeded in cylindrical polyurethane (PU) scaffolds, 10mm thick and
10mm diameter. Dynamic compressive loading to a maximum of
5% strain was applied to the cell seeded scaffolds in a sterile me-
dium-filled BioDynamic chamber on days 5, and 7 of culture at 1 hz
and 2 hz frequencies and durations (30, 60 and 120 mins). Between
loading cycles, scaffolds were cultured in an incubator in standard
conditions. Cells survived and cell number increased over a 12 day
time course of the experiment. Cells in PU scaffolds responded
differently to loading in a frequency/ duration dependent manner.
60minutes of loading at 1Hz increased final cell number but had no
effect on total collagen production. Increasing either the duration of
the loading period or the frequency of loading eliminated the effect
of loading on cell number but total collagen content was higher. This
study demonstrates that the frequency of load and the number of
loading cycles applied during the processing of constructs influences
the production of bone matrix. These results indicate that mechan-
ical stimuli in dynamic bioreactor culture should be carefully
modulated to produce the required product.
(P 143) Effects of Human Amniotic Fluid Derived Stem Cells
on Cardiac Function After Myocardial Infarction
D.M. Delo1, Z. Wang1, R. Shaffer1, X. Guan1, S. Neshat1,
T. Smith2, M. Callahan2, L. Groban3, A. Atala1, S. Soker1
1Wake Forest University Institute for Regenerative Medicine,
Wake Forest University Health Sciences.
2Department of Orthopaedic Surgery, Wake Forest University
Health Sciences.
3Department of Anesthesiology, Wake Forest University Health
Sciences.
Cell therapy has been proposed as a means to promote the regen-
eration of injured heart muscle. We have established lines of
multipotent stem cells derived from primitive fetal cells present in
human amniotic fluid (hAFS) cells. In this study, we hypothesize
that AFS cells can differentiate into cardiac cells and be used for
cardiac tissue regeneration. AFS cells were treated with 5-aza-2-
deoxycytidine to induced cardiogenic differentiation. The cells
were analyzed for expression of cardiogenic markers. We used an
ischemic injury model in rats to test the ability of the hAFS cells to
survive and integrate after direct injection into the myocardium.
Immediately after ligation, 5 million AFS cells were injected into
the heart. Echocardiography was performed at 1, 2, and 3months,
and invasive hemodynamic studies at 3months. The hearts were
removed and analyzed for integration and morphology. We ob-
served that by 20 days after induction, AFS cells stained positively
for cardiomyocyte markers including cardiac troponin T and tro-
ponin I. PCR analysis revealed expression of cardiomyocyte
markers, including Nkx 2.5 and Mlc2v. Histology indicated that
AFS cells integrated into the injured myocardium. Echocardio-
graphic analysis and invasive hemodynamics suggested that AFS
cells improve cardiac function after myocardial infarction.These
results demonstrate that stem cells derived from amniotic fluid can
differentiate in vitro and express cardiac markers. In vivo studies
indicated that AFS cells have a potential to improve cardiac func-
tion after myocardial infarction. These cells represent a promising
novel source of cells for therapy of a variety of cardiac diseases.
(P 144) Effects of Hypoxia on Rat Mesenchymal Stem Cell
Expansion in Hollow-Fiber Membrane Bioreactor
X.L. Li1, T.Q. Liu1, X.H. Ma1, Z.F. Cui2
1Dalian R and D Center for Stem Cell and Tissue Engineering,
Dalian University Of Technology, China.
2Oxford Centre for Tissue Engineering and Bioprocessing, Oxford
University
Rat mesenchymal stem cell (MSC) represents a small portion of
the cells in the stromal compartment of bone marrow with many
virtues. Low oxygen tension exists natively for MSCs in bone
marrow microenvironment, ranging from 1 to 7%. So it is neces-
sary to investigate the effect of low oxygen tension close to normal
physiologic levels on the growth of MSCs, under the well con-
trolled conditions in bioreactors. rMSCs were cultured under
physiologically relevant oxygen environments (5% O2) on the
hollow-fiber membrane constructs for up to 8 days. The cell growth
curves were obtained and colony counts were carried out.The ex-
panded cells were induced to differentiate toward osteoblasts,
cartilage cells and adipocytes. Flow cytmoetry analysis was also
applied to examine the capacity of the rMSCs both in self-renew
and in maintaining their pluripotentiality.The results showed that
hypoxic rMSCs exhibited a short lag phase ,but they subsequently
proliferated continuously throughout the culture period and at the
end we observed a significant increase in cell number. Moreover,
rMSCs grown at 5%O2 consistently showed a nearly two-fold in-
crease compared to those at other pO2 . In 5%O2 condition rMSCs
on hollow-fiber membranes can maintain significantly higher
colony-forming unit capabilities than normoxic controls, approx-
imately 115 and 45 respectively. Hypoxic rMSCs also expressed
higher levels of HIF-1a, CD44þ, CD 29þ, CD 13þ, markers than
normoxic controls.These findings demonstrate that low oxygen
conditions may selectively facilitate the survival of more primitive
cells and hypoxia can promote the proliferation of rMSCs on
hollow-fiber membranes in vitro.
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(P 145) Effects of Lactate on MSCs Survival, Proliferation and
Differentiation
MC. Degat1, B. David1, M. Bensidhoum1, D. Logeart-
Avramoglou1, L. Sedel1, H. Petite1
1Laboratoire de Recherches Orthope´diques CNRS UMR 7052.
Local supply of mesenchymal stem cells (MSC) has been proposed
for the repair or replacement of damaged tissue such as bone and
cartilage. In vivo transplantation of MSCs into avascular tissue
leads to oxygen deprivation, anaerobic respiration and lactate ac-
cumulation. Moreover, it was reported that lactate could reach
10mM in inflammatory environment. The purpose of this study
was to evaluate, the effects of lactate concentration on MSC via-
bility and differentiation capability.
MSCs were cultured either in the absence or in the presence of 5
to 50mM lactate (pH 7.4) over 15 days; MSCs proliferation was
assessed by DNA quantification every 3 days. Lactate effects on
MSC differentiation were studied by culturing MSCs either in the
absence or in the presence of 1 to 50mM lactate over 30 days in
osteo-inductive or adipogenic induction media. Osteoblastic dif-
ferentiation was assed by alkaline phosphatase (ALP) quantifica-
tion and Von Kossa staining; adipogenic differentiation was
assessed, by Oil Red O staining and quantification.
At low (1–5mM) concentrations, lactate had no effects on cell
proliferation over 15 days, nor modified ALP activity, calcium
deposition or adipogenic differentiation. In contrast, above 10mM
lactate, MSC proliferation was inhibited after just 3 days of culture
as were both osteoblastic and adipogenic differentiation after 10
days.
This study demonstrated that MSCs are very sensitive to high
lactate concentrations. Improved culture methods are therefore
needed to enable MSCs to conserve their proliferation capabilities
as well as multi-lineage potential in such conditions.
(P 146) Efficient Cell Encapsulation Based on Biodegradable
Stimuli-Responsive Hydrogels
E. Peeters1, D.J. Broer1, R. Penterman1, S. van Lierop1, R. Nie-
sen1, R. Kurt1, D. Halter1
1Philips Research Europe, High Tech Campus 4, 5656 AE Eind-
hoven, The Netherlands.
Stimuli-responsive hydrogels are chemically or physically cross-
linked polymer networks that can swell extensively in aqueous
environments while they do not dissolve in water. They are further
characterized by their ability to show drastic changes in the degree
of swelling in response to physical or chemical stimuli. Responsive
hydrogels have been investigated for use in targeted drug delivery,
controlled drug release systems and polymer actuators. Here we
report on the use of bio-degradable stimuli responsive hydrogels
for the efficient encapsulation of eukaryotic cells. The novel
method facilitates the use of conventional 2D cell culturing tech-
niques on a substrate provided with flat polymeric structures. The
subsequent application of a physical stimulus results in the release
of these polymer structures from the substrates and automatic en-
capsulation of the cultured cells. In this contribution we describe
the cell encapsulation mechanism based on stimuli-responsive
hydrogels, we discuss the biodegradability of the chemically cross-
linked polymer network, we present test results that indicate that
the materials used in these investigations show no direct or indirect
cytotoxic properties towards eukaryotic cells and finally, we show
the first examples of the encapsulation of human carcinoma epi-
dermoid cells.
The cell-filled polymer microcontainers, resulting from this
novel encapsulation method, offer advantages for use in cell
therapies as well as tissue engineering applications.
(P 147) Electro-Spinning of Collagen Nano-Fibres—Myths
and Reality
D.I. Zeugolis1, M.C. Lum2,3, A. Pandit1, M. Raghunath2,3,4
1National Centre for Biomedical Engineering Science, National
University of Ireland, Galway, Ireland.
2Tissue Modulation Laboratory, National University of Singapore
(NUS), 117510, Singapore.
3Division of Bioengineering, Faculty of Engineering, NUS,
117576, Singapore.
4Department of Biochemistry, Yong Loo Lin School of Medicine,
NUS, 117597, Singapore.
Electro-spinning has been recently introduced to fabricate fibrous
nano-scale scaffolds for tissue engineering applications. The pro-
cess involves suspension of polymers in a highly volatile solvent
(usually 1,1,1,3,3,3-hexafluoro-2-propanol) and extrusion of the
mixture within a strong electric field. Upon application of the high
voltage (10–30KV), the solvent evaporates and the nano-fibrous
meshes are collected. Collagen, an abundant structural protein, has
been used extensively for tissue engineering due to its superior
mechanical strength and low immunogenicity. Since the in vivo
diameter of collagen fibres ranges from a few nanometres to several
micrometers, the combination of technology and material attracted
much attention in order to fabricate biocompatible scaffolds that
would mimic the extracellular matrix. However, we showed re-
cently that suspending collagen in fluoroalcohols yields scaffolds
that are water soluble, pepsin-sensitive, not triple-helical, lack the
characteristic D-periodicity of collagen, and exhibit low denatur-
ation temperatures (<408C). These are all characteristics of gelatin
and not collagenous supramolecular assemblies. Therefore, such
scaffolds fail to mimic the extracellular matrix. In our attempt
to produce actual collagen nano-scaffolds, we evaluated electro-
spinning of collagen-polyethylene oxide suspension out of dilute
acidic solutions. The resultant nano-scaffolds formed amixed bead/
fibre landscape and exhibited the characteristic ultra-structural
D-periodicity of native collagen. They were also water-insoluble,
pepsin-resistant, triple-helical and of high denaturation temperature
(>608C). All these confirm typical in vitro collagenous supramo-
lecular assemblies. Overall herein we demonstrate that electro-
spinning of collagen-polyethylene oxide out of dilute acidic
solutions preserves the native characteristics of collagen and con-
sequently biomimetic scaffolds can be produced.
(P 148) Electrospinning of Highly Porous Scaffolds for Car-
tilage Tissue Engineering
A. Thorvaldsson1, H. Stenhamre2,3, P. Gatenholm2, P. Walk-
enstro¨m1
1Swerea IVF, Box 104, SE-431 22 Mo¨lndal, Sweden.
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2Biopolymer Technology, Department of Chemical and Biological
Engineering, Chalmers University of Technology, SE-412 96
Gothenburg, Sweden.
3Department of Clinical Chemistry and Transfusion Medicine,
Sahlgrenska University Hospital, Go¨teborg University, Gothen-
burg, Sweden.
Deep articular cartilage defects are a rather common and painful
condition and it is well established that once destroyed the articular
cartilage has limited regenerative capacity. In order to ease the pain
and restore joint function cartilage repair techniques has been
developed to recruit or deliver reparative cells to the defect, with or
without a three-dimensional scaffold.
In this study we describe a new and innovative technique for
creating highly porous scaffolds with a suitable combination of
nano- and microfibers. With this new technique the nanofiber-
coated microfibers can be formed into scaffolds with tailored
porosity for cellular infiltration and nanostructured surface mor-
phology for cell growth.
The nanofiber-coating was obtained by using a grounded col-
lector rotating around the microfiber forcing the nanofibers to
collide with, and be collected upon, the microfiber. Additionally,
a Teflon tube surrounding fibers and collector was used to force
the nanofibers to the microfiber. The scaffolds were fabricated
using polycaprolactone nanofibers and polylactic acid microfibers.
The nanofiber-coated microfibers were manually formed into
scaffolds with porosities > 95%. A preliminary cell study using
human articular chondrocytes was performed comparing purely
nanofibers, nanofiber-coated microfibers and pure microfibers
scaffolds.
Considerably enhanced cellular infiltration in scaffolds of
nanofiber-coated microfibers compared to scaffolds of only nano-
fibers was observed. Additionally, the study showed that the po-
rosity of the scaffolds containing nanofiber-coated microfibers
could be carefully modified, an important feature in creating
scaffolds for cartilage tissue engineering.
(P 149) Electrospinning of Hydroxyapatite/Chitosan Nano-
composite Nanofibers
Y.Z. Zhang1, B. Su1
1Department of Oral and Dental Science, University of Bristol,
Bristol, BS1 2LY, UK.
The basic building blocks of bone are the hydroxyapatite-nano-
crystals incorporated collagen nanocomposite nanofibers. This in-
nate nanofibrous structure has inspired researchers to develop
structural biomimicking bone-repairing materials by such tech-
niques as electrospinning. Although numerous previous studies
have suggested that the inorganic-organic hybrid of hydroxyapatite/
chitosan (HA/CS) can be used as one of the most promising bio-
composites for engineering load-bearing bone tissue, electrospin-
ning HA/CS nanocomposites into nanofibers has been a challenging
task to perform because of its limited usable solvents and poor
electrospinnability. In this paper, we present for the first time a
successful electrospinning of HA/CS nanocomposite, which was
dissolved in a mixed solvent system of acetic acid and dimethyl
sulfoxide and used a small amount of ultrahigh-molecular-weight
poly(ethylene oxide) as an effective fiber-forming facilitating ad-
ditive. The used HA/CS nanocomposites with the HA mass ratio of
30% were prior synthesized by a wet chemical co-precipitation
method so as to attain homogenous dispersion of the spindle-shaped
HA nanoparticles (ca. 10030 nm) within the chitosan biopolymer.
SEM and TEM observation indicates that continuous and uni-
form HA/CS nanofibers with a diameters of several hundreds
nanometers had been produced successfully and the HA nanopar-
ticles with aggregations to some extent were incorporated discretely
along the electrospun nanofibers. Further XRD and SAED analysis
revealed that the crystalline nature of the HA remains and had
survived the acetic acid-dominant solvent system. Our currently
developed nanocomposite nanofibers of HA/CS may be employed
as a novel biomimetic materials for bone tissue engineering appli-
cation.
(P 150) Electrospun Polyurethane Scaffolds for Mechanical
Stimulation of Cells in Bone Tissue Engineering
D. Clarke1, D. Puppi2, N. Detta2, M. C. Coll Ferrer3, A. Craw-
ford4, G. Reilly1, F. Chiellini2
1Centre for Biomaterials and Tissue Engineering, Kroto Research
Institute, University of Sheffield North Campus, Broad Lane,
Sheffield S37HQ.
2Laboratory of Bioactive Polymeric Materials for Biomedical and
Environmental Applications (BIOlab)—UdR INSTM, Department
of Chemistry & Industrial Chemistry, University of Pisa, Via
Vecchia Livornese 1291-5122 S. Piero a Grado (Pisa, Italy).
3Department of Chemistry, University of Sheffield.
4Department for Adult Dental Care, 2nd Floor,School of Clinical
Dentistry, Claremont Crescent, Sheffield, S102TA.
Polyurethanes (PU) are regarded as a suitable biomaterial for mus-
culoskeletal tissue engineering due to their biocompatibility and
durability. Here we have electrospun a 3D microfibrous scaffold
using the medical grade PU Tecoflex SG80A (Lubrizol) for use in
mechanical conditioning experiments. Scaffolds were electrospun
using a electrospinning rig (Linari) from a 10% solution (w/v) of
Tecoflex in 70:30 THF:DMF, for 3.5 hours, flow rate 5ml/hr.
Mechanical properties were analysed in tension (Instron). Scaf-
fold thickness ranged from 653 to 1950 microns, with mean break-
ing strain 464.18 þ/30.76%, mean breaking stress 3.785 þ/
0.39MPa and Young’s modulus 0.88þ/0.05MPa.
Scaffolds were analysed for cytotoxicity by a conditioned me-
dium test using the osteoblast cell line MC-3T3-E1 which indi-
cated that there were no soluble toxic factors. Cell attachment was
analysed by seeding cells on 5 cm discs of scaffold and culturing
for 7 days. There was good attachment as seen by the high number
of viable cells present on day 7 (MTT assay) as compared to
another electrospun ‘home-made’ PU scaffold.
For mechanical conditioning ’Dogbone’ shaped scaffolds were
seeded with 100,000 cells and cultured for 12 days. Scaffolds were
loaded in dynamic tension at 2% strain for 2 hrs, 1 Hz on days 7 and
9 of culture in a sterile media-filled Bose biodynamic chamber.
There was an increase in the number of viable cells and total
collagen production (Sirius red) on stimulated samples compared
with non-loaded controls. In conclusion: we have electrospun a
polyurethane which is suitable for mechanical conditioning ex-
periments in musculoskeletal tissue engineering.
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(P 151) Electrospun Scaffold for an In Vitro Tissue Engineered
Blood-Brain Barrier Model
S. Baiguera1, C. Del Gaudio2,3, M. Grigioni3, M. Folin1, A. Bianco2
1Department of Biology, University of Padova, Italy.
2University of Rome ‘‘Tor Vergata’’, Department of Science and
Chemical Technologies, INSTM Research Unit Tor Vergata,
Roma, Italy.
3Istituto Superiore di Sanita`, Laboratory of Biomedical En-
gineering, Roma, Italy.
The in vitro blood-brain barrier (BBB) model, based on co-culture
of endothelial cells and astrocytes on opposite sides of a mem-
brane, is an isolated system allowing the selective study of phys-
iology, pharmacology and pathophysiology. Therapeutic
approaches for neurological disorders treatment, based on in vitro
effective central nervous system (CNS) drugs, show several limi-
tations, being excluded in vivo by the BBB. Therefore, a reliable
BBB model that allows for inexpensive and mass testing of puta-
tive CNS therapeutic agents is a relevant issue to be addressed.
Several BBB in vitro models have been studied, based on com-
mercially available polymer membranes. However, these mem-
branes lack certain attributes preventing a reasonable modelling of
in vivo situation. This work is based on the hypothesis that co-
culturing endothelial and astrocyte cells on opposite sides of a
biodegradable, fibrous membrane will allow the development of an
in vivo resembling BBB model. Electrospun poly(e-caprolactone)
(PCL) micrometric and sub-micrometric fibrous mats (average
fiber diameter 3.6 0.8 vs 0.8 0.2 microm, respectively.
(P 152) Electrospun Spiral-Wounded Polycaprolactone Scaf-
folds with or without Stem Cells for Cranial Bone Defects:an
Animal Model
I.A. Isoglu1, N. Bolgen1, I. Vargel2, T. Cavusoglu2, P. Korkusuz3,
E. Guzel3, E. Piskin1
1Hacettepe University, Chemical Engineering Department and
Bioengineering Division, Ankara, Turkey.
2Kirikkale University, Faculty of Medicine, Department of Plas-
tics and Reconstructive Surgery, Kirikkale, Turkey.
3Hacettepe University, Faculty of Medicine, Department of His-
tology and Embryology, Ankara,Turkey.
PCL with two different molecular weights (high and low) were
synthesized, and the blends of these two were electrospun into
nonwoven membranes composed of nanofibers/micropores. The
matrices were then spiral-wounded to produce scaffolds with 3D-
structures having both macro- and microchannels. 8-mm-diameter
critical size (non-self-healing size) cranial defects were created in
rats, and scaffolds in the same size of the defects were implanted
into these defects. In a parallel group of study, mesencyhmal stem
cells derived from rat bone marrow stem were injected into the
defects with or without scaffold. The test animals were sacrificed
after 1, 3 and 6months of post-implantation. Soft and hard tis-
sue specimens were removed and bone regeneration and tissue
response were followed by histological tests. A significant in-
growth of connective tissue cells and new blood vessels allowed
new bone formation, especially with the macrochannels of the
spiral-wounded PCL membranes. Regenerations were better when
results were observed in the group scaffolds used with mesen-
chymal stem cells.
(P 153) Endothelial Cell Differentiation of EPC Is Increased
by Interaction Between CD34-Positive Cells and CD14-
Positive Cells
G. Krenning1, B.W.A. van der Strate1, M. Schipper1, X.J. Gallego y
van Seijen1, B. Fernandes2, M.J.A. van Luyn1, M.C. Harmsen1
1Stem Cell & Tissue Engineering Research Group, Dept. Pathol-
ogy & Medical Biology, University Medical Center Groningen,
University of Groningen, Hanzeplein 1, NL-9713GZ, Groningen,
The Netherlands.
2Medtronic Bakken Research Center BV, Endepolsdomein 5, NL-
6229GW, Maastricht, The Netherlands.
Introduction: Neovascularization induced by endothelial progeni-
tor cells (EPC) for the treatment of ischemic diseases, has been a
topic of intense research. The rare CD34-positive stem cell is often
designated as the archetype EPC, because it contributes to repair of
ischemic injuries. However, incorporation of CD34-positive cells
into the neovasculature is limited, suggesting a paracrine mode of
action. CD14-positive cells can also differentiate towards an en-
dothelial cell phenotype. However, the low proliferative capac-
ity of monocyte-derived endothelial cells hampers their use as
therapeutic cells. We hypothesized that an interaction between
CD34-positive and CD14-positive cells augments endothelial dif-
ferentiation of the latter cell type. The combined properties of
CD34-positive and CD14-positive cells may therefore render these
cells suitable to treat ischemic diseases.
Results: In vitro, 63% of the cultured CD14-positive cells
adopted an endothelial phenotype, while in CD34/CD14 co-
cultures 95% of the cells differentiated into endothelial cells. Fur-
thermore, cell proliferation was increased by 5–12% in the CD34/
CD14 co-cultures compared to both monocultures. CD34-cell
conditioned medium also increased endothelial differentiation
of CD14-positive cells; this effect was diminished by HGF-
neutralizing antibodies.
Conclusion: Endothelial differentiation of CD14-positive cells
increases through co-cultivation with CD34-positive cells. Fur-
thermore, interaction between CD34-positive and CD14-positive
cells results in increased cell proliferation. Increases in differen-
tiation and proliferation of CD14-positive cells did not depend on
cell-cell contact, but on paracrine signaling through HGF. Taken
together, the combination of CD34-positive and CD14-positive
cells is a suitable cell source that may augment therapeutic neo-
vascularization and can be applied as cell therapeutic for treatment
of ischemic diseases.
(P 154) Endurance Strength of Artificial Ligament Materials
M. Hohlrieder1, J. Stampfl2
1AMI GmbH.
2TU Wien.
Although replacement of injured anterior cruciate ligament with
allo- and autografts is currently performed on a routine basis, there
are still a number of problems related to explant morbiditiy, limited
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availability of autologous material, the loss of stability due to re-
modelling processes of the new ligament or disease transmissions
in case of taking an allograft. Artificial ligaments could offer
substantial advantages in this respect.
The goal of this work is to assess various potential candidates for
artificial ligament materials (PET, polyester, PE, UHMWPE,
Aramid, alumina ceramics, PEEK) to figure out, whether one meet
the enormous requirements, that a human anterior ligament
achieves. All materials were tested with a pneumatically driven
knee joint simulator which can strain the ligaments similar to the
natural situation. In order to evaluate the influence of tribological
parameters, two different feed-through-systems (made of tita-
nium or PEEK, respectively) were investigated. Depending on the
stiffness of the material we reached max. values of 670N in full
extension.
The time to failure at the above mentioned conditions varied
between 100.000 and 300.000 cycles, depending on ligament
material and feed-through material. The ligaments failed by an
excessive amount of abrasion and/or fatigue. By considering that a
knee is bent in average 4 million times a year, it can be concluded
that currently available materials by far miss the longevity which
would be required for an artificial ligament replacement. New re-
placement strategies beyond the currently known routes based on
autologous material thus have to rely on tissue engineering ap-
proaches.
(P 155) Engineering Muscularized Vascular Conduits
G.J. Christ1
1Wake Forest Institute for Regenerative Medicine, Wake Forest
University Health Sciences, Winston-Salem, NC 27157.
Although the presence of a confluent monolayer of endothelial
cells on the luminal surface has been shown to prolong the patency
rates of implanted grafts in a variety of cardiovascular applications,
the functional performance of these grafts over time still remains
suboptimal compared to the native artery. A potential cause for the
current deficiencies in bioengineered vascular grafts is the lack of
medial smooth muscle cell layer upon implantation. In fact, vas-
cular Smooth muscle cells (VSMCs) impart important func-
tional characteristics in the native artery, and therefore, should
logically be incorporated in the development of tissue engineered
blood vessels designed for vascular repair or replacement. How-
ever, the architecture and low porosity of both naturally derived
(i.e., decellularized vessels) and many synthetic biomaterials has
impeded efforts to incorporate a VSMC layer in tissue engineered
blood vessels. To this end, the goal of our work is to optimize
methods for seeding, proliferation and maturation of VSMCs
in vitro for subsequent implantation in vivo. Thus far we have
focused our efforts on surface modification of decellularized
scaffolds, as well as electrospinning of synthetic constructs com-
prised of PCL/collagen/elastin that would promote/enhance sub-
sequent proliferation and formation of a VSMC layer during
bioreactor preconditioning in vitro. This approach provides im-
proved VSMC content on biocompatible and biodegradable scaf-
folds that can be further remodeled in vivo. The overall goal is to
derive engineered constructs in vitro that more closely mimic na-
tive vasculature. Our initial work indicates that this approach
provides accelerated maturation of tissue engineered blood vessels
in vivo.
(P 156) Enhanced Control of Porosity in Electrospun Nano-
fiber Meshes
A.C. Guimara˜es1,2, A. Martins1,2, R.L. Reis1,2, N.M. Neves1,2
13B’s Research Group - Biomaterials, Biodegradables and Bio-
mimetics, Department of Polymer Engineering, University of
Minho, Campus de Gualtar, 4710-057 Braga, Portugal.
2IBB—Institute for Biotechnology and Bioengineering, PT As-
sociated Laboratory, Braga, Portugal.
Electrospinning has gained popularity as a simple and versatile
technique to produce synthetic polymeric ultrafine fibers. This
technique allows the production of non-woven meshes with fiber
diameters in the nanometer range, which results in a high surface
area-to-volume ratio and high porosity. Additionaly, these nano-
fiber meshes can mimic the extracellular matrix of human tissues
and, therefore, can be used as scaffolds for Tissue Engineering
(TE) applications. However, electrospun nanofibers meshes have
an important drawback to this type of application. The obtained
pore size is tipically too small to allow cell penetration into the
inner regions of the nanofibrous scaffold. To overcome this prob-
lem, PCL and PEO solutions were electrospun simultaneously to
obtain a dual composition nanofiber mesh. Then,a selective dis-
solution of PEO nanofibers was performed.
These structures were characterized in terms of morphology,
mechanical properties and cellular response. PCL nanofiber me-
shes with comparable volume of material were used as control. The
dual composition electrospun nanofiber meshes showed an in-
creased porosity when compared with PCL meshes. The biologic
assays were conducted with human osteoblast-like cells (Saos-
2 cell line). By SEM and confocal microscopy, it was shown that
the cells can penetrate into the nanofibrous structure, forming a
fully cellularized construct appropriated for TE applications.
(P 157) Enhanced Vascularisation Induced by Endothelial
Progenitor Cells (EPCs) Improves Matrix Organisation in
Wound Healing
B. Hendrickx1, S. Van den Berge1, S. Dickens1, A. Luttun2,
J.J. Vranckx1
1Dept of plastic and reconstructive surgery—Laboratory of Plastic
Surgery and Tissue Engineering Research.
2CMVB Center for Molecular and Vascular Biology KULeuven.
Introduction: We previously demonstrated the increase in vascu-
larisation by a subset of EPCs, called Blood Outgrowth Endothelial
Cells (BOECs), in secondary wound healing. Here, we investigated
a potential link between vascularisation and quality of dermal re-
generation.
Materials &Methods:Wounds were made on the back of athymic
nude mice (n¼ 60) and were treated either with saline (n¼ 15),
human BOECs (n¼ 14), laminated human fibroblast sheets (n¼ 14)
or a combination of both (n¼ 17). One group of animals (n¼ 24)
was sacrificed on day 5, another group (n¼ 36) on day 10 for his-
tological evaluation of vascularisation (CD31, a-SMA) and ma-
trix composition ( fibrillar collagen I and III) of the dermis within
the wound area.
Results: Histological examination at day 5 revealed a significant
increase in CD31þ vessels at the wound borders in the conditions
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treated with BOECs. Moreover, a significant increase in vascular
density was visible in the entire wound area on day 10. Conditions
treated with BOECs revealed more smooth muscle cell-coated
vessels, indicative of a more functional revascularization. Im-
portantly, analysis of the dermis revealed a higher collagen content
in the conditions treated with the fibroblast sheet, but the per-
centage of organized (red-orange birefringent) collagen was higher
in both BOEC treated conditions.
Conclusion: Here we prove the link between an induced increase
of vascularisation by BOECs and the quality of the dermal matrix
organisation. Since BOECs and dermal fibroblast sheets can easily
be derived from any patient, they can be considered as powerful
tools for the creation of an autologous vascularised dermal template.
(P 158) Enzyme-Triggered Injectable Hydrogel of Tetronic-
Tyramine Conjugates for Tissue Regeneration
K.M. Park1, Y.K. Joung1, K.D. Park1
1Department of Molecular Science and Technology, Ajou Uni-
versity, Suwon 443-749, Republic of Korea.
Over the past few decades, hydrogels have been an issue of in-
tensive research for various biomedical applications. Especially,
injectable system has been paid much attention. Such a system
makes cell, drug and bioactive molecules easily entrapped in situ by
a simple syringe injection of their aqueous solutions at target sites.
In these systems, recently enzyme-triggered in situ hydrogel system
has been studied. Enzymatic cross-linking systems have some ad-
vantages, such as biocompatible and fast reaction in mild condition.
In this study, we report enzyme-triggered injectable hydrogel of
Tetronic-Tyramine (Tetronic-TA) conjugates.Tetronic-TA conju-
gates were prepared by first reacting Tetronic with succinic anhy-
dride and subsequent conjugating with tyramine (TA) using DCC/
NHS. To confirm their chemical structure, 1H NMR and FT-IR
spectra were measured. Tetronic-TA hydrogel was formed above
10 wt% in the presence of horseradish peroxidase (HRP) and H2O2
under physiological conditions. Their mechanical properties, ge-
lation time, swelling ratio and degradation time were evaluated
depending on the concentration of polymer, HRP and H2O2. In
addition, in vitro cell test was investigated using osteoblast to
confirm its cytotoxicity. The cells were cultured in Tetronic-TA
hydrogel matrix (3D culture) and on its surface (2D culture) for
24 hrs. The cultured cells in the hydrogel were observed by Live/
Dead assay. The hydrogel showed low cytotoxicity. The obtained
results demonstrated that Tetronic-TA hydrogel has potentials of
injectable hydrogel for tissue regeneration.
Acknowledgement: This work was supported by a grant from
the Korea Health 21 R&D Project, Ministry of Health&Welfare,
Republic of Korea (02-PJ3-PG6-EV11-0002).
(P 159) Esophageal Replacement By Aortic Allograft in a
Porcine Model: Preliminary Results
S. Gaujoux1,2,3, Y. LeBalleur4, B. Lambert5, P. Bruneval6, J.
Larghero3, S. Zohar7, S. Lecourt3, F. Prat1,4, P. Cattan2
1Ecole de Chirurgie AP-HP.
2Service de chirurgie digestive Hoˆpital Saint Louis AP-HP.
3Service de the´rapie cellulaire Hoˆpital saint Louis AP-HP.
4Service de gastroenterologie Hoˆpital Cochin AP-HP.
5Service de chirurgie ge´ne´rale Hoˆpital Kremlin Bice`tre AP-HP.
6Service d’anatomopathologie Hoˆpital Europeen Georges Pom-
pidou AP-HP.
7DBIM Hoˆpital Saint Louis AP-HP.
Background: Usual techniques of esophageal reconstruction carry
a high morbi-mortality. The objective of this study was to evaluate
the feasibility of circumferential replacement of the esophagus by
aortic allograft in a porcine model.
Methods: In 21 minipigs, 3 centimeters of cervical esophagus
were replaced by a fresh aortic allograft. Animals were divided in
two groups according to the endoscopic insertion of a removable
stent or not. No immunosuppressive therapy was given. In case of
stent migration or stenosis following stent removal at one month, a
new stent was placed. Histological analysis of the graft was per-
formed at 1 and 3months.
Results: All pigs without stent insertion (n¼ 3) experienced an
early death because of anastomotic leakage, leading to interruption
of this approach. In pigs with stent insertion (n¼ 18), one-month
mortality rate was 33%, due to hematoma, small bowel obstruction,
pneumonia, or technical failure during stent insertion. Among the
12 survivors, 10 experienced a stent migration or an obstructive
granuloma. Stent removal systematically carried a necrotic aortic
allograft with the occurrence of a stenosis (5–7 days). Histological
analysis of the grafted area, showed a scar retraction with mal-
pighian epithelium covering a fibrotic tissue, without muscular cell.
Conclusions: After circumferential esophageal replacement by
an aortic allograft, one-month survival is 66%. Esophageal stenting
is necessary at least for 3months to avoid anastomotic leakage and
stenosis. The aortic graft is subject to early necrosis and leave place
to a fibrotic tissue covered by a malpighian epithelium, without
muscular cell at 3months.
(P 160) Evaluation of In Vitro Elution Profile, Antimicrobial
Efficacy and Cytotoxicity of 3D Bioactive Polycaprolactone
Honeycomb Scaffold
E.Y. Teo1, S.-Y. Ong2, J. Lu2, S. Moochhala2, S.H. Teoh1,3
1Centre for Biomedical Materials Applications and Technology
(BIOMAT), Dept of Mechanical Engineering, National University
of Singapore.
2Combat Care Lab, Defence Medical & Environmental Research
Institute, DSO National Laboratories.
3Osteopore International Pte Ltd.
Secondary infections and inflammations are common problems
faced after an occurrence of trauma. These incidents could bring
about undesirable or even disastrous implications when there
is inadequate treatment and attention rendered. Therefore the
development of a 3D antibiotics incorporated-bioactive poly-
caprolactone honeycomb scaffold could prove beneficial for such
cases. Three different percentages (5wt%, 15wt% and 25wt%) of
antibiotics incorporations were tested in this study. The efficacy of
the eluted antimicrobial drugs was evaluated using the log reduction
method on two bacteria strains (Staphylococcus aeurus and Pseu-
domonas aeruginosa). The elution profiles of the drug incorporated
scaffolds were also evaluated at various timepoints up to a period of
1 week. After which in vitro cytotoxicity test was carried out,
noting the human dermal fibroblasts metabolic activity and pro-
liferation when exposed to scaffold with impregnated gentamicin
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sulfate as a model drug. It is observed that the 3D bioactive poly-
caprolactone honeycomb scaffold is an efficient delivery system for
antibiotic drugs, fast and effective in the elimination of both strains
of bacteria and without significant cytotoxic effect thus suitable for
many different applications and implantations.
(P 161) Evaluation of Mesenchymal Stem Cells and Anterior
Cruciate Ligament Fibroblasts as Cell Sources for Tissue-
Engineered Ligament
H.F. Liu1, H.B. Fan1, S.L. Toh2,3, C.H. Goh1,2
1Department of Orthopedic Surgery, National University of Sin-
gapore, Singapore.
2Division of Bioengineering, National University of Singapore,
Singapore.
3Department of Mechanical Engineering, National University of
Singapore, Singapore.
The aim of this study was to compare the cellular responses of bone
marrow-derived mesenchymal stem cells (BMSCs) and anterior
cruciate ligament fibroblasts (ACLFs) on combined silk scaffolds
for ligament tissue engineering application. Rabbit BMSCs and
ACLFs were isolated and cultured in vitro for two weeks after
seeding on the silk scaffolds. Samples were evaluated and com-
pared for their cellular morphology, proliferation, gene and protein
expression of tenascin-C, type I and type III collagen. In addition,
the two cell types were transfected with green fluorescent protein
(GFP) to trace their fate in the knee joints. Preliminary re-
sults comparing cell proliferation indicated that BMSCs prolifer-
ated faster than ACLFs. Gene expression of the phenotypic
markers measured using real-time reverse transcription polymerase
chain reaction (RT-PCR) indicated the transcript levels of BMSCs
were significantly increased after two weeks of culture, whereas
those of ACLFs had no significant difference. The protein levels
and localization were determined by western blots and immuno-
histochemical staining, the results showed more production of lig-
ament-related extracellular matrix (ECM) by BMSCs as compared
to ACLFs. Moreover, 4 weeks postoperatively, more fluorescent
cells were presented in BMSC-loaded constructs than in ACLF-
loaded constructs. Therefore based on the cellular response in vitro
and in vivo, BMSCs were found to be a better cell source than
ACLFs for the further study of ACL tissue engineering.
(P 162) Evaluation of Nerve Regeneration Across using a
Fibroblast Nerve Conduit Filled with a Collagen-Based Bio-
material to Bridge Peripheral Nerve Gaps
R. Caissie1,2, F. Tomasetig1,M. Grenier1, P.E. Landry2, F. Berthod1
1Laboratoire d’Organoge´ne`se Expe´rimentale (LOEX), CHAUQ,
Hoˆpital du St-Sacrement and De´partement de Chirurgie, Uni-
versite´ Laval, Que´bec, QC, Canada.
2Oral and Maxillofacial Surgery Department, CHAUQ, Hoˆpital de
l’Enfant-Je´sus and Universite´ Laval, Que´bec, QC, Canada.
The autograft has long been the gold standard solution for nerve
gap repair although it inflicts a sensory deficit at the donor site and
rarely adapts perfectly to receiver site anatomy. Our current
technology for nerve repair using autologous nerve grafts is limited
by the availability of donor tissue and its related morbidity.
The aim of this work is to prepare a nerve conduit made of
fibroblasts that will serve as a nerve guide to enhance recovery
of sensory and motor functions. Fibroblast nerve guide tubes,
empty (control) or filled with a collagen matrix enriched or not with
NGF will be used to bridge a 20mm gap of sectioned rat sciatic
nerves. Tubes will be transplanted for 120 days. The quantitative
analysis or regenerating nerve fibers will be assessed through se-
rial histochemical and immunohistochemical analysis. Functional
motor reinnervation will be tested using the Walking track analysis
and Relative gastrocnemius muscle weight indexes.
The use of tissue engineered autologous nerve grafts associated
with neurotrophins could enhance and replace current treatment
modalities used for iatrogenic, post-traumatic or neoplastic nerve
gap repair.
(P 163) Evaluation of the Influence of the Mesenchymal Stem
Cells (MSC) Density Seeded on Coralline Scaffolds on Bone
Formation after Implantation in Sheep
B. David1, M. Bensidhoum1, D. Bossis2, V. Viateau1, V. Myrtil1,
G. Guillemin1, H. Petite1
1Laboratoire Biome´canique et Biomate´riaux Oste´o-Articulaire,
UMR CNRS 7052, Universite´ Paris 7, France.
2Laboratoire d’Imagerie Parame´trique, UMR CNRS 7623, Uni-
versite´ Paris 6, France.
Aim of the study
Pathological events such as trauma, inflammation, and surgical
treatment of tumors are often associated with extensive bone loss.
Reconstruction of these defects represents a significant clinical
problem in the those cases.
Present therapeutic approaches include transplantation of bone
grafts (autologous, homologous or heterologous grafts) and im-
plantation of different biomaterials. However, none of these have
proven to be fully satisfactory. The present study aimed at evalu-
ating the influence of the mesenchymal stem cells (MSC) density
seeded on coralline scaffolds (acropora) on the bone formation
after 8 weeks in sheep.
Materials and Methods: Prior to implantation, three-dimensional
coralline scaffolds (333 mm) seeded with sheep MSCs (bio-
hybrids) (1 million cells/ml) were cultured (i) in static conditions
for 24 hours, 1 week or 3 weeks or (ii) in dynamic conditions in a
perfusion bioreactor for1 or 3 weeks. The Biohybrids were im-
planted subcutaneously in sheep for 8 weeks.
The harvested biohybrids were embedded in methacrylate 2%,
incubated at 17 8C 4 weeks. Sections were surface-stained with
picrofuchsin and analysed (matlab).
Results: A positive correlation between bone neoformation and
the initial number of cells seeded on the biomaterial was found.
The osteogenic ability of biohybrids was significantly higher
compared with nude scaffolds. The increased bone formation
found in the scaffolds cultured for 1 or 3 weeks was independent of
the applied culture condition.
Conclusion: The present study confirmed the osteogenic ability
of biohybrids composed of MSCs and an osteoconductive scaffold.
Biohybrids engineering is a valuable alternative to repair large
segmental defects.
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(P 164) Evaluation of the Integration and Neovascularisation
of a Novel Fibrin-Based Dermal Scaffold
S.C. Dann1, F.C. Edwards1, Y. Di1, E.A. Clayton1, J.F. Dye1
1RAFT Institute.
Enhanced migration of endothelial cells in vitro has been dem-
onstrated in fibrin gels when compared with collagen. Based on
this potential pro-angiogenic property, a fibrin-based dermal scaf-
fold (Smart Matrix) has been developed with a view to treating
full-thickness skin loss. We aimed to establish evidence of in vivo
integration of the smart matrix and wound bed, through cellular-
isation and new vessel formation within the neodermis.
Scaffold integration was evaluated in vivo using a porcine
full-thickness wound chamber model. Punch biopsies of scaffolds
were taken for histological and immunocytochemical analysis
(CD31, vWF, VE-cadherin) at days 3, 7, 14 and 21. Neovascu-
larisation was assessed by examination, and neovessel profile
counts per field at day 7. Stability of these structures was in-
ferred by extent of associated pericytes (a-SM-actinþve) staining.
Cellular ingress from the wound bed occurred more rapidly into
Smart Matrix than Integra. However, ingress into Smart Matrix,
but not Integra was associated with a variable inflammatory (pre-
dominantly neutrophil) infiltration. The degree was mainly de-
pendent on the concentration of calcium used in the scaffold
manufacture process, being significant at >12mM. The rate and
extent of neovascularisation was distinct between Integra and
Smart Matrix. Whereas capillary ingress into Integra was via an-
giogenesis, Smart Matrix displayed evidence of vasculogenesis
through differentiation of granulation tissue, and the profile of
endothelial differentiation marker expression. The vascular density
in Integra at day 21 remained relatively low.
Fibrin-based matrices appear to offer a more favourable envi-
ronment for accelerated tissue re-growth compared to conventional
collagen-based scaffolds.
(P 165) Expanded Clinical Indications for a Tissue Engineered
Blood Vessel
N. L’Heureux1, S. Garrido2, A. Marini2, L. de la Fuente2,
L. Cierpka3, M. Maruszewski3, A. Kocher4, K. Zagalski3, W.
Wystrychowski3, I. Gasperovich5, N. Dusserre1, T. McAllister1
1Cytograft Tissue Engineering.
2IADT, Buenos Aires Argentina.
3KKCO Katowice, Poland.
4Medical University of Wien, Austria.
5NUSK, Bratislava, Slovakia.
We have developed a completely autologous tissue engineered
blood vessel (TEBV) using a process called sheet-based tissue
engineering. In this approach, we depart from the usual tissue
engineering strategy by eliminating the need for synthetic scaf-
folds. In initial clinical trials, we implanted the TEBVs as arterio-
venous shunts for hemodialysis access and demonstrated patency
at time points beyond 12months. In an effort to justify evolution to
coronary use, we have expanded our mechanical testing to include
dynamic fatigue, low pressure static fatigue, and step-wise fatigue
testing. TEBVs were built from cells harvested from patients with
advanced cardiovascular disease as described previously. Static
fatigue tests were run by pressurizing the vessels to 250 mmHg for
5 days and then increasing pressure to burst. Dynamic fatigue
testing was performed by cycling the pressure between either 120/
80 or 600/400 mmHg for 14 and 3 days respectively (1Hz). Ves-
sels were then pressurized to burst. Step-wise fatigue testing was
performed by pressurizing internal membranes (TEBVs with only
3 decellularized plies) to1200 mmHg for 15minutes and then in-
creasing pressure by 200 mmHg increments and holding for an
additional 15minutes or until failure. TEBVs demonstrate burst
pressures in excess of 3000 mmHg. Burst pressure did not diminish
significantly after fatigue loading relative to unloaded controls.
These mechanical results, coupled with positive initial results in
peripheral indications, would appear to support the evolution to
coronary use. We have enrolled patients for coronary implant and
will report clinical updates for both lower limb and coronary in-
dications.
(P 166) Expansion of Cord Blood CD34þve Cell Fraction us-
ing Chromatin Modifying Agents, Different Supporting Stro-
mal Cells and Different 3D Scaffolds.
C. Grech1, A. Cassar1, P. Schembri-Wismayer1
1Anatomy Department, Faculty of Medicine and Surgery, Uni-
versity of Malta
Cord blood provides an easily accessible source of stem cells.
Transplantation is however limited by the number of cells per cord
blood unit, which are insufficient for adequate haematopoietic
restoration of many adults.
Attempts to ameliorate this have included incomplete myeloa-
blation, multiple unit transfusion and ex-vivo expansion. We
present our studies in the latter.
Following consent, the mononuclear cell fraction was isolated
from cord blood samples by density gradient centrifugation and
immediately cryopreserved. Upon thawing, samples were pooled
and cultured for a week with or without DNA-modifying agents
and/or supporting cells. They were then analysed by flow cyto-
metry to assess the CD34þ cell fraction.
Demethylating agent 5-aza-cytidine followed by Histone dea-
cetylase inhibitor trichostatin A resulted in the greater increase,
confirming previous studies.
Co-culturing the mononuclear cells with skin-fibroblasts, cells
derived from the cord stroma and from the term placenta also
increased the CD34þ fraction.
A further, statistically significant increase was seen upon co-
culture with a mixture of all three cell-types indicating a possible
synergistic effect in supporting progenitor expansion.
This optimised 2-D co-culture cell mixture was then compared
with the same mixture grown in 3-D scaffolds of bovine cancellous
bone (Surgibone), adjacent glass beads and non-woven fabrics.
Bone matrix appeared to best support CD34þ cell fraction ex-
pansion.
DNAmodifying agents largely obviated the effects of co-culture,
possibly due to the effect of the chemical modifiers on the stromal
cells themselves. Using these two sets of response modifiers in a
consecutive manner may therefore produce the best effects.
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(P 167) Expression and Purification of Recombinant Aprotinin
for Enhanced Stability of Fibrin Biomaterials
K.M. Lorentz1, P. Frey1, J.A. Hubbell1
1Ecole Polytechnique Federale de Lausanne.
Fibrin is an integral component of the clot during wound healing
and can be harvested autologously for creation of biologically
active, biocompatible, hydrogel matrices. However, fibrin gels can
lose utility due to their rapid rate of degradation via the actions of
plasmin, especially in the context of the in vivo environment.
Covalent-binding of plasmin-inhibitors to the matrix would allow
for prolonged stability of fibrin while bypassing any alterations in
its structure. Previous studies have successfully bound bioactive
factors to fibrin matrices via a transglutaminase (TG) factor XIIIa
substrate sequence tag, derived from a2-plasmin inhibitor. Using
standand cloning techniques, a recombinant protein, aprotininTG,
was created by fusing the TG-substrate sequence onto the
C-terminus of the plasmin inhibitor, aprotinin. AprotininTG was
then expressed in Escherichia coli and was purified from crude cell
lysate using GST affinity chromatography. Bioactivity of the re-
combinant protein was assessed via a plasmin-inhibition assay.
Thus, a mutant form of aprotinin has been created as a fusion
protein which allows for efficient covalent cross-linking of the
plasmin inhibitor into fibrin matrices. Use of aprotininTG within
fibrin matrices may reduce their rate of degradation and therefore
further augment their utility as biomaterials.
(P 168) Expression, Purification and Bioactivity of Re-
combinant Human Bone Morphogenetic Protein-4, -9, -10, -11
and -14 Produced in Escherichia Coli for Tissue Engineering
Applications
P.C. Bessa1,2,3, M.T. Cerqueira1,2, T. Rada1,2, M.E. Gomes1,2,
N.M. Neves1,2, M. Casal3, R.L. Reis1,2
13B’s Research Group—Biomaterials, Biodegradables and Bio-
mimetics, University of Minho, Braga, Portugal.
2IBB—Institute for Biotechnology and Bioengineering, PT Gov-
ernment Associated Laboratory, Braga, Portugal.
3CBMA—Molecular and Environmental Biology Centre/ Biology
Department, University of Minho, Braga, Portugal.
Bone morphogenetic proteins (BMPs) are cytokines from the TGF-
b superfamily, with important roles during embryonic develop-
ment and in inducing bone and cartilage in the adult body. In
this contribution, we report the expression of recombinant
human BMP-4, BMP-9, BMP-10, BMP-11 (or growth differenti-
ation factor-11, GDF-11) and BMP-14 (GDF-5), using Escherichia
coli pET-25b expression system. The BMPs were purified by
affinity chromatography and its bioactivity accessed in C2C12
cell line, by screening the expression of osteogenic markers with
RT-PCR. The expression of Smad-1, Smad-3, Smad-5, Runx2/
cbfa1, Osterix, Bone sialoprotein, Osteopontin and ALP was
increased with some or all of these BMPs, while Smad-7 was
down-regulated, coinciding with the different changes in cell
morphology. No cytotoxicity was observed and around 200mg of
BMPs were purified per Liter of batch. Ongoing work includes
bioactivity assays in human adipose stem cells and with the effect
of heparin on the BMP activity. The approach described here is a
promising method for producing large scale amounts of recombi-
nant BMPs, in pure and bioactive form, for novel biomedical ap-
plications.
Acknowledgments: Fundac¸a˜o para a Cieˆncia e Tecnologia for
PhD grant SFRH/BD/17049/2004 and project ElastM POCI/CTM/
57177/2004 supported by FEDER and the Fundac¸a˜o para a Cieˆncia e
Tecnologia; European STREP Project HIPPOCRATES (NMP3-CT-
2003-505758). The work was carried out under the scope of the
European NoE EXPERTISSUES (NMP3-CT-2004-500283).
(P 169) Extracorporeal Shockwave Treatment of Early
Spontaneous Osteonecrosis of the Knee
M. Vitali1, C. Sosio2, L. Mangiavini2, G.M. Peretti2,3, G.F. Fra-
schini2
1Recidency Program in Orthopaedic and Traumatology I, Uni-
versity of Milan.
2Department of Orthopaedics and Traumatology, University Vita-
Salute San Raffaele, Milan.
3Faculty of Exercise Science, University of Milan.
This work reported of eleven cases of early spontaneous osteone-
crosis of the knee successfully treated with a novel extracorporeal
shockwave treatment.
Traumatic and vascular theories have been proposed as a caus-
ative factor of spontaneous osteonecrosis of the knee, but precise
etiology still remains speculative.
ESWT, thanks to its neo-angiogenetic effect, can be suggested
as an effective regenerative treatment for spontaneous osteone-
crosis of the knee.
Ten patients with medial femoral condyle spontaneous osteo-
necrosis of the knee were evaluated. Exclusion criteria was evi-
dence of structural collapse of subchondral bone. Two patients had
received femoro-popliteal by-pass, while others five presented
deficit of the vascular axis of the homolateral lower limb docu-
mented by an eco-colordoppler. Clinical evaluation was taken at
diagnosis using KSS, McGill Pain Questionnaire.
Patients were treated with a cycle of three ESWT performed
with 2000 pulses of 0,28 mJ/mm2 with Wolf Piezoson 300 with
6,5MHz ultrasounds for three times in a month.
Clinical evaluation was performed at first and at third month
after treatment and a RMI evaluation was performed at fourth
month after the treatment.
Clinical evaluation showed significant improvement of symp-
toms (p<0.001) and articular functionality (p< 0.001). MRI of all
cases revealed the continuity of the cartilage with a reduction in
bone marrow edema and no collapse of lesion; in one case the total
recover up to a normal signal in the subcondral bone was docu-
mented.
Therefore, a single cycle of ESWT produced an improvement of
clinical and MRI aspects in eleven cases of spontaneous osteone-
crosis of the knee.
(P 170) Fabrication and Characterization of Carbon Nano-
tubes Based Coatings for the Repair of Cartilage Tissue
L. Pastorino1, F. Caneva Soumetz1, C. Ruggiero1
1University of Genoa, Dept. of Communication, Computer and
System Sciences—DIST, Via Opera Pia 13, Genova, 16145, Italy.
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The possibility to develop novel biomaterials is critical in order to
improve the success of any tissue repair strategy. An ideal bio-
material for bone tissue regeneration should possess chemical-
physical properties similar to the cartilage being regenerated
and good biocompatibility with surrounding tissue. The engineer-
ing of the surface properties of biomaterials at the molecular level
is then critical to develop bioactive devices with which to elicit
appropriate cellular responses (1). In this work biocompatible
ultra-thin film coatings, with specific and predetermined proper-
ties, were prepared on a silicon substrate by the layer by layer
(LBL) self assembly technique (2). Specifically multilayered
coatings containing funtionalized single walled carbon nanotubes
(SWCNTs), growth factors and polyelectrolytes were assembled,
structurally characterized and are currently tested for the growth of
chondrocytes, in order to evaluate their potential for the treat-
ment of materials employed in cartilage tissue engineering. Quartz
crystal microbalance technique and atomic force microscopy
showed the reliability and reproducibility of the multilayered
coatings fabrication procedure. Preliminary results on cell response
characterization showed that the developed coatings have a high
potential for the engineering of the surface properties of biomedical
implants.
1T.A Desai (2000): ‘‘Micro- and nanoscale structures for tissue engi-
neering constructs’’. Med Eng Phys. Vol. 22: 595–606.
2F. Caneva Soumetz, L. Pastorino, C. Ruggiero (2008): ‘‘Human osteo-
blast-like cells response to nanofunctionalised surfaces for tissue engi-
neering’’. Journal of Biomedical Materials Research: Part B—Applied
Biomaterials. Vol. 84: 249–255.
(P 171) Fabrication of Blended 3D PCL/PLGA Scaffolds using
a Precise Multi-Head Deposition System Based on Solid Free-
Form Technology
J.Y. Kim1, J.-W. Rhie2, E.K. Park3, S.-Y. Kim4, D.-W. Cho1
1Department of Mechanical Engineering, POSTECH, Korea.
2Department of Plastic Surgery, College of Medicine, The Cath-
olic University of Korea, Korea.
3Department of Pathology and Regenerative Medicine, School of
Dentistry, KNU, Korea.
4Department of Orthopedic Surgery, KNUH, Korea.
We present a novel approach to manufacturing biodegradable
poly-caprolactone/polylactic-co-glycolic acid (PCL/PLGA) scaf-
folds using SFF technology. In this study, blended 3D PCL/PLGA
scaffolds with a uniform pore size of 600 mm and a line width of
200 mm were fabricated using a precise multi-head deposition
system (PMDS) that we have developed. We developed the PMDS
for fabricating 3D scaffolds using SFF technology. This system
made it possible to create a repeatable 3D microstructure with a
resolution of several tens of micrometers. The fabrication of the
scaffold required the integration of multiple technologies, includ-
ing 3-axis motion control, thermal control, pneumatic control, and
CAD/CAM software. PLGA (Mw¼ 50,000–75,000) is a well-
known biodegradable material for bone and cartilage regeneration.
However, it is brittle and has low mechanical strength. In this
study, PCL (Mw¼ 65,000) and PLGA polymer were well blended
at a ratio of 1:1 under a melting temperature no higher than 1508C
to compensate for the shortcomings of pure PLGA. The PCL/
PLGA scaffolds were fabricated at a fixed pressure of 650 kPa and a
temperature of 1308C. The pore size and line width were manip-
ulated by changing the speed of the X-Y stage. Stacked scaffolds
with a staggered shape were constructed using a layer-by-layer
process to achieve an overall scaffold size of 7.47.43.2mm. In
addition, mechanical testing and cell interaction experiments were
conducted to evaluate the performance of the scaffolds. we have
demonstrated that the PMDS can be successfully used to fabri-
cate blended 3D PCL/PLGA scaffolds.
(P 172) Fabrication of Well-Aligned Nanofibrous Scaffolds by
a Novel Electrospinning Method
Y. Mohammadi1, A. Gazme1, S. Garshasbi1, M. Soleimani1,
V. Haddadi-Asl2
1Stem Cell Technology Company, Tehran, Iran.
2Polymer Engineering Department, Amirkabir University of
Technology, P.O. Box 15875/4413, Tehran, Iran.
An ideal scaffold should mimic the structural and functional
properties of the native extracellular matrices. Native ECMs are
typically fibrous structures with various nano-sized diameters.
Electrospinning is a well known technique to produce nanofibers
and has been utilized by many researchers to make nanofibrous
matrices for tissue engineering applications. Most native ECMs
found in tissues or organs, however, have regular or defined ori-
entation architecture, which is significant for tissue function. Ef-
forts are being made in various research groups to produce aligned
nanofibrous structures all over the world and some breakthroughs
have been obtained.
In the present work, a modified electrospinning system with a
high level of control over the alignment of the nanofibers is in-
troduced. Applying this new mechanism, it’s not only possible to
control the extent and pattern of alignment precisely but also one
could easily produce two/three-dimensional hybrid structures
composed of well-aligned nanofibers. In this method, the nanofi-
bers are aligned between the two parallel disc-shaped rotating
electrodes and guided to the collector, where they have no choice
but being collected without any changes in their alignment. It’s
worth mentioning that the movement of the collector in any desired
direction and with any desired speed(s) can lead to the formation of
two/three-dimensional structures of nanofibers each layer of which
can have the same or different materials and/or alignments. The
new mechanism has been successfully applied for most of the
biocompatible polymers and a vast range of well-aligned two/
three-dimensional nanofibrous structures have been created.
(P 173) Fast Responding PNIPAAm Hydrogels
A.S. Chetty1, V.Vargha2
1Council for Scientific and Industrial Research (CSIR), Material
Science and Manufacturing, Pretoria, South Africa.
2Budapest University of Technology and Economics, Department
of Physical Chemistry and Material Science, Laboratory of Plas-
tics and Rubber Technology, Budapest, Hungary.
Limited cell source and the reliability of the conventional cell cul-
turing technique are some of the major challenges facing tissue en-
gineering. The use of Poly(N-Isopropylacrylamide) (PNIPAAm) as a
temperature-induced molecular switch for cell adhesion and cell
release, has revolutionised the cell culturing fraternity. The use of
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PNIPAAm as a cell culturing substrate allows viable tissue-like cell
constructs to be cultured in vitro without requiring destructive en-
zymes. PNIPAAm is a temperature sensitive polymer which changes
its surface properties reversibly between hydrophobic and hydro-
philic states at temperatures above or below its lower critical solution
temperature (LCST) (~32–338C). PNIPAAm, however displays poor
mechanical properties, and slow reswelling properties due to strong
hydrophobic interactions between the isopropyl groups in its back-
bone. In this study a variety of PNIPAAm hydrogels were prepared
by free radical polymerisation in water, THF:water or acetone:water
mixtures. PNIPAAm hydrogels were crosslinked either with meth-
ylene-bisacrylamide (BIS) or polyethylene glycol dimethacrylate.
When BIS was used, a feed crosslinker content of 1 to 9 molar
percent was investigated with a NIPAAm/BIS molar ratio (R)
varying from 91 to 10 respectively. Crosslinked gels were char-
acterised by gravimetric swelling ratios, gravimetric deswelling ki-
netics, LCST, environmental scanning electron microscopy, and
dynamic oscillating rheology. Preliminary results indicate that the
choice of polymerising solvent greatly influenced the swelling ca-
pability, porosity and heterogeneity of the gels. The swelling ca-
pacity and porosity of the gels decreased at both 258C and 378C as
the crosslink density increased. All gels maintained their phase
transition temperatures irrespective of the BIS content investigated.
(P 174) Ferrimagnetic Glass-Ceramics for Magnetic Induction
Hyperthermia
O. Bretcanu1, E. Verne’1
1Politecnico di Torino.
Magnetic induction hyperthermia is one of the therapies employed
in cancer treatment. This method involves biocompatible magnetic
materials, which generate heat under an alternating magnetic field.
These biomaterials are implanted into a neoplastic tissue and
the patient is placed in an external magnetic field. The magnetic
materials will heat, due to various loss mechanisms, producing
tissue necrosis or thermoablation. The heating temperature de-
pends on the materials properties, magnetic field parameters (in-
tensity, frequency) and tissue characteristics (blood flow, tissue
density, type of tumoral cells, etc.
The aim of this work is the preparation and characterization of
innovative bioactive ferrimagnetic glass-ceramics in the system
SiO2–Na2O–CaO–P2O5–FeO–Fe2O3
These biomaterials contain different amounts of nanometric or
sub-micrometric magnetite crystals, homogeneously distributed
in an amorphous matrix. They are bioactive, making them also
suitable for bone substitutions. The hysteresis loss and the spe-
cific power loss are compatible with the temperatures required for
hyperthermic treatments of neoplastic tissues. These glass-ceramic
materials are biocompatible with the osteoblast cells. The surface
of these materials was modified (by a suitable functionalisation
process), in order to improve its integration into natural tissue.
(P 175) FGF2-DDS Could Enhance Peripheral Nerve Re-
generation and Schwann Cell Proliferation in Bioabsorbable
Nerve Conduit
K. Takamatsu1, K. Kazuki1, M. Yoneda1, K. Takaoka1
1Department of Orthop. Surg. Osaka City Univ. graduate school.
Introduction: Recently, various biodegrable polymer tubes have
been reported. However those results were not satisfying enough
for clinical use.
We have already investigated that our biodegradable nerve con-
duit filled with gelatin incorporating FGF-2 is a reliable drug de-
livery system(DDS) and it could release FGF-2 for two weeks.
The purpose of this study is to introduce our novel biodegradable
polymer tube filled with gelatin incorporating FGF-2 as DDS and to
report its effect on peripheral nerve regeneration and angiogenesis.
Materials and Methods: Study #1; effects of DDS of FGF-2 on
peripheral nerve regeneration, Schwann cell and angiogenesis :we
implanted biodegradable polymer conduit filled gelatin with or
without incorporating FGF-2 into 12mm sciatic nerve gaps in
Wistar rats. At 12 weeks after implantation, number of re-
generating nerves and vessels in transverse sections at mid-conduit
were observed histologically.
Study #2; enhancement of DDS FGF-2 on peripheral nerve re-
generation, angiogenesis and Schwann cell migration: In the same
series, at 5D, 10D, 15D, 20D post operation, relationship of re-
generating nerves, Schwann cells and vessels from proximal stump
in longitudinal sections were observed immuno-histologically.
Results: Study #1; Concerning FGF-2, the results of nerve re-
generation at 12 weeks obviously showed the advantage of DDS
with FGF-2. And the number of vessels and total area of vessels in
conduit significantly increased with FGF-2, too.
Study #2; DDS of FGF-2 could enhance nerve regeneration at
15D and 20D, Schwann cell migration throughout 20 days, an-
giogenesis at 15D and 20D.
Among them, angiogenesis was obviously enhanced.
(P 176) Fibrin-An Injectable Smart Hydrogel
M. Hofmann1,2, T. Morton1,2, K. Scho¨bitz1,2, H. Redl1,2, M. van
Griensven1,2
1Ludwig Boltzmann Institute for experimental and clinical Trau-
matology in the Research Centre of the AUVA, Vienna Austria.
2Austrian Cluster for Tissue Regeneration, Vienna, Austria.
This study investigates the release of VEGF-165 from fibrin in vitro
and in vivo.
Fibrin (FS) is a two component system, composed of fibrinogen
and thrombin.
For the in vitro studies different concentrations of VEGF-165
were mixed into fibrinogen solution. During the injection both
components (fibrinogen & thrombin) were mixed and crosslinked
to fibrin. After polymerization the fibrin was covered by PBS and
incubated for 7 days. At specific time points parts of the PBS were
collected and replaced by new PBS. The collected supernatants
were analyzed by VEGF ELISA. Results showed that the release of
VEGF is continuous over the time period of 7 days.
For the in vivo studies a hindlimb ischemia/reperfusion injury
transgenic mouse model was used. Transgenic VEGFR-2 lucifer-
ase knock-in mice were used for non-invasive, real-time assess-
ment of the VEGF-R2 expression. Ischemia was maintained for 2 h
with subsequent reperfusion for 24 h. Control animals received no
treatment whereas the animals of the FS/VEGF group received an
injection of 200 ng VEGF/ final FS clot in their hindlimb subcu-
taneously, 15min prior to reperfusion. At different time points
bioluminescence detection to observe VEGF-R2 expression was
performed. With VEGF in the fibrin biomatrix a significant in-
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crease in receptor expression was observed compared to baseline
levels as well as to the control group.
We conclude that fibrin, as an injectable smart hydrogel, is ef-
fective in continuously releasing VEGF in vitro as well in vivo.
(P 177) Filling Cranial Defects in Rats: 6Months Animal Study
H.M. Aydin1, I. Vargel2, T. Cavusoglu2, P. Korkusuz3, E. Guzel3,
E. Piskin1
1Hacettepe University, Chemical Engineering Department and
Bioengineering Division, Ankara, Turkey.
2Ky´ry´kkale University, Faculty of Medicine, Department of
Plastics and Reconstructive Surgery, Ky´ry´kkale, Turkey.
3Hacettepe University, Faculty of Medicine, Department of His-
tology and Embryology, Ankara,Turkey.
Poly(L-lactide) and poly(e-caprolactone) with average molecular
weights of 200 kDa and 40 kDa, respectively, were synthesized by
ring opening polymerization of the respective dimer/monomer, and
their blends with a ratio of 50/50 (w/w) were prepared. Scaffolds
with highly open pores structures (interconnected) with pore sizes
in the range of 250–355 mmwere produced by using a two-porogen
technique, namely salt leaching followed by supercritical fluid
treatment. Discs with a diameter of 8mm and a thickness of 1mm
were cut from the microporous sheets. Scaffolds were investigated
by SEM and micro-CT. Micro-CT analyses showed 94 percent
porosity. Defects with the aforementioned diameters (critical de-
fect size) were created in female Sprague Dawley rats (n¼ 96).
Animals were randomly assigned into three groups as follow:
(i) Only scaffold group (n¼ 32); (ii) scaffoldþ stem cell (mesen-
chymal stem cells from rat bone marrow) group (n¼ 32); and (iii)
control group (n¼ 32). Samples were collected from the defect site
at days 30, 90 and 180. Bone regeneration was assessed by histo-
logical tests.
(P 178) Flexible Micropatterned Porous Scaffolds
Bernke Papenburg1, Sigrid Schuller2, Dimitris Stamatialis1, Dirk
Grijpma2, Jan de Boer3, Clemens van Blitterswijk3, Matthias
Wessling1
1Membrane Science and Technology, Institute for Biomedical
Technology, University of Twente, Enschede, The Netherlands.
2Polymer Chemistry and Biomaterials, Institute for Biomedical
Technology, University of Twente, Enschede, The Netherlands.
3Department of Tissue Regeneration, Institute for Biomedical
Technology, University of Twente, Enschede, The Netherlands.
Introduction: In various tissue engineering areas two major issues
are extensively studied; i.e. efficient nutrient supply and optimal
cell organization. Through scaffold design, both these issues can be
addressed:
- inner-porosity to provide nutrient supply,
- micropatterning to induce cell organization.
Micropatterning of the scaffold surface can promote enhanced
cell attachment and orientation. Moreover, the micropattern can
optionally be used for additional perfusion to improve nutrient
supply [1].
Method: Previously [1], we showed fabrication of 3-D multi-
layer stacked porous micropatterned scaffolds of well-known
semi-crystalline poly(l-lactic acid) (PLLA) by one-step fabrication
method Phase Separation Micromolding (PSmM). With PSmM, a
polymer solution is solidified on a micropatterned mold by im-
mersion precipitation, inducing the micropattern to be replicated
into the polymer sheet. The resulting PLLA sheets were highly
porous (>80%) and the incorporated micropattern designs induced
alignment of mouse pre-myoblasts, C2C12 cells.
Results and Discussion: In this work, we develop highly porous
micropatterned sheets from amorphous Poly(trimethylene car-
bonate) (PTMC). The flexibility of the PTMC sheets can be ad-
vantageous in tissue engineering application where high flexibility
at the site of implantation is required. By variation of processing
conditions (e.g., polymer concentration, additives) we obtain
highly porous PTMC sheets with pores in the range of 1–50 mm.
Additionally, the micropattern is tailored to obtain various surface
topographies. Cell culturing experiments show great potential of
these scaffolds for tissue engineering applications concerning cell
attachment, viability, proliferation and organization.
1Papenburg, B.J, et al., Biomaterials 28(2007), 1998.
(P 179) Functional Reconstruction of Engineered Digits
M. Komura1, M. Nomi1, S. Soker1, J.J. Yoo1, A. Atala1
1Wake Forest Institute for Regenerative Medicine, Wake Forest
University Health Sciences, Winston-Salem, NC 27157.
Surgical reconstruction of digits injured by trauma are challenging
due to limited tissue availability. We explored the feasibility of
engineering skeletal muscle and cartilage structures in vivo which
could be potentially used for functional digit reconstruction.
Composite scaffolds consisting of synthetic PGA polymers (1.0
0.50.5 cm) and naturally derived collagen matrices (1.40.4
0.3 cm) were constructed. Chondrocytes were seeded onto the PGA
polymer matrices and muscle cells onto the collagen matrices. The
scaffolds containing both cell types were analyzed in vitro for cell
viability and tissue formation. The engineered digits were im-
planted subcutaneously in athymic mice (n¼ 36) and followed
for up to 6months. The cells seeded on the composite digit con-
structs readily attached to their designated region of the scaffold
and remained viable. Grossly, the implanted scaffolds formed
muscle and cartilage tissues adjacent to each other. Each tissue
type was confirmed histo- and immunohistochemically using cell
specific antibodies. Biomechanical studies showed that the carti-
lage tissue was elastic and could withstand high degrees of pres-
sure. Physiologic organ bath studies of the retrieved muscle tissues
showed adequate contractility in response to electric field stimu-
lation.
(P 180) Gelatin Hydrogel Crosslink by Transglutaminase in
Bone Tissus Ingeneering: Application for MSC Survival
M.Deschepper 1, H.PETITE2, B.David2, V.larretta-Garde3
1PHD student Paris VII.
2CNRS.
3Errmece.
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Tumor resection and trauma are often associated with large defects
which need to be reconstructed. Autografts are considered as the
golden standard in this respect. However, the volume of autoge-
nous bone transplants is rather limited and their harvesting and
transplantation might be connected to complications such as in-
fection and donor site pain. Bone cellular therapy using adult
mesenchymal stem cells (MSCs) in combination with a osteo-
conductive biomaterial is gaining interest, but not yet a clinically
applicable alternative due to cellular death. The aim of this work
was to explore the capability of a hydrogel made of gelatine cross-
linked chemically by Transglutaminase (Tgase) for enhancing
MSCs survival. In a first time biochemical experiments were as-
sessed on the hydrogel, then in a second time imaging and bio-
logical tests were done on MSCs included in gelatin hydrogel.
Assessing gelation time and rheological properties resulted in a
hydrogel with optimal concentrations of gelatin and Tgase of 5%
and 1.5U/ml respectively. Cell cycle analysis, cell counting and
DNA quantification revealed that (i) MSCs did not proliferate but
survived inside the hydrogel, (ii) Tgase had no effect on cell
proliferation whereas (iii) gelatin inhibited MCS proliferation,
freezing the cells in the G0/G1 stage. The present work demon-
strated that dense gelatin hydrogels are not suitable for use as
proliferation scaffold in bone tissue engineering. Cellular survival
for over 10 days on the other hand could be confirmed for the
hydrogel used.
(P 181) Gelatin Matrix to Support Angiogenesis
B. Schlosshauer1, L. Dreesmann1, M. Ahlers2
1NMI Natural and Medical Sciences Institute.
2GELITA AG, Eberbach, Germany.
Objective: To bridge gaps of lesioned nerves after PNS injury we
have started to develop a nerve guide implant made of stabilized
gelatin. The novel concept is to design an implant material that
facilitates angiogenesis which in turn promises to improve neu-
ronal regeneration.
Materials and Methods: Chemical crosslinking together with
sponge formation techniques were employed to generate stabilized
gelatin sponges. Four different in vitro approaches with fibroblasts
and endothelial cells in conjunction with immunocytochemistry
and an enzyme assay were performed to test biocompatibility/
toxicity, cell adhesion, -migration and -proliferation. To analyze
angiogenesis in vivo, gelatin structures were implanted onto the
chorioallantois membrane (CAM) of the chicken egg and subcu-
taneously into mice.
Results: Preconditioned gelatin specimens were positively tested
in vitro with regard to all four parameters. Implantation of gela-
tin sponges onto the CAM induced robust formation of blood
vessels. Angiogenesis inside gelatin implants occured more than
200 times faster than in a commercial collagen sponge. After
subcutaneous implantation of sponges into mice, immigration of
cells and subsequent formation of functional vasculature became
evident.
Conclusion: In summary, the novel matrix based on crosslinked
gelatin promises to be a valuable component of future implants in
order to improve regeneration by concomitant pro-angiogenic
stimulation.
Supported by BMBF 0313144A, B.
1Dreesmann, L., Ahlers, M, Schlosshauer, B. (2007) The pro-angiogenic
characteristics of a cross-linked gelatin matrix. Biomaterials 28, 5536–
5543.
2Schlosshauer, B., Dreesmann, L., Schaller, H.-E., Sinis, N. (2006) Syn-
thetic nerve guide implants in humans—a comprehensive survey. Neuro-
surgery 59, 740–748.
(P 182) Gene Expression Regulation During the In vitro De-
velopment of a Bioengineered Corneal Endothelial Barrier
M. Alaminos1,2, M. Gonza´lez-Andrades1, I. Garzo´n1, J.I. Mun˜oz-
A´vila2, MC. Sa´nchez-Quevedo1, S. Medialdea3, A. Campos1
1Department of Histology, University of Granada, Spain.
2Univ. Hospital San Cecilio, Granada, Spain.
3Univ. Hospital Virgen de las Nieves, Granada, Spain.
Introduction: Strict regulation of the transendothelial ion flux be-
tween the corneal stroma and the anterior chamber of the eye is
necessary for the cornea to remain transparent and allow the in-
coming light to reach the retina. Nevertheless, the ion transport
regulatory mechanisms that develop during the formation of the
corneal endothelial barrier are unknown.
Materials and Methods: In this work, we have quantified the in-
tracellular content of sodium, potassium and chlorine in the con-
fluent and non-confluent rabbit corneal endothelial barrier by
electron-probe X-ray microanalysis. Then, we carried out a gene
expression profiling at the mRNA and protein levels by RT-PCR,
Western-blot and immunocytochemistry on the confluent and non-
confluent endothelial barrier.
Results and Discussion: Our results revealed that non-confluent
endothelial cells showed higher intracellular contents of potassium
and chlorine than confluent cells, with a hypertrophic volume in-
crease. In contrast, the intracellular contents of potassium and
chlorine decrease when cells reach confluence and the endothe-
lial barrier forms, showing a decrease in cell volume. Our genetic
and protein analysis showed a higher expression of KCNC3 in
confluent cells, and of CFTR and CA2 in non-confluent cells.
These results suggest that endothelial cell confluence and cell-cell
contacts are able to control and regulate the normal transen-
dothelial ionic current that keeps the corneal stroma dehydrated
and transparent. For that reason, only confluent corneal endothelial
cells should be used to develop artificial corneas by tissue engi-
neering.
Supported by CM2005/011 from Junta de Andalucia.
(P 183) Generation of a Novel Sca-1pos Linneg Murine Me-
senchymal Stem Cell Immortalized Line for Tissue En-
gineering Applications
G. Forte1, O. Franzese2, S. Pagliari1, F. Pagliari1, R. Fiaccavento1,
F. Carotenuto1, A. Laudisi2, E. Bonmassar2, M. Minieri1,
E. Traversa3, P. Di Nardo1
1Dept. Internal Medicine.
2Dept. Neuroscience.
3Dept. Chemical Science and Technology.
Tissue engineering techniques rely on adult stem cells as a prom-
ising source of multipotent progenitors to repair damaged tissues
and organs. In this context, the search for the ideal candidate for
856 POSTER PRESENTATIONS
stem cell therapy is still ongoing and further in vitro investigations
are required. Unfortunately, ex vivo-derived progenitor cells dis-
play high donor variability and limited lifespan in culture, pro-
ceeding to senescence within few passages. Recently, a unique
Sca-1posLinneg mesenchymal stem cell line (Sca-1 mTERT-MSC)
was generated by mTERT ectopic transduction of bone marrow
purified Sca-1pos MSC. This cell line, obtained by serial passages of
single cell cloning, displays spindle-shaped morphology and con-
tinuously expresses mesenchymal stem cell markers (Sca-1, c-kit,
Nanog, Nestin, Nucleostemin), while retaining the ability to dif-
ferentiate towards osteogenic, adipogenic andmyogenic lineages in
standard culture conditions. Moreover, TERT-transduced MSC
show enhanced resistance to H2O2-induced apoptosis similarly to
early passage cells. Finally, when cultured onto three-dimensional
biocompatible scaffolds, Sca-1 mTERT-MSC line displays the
ability to maintain the typical stem cell phenotype and multi-
potency, thus suggesting its utilization as a powerful tool for en-
graftment and in vitro differentiation studies.
(P 184) Generation of Immobilised Gradients Without
Microfluidics for Adhesion of Neural Cells
F. Montemurro1, T. Lenzi1, C. Pardini2, G.Vozzi1, F. Vaglini2,
A. Alhuwalia1
1Research Center Piaggio Pisa Italy.
2Department of Neuosciences Pisa Italy.
The idea of a chemotatic, haptotatic or morphogen gradient is inti-
mately associated with the concept of positional information. A cell
is believed to read its position in a concentration gradient of an
extracellular signal factor, and to determine its functional and de-
velopmental fate. Biomolecular gradients have been difficult to
produce because the distances involved are over a maximum of 10s
of cell distances. Today multichannel microfluidic techniques are
routinely used to create gradients of various shapes and sizes, but
they create cell damage owing to the presence of even a minimal
flow over cells. Gradients can be produced using gels in which a
temporary gradient is set up by moistening one side of a gel with the
molecule of interest, and then using the gel as a stamp. Based on this
principle we have developed an immobilised gradient generator, that
consists of a 2 chamber device, in which the larger chamber is filled
with a liquid containing the ligand at a given concentration, and the
smaller chamber is filled with an agarose gel. Given the diffusion
constant of the ligand within the gel, it is possible to generate a
precise concentration profile within the gel, as a function of time.
The gel is then quickly stamped onto a derivatised glass slide.
Using this method, we have printed immobilised polylysine
gradients from 0 to 300 microg/ml over 2.4 cm, for the study of
mesenchepalic neural stem cell adhesion.
(P 185) Glass-Ceramic as Scaffold for MSCs Growth
L. Meseguer1, A. Bernabeu1, M. Clavel-Sainz1, S. Sa´nchez2,
S. Padilla2, A. Martı´n2, M. Vallet-Regı´2, F. Lo´pez1, Cl. Mese-
guer1, P. Sa´nchez1
1Lab. de Cirugı´a Ortope´dica Experimental. Hospital Universitario
V. Arrixaca. Universidad de Murcia, S.
2Dpto. Quı´mica Inorga´nica y Bioinorga´nica. Universidad Com-
plutense de Madrid, S.
Introduction: A bioactive glass-ceramic (GC) was evaluated about
the capacity of mesenchymal stem cells (MSCs) to adhere, pro-
liferate and differentiate into osteoblast (OBs) with or without GC
was investigated.
Materials and Methods: The GC was obtained by heat treat-
ment of a bioactive glass (55-SiO2; 41-CaO; 4-P2O5; mol %), ob-
tained by the sol-gel method. The adult MSCs were isolated from
bone marrow of adult rabbits obtained by direct aspirations of ileac
crest. The OBs used as control were obtained by the method of
enzymatic digestion. The behavior of isolatedMSCs on the GC, two
series of 96-well plates were seeded, with GM and OM. Then
5103 cells were seeded. At 24 hours, 7, 15, 21 and 27 days
cell adherence and growth were analyzed. A variance analysis
(ANOVA) was carried out with a minimal significance of p< 0.05.
Results: The MSCs under the conditions of this study expressed
an osteoblastic phenotype and took place by either the action of
exposing the MSCs to a MO as well as by the effect of the GC.
Conclusions: The GC has provided a favourable environment to
support adhesion, proliferation and differentiation of MSCs to
OBs.
(P 186) Heparin-Collagen Coated TCP/HA Granules as a
Carrier for BMP-7
P.J. Geutjes1, G. Hannink2, L. Gierman1, B.W. Schreurs2, W.F.
Daamen1, P. Buma2, T.H. van Kuppevelt1
1Department of Biochemistry 280, Radboud University Nijmegen
Medical Centre, The Netherlands.
2Orthopaedic Research Lab 357, Radboud University Nijmegen
Medical Centre, The Netherlands.
Bone regeneration via the delivery of BMPs (bone morphogenic
proteins) often goes with problems in controlling its binding and
release. The aim of this study was to attached heparin covalently to
type I collagen-coated TCP/HA (tricalcium phosphate hydroxy-
apatite) granules to specifically bind the heparin binding growth
factor BMP-7.
We used TCP/HA granules with a diameter of 2–4mm. These
granules were coated with collagen (COL) by mounting the
granules in a 0.5% (w/v) collagen suspension followed by subse-
quent freezing and freeze drying. Coated granules were cross-
linked in the presence and absence of 0.5% (w/v) heparin (HEP) by
means of carbodiimide cross-linking. Recombinant human BMP-7
was loaded onto the granules by a two hour incubation in 1.0 mg/ml
BMP-7 in PBS (pH 7.4) followed by three washings in PBS. The
granules were characterised using scanning electron microscopy
(SEM) and immunofluorescent assay (IFA). The free amino groups
and heparin content were determined with biochemical assays. The
amount of BMP-7 bound to the TCP/HA, TCP/HA-COL and TCP/
HA-COL-HEP granules was analysed with SDS-PAGE silver
staining.
SEM analysis showed a highly porous collagen network on both
TCP/HA-COL and TCP/HA-COL-HEP granules. IFA could lo-
calise the heparin and BMP on the granules. On SDS-PAGE the
heparin coated granules showed more bound BMP even after 21
days. These heparin coated granules can also be used for the de-
livery of other heparin binding growth factors such as VEGF, FGF
and/or PDGF, which may enhance angiogenesis and osteogenesis.
This delivery system may provide a powerful modality for bone
regeneration.
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(P 187) High-Throughput Biological Screening of Cell-Surface
Topography Interactions
H. V. Unadkat1, B. J. Papenburg2, D. Stamatialis2, M. Wessling2,
C.A. van Blitterswijk1, J. de Boer1
1Department of Tissue Regeneration, University of Twente,
Postbus 217, 7500 AE Enschede, The Netherlands.
2Membrane Science and Technology Group, University of
Twente, Postbus 217, 7500 AE Enschede, The Netherlands.
The advent of micro- and nanotechnologies has generated im-
mense possibilities to create substrates with different surface to-
pographies. Also, in the past few years there have been various
studies dealing with the effect of biomaterial surface on cell be-
haviour. It appears that cell shape is an important factor governing
cell fate (i.e. migration, growth, differentiation and apoptosis).
With the advancements in micro- and nano- technologies it is now
possible to generate tools that can influence cell shape and thus cell
behaviour. However, most studies in the past have dealt with just a
few variations in surface topographies. In the present study we
have defined around 8000 variations in surface topography. The
topographies were created on a 22 cm silicon mould using ste-
reolithography and the mould was used to replicate the features
onto PLLA and PEO/PBT polymers, which are refered to as To-
poChips. Next, we seeded GFP-positive CHO cells and mouse
embryonic stem cells onto TopoChips and analysed GFP and nu-
clear staining respectively using a fluorescent microscope and a
micro-array scanner. Current research is aimed at developing re-
porter assays to reveal the biological response of cell grown on the
array of surface topologies on the TopoChip.
(P 188) How To Optimise the Maturation Conditions in a
Bioreactor? Toward an Intelligent Bioreactor for Vascular
Tissue Engineering
F. Couet1, D. Mantovani1
1Laboratory for Biomaterials and Bioengineering & Que´bec
University Hospital Research Centre, Laval University, Que´bec
City, Canada.
The need for bioreactors is well established in tissue engineering.
Bioreactors are generally designed to closely recreate specific
physiological environments in which cell-colonized scaffolds
(constructs) are expected to maturate and achieve functionalities.
This process is function of a number of interlinked dynamical pa-
rameters. The clear establishment of those parameters (and ranges)
susceptible to lead to the optimal construct maturation is not trivial.
A number of scientists might be interested in knowing which dy-
namic regimes should be applied during maturation to ensure ex-
pected maturation of tissue engineered constructs. This work aimed
to instrument a bioreactor with advanced process-control tools in
order to optimize the maturation process. It was hypothesised that a
Partially Observed Markov Decision Process (POMDP) will pro-
vide the necessary framework to appropriately control the biore-
actor. Sensors in the construct under maturation generate the applied
parameters and ranges. An output action was expected on the con-
struct. When the consequences of the actions are uncertain and
cannot be predicted with certainty, POMDP is appropriate to gen-
erate an experience plan, susceptible to translate inputs from sensors
to output actions to be executed. A randomized point-based value
iteration solver for POMDP, called PERSEUS, was combined with
this control system. The bioreactor was instrumentedwith an optical
interferometer to measure tissue growth. A mass-flow/pressure
controller was used to dynamically regulate the pressure signal in-
side the construct, the flow was generated by a peristaltic pump and
controlled by a computer. Results confirmed that the POMDP al-
lowed the control of the bioreactor to apply dynamic routine.
(P 189) Human Bone Marrow Mesenchymal Stem Cells Ex-
pressing CD105 After Ex vivo Replication Defective Adeno-
virus BMP-2 Mediated Gene Transfer
H.Y. Chung1, T.M. Lin1, S.C.N. Chang2, L.B. Jeng3, H.H. Chao4
1Department of Medical Research, China Medical University
Hospital, Taichung, Taiwan.
2Department of Plastic Surgery, China Medical University Hos-
pital, Taichung, Taiwan.
3Department of Surgery, China Medical University Hospital,
Taichung, Taiwan.
4Department of Pediatric Surgery, China Medical University
Hospital, Taichung, Taiwan.
Tissue engineering integrating ex vivo gene therapy and polymer
science may have clinical significance to bone regeneration ap-
plication. This study aims to understand in vitro cellular differ-
entiation post adenoviral infection.
The experimental group was composed of ex vivo replication
defective adenovirus BMP-2 mediated gene transfer to the ex-
panded human MSCs. The controls were performed using human
MSCs. We tested the parameters in flow cytometry as CD166,
CD105 and CD34 post infection 2, 3, 6 and 9 days.
Comparison between the experimental and control groups, there
were no difference in the expression of CD 34. While CD 166
showed no significant increase in the experimental group. Both
groups demonstrated less decrement of CD 105 in the experimental
one in flowcytometry and western blotting study.
This data evidenced that ex vivo replication defective Adenovirus
mediated human BMP-2 gene transfer to MSCs enhances the ex-
pression of CD 105 which is an accessory protein of multiple kinase
receptor complexes of the TGF-b superfamily. TGF-b is directly
implicated in vascular development and thought to control inter-
action between endothelial cells and smooth muscle cells. BMPs
may also be involved in these processes. BMP-2 and -7 can act on
vascular smooth muscle cells to inhibit their proliferation without
stimulating extracellular matrix synthesis, whereas activin-A has a
growth-stimulatory effect.
(P 190) Human Dental Pulp an Abundant Source of Multi-
potent Adult Progenitor Cells
S.G. Thompson1, J.A. Hunt1, J.M. Curran1, N.P. Rhodes1
1UK Centre for Tissue Engineering, University of Liverpool,
Clinical Engineering, Liverpool, L69 3GA, UK.
Whilst protocols for the isolation of progenitor cells from nu-
merous sources are described in extreme detail, characterisation
of individual subpopulations has proved cumbersome. Dental
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pulp from both deciduous and adult teeth has been identified as a
potential source of primitive cells, which could provide a safe,
reliable and abundant supply of progenitor cells.
Isolated pulp was dispersed and cells resuspended in culture
medium. Undifferentiated confluent cells were removed and ana-
lysed by flow cytometry. Colony forming unit (CFU) analysis was
performed using complete MethoCult Media. Cells were cultured
in media known to cause lineage differentiation along adipogenic,
chondrogenic, osteogenic and neurogenic pathways. Phenotyping
by immunostaining, histological staining and western blotting for
proteins associated with the desired lineage was carried out at days
7, 14, 21 and 28.
Heterogeneous pulp cells exhibitedmarkers associatedwith adult
MSCs, HSCs and ESCs as observed by flow cytometry. Further
analysis of undifferentiated cells ascertained the expression of
STRO-1, Oct-4, Sox2 and Tra-1-81 within subsets of the popula-
tion. Upon introduction into methylcellulose, cells formed CFUs.
Individual subpopulations were homogeneously isolated using
high-speed FACS sorting based on CD90. CD90þ/- cells intro-
duced into adipogenic, chondrogenic, osteogenic and neurogenic
differentiation medias exhibited morphological transformations
and furthermore demonstrated a gradual increase in proteins as-
sociated with the desired lineage, most notably the expression of
neurotransmitter Synaptophysin in cells treated with neural dif-
ferentiation media. Histology confirmed differentiation. The mul-
tipotentiality of the CD90- population indicated additional sources
of primitive cells within dental pulp, identifying dental pulp as a
clinically applicable cell source.
(P 191) Human Dermal Fibroblasts Cultured on Xenogeneic
Extracellular Matrix—In Vitro Construction of a Potential
Skin Substitute.
D.N. Coakley1,2, F.M. Shaikh1,2, A. Callanan2, E.G. Kavanagh1,2,
P.E. Burke1,2, P.A. Grace1,2, T.M. McGloughlin2
1Department of Surgery, Mid-Western Regional Hospital, Lim-
erick, Ireland.
2Centre for Applied Biomedical Engineering Research, University
of Limerick, Ireland.
Introduction: The use of bioengineered skin constructs has devel-
oped owing to the limitations of autologous skin grafting. These
constructs feature a matrix, typically collagen, onto which cells
important for skin repair are seeded. To successfully induce tissue
repair, bioactive constructs must be able to promote adhesion,
migration and proliferation of cells. The aim of this study was to
investigate the suitability of an emerging acellular xenogeneic
extracellular matrix - porcine urinary bladder membrane (UBM) as
a substrate for culturing human dermal fibroblasts with a view to
creating a novel skin substitute.
Methods: Human dermal fibroblasts were seeded on sheets of
UBM, scaffolds were cultured for 16 days and the composites
analysed for cellular viability, attachment, propagation and colla-
gen production. Cell viability and mitochondrial activity was as-
sessed using live-dead immunoflourescence and MTT assays
respectively. The cellular and matrix morphology was examined
using optical and scanning electron microscopy (SEM).
Results: The cell-scaffold composites showed excellent viability
with live cells at 16 days. Over 90% cellular adhesion was noted.
Cells revealed a time weighed increase in numbers, forming a fully
confluent monolayer by day 6. Collagen synthesis was reduced by
16% when compared to the control group.
Conclusions: We have found UBM to be a suitable substrate for
adherence and propagation of dermal fibroblasts, while also dem-
onstrating the ability of UBM to modulate the synthesis of collagen
by dermal fibroblasts. These results suggest that UBM/dermal fi-
broblast co-constructs may be suitable for future tissue engineering
efforts in the area of wound healing
(P 192) Human Hair Derived Keratins Mediate Schwann Cell
Behavior In Vitro and Facilitate Rapid Regeneration of Per-
ipheral Nerves In Vivo
P. Sierpinski1, J. Garrett2, J. Ma2, P. Apel2, T. Smith2, A. Atala1,
A. Koman2, M. Van Dyke1
1Wake Forest Institute for Regenerative Medicine, Wake Forest
University Health Sciences, Winston-Salem, NC 27157.
2Department of Orthopaedic Surgery, Wake Wake Forest Uni-
versity Health Sciences, Winston-Salem, NC 27157.
Nerve defects are a common result of peripheral nerve injury
and present a significant challenge clinically. It has been shown
that the insertion of tissue engineering scaffolds into a nerve
guidance conduit can enhance regeneration. Keratins extracted
from human hair fiber are a novel group of biomaterials that can be
processed into hydrogel conduit fillers. In this study, keratin gels
were prepared by treating human hair fibers with peracetic acid,
followed by extraction and purification to a powder. Hydrogels
were prepared by re-hydrating the powder. Micro-architecture of
the gels was observed by scanning electron microscopy (SEM).
Proliferation, migration, and adhesion of RT4-D6P2T Schwann
cells was assessed. To determine the effects of keratin on nerve
regeneration in vivo, repair of tibial nerve axotomy in mice was
assessed. Examination of lyophilized hydrogels by SEM showed a
fibrous and highly porous architecture. Keratin was not cyto-
toxic and increased cell proliferation at concentrations ranging
from 0.1 mg/mL to 1 mg/mL over serum containing media control.
Migration in the presence of keratins was significantly enhanced at
0.1 and 1.0 mg/mL concentrations. Schwann cell adhesion on
keratin coatings was higher than on uncoated and fibronectin
coated slides. Six weeks following nerve transaction and repair,
latency and amplitude was found to be better in the keratin group
compared to both empty conduits and the autograft control. Muscle
force testing demonstrated comparable muscle reinnervation in all
treatment groups. Histomorphometric analysis showed a signifi-
cant increase in nerve diameter in the keratin group over empty
conduit controls.
(P 193) Human Osteoblastic Response to a Novel Calcium
Phosphate / SiO2-Xerogel Composite In Vitro/In Vivo for Bone
Tissue Engineering
B.W. Thimm1, S. Ghanaati1, C. Orth1, R.E. Unger1, C.J. Kirk-
patrick1
1Institute of Pathology, University Mainz.
Novel calcium phosphate / SiO2-xerogel (BONITmatrix
)—
collagen scaffolds (BM-collagen) for bone substitutions were tes-
ted for their osteoblastic response in an in vitro/in vivo study.
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Previous in vitro studies have shown promising endothelial cell
growth, which is important for vascularization. The main goal of
this study was to examine osteoblast biocompatibility.
Primary human osteoblasts (HOS) and the human osteoblast-like
cell line MG63 were used for this study. In addition, the coculture
of HOS and microvascular endothelial cells (HDMEC) and their
potential for angiogenesis was studied in vitro.
HOS and MG63 demonstrated strong cell proliferation as shown
by calcein-AM staining and subsequent confocal microscopy. Cell
morphological investigations on BM-collagen, a generous gift of
DOT (Rostock), by means of SEM confirmed latter observa-
tions. RT-PCR analyses revealed physiological gene expression. A
long-term coculture of HOS and HDMEC demonstrated positive
endothelialization and an incipient window formation for a po-
tential vascularization.
For in vivo studies, 40 female 5-week-old Wistar rats were
randomly divided into 2 groups of 20 animals each. From each
group 4 animals were used for each of the following time points: 3,
10, 15, 30, and 60 days. Group 1 was treated with BONITmatrix.
Group 2 was a sham group.
At the time points indicated the biomaterials were explanted
along with the surrounding peri-implant tissue and fixed for his-
tological, histochemical and electron microscopical analysis. Cells
involved in the inflammatory response as well as development of
neo-angiogenesis associated with the biomaterial were quantified
at the above mentioned 5 time points.
(P 194) Human Primary Osteoblasts Matrices as a Model
System for Bone Metastasis Research
J.C. Reichert1, L.J. Burke1, J.A. Clements 1, D.W. Hutmacher1
1Institute of Health & Biomedical Innovation, Queensland Uni-
versity of Technology, Brisbane, Australia.
Prostate cancer is the most common cancer in males and the second
leading cause of male cancer deaths. Metastasis of prostate cancer
cells, specifically to bone, is reliant on the reciprocal interactions
between cancer cells and the bone niche/microenvironment. These
interactions are dependent on factors such as cytokines, growth
factors, serine proteases and bone related proteins.
The production of suitable matrices to study metastasis, carci-
nogenesis and in particular prostate cancer/bone microenviron-
ment interaction has been limited to specific protein matrices or
matrix secreted by immortalised cell lines. The latter are limited
since they are produced from a homogeneous population of cells
and tend to be locked into a particular stage of differentiation
retaining a set of characteristics representative of that phenotype.
As such, they may have undergone transformation processes al-
tering signalling pathways and modifying gene or receptor expres-
sion.
We have used matrices formed from human bone explant cul-
tures. Primary human osteoblasts were cultured for 5 weeks in
osteogenic medium to allow secretion of a mineralized matrix.
Cells were removed with ammonium hydroxide leaving the matrix
intact. Prostate cancer cells (eg PC3, LNCaP) were seeded onto the
osteoblast matrix and allowed to grow. Prostate cancer cells ad-
hered strongly to the matrix, were resistant to EDTA-mediated
detachment and displayed altered morphology when compared to
conventional coatings such as collagen I. Analyses of gene and
protein expression are currently underway.
We show that matrices produced by primary osteoblasts are an
excellent paradigm to study tumour/bone interaction such as those
observed in bone metastasis.
(P 195) Hybrid Polymer/Ceramic Nanofibre Scaffolds for Soft
Tissue Engineering
P. Zdebiak1, M. El Fray1
1Szczecin University of Technology, Polymer Institute, Division
of Biomaterials and Microbiological Technologies, Pulaskiego 10,
70-322 Szczecin, Poland.
From a biological viewpoint, almost all of the human tissues and
organs are deposited in nanofibers forms or structures, including
dentin, collagen, cartilage, and skin. All of them are characterized by
well organized hierarchical fibrous structures realigning in nano-
meter scale. As such, current research in electrospun polymer
nanofibers has focused one of their major applications on bioengi-
neering. Their promising potential can be seen in various biomedical
areas, including three dimensional scaffolds for cartilage regenera-
tions. The materials used include segmented polyuretanes, Pluro-
nics, poly(glycolic acid), poly(lactic acid), and their copolymers.
The development of new biomaterials for various engineering
applications requires different systems, including polymer/ceramic
composite materials with their interesting combination of specific
physico-chemical, mechanical and processing properties. Com-
bining unique properties of the organic component (oligomer or
polymer) and the inorganic one (inorganic particles or aggregates,
including ceramics), they fulfill the highest requirements of mod-
ern materials for medical applications.
New organic/inorganic hybrid materials prepared from multi-
block terpolymer as a polymeric matrix containing phthalic acid
segments (PBT) as hard block and hydrogenated dimer fatty acid
(DLA) as hydrophobic soft block, and poly(ethylene glycol) (PEG)
as second soft block of hydrophilic nature are presented in this
work. Two types of nancrystalline hydroxyapatites (non-calcined,
HAP I, and sintered, HAP III) were used in amount of 0.5wt% as
inorganic phase within hydrophilic/hydrophobic multiblock ter-
polymer matrix. The results related to the preparation of electro-
spun nanofibers for cartilage regeneration will be presented.
(P 196) Hydrostatic Pressure Culture System for Human
Chondrocyte Cultivation and Stimulation in Gellan Gum
Hydrogel Disks
C. Correia1,2, A.J. Pedro1,2, J.T. Oliveira1,2, R.A. Sousa1,2, R.L.
Reis1,2
13B’s Research Group—Biomaterials, Biodegradables and Bio-
mimetics, University of Minho, Campus de Gualtar, 4710-057
Braga, Portugal.
2IBB—Institute for Biotechnology and Bioengineering, Braga,
Portugal.
Cartilage tissue loss, resulting from injury or disease, is a major
health problem worldwide. Tissue Engineering (TE) has a great
potential for the treatment of vast number of pathologies. In this
regard, bioreactor systems are used as frameworks for studying
fundamental aspects of cell response and tissue development, as
well as scale–up platforms for industrial application. It has been
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shown that mechanotransduction mechanisms modulate cell
functioning, including cell differentiation, proliferation and ex-
tracellular matrix (ECM) deposition, and that chondrocytes are
mechano–sensitive cells. Hydrogels are often used in TE to en-
capsulate chondrocytes and engineer cartilage–like constructs,
which are incompatible with flow perfusion bioreactors. In this
work, hydrostatic pressure (HP) was used as an alternative to
mechanically signal human chondrocytes encapsulated in gellan
gum hydrogel discs, as it has a profound effect on cartilage me-
tabolism in normal and pathological conditions. HP was applied in
both static and dynamic regimens. Dynamic conditions were used
in order to mimic the non–continuous in vivo loading of articular
cartilage and induce the production of cartilage–like ECM. The
effects of HP over chondrocytes was assessed by morphological
and histological characterization of the constructs: detection of
Sulphated glycosaminoglycans (GAGs), collagen type I and II;
evaluation of mRNA expression by real time RT–PCR analysis,
and visualization of the chondrocytes inside the produced matrix
by bright–field microscopy. HP was shown to affect the synthetic
capacity and viability of chondrocytes, depending on the mode,
duration and magnitude of pressure. The properties of the hydrogel
were also shown to depend of HP conditions.
(P 197) Hypoxia Exerts Differential Effects on the Chondro-
genic and Osteogenic Differentiation of Human Adipose-
Derived Mesenchymal Stem Cells
C. Merceron1, C. Vinatier1, M. Masson1, L. Guigand2, J. Amiaud2,
Y. Cherel2, M. Gatius1, P. Weiss1, J. Guicheux1
1INSERM U791, University of Nantes, Centre for osteoarticular
and dental tissue engineering, department of skeletal tissue
physiopathology, Nantes, France.
2INRA UMR 703, National Veterinary School, Nantes, France.
Human adipose tissue-derived stem cells (hATSC) have been
contemplated as reparative cells for cartilage engineering. Chon-
drogenic differentiation of hATSC can be induced by an enriched
culture medium and a three dimensional environment. Given that
bone is vascularized and cartilage not, oxygen tension has been
suggested as a regulatory factor for osteo-chondrogenic differenti-
ation. Our work aimed at determining whether hypoxia affects
the osteo-chondrogenic potential of hATSC. HATSC were cultured
in chondrogenic or osteogenic medium for 30 days, in pellets or
monolayers, and under 5% or 20% oxygen tension. Cell differenti-
ation was monitored by real-time PCR (COL2A1, aggrecan and
osteocalcin). The chondrogenic differentiation was further evaluated
by Alcian Blue and immunohistological staining for glycosamino-
glycans (GAG) and type II collagen respectively. The osteogenic
differentiation was also assessed by the staining of mineralized
matrix (Alizarin Red ) and measurement of alkaline phosphatase
activity (ALP). The expression of chondrogenic markers was up-
regulated when hATSC were exposed to hypoxia in chondrogenic
medium. Conversely, osteocalcin expression, mineralization and
ALP activity were severely reduced under hypoxic condition even in
the presence of osteogenic medium. Our data strongly suggest that
hypoxia favors the chondrogenic differentiation of hATSC as evi-
denced by the expression of the chondrogenic markers, whereas it
could alter their osteogenic potential. Our results highlight the dif-
ferential regulatory role of hypoxia on the chondrogenic and oste-
ogenic differentiation process of hATSC. These data could help us
exploit the potential of tissue engineering and stem cells to replace or
restore the function of osteoarticular tissues.
(P 198) Hypoxia Modulates Matrix Metalloproteinase-9 Se-
cretion on Tissue-Engineered Mucosa
S. Perez-Amodio1, W. Tra1, S. Posthumus-van Sluijs1, H. Ra-
khorst1, S. Hofer2
1Department of Plastic and Reconstructive Surgery, Erasmus MC,
Rotterdam, The Netherlands.
2Department of Plastic Surgery, University of Toronto, Canada.
Oral cancer is the sixth most common cancer in the world. After
oncological resection the defect is reconstructed using free skin
flaps. Tissue-engineered mucosa (TEM) can be used to reconstruct
the defects after resection. Upon transplantation, a period of hyp-
oxia occurs resulting in a limited cellular respiration which can
lead to graft rejection. Therefore the aim of this study was to
determine the effect of hypoxia on TEM.
Human keratinocytes and fibroblasts were isolated from buccal
mucosa and seeded onto a scaffold of acellular human donor skin.
After 14 days of culture at the air-liquid interfase TEMwas exposed
to 1.5% and 20% O2 during 6, 12 and 24h. After each incubation
period, media was harvested and TEM was snapfrozen or embed-
ded in paraffin. The effect of hypoxia on TEMwas visualized using
hematoxiline/eosine (HE) staining and a Hydroxiprobe-1 kit. The
harvested media was analyzed forMMP-9 activity. TIMP-1, TIMP-
2 and HIF-1a proteins were analyzed by western blot. Secretion of
VEGF and PDGF was assessed by ELISA.
TEM exposed to hypoxia showed presence of hypoxic cells and
a disturbed basal cell layer compared to TEM exposed to nor-
moxia. Significantly higher levels of MMP-9 activity were de-
tected in supernatant of hypoxic TEM. An increased expression of
TIMP-1, TIMP-2 and HIF-1a was found in TEM cultured under
hypoxic conditions. In addition, the secretion of VEGF and PDGF
was enhanced on TEM exposed to hypoxia.
Our results suggest that hypoxia preconditioning of TEM may
favour wound healing and angiogenesis upon transplantation.
(P 199) Hypoxic Culture and Expansion of Mesenchymal Stem
Cells in Air-Lift Loop Hollow Fiber Membrane Bioreactor
X.Q. Li1, T.Q. Liu1, K.D. Song1, X.H. Ma1, Z.F. Cui2
1Stem Cell and Tissue Engineering Lab of Dalian University of
Technology, Dalian, China.
2Oxford Centre for Tissue Engineering and Bioprocessing, De-
partment of Engineering Science, Oxford University, Oxford OX1
3PJ, UK.
Mesenchymal stem cells (MSCs) are the promising ‘‘seeding
cells’’ for tissue engineering and excellent tools for gene therapy.
However, MSCs are in limited quantity and their viability de-
creases with the individual age increases, which makes it necessary
for them to be expanded in vitro. Many researches indicated that
hypoxia accelerated MSCs proliferation and differentiation, but all
were in two dimension and static conditions. So in this paper,
MSCs were cultured and expanded in hypoxic, three-dimensional
and dynamic conditions in vitro.
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MSCs of P4 mixed with type I collagen were innoculated into
hollow fiber membranes (HFM), where the gel with MSCs formed
and then was innoculated into an air-lift loop hollow fiber mem-
brane bioreactor (ALHFMB) for the dynamic culture in an incu-
bator.
During the experiments, the OD value of medium was detected
every 24 hr to calculate cell number and to obtain cell growth
curves, and the metabolic parameters, such as glucose, lactic acid,
ammonia, glutamine, pH, O2 and CO2 were also detected to
evaluate the cells growth.
Moreover, the expanded cells were identified through antibodies
CD29, CD44 and CD45 and through inducing them into osteo-
blasts, chondrocytes and adipocytes.
The results showed that in the ALHFMB, O2 concentration kept
constant; MSCs metabolized robustly and expanded about 50-fold
within 7 days in hypoxic condition, more than that in normoxic
conditions; most of the expanded cells were CD29 and CD44
positive and CD45 negative; after being induced, the expanded
cells still reserved the strong muti-differentiation potential of be-
coming bone, cartilage and adipose.
(P 200) Immobilization of Biomolecules on Chitosan Surface
for Selective Recruitment, Controlled Growth and Differ-
entiation of Cells from Mixed Populations
C.A. Custo´dio1,2, C.M. Alves1,2, R.L. Reis1,2, J.F. Mano1,2
13B’s Research Group—Biomaterials, Biodegradables and Bio-
mimetics, Dept. of Polymer Engineering, University of Minho,
Campus of Gualtar, 4710-057 Braga, Portugal.
2Institute for Biotechnology and Bioengineering, PT Government
Associated Laboratory, Braga, Portugal.
One of the issues for the future of the art in Tissue Engineering is
the inadequate initial interaction between polymer/surfaces and
cells leading to in vivo adverse body reactions. The selectivity of
biomaterial surfaces for a particular cell type present in a mixed
cell population can be achieved by engineering a polymer surface
with specific molecules.
In the present work, for the precise control of cell adhesion,
growth and differentiation, we modified the surface of chitosan by
means of covalent immobilization of different biomolecules. With
this purpose, specific proteins and antibodies were activated using
1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide hydrochloride
(EDC) and the reaction as stabilized with N-hydroxysuccinimide
(NHS). The reaction was optimized by manipulating multiple var-
iables like time incubation, pH, protein concentration and protein:
EDC:NHS ratio, in order to control the activation of the carboxyl
group of the proteins and thus its covalent binding to the amino
groups of the chitosan surface. Quantification of immobilized al-
bumin and fibronectin was performed by colorimetric and fluores-
cence methods. Fluorescence microscopy using labelled antibodies
and confocal microscopy were also performed. Adhesion and via-
bility of leukocytes and osteoblast like cells were assessed by MTS
and DNA assays. The results revealed that the use of EDC/NHS
activated the immobilization of the different molecules on chitosan
surfaces. Membranes modified with adhesive and non-adhesive
proteins revealed distinctive cell recruitment profiles as assessed by
cell adhesion and proliferation rates.
(P 201) Impact of Physical and Chemical Treatments on
In Vitro and In Vivo Biocompatibility of Human Bone Tissues
S. Fawzi-Mohammed1, R.M. Goebbels1, O. Cornu1, C. Delloye1,
D. Dufrane1,2
1University Tissue Bank.
2Experimental surgery laboratory.
Objective: Chemical and physical treatments were developed to
reduce the immunogenicity and risk of virus/bacteria/prion trans-
mission. This work studies the impact of treatments on in vitro and
in vivo biocompatibility properties of tissues.
Methods: Three types of tissues were tested: i) fresh-frozen bone
(FFB) as control, ii) freeze-dried treated irradiated bone (FDTB)
and iii) frozen treated irradiated bone (FTB).
In vitro testing was performed by indirect (MTS, LDH) and
direct (cell attachment, cell adhesion) toxicity assays with Saos2
cell line. For in vivo testing, each group was subcutaneously
implanted in immunocompetent Wistar rats to assess the immuno-
logical (CD3, CD68), recolonization (Masson’s Trichrom) and
revascularization (vWF) processes at 2 / 4 weeks post implantation.
Results: For FFB as well as FDTB, no modification of cell vi-
ability (MTS/LDH) was observed for Saos2 in contact with tissue
extract. In contrast, a significant reduction of cell viability (MTS)
was observed for FTB (p< 0.05). After 3 hours of direct contact
between Saos2 and bone tissues, a significant decrease of adhesion
was demonstrated in case of FTB in comparison to FFB and FDTB.
At 24h of contact, cellular adhesion was significantly decreased for
FDTB and FTB (p< 0.05). A significant higher immunological
reaction (lymphocytes/macrophages recruitment and bone resor-
ption) was found for FFB, after subcutaneous implantation in rats,
in comparison to FDTB and FTB. In contrast, decellularized
(FDTB/FTB) tissues significantly improved neo-vascularization in
connective matrix after 15 days of implantation.
Conclusion: Human bone processing with defatting and decel-
lularization promotes in vitro biocompatibility and in vivo tissue
tolerance.
(P 202) Impaired Survival of Bone Marrow Stromal Cells in
Hydrogels
S. Zeiter1, M.J. van der Werf1,2, K. Ito2
1AO Research Institute, Switzerland.
2Department of Biomedical Engineering, Eindhoven University of
Technology, Netherlands.
Introduction: Bone marrow stromal cells (BMSC) are often used
for cell based tissue repair, cultured in a hydrogel. For substantial
tissue regeneration, BMSCs need to survive in this 3D scaffold. We
hypothesize that undifferentiated BMSCs will not thrive within
these gels in contrast to articular chondrocytes (ACs) and nucleus
pulposus cells (NPs), but that early chondrogenic differentiation of
the former will increase survival.
Materials and Methods: BMSCs, ACs and NPs were isolated
from five calves. Primary NPs, ACs and passaged BMSCs (P2)
were cast in 1.2% alginate or 2% agarose (4mm2mm) and
cultured for 21 days in high-glucose DMEM with 10% FCS. Half
the BMSCs were cultured in chondrogenic DMEM with 1% ITSþ,
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10ng/m TGFb1 and 10-7M Dexamethasone. Living cell number
(Live/Dead), DNA (relative to day 0) and gene-expression was
measured on days 0, 7 and 21.
Results: By day 21, NPs and ACs proliferated in both scaffolds.
In contrast, DNA content of BMSC constructs decreased in both
alginate (20%) and agarose (60%). However, the addition of
TGFb1 stimulated cell survival in alginate (116%) and in agarose
(400%) while pushing them towards chondrogenic lineage. NPs
and ACs both maintained their phenotype.
Discussion: These hydrogels appear to provide an appropriate
environment for NPs and ACs but much less so for undifferentiated
BMSCs. Since cell number and survival are key factors for tissue
regeneration, cell survival of BMSCs within hydrogels should be
improved. Preconditioning of BMSCs using TGFb1 could be a
worthwhile strategy.
(P 203) Improving Endothelial Cell Adhesion and Prolifera-
tion on Titanium by Sol-Gel Derived Oxide Coating
F. Chai 1, A. Ochsenbein 2, S. Winter 2, M.Traisnel 3, J. Breme 2,
H.F. Hildebrand1
1Lab of Biomaterial Research, UPRES EA 1049, Faculte´ de
Me´decine, 59045 Lille—France.
2Lehrstuhl fu¨r Metallische Werkstoffe, Universita¨t des Saarlandes,
66041 Saarbru¨cken—Germany.
3Laboratoire des Proce´de´s d’Elaborations des Reveˆtements
Fonctionnels (PERF) ENSCL, UMR-CNRS 8008, 59652 Ville-
neuve d’Ascq—France.
In-stent restenosis becomes increasingly prevalent as a difficult-to-
treat disease. An alternative therapeutic strategy to drug-eluting
stents for that is enhancing, rather than inhibiting, endothelializa-
tion of metallic stent surfaces.
In this light, the present study attempted to modify surface
chemistry and topography of commercial pure titanium (cp-Ti) by
different oxides (TiO2, SiO2, SiO2/TiO2 and Nb2O5) coating via
the sol-gel process that can probably improve endothelial cell
adhesion and proliferation, therefore stimulate endothelialization
without using any bioactive agents. The modified surfaces were
then physicochemically characterized in the thickness, nano-scale
topography and wettability, and biologically evaluated with the
HPMEC endothelial cell line by cell counting, cell morphology
and expression of focal adhesion molecules.
Ellipsometry determined the thickness of oxide layers to ap-
proximately 100 nm; atomic force microscope revealed a nano-
porous structure in the TiO2 and Nb2O5 layers and the Ra values
ranged from 20 to 50 nm. The surface energy determined by sessile-
drop method showed the highest polar component for SiO2 (30.7
mJ/m2) and the lowest for cp-Ti and 316L stainless steel (6.7 mJ/
m2). In 3-day culture, the higher endothelial cell proliferation rates
were found on SiO2/TiO2, Nb2O5 and TiO2 than cp-Ti. TiO2
showed a higher cell adhesion rate than cp-Ti in kinetic adhesion
assay.
These results offer an insight into that certain oxide coating
processing could significantly improve endothelial cell adhesion
and proliferation especially in early culture period, which will
favor the endothelialization before the formation of smooth muscle
capsules.
(P 204) In Vitro Biocompatibility and Cristallinity of Poly-
lactides
A. Alonso-Varona1, T. Palomares2, B. Castro3, E.Zuza4, M. del
Olmo3, J. Bejar5, N. Lopez4, J. Mendez6, J.R. Sarasu´a4
1Department Cell Biology and Histology, Fac. Medicine and
Odontology, University of the Basque Country.
2Department of Surgery and Radiology, Fac. Medicine and
Odontology, University of the Basque Country.
3Histocell, SL.
4School of Enineering, University of the Basque Country
5Department of Plastic Surgery, Cruces Hospital.
6Department of Surgery, Basurto Hospital
Thermoplastic aliphatic biodegradable polyesters based on lactid
acid (polylactides or PLAs) are attractive candidates as scaffold for
tissue engineering because they are biodegradable, bioresorbable
and biocompatible. A remarkable feature of polylactides is their
crystal polymorphism that affects cell response to roughness and
surface morphology. In this work, we carry out a biological eval-
uation of polylactide scaffolds of different composition and crys-
talline characteristics (PLLA, PDLA and the equimolar blend of
PLLA/PDLA) in terms of citotoxicity assays and scanning elec-
tronic microscope studies with four types of cells: L929 fibroblasts,
human neonatal keratinocytes, human neonatal fibroblasts and
osteoblasts. For citotoxicity studies, we used the extract assay.
Cells were plated in 96-well clusters. The extract solutions were
thawed and prepared into full culture medium adequate for each
cell type. A positive control of full medium containing 0.015%
sodium dodecyl sulphate was also assessed. The plates were in-
cubated at 378C for 24, 48, and 72 h. and toxicity determined by a
MTT method. For scannig electronic microscope studies, cells
were plated onto the films and, after 48h, processed and observed
in a Hitachi SEM. No toxicity was observed between PLLA and
PLLA/PDLA extracts in all cell types. PDLA produced a signifi-
cant decrease in proliferative activity of cells. Direct contact be-
tween cells and materials did not evoke any adverse effect at the
SEM level. No differences were found between composition and
crystalline characteristics of polylactides, nor between cell types in
cell monolayer formed.
Grants by Dpt Sanidad (PI2005111043) and Industria (ETOR-
TEK) Gobierno Vasco.
(P 205) In Vitro Biocompatibility of Plain and Doped Silicon
Nanowires
S. Odabas1, B. Garipcan1, G. Demirel1, J. Burger2, B. Nabet3, J.E.
Spanier2, E. Piskin1
1Department of Chemical Engineering and Bioengineering Divi-
sion, Hacettepe University.
2Department of Materials Science and Engineering, Drexel Uni-
versity, Philadelphia PA 19104, USA.
3Department of Computer and Electrical Engineering, Drexel
University, Philadelphia PA 19104, USA.
The unique capabilities of one dimensional nanomaterials make
them potential candidates for catalysts, biological and chemical
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biosensors, drug carrier systems and even tissue engineering
applications. However, interactions of nanomaterials with biolog-
ical systems and the environment could lead to side effects. While
there have been reports on the cytotoxicity of carbon nanotubes,
quantum dots and gold nanoparticles, not so many studies have yet
appeared on the biological effects of silicon nanowires, which are
becoming increasingly important as a nanostructure. Also, Si na-
nowires have advantages over polycrystalline metals and most
importantly, the degradation products of Si nanomaterials, prin-
cipally in the form of Si(OH)4 are metabolically tolerant in vivo. In
this study, cytotoxic behaviors of doped and plain Si nanowires
were investigated for possible biomedical use. The plain and doped
Si nanowires were synthesized via gold catalyzed CVD method.
For investigation the biocompatibility of the materials, MTT via-
bility, cell proliferation, PI/AO staining and blood biocompatibility
tests were performed. According to these standard tests, there were
no significant cytotoxic effects for both the plain and dopped sil-
icon nanowires. Cells have shown quite high viability as above
80% within 48 hrs for both types of nanowires. Also, these na-
nostructures have shown no considerable negative blood response
with respect to control group. Therefore, it was concluded that
these plain and doped nanowires can be used for medical appli-
cations safely.
(P 206) In Vitro Characterization of Bidirectional Tet-
Inducible Expression Systems for Bone Tissue Engineering
G.A. Feichtinger1,2, H. Redl1,2, M. van Griensven1,2
1Ludwig Boltzmann Institute for Experimental and Clinical
Traumatology, Vienna, Austria.
2Austrian Cluster for Tissue Regeneration.
Gene medicine approaches for osteoinduction could provide potent
alternatives to current growth factor or stem-cell based approaches.
Our aim was to design Tet-inducible single vector systems for
the simultaneous bidirectional over-expression of osteoinductive
growth- and transcription-factors in target cells.
These new system mediate inducible expression of two different
genes of interest and constitutive expression of the reversed Tet-
activator in only one plasmid.
In vitro characterization was carried out in C2C12 cells trans-
fected with the described TetON systems at different doxycycline
concentrations. Osteogenic differentiation was detected by alkaline
phosphatase assays, RT-PCR and von Kossa staining. Time and
dose dependent kinetics were studied for 10 days monitoring the
expression of fluorescent reportergenes.
Osteogenic differentiation was confirmed for all therapeutic
expression systems. No expression was detectable without doxy-
cycline. The combined expression of BMP2 and BMP7 generated
the most potent osteogenic response probably due to BMP2/7
heterodimer formation. Initial expression activation was observed
12 hours after doxy application in a dose dependent manner de-
creasing within 10 days.
Our in vitro data strongly supports the therapeutic potential of
bidrectional expression systems to induce osteogenic differentia-
tion. We conclude from our in vitro results that the constructed
single vector, bidirectional inducible expression systems provide a
promising and safe alternative to currently employed growth factor
therapies. Furthermore, linked expression of therapeutic genes
with suitable reportergenes in this new system will allow moni-
toring of tet-regulated gene-expression levels by in vivo imaging
methods.
This work was supported by the European projects.
Hippocrates (NMP3-CT-2003-505758) and Expertissues (NMP-
CT-2004-500283)
(P 207) In Vitro Differentiation of Osteoblast Like Cells from
Peripheral Blood
A. Schmitt1, P. Buschner1, C. Ko¨nig1, U. Sto¨ckle1, A.K. Nu¨ssler1
1Klinikum rechts der Isar, TU Munich, Department of Trauma-
tology.
The aim of the present study was to evaluate the applicability of
peripheral blood monocytes for in vitro generation of osteoblasts.
Monocytes obtained from venous blood were cultivated on
fibronectin-coated cell-culture dishes without any addition of cy-
tokines. Differentiation of monocytes to osteoblast-like cells was
initiated by cultivating them in differentiating-medium containing
dexamethasone, ß-glycerophosphate and ascorbic acid. Osteogenic
differentiation of the cells was confirmed by detection of alkaline
phosphatase activity and detection of mineralized extracellular
matrix production by vanKossa-staining. Additionally, we analyzed
the ability of monocytes proliferation in vitro and the influence of
different pretreatments to differentiate into osteoblast-like cells.
We were able to confirm a successful differentiation of mono-
cytes into osteoblast-like cells by detection of alkaline phosphatase
and mineralized, extracellular matrix. We found, that pretreatment
of monocytes with medium conditioned by CD14-negative blood
cells increased the efficacy of differentiation compared to a
pretreatment with dedifferentiation-medium, containing IL3, ß-
mercaptoethanol and M-CSF followed by our differentiation me-
dium. Examination of cultures clearly revealed that monocytes
have a rather low in vitro proliferation capacity compared to
mesenchymal stem cells or primary osteoblasts.
Our work confirms the ability of monocytes to differentiate into
cells with osteoblast characteristics and the effectiveness of oste-
ogenic differentiation can be increased by pretreatment with con-
ditioned medium. Nevertheless, before monocytes can be used as a
source for tissue engineering the proliferation capacity of mono-
cytes must be further improved.
(P 208) In Vitro Evaluation of Chromosomal Stability of
Rabbit Fibroblasts for the Development of Oral Mucosal
Analogous on Collagen Scaffolds
D.P. Martinez-Hernandez1, M.L. Bueno-Angulo2, M.R.
Fontanilla-Duque3
1Bacteriologist Esp., Candidate MSc Microbiology, Universidad
Nacional de Colombia.
2Associate Professor MSc, Coordinator Cytogenetic Laboratory,
Universidad Nacional de Colombia.
3Associate Professor PhD, Coordinator Tissue Engineering La-
boratory, Universidad Nacional de Colombia.
One of the tissue engineering goals is to reduce the impact caused
by the difficulty in obtaining enough autologous tissue grafts when
healing and repair of extent defects are required. In order to de-
velop this kind of tissue, cells are seeded and cultured in vitro,
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growing in over several orders of magnitude that there is a loose in
the chromosome stability (CS).
In the present study we used conventional cytogenetic tech-
niques (Sister Chromatid Exchange [SCE]), chromosomal aberra-
tions) and toxicological cytogenetic techniques (Micronucleus Test
[MN]) to evaluate the behavior of primary rabbit oral mucosal
fibroblasts between passages 2 and 5, expanded and cultured in
plastic flasks or seeded in a collagen scaffold to investigate whether
the cell management or its interaction over different supports has an
effect on CS.
Chromosomal instability, defined as an increase in structural and
numerical chromosomal changes, was observed as a result of ex-
tensive cellular manipulation over time. Our observations showed
nucleoplasmic bridges in binucleated cells, increase of SCE
number, and presence of MN scored in binucleated cells. In ad-
dition, a polyploidy cell constitution was evident when passage 4
took place. Instead, no significant effect was found on rabbit oral
mucosal fibroblasts on CS when seeded over collagen scaffolds or
plastic flasks.
These findings suggest that passage number over time in rabbit
oral mucosal fibroblasts culture is a determinating factor on CS.
Further studies in vivo are required to evaluate the clinical effi-
ciency of collagen scaffolds with seeded fibroblasts in the repair of
extent oral mucosal defects.
(P 209) In Vitro Generation of an Endothelialized Adipose
Tissue Construct for the Engineering of Vascularized Adipose
Tissue
F. Verseijden1, S. Posthumus-van Sluijs1, E. Farrell2, G.J.V.M.
van Osch2,3
1Department of Plastic and Reconstructive Surgery, Erasmus MC,
University Medical Center, Rotterdam, The Netherlands.
2Department of Orthopaedics, Erasmus MC, University Medical
Center, Rotterdam, The Netherlands.
3Department of Otorhinolaryngology, Erasmus MC, University
Medical Center, Rotterdam, The Netherlands.
Cell survival is a major limitation in the use of larger tissue-en-
gineered adipose tissue constructs for implantation. Ingrowth of
blood vessels from the host into the construct is a time consuming
process resulting in hypoxia and nutrient limitations. Adding en-
dothelial cells to adipose tissue constructs in vitro could contribute
to the formation of a vascular network inside the construct once
implanted. We tested the feasibility of generating a spheroı¨d co-
culture in which human umbilical vein endothelial cells (HUVEC)
are able to maintain viability, while adipose tissue derived stromal
vascular cells (ADSC) differentiate towards adipocytes.
For spheroı¨d formation 95%, 80% and 60% ADSC and 5%, 20%
and 40% HUVEC were pooled to a total of 2105 cells, centri-
fuged and cultured on a carefully preselected 1:1 mix of adipogenic
medium and endothelial growth medium. Flow cytometry showed
that on average 35% 9% of the HUVEC survived after 7 days of
culture and were still present at day 14. Oil-Red-O staining and
CD31 staining of spheroı¨d cross-sections revealed that the ADSC
in the spheroı¨ds accumulated lipid droplets in their cytoplasmwhile
the HUVEC were present as round, individual cells throughout the
spheroı¨ds. The distribution of HUVEC in the spheroı¨ds was similar
for all concentrations of HUVEC seeded.
In conclusion, we succeeded to generate spheroı¨d cocultures of
ADSC and HUVEC, and to differentiate ADSC towards adipocytes
while maintaining significant numbers of endothelial cells. This
approach potentially accelerates the vascularization of adipose
constructs upon implantation. This will be tested shortly with
in vivo experiments.
(P 210) In Vitro Model of Angiogenesis by Adult Bone
Marrow-Derived Stem Cells and Adipose-Derived Stem Cells
in a Fibrin Matrix
F. Verseijden1, S. Posthumous van Sluijs1, P. Pavljasevic2,
G.J.V.M van Osch2,3, E. Farrell2
1Department of Plastic Surgery, Erasmus MC.
2Department of Orthopaedics, Erasmus MC.
3Department of Otorhinolaryngology, Erasmus MC.
In vivo degradation and cellular necrosis at the centre of in vitro
engineered tissue constructs is a major problem caused by the lack
of sufficient vascularisation. The starting point of our investigation
was the question whether adult human bone marrow derived stem
cells (MSC) and adipose-derived stem cells (ADSC) could be used
for in vitro angiogenesis purposes using an in vitro angiogenesis
model.
An angiogenesis model was developed consisting of MSC or
ADSC pellets in a fibrin gel. These pellets were cultured on growth
factor supplemented endothelial medium for 14 days. Pellet mor-
phology was observed by light microscopy and the secretion of
important angiogenic factors was assessed by multiplex ELISA.
Extensive capillary-like outgrowth was observed in both MSC and
ADSC cultures already after 3 days of culture. Secreted protein
levels of PDGFB, TPO, ANG-2 and HGF of both MSC and ADSC
were comparable to that of human umbilical vein endothelial cell
pellets when used in the same model. The next phase of our in-
vestigation is to understand the contribution of different cell types
to the formation of the observed capillary-like structures. It is
possible that these outgrowths consist of not only cells differenti-
ated towards the endothelial lineage, but also the original cell type
acting in a supporting fashion. Identifying the role of differentiated
and undifferentiated stem cells in the development of premature
vessel networks in vitro may help to improve vascularisation of
tissue engineered equivalents in vivo.
(P 211) In Vitro Reactivity of a Porous SI-MG-CA-P Glass
Scaffold
E.J.C. Davim1, M.H.V. Fernandes1, A.M.R. Senos1
1Department of Ceramics & Glass Engineering, CICECO, Uni-
versity of Aveiro, 3810-193 Aveiro, PT.
A scaffold for tissue engineering should provide a template and
support tissue growth. An ideal scaffold should have inter-
connected pores, micro and macroporosity and adequate surface
activity. One key reason that makes bioactive glasses a relevant
scaffold material is the possibility of controlling a range of che-
mical properties and thus the rate of bioresorption. Thus, the ad-
justment of solubility seems to be of utmost importance for the
manufacturing of implant materials with resorption rates matching
the growth rates of bone.
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In this work porous Si-Mg-Ca-P glass scaffolds were developed
by the salt sintering process. Mixtures of NaCl (200 to 300 mm) and
glass powders (20 mm average particle size) were sintered up to
8008C and then the salty phase leached by water. Weight percents
of salt from 30 to 70 were tested. The resulting porous scaffolds
had pore volume between 57 and 85%, average pore diameters
between 150 and 400 ı`m and specific surface areas varying from
3.4 to 11m2/g depending on the glass to salt ratio in the mixture.
In vitro reactivity studies carried out in SBF up to 14 days showed
that degradability of the scaffolds generally increased with in-
creasing surface area. Dissolution of Ca and P, as assessed by ICP,
additionally indicated the bioactive character of the glass scaffolds.
Solubility tests according to DIN ISO719 complemented the SBF
results. The present study is believed to provide further under-
standing of the mechanisms regulating surface reactivity of porous
glass scaffolds for tissue engineering exhibiting both biodegrad-
able and bioactive behaviours.
(P 212) In Vitro Reconstruction of Actinic Skin
Zavan B. 1, V. Vindigni1, L. Michelotto1, E. Nalesso1, G. Aba-
tangelo1, R. Cortivo1
1University of Padova, Department of Histolgy.
The identification of genetic changes has led to an increased un-
derstanding of tumorigenesis, identifying the involvement of pu-
tative oncogenes and tumor-suppressor genes. Such approaches
are equally applicable to nonmelanoma skin cancer (NMSC), such
as basal cell carcinoma (BCC) and squamous cell carcinoma
(SCC).
NMSCs represent the most common types of cancer in white
population and the incidence of skin cancer shows a steadily in-
crease, reaching epidemic proportions. It could be therefore pos-
sible to investigate the key genetic changes and molecular
characteristics of each stage of progression of SCC development.
DNA copy number changes represent molecular fingerprints of
solid tumors and are as such relevant for better understanding of
tumor development and progression. In this study, we applied
CGH array to identify gene-specific DNA copy number changes in
chromosomal skin cancers.
Up to now, many studies on tumor cells have been performed
under standard in vitro cultures.
In standard culture conditions, neoplastic cells, as expected, can
grow only in a two-dimensional array that differs from their na-
tive three-dimensional organization in nodules or masses and al-
though interesting results have been obtained, three-dimensional
scaffolds would better allow the tumor cells to organize into
nodules or masses. With the present project we cultured kerati-
nocytes isolated from skin cancer in 3D conditions by using
scaffolds made with hyaluronic acid derivatives. These three-
dimensional tumor cell cultures were be used to study genetic
changes and in particular to define genetic profile, cell spatial or-
ganization, cell/cell and cell/extracellular matrix interactions of
skin cancer keratinocytes.
(P 213) In Vitro Study of the Effect of Some Blood Components
Embedded on the Implants Surface Upon Proliferation Ane
Synthetic Activity of Bone Cells
V. Pesˇa´kova´1, H. Hulejova´1, L. Himmlova´2, T.Riedel3, D. Kubies3
1Institute of Rheumatology, Prague, Czech Republic.
2GFH Institute of Dental Research, Prague, Czech Republic.
3Institute of Macromolecular Chemistry, Academy of Sciences,
Prague, Czech Republic.
The blood tissue is the site of the first connection between the
implant and the live tissue. Therefore, the effect of blood com-
ponents on response of cells growing in the implant immediate
vicinity should be of the particular interest to understand the
healing process.
The coating by human serum (an albumin-rich medium), by an
activated human plasma (a fibrin-rich medium) and a platelet-rich
plasma (PRP, a fibrinogen and platelet-rich medium) were used for
the surface modification of selected commercially available bone
implant materials (Ti-HA, Ti-Etching, Ti-Plasma spray, zirco-
nium ceramics ,Carbon composit). The effect of the surface
modification on proliferation and synthetic activity of osteoblasts
was studied. The platelet adhesion and activation were followed as
well.
All coatings led to higher cell proliferation than observed on
non-coated surfaces. The serum coating had a minor stimulation
effect on osteoblasts viability whereas the plasma coating led to
uniform surfaces exhibiting a similar high proliferation (with no
respect to the surface origin) comaparable with the TCPS control.
The PRP coating caused a significantly higher proliferation only in
the case of Ti-HA and Ti-Etching surfaces.
There was observed an increasing tendency in productions of
TNF-alpha and BAP for coated surfaces as well as for surfaces
with lower cell proliferation. The coatings also decreased the
production of the chemokine IL-8. Interestingly, the plasma coat-
ing led to uniform surfaces with the lowest IL-8 production,
probably as a result of the fibrin mesh present on the surface.
This work was supported by IGA MH CR project No.8829-3/
2006.
(P 214) In Vitro Therapy of Cartilage Defects using Human
Osteoarthritic Condyles and Chondrogenic Spheroids as
Transplants
F. Voß1, R. Linke2, U. Anderer1
1Department of Cell Biology and Tissue Engineering, Lausitz
University of Applied Sciences, 01968 Senftenberg, Germany,
uanderer@fh-lausitz.de.
2Klinik fu¨r Orthopa¨die, Carl-Thiem-Klinikum Cottbus, 03048
Cottbus, Germany.
Objectives: Cartilage defects after traumatic injuries or also in
degenerative diseases like osteoarthritis lack appropriate self-re-
pair and require therefore cell based therapies for tissue regener-
ation. To avoid the application of dedifferentiated single cells as
therapy basis pre-differentiated cell aggregates should be used as
transplants. To meet this objective in vitro tissues from culture
expanded human chondrocytes were engineered to be used as
transplants. Cartilage defects to be repaired in vitro were fissures
and fluffy cartilage of condyles from OA patients after total
knee joint replacement. To evaluate the in vitro therapy process
the integration of the transplants into the OA defects as well as
repair tissue formation, morphology, and maturation was exam-
ined.
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Material and methods: Three-dimensional cartilage-like spher-
oids were cultured in medium supplemented only with human
serum or further additives like TGF-ß and/or ascorbic acid. Pre-
differentiated cell aggregates were transferred to the naturally
formed OA-defects on human condyles. The tissue regeneration
process in vitro was analysed using histology (HE, Safranin-O) as
well as fluorescence-based immunohistology (collagen type I and
type II, S100) of cryosections.
Results: The cartilage-like spheroids integrated well into the
OA-defects and set up a repairing process. The level of transplant
integration, cell migration into fissures and repair tissue maturation
is dependend on the pre-differentiation via human serum, TGF-ß
and/or ascorbic acid. On one hand, integration and migration are
dominating, on the other hand there is a higher differentiation
degree of the pre-formed tissues after a special time point of in vitro
therapy.
(P 215) In Vitro Toxicity of Novel Bone Cement PMMA-co-
EHA
T. Almeida1, B.J.M. Leite Ferreira2, J. Loureiro1, T. Lopes1, R.N.
Correia2, C. Santos1
1CESAM and Department of Biology—University of Aveiro.
2CICECO and Department of Ceramic Engineering and Glass—
University of Aveiro.
Poly(methylmethacrylate) (PMMA) bone cement is largely em-
ployed in orthopaedic surgery since it was developed by Charnley
and Smith in 1960. However, it is known to promote bone necrosis
at the site of implantation due to its exothermal polymerization and
local effects of methyl methacrylate monomer leaching out of the
material as it cures in situ. There are also some mechanical prob-
lems associated with this cement, such as brittleness and poor
fatigue life.
In the present work we evaluated the in vitro toxicity of a novel
bone cement, PMMA-co-ethylhexylacrylate (EHA) (1:1) devel-
oped as an attempt to improve some properties of conventional
polyacrylate. Human osteoblast-like MG63 cells were exposed to
cement extract dilutions and the cell metabolic function was de-
termined by MTT assay. A new flow cytometry (FCM) protocol
was also used to monitor cell cycle progression during exposure
time, measuring DNA content by propidium iodide uptake.
MTT results demonstrated that the most concentrate extract
exerted some reduction on culture growth (41.1% 3.1). However,
the analysis of cell cycle suggests that the damage produced by the
cement extract is not irreversible and the surviving cells maintain
their proliferation capability.
This preliminary study indicates that PMMA-co-EHA has po-
tential to be used as bone cement.
(P 216) In Vivo Cardiac Tissue Engineering in Vascularised
Chambers
R.J. Dilley1,2, S.Tourbach1, A.N. Morritt 1, S.K. Bortolotto1, W.A.
Morrison1
1Bernard O’Brien Institute of Microsurgery, St Vincents Hospital,
Fitzroy, Victoria, Australia.
2Australian Tissue Engineering Centre, Fitzroy, Victoria, Aus-
tralia.
Vascularised chambers have proven to be effective for cardiac
tissue engineering in vivo, enabling cardiomyocyte suspensions to
assemble into contractile tissue and grow in a protected environ-
ment. Here we report a simplified model of in vivo tissue engi-
neering with a minced muscle preparation that avoids enzymatic
cell isolation and culture protocols, and improves efficiency. We
have used this model to compare outcomes from neonatal or adult
rat tissue and to investigate tissue growth mechanisms. Minced rat
heart (neonatal or adult) in Matrigel was seeded into a vascularised
chamber and harvested between 2–10 weeks later. Neonatal car-
diac tissue structure was maintained and from 6 weeks all con-
structs had discrete focal areas of spontaneous contractile function.
Vascular and lymphatic vessels were evident throughout the tissue
and cells expressed myocyte and gap junction proteins. Cardio-
myocytes increased in size and were positive for proliferation
markers Ki67 and PCNA. Adult rat heart muscle however showed
no spontaneous contractile activity and tissue structure was lost
over time. In chambers which were prevascularised for one week
before tissue implantation the cardiac tissue was larger (100%
increase at 2 weeks.
(P 217) In-Vitro Analog of Human Bone Marrow From 3D
Scaffolds with Inverted Colloidal Crystal Topology
J.E. Nichols1,2, N.A. Kotov3,4, J.A. Niles1,2, S. Warner 1,5, A.
Cantu1, R. Mlcak1,6, R. Yancy1,2, E. Valdivia1,2, J. Cortiella1,5
1Labratory of Regenerative and Nano-Medicine.
2Department of Internal Medicine.
3Departments of Biomedical Engineering, University of Michigan.
4Departments of Chemical Engineering, University of Michigan.
5Department of Anesthesiology.
6Shrine Burns Hospital.
In-vitro replicas of bone marrow could provide a continuous source
of blood cells for transplantation or serve as a laboratory model to
examine immune system dysfunctions and drug toxicology. Here
we report the development of an in vitro artificial bone marrow
based on a 3D scaffold with inverted colloidal crystal (ICC) ge-
ometry mimicking the structural topology of actual bone marrow
matrix. To facilitate adhesion of cells, scaffolds were coated with a
layer of transparent nanocomposite. After seeding with hemato-
poietic stem cells (HSC), ICC scaffolds were capable of supporting
expansion of CD34þ HSCs with B-lymphocyte differentiation. 3D
organization was shown to be critical for production of B cells and
antibody. Functionality of bone marrow constructs was confirmed
by implantation of matrices containing human CD34þ cells onto
the backs of SCID mice with generation of human immune cells.
Animals were sacrificed after 2 weeks and then the implanted
matrix, mouse bone marrow and spleens were collected for leu-
kocyte subset phentotyping. Examination of the cells populating
the spleens of these mice indicated that the majority of cells (89%)
were also of human origin as indicated by evaluation of MHC class
I co-staining and the predominant cell type found was CD19þ
IgDþIgM positive. Median engraftment time for bone marrow
reconstitution by transplant of bone marrow or cord blood is typ-
ically 18–26 days. One can suggest that engraftment of HSCs in the
artificial bone marrow construct with continued production of
CD34þ cells is similar to that seen in human or murine reconsti-
tution of irradiated marrow.
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(P 218) Increase in Cell Migration and Angiogenesis in a
Composite Silk Scaffold for Tissue-Engineered Ligaments
Y.K. Seo1, K.Y. Song2, S.Y. Kwon3, H.S. Lee3, Y.S. Park4, J.K.
Park1
1Department of Chemical and Biochemical Engineering, Dongguk
University, Seoul, Korea.
2Department of Pathology, Chung-Ang University, Seoul, Korea.
3Department of Orthopedic Surgery, St. Mary’s Hospital, Catholic
University, Seoul, Korea.
4Department of Medical Information Engineering, Kwangju
Health Colleage, Kwangju, Korea.
The purpose of this study was to evaluate the biocompatibility of
silk and collagen-hyaluronan (HA) in vitro by assessing ACL cell
and T lymphocyte cultures on scaffolds. The use of composite
scaffolds as artificial ligaments in ACL reconstruction and their
effects on angiogenesis were evaluated in vivo. The immune re-
sponse was higher in both scaffolds after 72 h compared with the
control culture condition without scaffolding, as assessed by T
lymphocyte cultures in vitro. There was no significant difference in
the immune response in vitro between the silk and composite silk
scaffolds.
Silk and composite silk scaffolds were implanted as artificial
ligaments in ACLs removed from the knees of dogs, and they were
harvested six weeks after implantation. On gross examination, the
onset of an inflammatory tissue reaction, such as synovitis, was
seen in both the silk scaffold and the composite silk scaffold
groups. A histological evaluation of the artificial ligament implants
revealed the presence of monocytes in the silk composite scaf-
fold and the absence of giant cells in all cases. MT staining in
the composite silk scaffold-grafted group showed granulation tis-
sue consisting of fibroblasts, lymphocytes, monocytes, and
newly formed collagen fibers. In addition, CD31 staining revealed
the formation of new blood vessels. On the other hand, no repar-
ative tissues, such as blood vessels, collagen, and cells, were ob-
served in the silk scaffold-grafted group. These results suggest that
the lyophilized collagen-HA substrate is biocompatible in vitro
and enhances new blood vessel and collagen formation in vivo.
(P 219) Influence of Bioimplant Modification on Gene Ex-
pression of Human Chondrocytes ‘‘in vitro’’.
H. Hulejova´1, M. Lisˇkova´1, L. Sˇenolt1, M. Petrty´l2, Z. Bastl3,
Z. Krulisˇ4, Z. Hora´k4
1Institute of Rheumatology, Prague, CZ.
2Czech Technical University, Faculty of Civil Engineering in
Prague, CZ.
3Institute of Physical Chemistry, Academy of Sciences, Prague,
CZ.
4Institute of Macromolecular Chemistry, Academy of Sciences in
Prague, CZ.
Introduction: Cycloolefin copolymer (COC) and cycloolefin co-
polymer/polyethylene (COC-blend) were selected based on our
previous experiments as materials suitable for skeletal implants. In
this study, we evaluated biotolerance of abovementioned materials
in culture of chondrocytes in vitro.
Material and methods: Two types of materials (COC and COC-
blend) either coated with collagen type II or uncoated were tested
in vitro. For better adhesion of collagen, the surface was modified
with N and O ions. Commercially available chondocyte cell lines
(Normal Human Articular Chondrocytes, Knee cryopreserved,
DIAGENES) were used for in vitro experiments. After 48 hours of
exposure to these materials, total RNA from chondrocytes was
isolated and reverse transcribed to cDNA. Gene expressions of
several metalloproteinases (MMP-1,-3,-13), pro-inflammatory
cytokines (IL-1, TNF-alpha) and apoptotic molecules (BAX, Bcl-
2) were studied by qRT-PCR.
Result & Discussion: All tested materials did not significantly
influence gene expression of tested pro-inflammatory cytokines
and apoptotic molecules by chondrocytes. Nevertheless, materi-
als with plasmatically modified surface and application of collagen
type II were shown to induce expression of several MMPs (2–7 fold
increase) by chondrocytes in vitro. To be sure that modified ma-
terials can be efficacious for artificial substitution of osteochondral
defects in humans, in vivo experiments are necessary.
This work was supported by Grant Agency Czech Republic,
project No. 106/06/0761
(P 220) Influence of Erosions on Levels of Collagen Degrada-
tion Biomarkers and Inflammation in Hand Osteoarthritis
M. Braun1, H. Hulejova´1, A. Pavelkova´1, M. Oleja´rova´1, J. Gat-
terova´1, L. Sˇenolt1, K. Pavelka1
1Institute of Rheumatology, Prague, Czech Republic.
Introduction: This study demonstrate the influence of inflammatory
and degradation processes in small eroded joints in hand osteoar-
thritis (OA) on levels of selected bone, cartilage and synovial
biomarkers and their role in differentiation between erosive (EOA)
and non-erosive (NEOA) forms.
Patients: Serum and urine samples from 89 clinically and ra-
diologically examined patients (56 with EOA, 33 with NEOA)
who fulfilled ACR hand OA criteria were analyzed. Between EOA/
NEOA were no differences in age (64/62 years), sex or disease
duration.
Methods: Urinary deoxypyridinoline (DPD), bone turnover
biomarker was determined using IMMULITE, pentosidine (PEN)
indicating rather cartilage degradation was measured in serum and
urine by HPLC. Inflammatory parameters were analyzed in serum:
hyaluronic acid (HA) by ELISA, C-reactive protein (CRP) using
high-sensitive immunoturbidimetry.
Results: Significantly higher HA was found in EOA in com-
parison with NEOA (100.78 vs. 58.11 ng/ml; p¼ 0.02), but no
difference was in CRP. Collagen catabolic processes in bone and
cartilage were reflected by insignificant DPD and PEN increase in
EOA too. Moreover, we found positive correlation of HA and both
cross-links with age, urinary DPD with PEN and serum and urinary
PEN. Follow-up of laboratory biomarkers is intended to see the
response to metotrexate 1-year therapy.
Conclusions: The results, particularly HA levels suggest that
erosions and age in hand EOA may be the reason for local joint
inflammation and slightly increased collagen catabolism as re-
flected by mild elevation of both DPD and PEN in EOA.
Supported by Czech Ministry of Health, projects Nos. NR/8447-
4 and 00023728.
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(P 221) Influence of Thickness on the Transmittance in Fibrin-
Agarose Corneal Constructs
R. Go´mez-Sotomayor1, M. Alaminos1, M.M. Pe´rez2, A. Ionescu2,
J.C. Cardona2, A. Campos1
1University of Granada, Department of Histology.
2University of Granada, Department of Optics.
Introduction: Previous characterization of the optical properties of
biomaterials used for construction of corneal substitutes by tissue
engineering is essential to ensure a proper functionality of the
bioengineered constructs. The aim of this work was the study of
transmittance (the material property of allowing light to pass
through) in matured fibrin-agarose constructs and its dependence
with thickness and incident light wavelength.
Methods: In this work, we developed an artificial substitute of
the human corneal stroma by using fibrin-agarose biomaterials
with human keratocytes immersed within. After 28 days in culture,
we evaluated the spectral radiance of the artificial tissues using a
spectroradiometer PR-704 (Photoresearch) under geometry CIE
458d illuminating condition. The transmittance for 5mm con-
structs thickness and the prediction for other thickness values
(from 4.5 to 0.5mm in 0.5mm steps) were calculated within the
visible spectrum (400–700 nm) using the theory of Kubelka-Munk.
Results: The spectral transmittance for 5mm construct was
0.383 for 400 nm, increasing in a progressive manner to 0.660 for
700 nm. This transmittance improved up to 0.90–0.95 for a
thickness similar to the one of central human cornea. Statistically
significant differences were found between the short and large
wavelengths, being smaller for the first ones.
Discussion and Conclusions: Transmittance is in inverse rela-
tionship with thickness and direct relationship with wavelength,
with differential behaviour for small and large wavelengths.
Spectral transmittance of these constructs is expected to be high at
the physiological thickness of the human cornea.
Supported by PI-0132/2007 and P06-CTS-2191 from Junta de
Andalucia.
(P 222) Injectable Alginate Gel Formulations with Controlled
Degradability
J.E. Melvik1, J. Bjørnstad1, A. Kristiansen1
1NovaMatrix/FMC Biopolymer.
Alginates are biocompatible polymers with the unique property to
form gel structures under physiologic relevant conditions. The
successful use of alginates as implantable biostructures may in
several cases, however, rely on the ability to control in vivo deg-
radation of the polymer network. In this work, a recently developed
internal alginate gelling system allowing gels to be moulded
in vitro or injected before gelling, was studied with respect to
degradability. Gel formulations were prepared by mixing sodium
alginate with calcium alginate particles. In order to test gel stability
in vitro, several different formulations were prepared and com-
pared in a long term study. For this, gel formulations were moulded
and stored in physiologic solutions at 378C and gel stability was
recorded with time. In a selected test solution the different gel
formulations were found to completely degrade from within two
weeks up to months. Lower gel stability was generally obtained by
using alginates with low Mw, high mannuronic acid content and
lower degree of calcium cross-linking. One alginate formulation
with high biodegradability was also tested by subcutaneous or
intramuscular administration into rats. At both sites the injected
alginate composition was found to disappear within short time but
considerably faster at the intramuscular site. Our data supports that
specific alginate qualities and gelling formulations with controlled
degradation profiles may be successfully designed as implantable
or injectable matrices for cells or other.
(P 223) Injectable Hydrogels Based on Chitosan
L. F. Boesel1, R. L. Reis2,3, J. San Roma´n1
1ICTP-CSIC, Dept. of Biomaterials, Madrid, Spain.
23Bs Research Group, Univ. of Minho, Braga, Portugal.
3IBB—Institute for Biotechnology and Bioengineering, Braga,
Portugal.
Oligo-D-glucosamine (‘‘oligomer’’ of chitosan) seems well suited
for injectable, biodegradable systems (IBS), due to their solubility
in water, easier funtionalization and the possibility of working at
high concentrations.
Chitosan was enzymatically degraded with a commercial en-
zyme (Multifect Pectinase FE) at 508C and pH 5.5 during 17h,
adapting a previous procedure. The oligomers were precipitated
in ethanol and analysed by MALDI-TOF/MS and FTIR. They
were then functionalized by reaction with methacrylic anhydride
(MethA), varying ratio of amount of substance of MethA : amount
of substance of -NH2 groups in the oligomer. The obtained me-
thacrylamide-oligomers were polymerized with a potassium per-
sulfate/vitamin C initiation system. Both the modified oligomers
and the polymerized product were analysed by FTIR and NMR.
In FTIR, there was the appearance, on the spectrum of the ac-
rylic ester oligomer, of bands atributted to ¼CH2 stretching
(~3100 cm-1) and the strengthening and splitting in two of the
bands of amide I (~1650 cm-1), due to the reaction of carbonyl from
the anhydride with amine of chitosan. After polymerization with
the above mentioned system, the methacrylamide oligomers be-
came insoluble due to the crosslinking at the double bonds of the
acrylic side groups, and the spectrum shows notable changes.
We have shown that injectable systems based on chitosan
oligomers may be easily prepared. These materials have varying
properties depending on the amount of methacrylamide groups
incorporated in the oligomer chains.
LF Boesel acknowledges the support of the Marie Curie actions
(Renewinj project).
(P 224) Inkjet Gene Printing: A Novel Approach to Achieve
Gene Modified Cells for Tissue Engineering
T. Xu1, J. Rohozinski1, W. Zhao1, E. Moorefield1, A. Atala1, J.J.
Yoo1
1Wake Forest Institute for Regenerative Medicine, Wake Forest
University Health Sciences, Winston-Salem, NC 27157.
Gene modification of cells has been used in various areas of re-
search for improving cell and tissue function. Although there are
many established methods to deliver genes into cells, application
of the existing techniques requires additional steps toward building
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new tissues for therapy. We have developed a novel method that
allows for safe delivery of genes into cells during the process of
building tissue constructs using the inkjet technology.
Methods: HP Desktop printers were used. Porcine aortal endo-
thelial cell lines (EC) and pmaxGFP plasmids were loaded into ink
cartridges and printed together onto collagen gel-coated substrates.
To evaluate the effects of in vivo gene transfection, a fibrin solution
and a mixture of EC cells and pmaxGFP plasmid were directly
printed into the subcutaneous tissues in athymic mice.
Results: Gene transfection in vitro: After gene printing, the cells
expressed GFP gene in culture over a 10-day period. Compared with
the liposome and physical methods, the inkjet gene printing method
showed significantly higher cell viability after transfection. Over
90%of the cellswere intact during the transfection process.Approxi-
mately 12% of the printed cells were transfected with the plasmid
genes. These data suggest that the inkjet process, which creates heat
and shear shock, facilitates the entry of plasmids into cells.
Conclusions: This study shows that safe delivery of genes into
living cells can be achieved using the inkjet printing technol-
ogy. Organ printing technology, combined with gene transfer,
may allow for enhanced tissue formation with target function
achievement.
(P 225) Integrative Capacity and Functional Competence of
Detergent-Decellularized Xenogeneic Pulmonary Valves
A. Lichtenberg1, S. Cebotari2, I. Tudorache2, M. Suprunov1,
P. Akhyari1, G. Tudorache2, G. Brandes3, A. Haverich2,
A. Hilfiker2
1University of Heidelberg, Dep. of Cardiac Surgery.
2Medical School Hannover, Dep. of Thoracic and Cardiovasular
Surgery.
3Medical School Hannover, Dep. of Cell Biology.
Introduction: The regenerative ability of implanted xenogeneic
decellularized heart valves is still discussed controversial. The aim
of this study was to evaluate the in-vivo integration capacity of
decellularized xenogeneic porcine pulmonary valves (PV) in
comparison to allogeneic ovine grafts.
Methods: Six porcine and six ovine PV were decellularized us-
ing detergents (0.5%Sodium-deoxycholate/0.5%SDS). The valves
were implanted into the orthotopic position in sheep as conduits.
Three of each were echocardiographically investigated and har-
vested after 3 and 6months, respectively. For morphological eval-
uation of explanted PV, H&E-, Elastica van Gieson-, Pentachrome-,
von Kossa, collagen-IV-, perlecan-, eNOS-, a-actin-, procollagen-I-
immunostaining, and scanning electron microscopy were per-
formed.
Results: All implanted PV were functionally competent without
insufficiency, stenosis, significant macroscopic degeneration or
thrombosis. Microscopic evaluation showed a similar in-vivo en-
dothelial and interstitial scaffold reseeding in both group with
distinct increase of reseeding extension after 6months. Signifi-
cantly higher expansion of the neo-intima hyperplasia was ob-
served in xenogeneic PV as compared to allogeneic grafts. No
significant calcification was found in both groups.
Conclusion: Integrative ability and functionality of xenogeneic
decellularized PV were similar up to 6months as compared to
allogeneic valves. Whether the significantly higher neo-intima
hyperplasia in xenogeneic valve further increases and interferes
with late function has to be investigated in future long-term animal
experiments.
(P 226) Integrin Alphav Subunit—Membrane Marker Med-
iating Differentiation of Human Bone Derived Cells?
E. Wrobel1, J. Szary1, J. Przybylski1, M. Lewandowska-Szumiel1
1Department of Biophysics and Human Physiology, Medical
University of Warsaw, Warsaw, Poland.
Integrins are a family of adhesion receptors which may regulate
many cellular functions, like adhesion, motility, phenotype and
cell maturation. Recent studies indicated that integrin beta1 plays a
role in osteoblastic differentiation1. As for alphaV and beta1 in-
tegrins, it was shown that they are characteristic molecules for
osteoclast functions2. The aim of our study was to investigate
whether the alphaV integrin subunit is involved in the human os-
teoblast differentiation process. The localization and level of ex-
pression of mRNA for alphaV integrin was determined three times
during osteoblast differentiation. AlphaV subunit of integrin was
detected by immunofluorescence staining method and observed in
a fluorescence microscope. The experiments were performed on
culture plastic and on alumina. The results of RT-PCR were ana-
lyzed with Gel Doc 2000 using Quantity One software. We found
that the alphaV integrin was present in focal contacts and cell
cytoplasm at subsequent stages of cell maturation. In addition, we
found that the expression of mRNA alphaV integrin differed at
various observation periods, and shows the highest level in mature
osteoblasts. For better understanding of the integrin function, we
treated the cell culture with monoclonal antibodies against human
alphaV integrin to block its ligand-binding activity. Blocking this
integrin transduction pathway caused changes in cell activity and
reduced the expression of alkaline phosphatase. Our results suggest
that alphaV integrin is involved as an important receptor mediating
human osteoblast differentiation.
Work supported by the Polish Government (3T08A00130).
1Liping Wang et al.; Biomaterials 27(2006).
2Ichiro Makamura et al.; J.Bone Miner Metab 25(2007).
(P 227) Intelligent Hydrogels for Chondrogenesis of Human
Adipose-Derived Stem Cell
H.H. Jung1,2, K. Park1, B.S. Kim2, D.K. Han1
1Korea Institute of Science and Technology.
2Hanyang University.
The composite of Pluronic F127 and hyaluronic acid (HA) was
investigated, exploring the benefits of each hydrogel in the chon-
drogenesis of human adipose-derived stem cell (ASC). F127 was
chemically modified through a series of reactions to graft heparin
and then dexamethasone (Dex), respectively. Crosslinked HA was
used as a physical stabilizer of F127. The modified F127/HA was
also physically coupled to TGF-beta1 by the immobilized heparin.
We hypothesize that as the physical stability of hydrogels is
maintained, chondrogenesis can occur with the aid of the incor-
porated chondrogenic factors. The sol-gel transition of F127/HA
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was found to be similar to that of F127 itself. From in vivo test
using nude mouse for 4 weeks, the volume of the composite hy-
drogel seemed to be well-maintained as compared to either F127 or
HA alone. DAPI staining showed that ASCs were widely dispersed
inside the hydrogel matrix. No significant difference was noticed
among the test groups. Immunofluorescent staining of type II
collagen indicated that the group, F127/HA/TGF/Dex could sus-
tain more active green fluorescence than F127/HA. This work
confirmed that the combination of two hydrogels (F127/HA/Dex
and F127/HA/TGF) is possible to make it thermoreversible and
physically more stable. In addition, this system proved that the
incorporation of chondrogenic inducers was effective in inducing
in situ directly chondrogenic differentiation of ASC.
(P 228) Interaction of Cells Involved in Wound Repair with
Different Fibrin Sealant Matrices
D. Macasev1, J. Barry1, C. Hedrich1, P. Lintl1, M. Bittner1,
H. Gulle1, A. Goppelt1
1Baxter AG.
Commercial fibrin sealants are widely used in various surgical
indications as an adjunct to haemostasis and for sealing of soft
tissue. Current fibrin sealants are composed primarily of fibrinogen
and thrombin, both isolated from human plasma. Depending on the
isolation and the production process of the fibrinogen and thrombin
component fibrin sealants may contain a number of other proteins,
such as growth factors, albumin, Factor XIII, and fibronectin. In
recent years fibrin sealants have been used successfully as a vehicle
for delivery of endothelial cells, fibroblasts and keratinocytes in
different applications such as wound healing and angiogenesis.
The usability of a fibrin sealant as delivery matrix and as a scaffold
for wound healing will very much depend on the quality of its
individual constituents and the overall composition of excipients.
Alternations in the fibrin structure and function have implications
for the wound healing especially in diseases where the fibrin
structure may be modified. The results presented in this paper show
significant differences between the commercial fibrin sealants
Artiss (Baxter) and Evicel (Omrix) with respect to morphology,
adhesion and viability of primary human dermal fibroblasts, human
umbilical vein endothelial cells and human epidermal keratino-
cytes. In contrast to Artiss, viability of cells was significantly de-
creased on Evicel, indicating that composition and/or structure of
this fibrin matrix did not promote fibrin-cell interactions. Artiss
with a more physiological clot properties is significantly better in
supporting cell adhesion and viability. In conclusion, our study
clearly demonstrates differences of commercially available fibrin
sealants in cell compatibility.
(P 229) Intraoperative Tissue Engineering for Multilevel
Posterolateral Cervical Fusion
G. Vadala1, A.C. Di Martino1, R. Papalia1, M.C. Tirindelli2,
V. Denaro1
1Department of Orthopaedic and Trauma Surgery, Campus Bio-
Medico University of Rome.
2Department of Haematology, Campus Bio-Medico University of
Rome.
Introduction: The outcomes of posterolateral multilevel spine
fusion in difficult clinical settings such as old multi-diseased
osteoporotic patient remain unpredictable. The osteoprogenitor
cells in bone marrow decrease with aging without losing their
osteogenic potential. Bone marrow cells (BMCs) from iliac crest
aspiration can be concentrated in the operating room and the
platelet-rich fibrin (PRF) can be obtained from peripheral blood as
source of autologous ostoprogenitor cells and growth factors re-
spectively.
The objective of this report is to describe the use of autologous
BMCs concentrate enriched with PRF on corticocancellous bone
allograft to improve multilevel posterolateral cervical fusion.
Method: We presented the case of a 88-year-old men affected by
cervical stenosis and subjected to decompression and a postero-
lateral C3-C7 instrumentation with apposition of posterolateral
corticocancellus bone allograft augmented with autologuos BMCs
concentrate from iliac crest aspiration enriched with PRF from
peripheral blood.
Results: At 6-months follow up the bone allograft shows con-
solidation signs evaluated by Lateral Dynamic X-Rays and CT
scan.
Conclusion: This paper describes a simple and effective method
for potentially improving fusion rate in aged osteoporotic patients
by using corticocancellus bone allograft augmented with autologus
BMCs concentrate from iliac crest enriched with PRF from pe-
ripheral blood, rapidly obtained before the surgical procedure.
Corticocancellous bone allograft acted as an osteoconductive and
osteoinductive structural support for cells and growth factors
forming a ‘‘tissue engineered’’ construct ready to be used in the
operating room.
(P 230) Investigating the Role of Collagen in Osteogenic Dif-
ferentiation of Human Mesenchymal Stem Cells
H. Fernandes1, A. Leusink1, K. Dechering2, E.P. van Someren3,
C.A. van Blitterswijk1, J. de Boer1
1Department of Tissue Regeneration, University of Twente.
2Department of Molecular Pharmacology, Organon.
3Department of Cell Biology and Applied Biology, University of
Nijmegen.
Secretion and subsequent mineralization of extracellular matrix
(ECM) by osteoblasts is a hallmark of osteogenic differentiation.
Because bone ECM is mainly composed of collagen type I, we
investigated its effects in osteogenic differentiation of human
mesenchymal stem cells (hMSCs).
First, we grew hMSCs on collagen-coated plates for 7 days and
we observed that hMSCs cultured in the presence of basic or os-
teogenic medium showed no consistent increase on alkaline
phosphatase (ALP) expression when compared to control.
Next, we inhibited collagen synthesis by excluding ascorbic acid
(AscAc)—a cofactor essential for collagen synthesis—from the
culture medium. We consistently observed a decrease in prolifer-
ation, ALP expression and calcium deposition.
In contrast, inhibiting collagen crosslinking with b-aminopro-
pionitrile (BAPN) - an irreversible inhibitor of lysyl oxidase—had
no effect on proliferation and ALP expression but, to our surprise,
it consistently enhanced calcium deposition up to 5-fold.
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In vivo bone formation by hMSCs showed a substantial decrease
in bone formation in the absence of AscAc whereas BAPN-treated
hMSCs produced a comparable amount of bone as cells grown in
control medium.
In summary, we showed that collagen, as well as its level of
crosslink, controls proliferation and differentiation of hMSCs
which could be further exploited to improve hMSCs-based bone
tissue engineering.
(P 231) Investigation of Bone Formation on Collagen-GAG
Scaffolds with Varying Composition
C.M. Tierney1,2, M.J. Jaasma1,2, F.J. O’Brien1,2
1The Royal College of Surgeons in Ireland.
2The Trinity Centre for BioEngineering, Trinity College Dublin.
Collagen-glycosaminoglycan (GAG) scaffolds are currently being
used in many tissue engineering applications including nerve,
cartilage and skin (1). The aim of this study was to investigate the
process of in vitro bone formation on a series of collagen-GAG
scaffold variants to find an optimal composition for use in bone
tissue engineering. Collagen-GAG scaffolds were made as previ-
ously described and crosslinked at 1058C (2). Scaffolds were di-
vided into two groups: [1] Collagen Variants: 0.5%, 0.75% and 1%
Collagen (w/v) and [2] GAG Variants: 0%, 0.022%, 0.044%
and 0.088% GAG (w/v). Scaffolds were seeded with 2106
MC3T3-E1 cells and pre-cultured for 2 days to allow for prolifer-
ation before the addition of ascorbic acid and b-glycerophosphate.
Scaffolds were assessed at time points of 1, 3, 7, 14, 21 and 28 days.
Cell number, metabolic activity, alkaline phosphatase (pNPP as-
say) and osteopontin (ELISA) were measured at each time point
and scaffolds histologically assessed for mineralisation. Cell
number and metabolic activity was highest on the 1% collagen and
the 0.088% GAG scaffolds by day 28. Alkaline phosphatase was
seen to peak at day 14 although no difference was seen between
scaffolds. Nodules of mineralisation within the scaffold stained
with alizarin red appeared at day 14 and continued until day 28. The
results demonstrate that the 1% collagen and 0.088% GAG scaf-
folds variants are optimal for bone tissue engineering.
Acknowledgements: Science Foundation Ireland & Integra Life
Sciences.
1Yannas I.V, et al. PNAS USA.1983; 86:933–937.
2O’Brien F. J, et al. Biomaterials. 2004; 25: 1077–1086.
(P 232) Investigation of Osteoblast Response to Biodegradable
Bacterial Cellulose Scaffolds
C. Babac1, K. Tuzlakoglu2,3, T. Kutsal1, R.L. Reis2,3, E. Piskin1
1Hacettepe U¨niversitesi, Kimya Mu¨hendisliði Bo¨lu¨mu¨ ve Biyo-
mu¨hendislik ABD, Beytepe, Ankara.
23B’s Research Group—Biomaterials, Biodegradables and Bio-
mimetics, Univ. Minho, Campus de Gualtar, 4710-057 Braga,
Portugal.
3IBB—Institute for Biotechnology and Bioengineering, PT Gov-
ernment Associated Laboratory, Braga, Portugal.
Aim of this project is to investigate the ability of bacterial cellulose
(BC) and oxidized Bacterial cellulose (OBC) use as a scaffold in
tissue engineering. Bacterial cellulose was produced with being
provided optimum conditions from Acetobacter xylinus. BC was
transformed dialdehyde cellulose (DAC) as biodegradable form by
treating with periodate. Oxidation was carried out in aqueous so-
lution at 508C in the dark for 24 hours. The mole-to-mole ratio of
sodium metaperiodate to anhydroglucose repeat unit (AGU) of
cellulose was 0.5, 1.0 and 1.5.
In order to test cell response to the developed scaffolds osteo-
blast-like cells (SaOs-2) were cultured on them during two weeks.
Cell adhesion and morphology were analyzed by SEM while the
cell viability and proliferation were assessed byMTS test and DNA
quantification assays. Cell culturing experiments showed that cells
were able to attach on their surfaces. However it was found that
oxidation influenced cell viability, showing that there was an op-
timum oxidation degree for cell attachment. Besides the chemical
properties of the surface, the morphology was also found to be
dependent of oxidation degree. The one showed better ability for
cell attachment (AGU/cellulose: 1.0) has the surface more porous
which is a desirable property for a tissue engineering scaffold. Cell
attachment and proliferation on these scaffolds were successful,
whereas spreading of the cells on the material was not very fa-
vorable. Consequently, they can be used with surface modification
or with bioactive agent for spreading the cells on the scaffold better.
(P 233) Investigation the Influence of Ar Plasma Treatment on
Cell Response for Wet-Spun Starch/Polycaprolactone Fiber
Mesh Scaffolds
K. Tuzlakoglu1,2, I. Pashkuleva1,2, R. L. Reis1,2
13B’s Research Group—Biomaterials, Biodegradables and
Biomimetics—Department of Polymer Engineering, University of
Minho, Braga, Portugal.
2IBB, Institute for Bioengineering and Biotechnology, PT Asso-
ciated Lab, Braga, Portugal.
In design of a tissue engineering scaffold, surface physicochemistry
is one of the most important issues to be considered. The physi-
cochemical properties of the surface directly influence the scaffold
performance by affecting the cellular response and ultimately ef-
fecting the new tissue formation. In order to improve the cell af-
finity, the surface hydrophiliticy, surface energy, surface roughness
and surface charge can be modify by different methods. Plasma
treatment is a versatile method for surface treatment of biode-
gradable polymers without altering their bulk properties. By this
method, it is possible to introduce or graft desired functional groups
onto the surface. This study aims to investigate the influence of Ar
plasma treatment on osteablast cell response for fiber mesh scaf-
folds from a starch-polycaprolactone blend. The scaffolds with
77% porosity were successfully produced by a wet spinning tech-
nique. The fiber surfaces were then treated by plasma at 30W for
15min using Argon as a working gas. It was observed that the
surface morphology and chemical composition were significantly
changed due to the etching and functionalization of the fiber sur-
faces. XPS analyses showed an increase of the oxygen content of
the fiber surfaces after plasma treatment (untreated scaffolds O/
C:0.26 and plasma treated scaffolds O/C:0.32). Both untreated and
treated scaffolds were examined using human osteoblast-like cells
(SaOs-2) during 2 weeks of culture. The cell seeded on wet-spun
SPCL fiber mesh scaffolds showed high viability and alkaline
phosphatase enzyme activity. Those values were found to be even
higher for the cells seeded on the plasma treated scaffolds.
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(P 234) Keratinocytes Derived from Human Eccrine Sweat
Glands
T. Biedermann1, L. Pontiggia1, S. Bo¨ttcher-Haberzeth1,
C. Schiestl2, M. Meuli2, E. Reichmann1
1Tissue Biology Research Unit, University Children’s Hospital
Zurich.
2Department of Surgery, University Children’s Hospital Zurich.
In injured interfollicular skin, stem cells from the hair follicle can
re-establish a multilayered epidermis. In contrast, palmo-plantar
skin does not contain hair follicles. Instead this type of skin is rich
in eccrine sweat glands, which are also found throughout almost
the entire body. This raises the question if there are also multi-
potent epithelial stem cells located in eccrine sweat glands.
We employed primary human sweat gland cells in engineered
skin substitutes. Cultured sweat gland cells were grown on colla-
gen hydrogels containing human dermal fibroblasts. The dermo-
epidermal substitutes were transplanted onto full-thickness skin
defects created on immuno-incompetent rats. We found that epi-
thelial cells derived from human eccrine sweat glands can develop
into a fully functional stratified and cornified epidermis. We con-
clude that sweat gland cells can be manipulated to display the
characteristics of epidermal keratinocytes. Our data suggest that
sweat glands harbor multipotent stem cells that can give rise to a
functional epidermis in a wound situation.
(P 235) Kinetics of Chondrocytes Gene Expression Following
Bioreactor Stimulation—Towards Optimization of Loading
Intervals
S. Grad1, R. Peter1, M. Alini1
1AO Research Institute, Davos, Switzerland.
Introduction: Intermittent loading has widely been used to stimu-
late cell-scaffold constructs for cartilage tissue engineering. The
optimal interval between loading cycles may depend on the ki-
netics of gene expression levels upon mechanical stimulation. The
aim of this study is to determine the course of chondrocyte mRNA
levels of genes responsive to applied surface motion [1]. Methods:
Bovine articular chondrocytes were seeded into polyurethane
scaffolds and mechanically stimulated using our loading device
that simulates the motion of articulating joints. A ceramic ball
dynamically compressed the scaffold and simultaneously articu-
lated over the scaffold at 1Hz. Scaffolds were loaded during 1h
twice a day for 3 days. Gene expression levels were determined
immediately, 2 h, 6 h, 12 h, 18 h, 24 h, and 36 h after the last loading
period. Results: Proteoglycan-4 (lubricin) and cartilage oligomeric
matrix protein mRNA increased after loading and reached highest
levels after 12 h. By 36 h the expression of these genes progres-
sively decreased towards control levels. The MMP-13 expression
was decreased after loading and remained down-regulated
throughout the 36 h observation period. Discussion: This finding of
peak expression levels 12h after loading validates our strategy of 2
loading periods per day and may explain previous observations of
enhanced responses in cells loaded twice versus once a day. It also
suggests that shorter loading intervals may not be advantageous.
While kinetics of mRNA levels depend on the gene and on the
stimulus, they are valuable not only for optimizing tissue engi-
neering protocols, but also for investigating mechanotransduction
mechanisms.
1Grad þ, Tissue Eng 12(11), 2006.
(P 236) Local Delivery of VEGF165 from Fibrin Biomatrix
Significantly Reduces Tissue Necrosis in a Dose Dependent
Manner
R. Mittermayr1,2, F. Krammel1,2, J. Hartinger1,2, B. Simon1,2,
T. Morton1,2, M. Hofmann1,2, M. van Griensven1,2, H. Redl1,2
1Ludwig Boltzmann Institute for Experimental and Clinical
Traumatology—AUVA Research Center.
2Austrian Cluster for Tissue Regeneration, Vienna, Austria.
Tissue transplantation needs sufficient blood supply to ensure
survival of the transplanted tissue and a successful outcome. An
intact fibrin network is critical for effective wound healing. Pre-
vious studies have suggested that vascular endothelial growth
factor (VEGF) is a regulator of physiologic and pathologic an-
giogenesis and is known to physiologically bind to fibrin. In the
current study we evaluated the efficacy of fibrin biomatrix (Tisseel
4U thrombin/ml, Baxter Biosurgery) supplemented with increasing
VEGF165 concentrations in prevention of necrosis in a rodent
epigastric flap model. After tissue harvesting flaps were randomly
assigned to sprayed fibrin biomatrix without or supplemented with
VEGF165 at 20, 200, 400, and 800 ng/mL final fibrin clot. Quilting
sutures served as controls. Development of necrotic flap tissue was
documented by digital photography over a 1 week period and
quantified using planimetric analysis. Flap perfusion was measured
using a 2D laser Doppler system. Comparing the planimetric
analysis of necrotic tissue on day 7 post surgery, it was found that
VEGF165 at a concentration of 200 and 400 ng/mL final fibrin clot
resulted in a significant reduction in tissue necrosis compared to
the control group. The fibrin biomatrix by itself had also trendwise
less necrotic areas than the control group. Significantly improved
flap perfusion was also found in the 200 and 400 ng/mL VEGF/FS
group compared to control. In summary, we found that flap ne-
crosis was substantially reduced and flap perfusion significantly
increased when using sprayed fibrin biomatrix with VEGF in a
dose dependent manner.
(P 237) Low-Pressure H2O/O2 Plasma Assisted Treatment of
PCL Membranes for Cell Cultivation
H. Turkoglu Sasmazel1, S. Manolache2, M. Gumusderelioglu3,
F. S. Denes2
1Department of Materials Engineering, Atilim University, Ankara,
Turkey.
2Center for Plasma-Aided Manufacturing & Department of Bio-
logical Systems Engineering, University of Wisconsin-Madison,
USA.
3Bioengineering & Chemical Engineering Departments, Hacettepe
University, Ankara, Turkey.
The aim of this study is to develop novel tissue substituents
by using low pressure plasma assisted treatment with biosignals
for L929 mouse fibroblast cell cultivation. For this purpose,
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biodegradable, PCL (poly-e-caprolactone) membranes were man-
ufactured by solvent casting method.
Plasma assisted technique was focused on enhancing COOH
functionalities on PCL surface using a three step process: H2O/O2
plasma treatment; in situ or ex situ gas/solid reaction to con-
vert OH functionalities into COCl groups; and hydrolysis for
final COOH functionalities. Experimental parameters for plasma
modifications were optimized according to DoE (Design Expert 7,
USA). COOH and OH functionalities on modified surfaces were
detected quantitatively by using fluorescent labeling technique and
an UVX 300G sensor. Chemical structural information of PCL
membranes were acquired using pyrolysis GC/MS analysis. High
resolution ESCA spectra showed negligible decarboxylation of
PCL samples during the plasma procedure and highly increase in
carboxylic functionalities after oxalyl chloride functionalization.
By AFM study, it was seen that nanoscale features of the surfaces
were dramatically changed during the treatments.
By using fluorescent labeling techniques, the amount of im-
mobilized insulin and heparin were determined as 219.23
nmolcm2 and 271.20 nmol.cm2, respectively.
MTT results showed that heparin immobilized PCL mem-
branes were effective on L929 cell growth, especially, in the late
stage of the culture. Consequently, the present study showed that
applied plasma treatment method works well for the immobiliza-
tion of biomolecules onto PCL membranes and these improved
PCL membranes can be used as artificial tissue substituents.
(P 238) Low-Serum Conditions for Expansion Culture of
Multiple Cell Types
T. Klein1, K. Schrobback1, N. Georgi1, J. Reichert1, D. Loessner1,
R. Crawford1,2, J. Clements1, D. Hutmacher1
1Institute of Health and Biomedical Innovation, Queensland
University of Technology.
2The Prince Charles Hospital.
Serum is commonly used at a concentration of 10–20% for culture
of virtually all cell types to allow for their attachment, proliferation
and survival in vitro. However, serum has several disadvantages
for regenerative medicine as it is undefined, highly-variable and of
animal origin. The large variability between serum batches dra-
matically influences cell behaviour, necessitates cell-specific batch
selection and makes interstudy comparisons challenging. An al-
ternative medium with low (2%) serum content (Mesenpro) has
recently been developed for mesenchymal stem cell (MSC) ex-
pansion to eliminate the need for serum batch testing and con-
comitantly reduce the serum content. We have evaluated the
effects of this medium on the growth and differentiation charac-
teristics of several cell types to determine whether it can serve as a
standard low-serum condition for general expansion culture.
Primary human MSCs, chondrocytes, osteoblasts, and ovarian
and prostate cancer cell lines were cultured for up to 4 weeks in the
commonly used medium for the cell type or in Mesenpro. Cell
proliferation was measured and gene expression was analyzed by
quantitative real-time RT-PCR. Additionally, MSCs and chon-
drocytes were further cultured in serum-free differentiation con-
ditions and evaluated using lineage-specific stains.
All cell types were successfully expanded using Mesenpro and
differences in proliferation and gene expression were found relative
to the standard conditions. MSCs were able to differentiate down
the adipogenic, osteogenic and chondrogenic pathways and chon-
drocytes maintained their chondrogenic capacity following Me-
senpro expansion. These results indicate that Mesenpro is a viable
option for standardized low-serum expansion of several cell types.
(P 239) Macroencapsulation of Human Parathyroid Tissue for
Treatment of Hypoparathyroidism: In Vivo Study
D. Dufrane1, R.M. Goebbels1, N. Bouillez1, P. Gianello1,
M. Mourad1
1Experimental surgery laboratory
Purpose: This work studied the potential of tissue macro-
encapsulation to cure hypoparathyroidism.
Methods: Human parathyroid glands (from 7 patients,
55 17 yrs old) were mechanically prepared by cutting from hy-
perplastic parathyroid. Tissue particles (500mm) were encapsulated
in a macrodevice (3 pieces per graft) made of alginate 3%w/v and
incubated at 378C during overnight. The male Wistar rats
(6–8 weeks old) underwent subtotal thyroidectomy and total para-
thyroidectomy. Three experimental groups were designed: rats
transplanted with (i) macroencapsulated human tissue (n¼ 6),
(ii) non-encapsulated human tissue (Ctrlþ, n¼ 4) and (iii) empty
macrodevice (Sham, n¼ 3). Serum calcium was measured before
the surgery, before transplantation and weekly after transplantation.
Immunohistochemistry analysis was performed to assess im-
munological response (lymphocyte, CD3/macrophages, CD68) and
revascularization (von Willebrandt factor) after graft explantation.
Results: After parathyroidectomy the average starting serum
calcium before transplantation was 6.1 1.1 mg/dl. No correction
of calcium sera levels was obtained for Ctrlþ and Sham animals
until a mean of 40 days post-transplantation (ratio between serum
calcium after transplantation and initial calcium level prior trans-
plantation (%): þ1.2% and -29% for each expiremental group,
respectively). In case of Ctrlþ animals, non-encapsulated human
tissue was severely rejected as evidenced by infiltration of CD3
and CD68 positive cells. No degradation of macrocapsules was
found in case of Sham animals up to 1month post-transplantation.
In contrast, the serum calcium rose by an average of 20% (of initial
values) when macroencapsulated human tissue was implanted
subcutaneously at day 29.
Conclusion: Encapsulated human parathyroid tissues can sig-
nificantly correct hypocalcemia following parathyroidectomy in a
xenograft model.
(P 240) Made-to-Order Collagen Matrix: Application of Ex-
cluded Volume Effect to Control Quantity, Pattern and Type
of Collagen Deposited by Fibroblasts
Y. Peng1, C. Chen1,2, M. Raghunath1,3
1Tissue Modulation Laboratory, Division of Bioengineering, Na-
tional University of Singapore.
2Graduate Program in Bioengineering, NUS Graduate School,
National University of Singapore.
3Department of Biochemistry, YLL School of Medicine, National
University of Singapore.
The excluded volume effect (EVE) caused by macromolecules
crowding in a given volume affects reaction kinetics. The im-
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plementation of EVE in fibroblast cultures greatly accelerates the
enzymatic conversion of procollagen to collagen.
Fetal lung fibroblasts were treated with ascorbic acid in low-
serum medium, with or without crowders: 500 kDa Dextran Sulfate
(DxS500), 70 kDa Ficoll (Fc70) and 400 kDa Ficoll (Fc400).
Collagen from the cell layer was extracted with pepsin and an-
alyzed using SDS-PAGE. Under standard culture conditions for
2 days, minimal collagen was found in the cell layer. 2 days of
EVE, by Fc70 and Fc400, increased collagen deposition at the cell
layer by 10-fold. Under EVE by DxS500, deposition increased by
20-fold.
Immunohistochemical analysis of the cell layer revealed colla-
gen I deposited under standard culture conditions was minimal and
in wispy, thin strands. Collagen I deposited under EVE by Fc70
and Fc400 was laid down in an extensive network of fibers. Con-
trastingly, DxS500-induced collagen I deposition was granular.
Collagen deposited on the cell layer under EVE for 9 days
comprised mainly collagen I. When EVE was applied for 2 days
and followed by 7 days of standard condition, collagen type
composition changed to a mixture of collagen I and V.
Various crowders, DxS 500, Fc 70 and Fc 400, can be used to
accelerate quantity and different patterns of collagen deposition.
EVE applied in timed pulses controls the type of collagen laid
down by the fibroblasts. Hence, EVE allows for more refined
control of collagen matrix formation for tissue engineering pur-
poses.
(P 241) Magnetic Carrageenan Nanospheres for Medical
Imaging
A.L. Daniel-da-Silva1, T. Trindade1, B.J. Goodfellow1, A.M. Gil1
1University of Aveiro, Departament of Chemistry- CICECO.
Magnetite (Fe3O4) nanoparticles due to their low toxicity and
magnetic properties have a recognized potential for several bio-
medical applications including diagnosis and targeting drug deliv-
ery [1]. In order to prevent the agglomeration and improve the
dispersion in aqueous medium, nanoparticles may be prepared
using water compatible stabilizers.In our previous work [2]
k-carrageenan, a non toxic sulphated polysaccharide has been suc-
cessfully used as colloidal stabilizer in the synthesis of magnetite
nanoparticles, preventing their spontaneous agglomeration and
conferring biocompatibility to the resulting composite.In this work
magnetic k-carrageenan nanospheres with an average diameter of
ca.75 nm have been prepared using water-in-oil (w/o) microemul-
sions. The w/o microemulsions were obtained by sonication of
a quaternary system comprising n-heptane as the organic phase,
cetyltrimethylammonium bromide (CTAB) as surfactant and 1-
butanol as the co-surfactant.The aqueous phase contained the bio-
polymer and magnetite nanoparticles (d~8 nm). The latter were
previously prepared by co-precipitation within the k-carrageenan
matrix under alkaline conditions [2]. Magnetic measurements
showed superparamagnetic magnetite nanoparticles at ambient
temperature.The resulting composites are therefore of potential in-
terest as contrast enhancers in magnetic resonance imaging (MRI).
Since the average diameter of these nanopheres is lower than
100 nm, blood half-life can be prolonged, allowing for imaging of
different tissues. Moreover, since k-carrageenan forms thermo-
reversible gels, the controlled release ofmagnetic particles or loaded
drugs can be envisaged by both thermal and magnetic stimuli. In
addition carrageenan can be further functionalized for the conju-
gation of biomolecules on the surface of the nanospheres.
1A.K. Gupta et al., Biomaterials 2005, 26, 3995.
2A.L. Daniel-da-Silva et al.,Biomacromolecules 2007, 8, 2350.
(P 242) Magnetic Field Affects Proliferation of Human Cells
In vitro
P. Wozniak 1, P. Jelen 1, J. Przybylski 1, M. Lewandowska-
Szumiel1
1Medical University of Warsaw, Department of Biophysics and
Human Physiology, Warsaw, Poland.
Many physical factors have been examined to allow more effective
cultivation and expansion of cells in culture for tissue engineering
purposes. One of the possible stimuli to take into consideration is
Static Magnetic Field (SMF). Although the literature data is
equivocal and the working mechanism is unknown, some authors
point to the effects of SMF on the cells’ shape, growth or metabolic
activity (1).
As our previous experiments demonstrated the influence of SMF
on human osteoblast-like cells (MG-63), we decided to confirm
this observation and examine the effect of SMF on Human Bone
Marrow Derived Mesenchymal Stem Cells.
The experiment was performed in a 96-well tissue culture
polystyrene plate (XTT-assay) and in Petri dishes (cell counting).
When the cells adhered and spread on the bottom of the wells, the
plate was exposed to SMF. Neodymium magnets were placed
beneath the tested wells (or dish) and kept there for the next 5–7
days. Finally, cell proliferation assay (XTT), cell count (Bu¨rker
camera) and microscopic observations were performed.
SMF enhanced the cell number for both kind of tested cells. This
effect was confirmed by both methods used. The morphology of
cells was not affected by the application of SMF.
The application of SMF seems a promising tool for the en-
hancement of cell growth, especially in the situation of a restricted
number of available donor cells in tissue engineering applications.
Work supported by Grant No.3 T08A01829, Ministry of Edu-
cation and Science.
1Leszczynski, D. 2005. Prog. Biophys. Mol. Biol 87(2–3):247–53.
(P 243) Magnetic Nanoparticle-Based Gene Trasnfection using
Oscillating Magnet Arrays
J. Dobson1,2, S.C. McBain1, N. Farrow1, CD Batich2
1Keele University, Institute for Science and Technology in Med-
icine.
2University of Florida, Department of Materials Science and En-
gineering.
Magnetic nanoparticle-based gene transfection has been shown to
be effective both in combination with viral vectors and with non-
viral agents. In these systems, therapeutic or reporter genes are
attached to magnetic nanoparticles which are then focused to the
target site/cells via high-field/high-gradient magnets. The tech-
nique has been shown to be efficient and rapid for in vitro trans-
fection and compares well with cationic lipid-based reagents,
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producing good overall transfection levels with lower doses and
shorter transfection times. In spite of its potential advantages
(particularly for in vivo targeting), the overall transfection levels do
not generally exceed those of other non-viral agents. In order to
improve the overall transfection levels while maintaining the ad-
vantages inherent in this technique, we have developed a novel,
oscillating magnet array system which adds lateral motion to the
particle/gene complex in order to promote transfection. Experi-
mental results indicate that the system significantly enhances
overall in vitro transfection levels in several cell types compared to
both static field techniques (p<0.005) and the cationic lipids
(p<0.001) tested. In addition, it has the previously demostrated
advantages of magnetic nanoparticle-based transfection—rapid
transfection times and requiring lower levels of DNA than cationic
lipid-based transfection agents. This method shows great potential
for non-viral gene delivery both in vitro and in vivo.
(P 244) Markers to Evaluate the Quality and Self-Renewing
Potential of Engineered Human Skin Substitutes In Vitro and
after Transplantation
L. Pontiggia1, T. Biedermann1, M. Meuli2, D. Widmer1,
S. Bo¨ttcher-Haberzeth1, C. Schiestl2, J. Schneider1, E. Braziulis1,
E. Reichmann1
1Tissue Biology Research Unit, University-Children’s Hospital,
Zurich.
2Department of Surgery, University Children’s Hospital, Zu¨rich.
We screened a series of antibodies for their exclusive binding to the
human hair follicle bulge. In a second step these antibodies were to
be used to identify basal keratinocytes and potential epithelial stem
cells in the human epidermis and in engineered skin substitutes. Of
all the antibodies screened, we identified only one, designated C8/
144B, that exclusively recognized the hair follicle bulge. However,
C8/144B-binding cells were never detected in the human epider-
mal stratum basale. In the bulge C8/144B-binding cells gave rise to
cytokeratin 19-positive cells which were also tracked in the outer
root sheath between bulge and the hair follicle matrix. Re-
markably, cytokeratin 19-expressing cells were never detected in
the hair follicle infundibulum. Yet, cytokeratin 19-expressing
keratinocytes were found in the epidermal stratum basale of nor-
mal skin as a subpopulation of cytokeratin 15-positive (not C8/
144B-positive) basal keratinocytes. cytokeratin 19/cytokeratin 15-
positive keratinocytes decreased significantly with age. We suggest
that cytokeratin 19-expressing cells represent a subpopulation of
basal keratinocytes that is particularly adapted to the lateral ex-
pansion of growing skin. Cytokeratin 19-expressing basal kerati-
nocytes may, or may not be unipotent epithelial stem cells. Our
data show that cytokeratin 19 in combination with cytokeratin 15 is
valuable marker to routinely monitor epidermal homeostasis and
(at least indirectly) the self renewing potential, and thus to compare
the quality of engineered skin to normal epidermis.
(P 245) Matrix Elasticity Influences Chondrocyte Dediffer-
entiation
E. Schuh1, J. Rohwedel1, J. Kramer1, R. Mu¨ller2, N. Rotter3
1Institute of Medical Molecular Biology , University of Lu¨beck.
2Institute for Biomechanics, ETH Zu¨rich.
3Department of Otorhinolaryngology, UHSH.
Cells sense and respond to the mechanical properties of their en-
vironment. It has been demonstrated that matrix elasticity plays an
important role not only for cell spreading and adhesion but also for
cell differentiation.
The aim of this study was to examine the influence of me-
chanical properties on the differentiation of chondrocytes cultured
in monolayer.
We used a 2D-culturing-system in which polyacrylamide gels
with different percentages of BIS-Acrylamide were coated with
collagen type I. This system allows altering the matrix elasticity
while leaving all other matrix-parameters constant.
Matrices with a Young’s Modulus of 5 kPa, 10 kPa, 40 kPa and
100 kPa were produced, as determined by atomic force micros-
copy. Porcine and human chondrocytes were cultivated on matri-
ces in low density culture for up to two weeks. The differentiation
of chondrocytes was investigated by measuring collagen type I and
II gene expression using RT-PCR and by immunofluorescence
staining for collagen type II.
Obvious differences between cells cultivated on the different
matrices were monitored especially after the first days of cultiva-
tion. Human and porcine chondrocytes grown on stiffer matrices
showed a more flattened morphology, lower collagen type II and
higher collagen type I expression when compared to cells grown on
softer matrices.
Our findings indicate that chondrocytes sense the elasticity of
the matrix and respond by dedifferentiating slower on soft matrices
than on stiff matrices. These data might be used in the design of
novel scaffolds with mechanical properties specifically tailored to
chondrocyte differentiation in tissue engineering applications.
This work was supported by EXPERTISSUES.
(P 246) Matrix Metalloproteinase-1 Treatment of Muscle Fi-
brosis
J.L. Kaar1, Y. Li1, H.C. Blair1, G. Asche1, R.R. Koepsel1,
J. Huard1, A.J. Russell1
1McGowan Institute of Regenerative Medicine.
The onset of scarring after injury may impede the regeneration and
functional recovery of skeletal muscle. Matrix metalloproteinase-1
(MMP-1) hydrolyzes type I collagen and thus may improve muscle
regeneration by resolving fibrotic tissue. We examined the effect of
recombinant human MMP-1 on fibrosis in the lacerated gastrocne-
mius muscle of NOD/scid mice, allowing treatment potential to be
ascertained in isolation from immune response. The efficacy of
proMMP-1 and active MMP-1 were compared with or without
poly(ethylene glycol) modification, which was intended to increase
the enzyme’s stability. Active MMP-1 was most effective in re-
ducing fibrosis, although treatment with proMMP-1 was also ben-
eficial relative to controls. PEG-modified MMP-1 had minimal
activity in vivo, despite retaining activity towards a thioester sub-
strate. Moreover, the modified enzyme was inactivated by trypsin
and subtilisin at rates comparable to that of native MMP-1. These
results and those of computational structural studies suggest that
modification occurs at the C-terminal hemopexin domain of MMP-
1, which plays a critical role in collagen turnover. Site-specific
modifications that spares catalytic and substrate binding sites while
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protecting susceptible proteolytic digestion sites may be beneficial.
We conclude that active MMP-1 can effectively reduce muscle
scarring and that its activity is related to the ability of the enzyme to
digest collagen, therebyfacilitating remodelingof the injuredmuscle.
(P 247) Measurement of Oxygen Consumption Rate for Aortic
Valve Interstitial Cells (VICs): Application to Tissue En-
gineering
L. Wang1, S. Wilshaw1, S. Korossis1, J. Fisher1, Z.M. Jin1,
E. Ingham1
1Institute of Medical and Biological Engineering, University of
Leeds, U.K.
Objectives: To investigate the factors influencing the metabolism
of oxygen by aortic valve interstitial cells (VICs) and in aortic
valve leaflet tissue, with a view to generate input parameters to
oxygen transport computational models.
Methods: Isolated porcine VICs at 50% and 100% confluency
and passages 5 (P5) and 10, or fresh porcine valve leaflets (n¼ 4)
were incubated in an oxygen respiration chamber (Strathkelvin
Instruments) at 378C in DMEM. The dissolved oxygen concen-
tration in the medium was continuously recorded at 1Hz using a
Clark-type oxygen electrode and a 782 oxygen meter. The con-
sumption rates at different oxygen concentrations were evaluated
from the drop in the recorded oxygen tension over time. The
maximum oxygen consumption rate (nmol/million cells/hour) was
calculated by employing the Michaelis-Menten equation.
Results: In all cases, the oxygen consumption rate was relatively
constant until the concentration dropped to 4% (v/v) and then be-
came approximately logarithmic to the drop in oxygen tension.
There was no significant difference between the consumption rate of
fresh tissue and freshly isolated VICs (300–380 nmol/million cells/
hour). Significant differences were found between cells at P5 and
P10, as well as between cells that were 50% and 100% confluent.
Conclusions: This study demonstrated that the metabolic ac-
tivity of VICs, with regards to oxygen consumption, is dependent
upon age and proliferation status. These conclusions provide
valuable input to computational models of oxygen transport in
tissue engineered valves, as well as to bioreactor optimisation.
(P 248) Mechanical Loading on the Growth Plate: Implication
for Endochondral Bone Formation
S.Y. Kong1, Y.J. Choi1, H.W. Kim1
1Brain Korea 21 Project of Nanobiomaterials for Cell-based Im-
plants, Department of Orthopaedic Surgery College of Medicine
Yonsei University.
Multiple factors that regulate bone cell activities, mechanical en-
vironment plays a critical role. There will be a reduction of bone
mass and even irreversible changes in the skeleton when human is
exposed to the situation where normal weight bearing is prohibited
due to medico-surgical diseases. This study was conducted to re-
veal any histopathological changes occurring in the growth plate
when the rats were subjected to be deprived of normal weight
bearing using the model of hindlimb unloading.
Thirty male SD rats, aged 6 weeks, were acclimatized with
standard conditions. They were divided into two groups according
to periods of Hind limb Unloading 3 weeks and of Reloading 1
week, and each control groups were maintained for an identical
period in the same conditions. BrdU immunohistochemistry and
TUNEL assay were performed. Heat shock protein 47, 70 were
immunolocalized to assess the chondrocytic activities in terms of
production of stress protein.
The length of the growth plate and the proliferative potential of
chondrocytes were decreased in the unloading group than those of
control groups. Inter-group differences were more significant in the
proliferative and hypertrophic zones. The expression of HSP47
was seen in proliferation zone and those superior to hypertrophy
zone. Besides, the expression of HSP47 was the strongest in un-
loading group.
Alterations in the weight bearing induced changes in the chon-
drocytic proliferative potential of the growth plate. This may
suggest that deprived weight bearing due to various clinical situ-
ations hamper normal longitudinal bone growth.
(P 249) Mechanical Properties of Tissue Engineering Scaffolds
M. Lebourg1, J.Mas1, J.L. Go´mez Ribelles1,2, J. Suay Anto´n1,2
1Centro de Biomateriales, Univ. Polite´cnica de Valencia, Cno. de
Vera s/n, E-46071 Valencia, Spain.
2Regerative Medicine Unit. Centro de Investigacio´n Prı´ncipe Fe-
lipe, Av. Autopista del Saler 16, E-46013 Valencia, Spain.
Mechanical properties are of great importance for the clinical use of
scaffolds in tissue engineering. Depending on the desired applica-
tion, the scaffold may have to be very elastic to adapt itself to the
size of the explant or quite rigid to support tensions for example.
We synthesized polymeric scaffolds with varying porosity and
microstructure by mixed porogen leaching/ freeze extraction pro-
cesses, and drove systematic mechanical properties measurements
in compression, in order to characterize the response of scaffolds,
and the influence of macro and microporosity on the observed
properties. In an attempt to develop a mathematical model based on
the cellular solids theory by Ashby and Gibson we designed a
gradual compression test to obtain further theoretical knowledge on
the collapse process of porous scaffolds.
(P 250) Mechanical Stimulation of an Osteoblastic Cell Line
on a Three-Dimensional Collagen Scaffold
S. Bo¨hm1, S. Diederichs1,2, T. Scheper1, C. Kasper1, M. van
Griensven2
1Institut fu¨r Technische Chemie, Leibniz university of Hannover.
2Ludwig Boltzmann Institute for Experimental and Clinical
Traumatology.
The aim of this work was to study the effect of mechanical strain on
the osteogenic differentiation of MG-63 cells in a three dimensional
collagen scaffold. The cells were stimulated for 15minutes,
60minutes, two hours, four hours and eight hours. The stimulations
were performed once and thrice. Furthermore, a continuous stimu-
lation was applied where the previous stimulations were performed
in series. Parallel to the stimulations control cells without stimula-
tion were cultivated on the collagen scaffold. After the experiments
the viability of the cells was proved with an MTT assay. The via-
bility was not affected by themechanical stimulation. ThemRNA of
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the cells was isolated and a PCR was performed to investigate the
expression of bone markers. The expression of typical bone markers
was determined. It was noticeable that each stimulation scheme had
different influence on the cells. The expression of bone mark-
ers varied in the different stimulations. The activity of alkaline
phosphatase was examined by an AP-activity test and was veri-
fied for almost all stimulations. There was no difference between the
AP activities of the stimulated und unstrained cells. The synthesis of
alkaline phosphatase and RUNX2 were tested with immunological
staining. RUNX2 was not detected in any experiment. Alkaline
phosphatase was substantiated in the most experiments. The miner-
alisation of the extracellular matrix was proved with an alizarinred/
calcein-double staining. Especially by the threefold stimulations
and the unstrained cells an explicit mineralisation was recognized.
Recapitulatory, thrice two hours of strain induced strongest effects
and enhanced osteogenic differentiation.
(P 251) Mechano-Compatible Collagen-Based Scaffolds for
Vascular Tissue Engineering: Low Doses of UV Affect the
Viscoelastic Behaviour
M. Achilli1, S. Meghezi1, J. Lagueux1, D. Mantovani1
1Laboratory for Biomaterials and Bioengineering & Quebec
University Hospital Research Centre, Laval University, Que´bec
City, Canada.
Although collagen shows promising properties, the mechanical
properties of materials fabricated from reconstituted collagen are
generally far from those of biologic tissue. This mismatch is par-
ticularly evident in scaffolds that are supposed to support and
stimulate vascular tissue engineering. Therefore, the purpose of this
study was to investigate new approaches for improving the
mechano-compatibility of collagen-based constructs and to study
the effects of low doses UV radiation, which have been shown in
previous works to stimulate cell activity. Constructs made of col-
lagen and smooth muscle cells were cultured in a custom-made
rotating device. The compliance of the constructs was measured
starting after 1w of culture. The microstructure of the resulting
collagen and the cell-matrix interactions was investigated by
Atomic Force Microscopy and Confocal Laser Scanning Micro-
scopy. Finally, the effects of lowUV radiation (0 to 75 J/cm2) on the
viscoelastic properties of collagen scaffolds were investigated.
Results show that the mechanical properties of the irradiated scaf-
folds are encouraging, although still lower then physiological ones.
Analyses with AFM and CLSM showed the strong interaction be-
tween cells and collagen matrix. In the gel it was possible to detect a
binding pattern of 67.4 1.5 nm, which is in agreement with the
theoretical one reported in literature. Furthermore, the scaffold ap-
pears to be as a random fibrillar matrix. In order to improve these
properties, appropriate maturation in a home-made bioreactor under
specific mechanical stress and strain are envisaged. The use of silk
as reinforcement for the collagen is also under investigation.
(P 252) Mechanobiology in Bone Tissue Engineering: Re-
sponses to Fluid Flow
H.L. Morris1, J.W. Haycock1, G.C. Reilly1
1Department of Engineering Materials, University of Sheffield,
S37HQ, UK.
Matrix production by tissue engineered bone is enhanced when the
tissue is subjected to mechanical forces in a bioreactor. For this to
occur bone must be able to sense mechanical force and translate
this to a matrix producing response. In bone, in vivo, mechan-
osensitivity is proposed to result from the application of shear
forces on the cell membrane of osteocytes. However, in tissue
engineered bone osteoblasts and their precursors must directly
sense and respond to mechanical forces in a less constrained en-
vironment. Previously we showed that the cell coat (glycocalyx) is
responsible for transmitting fluid flow shear forces in osteocytes.
The aim of the current work is to investigate whether the glyco-
calyx is also a mechanosensor of fluid shear stress in osteoblasts in
a tissue engineering environment. Using the late-stage osteoblast
cell line MLO-A5 we showed that these matrix synthesising os-
teoblasts have a glycocalyx rich in Hyaluronic Acid (HA) which
can be degraded with hyaluronidase treatment, whilst leaving the
cell attached to the surface. As fluid flow experiments are usually
conducted in a 2D environment but tissue engineering requires a
3D scaffold we compared cell shape and attachment on the base of
a flow chamber and a polyurethane open foam scaffold using actin
phalloidin staining and confocal microscopy. As expected there
was a marked difference in cytoskeleton organisation and cell
shape between 2D and 3D. In conclusion, we have established
MLO-A5 will be an good model cell type with which to study the
mechanobiology of synthesising ostoblasts.
(P 253) Mesenchymal Stem Cell Behaviour on Topographical
Cues
D. Yucel1, H. Kenar1, G.T. Kose2, V. Hasirci1
1METU, BIOMAT, Department of Biological Sciences, Bio-
technology Research Unit, Ankara, Turkey.
2Yeditepe University, Faculty of Engineering and Architecture,
Department of Genetics and Bioengineering, Istanbul, Turkey.
To mimic natural organization of cells, the control of cell behavior
and cell-material surface interactions using physical cues is an
important point to be considered in tissue engineering. The scope
of this study is to investigate the effect of micropatterned surfaces
on the morphology, alignment and proliferation of Wharton’s
Jelly-derived Mesenchymal Stem Cells (MSC).
A blend of polyesters, poly(hydroxybutyrate-co-hydroxyva-
lerate) (PHBV) and poly(L-D, L-lactic acid) (P(L-D,L)LA) was
used to prepare micropatterned (MP) films carrying features such
as channels with different dimensions and channel wall inclination.
Human Wharton’s Jelly MSC were seeded on the sterile micro-
patterned films and cultured for 4 days in an incubator maintained
at 378C and 5% CO2. The cells were stained with FITC conjugated
phalloidin and DAPI for assessment of cytoskeletal and nuclear
alignment.
It was observed that MSCs attached on fibronectin adsorbed
micropatterned polymeric films especially in and at edges of the
channels and they had a tendency to align along the axis of the
channels. The alignment of MSC cytoskeleton and nuclei was
more distinct in the narrower channels, those the dimensions of
which are closer to that of the MSCs.
Acknowledgments: This study was supported by EU FP6 NoE
Project Expertissues and by a grant from METU (BAP-2004-07-
02-00-17).
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(P 254) Microarray-Determined Potenciality of Wharton’s
Jelly and Adult Stem Cells
A. Rodrı´guez-Morata1, I. Garzo´n2, M. Alaminos2, M.C. Sa´nchez-
Quevedo2, N. Garcı´a-Honduvilla3, J.M. Garcı´a2, P.V. Crespo2,
J. Buja´n3, A. Campos2
1Hospital Clı´nico Virgen de la Victoria, Division of Vascular
Surgery, Ma´laga, Spain.
2University of Granada, Department of Histology.
3University of Alcala´, Department of Medical Specialties.
Introduction: In this work, we have carried out a comprehensive
gene expression analysis in monopotent and multipotent epithelial
and connective human stem cells to determine which one of these
cell types are more suitable for use in tissue engineering protocols.
Materials and Methods: Primary cultures of human Wharton’s
jelly multipotent stem cells, epithelial stem cells (keratinocytes)
and connective stem cells (fibroblasts) were established. RNA was
isolated and high-density gene expression profiling was performed
by using Affymetrix Human Genome U133 plus 2.0 microarrays.
Genes with an average expression above 5000 F.U. were selected
for each group, and identification of specific genetic pathways and
functions was done by using the program Cytoscape-BiNGO.
Results and Discussion: Wharton’s jelly stem cells showed
overexpression of 306 genes, corresponding to 109 different cell
functions, including extracellular matrix and collagen synthesis
and bone and muscle development. Monopotent keratinocytic stem
cells overexpressed 280 genes and 74 cell functions, including
epidermis development, whereas fibroblast cells showed upregu-
lation of 257 genes corresponding to 72 functions, including ex-
tracellular matrix synthesis. All samples overexpressed several
common genes (cell growth, proliferation, metabolism, cytoskel-
eton, biosynthesis, etc.), although some pathways were specific of
multipotent Warton’s jelly cells (actin and collagens IV and V
synthesis, cell motility, Golgi complex synthesis, organs devel-
opment and regulation). We conclude that adult monopotent stem
cells should be used for tissue engineering of epithelial tissues,
whereas both multipotent or monopotent stem cells could be used
for developing of connective tissues.
Supported by FIS PI061784, CM011/2005 and P06-CTS02191.
(P 255) Microfabricated Hydrogel Scaffold for Regenerative
Medicine Applications
A. Tirella1, G. Vozzi1, A. Alhuwalia1
1Research Center Piaggio Pisa Italy.
Cellular adhesion, proliferation and differentiation is closely con-
nected with chemical and mechanical properties of the scaffold
used, in order to simulate the biological mechanical properties of
tissue, the shape of the scaffold is modulated using several pa-
rameters (porosity, line width, topology). Traditionally micro-
fabricated scaffolds used in tissue engineering applications are
made of synthetic polymers such as PLLA, PLGA or PCL. These
polymers present surface properties able to promote cell activities,
and the modulation of the scaffold shape can mimic the mechanical
properties of biological tissue.
Now we propose a new concept of microfabricated scaffold in
order to biomimicry all tissue properties both from the topological
to the chemico-mechanical point of view. Using hydrogel it is
possible to realize bioispired scaffolds, in particular we analyzed
alginate mechanical properties and demonstrate its similitude with
several biological tissue. In particular, characterizing the cross-
linking reaction between sodium-alginate and calcium-phosphate
concentration and their reaction time it is possible to modulate the
elastic modulus of obtained material . Using PAM (Pressure Ac-
tivated Microsyringe) technique we defined the working conditions
in order to realize different shape of alginate-hydrogel scaffolds.
Using a FEM simulation it was possible to optimize this technique
in order to extrude a mixture of cells in alginate hydrogel, realizing
a total new concept of engineered tissue. Cellular experiments
using murine hepatocyte cell line (HepG2) were performed and the
results showed that not only survive but also proliferate and pre-
serve their phenotype.
(P 256) Microfluidic Gradient Maker for Pattern Generation
A. Tirella1, D. Mazzei1, G. Vozzi1, A. Ahluwalia1
1Interdepartmental Research Center.
First proposed by Whitesides in 1999, the gradient maker has been
extensively used by several researchers for generating large con-
centration gradients over small length scales. Basically, the gra-
dient maker (GM) is a microfluidic device consisting of a series of
channels connected to a chamber in which the gradient is formed.
Since it was first conceived, the gradient maker has undergone
several variations and it is now possible to create time independent
solution or surface concentration gradients with complex spatial
forms.
One of the main topics under investigation is the study of
morphogen or chemotatic gradients which are known to guide cell
differentiation and movement.
Here we propose the use of the gradient maker in tissue engi-
neering, to create spatial and temporal information for cell as-
sembly, and as a substitute for traditional tissue engineering
scaffolds. The paradigm of development in biology is based on
cells assembling and organizing by responding to morphogenetic
signals, be they spatial or biochemical, through a process of ac-
cumulation and accretion rather than degradation and attrition.
Through the use of appropriate activator-inhibitor signals the
gradient maker can create repetitive or complex chemical ‘scaf-
folds’, in a manner which mimics that of organ and tissue devel-
opment in living systems. Using fluid-dynamic and transport
models of a microfluidic network, we demonstrate how spatial
specific chemical information can be imprinted in a cell culture
environment either by employing activator-inhibitor complexes as
proposed by Meinhardt and Gierer, or using simple diffusion of
one or more cell modulators
(P 257) Microparticles for Incorporation in In Situ-Forming
Implants in Osseous Defect Reconstruction
A. Lochmann1,2, H. Nitzsche 2, S. von Einem3, E. Schwarz3,
K. Ma¨der1,2
1Translational Centre for Regenerative Medicine Leipzig, Philipp-
Rosenthal-Straße 55, D-04103 Leipzig, Germany.
2Institute of Pharmacy, Martin Luther University Halle-Wittenberg,
W.-Langenbeck-Str. 4, D-06120 Halle, Germany.
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3Institute of Biochemistry and Biotechnology, Martin Luther
University Halle-Wittenberg, K.-Mothes-Str. 3, D-06120 Halle,
Germany.
Positive results of growth factor administration in bone defect re-
generation can be limited by inappropriate release kinetics. It is
vital to minimize disease prolonging effects by finding the right
release pattern in a suitable dosage form. In this approach, the
release from an in situ-gelling system shall be adjusted by incor-
poration of microparticles into the gel matrix.
In situ-forming implants were made from chitosan and
beta-glycerophosphate. Chitosan was dissolved in a hydro-
chloric acid solution and mixed with an aqueous solution of beta-
glycerophosphate. Recombinant human Bone Morphogenetic
Protein 2 (rhBMP-2) had been added to the chitosan solution.
Microparticles were produced by a W/O/W-double emulsion
method using polymers of different hydrophilicity. rhBMP-2 was
incorporated in the inner phase with and without stabilizing agent.
Release measurements were carried out by determining the
amount of rhBMP-2 in supernatant and quantification with ELISA.
Opaque, stable gels containing rhBMP-2 were produced. A pilot
study was carried out to determine release kinetics. By 15 hours, 10
percent of the amount of rhBMP-2 incorporated had been released.
In contrast to the gel, microparticles of the most hydrophobic
polymer used did not show any release within two weeks, but after
an incubation time of 9 weeks, rhBMP-2 could be found.
The size and shape of the microparticles were investigated. Both
were found to depend on the load with rhBMP-2, as well as on the
type of the organic phase and the use of stabilizer within the inner
aqueous phase.
(P 258) Micropatterned Chitosan Films for Cell Guidance
A. Kiziltay1, M. Hindie2, N. Hasirci3, V. Hasirci2
1METU, BIOMAT, Department of Biotechnology, Ankara, Tur-
key.
2METU, BIOMAT, Departments of Biological Sciences and
Biomedical Engineering Biotechnology Research Unit, Ankara,
Turkey.
3METU, BIOMAT, Departments of Chemistry and Biomedical
Engineering, Ankara, Turkey.
Use of polymers in tissue engineering is essential for the design of
scaffolds. Natural and biodegradable polymers like gelatin, colla-
gen and chitosan are used for this purpose along with synthetic
polymers. A critical issue is the adhesion and proliferation of the
cells on the surface. Therefore, modification of the surface chemi-
stry and topography may be needed for optimum results. One ap-
proach is the creation of micro or nano patterns on the surface.
In this study, micropattered chitosan films with different dea-
cetylation degrees (75% and 85%) were prepared on micro-
patterned PDMS templates and crosslinked with epichlorohydrin.
Mechanical properties and surface hydrophilicities were examined.
The effect of microscale surface features on adhesion behavior of
human osteosarcoma cells, SaOs-2, were examined. Some samples
were further modified by adsorption of fibrinogen to enhance at-
tachment. Cell morphology and cytoskeletal organization were
studied by fluorescence microscopy. MTS assay was used on days
1 and 7 to determine the cell proliferation. It was observed that
Saos-2 cells align along the grooves. Fibronectin coating did not
improve the cell adhesion. No significant difference in morphology
and alignment of Saos-2 cells was observed as a result of chitosan
deacetylation, surface morphology and fibronectin coating. Saos-2
proliferation, however, was higher for the 85% deacetylated
samples than the 75%.
Acknowledgements: This project was conducted within the
scope of the European NoE project EXPERTISSUES and MC
RTN project BIOPOLYSURF.
(P 259) Microtomography Characterization of Scaffolds for
Bone Regeneration.
R. Pecci1, D. Meleo2, L. Pacifici2, R. Bedini1
1Department of Technologies and Health, Italian National Ins-
titute of Health, Rome, Italy.
2Unit of Dentistry and Prosthodontics, Department of Odontos-
tomatology, Faculty of Medicine and Surgery I, La Sapienza
University, Rome, Italy.
In the last few years the huge steps made by scientific research and
the continuous evolution of surgical techniques have allowed the
use of bone substitutes, both in dental and orthopaedic field. The
use of bone grafts or alloplastic materials is based on the as-
sumption that new bone growth would be stimulated because these
materials may: 1) include cells that can rebuild bone (osteogen-
esis); 2) serve as scaffold, favouring the migration of osteogenic
cells and the formation of bone tissue (osteoconduction); 3) con-
tain, in their matrix, substances of bone induction (osteoinduction).
Prosthetic materials overcome some of these issues, but their ef-
fectiveness is limited by unpredictable graft resorption, infection
and structural failure. The search for a reliable implantable mate-
rial has spurred a new line of research on biocompatible implant-
able scaffolds. Structure and architecture of scaffolds are very
important factors for bone regeneration tissue engineering because
they act as a template for cell interactions and as a mechanical
framework which osteogenic cells can attach and proliferate on.
The aim of the present study is to analyze microarchitectural and
morphometric parameters of some biomaterials from different
origins using microtomographic technique. X-ray micro-computed
tomography (Skyscan 1072, Belgium) is a well known technique
used for non-inasive and non-destructive 3D characterization of
various materials in different field. Micro-CT analysis allows to
accurately quantify scaffold porosity, surface area and 3D mea-
sures such as pore size, pore distribution and strut thickness: these
data are essential for the success of the graft, being striclty related
to bone growth.
(P 260) Modelling Glucose and Oxygen Diffusion in Fibroblast
Seeded Collagen Scaffolds Cultured in a Spinner Bioreactor
P.A. Pulido1,2, H.A. Duran2, M.R. Fontanilla1
1Department of Pharmacy, National University of Colombia.
2Department of Chemical Engineering, National University of
Colombia.
The manufacturing of tissue from isolated cells seeded onto bio-
compatible scaffolds requires studying nutrient transport from the
bulk medium to the system which is composed of the submerged
scaffold and the fluid medium. The Tissue Engineering Group of
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the National University of Colombia made some advances in de-
veloping artificial oral connective tissue for grafting wounded oral
mucosa. To evaluate some of the group’s experimental results, a
mathematical model based on principles of transport phenomena
has been developed to study glucose and oxygen transport inside
oral fibroblast-seeded collagen I scaffolds cultured in a spinner-
like bioreactor. The model allows estimates of cellular density as
well as glucose and oxygen consumption as a function of scaffold
width and diameter. The model also permits establishing the effect
of scaffold micro-structural properties and the amount of initial
nutrients required for artificial tissue formation. Furthermore, the
mathematical model could be used to optimize the scaffold micro-
structural properties and the scaling up of artificial connective
tissue production.
(P 261) Modification of Polylactide Surfaces with PLA-b-PEO
Block Copolymers Deposited from Selective Solvents
E. Chanova1, S. Popelka1, L. Machova1, F. Rypacek1
1Institute of Macromolecular Chemistry AS CR, v.v.i.
Amphiphilic di-block copolymers composed of polylactide (PLA)
and omega-methoxy-poly(ethylene oxide) (mPEO) in selective
solvents can associate to micelles and/or with surfaces compatible
with PLA block. Formation of surface brush layers based on de-
position of PLA-b-PEO copolymers from selective solvents is
studied as a method of surface modification of PLA-based bio-
materials for tissue engineering. A series of PLA-b-PEO copoly-
mers with different molecular parameters, block lengths and
stereoregularity of PLA block (DL or L) were synthesized and
characterized by 1H NMR spectroscopy and SEC. The solution
properties and self-association of copolymers in various solvent
mixtures, such as acetone/methanol, dioxane/methanol, acetone/
water, were investigated by dynamic light scattering (DLS) and the
size distribution and stability of aggregates were related to mo-
lecular parameters of copolymers and mixed solvent composition.
Selected compositions of copolymer micelles (nanoparticles) were
deposited by spin-casting on poly(L-lactide) surfaces. The surface
properties of PLA modified with deposited copolymer films were
characterized by contact angle measurements and the stability of
films in aqueous environments was evaluated. The efficiency and
stability of PLA surface modification, based on wettability changes
was related to the solution properties and molecular parameters of
copolymers. The most efficient surface modification was achieved
by deposition of PLLA-b-PEO with 10 KDa PEO block.
The support by Academy of Sciences of CR (1QS500110564),
Center for Cell Therapy and Tissue Repair (MSMT:
1M0021620803) and 6FP-EU NoE ‘‘EXPERTISSUES’’ (NMP3-
500283-2) is acknowledged.
(P 262) Modification of Surface Chemistry in Conjunction
with Defined Media to Replace Recombinant Growth Factors
During In Vitro Expansion of Mesenchymal Stem Cells
N. Bryan1, N.P. Rhodes1, J. Curran1, R. Chen1, J.A. Hunt1
1University of Liverpool.
The ex vivo control of cell function and fate relies heavily on the
provision of a suitable substratum on which a cell can adhere and
then spread thus emulating the native niche in which a cell func-
tions in vivo. Mesenchymal stem cell (MSC) culture requires ex-
ogenous growth factors and cytokines to modulate proliferation
and differentiation. In this study, chemical modifications to the
substratum not only guided the growth of cells geometrically but
also provided the potential to mimic the native ligands of a plethora
of cell surface receptor molecules thus initiating not only confor-
mational, but intracellular signalling responses.
PLLA and PCL substrates were modified with hydroxyl,
carboxyl, amino and methyl groups. Human MSCs were char-
acterised then seeded at specified densities and cultured for 7 and
21 days onto these substrates in defined media derived de novo
in house and containing no additional growth factors. Phenotype
was confirmed using immunohistochemistry and confocal micros-
copy.
The modified substrates in conjunction with defined media de-
void of exogenous growth factors all demonstrated the capacity to
support cellular adhesion up to 7 days, the PLLA-based modifi-
cations being superior. At 21 days, cells on all but the methyl
modified surfaces had predominantly formed rounded aggregates
whilst cells exposed to the methyl surface remained spread and
expressed Nucleostemin and STRO1.
This research established the fundamental principles for smart
materials, developing the hypothesis that controlled modulation
of substrate chemistries can be used to remove the need for purified
or bacterially derived growth factors during periods of ex vivo
culture.
(P 263) Modified Collector Geometry for Electrospun Nano-
fibers
I. Wimpenny1, Y. Yang1, N. Ashammakhi1
1Institute of Science and Technology in Medicine, Keele Uni-
versity, UK.
Introduction: This research aims to investigate the mechanism
by which nanofibres attach to various modified collector geome-
tries.
Materials and Methods: Polycaprolactone (PCL) polymer solu-
tions were prepared in a mixed solvent solution, comprising tet-
rahydrofuran, dimethylformamide and chloroform. Polymer
concentrations varied from 3% to 15%. A syringe pump was uti-
lized to maintain consistent flow of polymer solution. A modified
collector was constructed from interlocking aluminium sheets,
allowing the size and orientation of pores to be manipulated.
Polysulphone fibre (ca. 200 mm fibre diameter) was used to bridge
large pores as an investigation of the physical effect of materials on
nanofibre deposition.
Results and Discussion: As expected, the fibre morphologies
changed with regard to polymer concentration, whereby frequent,
elongated beading was observed on 3% PCL solutions. 7.5%–15%
PCL did not express beading.
By altering the polymer concentration, the deposition of the
nanofibres was altered, in some instances causing bridging across
large pores, to deposition at the edges of the collector, or pene-
tration through it.
A 7.5% PCL solution resulted in concentrated fibre deposition
on the edges of the grid. It is likely that nanofibres formed from
higher polymer concentrations provide more significant residual
charge and physical presence, leading to alteration in the nanofibre
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deposition. Also, higher concentrations of polymer will result in
increased chain entanglement, therefore allowing the formation of
longer fibres by an increased incidence of bifurcation, creating the
observed ‘bridges’.
The minimum pore size expressing bridging was predominantly
dictated by the concentration of the polymer. 3%PCL showed
occasional ‘bridging’ across smaller pores.
(P 264) Modified Iron Oxide Nanoparticles: a Suitable Tool
for Cellular Imaging
P. Lesny1,2, D. Horak2,3, M. Babic2,3, M. Kapcalova1, L. Bie-
berova4, V. Herynek2,5, M. Hajek2,3, P. Jendelova1,2, E. Sykova1,2
1Institute of Experimental Medicine, ASCR, Prague, Czech Re-
public.
2Center for Cell Therapy and Tissue Repair, Charles University,
Prague, Czech Republic.
3Institute of Macromolecular Chemistry, ASCR, Prague, Czech
Republic.
4Department of Surgery, Central Military Hospital, Prague, Czech
Republic.
5Institute for Clinical and Experimental Medicine, Prague, Czech
Republic.
Using stem cells in human medicine remains a distant goal because
of the still-considerable risk of tumor formation or differentiation
into an improper phenotype. Non-invasive cellular imaging allows
the real-time tracking of grafted cells as well as the monitoring
of their migration. To improve MR imaging, superparamagnetic
iron-oxide nanoparticles (SPION) were modified with differ-
ent coatings (Poly-L-Lysin—PCSPION, D mannose—MCSPION,
polydimethylacrylamid—PDMASPION) and compared to com-
mercial dextran-coated SPION, Endorem(R). Cell viability (mea-
sured by the WST-1 assay), labeling efficiency and the MR
detection limit were studied in mesenchymal stem cells, olfactory
ensheathing cells, chondrocytes and hepatocytes. Depending on
cell and SPION type, cell viability decreased by 3–56% after
labeling; the best results were obtained with PCSPION and
MCSPION. Hepatocytes were viable only after labeling with
Endorem. The labeling efficiency was highest with PCSPION. The
average iron content per labeled cell ranged from 14.6 pg to 51.7
pg, depending on the SPION type. Cells labeled with DCSPION,
PDMASPION or PCSPION possessed higher relaxivity compared
to cells labeled with Endorem. MR images of phantoms containing
suspensions of MCSPION-, PDMASPION- and PCSPION-labeled
cells showed a much stronger hypointense signal than did images of
Endorem-labeled cells. InMR images of a rat brain with PCSPION-
labeled cells injected intracerebrally, 1000 labeled cells were de-
tected. The better internalization of PCSPION, PDMASPION or
MCSPION into cells and their improved resolution on MR images
enables the easier detection and tracking of cells in the tissue after
transplantation. Supported by AV0Z50390703, KAN201110651,
GACR309/06/1594, GACR304/07/1129, 1M0538, LC554.
(P 265) Morphology and Human Bone Cell Interaction of
Fibre Reinforced Composite Scaffolds for Bone Regeneration
V. Guarino1, F. Causa2, G. Ciapetti3, D. Martini4, N. Baldini3, L.
Ambrosio1
1Institute of Composite and Biomedical Materials, CNR P.le
Tecchio 80, 80125, Naples, Italy.
2Department of Experimental and Clinical Medicine, University
of Magna Graecia, Germaneto, 88100, Catanzaro, Italy.
3Laboratory for Pathophysiology of Orthopaedic Implants, Istituti
Ortopedici Rizzoli, via di Barbiano 1/10, 40136 Bologna, Italy.
4Department of Human Anatomy, University of Bologna, via Ir-
nerio 48, 40126 Bologna, Italy.
The employment of composite scaffolds with a well-organized
architecture and multi-scale porosity certainly represents a valu-
able approach for achieving tissue engineered construct able to
reproduce the middle and long-term ‘‘in vitro’’ behaviour of hi-
erarchically complex tissues such as spongy bone. In this paper, it
was proposed a PCL/PLA composite scaffold (fibres of PLA in
PCL matrix), prepared through the synergic use of phase inversion
and salt leaching technique, commonly employed in the scaffold-
ing for tissue engineering, and the filament winding technology,
traditionally used in the composite material engineering. Con-
tinuous fibres integrated with the polymeric matrix allow mim-
icking the collagen fibres spatial organization of the ECM present
in all tissues and, then, also support the stress transfer from the
polymer matrix, moving towards mechanical performances like
mineralized tissues.
Proposed scaffolds, examined according to the conventional
analytical methods (i.e. mercury intrusion porosimetry), shows
very interesting pore morphological features in terms of porosity
degree and bi-modal pore size distribution which embraces the
basic requirements for reaching 1) an adequate supply of nutrients
by diffusion into tissue culture media in vitro or through newly
formed blood vessels in vivo, 2) an optimal ingrowth of the healing
bone tissue. The attachment and cell proliferation of human bone
cells (marrow stromal cells, trabecular osteoblasts) cells confirmed
the main contribution of the scaffolds morphology on the cell/
material interaction. In detail, changes in polymer fibers induced
by the interaction with MSC and HOB in vitro adumbrate the
potential active role in vivo of the scaffold.
(P 266) Mri Depiction and Quantification of Blood-Spinal-
Cord-Barrier Permeability After Spinal Cord Contusion
Injury
N. Walder1, Z. Majdisova2, E. Sezemsky1, P. Szomolanyi2,
M. Brejnikow1, R. Schmidhammer1, S. Trattnig2, H. Redl1
1Ludwig Boltzmann Institute for Experimental and Clinical
Traumatology in the Research Center of the AUVA, Vienna,
Austria, Austrian Cluster for Tissue Regeneration.
2MR Center of Excellence, Department of Radiology, Medical
University Vienna, Vienna, Austria, Austrian Cluster for Tissue
Regeneration.
Objectives: The Blood-Spinal-Cord-Barrier (BSCB) represents a
selective physiologic barrier that provides a stable microen-
viroment within the neuronal tissue. Spinal cord injury (SCI)
causes a BSCB breakdown, which results in increased capillary-
permeability for plasma molecules that increase neuronal dam-
age as well as for intravenously administered neuroprotective
drugs.
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Here we used contrast enhanced MRI to determine evolution and
duration of BSCB-breakdown after standardized SCI and define
the ‘‘therapeutic window’’ for this injury model.
Materials/Methods: In male Sprague-Dawley rats, a lami-
nectomy was carried out at TH11 and a contusion injury was in-
flicted, using the IH Impactor with a force of 150 kdyn. Rats were
divided into groups with different observation times: 0h (n¼ 8);
24 h, 72 h, 4 d, 6 d, 10 d (n¼ 5 each).
At the end of the observation time each rat received an intra-
venous injection of 0.8ml/kg gadopentetate dimeglumine (Mag-
nevist, Bayer HealthCare). Rats were euthanized 10minutes (0 h
group, n¼ 3) or 1 hour after contrast agent administration and MRI
was performed on a 3Tesla scanner.
Results: Pronounced signal enhancement at the injury epicenter
was measured after observation periods up to 4 days, gradually
decreasing in cranial and caudal direction. After 6 days or later, no
signal enhancement was visible.
When euthanization and MRI were performed 10minutes after
contrast agent application, signal increase was mainly detectable in
the SC arteries, whereas distribution within the neuronal tissue
could be observed after 1 hour.
Conclusion: The inflicted SCI increases BSCB-permeability for
4 days. Delayed dispersion of the contrast agent within the neu-
ronal tissue has to be considered.
(P 267) Mri Visualization of Human Mesenchymal Stem Cells
Targeting Brain Tumors in an Orthotopic Mouse Model
D. Delo1, D.T. Josiah1, D. Zhu1, T. Atwood1, H. Caldas1
1Department of Neurosurgery and Brain Tumor Center of Ex-
cellence, Wake Forest University School of Medicine Winston-
Salem, NC, USA.
An estimated 20,500 people in the United States were diagnosed
with primary brain tumors in 2007, with gliomas comprising ap-
proximately 60% of these cases. Glioblastoma multiforme (GBM)
representing the most malignant and most common glioma. GBM
remains virtually untreatable despite extensive surgical resection,
radiotherapy and chemotherapy. Treatment difficulty is amplified
because of their exceptional migratory nature and their predilec-
tion to integrate into normal brain tissue. Recently it has been
suggested that adult mesenchymal stem cells have the potential
to seek, migrate and integrate into brain tumors. We hypothesize
that human mesenchymal stem cells (hMSCs) homing capabili-
ties could be exploited to seek out and delineate brain tumors re-
gardless of their size or location using superparamagnetic/
fluorescent particles (FSPMP). This strategy could allow for the
detection of newly developing smaller tumors or areas of tumor
infiltration that would otherwise go undetected and consequently
untreated.
HMSCs were intracellularly labeled with FSPMP and were
easily visualized by fluorescence and magnetic resonance imaging
for up to 11 weeks; furthermore using in vitro studies, we were able
to detect the labeled hMSCs at single cell level by MRI. In vivo
studies using a murine orthotopic GBM xenograft model demon-
strated that FSPMP labeled hMSCs were able to migrate towards
established intracranial gliomas and were detectable after intra-
cranial injection by both fluorescence and MRI.
In conclusion, our data suggest that hMSCs labeled with su-
perparamagnetic particles are a promising adjunctive strategy for
brain tumor therapy that could result in earlier diagnosis and better
evaluation of the therapeutic regimen.
(P 268) Multicomponent Scaffold for Osteochondral Defects
Tissue Engineering
A. Motta1, D. Maniglio1, E. Merzari1, C. Foss1, E. Bella1,
C. Migliaresi1
1Department of Materials Engineering and Industrial Technolo-
gies, University of Trento, Trento, Italy.
In tissue engineering approaches for osteochondral defects repair,
different techniques are currently evaluated: cell therapy, the use of
active molecules to stimulate the repair process and finally the use
of 3-D scaffolds, eventually combined with cells and-or growth
factors. An osteochondral graft should distribute and support static
and dynamic loads, protect trabecular bone, present a smooth
surface and a low coefficient of friction of the cartilage side, and
possess adequate wear resistance. Moreover, it should allow
growth and proliferation of osteoblasts from the bone side and
chondrocytes of the articular cartilage while consenting a close
biochemical dialogue between those cell types.
On the basis of the above requirements, a multicomponent
asymmetric scaffold made by two silk fibroin-based sponges sep-
arated by an electrospun nanometric biodegradable polymer net
have been prepared. The aim of the net is to avoid the migration of
osteoblasts to the cartilage site and the passage of blood cells from
the subchondral vascularized zone. Sponges have been prepared by
using fibroin/PEG blends, at different PEG content, for the chon-
dral site and pure fibroin for the subchondral site, being PEG ca-
pable of reducing proliferation rate of chondrocytes. Nets have
been prepared by electrospinning of PDLA. The single model
scaffold components have been characterized by traditional
physico-chemical techniques and separately seeded with osteo-
blasts or chondrocytes in static conditions, while cell culture ex-
periments under dynamic compressive loads have been performed
on the assembled scaffold by using a made-in-house bioreactor.
Aknowledgements: Expertissues NoE is aknowledged for the
support.
(P 269) Muscular Compensation in Patient with Massive
Rotator Cuff Tear: Superficial Electromyography Study
P. Ciampi1, N. Mancini1, G.M. Peretti1,2, G. Fraschini1
1Department of Orthopedics and Traumatology, San Raffaele
Scientific Institute, Milan, Italy.
2Faculty of Exercise Sciences, University of Milan, Italy.
The shoulder girdle is an extremely mobile joint. Rotator cuff tears
alter the existing equilibrium between bony structures and muscles.
The ‘‘subacromial impingement syndrome’’ resulting from this
unbalance leads to an extension of the rotator cuff lesion.
Many authors have postulated a mechanism of compensation,
but its existence still requires evidence. According to this model,
the longitudinal muscles of the shoulder and the undamaged mus-
POSTER PRESENTATIONS 883
cles of the rotator cuff would be able to functionally compensate,
supersede the function of rotator cuff, and reduce symptoms.
The aim of this study was to evaluate muscular activation of the
medium fibers of deltoid, the superior fibers of pectoralis major,
the latissimus dorsi and the infraspinatus by a superficial electro-
myographic study (EMG) and the analysis of kinematics in patients
with a massive rotator cuff tear.
We evaluated 30 subjects: 15 had pauci-symptomatic massive
rotator cuff tear (modest pain and preserved movement), and 15
were healthy controls.
Paired and unpaired t-test showed significant different activa-
tions (p< 0.05) of these 4 muscles between the pathological and
healthy joints in the same patient and between the experimental
group and control group.
This study showed that a mechanism of muscular compensation
is activated in patients suffering from rotator cuff tear involving the
latissimus dorsi and the pectoralis major. It is therefore probable
that in these patients, these muscles adapt in order to compensate
for the pathological situation. We believe that these data are
valuable in the surgical and rehabilitation planning of patients with
massive rotator cuff tear.
(P 270) Myocardial Tissue Engineering: The In Vitro Gen-
eration of a Vascularized 3D Matrix
Antonia Ba¨r1, Philipp Fischer2, Axel Haverich3, Andres Hilfiker1
1LEBAO, Medical School Hannover, Hannover, Germany.
2Cardiology & Angiology, Medical School Hannover, Hannover,
Germany.
3Cardiac, Thoracic, Transplantation & Vascular Surgery, Medical
School Hannover, Hannover, Germany.
Background: A major problem in generating 3D-artificial myo-
cardial tissue is an efficient supply of oxygen and nutrients to cells
in vitro. Here we report the generation of an in vitro vessel-bed
based on biological vessel structures for vascularization of artifi-
cial tissue constructs.
Methods: Dezellularized segments of porcine small intestine
with preserved pedicles were cut open along longitudinal axis and
resulting patches were sutured to silicone cushions. Vessel struc-
tures were reseeded with 5107 TAMRA labeled human cord
blood derived endothelial cells (hCBEC) and cultivated in perfu-
sion bioreactor for 4 or 14d. Fluorescence microscopy was per-
formed to detect seeded cells in the construct. Oxygen saturation,
pH, Glucose and Lactate were measured during cultivation.
Results: Immunohistochemistry against Laminin and Collagen
IV revealed the intactness of the basal lamina in the vessel bed.
Adherence of hCBEC to these proteins was shown by attachment
experiments in vitro. Glucose reduction and Lactate accumulation
were indicative for the metabolic activity of the seeded hCBEC.
Monitoring of pH and oxygen saturation showed a slight shift in
pH to 7.0 and a constant level of oxygen saturation of 99%, indi-
cating proper culture conditions provided by the bioreactor. Over
time an increasing colonisation of vessels by hCBEC was ob-
served. Dil-acLDL assay revealed endothelial character of seeded
hCBEC.
Conclusion: Our constructs may be a first step towards the
generation of 3D-artificial vascularized myocardial tissue for sur-
gical reconstruction. The use of these patches might serve for other
3D-artificial tissue constructions as well.
(P 271) Nanofiber and Polyester Culture Plates for a High
Throughput Functional and Morphological Studies
C.M. Moon 1, Y.J. Choi2, T.G. Jung2, Z.G. Xu1, J.E. Lee1,
J.Y. Han1, H.I. Bae1,2
1Kyungpook National School of Medicine.
2CorePath Ltd.
According to development of nanotechnology, biocompatible
nanofibers have been studied with synthetic and natural polymers
as wound dressings, drug delivery systems, vascular grafts, and
scaffolds for tissue engineering. Adhesion of cells on surface is
important fields of cell culture and tissue engineering. Poly(3-
hydroxybutyrate-co-3-hydroxyvalerate)(PHBV) is one of the most
promising materials for tissue engineering. Composite solution of
PHBV and the natural calf collagen peptide (PHCP) were dis-
solved in 2 wt% 2,2,2-trifluoroethanol(TFE) and the composite
nanofibers were electrospun on polyethylene terephthalate(PET)
film, which were carefully cut and moulded to fit precisely to
each well sizes of 24, 48, 96 well culture plates and the round-
cut nanomesh discs were located on the bottoms of the wells in
a plate(nanomesh plates). In this study, nanomesh and type I
collagen-coated PET disc plates (polyester plates) were also ap-
plied for the cell culture. The HCT116 colon cancer cells was
spread on the both plates and cultured with anticancer drugs. The
results were determined by MTT test, Calcein-AM assay, SEM,
double IF, and immunocytochemistry. The nanomesh discs are
exceptionally easy to freeze in a cryovial, to store in a LN2 tank,
and to reculture the cells. The nanomesh plates should be a good
support for three-dimensional cell and tissue culture and engi-
neering. The polyester plates were very convenient for morpho-
logical and functional tests of the cells. The 96 well nanomesh and
polyester discs should be useful for a high throughput evaluation of
different drug-treated cells or cell lines at the same time.
(P 272) Nanoscale Modification of Biological Polymer Surface
via Vacuum Ultraviolet Irradiation
E.A. Remeeva1, E.A. Nemets1, V.I. Sevastianov1
1Centre for Biomaterial Research, National Research Institute for
Transplantology and Artificial Organs, Moscow, Russia.
The effect of the vacuum ultraviolet (VUV) treatment of the poly
(hydroxybutyrate-co-hydroxyvalerate) (PHBV) films onto their
physicochemical and biological properties was studied. The air
pressure during irradiation process was 0.02, 2.5 and 10 Torr. Sur-
face topography was studied by means of AFM. Surface hydrophi-
licity degree was determined by its wetting contact angle value. XPS
technique was used for surface chemistry analysis. Total internal
reflection fluorescence method was applied for irreversible human
serum albumin (HSA) adsorption study. Platelet adhesion was in-
vestigated using scanning electron microscope (SEM). NIH 3T3
mouse fibroblasts were cultured on all samples for 1, 3 and 6 days
and observed by SEM. Topography of PHBV surface became
smoother after VUV irradiation. RMS roughness of surface (Rq)
reduced from 81nm for the untreated PHBV to 22–40 nm for the
VUV-treated one. The increase of pressure in the reactor chamber
leads to contact angle decrease (82 degrees for untreated and 62 for
modified samples). Noticeable changes were revealed in C-C, C-H
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(from 25% to 52%) and C-O-C, C-OH (from 55% to 36%) groups
containing. It was shown that VUV modification decreases amount
of HSA adsorbed (from 63.4 to 30.9 ng/cm2) and minimizes platelet
activation (in 2.5 times) and adhesion (in 6 times). For VUV-treated
samples fast cell attachment and growth was registered. Fibro-
blasts were well-spread and showed a polygonal cell shape. VUV-
irradiation seems to be a possible modification to enhance hemo- and
biocompatibility of the PHBV films. Such matrices may be recom-
mended for in vitro cell culturing with subsequent transplantation.
(P 273) Nanostructured Polymeric Constructs as Blood Sub-
stitutes
A. Dessy1, A. M. Piras1, F. Chiellini1
1Laboratory of Bioactive Polymeric Materials for Biomedical and
Environmental Applications (BIOlab)—UdR INSTM, Department
of Chemistry, University of Pisa, Via Vecchia Livornese 1291,
56122 S. Piero a Grado, Pisa (Italy).
The present work is aimed at the development of biopolymeric
nanoparticles to be used as blood substitutes. Developing alterna-
tive strategies to commonly used blood transfusion is essential
because of the fewness of donor, the short time storage of blood
samples and the presence of blood antigens. Two alternative
polymeric matrices were used, the synthetic 2-methoxyethanol
hemiesters of poly(maleic anhydryde-alt-butylvinylether) grafted
with polyethylen glycol (PEG) VAM41-PEG and the natural de-
rived polymer Alginate. Hemoglobin loaded nanoparticles based
on VAM41-PEG were prepared by means of the co-precipitation
technique. The process was performed under controlled conditions
(N2 atmosphere, 48C), in the presence of reducing agents (such as
ascorbic acid and methylene blue).
The prepared nanoparticles have shown a spherical morphology
and a diameter distribution of about 140 nm, detected by means of
Scanning Electron Microscopy (SEM) and light scattering analy-
sis, while the quantification of loaded haemoglobin, performed by
means of Drabkin’s assay, revealed a protein loading of about 50%.
Zeta potential measurements confirmed PEG chains exposure on
nanoparticles surface giving these structures stealth properties
once in-vivo.
Alginate beads loaded with Hemoglobin were obtained via io-
nical gelation with a diameter of about 2mm. UV-Vis analysis
revealed that the protein maintain its functionality when loaded
inside these structures.
Although further investigation aimed at testing alternative re-
ducing agents, modifying the starting polymeric matrix and re-
ducing Alginate beads size are currently ongoing, these results
appear promising in order to produce polymeric nanoparticles to be
used as blood substitutes.
(P 274) Neo-Artery In Vivo Re-Growth using a Tissue-
Engineered Hyaluronan Based Scaffold
V. Vindigni1, B. Zavan1, S. Lepidi1, R. Cortivo1, G. Abatangelo1
1University of Padova, Dpt. Histology, Italy.
The development of vascular tissue engineering has emerged as a
promising technology in the design of an ideal, responsive, living
conduit with properties similar to that of the native tissue.
The missing link in tissue engineered blood vessels is the elastin
biosynthesis. Several biomaterials are currently used in this field
but few of them support elastin biosyntheses in three dimensional
arrangement. Aim of the present study was to test the ability of
HYAFF 11 biodegradable grafts to develop a neo-vessel of
larger sizes in a porcine model, focusing on extracellular matrix
remodelling and elastin biosynthesis.
HYAFF 11 tubes were implanted in an end-to-end fashion in
the common carotid artery. Grafts were analysed for patency using
Duplex-scan every 15 days. Results were evaluated by histology and
molecular biology to evaluate extracellular matrix and components.
All the animals survived the observation period without com-
plications. Intimal hyperplasia and graft thrombosis were the cause
of occlusion as demonstrated by histological examination. There
were no signs of stenoses or aneurysms in the remaining grafts. At
5months, the biomaterial was almost completely degraded and
replaced by a neo-artery segment composed of mature smooth
muscle cells, collagen and elastin fibres organized in layers, and
completely covered on the luminal surface by endothelial cells.
Although patency rates seem to be inferior to those obtained in
previous small animal studies, Hyaluronan-based grafts of larger
size confirmed the ability to guide the development of a well
functioning neo-artery, with the remarkable property of forming
organized layers of elastin fibres.
(P 275) New Generation Bioactive Composites Promoting
Growth of Adult Human Mesenchymal Stem Cells
E. Pamula1, K. Cholewa-Kowalska2, J. Kokoszka2, E. Knight3,
A.M. Osyczka3
1AGH-University of Science and Technology, Faculty of Mate-
rials Science and Ceramics, Department of Biomaterials.
2AGH-University of Science and Technology, Faculty of Mate-
rials Science and Ceramics, Department of Glass Technology and
Amorphous Coatings.
3Jagiellonian University, Faculty of Biology and Earth Sciences,
Institute of Zoology, Department of Cytology and Histology.
Bioactive materials are recognized in orthopedics, dentistry and
oral surgery for their superior integration with bone tissue. The
bioactive properties of certain glasses and glass-ceramics are at-
tributed mostly to the spontaneous hydroxyl carbonate apatite
(HCA) formation on their surface. Incorporation of bioactive glass
into a metal, hydroxyapatite or polymer matrix offers several bi-
ological advantages such as a higher bioactivity and better integrity
with a host tissue. Thanks to addition of bioactive glass it is also
possible to control degradation kinetics of the resulting compos-
ites. We report here manufacturing procedures and biological
properties of new hydroxyapatite (HA) and poly L-lactic-co-
glycolic acid (PLGA) composites with bioactive glass. Starting
compounds included bioactive glass of CaO-P2O5-SiO2 system
obtained by the sol-gel method, two synthetic and one natural
hydroxyapatite powders, and PLGA. Composites HA/bioglass and
PLGA/bioglass were obtained by sintering HA-bioglass powder
mixture at 1100–1300oC, and by solvent casting of polymer-
bioglass powder mixture followed by drying in air and vacuum,
respectively. All composites showed homogenous HCA layers on
their surfaces after contact with simulated body fluid (SBF). Bone
marrow-derived adult human mesenchymal stem cells were seeded
on the material surfaces at a density of 10000 cells/cm2 and
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cultured up to 7 days. A significant increase of live cell number was
observed for bioactive glass-containing composites compared to
starting compounds. We propose the new bioactive glass-based
composites as promising biomaterials supporting growth of adult
human mesenchymal stem cells.
(P 276) New Hydrophilic, Partially Degradable and Bioactive
Cements (HDBC) to Improve Interface with Bone
A. C. Mendes1,2, L. F. Boesel1,2, R. L. Reis1,2
13B’s Research Group—Biomaterials, Biodegradables and Bio-
mimetics, Dept. of Polymer Engineering, Univ. of Minho, Campus
de Gualtar, 4710-057 Braga, Portugal.
2IBB—Institute for Biotechnology and Bioengineering, PT Gov-
ernment Associated Laboratory, Braga, Portugal.
Acrylic bone cements aim to fix prosthesis to bone during hip
arthroplasty. The commercial acrylic bone cements perform their
function, however at the long term they fail due to aseptic loos-
ening of two interfaces: prosthesis-cement and cement bone. To
minimize these problems, the bone growth should be promoted on
the surface and inside of the partially degradable bone cement.
In our work five different formulations were developed con-
taining in the powder a biodegradable component such as modified
corn starch with acrylic segments (methacrylated starch) as well
cellulose acetate blended with corn starch (SCA). These compo-
nents reacted with acrylic monomers (methylmethacrylate (MMA)
and 2-hydroxyethyl methacrylate (HEMA)) to produce hydrophilic
partially degradable bone cements by radical polymerization. Di-
verse molar ratios MMA/HEMA as well the amount of initiator/
activator were employed in such cements.
The residual monomer content was studied by 1H NMR in these
new formulations allowing the selection of the two with less
amount of residual monomer for later degradation studies. Higher
concentration of reducing sugars was found (0.42 mg/mL) in
samples immersed in PBS supplemented with a-amylase counter-
acting with samples without enzyme (0.01 mg/mL) suggesting that
enzymatic degradation had occurred. This result was confirmed by
percentage of weight loss as well as morphologic analyses.
Our study revealed that bone cements performed with metha-
crylated starch seem to be promising due to less content of released
monomer and good degradability properties, promoting at later
stages bone growth by cellular adhesion and improvement of the
interface with bone.
(P 277) New Pamam Dendrimers/Alginate Nanoparticles for
Gene Delivery
S. Sargo1, J.L. Santos1, J. Rodrigues1, A.P. Peˆgo2, P.L. Granja2,
H. Toma´s1
1Centro de Quı´mica da Madeira, Departamento de Quı´mica,
Universidade da Madeira, Campus Universita´rio da Penteada,
9000-390 Funchal, Portugal
2INEB—Instituto de Engenharia Biome´dica, Universidade do
Porto, Rua do Campo Alegre, 823, 4150–180 Porto, Portugal
The basic idea in tissue engineering via gene delivery is to promote
cell proliferation and differentiation inside a scaffold as well as the
secretion of mitogens and/or morphogens from cells by gene
transfection and expression. Efficient gene delivery vectors should
thus be developed to accomplish this objective.
PAMAM (poly(amidoamine)) dendrimers with cationic termini
have been used as vectors for gene delivery, being the results very
promising. Nevertheless, several studies report concentration and
generation dependent dendrimer toxicities. So, we hypothesized
that a possible way to minimize this problem would be to combine
the dendrimers with alginate, a natural anionic polymer that has
found biomedical and biotechnology applications due to its bio-
compatibility and biodegradability.
The aim of this work was then to prepare and characterize a new
family of nanoparticles based on PAMAM dendrimers and alginate
able to act as vectors for gene delivery and presenting reduced
cytotoxicity. Different generations of dendrimers, as well as algi-
nates with different ranges of molecular weight were used. Na-
noparticles varying in composition, size distribution and charge
were obtained, characterized and their in vitro cytotoxicity was
evaluated by the MTS assay using HEK 293T cells. Nanoparticles
transfection efficiency was assessed using the same cell line and a
plasmid containing the b-galactosidase gene.
(P 278) New Platelet-Rich Plasma Based Membrane with
Improved Mechanical Properties
E. Lucarelli1, R. Beretta2, B. Dozza1, S. Squarzoni3, C. Divieto1,
G. Tresca1, D. Donati1
1Bone Regeneration Laboratory, Research Institute Codivilla-
Putti, Rizzoli Orthopaedic Institute, Bologna, Italy.
2Cascade Medical Enterprises LLC, Wayne NJ, USA.
3Institute of Molecular Genetics (IGM)-CNR, Unit of Bologna c/o
Rizzoli Orthopaedic Institute, Bologna, Italy.
Platelet-rich plasma (PRP) is used in a variety of surgical settings
for soft tissue healing enhancement. It is used in orthopaedic surgery
and especially in oral maxillofacial surgery where it accelerates
autogenous bone graft healing. Once injected, or implanted, PRP is
supposed to release locally growth factors for several days inducing
tissue repair. PRP is currently available in liquid or gel form that has
no, or poor mechanical properties and makes difficult the handling
and the confinement of the growth factors at a specific location in
open surgery. We investigated whether PRP mechanical properties
could be improved. We obtained a PRP a disk-shaped that we
named PR-fibrin matrix (PRFM). The PRFM obtained had a tear
elastic modulus of 163þ 11 and a tear load of 267þ 36. PRFM
maintained its mechanical properties during the period it was being
tested (18 days). We also tested whether the PRFM could also be
used as a scaffold for cell delivery. Results demonstrated that PRFM
supported the culture and the delivery of mesenchymal stem cells
(MSC). The improved mechanical properties of PRFM make the
membrane easy to be handled. Furthermore, PRFM provides a solid
scaffold for cell application that can contribute to bone and tissue
regeneration.
(P 279) New Thermo-Responsive Hydrogels Based on
Hyaluronic Acid/ Poly(N-Isopropylacrylamide) Semi-
Interpenetrated Polymer Networks: Swelling Properties and
Drug Release Studies
Joa˜o R. Santos1,2, Nata´lia M. Alves1,2, Joa˜o F. Mano1,2
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2IBB—Institute for Biotechnology and Bioengineering, PT Gov-
ernment Associated Laboratory, Braga, Portugal.
Smart or stimuli-responsive hydrogels present the ability to change
their volume or shape in response to an environmental signal. They
have attracted great interest due to their potential application in
biomedical areas such as drug delivery and tissue engineering.
Among the family of temperature intelligent hydrogels, poly(N-
isopropylacrylamide) (PNIPAAm) -based hydrogels show reversible
volume phase transitions during heating/cooling across a certain
temperature (~328C), which corresponds to its lower critical solution
temperature (LCST). These hydrogels significantly reduce their
volume upon heating above the LCST and increase their volume
upon cooling below the LCST. In this work semi-interpenetrating
polymer networks (semi-IPNs) composed of PNIPAAM and hya-
luronic acid (HA), which is a biodegradable, biocompatible, and
natural pH-responsive polysaccharide, were prepared for pH/
temperature–sensitive swelling and drug delivery studies. N,N0-
methylenebisacrylamide was used to crosslink PNIPAAM. It was
found that when the temperature increased the prepared HA/PNI-
PAAM hydrogels showed a faster deswelling than PNIPAAM hy-
drogels preparedwith the same crosslinking degree. The reversibility
of the pH- and temperature-dependent behaviour was also analysed
for the developed semi-IPN hydrogels. Regarding the drug release
studies, gentamicin was incorporated (as model drug) and the release
profile was followed in the two hydrogels (with and without HA).
(P 280) NMR Spectroscopy—a Powerful Tool in Quality
Control of Biosynthetic Mineralized Composite Materials
R. A. Brooks 1, M. J. Duer2, C. N. Grover2, D. G. Reid2
1Orthopaedic Research Unit.
2Department of Chemistry.
Solid state nuclear magnetic resonance spectroscopy (SSNMR) is
a powerful tool for characterizing biomaterials. Easily measured
13C NMR properties can give significant information about
composition, from resonance frequencies, and short range struc-
tural order, from resonance frequency dispersion, with less ordered
structures tending to show broader signals.
We are currently using SSNMR to study a variety of natural and
in vitro-derived biominerals, such as from mineralizing cell lines
(Saos-2 and MC3T3) and rat foetal calvarial cells. The primary aim
of this work is to optimize biosynthesis of functional 3D scaffolds
for biomineralization, while a secondary goal is the incorporation
of NMR-active nuclei to aid assignment and structural character-
ization. The SSNMR is particularly useful in establishing whether
collagen has been expressed, and if so whether it is possessed of the
high degree of order which would be supposed necessary if it were
to act as a scaffolding or templating structure for biomineral de-
position. In particular the presence of a signal from the 3-carbon of
hydroxyproline, at about 71 ppm, is a good diagnostic of collagen
production, and its linewidth of structural ordering. Initial data
show that the rat calvarial cells are producing bone-like biomineral
within a collagenous matrix which however is not as ordered as that
of bone itself. Under our culture conditions however the two cell
lines are failing to produce significant collagen, or if they are it is
highly disordered and therefore unlikely to be an effective scaffold.
(P 281) Non Invasive Longitudinal Tracking of Human
Amniotic Fluid Stem Cells in the Mouse Heart
D.M.Delo1, J. Olson2, P. Baptista1, J.M. Zhu2, A. Atala1, S.Soker1
1Wake Forest Institute for Regenerative Medicine, Wake Forest
University Health Sciences.
2Wake Forest University Center for Biomolecular Imaging.
Recently, stem cells have been isolated from human amniotic fluid
(hAFS), and have potential applications for therapies. However,
the clinical implementation of these therapies introduces the need
for methods of noninvasive tracking of AFS cells. The purpose of
this study was to evaluate a high resolution magnetic resonance
imaging (MRI) technique for in vivo detection and tracking of
superparamagnetic micron sized iron oxide particle (MPIO)-
labeled AFS cells injected in the mouse heart. MRI images of
mouse heart were acquired at set time-points during the 4 week
course of this longitudinal study. At the end of the study, histo-
logical analysis was used to correlate cell localization with the
MRI results. Introduction of MPIOs into hAFS had no significant
effect upon cell proliferation and differentiation. Flow cytometry
analysis indicated that hAFS cells remained labeled for up to 4
weeks. MRI of MPIO-labeled hAFS cells injected in agarose gels
resulted in significant hypointense regions. Labeled hAFS cells
injected into mouse hearts produced hypointense regions in the MR
images that could be detected 24 hours and 7, 14, 21 and 28 days
post injection. The co-localization of labeled cells within the hy-
pointense regions was confirmed by histological analysis. These
results indicate that MRI can be used successfully for noninvasive
tracking of AFS cells injected in the mouse heart. The potential
utility of this finding is that injected stem cells can be tracked
in vivo in the heart and might serve as a noninvasive method to
longitudinally monitor cell survivability, proliferation and inte-
gration into myocardial tissue.
(P 282) Non-Invasive Imaging of Collagen Type I Expression
in a Transgenic Mouse Model
J. Liu1, R. Arends2, A. Martens3, C.A. van Blitterswijk1, J. de
Boer1
1Department of Tissue Regeneration, Institute for Biomedical
Technology, University of Twente, Enschede, The Netherlands.
2Pharmacology Department, NV Organon, Oss, The Netherlands
3Department of Immunology, University of Medical Center
Utrecht, Utrecht, The Netherlands.
Background: One strategy in bone tissue engineering is to combine
cells, biomaterials and growth factors, and to implant these ac-
tive scaffolds in animal models to evaluate bone formation. The
current evaluation methods are time-consuming, invasive and dif-
ficult to quantify. Furthermore the dynamic nature of bone regen-
eration is ignored. In vivo bioluminescent imaging (BLI) may
be a strategy to overcome these problems. In this study, a transgenic
mouse model for collagen (I)-luciferase was evaluated under sev-
eral bone remodeling processes to validate this reporter for future
use in bone regeneration.
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Results: Collagen (I)-luciferase mice emitted very strong light
from the bony parts of the body, such as the vertebral column,
paws, feet, jaw and joints. The light intensity was highest at young
age and dropped dramatically in the first six months. Ovariectomy
did not significantly change the luciferase signal. In contrast, in
another bone remodeling model in which we created a Ø1mm hole
in one of the vertebra in the tail, we observed higher light intensity
from that area compared with sham mice. The intensity peaked
around 20 days after operation, and returned to the basal level after
8 weeks. We are currently investigating BLI of ectopic bone for-
mation by implanting ceramic BCP particles with BMP2.
(P 283) Novel Biosensor Based Polymer for Blood Glucose
Detection
Fahmy Sherif1, Amatai Gabrial1, Koepsel Richard1, Russell Alan1
1Mcgowan insitute for reg. Medicine, university of Pittsburgh.
A novel polymeric nanofiber loaded with enzyme for the detection
of blood glucose level has been developed and optimized. The new
device can detect the glucose level down to small concentration
with a very high accuracy.
(P 284) Novel Cell-Seeded, Tubular-Shaped and Highly Dense
Collagen Gel for Tissue Engineering
L.A. Micol1, M. Ananta2, V. Mudera2, J.A. Hubbell1, R.A.
Brown2, P. Frey1,3
1EPFL Laboratory for Regenerative Medicine & Pharmacobiol-
ogy, Integrative Biosciences Institute, 1015 Lausanne, Switzerland.
2UCL Tissue Repair & Engineering Centre, Institute of Ortho-
paedics, Stanmore Campus, HA7 4LP, United Kingdom.
3CHUV Laboratory of Experimental Pediatric Urology, Depart-
ment of Pediatric Surgery, 1011 Lausanne, Switzerland.
Collagen is known to be the most abundant protein in mammals. It
gives structure, consistency and resistance to soft tissues. Many of
these tissues are anatomically composed of tubes. We developed a
new method to obtain a readily cell-seeded and tubular-shaped
scaffold based on collagen gel. The resulting construct has an es-
pecially high collagen density and is characterized by very inter-
esting mechanical properties for tissue engineering regarding for
example burst pressure and water tightness. We showed that pri-
mary smooth muscle cells of human urinary tract origin seeded in
this scaffold could proliferate during 14 days (end of the culture).
These results support that the obtained scaffold is a significant step
towards regenerative medicine of tubular anatomic structures such
as blood and lymphatic vessels or urinary tract.
(P 285) Novel Collagen and Ceramic Based 3D Biomaterials
for Tissue Engineering Applications
S. Ro¨ker1, S. Diederichs1, Y. Stark1, S. Bo¨hm1, I. Ochoa2, J.A.
Sanz2, J.M. Garcia-Aznar2, M. Doblare´2, M. van Griensven3,
T. Scheper1, C. Kasper1
1Institut fu¨r Technische Chemie, Leibniz Universita¨t Hannover,
Callinstr. 3, 30167 Hannover, Germany.
2Dpt. Of Mechanical Engineering, Universidad de Zaragoza, Be-
tancourt Building, Maria de Luna 7, 50018 Zaragoza, Spain.
3Ludwig Boltzmann Institute for Experimental and Clinical Trau-
matology,Donaueschingenstrasse 13, 1200Wien (Vienna),Austria.
The principle of Tissue Engineering is to build artificial replace-
ments by means of vital components. In order to achieve a func-
tional graft, applicable cells were seeded on three-dimensional
scaffolds and expanded in vitro.
The common used cell culture techniques generate cell layers,
but it is not possible to create a three dimensional, functional
multilayer cell structure on the surface of a cell culture dish.
Therefore, three dimensional scaffolds are necessary, which pro-
vide a specific environment and architecture for the formation of
the tissue.
The scaffolds must accomplish several requirements. The most
important attribute of the scaffold has to be its biocompatibility.
Furthermore, the material composition and structural characteris-
tics are very important. The surface constitution should promote
the adhesion of the cells and a porous structure assures the supply
with nutrition and the removal of metabolic waste of cells. In
addition to the macroporous structure, microporosity is beneficial
for capillary ingrowth and cell-matrix interactions. Moreover, the
design of the scaffold should provide the neovascularisation from
the surrounding tissue when it is implanted in to the patients defect.
Numerous materials have already been tested for their applica-
bility, and both ceramics and natural and synthetic polymers are
the most promising materials for Tissue Engineering. In this study,
we characterized collagen- and ceramic based scaffold materials
with regard to their three dimensional structure and biomechanical
properties. Different applications including the dynamic cultiva-
tion on these cell seeded scaffolds in a novel rotating bed reactor
are presented.
(P 286) Novel Conjugates of Dendrimers and Fatty Acids for
Gene Delivery Applications
J.L. Santos1, J. Rodrigues1, A.P. Pego2, P.L. Granja2, H. Tomas1
1Centro de Quı´mica da Madeira, Departamento de Quı´mica,
Universidade da Madeira, Campus Universita´rio da Penteada,
9000-390 Funchal, Portugal.
2INEB—Instituto de Engenharia Biome´dica, Universidade do
Porto, Rua do Campo Alegre, 823, 4150-180 Porto, Portugal.
Polycationic dendrimers, such as polyamidoamine (PAMAM)
dendrimers with amino termini, have been studied as gene delivery
vectors in unmodified and modified forms with a relative success.
However, our previous experience revealed that mesenchymal
stem cells (MSC), as well as osteoblastic cells (both cell lines and
differentiated cells derived from bone marrow), which have par-
ticular importance in the scope of bone tissue engineering, are very
difficult to transfect in vitro using PAMAM dendrimers.
In the present work, different generations of PAMAM den-
drimers were coupled with fatty acids (lauric, miristic and palmitic
acids) with the goal of improving their performance as DNA car-
riers. We explored the idea that the hydrophobic character of the
fatty acid moieties could positively contribute for the transport of
the vector/DNA complexes across the plasma membrane.
The conjugation of the fatty acids with the dendrimers was
performed and the conjugates were characterized by NMR and MS
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techniques. Their cytotoxity was assessed by using the MTS assay.
The complexes formed between the conjugates and plasmid DNA
were characterized in terms of charge and size, by means of the
DNA retention assay, as well as zeta potential determination and
particle size measurement. The transfection efficiency was evalu-
ated in MSC cultures using a plasmid DNA containing the Green
Fluorescent Protein reporter gene. A correlation between vectors
structure and their performance is proposed.
The support of the FCT-Portuguese Foundation for Science
and Technology through the J.L.Santos Ph.D. grant (SFRH/BD/
19450/2004), the Project PTDC/SAU-BEB/71161/2006 and the
NMRNational Network (REDE/1517/RMN/2005) is also acknowl-
edged.
(P 287) Novel Dexamethasone Releasing Multicomponent
Implant
L. Nikkola1, H. Jukola1, K. Vapalahti1, N. Ashammakhi1
1Tampere University of Technology, Dept. of Biomedical En-
gineering, Tampere, Finland.
Several inflammatory conditions are usually treated with cortico-
steroids. Earlier, we reported (Vapalahti et al. 2005) development
of dexamethasone (DX) loaded fibers for treatment of inflamma-
tory conditions. We also reported (Nikkola et al. 2005) the heat
pressing technique for controlling the drug release from biode-
gradable polymer matrix. Thus, we assessed the development of
multicomponent implant releasing dexamethasone to be used for
bone fixation.
Two types of dexamethasone loaded poly(lactide-co-glycolide)
fibers were manufactured by melt extrusion and fiber spinning.
Some fibers were sterilized to obtain change in drug release
properties. Different DX-fibers were then heat pressed to form one
multicomponent rod. Half of the rods where sterilized. Drug re-
lease was measured form initial fibers and multicomponent rods
using a UV/VIS spectrometer. Shear strength and changes in vis-
cosity were also measured.
Drug release was commenced earlier from multicomponent rods
than initial fibers. The drug release period of multicomponent rods
and sterilized rods were 30–70 days and 23–57 days, respectively.
The initial shear strength of multicomponent rod was 135MPa and
degreased 105Mpa during two weeks.
Results showed that heat pressing has effect on drug release and
the release profiles were integrated from initial fiber drug release
profiles. Even though the hear strength decreased 30MPa during
twoweeks, it still retain over e.g. the shear strength of cortical bone.
Thus, developed multicomponent implant could be developed
further to be used in bone fixation treating late inflammatory re-
action.
(P 288) Novel Hypoxia Mimicking Bioactive Materials for
Tissue Engineering
M. Azevedo1, G. Jell1, R. Hill1, M. M. Stevens1
1Department of Materials and Institute of Biomedical Engineer-
ing, Imperial College London, UK.
Next generation regenerative medicine concepts will depend on
smart materials which activate ‘‘self healing’’ mechanisms. During
endochondral bone formation or mature bone and cartilage re-
generation, cells respond to changes in the oxygen pressure
through a hypoxia-sensing pathway. This pathway then activates
numerous genes necessary for osteo/chondrogenesis tissue regen-
eration, including progenitor cell recruitment, cell proliferation
and differentiation. Here we propose that these fundamental pro-
cesses involved in normal bone and cartilage development and
repair can be leveraged for successful bone and cartilage tissue
engineering strategies.
Here we report the development of new resorbable bioactive
glasses (BG) as the delivery system for hypoxia stimulating ions.
We achieve controlled ion release profiles that as assessed by ICP.
The chemical composition of the BG was tailored to specific ap-
plications (cartilage or bone). Human osteoblasts osteosarcoma
cells (SaOs2), were cultured with the dissolution products of dif-
ferent concentrations of BG formulated with and without hypoxia
stimulating ions. Cell toxicity and proliferation assays were com-
pleted and hypoxia response was assessed by HIF-1a and VEGF
gene expression.
The dissolution products of the hypoxia ion containing BG were
shown to activate the hypoxia pathway and increased the produc-
tion of VEGF. Moreover, a non-toxic level of hypoxia stimulating
ions in the media was determined. These results demonstrate the
potential of hypoxia mimicking materials for TE applications.
(P 289) Novel Nano-HA Composite Scaffold with Woodpile-
Network Structure
L.H. Li,1,2, I. Manjubala 1, C.R. Zhou2, P.Fratzl1
1Max Planck Institute of Colloids and Interfaces, Department of
Biomaterials, 14424 Potsdam, Germany.
2Jinan University, Department of Materials Sciences and En-
gineering, 510630 Guangzhou, China.
Bone is a highly complex material with hierarchical architecture
and composition. To fulfil the needs of an ideal bone implant, we
designed a 3D porous woodpile-network composite scaffold with
nano-Hydroxyapatite (HA), micro-HA, poly (L-lactic acid)
(PLLA) and chitosan via rapid prototyping technique and freeze-
drying technique. The composite hybrid material integrated the
osteoconductivity, biocompatibility and mechanical strength of
three types of biomaterials. These scaffolds were examined with
SEM, XRD, FTIR and compression test. The composite scaffolds
had a ‘‘wood-pile’’ structure, where struts on the same layers were
laying parallel, but each layer was turned 908 with respect to the
previous one. The dimension of one strut and the distance between
two struts were about 500 mm. Fine chitosan fibres filled the pores
and tangled the strut, whereas it possesses hierarchical size of
macro pores, micropores and film networks. Agglomeration of
hydroxyapatite crystals was not evident. From the FT-IR spec-
troscopy, all three components were included in the peaks of the
composite scaffold. All the three components did not be destroyed
or inter-react chemically due to the tender method of processing.
There is no difference detected in the XRD peaks position of the
nano HA composite scaffold materials with the crystalline nanoHA
and HA powders, but there is a broadening of the peaks suggesting
a decrease in crystallinity of the HA component in the composite.
The compressive strength and modulus increased much more than
that of HA-chitosan composite, due to the addition of PLLA, nano
HA and networks.
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(P 290) Novel PHB/PCL Scaffolds Produced by Melt Base
Technologies.
V.M. Correlo1,2, P. Sol1,2, Silviene Novikoff 1,2, N.M. Neves1,2,
R.L. Reis1,2
13B’s Research Group—Biomaterials, Biodegradables and Bio-
mimetics, Dept. of Polymer Engineering, University of Minho,
Campus de Gualtar, 4710-057 Braga, Portugal (www.3bs
.uminho.pt, rgreis@dep.uminho.pt).
2IBB—Institute for Biotechnology and Bioengineering, PT Gov-
ernment Associated Laboratory, Braga, Portugal.
On this work, the natural origin polymer Polyhydroxybutyrate
(PHB) was melt blended with synthetic aliphatic polyester Poly-
e-caprolactone (PCL). The ratio of PHB/PCL was varied from
25% to 75% by weight. These blends were further injection
moulded and characterized. The thermal properties of the devel-
oped blends were accessed by differential scanning calorimetry
(DSC). The effect of the ratio PHB/PCL on the mechanical prop-
erties (tensile modulus and tensile strength) was determined by
tensile tests.
After being characterized, the blends were compression molded
with salt (salt particles size: 250–500mm) having two different
levels of salt content (60% and 80%) by weight. By leaching the
salt particles it was possible to produce porous scaffolds with
distinct morphologies. The relationship between scaffold mor-
phology and mechanical properties was evaluated using scanning
electron microscopy (SEM), micro-computed tomography (mCT),
compression testing and differential scanning calorimetry (DSC).
The produced scaffolds are characterized by having different
morphologies depending on the amount of NaCl used. Specimens
with higher porosity level have a less organized pore structure but
increased interconnectivity of the pores. A decrease in the salt
particle content used to create the porosity caused in general an
increase in the mechanical properties of the foams. Cytotoxicity
tests were also carried out using standard tests namely MTS test
with a 24h extraction period, showing the low level of cytotoxicity
of the materials developed.
(P 291) Novel Technique for HA Particle Coating Within 3D
Polymeric Structures
H.M. Aydin1, Y. Yang2, T. Kohler3, E. Piskin1
1Hacettepe University, Chemical Engineering Department and
Bioengineering Division, Ankara, Turkey
2Keele University Thornburrow Drive, Hartshill, Stoke-on-Trent,
ST4 7QB , UK
3Institut f. Biomechanik, Wolfgang-Pauli-Str. 10, 8093 Zu¨rich,
Switzerland
Poly(L-lactide) (PLLA) and poly(e-caprolactone) (PCL) with av-
erage molecular weights of 200 kDa and 40 kDa, respectively, were
synthesized by ring opening polymerization of the respective di-
mer/monomer. Polymer blends were prepared in three different
weight ratios, 25/75, 50/50 and 75/25 w/w. After a set of me-
chanical tests and in vitro degradation studies for 6months, 50/50
PLLA/PCL blend was found optimal by considering mechanical
properties, degradation rate and ease of handling. Scaffolds pre-
pared by salt leaching/sc-CO2 treatment technique. The disk
shaped scaffolds were highly porous with interconnected pores
having in the range of 250–355 microns. The scaffolds divided into
the following three groups: (i) the first group was coated with
collagen (from rat tail); (ii) the second group was coated with
hydroxapatite (HA) particles (particle size: 25–40 microns); and
(iii) the third group was the original. SEM and micro-CT images
clearly showed that the HA particles were very homogeneously
distributed all over the scaffold matrix. The pore volume decreased
from 94 to 82% after HA coating. These scaffolds were investi-
gated for their biocompatibility by performing a short term static
cell culture with MG63 osteoblastic cell line. Confocal microscopy
images showed better cell attachment and growth with the scaf-
folds having HA particles.
(P 292) Numerical Analyses of the Polymeric Scaffolds for
Bone Tissue Engineering
M. Heljak 1, W. Swieszkowski1, C.X.F. Lam2, D.W. Hutmacher3,
K.J. Kurzydlowski1
1Faculty of Materials Science and Engineering, Warsaw Uni-
versity of Technology, Poland.
2Division of Bioengineering, National University of Singapore,
Singapore.
3Institute of Health and Biomedical Innovation, Queensland
University of Technology, Australia.
The favourable scaffold for bone tissue engineering should be
characterized, among others, by high mechanical strength and 3D
open porosity, which guarantee biocompatibility and suitable en-
vironment for tissue regeneration. Numerical modeling could be
used as a tool for preclinical evaluation and optimization of the
scaffold.
The objective of this study was: 1) to generate and validate
numerical (FEM) models of PCL scaffolds produced by Fused
Deposition Modeling (FDM), and 2) to use these models to predict
and evaluate mechanical performance of the scaffolds for bone
tissue engineering. Two types of scaffolds were analysed. They
differed in lay-down of fibers (0/908 and 0/60/1208 lay-down
pattern). The ultimate goal of study was to created optimal scaffold
model for simulations of new bone formation.
The numerical models of the scaffolds were generated using
ABAQUS. The generated mesh was optimized by SED criterium
and finally consisted of about 50,000 finite elements. Modeled
scaffolds were undergone simulations of compression loading.
Results of simulations showed consistence with experimental data.
Using validated models, analysis of octahedral shear strains con-
sidered as important factors affecting bone cell differentiation was
carried out.
Results showed that, in case of scaffold fabricated by FDM,
delamination of fibers is a significant threat. One of factors,
which could be important for durability of filament joints is
scaffold resistance for buckling. For example, scaffolds with 0/908
lay-down pattern have higher strength for buckling and higher
stiffness (about 40%) than those with 0/60/1208 lay-down pattern.
Scaffolds with 0/908 lay-down pattern have also higher yield
strength.
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(P 293) Numerical Simulation and Analysis of Fluid Field in
a Rotating Bioreactor on Three-Dimensional Fabrication of
Tissue-Engineered Bones
K.D. Song1, T.Q. Liu*1, X.H. Ma1, Z.F. Cui2
1Dalian University of Technology, Dalian R&D Center for Stem
Cell and Tissue Engineering, Dalian, 116023, China.
2Oxford University, Department of Engineering Science, Oxford
OX1 3PJ, UK.
The two-dimensional flow field of rotating wall vessel bioreactor
(RWVB) was simulated and calculated with Fluent software. The
distributions of dynamic and total pressure, shear stress and velocity
within the culture chamber were calculated when the engineered
bone tissues with different size were installed in different radial
positions in the vessel. The results showed that the dynamic pressure,
velocity and shear stress around the surface of cell-scaffold construct
at different locations in RWVB were changed periodically, which
could result in the periodical stress stimulation for the cultured ob-
jects. Additionally, the shear stress in the bioreactor is relatively low
and the fluid velocities are uniform. The inner culture environment is
capable of fabricating engineered bone tissues. The above conclu-
sions could be further confirmed by relative experimental results,
such as themorphology of the harvested bone tissues observed under
optical microscope and scanning electron microscope (SEM), aliz-
arin red staining to visualize the newly formed bone, Acridine
orange/ethidium bromide (AO/EB) double fluorescence staining
used to analyze cell activity, etc. It is concluded that RWVB is an
ideal culture system for tissue engineering applications.
(P 294) on the Accuracy of Techniques to Determine Cell
Viability in 3D Tissues or Scaffolds
B. Gantenbein-Ritter1, E. Potier1,2, S. Zeiter1, M. van der Werf1,2,
C. M. Sprecher1, K. Ito1,2
1AO Research Institute, AO Foundation, Davos, Switzerland.
2Department of Biomedical Engineering, Eindhoven University of
Technology, The Netherlands.
Introduction: Cell viability is a key parameter for 3D tissue engi-
neering. Several methods are commonly used, but their accuracy
has not been evaluated. Here, we compare three methods, i) lactate
dehydrogenase staining on cryosections (LDH), ii) Calcein AM /
ethidium homodimer-1 (CaAM/EthH) staining and subsequent
confocal laser scanning, and iii) digestion with trypsin and sub-
sequent staining with Trypan Blue (TB) and counting with hae-
mocytometer.
Material and Methods: Chondrocytes from bovine articular
cartilage were expanded in monolayer under standard culturing
conditions. Two cell populations, living and dead, were then
generated in cell suspension. Dead cells were killed by acidic
shock and enzyme activity was destroyed by heat treatment at
608C. Five different cell mixtures with 0%, 25%, 50%, 75% and of
100% living cells were prepared, measured for cell viability with
Trypan Blue (Premix) and seeded in fibrin carriers (7106 cells/
ml, n¼ 5 for each method). For cell counting, custom-written
macros were used for LDH (KS400, Zeiss, Germany) and for
CaAM/EthH ( imageJ, NIH, USA) images.
Results and Conclusions: For assessment of cell viability per-
centage, only the CaAM/EthH method was not significantly dif-
ferent from the Premix (Fisher’s PLSD, p¼ 0.25). However it was
the least accurate for assessment of absolute number of living and
dead cells. For absolute number of living cells, TB was the only
method that was not significant different from Premix (p¼ 0.24).
Similarly, for absolute number of dead cells, only the LDH method
agreed with Premix values (p¼ 0.37).
(P 295) On the Dynamic Characterization of Collagen Gel
Scaffolds for the Tissue Engineering of Intervertebral Disc
(IVD)
C.Z. Liu1, I.M. Sebastine1, D. J. Williams1
1Wolfson School of Mechanical and Manufacturing Engineering,
Loughborough University, Loughborough LE11 3TU, UK.
The tissue engineering method has potential for the regeneration of
IVD and collagen gels show promise as scaffolds for this Nucleus
Pulposus (NP) constructs. The mechanical properties and structure
of such gels play an important role in the regulation of cell growth,
ECM secretion and consequent tissue formation. There are, how-
ever many uncertainties in the gelling process for collagen gels and
the resulting dynamic characteristics are still unclear. In this study
different processing conditions including formulation and pH were
investigated for a typical collagen. The viscoelastic performance,
dynamic mechanical properties and micro-structure physical prop-
erties of the resulting gels were determined with the aim of de-
veloping an appropriate scaffold for IVD NP tissue engineering
that could be consistently processed.
During the early stages of the sample conditioning process (i.e.
ramping from 48C to 378C), viscous behaviours dominated. Sub-
sequently the elastic properties quickly dominate the gel behav-
iour, at 378C G0 > G@. Further incubation results in steady increase
of strength. CryoSEM examination showed that collagen formed
fibres with a diameter of about 1.2 um and an inter-connected
porous structure with average pore size of around 15 um. Ex-
amination of the fibres by TEM revealed the banding pattern
typical of collagen indicating that it had not been denatured in
the gelling process. DMA testing results indicated that property-
consistent collagen gels could be only fabricated under controlled
gelling conditions. Further work is necessary to determine the
suitability of candidate gels for tissue culture using cell types ap-
propriate for IVD NP.
(P 296) Optical Characterization of Fibrin and Fibrin-Agarose
Corneal Constructs: the Coefficients of Absorption, Scattering
and Extinction
R. Go´mez-Sotomayor1, M.M. Pe´rez2, J.I. Mun˜oz-A´vila3,
M. Alaminos1,3, A. Ionescu2, J.C. Cardona2, A. Campos1
1University of Granada, Department of Histology.
2University of Granada, Department of Optics.
3Univ. Hospital San Cecilio, Granada, Spain.
Introduction: Characterization of the optical properties of bioma-
terials used for construction of corneal substitutes by tissue engi-
neering is very important in order to ensure the appropriate
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functionality of the artificial corneas. As the main filter to visible
and UV light, scattering (S), absorption (K) and extinction (SþK)
coefficients of bioengineered human corneas should be comparable
to normal native corneas.
Methods: Partial bioengineered human corneas were developed
in the laboratory using fibrin-agarose scaffolds with human kera-
tocytes immersed within. After 28 days in culture using specific
culture media, the optical properties of the artificial corneal tissues
were analyzed by determining the spectral radiance of these tissues
using white and black backgrounds with a spectroradiometer PR-
704 (Photoresearch) under geometry CIE 458d illuminating
conditions. Optical constants, including S, K and SþK coeffi-
cients, were calculated from the spectral reflectance data using
Kubelka-Munk’s ecuations within the visible spectrum (400–
700 nm). The statistical analysis was computed by using SPSS 15.0
software.
Results and Conclusions: Our results revealed that fibrin-agarose
corneal constructs showed high values of S and K, with a direct
correlation between the incident wavelength used and the levels of
S, K and SþK. Differences were particularly significant for the
case of K.
Supported by PI-0132/2007 and P06-CTS-2191 from Junta de
Andalucia.
(P 297) Optimization of a Human Osteoblastic-Endothelial
Co-Culture System
P.S. Gomes1, M.H. Fernandes1
1Laborato´rio de Farmacologia e Biocompatibilidade Celular-
Faculdade de Medicina Denta´ria, Universidade do Porto, Portugal
Angiogenesis, the formation of new capillaries from pre-existing
vessels, is a tightly regulated process that is required for adequate
bone growth and regeneration. Established research reports that
fracture healing and ectopic bone formation can be disrupted by the
direct or indirect inhibition of angiogenesis, while in other studies,
the induction of vascular nutrition increases bone formation, in a
significant way.
Several in vitro methodologies have been developed in order to
further comprehend endothelial-osteoblastic cellular intercommu-
nication that is supposed to combine soluble factors and junctional
communications at the same time.
In this work, we aim to optimize the establishment and devel-
opment of in vitro co-culture systems of osteoblastic-like MG63
cells and human umbilical vein endothelial cells (HUVECs).
HUVECs were isolated form fresh umbilical cords and ex-
panded until desired confluence. Co-cultures were assayed after
simultaneously culture of HUVECs (3rd subculture) and MG63
cells at 10:1, 5:1, 2:1 and 1:1 proportion, respectively.
Different proportions of cultured cells led to a distinct pattern
regarding cellular organization. Scanning electron microscopy and
confocal laser scanning microscopy (tracking staining of PECAM-
1—a specific endothelial cell marker—and MG63-cell tracker
stained cells) allowed to confirm that cellular interaction, endo-
thelial cell viability and phenotypic expression are related to the
initial cell proportion. In addition, cell proportion greatly deter-
mined the sustainability of the co-culture system.
This research offers the possibility to delineate optimized tissue
engineering constructs for bone regeneration based on the inter-
action between osteoblastic and endothelial cells.
(P 298) Optimization of Chitosan-Based Composite and Bi-
layered Scaffolds Produced by Particles Aggregation for
Osteochondral Tissue Engineering: Influence of Hydro-
xylapatite
P.B. Malafaya1,2, R. L. Reis1,2
13B’s Research Group—Biomaterials, Biomimetic and Biode-
gradables, Department of Polymer Engineering, University of
Minho, Campus de Gualtar, 4710-057 Braga, Portugal
2IBB—Institute for Biotechnology and Bioengineering, PT Gov-
ernment Associated Laboratory, Braga, Portugal
Osteochondral tissue engineering presents a challenge to the
present research due to requirements’ combination of both bone
and cartilage tissue engineering. In the present study, bilayered
chitosan scaffolds are proposed based in the optimization of
polymeric and composite scaffolds. m-CT was carried out for ac-
curate morphometric characterization quantifying porosity, inter-
connectivity, ceramic content, particles and pores size. The results
showed that the developed scaffolds are highly interconnected and
present ideal pore size range, being morphometrically adequate for
the proposed applications. DMA shown that scaffolds are me-
chanically stable in wet state under dynamic compression solici-
tation. The obtained elastic modulus at 1Hz frequency was
4.21 1.04MPa, 7.98 1.77MPa and 6.26 1.04MPa for poly-
meric, composite and bilayered scaffolds, respectively. In com-
posite scaffolds, surprisingly it was observed a cytotoxicity
behaviour when unsintered hydroxylapatite was used. This study
reports the investigation that was conducted to overcome and ex-
plain this behaviour. Cytotoxicity was evaluated by MTS with
L929 fibroblast cell line for different conditions and ICP was car-
ried out to confirm the influence of several elements. Sintered hy-
droxylapatite was further used showing no cytotoxicity. Bioactivity
studies with simulated body fluid (SBF) and simulated synovial
fluid (SSF) were conducted to assure that the polymeric component
for chondrogenic part would not mineralized as confirmed by SEM,
ICP and EDS for different immersion periods. It is concluded that
chitosan-based bilayered scaffolds produced byparticle aggregation
could serve as alternative, biocompatible, and safe biodegradable
scaffolds for osteochondral tissue engineering applications.
Acknowledgements: FCT (SFRH/BD/11155/2002) and EU
funded projects HIPPOCRATES and EXPERTISSUES.
(P 299) Optimization of In-Vitro Expansion of Mesenchymal
Stem Cells Isolated from Human Umbilical Cord
I. Majore1, P. Moretti1, T. Hatlapatka1, C. Kasper1, F. Stahl1,
T. Scheper1
1Institute of Technical Chemistry, University of Hannover.
Nowadays acute demand of human mesenchymal stem cells
(hMSC) exists in the areas of regenerative medicine and cell based
therapies. The extraction of hMSC from human bone marrow, the
most commonly used source for these stem cells, is often less
effective because of the low frequency of hMSC (~0.01%) in
marrow aspirates. Investigations over the last years show that
hMSC can be highly successfully isolated also from extra-
embryonic tissues such as umbilical cord (UC), where the fre-
quency of MSC is approx. 30 times higher.
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We optimized culture conditions for extensive expansion of
hMSC obtained from UC perivascular tissue or whole UC. Cells
were seeded in culture flasks in different densities varying from
62.5 to 4000 cells/cm2 and cultured in four slightly different al-
faMEM containing 10% human serum and gentamycin. Cell
growth and vitality, consumption of glucose, glutamine and es-
sential amino acids as well as cell surface epitopes were analyzed
by microscopic, fluorescencespectroscopic, HPLC and flow cyto-
metric methods.
Cells were highly positive for typical stem cell surface markers
CD73, CD90, CD105 and CD44. They exhibited high proliferative
activity particularly supported by alfaMEM containing 2mM
L-glutamine or alfaMEM additionally supplemented with osteo-
genic agents (dexamethasone, ascorbate-2-phosphate, and beta-
glycerophosphate). Cell progeny without intrinsic loss of viability
was possible over 10 passages using initial cell seeding density of
4000 cells/cm2. However cell seeding in lower densities (250, 500
cells/cm2) on larger cultivation area allows to avoid frequent en-
zymatic disruption of cell-cell contacts and therefore displays a
better expansion strategy.
(P 300) Optimization of Vitrification Protocols with CPA
(D25) for Hematopoietic Stem/Progenitor Cells Derived from
Human Umbilical Cord Blood
L. Zhang1, X.H. Ma1, G.F. Zhao1, K.D. Song1, T.Q. Liu1, Z.F.
Cui2
1Dalian University of Technology, Dalian R&D Center for Stem
Cell and Tissue Engineering, Dalian, 116023, China.
2Oxford University, Department of Engineering Science, Oxford
OX1 3PJ, UK.
Hematopoietic stem cells call for feasible cryopreservation meth-
ods before the clinical transplantation. In this work, according to
the study on the vitrification characteristics of CPA (D25), the
stepwise loading and removing processes were designed. Also,
different equilibrium time and various concentrations of trehalose
added in the elution process were investigated to weaken the os-
motic and toxic injuries. Mononuclear cells (MNCs, rich in
HSPCs) were cryopreserved using the vitrification protocol, and
the conventional method (10%DMSO, 18C/min cooling rate) was
conducted as the control. The results showed that CPA (D25)
possesses satisfactory vitrification ability when the cooling rate is
higher than 308C/min and with the increase of the warming rate,
the de-vitrification time could be restrained effectively. The pro-
gram of five-step addition with the interval of 90s and five-step
elution with the interval of 60s respectively at each intermediate
step attained the optimal HSPCs viability, around 83%, and 5%
increase of cell viability was obtained by introducing 0.5M tre-
halose into the elution process. The recovery of MNCs after vit-
rification was 81.5%, higher than 74.7% of the conventional
cooling method. The recovery of CD34þ cells for the vitrification
sample was 52.6% compared with 51.2% of the control. It was
concluded that CPA (D25) could achieve vitrification with the
optimized loading and removing process at an affordable cooling
rate, the cell viability and the recovery of CD34þ cells were
clinical acceptable, higher than that of the conventional method,
and this programmed vitrification protocol is much more conve-
nient and economical.
(P 301) Optimum Ratio of Osteoblasts and HSCs Co-Cultured
in Hypoxic Condition
G.F. Zhao1, T.Q. Liu1, K.D. Song1, L. Zhang1
1Dalian R&D Center for Stem Cell and Tissue Engineering, Da-
lian University of Technology.
Evidence indicates that osteoblasts are crucial components of the
haematopoietic microenvironments in adult bone marrow and can
promote haematopoietic stem cells (HSCs) expansion both in vivo
and in vitro culture. In this study, we constructed a novel hypoxic
co-culture system and compared the expansion results under dif-
ferent quantity of human osteoblasts to obtain better HSCs expan-
sion parameters in vitro culture. In the condition of 5% O2, 20%
CO2, gelatin-alginate-chitosan (GAC) bio-microcapsules that en-
capsulated with osteoblasts were implanted to serum-free IMDM
medium, and then cord blood mononuclear cells were inoculated to
this culture system. The constituent ratio of osteoblasts and HSCs
were respectively 1:2(group A), 1:1(group B), 2:1(group C), and
non-osteoblasts group as control(group D). The initial HSCs density
was 2105 and the medium was half exchanged when the density
was higher than 2106. After 7 days culture, the number of total
nucleated cells increased by 43.4 3.3-fold in group A, by
61.6 3.7-fold in group B, by 108.8 4.2-fold in group C, and by
2.5 0.51-fold in group D, compared with those before culture. The
expansion folds of CD34þ cells were 51.7 3.9, 104.2 6.3,
171.6 6.6, 0.77 0.16, respectively. The expansion of BFU-E,
which was similar among groups A, B, and C, was about 5 times.
The percentage increasing of CFU-GM and CFU-GEMM of group
C were obviously higher than that of group A and B. In hypoxic
condition,osteoblasts can significantly stimulate HSCs proliferation
and maintain cell growth in vitro for a longer time. The optimum
ratio of osteoblasts-HSCs numbers were 2:1 for ex vivo co-culture.
(P 302) Origin of Cells in Scaffold Based Cartilage Defect
Treatment
S. Nuernberger1,2,3, D. Barnewitz4, C. Meyer5, I. Wilke4,
V. Ve´csei 1, S. Marlovits1,2
1Medical University of Vienna, Department of Traumatology,
Vienna, Austria.
2Austrian Cluster for Tissue Regeneration.
3Cell Imaging an Ultrastructure Research Unit, Vienna, Austria.
4Research Centre for Medical Technics and Biotechnology, Bad
Langensalza, Germany.
5University of Giessen, Clinic and Polyclinic for Traumatology,
Giessen, Germany.
Objectives: Partial thickness defects of articular cartilage are
known not to heal spontaneously. The main reason is the low
number of cells manifesting in the defect. The present study in-
tends to determine the origin of the invading cells and how these
cells participate in defect-filling in the presence of a scaffold.
Material and Methods: A collagen type I gel (CaReS), collagen
type I/III membrane (Biogide), and a hyaluronan scaffold
(Hyaff) were implanted into the lateral facette of the femor-
opatellar joint of two horses. The repair tissue was taken 1.5 years
after implantation and analysed by histochemical, immunohisto-
chemical, ultrastructural and element analytical (EDAX) methods.
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Results: Cell bearing repair tissue was found in all defects. It
was largely fibrous but showed some differentiation at the interface
regions. In the bordering cartilage, chondrocytes were found to
form cell processes and penetrate the extracellular matrix. The
matrix showed proteoglycan-depletion, especially around the
chondrons. Indications suggest that also cells from the synovial
space invaded the scaffold.
Conclusions: The present data imply that cells invading from the
surrounding tissue are sufficient to fill a cartilage defect and form
repair tissue if a scaffold is available for adhesion and distribution
in the defect-area. Especially chondrocytes have a supportive ef-
fect for the integration of scaffold and repair tissue into the defect
and intensify the contact between both. Based on our results we
suggest that also in cell-loaded scaffold implants invading cells
have a positive, supplementary effect on cartilage scaffold inte-
gration.
(P 303) Osteoblast Attachment Studied using Microtextured
Thin Film Biomaterial Surfaces
K. Myllymaa1, S. Myllymaa1, H. Korhonen1, V-P. Kouri2,
Y.T. Konttinen2, R. Lappalainen1
1University of Kuopio, Dept. of Physics, Finland.
2University of Helsinki, Biomedicum, Finland.
In this study, we investigated the effect of surface microtexturing
with different thin films to adhesion and growth of Saos-2 cells.
Microtextured surfaces were fabricated onto silicon wafers by us-
ing UV-lithography and physical vapour deposition of amorphous
diamond, titanium and tantalum. The size of square or circular
features were 5, 25 and 125 mm for diameters. The qualitative as-
pects and morphological details of the cellular attachment were
studied using ESEM. Confocal laser scanning microscopy was used
to study cell orientation and focal adhesion points. Specific quali-
tative studies show how the cells attach to the thin film features.
Only few cells can be seen attach to the silicon. We can summarize
the results from all tests as follows:1) Biocompatibility of these
materials can be assessed as a pairwise comparison between the
biomaterial and a reference material to construct a biocompatibility
ranking series: Ti>AD>Ta>Si, 2) the size of the features affects
the number of attachment cells to each feature, 3) the distance
between features affects the dividedness or undividedness of the
cell population, 4) the shape of the features direct the cells to grow
closely around biocompatible features. UV-lithography with thin
film techniques provides a convenient, effective and low-cost
method for the formation different microenvironments for studying
how the cells attach and adhere to a metallic implant and how we
can guide cellular behaviour in various microdomains of medical
devices. This functionalization allows development of intelligent
implants, which in their versatile behaviour correspond to the
complex requirements of the human body.
(P 304) Osteoblastic Behaviour of Serially-Passaged Adipose
Tissue-Derived Mesenchymal Stem Cells
C. Bessa Pereira1,2, M.H. Fernandes1
1Faculdade de Medicina Denta´ria, Universidade do Porto, Portu-
gal.
2Faculdade de Cieˆncias, Universidade do Porto, Portugal.
Mesenchymal stem cells derived from adipose tissue have the
potential to differentiate along different lineages, including the
osteoblast phenotype. This characteristic makes them prospective
useful for tissue engineering applications regarding the repair and
regeneration of bone defects. The aim of this work is to evaluate
the expansion and the osteogenic potential of serially-passaged
adipose tissue-derived mesenchymal stem cells in different culture
conditions. For comparison, stem cells derived from bone marrow
were evaluated in parallel.
Stem cells derived from subcutaneous adipose tissue and bone
marrow were obtained from 3-months-old Wistar rats and cultured
in alpha-minimum essential medium containing 10% fetal bovine
serum, antibiotics and 50 ug/ml ascorbic acid, both in the absence
and in the presence of 10 nM dexamethasone. At 70–80% conflu-
ence, cells were subcultured in a combination of non-induced and
osteogenic-induced conditions. Cultures were assessed for cell
viability/proliferation, cell-cycle analysis and osteoblastic differ-
entiation.
Results show that mesenchymal stem cells derived from rat
adipose tissue presented a high proliferation rate over several
passages. Dexamethasone, a classic osteoblastic inducer, caused a
significant reduction in cell growth rate with a simultaneous
increase in the expression of alkaline phosphatase. In mineralising-
favouring conditions, i.e., cultures supplemented with Na-beta-
glycerophosphate, mineralisation of the extracellular matrix was
observed in selected conditions. Comparatively, mesenchymal
stem cells derived from rat bone marrow presented a lower
expansion potential but a higher expression of osteoblastic dif-
ferentiation markers. In conclusion, the suitability of adipose tis-
sue-derived stem cells regarding the osteogenic potential in bone
regeneration approaches needs to be further investigated.
(P 305) Patient’s Age as an Important Factor Affecting
Number of Articular Cartilage Chondrocytes
A. Kaznica1, R. Joachimiak1, T. Drewa1, T. Rawo2, K. Slynarski3,
J. Deszczynski2
1Department of Tissue Engineering, Chair of Medical Biology,
Medical College, Nicolaus Copernicus Univeristy, Bydgoszcz,
Poland.
2Department of Orhopedic Surgery and Rehabilitation, 2nd
Medical Faculty of Warsaw Medical University, Warsaw, Poland.
3Department of Orthopedic Surgery, Otwock, Poland.
Background: Articular cartilage defects are common problem
correlated with age. They are characterised by limited regenerative
capacity of articular chondrocytes. Cultured autologous chon-
drocytes have been proposed as a source to repair of cartilage
defects. The aim of this study was to check differences between
number of isolated cells depending on patient’s age.
Methods: Samples of articular cartilage (n¼ 7) were obtained
from non-bearing surface of the joint from patients in different age.
The first of examined groups were patients between 18–26 years
old (n¼ 3). The second group were patients between 48–54 years
old (n¼ 3). The last group consisted of one 73-year old patient.
The samples were minced and digested with colleganase P and
collagenase II at 378C for 18 h to isolate chondrocytes. Total cell
number was quantified using haemocytometer and cell viability
was detrmined by trypan blue exclusion test.
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Results: Number of isolated chondrocytes from young patients
(n¼ 3) was 1,55105 3,3105, from the second group was
1,67104 7,7104. Cells obtained from 73-year old patient was
remarkably lower—2,0103.
Conclusions: Age of the patient significantly affects on number
of isolated living chondrocytes. Chondrocytes with age begin to
lose their ability to maintain articular cartilage well. Further studies
should be focused on graft function constructed from autologous
chondrocytes obtain from patients in different ages.
(P 306) Performance of a Spinner Like Bioreactor for Dermal
and Oral Connective Engineered Tissue
J.F. Diaz1, L.A. Castro2, M.R. Fontanilla3,4,1
1Graduate Program in Microbiology, National University of Co-
lombia.
2Graduate Program in Chemical Engineering, National University
of Colombia.
3Department of Pharmacy, National University of Colombia.
4Biotecnology Institute, National University of Colombia.
The high cost and the lack of regulations for importing registered
skin tissue-engineered products into Colombia limits their avail-
ability to low-income patients. In the case of oral mucosa, tissue–
engineered replacements are not even commercially available yet.
Therefore, the ability to generate reasonably priced skin and oral
replacements would be desirable. To this end, our group con-
structed a spinner-like bioreactor for bank-level production of
dermal and oral connective tissue equivalents.
The bioreactor was designed with a 2 L maximum capacity and a
scaffold supporting system, consisting of seven removable Teflon
dishes attached to four removable Teflon columns suspended from
the bioreactor’s lid. This removal system allows the amount of
tissue equivalent produced to be controlled. A heat exchanger and
CO2 injection systems permit the bioreactor to operate automati-
cally. To characterize the hydrodynamic properties of the biore-
actor, the mixing time (MT) and the residence time distribution
(RTD) were measured at different bioreactor configurations
(number of dishes and columns), and at different stirring speeds
(60, 80 and 100 r.p.m.). It was found that, irrespective of the
configuration and the stirring speed used, it behaved as a well-
mixed bioreactor. Histological analysis was performed on fibro-
blast-seeded collagen I scaffolds cultured in the bioreactor and
sampled every other day, for two weeks. The results showed
scaffold fibroblast adhesion and formation of artificial tissue with a
more uniform distribution of cells, as compared with tissue ob-
tained under static culturing conditions.
(P 307) Periodontal Regeneration of Maxilla Alveolar Bony
Defect Repaired with BMP-2 Gene Engineered Autologus
Bone Marrow Mesenchymal Stem Cells
H.H. Chao1, T.M. Lin2, H.Y. Chung2, Sophia C.N. Chang3
1Department of Pediatric Surgery, China Medical University
Hospital, Taichung, Taiwan.
2Department of Medical Research, China Medical University
Hospital, Taichung, Taiwan.
3Department of Plastic Surgery, China Medical University Hos-
pital, Taichung, Taiwan.
Introduction: The need of periodontal and alveolar bone regener-
ation was increased in modern clinical dental therapy. Recently,
the application of bone morphogenetic proteins (BMPs) to the
periodontal defect presented limited regenerative ability of such an
approach with the establishment of abnormal periodontal rela-
tionship and complications such as ankylosis and root resorption.
Short half life of rhBMP-2 and the need supraphysiological con-
centration also demonstrated the shortage of protein regeneration
therapy. The purpose was to evaluate the regeneration of peri-
odontal apparatus in critical maxilla alveolar bony defects by
BMP-2 gene engineered autologus bone marrow mesenchymal
stem cells (MSCs).
Materials and Methods: Twelve critical maxillary periodontal
defects were surgically created over the premolar area combined
with root denuded at least 21 cm2 below cementoenamel junction
(CEJ) in nine matured male miniature swine. Bilateral maxillary
defects were randomly assigned into 2 groups: BMP-2 gene en-
gineered MSCs/polymer (BMP-2 group), and MSCs/polymer as
control. Histological examination was performed at the end of
study to exam the microscopic healing and relationships between
bone, periodontal ligaments, cementum, and tooth surfaces. Three-
dimension computerized tomography was utilized to calculate the
total volume of bone regenerated during experiments.
Results: Our data demonstrated the regeneration of periodontal
apparatus was significant better in BMP-2 group. New cementum
with Sharpey’s fiber was observed on the instrumented denuded
root surfaces in BMP-2 group. Larger amounts of bone were re-
generated in BMP-2 group than control group after 24 weeks im-
plantation. This approach is suitable for periodontal regeneration
and may achieve healthy periodontal relationship.
(P 308) Phosphorylation Efficiency of Chitosan at Different
Times and Temperatures for Bone Graft Substitute
J.I. Arias1, A. Neira-Carrillo1, M. Yazdani-Pedram1, M.S. Fer-
nandez1, J.L. Arias1
1Faculty of Veterinary Sciences and Center for Advanced Inter-
disciplinary Research in Materials (CIMAT), Univerisdad de
Chile, Santiago, Chile.
Research in bone implants has been focused to mimic the natural
process of regeneration by using substitutes possessing character-
istics of osteo-induction, integration, conduction and mechanical
properties similar to that of natural bone.
Chitosan is a plausible alternative because it is non toxic, non
antigenic, biocompatible, biodegradable and promotes normal cell
behaviour.
Functionalized chitin and chitosan with phosphate groups has
shown to promote the calcium ions binding, which may then in-
duce the formation of a calcium phosphate layer promoting the
osteoconduction of polymer-based implants.
Different authors have used Sakagushi (1981) method of phos-
phorylation at different temperatures (70 to 1608C) for 1 h for of
reaction, without addressing why this time was selected.
Here we used 1 to 48 h of reaction at a constant temperature of
708C. Phophorylation efficiency was evaluated by FT-IR showing
maximum substitution of phosphate groups, as reveled by the ap-
pearance of P-O stretching bands at 1050 and 603 cm-1 from the
PO4 groups, at 3 hours. These results were confirmed by the use of
polycationic titrations (pDADMAC).
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These results can be explained by a saturation of the number of
phosphate groups per surface area in the first 3 hours and/or by a
change in the tridimensional structure of the chitosan molecules
hiding the groups potentially capable to be functionalized with
phosphate group after 3 h. Partially supported by FONDAP
11980002 and FONDECYT 1080185.
(P 309) PLA/PGA–Based Polyesters Filled with Calcium
Carbonate May Serve as Cell Scaffolds with Controlled Re-
sorption In Vitro
J. Wo´jtowicz 1, S. Slomkowski2, S. Sosnowski2, M. Wojewo´dzka1,
A. Mikulska1, M. Lewandowska-Szumiel1
1Department of Biophysics and Human Physiology, Medical
University of Warsaw, Warsaw, Poland.
2Center of Molecular and Macromolecular Studies, Polish Acad-
emy of Sciences, Lodz, Poland.
The ideal tissue engineered product (TEP) should become fully
replaced by host tissue; however, there are problems with con-
trolling scaffold resorption after implantation. Thus, we are
working on a TEP with scaffold resorption being highly advanced
before implantation. This investigation is the first step toward this
goal. 8 types of PLA/PGA–based polyesters were used both with
and without a CaCO3 filler (added to neutralise acidic hydrolysis
products). The materials were investigated in MG63 osteoblast
culture. Cell and material morphology was observed in optical and
electron microscopes. Cell viability (XTT) was determined after 4
and 11 days. The biomaterials’ resorption was assessed by Size
Exclusion Chromatography (SEC).
As found, cell viability was diminished after 4 days on all ma-
terials but PGA/PLA. This is probably because of the overrun local
lethal acids concentration due to the materials’ resorption, shown
to occur during the experiment (SEC results). After 11 days, cell
viability drop (comparing to the control) was almost the same as
earlier on samples with CaCO3, but much higher on polymers
alone. The alkalising benefit from CaCO3 was not fully achieved
probably because the filler was hidden under the material surface,
additionally worsening the surface topography (SEM) favoured by
cells. However, resorption was less advanced in samples with
CaCO3 (SEC), which probably positively influenced cell viability.
The investigated materials are still not a perfect support for cells;
however, the described system is promising for further research on
resorbable scaffolds—base for tissue created in vitro.
The work supported by Grant 3T08E06930
(P 310) Platelet Lysate as Substitute for Fetal Calf Serum in
the Culture of Stem Cells Derived from Adipose Tissue and
Amniotic Membrane
A. Peterbauer1,2, J. Aberl1, D. Mu¨llegger1, K. Schauer2,3,
G. Stadler2,3,4, A. Lindenmair 2,3,4, C. Gabriel1,2, H. Redl 2,3,
M. van Griensven 2,3, S. Wolbank1,2
1Red Cross Blood Transfusion Service of Upper Austria, Linz,
Austria.
2Austrian Cluster for Tissue Regeneration.
3Ludwig Boltzmann Institute for Experimental and Clinical
Traumatology, AUVA Research Centre, Linz/Vienna, Austria.
4Bio-Products & Bio-Engineering AG, Vienna, Austria.
For cell expansion, supplementing culture media with fetal calf se-
rum (FCS) is still the gold standard although FCS bears a potential
risk for carrying diseases and eliciting immunereactions. Therefore,
an alternative culture supplement without animal components would
be advantageous. Thrombocytes are regularly substituted in trauma
and oncologic patients with insufficient blood coagulation. They can
be stored up to 5 days before they have to be discarded. Instead of
wasting this precious raw material platelet lysate (PL) can be pro-
duced thereof containing growth factors at high concentrations.
Three batches of PL each consisting of 36 thrombocyte con-
centrates were produced and selected growth factors were deter-
mined by ELISA. PL was then used in comparison to FCS as
supplement for expanding and differentiating human adipose-
derived stem cells, human amniotic mesenchymal and epithelial
cells into the adipogenic and osteogenic lineage. Cultures were
characterized for their surface marker expression profile, prolifer-
ation capacity and their immunomodulatory properties. Adipogenic
differentiation was demonstrated by Oilred O staining, osteogenic
differentiation was detected by von Kossa and Alizarin Red
staining, alkaline phosphatase activity and calcium measurement.
Cells cultured in presence of PL display a higher proliferation
potential and in vitro life span compared to cells cultured under
FCS conditions. PL preserved the differentiation capacity of the
cells and did neither alter the surface marker expression profile nor
the immunomodulatory properties of the cells investigated and
should therefore be considered as substitute for FCS in cell culture
for cell-based therapies.
Acknowledgments: HIPPOCRATES (NMP3-CT-2003-505758),
Lorenz Boehler Fonds, EXPERTISSUES (NMP3-CT-2004-
500283).
(P 311) PLGA Based BMP-2 Nanocapsules for Bone Tissue
Engineering
P. Yilgor1,2, C. Orth3, S. Ghanaati3, N. Hasirci1,4, J. Kirkpatrick3,
V. Hasirci2,4
1METU BIOMAT Department of Chemistry, 06531, Ankara,
Turkey.
2METU BIOMAT Department of Biological Sciences, Bio-
technology Research Unit, 06531, Ankara, Turkey.
3JOGU, Institute of Pathology, Mainz, Germany.
4METU, Grad. Dept. Biomedical Engineering, 06531 Ankara,
Turkey.
The objective of this study was to use poly(lactic acid-co-glycolic
acid)-based nano/microcapsules in the encapsulation of BMP-2 for
the purpose of its controlled release with the bone tissue engi-
neering perspective. The structure, encapsulation efficiency, re-
lease kinetics and degradation behaviour of the PLGA particles
were studied. The particles were then implanted s.c. in Wistar rats
to study their biocompatibility and effect of BMP-2 on the peri-
implant tissue. Five week old Wistar rats were used for the im-
plantation of BMP-2 loaded and empty capsules, and analysis were
done at 3, 10, 30 and 40 days.
On day 3, the BMP-2 loaded nanocapsules were found to be
covered by a fibrin-rich peri-implant tissue. On day 10, the acute
inflammatory response declined. The number of the macrophages
and foreign body giant cells containing partly confluenced nano-
capsule-particles increased. At the same time, extracellularly lo-
cated particles could be observed. Together with clearly detectable
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blood vessels in the margin of the capsules, multinucleated tartrate-
resistant acid phosphatase (TRAP)-positive cells appeared adjacent
to the biomaterial. On day 30, the increased vascularization of the
biomaterial continued together with the decrease of the amount of
the TRAP-positive cells. Until day 40, the particles had a clear
round shape and were localized in direct contact to the multinu-
cleated giant cells. No sign of activated fibroblasts and fibrosis
were observed. The results of this preliminary data are encouraging
and the PLGA nanocapsules appear to have a potential as a func-
tional drug delivery system for various agents needed for suc-
cessful tissue engineering applications.
(P 312) Poly-L-Lactic Acid/Hydroxyapatite Electrospun Na-
nocomposites Induce Chondrogenic Differentiation of Me-
senchymal Stem Cell
G. Vadala1, A. Rainer2, C. Spadaccio3, M. Cimmino2, V. Denaro1,
M. Trombetta2
1Department od Orthopaedic and Trauma Surgery, Campus Bio-
Medico University of Rome.
2CIR—Laboratory of Chemistry & Biomaterials, Campus Bio-
Medico University of Rome.
3Department of Cardiovascular Science, Unit of Cardiothoracic and
Cardiovascular Surgery, Campus Bio-Medico University of Rome.
The use of mesenchymal stem cells (MSCs) for cartilage and bone
tissue engineering needs to be supported by scaffolds that may
release stimuli for modulate cell activity.
The objective of this study was to asses if MSC undergo differ-
entiation when cultured upon a membrane of nanofibers of poly-L-
lactic acid loaded with hydroxyapatite nanoparticles (PLLA/HAp).
The PLLA/HAp nanocomposite was prepared by electrospin-
ning. Membranes microstructure was evaluated by SEM. MSCs
were seeded on PLLA/HAp membranes by standard static seeding
and cultured either in basal medium or Chondrogenic Differ-
entiation Medium. Cell attachment and engraftment was assessed 3
days after seeding and MSC differentiation was evaluated by im-
munostaining for CD29, SOX-9 and Aggrecan under a confocal
microscope after 14 days.
PLLA/HAp membrane obtained was composed by fibers (av-
erage diameter of 7 mm) with nano-dispersed hydroxyapatite ag-
gregates (average diameter of 0.3 mm). 3 days after seeding, MSCs
were well adhered on the PLLA/HAp fibers with a spindled shape.
After 14 days of culture all MSCs were positive for SOX-9 in both
basal and chondrogenic media groups. Aggrecan was present
around the cells. MSCs were either CD29 positive or negative.
We demonstrated that PLLA/HAp nanocomposites are able to
induce differentiation ofMSCs in chondrocyte-like cells. Since HAp
has osteoinductive properties, the chondrogenic phenotype acquired
by the MSCs may be either stable or an intermediate stage toward
enchondral ossification. The presence of CD29 and SOX-9 double
positive cells indicate intermediate differentiation phases.
This nanocomposite could be a susceptible scaffold for bone or
cartilage tissue engineering using undifferentiated MSCs.
(P 313) Polymeric Nanocomposites in Bone Tissue Regenera-
tion
E. Stodolak1, A. Fraczek1, J. Podporska1, G. Tylko2, E. Knight2,
A.M. Osyczka2, M. Blazewicz1
1AGH—University of Science and Technology, Department of
Biomaterial
2Jagiellonian University, Faculty of Biology and Earth Sciences,
Institute of Zoology, Department of Cytology and Histology
Various aspects of medicine such as diagnostics, therapeutics,
controlled drug or gene delivery systems and tissue engineering
requires application of nanotechnology and specific nanodevices
and nanomaterials. Ceramic nanoparticles such as a silica, wol-
lastonite, carbon nanotubes are potential compatible components
of biomaterials The unique combination of mechanical, physical
and chemical properties of nanomaterials based on polymeric
composites make them attractive not only as reinforcement con-
stituent of various matrix (they have batter mechanical properties
than pure polymers), but also as a physicochemical surface mod-
ification (surface free energy, nanoroughness, microstructures).
The presence of nanoparticles in polymer matrix improve an in-
teraction with proteins and subsequently with cells.
We evaluated adult human bone marrow-derived mesenchymal
stem cell response to different polymers matrix (PSU, PL(L/DL)A,
PCL) modified with nSiO2, nCaSiO3, CNT nanoparticles. Differ-
ing concentration of the silica (0,5%wt, 2%wt) in the polymer
matrix increased the Young’s modulus three fold compared to pure
PL(L/DL)A (poly(L-lactid-co-D,L-lactid). Both ceramic particles
and carbon nanotubes influenced surface parameters such as wet-
tability. Nanocomposites with nCaSiO3 appeared hydrophilic
compared to pure polymer polycaprolactone (PCL). All nano-
partices also increased the roughness of the composite surface in
nano- and microscale.
Bone marrow-derived adult human mesenchymal stem cells
proliferated significantly better on composites containing 0,5% and
1% single wall carbon nanotubes, compared to the pure polymer
(polysulfone) sample. We suggest that all nanoadditives (mainly
carbon nanotubes) into polymer coating impoves attachment and
growth of adult human progenitor cells.
(P 314) Porous Polymeric Scaffolds Incorporating Ibuprofen
Prepared in Supercritical CO2 for Tissue Engineering of Bone
and Cartilage
D. Velasco1, C. Elvira1, J. San Roman1
1Department of Biomaterials. Institute of Polymers, CSIC.
The preparation of porous polymeric scaffolds for tissue engineer-
ing by using supercritical carbon dioxide (SCCO2) technology is a
clean process where the use of organic solvents is avoided. Porous
systems are obtained by polymer saturation with CO2 followed by
depressurization that induces pores nucleation.The aim of this work
is to obtain, in one step process using SCCO2 technology, porous
polymeric systems from samples of poly (methyl methacrylate)-
poly (lactic acid) (PMMA-PLA) blends, that also have incorporated
ibuprofen. The systems were characterized in order to find the ap-
propriate conditions to obtain scaffolds with appropriate porosity
and charge of ibuprofen. Different formulations with 10, 20 and
30%-wt of PLA were prepared by compression moulding and some
of them included 5 or 10%-wt of ibuprofen. Samples were placed in
the SCCO2 reactor at different conditions of pressure (160–260
bars), temperature (40–608C) and time, followed by fast depres-
surization of the system after desired time (2–41h). Porous samples
were characterized by NMR spectroscopy, DSC, ESEM and
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mercury picnometry. The results showed that samples exposed to
high pressures (260 bar) exhibited porous interconnections, due to a
better CO2 diffusion through the polymer matrix, giving a porosity
from 65 to 200 mm. When incorporating ibuprofen (soluble in SC-
CO2), drug retention was obtained by lowering the experimental
time and using different supercritical conditions, that is at 200 bar
and 608Cduring 24h. Drug release and biocompatibility studies will
be presented, and the results obtained showed a very interesting
behaviour and good biocompatibility.
(P 315) Preparation of Small Diameter Vascular Grafts by
Electrospinning of Biodegradable/Bioerodible Polymers
N. Detta1, D. Puppi1, F. Chiellini1, E. Chiellini1
1Laboratory of Bioactive Polymeric Materials for Biomedical and
Environmental Applications (BIOlab)—UdR INSTM, Department
of Chemistry & Industrial Chemistry, University of Pisa, Via
Vecchia Livornese 1291 56122 S. Piero a Grado, Pisa (Italy).
Conventional vascular prostheses are functional for replacement of
medium and large calibre vessels (diameter> 5mm) while they
fail when employed as small diameter grafts, because of throm-
bogenicity and compliance mismatch. Recently, tissue engineering
has emerged as a promising approach to address the shortcomings
of current therapies. Several opportunities for functional scaffolds
production are arising due to the development of different tech-
niques. In particular, electrospinning allows for the obtainment of
non-woven fibrous structures which mimic the morphology of the
extracellular matrix. The research project we are involved in, aims
at the production of arterial small-diameter polymer grafts through
electrospinning, as possible candidates in vascular tissue engi-
neering. Commercial polymers and novel multiblock copolymers
were electrospun and a roto-translating cylindrical collector for
fibrous tubes production (4mm diameter) was specifically de-
signed. Using this high performance device, provided with a PLC-
based controller and a software application for remote control,
different directions and degrees of alignment of the electrospun
fibers were achieved. Evaluation of the constructs, with regards to
morphology, chemical and physical characteristics, mechanical
properties, cytocompatibility and degradation rate is currently
being performed. Future plans include cell response evaluation of
the tissue engineered constructs cultured in a bioreactor designed
to fulfil the specific needs for this type of application. Attention
will be devoted to mechanical properties comparison among con-
structs with various degrees and directions of fibre alignment and
to the different cell behaviour that fibre orientation may cause. The
fibers will also be loaded with growth factors and drugs influencing
cell behavior and host immune response.
(P 316) Preparation of Temperature-Responsive Matrices with
Osteoinductive Behaviour Combining an Elastin-Like Poly-
mer and Chitosan
J. S. Barbosa1,2,3, A. M. Testera1, M. Alonso1, J. F. Mano2,3,
J.C. Rodrı´guez-Cabello1
1G.I.R. Bioforge, Universidad de Valladolid, Edificio IþD, Paseo
de Bele´n, 1, 47011 Valladolid.
2IBB—Institute for Biotechnology and Bioengineering, PT Gov-
ernment Associated Laboratory, Braga, Portugal.
33B’s Research Group—Biomaterials, Biodegradables and Bio-
mimetics, Dept. of Polymer Engineering, University of Minho,
Campus de Gualtar, 4710-057 Braga, Portugal.
In this work two natural-based polymers were combined in order to
produce new matrices intended to be used in drug delivery or as
matrices for tissue engineering applications: chitosan, a poly
(aminosaccharide) obtained by chitin’s partial alkaline deacetyla-
tion and an elastin-like polymer, ELP, obtained by the bioproduction
of genetically modified E. coli. This polymer was designed to be
biocompatible and to contain an osteoinductive sequence, besides
exhibiting a smart behaviour towards temperature.
The yield of the bioproduction process was assessed using
electrophoresis, which was also used to assess the polymer purity
upon the purification process. The general characterization of the
ELP was done with Differential Scanning Calorimetry, to deter-
mine polymer Inverse Temperature Transition at different pH, and
mass spectroscopy, to confirm the primary sequence of the re-
combinant protein.
The mechanical properties of the developed materials were
tested using dynamic mechanical analysis. This technique per-
mitted to assess the temperature dependence of their viscoelastic
properties while the samples were immersed in simulated physi-
ological solutions. In vitro citotoxicity and bioactivity of matrices
were also tested.
(P 317) Preparation, Detection and Controlled Release of
PLGA Microspheres-Based Scaffolds Embedded with BSA
Song K.D.1, Mei G.Y.1, Wen P.F.1, Liu T.Q.*1, Ma X.H.1, Cui
Z.F.2
1Dalian University of Technology, Dalian R&D Center for Stem
Cell and Tissue Engineering, Dalian, 116023, China.
2Oxford University, Department of Engineering Science, Oxford
OX1 3PJ, UK.
Biomaterial scaffolds play an important role in tissue engineering
by providing physical and biochemical support for kinds of stem
cells and progenitor cells. Bovine serum albumin (BSA) is a large
globular protein with a good essential amino acid profile. It has
been well characterized and the physical properties of this protein
are well known, Isolated BSA has been reported to be a very
functional protein. In this study, The microspheres with diameters
of almost one hundrand micrometers were prepared and optimized
by using bovine serum albumin (BSA) as the model protein and
poly lacticoglycolic acid (PLGA) as the exoperidium materials.
The protein microspheres were prepared by applying the multiple
emulsion solvent volatilixation method, the protein content and the
controlled release from the microspheres were measured with the
method of Bicinchoninic acid (BCA). Moreover, the concentration
of BSA, the rotation speed of stirrer, and the effect of the ratio of
span 80 and tween 80 on the envelopped rate, particle diameter,
carrying dosage and releasing amount of the microspheres were all
investigated. The results showed that the optimal operated pa-
rameters consisted of the ppropriate suitable concentration of BSA,
not so fast stirring speed and the ratio of span 80 and tween 80 were
about 10:1. It is concluded that by regulating the above paramters,
we could obtain the suitable microspheres with qualified sizes,
higher carrying dosage and envelopped rate and excellent released
functions.
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(P 318) Pretreatment with Protocatechuic Acid Increases
Neurons from Cultured Neural Stem/Progenitor Cells
S. Guan1, D. Ge1, T.Q. Liu1, X.H. Ma1, Z.F. Cui2
1Stem Cell and Tissue Engineering Laboratory, Dalian University
of Technology, Dalian 116024, China.
2Oxford Centre for Tissue Engineering and Bioprocessing, De-
partment of Engineering Science, Oxford University, Oxford OX1
3PJ, United Kingdom.
Neural stem/progenitor cells (NS/PCs) are capable of self-renewal
and can generate both neurons and glia. Protocatechuic acid
(PCA), a phenolic compound isolated from the kernels of Alpinia
(A.) oxyphylla, plays crucial roles in the proliferation and neuro-
protection of cultured NS/PCs in our previous study. However,
whether PCA modulates the differentiation effects of NS/PCs
needs to be elucidated. In this study, we examined the effects of
PCA on neuronal differentiation of NS/PCs in the different culture
manners. NS/PCs obtained from 13.5-day-old rat embryos were
propagated as neurospheres and cultured under differential con-
ditions with or without PCA over three passages. Such cells al-
lowed to be immobilized, adhered and spread in three-dimensional
(3D) type I collagen gels incorporating fibronectin (FN) or be
adhered and grew into monolayer on the FN coated planar dishes.
On both culture manners, the percentages of cells that adopted
neuronal phenotypes in the PCA pretreated groups significantly
increased, astrocytic percentages decreased and oligodendrocytic
percentages remained constant compared with the non-treated
control. The newborn neurons in the PCA group were morpho-
logically more mature than in the control. Further, in 3D collagen
gel, pretreatment with PCA increased the number of Tuj1-positive
neurons 2.7 fold greater than in monolayer culture. In particular,
the collagen-entrapped Tuj1-positive neurons formed functional
synapses and neuronal circuits by confocal images. These results
demonstrate that pretreatment with PCA effectively promotes the
differentiation of neuronal phenotypes, suggesting that PCA has
the new property of modulating the development of CNS stem cell.
(P 319) Processing of Polycaprolactone Filaments as Scaffold
Materials for Tissue Engineering
S. Saxena1, Geeta1, B. Gupta1, J. Hilborn2
1Indian Institute of Technology, New Delhi, India.
2University of Uppsala, Uppsala, Sweden.
Polymers based on polycaprolactone (PCL) are extremely impor-
tant due to the biodegradability of the material along with the
biocompatibility. Our efforts have been to develop a textile
structure by spinning PCL into monofilaments of required diameter
and subsequently making it into a knitted structure. This method is
helpful in designing the structures to a desired morphology and
architecture. The spinning of PCL was carried out by melt spinning
where PCL was brought to a temperature of 160C under nitrogen
atmosphere. The filament thus obtained was subsequently drawn at
various draw ratios so that the orientation of the chains takes place.
This introduces the strength into the filament. The filament was
further heat set to stabilize the structure. This is the stage where
filaments were made into a knitted structure with required porosity.
We have observed that the structure of the fiber is strongly de-
pendent on the processing parameters. The spinning rate, the draw
ratio and the heat set temperature influence the fibre structure, the
crystalline structure and the surface morphology which in tern
determines the degradability. The degradation of these knittings is
being studied at various pH so that a correlation for the real time
application may be established.
(P 320) Production of Recombinant Carbohydrate—Binding
Modules Fused To RGD: Functional Studies using Bacterial
Cellulose
F.K. Andrade1, S.M.G. Moreira1, L. Domingues1, F.M.P. Gama1
1IBB—Institute for Biotechnology and Bioengineering, Centre of
Biological Engineering, Universidade do Minho, 4710-057 Braga
Portugal.
The attachment of cells to biomedical materials can be improved
by using adhesion molecules, present in the extracellular matrix
substances, such as fibronectin, vitronectin, or laminin. In many
cases, Arg-Gly-Asp (RGD) was found to be the major functional
amino acid sequence responsible for cellular adhesion. In the
present study, a method for producing chimerics proteins, RGD-
CBM, with functions similar to fibronectin, which contains a
cellulose-binding module (CBM), was developed. The CBM used
was from the cellulosoma of the bacteria Clostridium thermo-
cellum. The genes encoding these CBM-containing chimeric pro-
teins were cloned, and the protein expressed and purified. Bacterial
cellulose (BC) secreted by Gluconacetobacter xylinus was pro-
duced. Polystyrene surfaces and bacterial cellulose sheets where
‘‘coated’’ with these RGD-containing proteins, and then used in
adhesion/biocompatibility tests, using a mouse embryo fibroblasts
culture. The results showed that the proteins containing the RGD or
GRGDY sequence were able to improve the adhesion of the fi-
broblast on the polystyrene plate, furthermore proteins containing
the RGD sequence were more effective than the proteins con-
taining the GRGDY sequence. Preliminary adhesion studies of
fibroblast cultures on cellulose sheets, functionalized with the re-
combinant proteins, showed positive effects on the adhesion and
proliferation of the cells. The results demonstrated that the proteins
containing the RGD sequence were able to increase significantly
the adhesion of fibroblast to BC surfaces when compared with the
controls (cellulose treated with the CBM or buffer). The results
also demonstrated that the protein containing one RGD sequence
have a stronger effect than the protein containing two RGDs.
(P 321) Proliferation and Differentiation of BMSCs on the
PLGA/DBP Scaffolds
G.A. Kim1, S.M. Kim1, S.H. Kim1, C.M. Kim 1, A.Y. Oh 1,
J.M. Rhee 1, G. Khang 1, M.S. Kim 2, H.B. Lee2, I.W. Lee3
1BK21 Polymer BIN Fusion Research Team, Chonbuk National
University.
2Nanobiomaterial Lab., KRICT.
3Dept. of Neurosurgery, College of Medicine, The Catholic Uni-
versity.
Bone marrow stem cells(BMSCs) have the intrinsic ability to self-
renew and differentiate into multiple functional cells. In this study,
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we fabricated natural/synthetic hybrid poly(lactide-co-glycolide)
(PLGA) scaffolds included demineralized bone particle(DBP)
(PLGA/DBP). Schwann cells(SCs) and Olfactory Ensheathing
cells(OECs) were seeded in PLGA/DBP scaffolds. We confirmed
that effects of PLGA/DBP scaffolds seeded OEC and SC on pro-
liferation and differentiation of BMSCs.
PLGA/DBP(20wt%) scaffolds were manufactured by solvent
casting/salt leaching method. We designed control groups that
BMSCs cultured with only PLGA and PLGA/DBP scaffold, and
experimental groups that BMSCs cultured with PLGA/DBP scaf-
fold seeded OECs, SCs or OECs and SCs(OECs/SCs). BMSCs
viability was determined by using MTT assays. RT-PCR was used
to examine the expression of BDNF, NSE and S-100 in BMSCs.
In MTT assays result, BMSCs viability was superior in PLGA/
DBP scaffold than PLGA scaffold. Cell proliferation in PLGA/
DBP scaffolds seeded OECs, SCs, and OECs/SCs, respectively
was increased during culture period. BDNF, NSE and S-100 gene
expressions were weakly detected in BMSCs cultured with PLGA/
DBP scaffold seeded only one type cells, and were strongly ex-
pressed in the group of PLGA/DBP scaffold seeded OECs and SCs.
PLGA/DBP scaffolds enhanced proliferation of BMSCs. In
addition, PLGA/DBP scaffolds seeded OECs and SCs promoted
proliferation and differentiation into neural cell of BMSCs. This
phenomenon was expected that the growth factor or cytokine in
DBP and molecules secreted by OECs and SCs affect to prolifer-
ation and differentiation of BMSCs.
Acknowledgements: This research was supported by KMOHW
(0405-BO01-0204-0006) and SCRC (SC3100).
(P 322) Promising Calcite-Based Tissue Engineered Product
for Bone
A. Chro´scicka1, Z. Jaegermann2, J. Wo´jtowicz1, A. Ratajska3,
J. Sadlo4, P. Wychowanski5, G. Hoser6, S. Michalowski2,
J. Przybylski1, M. Lewandowska-Szumiel1
1Department of Biophysics and Human Physiology, Medical
University of Warsaw, Warsaw, Poland.
2Institute of Glass, Ceramics, Refractory and Construction Mate-
rials, Warsaw, Poland.
3Department of Pathological Anatomy, Center of Biostructure,
Medical University of Warsaw, Warsaw, Poland.
4Institute of Nuclear Chemistry and Technology, Warsaw, Poland.
5Department of Dental Surgery, Medical University of Warsaw,
Warsaw, Poland.
6Medical Center of Postgraduate Education, Department of Clin-
ical Cytology, Warsaw, Poland.
In our research synthetic calcite (CaCO3) was tested as a candidate
scaffold for tissue engineered product (TEP) (until now only nat-
ural CaCO3 materials have been used). The aim was to confirm a
biocompatibility of synthetic calcite and its competence to os-
teoinduction when seeded with human bone derived cells
(HBDCs)—verified in vivo in SCID mice. The 5/5/5mm calcite
samples were precultured with HBDCs for 2 weeks in a bioreactor
(Spinner Basket) or pre-wet in a culture medium (control) before
implantation. The mechanical properties of precultured scaffolds
were compared to the control ones. The precultured and control
samples were subcutaneously implanted in SCID mice con-
tralaterally (one TEP and one control per mouse). The viability of
cells (XTT) was assessed prior to implantation. Four or twelve
weeks after implantation the explants were investigated histolog-
ically and by electron paramagnetic resonance spectroscopy
(EPR). The synthetic calcite was well tolerated by HBDCs before
implantation (XTT test). The precultured samples were mechani-
cally stronger than the control. Well organized connective tissue,
rich in blood vessels, with slight inflammation, was shown by
histological observations of both precultured and control explants.
After 12 weeks, bone tissue was found within the implants—only
for scaffolds with HBDCs. EPR analysis supported the histologi-
cal results–hydroxyapatite-characteristic spectra were found in
HBDCs-seeded explants after longer observation. The experiment
proved that synthetic calcite scaffold is a promising TEP-base and
should be proposed for next steps of preclinical trials.
Work supported by the Polish Government (R13 01901) and
Medical University of Warsaw (NZME/W2/07).
(P 323) Proteomic Anlysis of DJ-1 in Spastic Muscles: Im-
plications for Spastic Nerve From in Muscle Generation
H.W. Kim1, S.Y. Kong1, Y.H. Kwak2, Y.J. Choi1
1Brain Korea 21 Project of Nanobiomaterials for Cell-based Im-
plants, Department of Orthopaedic Surgery College of Medicine
Yonsei University.
2Department of Orthopaedic Surgery College of Medicine Yonsei
University.
This study was performed to see the characteristics of proteins
which expressed in spastic cerebral palsy patients by proteomic
analysis.
We studied 12 specimens from 6 patients with spastic cerebral
palsy, 3 patients who were diagnosed as myelomeningocele and
3 orthopaedic patients without underlying disease as a control
group. Specimens were obtained during orthopaedic procedures.
We studied the extracted proteins which showed difference by
2-dimensional electrophoresis and outstanding 13 proteins was
reevaluated by proteomics and the reverse transcriptional poly-
merase chain reaction(RT-PCR) was confirmed to clarify the re-
lationship between gene and protein.
Among 13 proteins which we got from 2-dimensional electro-
phoresis, 6 proteins were increased in control group by spot his-
togram and 9 proteins were increased in patients group by spot
histogram. The results of proteomic analysis for 13 proteins
showed that the expression of DJ-1 related to the cerebral palsy and
further study with MALDI-TOF analysis was done.
This study shows that in the cerebral palsy patients, strong ex-
pression of DJ-1 has relation to cerebral palsy not only degenera-
tive neuropathologic condition as Parkinson’s disease. In this
study, we show the possibility of connections between the cerebral
palsy and DJ-1 protein for the first time, although multiple
mechanisms act on it.
(P 324) Psoriatic Skin Model: Evaluation of Percutaneous
Absorption
R. Pouliot1,2, A. Duque-Fernandez1,2, J. Soucy3
1Faculte´ de Pharmacie, Universite´ Laval, Que´bec, Canada.
2Laboratoire d’Organoge´ne`se Expe´rimentale (LOEX), Hoˆpital du
St-Sacrement, Que´bec, Canada.
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3De´partement de dermatologie, Hoˆpital de l’Enfant-Je´sus, Que´-
bec, Canada.
Introduction: Psoriasis is a complex dermatosis for which no cure
has yet been found. Disease incidence is estimated at 2% of the
world’s population. As it is impossible at present to test anti-
psoriatic drugs on many pathological samples (ethical, availability,
interpersonal variations problems), drug formulations offered to
the psoriatic population are not well suited to their actual situation.
Purpose: The main objective of this research was to assess skin
penetration of drug capacities with a new psoriatic skin substitute
whose structure is very similar to in vivo pathologic conjonctive
tissue.
Methods: Healthy and psoriatic skin substitutes were pro-
duced using the self-assembly method, and their functionality was
tested by percutaneous absorption. Drugs with different physico-
chemical properties were chosen based on previous studies: ben-
zoic acid, caffeine and hydrocortisone.
Results: An efficient barrier function against all the 3 different
drugs tested was observed for normal skin substitutes when com-
pared to mouse skin. In fact, it was interesting to demonstrate that
the self-assembly method allows a more efficient stratum corneum
than mouse skin. It is known that in vivo psoriatic skin compared to
in vivo normal human skin shows a less efficient barrier function. It
appeared that psoriatic substitutes compared to normal substitutes
show similar results.
Conclusion: Being a non-invasive method for tissues, the pas-
sage of substances through the skin will allow a better under-
standing of the anti-psoriatic activity of tested molecules. We
believe that our psoriatic skin substitute is an interesting novelty
for the percutaneous absorption field of research.
(P 325) Quantification of Fluid Flow Inside Porous Scaffolds
by Means of an Experimental and Computational Analysis
S. De Boodt1, S. Truscello2, T. Leroy1, J. Schrooten2, H. Van
Oosterwyck3, D. Berckmans1
1Katholieke Universiteit Leuven, Division M3-BIORES: Measure,
Model & Manage Bioresponses, Belgium.
2Katholieke Universiteit Leuven, Department of Metallurgy and
Materials Engineering, Belgium.
3Katholieke Universiteit Leuven, Division of Biomechanics and
Engineering Design, Belgium.
As part of a bone tissue engineering therapy cell-seeded scaffolds
can be cultured in perfusion bioreactors prior to implantation. Fluid
flow mediated mechanical stimuli inside the scaffold appear to
affect the in vitro proliferation and osteogenic differentiation. This
study focuses on the flow characterization and quantification
through a regular scaffold by means of experimental and compu-
tational analysis.
Experiments were carried out in a perfusion bioreactor designed
for live imaging. Distilled water with microparticles was perfused
at a flow rate of 0.018ml/min through the titanium scaffold
(20 6 0.5 mm) with regular struts (0.5 0.5mm) and channels
of 0.3mm wide inclined at 458 to the main flow direction. Images
were captured at 10 fps with a CCD (Charge Coupled Device)
camera mounted on a stereomicroscope. For every two subsequent
images a vector field of 24 by 24 grid points was calculated with a
multi-scale Lucas-Kanade optical flow algorithm.
A computational fluid dynamic (CFD) model was developed to
predict the velocity profile and the wall shear stress (WSS). The
mesh presented 1,845,916 tetrahedral elements with an average
edge length of 25 mm .
Both experimental measurements and CFD model calculations
led to a similar flow field, with a peak velocity of 0.4 mm/s. The
model predicted an average WSS of 3.4 mPa.
The combination of experimental and computational techniques
enables the flow characterisation inside a scaffold, which is an
important step towards a better understanding of the importance of
the hydrodynamic environment for bone engineering.
(P 326) Quantifying and Overcoming Oxidative Stress in Cell
Cultures
M. R. Doran1, J. J. Cooper-White1
1Australian Institute for Bioengineering and Nanotechnology,
University of Queensland, Australia.
In biological systems, oxidative stress is defined as the state in
which the spontaneous formation of reactive oxygen species (ROS)
is greater than the cellular capacity to detoxify the reactive inter-
mediates or easily repair the damage. Physiochemical parameters
such as oxygen concentration, cell density, medium protein content
as well as protein composition influence the culture system’s ca-
pacity to both generate and to effectively eliminate ROS. While
these physiochemical parameters have all been demonstrated in-
dependently to influence the oxidative stress of the culture envi-
ronment, no literature exists which defines the relative contribution
each of these physiochemical parameters have on the final oxida-
tive load in cell culture. Understanding the specific contribution
that each of these physiochemical parameters plays is essential in
the optimization of bioprocesses, such as the expansion of stem
cells for cellular therapies, where cost and regulatory drivers
prohibit the use of animal derived proteins transferring significant
oxidative load onto the cell mass. Here we introduce a strategy to
quantify the contributions made by cell number, medium protein
content and percent oxygen make towards conditioning the culture
environment and specifically, mitigating oxidative stress.
Dihydrorhodamine 123 (DHR123) reacts with ROS resulting in
the generation of the fluorescent compound rhodamine 123. The
environmental oxidative load alleviated by varying each of the
physiochemical factors independently, and in combination is
quantified by measuring the relative fluorescence of oxidized
DHR123. We identify key relationships between physiochemical
parameters and suggest strategies for minimizing medium protein
content while simultaneously mitigating oxidative stress.
(P 327) Quantitative Assay of Stem Cells Loaded on Porous
Scaffolds using Bioluminescence
D. Logeart-Avramoglou1, K. Oudina1, L. Delpierre1, M. Bour-
guignon1, M.A. Nicola2, H. Petite1
1Laboratoire de Recherches Orthope´diques (B2OA)—CNRS
UMR 7052 (ST2I), Paris, France.
2PFID Pasteur Institute—75015 Paris, France.
In stem cell-based tissue engineering strategies, the capacity to
monitor in vitro and in vivo proliferation of cells seeded on porous
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scaffolds is of great importance to scaffold design. We used bio-
luminescence technology for quantitative cell assay inside scaf-
folds using cells tagged with the luciferase gene reporter.
A clonal cell line exhibiting high luciferase expression was se-
lected from murine mesenchymal stem cells genetically modified
using lentiviral vectors encoding luciferase. Two materials were
tested: AN69 hydrogel and porous coral scaffold. In vitro quanti-
tative evaluation of luminescence from cells loaded scaffolds was
performed in cellular destructive (measurement of light with a
luminometer after cell lysis) and non-destructive (using a bio-
luminescence imaging system) conditions. In vivo quantitative
evaluation of cells adhered onto materials was accomplished in
non-destructive conditions after subcutaneous implantation of im-
plants in mice.
In cellular destructive conditions, light emission from either
cells or cells adhered onto scaffolds indicated a linear relationship
with the cell number, despite attenuation of the transmitted light
photons due to the presence of the material. Based on the ratio of
slope values of standards plots, coefficient of transmission partic-
ular to each material scaffold was calculated as 0.27  0.05 for
AN69 hydrogels and 0.35  0.03 for coral. In non-destructive
conditions both in vitro and in vivo, analysis of luminescent images
also provided evidence of correlation between the emitted photon
flux and the number of cells adhering onto the materials. Biolu-
minescent imaging enabled non-invasive monitoring of the fate of
cells present in each scaffold in living mice for 28 days post-
implantation.
(P 328) Quantitative Evaluation of Adipose Tissue Engineering
in Scid Mice
B. Frerich1, K. Weinzierl2, K. Winter3, U.-D. Braumann4
1Department of Oral and Maxillofacial Surgery, University of
Leipzig.
2Department of Oral and Maxillofacial Surgery, University of
Halle.
3Translational Centre for Regenerative Medicine (TRM-Leipzig),
University of Leipzig.
4Interdisciplinary Centre for Bioinformatics (IZBI), University of
Leipzig.
Introduction: Adipose tissue has strong significance in plastic and
reconstructive surgery (body-contour, mobility of tissue layers).
The aim of our present study was to evaluate the feasibility of
adipose tissue engineering in a SCID-mouse model.
Methods: Adipose tissue stromal cells (ATSC) were harvested
from human adipose tissue obtained during elective surgery. Dif-
ferentiation was induced with two cycles of IBMX administration.
Adipose tissue equivalents were generated in vitro and trans-
planted into NOD-SCID-mice (n¼ 90) with and without co-
transplantation of endothelial cells (HUVEC). Histomorphometric
evaluation of adipose tissue formation was performed on whole
sections imaged by a ZEISS MIRAX SCAN slide scanner. The
resulting images were segmented into regions of different tissue
types and evaluated quantitatively by means of image processing.
Results: After explantation of SCID mice 10 days, 4 weeks,
6months postoperatively, mature adipose tissue could be observed.
Transplanted cells were S-100 positive (adipocyte-typic). Thick-
ness of the implants diminished from 10 days to 4 weeks and
remained almost constant until 6months with completion of adi-
pocytic differentiation. There was no significant advantage for
endothelial co-transplantation and small sized implants showed
significant better differentiation than larger sized implants (ca.
10mm).
Conclusion: Differentiation of three-dimensional adipose tissue
constructs is feasible and reproducible in vitro and in vivo, however
reliable solutions for microvascular network formation still have to
be found.
(P 329) Raman Monitoring of Cartilage Cell Differentiation
and Proliferation
A. Kunstar1, A.A. van Apeldoorn1, C.A. van Blitterswijk1
1Department of Tissue Regeneration, Institute for Biomedical
Technology, University of Twente, Enschede, the Netherlands.
Raman spectroscopy is a noninvasive, label free in vitro technique.
Combining cartilage tissue engineering techniques with Raman
analysis can provide the means to collect data on a wide spectrum
of nutrient, extracellular matrix, and cellular components of tissue
engineered samples. We studied how to use specific Raman
markers for the visualization of cartilage cell differentiation using
primary chondrocytes and pellet culture system.
In our study, Raman analysis was carried out by a confocal
Raman microspectroscopy setup. Primary chondrocytes were iso-
lated from calf articular cartilage, cultured in centrifuge tubes in
chondrocyte medium and centrifuged to form a pellet. Each exper-
imental group - 3 days, 1 week and 2 weeks cultured samples-were
further processed for histology and Raman analysis. In addition
different components of the extracellular matrix were measured to
identify the Raman peaks of the pellets.
Sulfated glycosaminoglycan was visualized with Safranin O
staining. We detected extracellular matrix formation in the chon-
drocyte pellets after 1 week culturing. Comparing the Raman
spectrums of the chondrocyte pellets cultured for 1 week and for 2
weeks with the spectrums of the components of the extracellular
matrix, the Raman peak at 878 cm1 (wavelength shift) can iden-
tified as the peak of the collagen type II and the peaks at 1043,
1081, 1129, 1209, 1243 and 1278 cm1 as the peaks of chondroitin
sulfate.
We were able to collect Raman data of different components
present in the extracellular matrix of chondrocyte pellet culture
samples and visualize chondrocyte differentiation.
(P 330) Rapid, Non-Viral Gene Transfection using a Magnetic
Nanoparticle-Based Halbach Array System
J. Dobson1, S.C. McBain1, N. Farrow1
1Keele University, Institute for Science and Technology in Med-
icine.
With the sequencing of the human genome and the advent of gene
therapy has come the need to develop effective delivery and
transfection agents. These agents must be able to target therapeutic
and reporter genes to the relevant cells and organs both in vitro for
basic investigations as well as in vivo for therapeutic applications.
Recent safety concerns over the use of viral vectors has begun to
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shift the emphasis toward the development of non-viral delivery
agents, primarily cationic lipids. At present, this is generally ac-
complished through lipid-mediated transfer or electroporation.
However, these techniques suffer from significant drawbacks
such as: (i) low levels of transfection in primary cells and some cell
lines (ii) their inability to effectively transfect tissue explants (iii)
detrimental effects on cell viability (primarily with electroporation)
and (iv) difficulty in translating to in vivo (clinical) applications.
We have developed a novel gene transfection system based on
attaching DNA to magnetic nanoparticles. High-gradient Halbach-
type magnet arrays direct the particle/gene complex to cells in vitro
resulting in significantly faster transfection times and higher
transfection efficiencies (up to 100 at short exposure times) in
comparison to the best cationic lipid-based agents available. It also
improves speed and efficiency in comparison to commercially
available magnetofection systems.
(P 331) Re-Endothelialization of Decellularized Pulmonary
Valve Scaffold Under Simulated Physiological Dynamic Con-
ditions In-Vitro
A. Lichtenberg1, I. Tudorache2, S. Cebotari2, M. Suprunov1,
P. Akhyari1, G. Tudorache2, A. Haverich2, A. Hilfiker2
1University of Heidelberg, Dep. of Cardiac Surgery.
2Medical School Hannover, Dep. of Thoracic and Cardiovascular
Surgery.
Objective: Optimization of techniques for serial production of
viable biological heart valves is of central interest in bio-
engineering. The aim of study was to generate decellularized
heart valves with preserved ultra-structure and to repopulate those
with endothelial cells (EC) under simulated physiological condi-
tions.
Methods: Ovine pulmonary valve conduits (n ¼ 16) were de-
cellularized in detergents (Sodium-deoxycholate/SDS) followed
by 8 wash cycles in PBS (12 h each). Viability of EC cultures
exposed to washing solution served to prove efficiency of washing.
Luminal surfaces of decellularized grafts (n¼ 11) were seeded
with ovine jugular vein EC (1.2107 cells) in special bioreactors.
After rolling culture for 48h, pulsatile circulation was started with a
flow of 0.1 L/min (system mean pressure: 25 4 mmHg). The flow
rate was gradually increased with 0.3 L/day to a final rate of 2.0 L/
min (cycle rate: 60 beats/min), while pH, pO2, pCO2, lactate and
glucose in the medium were maintained at constant physiological
levels.
Results: Resulting scaffolds were cell-free with preserved ar-
chitectonic of extracellular matrix. Biomechanical tests demon-
strated comparable properties to native tissue (n ¼ 5). Histological
examination, after 7d of dynamic cultivation, revealed a cells
monolayer covering the inner valve surface. Metabolic assays
demonstrated high activity of these cells, which express im-
munohistochemically vWF/eNOS, indicating an endothelial ori-
gin. Electron microscopy revealed their, typical endothelial,
cobble-stone arrangement.
Conclusion: Complete and flow-resistant re-endothelialization
of detergent decellularized matrix can be achieved in a pulsatile
bioreactor system under conditions simulating physiological en-
vironment. Permanent monitoring of biotechnological processes
and continuous adjustment to physiological parameters is essential
for cardiac valve engineering.
(P 332) Real Time Monitoring of Scaffold Degradation Under
Culture Conditions
C. Cunha-Reis1, A.J. El Haj1, Y. Yang1
1Institute for Science and Technology in Medicine, Keele Uni-
versity Medical School.
The understanding of scaffold degradation in pre and post im-
plantation stages can only be fully accomplished under real time
in situ evaluation. Therefore, the development of real time moni-
toring techniques for scaffold degradation is crucial for Tissue
Engineering. Our group has reported for the first time a consistent
strategy to achieve that goal [1]. We have proposed a fluorescence
based model in which a fluorescent probe is covalently bound to a
polymer used in scaffold manufacturing. We have shown that the
fluorescence intensity (FI) of the scaffolds can be used as an in-
dicator of the extent of scaffold degradation, and that it can be
measured in a real time mode.
This work aimed to confirm if this model could be applicable to
complex systems in which new extracellular matrix is being
formed as the scaffold degrades. The FI of chitosan scaffolds la-
belled with TRITC was quantified by confocal microscopy before
and after one week of culture with MG63 osteoblast like cells. Cell
morphology, viability and production of extracellular matrix were
assessed. The results showed that after one week of culture cell
viability was high and cell morphology was typical from this cell
line. During that period an abundant amount of collagen was
produced. No statistical difference was found on scaffold FI before
and after cell culture, showing that the model can be applied under
culture conditions.
1Cunha-Reis C, Bagnaninchi PO, El Haj AJ, Yang Y. Exploring fluores-
cence as a tool for real-time monitoring of scaffolds degradation. Tissue
Engineering 2007 Jul;13(7):1694–1694.
(P 333) Recombinant Erythropoietin Application in Complex
Therapy of Chronic Heart Failure (CHF)
M. Perepelyuk1, O. Kholodkova1, D. Pykhtyeyev1
1Odessa State Medical University, Odessa, Ukraine.
Background: CHF becomes widespread syndrome in many pa-
tients. It is related with the ageing and rise of the morbidity of
cardio-vascular system among this category of people. Modern
methods of CHF treatment doesn’t ensure the clinical success in
all cases, often are contradictive because of the accompanied pa-
thology.
Materials and methods: We used recombinant erythropoietin-ß in
complex therapy of CHF II-III functional class under NYHA in 17
males, average age 71  3,2. The cause of CHF in all patients was
integration of IHD and hypertonic disease; all the patients con-
ducted myocardium infarction more than 6months before the re-
search. Seven patients suffered from the constant form of atria
fibrillation. Basic therapy of CHF included ß-adrenal blockers, ACE
inhibitors, desaggregants, diuretics and anticoagulants instead of
desaggregants if necessary. Nine patients additionally got recom-
binant erythropoietin-ß in the dose of 2000 IU twice with an interval
of 2 days. Laboratory and instrumental tests were done before the
research and 2 weeks after first injection of erythropoietin.
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Results: in patients after erythropoietin treatment no arterial
pressure rise was observed. Clinical data were approximately similar
to those in the group without erythropoietin treatment. No positive
dynamic of creatinin and transaminases of blood were investigated.
The decrease of the level of Na-uretic peptide (22,8 % lower) and
improvement of global (systolic-diastolic) function of the left ven-
tricle under results by Tei-index (24,1 % decrease) were found.
Conclusions: the obtained data demonstrate safety and effec-
tiveness of recombinant erythropoietin-ß in complex therapy of
CHF of ischemic genesis in aged males.
(P 334) Recombinant Human Collagen as a Bioactive Element
in Scaffolds for Tissue Engineering
E.-M. Engelhardt1, S. Houis2, R.A. Brown3, J. Hillborn4,
M. Adam1, F.M. Wurm1
1EPFL, Laboratory of Cellular Biotechnology, Lausanne, Swit-
zerland.
2Institut fu¨r Textiltechnik, RWTH, Aachen, Germany.
3UCL, Institute of Orthopaedics and Musculoskeletal Sciences,
London, United Kingdom.
4Department of Materials Chemistry, Polymer Chemistry, Up-
psala, Sweden.
Scaffolds are made from naturally derived as well as from syn-
thetic polymers. Synthetic polymers have the advantages of being
manufactured with high reproducibility, controlled degradation
rate and mechanical properties. But they lack cell-recognition
signals that confer bioactivity to the scaffold. An attractive concept
is to combine synthetic materials with natural cell-recognition sites
present in ECM proteins like collagen. We will create a novel
bioactive scaffold by combining a knitted fabric of poly(lactic
acid-co-epsilon-caprolactone) (PLA-CL) polymer with a layer of
recombinant human collagen produced and deposited onto the
polymer by Chinese hamster ovary (CHO)-derived cell line.
We established CHO-derived cell lines that stably express re-
combinant human collagen I (chain alpha 1 and alpha 2) and IV
(chain alpha 2). Sirius Red assay and western blot showed that our
cell lines secreted recombinant human collagen into the cell culture
medium. These cell lines will be seeded onto PLA-CL scaffolds to
deposit a layer of recombinant collagen. CHO cells will be removed
by osmotic shock assuring a soft cell removal without detaching the
recombinant collagen present within the polymer. Human bladder
smooth muscle cells will be reseeded onto the new bioactive scaf-
fold and an in vitro analysis of their attachment and growth will be
performed. These experiments will establish the proof of principal
that a scaffold made of a synthetic polymer and recombinant human
collagen can be used to grow patient cells, paving the way to the
generation of a novel scaffold for tissue engineering with good
mechanical strength and cell recognition sites.
(P 335) Reconstruction of Bone Defect in Canine Femoral
Head By Structural Biphasic Calcium Phosphate Scaffolding
and Marrow-Derived Mesenchymal Stem Cells: an Experi-
mental Study
J. Peng1,2, A. Wang1,2, S.-b. Lu1,2, M. Sun1,2, W. Xu1,2,
J.-x. Huang1,2, J.-M. Tian1, L-Min Dong1
1Institue of Orthopedics, General Hospital of Chinese PLA,
Beijing, 100853, China.
2Institute of Nuclear Energy Technology, Tsinghua University,
Beijing, 100084, China.
Osteonecrosis (ON) or avascular necrosis (AVN) of the femoral
head is a debilitating and painful condition characterized by pro-
gressive joint degeneration in adults. We fabricated biomimetic
biphasic calcium phosphate (BCP) for tissue engineering in repair of
ON or AVN and observed its reconstructive result in canine femoral
heads with ON. BCP ceramic scaffolds mimicking a trabecular
structure were fabricated by a 3-D gel-lamination technique ac-
cording to 2-D images of trabecular specimens from the femoral
head. Then, the 3-D structure of the scaffolds was scanned and
reconstructed with use of micro-computed tomography (micro-CT)
for 3-D characterization of patterns of the material structure related
to trabecular parameters, including bone volume fraction (BVF);
bone surface/bone volume (BS/BV); trabecular thickness (Tb.Th),
number (Tb.N), spacing (Tb.Sp) and pattern factor (Tb.Pf); and
structure model index (SMI). After coating the biomimetic porous
BCPwith marrow stromal cells (MSCs) as seed cells in vitro, tissue-
engineered bones were implanted into the bony defects of canine
femoral heads by use of a trapdoor procedure. Femoral heads in a
control group were packed with autograft bone chips. Control and
BCP-scaffold femoral heads did not differ in micro-CT data, except
for a more plate-like ‘‘trabecular’’ pattern found in BCP-scaffold
heads. After 30weeks, the contour and integrity of the BCP-scaffold
femoral heads was basicallymaintained and showed trabecular bone
formation and integration. However, control femoral heads showed
collapsed contours and osteoarthritic changes. Biomimetic porous
BCP scaffolds coated with MSCs might be effective in repair of
bony defects in femoral heads with ON.
(P 336) Regeneration of Abdominal Wall Musculofascial De-
fect by a Human Acellular Collagen Matrix.
D. Dufrane1, M. Mourad1, M. van Steenberghe1, R.M. Goebbels1,
P. Gianello1
1Experimental surgery laboratory.
Purpose: This work studied the reconstruction of abdominal wall
defect by a ‘‘human acellular collagen matrix’’.
Methods: Fascia lata from human tissue donors (63 25 yrs old,
n¼ 4) were chemically/physically treated to reduce the immuno-
genicity and risk of conventional and non-conventional agents
transmission. Abdominal wall defect was cured, on 40 rats, by
implantation of (i) polypropylene (Pro)/ (ii) polyester (Mers) me-
shes and (iii) human acellular collagen matrix with 2 orientations:
fibres in parrallel (FLL) or perpendicular (FLT) to native rats ab-
dominal wall. Hernia recurrence, adhesions and histology for
inflammation (lymphocyte, CD3/macrophages, CD68) and remo-
delling (Masson’s Trichrom and dystrophin staining) were assessed
at 4 and 8 weeks post-implantation. Two large abdominal even-
trations were cured by human acellular matrix in human patients.
Results: A higher hernia recurrence rate was observed for rats
transplanted with FLL in comparison to FLT/Pro/Mers after 4 and
8 weeks post-implantation. A lower intestinal adhesions rate was
obtained for FLL/FLT than Pro/Mers meshes (50% of adhesion
coverage area at 8 weeks).
Conclusion: Human acellular collagen matrix, placed in FLT
position, can induced an abdominal wall reconstitution without
adhesions and hernia recurrence.
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(P 337) Regeneration of an Artery by using of the De-
Elastinized Aorta
D. Terada1, K. Sawada2, H. Ogata3, K. Hiraku3, W. Kamata3, K.
Yoshida3, S. Funamoto4, T. Fujisato1, A. Kishida4, T. Yamaoka3,
T. Nakatani3
1Osaka Institute of Technology.
2Osaka Seikei College.
3National Cardio Vascular Center.
4Tokyo Medical and Dental University.
Although an artificial blood vessel is in general use, the develop-
ment of regenerative vascular grafts is strongly desired especially
for the pediatric patients. In this study, regenerative collagenic
vascular graft was developed from porcine aorta by removing cells
and structural proteins except collagen from the tissue.
Porcine aorta was isolated from the Clawn miniature pig ( Japan
Farm, Co. Ltd.). The tissue was placed in a vacuum oven at 1208C
to cross-link collagen fibers. Elastin fibers were then taken away
from the tissue by enzymatic digestion using elastase solution at
378C for 3 days with gentle stir. The tissue was incubated in 80%
ethanol solution for 3 days at 378C to remove phospholipids from
the inside. The vascular grafts made of miniature pig descending
aorta were transplanted allogenically.
There was no thrombus on the intimal surface and aneurysm
formation even after 6months of the implantation. A large amount
of the cell migration into the graft was observed. These cells were
identified immunohistologically as smooth muscle cells and fi-
broblasts. Calcific depositions in the graft were not observed after
3months of the implantation. A few of depositions was seen after
6months. However that was not severe calcification. Currently
long-term implantation experiments are in progress.
The processed graft may have better ability to promote cell
infiltration and tissue remodeling as compared with only decel-
lularized tissues. We conclude that the collagenic vascular graft
developed in this study may be adapted to the vascular tissue re-
generation.
(P 338) Regeneration of Articular Cartilage using Mesenchy-
mal Stem Cells to Reconstruct Irreparable Chronic Focal
Cartilage Defects in a Large Animal Model
M. Zscharnack1, R. Schulz1, P. Hepp2, R. Richter2, S. Schmidt2,
F. Stein2, C. Poesel1, A. Bader1, C. Josten2, B. Marquass2
1Department of Cell Techniques and Applied Stem Cell Biology,
University of Leipzig.
2Department of Trauma and Reconstructive Surgery, Medical
Faculty of Leipzig.
Introduction: The aim of this project is to investigate the recon-
struction of a focal osteochondral defect of a knee joint in sheep by
using autologous, bone marrow-derived mesenchymal stem cells
(MSCs). The issue of whether chondrogenic pre-differentiation of
the MSCs in vitro bears an influence on the regeneration in vivo is
also to be addressed.
Methods: An osteochondral incision (Ø 7mm) was made in an
initial operation on the sheep knee and bone marrow aspirate was
removed from the iliac crest of 9 Merino sheep. The isolated and
expanded MSCs were cultured with 0.5 mio cells/ml in a collagen-
I-matrix. One part of the MSC gels was pre-differentiated with
chondrogenic mediumþ 10 ng/ml TGF-beta3, whilst the other part
of the gels was not pre-differentiated. The implantation of the
constructs then followed. The knee joints were explanted and in-
vestigated histologically after 6months.
Results: Gene expression, immunohistology and measurements
of sulfated glycosaminoglycans enabled the successful demon-
stration of a chondrogenic in-vitro-differentiation. In contrast to
the unseeded control gels, the stem cell-seeded implants showed
in vivo good structural bonding with a smooth surface and hyaline
type matrix. The chondrogenic pre-differentiated stem cell gels
showed the best results and yielded an ICRS Visual Histological
Score of 14.25 and an O’Driscoll Score of 17.38.
Conclusion: The collagen gel implants based on autologousMSCs
lead to a partial hyaline type structure of the regenerationmatrix after
6months. Despite its high variability the procedure is a promising
development in the area of biological cartilage regeneration.
(P 339) Regeneration of Dentin/Pulp-Like Tissue using a
Dental Pulp Stem Cell/ Poly (Lactic-Co-Glycolic) Acid Scaf-
fold Construct in Rabbits
R.M. El-Backly1,2, A.G. Massoud2, A.M. El-Badry3, R.A. Sherif2,
M.K. Marei1
1Tissue Engineering Laboratories, Alexandria University.
2Conservative dentistry department, Faculty of dentistry, Alex-
andria University.
3Oral Biology department, Faculty of dentistry, Alexandria Uni-
versity.
Introduction: Regenerative dental procedures are currently be-
ing explored by numerous researchers with more expanding fo-
cus on functional regeneration and biomimicking of natural
biological events. The objective of the present study was to eval-
uate the ability of tissue engineering to regenerate normal
healthy dentin/pulp tissue in ex-vivo sites, when transplanting cell/
scaffold constructs subcutaneously in the dorsal surface in the
rabbit model.
Materials and Methods: Biodegradable synthetic 50/50 poly
(lactic-co-glycolic acid) scaffolds were fabricated using the solvent
casting/particulate leaching technique to form scaffolds with dif-
ferent groups of porosity. Dental pulp stem cells were isolated from
healthy rabbit teeth and characterized using Confocal laser mi-
croscopy. These cells were used for seeding the scaffolds from
each group. Seeded scaffolds were analyzed using phase contrast
microscopy and scanning electron microscopy and implanted
subcutaneously in the dorsal surface of each rabbit and evaluated
up to six weeks post-transplantation.
Results & Conclusions: The scaffolds prepared showed good
porosity characteristics and supported the attachment, prolifera-
tion, migration, and differentiation of the dental pulp stem cells.
Dental pulp stem cells maintained their ability to differentiate in
culture flasks as well as on seeded scaffolds to form organized struc-
tures even without the addition of differentiation induction com-
ponents. When cell/scaffold constructs were transplanted in-vivo,
they supported angiogenesis and gave rise to a variety of newly
formed tissues that ranged from osteodentin-like tissues to more
tubular bi-layered structures as well as the presence of some
complex tissues similar to the configuration of the dentin-pulp
complex in a natural tooth.
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(P 340) Regeneration of Tympanic Membrane Perforation
using BFGF Releasing Alginate/PCL Patch
S.M. Lim1, S.H. Oh1, A.Y. Kim2, C.S. Cho2, J.M. Kim3, J.H. Lee1
1Hannam University.
2Eulji University Hospital.
3Chungnam National University Hospital.
Damage of tympanic membrane (ear drum) is one of common
diseases in otorhinolaryngology fields, which is frequently arisen
as a result of either otitis media or trauma. In recent years, basic
fibroblast growth factor (bFGF) which can enhance fibroblast
growth and angiogenesis has been employed into the various pat-
ches to improve restoration rate of damaged tympanic mem-
branes. However, daily administration of growth factor has been
considered as a critical limitation. In this study, we fabricated a
hydrophilized polycaprolactone (PCL) nanofiber patch by elec-
trospinning and the following oxygen plasma treatment. The pre-
pared patch was impregnated with bFGF/alginate/CaSO4 mixture
solution to provide the crosslinking of alginate and sustained re-
lease of bFGF. From the bFGF release experiment, we observed
that the bFGF is continuously released from the alginate/PCL
patch, up to 700 ng for 21 days. To compare tympanic membrane
regeneration through the various patches (PCL, alginate/PCL, and
bFGF/alginate/PCL), in vivo animal study was also conducted
using a guinea pig (acute damaged tympanic membrane model).
The bFGF/alginate/PCL patch showed faster tympanic membrane
regeneration than the other groups, probably due to the continuous
release of the bFGF. From the results, we conclude that the bFGF/
alginate/PCL patch can be a good candidate as an effective tym-
panic membrane regeneration patch.
(P 341) Repair of Large Full-Thickness Articular Cartilage
Defects using Novel Decellularized Artilage Scaffolds and
Adipose-Derived Stem Cells in a Rabbit Model
H. Kang1, Q. Yang1, S. Lu1, J. Peng1, Q. Guo1, A. Wang1,
B. Zhao1, L. Zhang1, W. Xu1, Feiyang 2, S. Wang2
1Key Laboratory of PLA, Institute of Orthopedics, General Hos-
pital of PLA, Beijing 100853, China.
2BNLMS State Key Laboratory of Polymer Physics & Chemistry,
Institute of Chemistry, Chinese Academy of Sciences, Beijing
100080, China.
The purpose of this study was to develop a natural, decellularized
cartilage scaffold, and evaluate the use of a autologous dipose-
derived stem cells (ADSCs) as a cell source for cartilage defect
repair in rabbits. ADSCs were isolated and induced with defined
medium (including TGF-b1)and placed in decellularized scaffold.
An articular cartilage defect was created on the patellar groove of
the femur, and the defect was filled with the ADSCs/scaffolds
constructs (Group A), RCCS bioreactor-based ADSCs/scaffolds
constructs Group B), scaffold alone (Group C), or empty (Group
D). 12, 24, 48 weeks after the operation, the histological analyses
showed that the defects were filled with reparative hyaline carti-
lage in Group A and Group B. Quantitative histologic analysis
revealed that an average score of bioreactor-based Group (Group
B) is higher than non-bioreactor Group A.
(P 342) Reporter-Vectors for Chondrogenic Differentiation
Status
G.A. Feichtinger1,2, S. Wolbank2,3, M. van Griensven1,2,
H. Redl1,2
1Ludwig Boltzmann Institute for Experimental and Clinical
Traumatology, Vienna, Austria.
2Austrian Cluster for Tissue Regeneration.
3Red Cross Blood Transfusion Service of Upper Austria, Linz,
Austria.
2D cultivated chondrocytes dedifferentiate towards a fibroblastic
phenotype. With the proceeding dedifferentiation, collagen type I
takes over the chondrocyte specific collagen type II expression. To
follow the state of dedifferentiation, we now introduce a combi-
nation of collagen I and collagen II reporter plasmids. The collagen
I plasmid contains the red fluorescent protein dsRed driven by a
collagen I alpha 1—enhancer/promoter combination. The collagen
II reporter contains a CMV-enhancer element for signal amplifi-
cation linked to a collagen II-promoter fragment containing
chondrocyte specific cis-acting activator and repressor recognition
sequences. In contrast to the collagen I reporter, the collagen II
plasmid includes the fluorescent protein EYFP. Therefore both
markers can be detected separately. Furthermore, the differentia-
tion kinetics can be monitored for both directions, de- and re-
differentiation. We achieved the design of a reporter-vector system
simultaneously indicating collagen expression-levels of trans-
fected cells by cloning of the two reporter-cassettes into one
plasmid. Initial transfection of porcine BMSC with the separate
reporter-vector systems confirmed the functionality of the designed
chimeric transcription activating elements by fluorescence mi-
croscopy. The collagen-expression specific response of the de-
signed reporter-vector systems is still under investigation in human
adipose derived stem cells. The described systems will be suitable
for investigating collagen I and collagen II expression of human
mesenchymal stem cells and articular chondrocytes in vitro.
This work was supported by the European projects
Hippocrates (NMP3-CT-2003-505758) and Expertissues (NMP-
CT-2004-500283)
(P 343) Rheological Analysis of Biomaterials Used for the
Development of an Artificial Substitute of the Corneal Stroma
R. Go´mez-Sotomayor1, J.D.G. Dura´n2, J.I. Mun˜oz-A´vila3,
M. Alaminos1,3, I. Carreras4, M.D. Caracuel1, F. Gonza´lez-
Caballero2, A. Campos.1
1University of Granada, Department of Histology.
2University of Granada, Department of Applied Physics.
3Univ. Hospital San Cecilio, Granada, Spain.
4University of Granada, Department of Surgery.
Introduction: New biomaterials have been recently used for the
construction of artificial corneas by tissue engineering. Evaluation
of the mechanical properties of these biomaterials is necessary
before the artificial corneas can be used for clinical purposes.
In this work, we have analyzed the physical properties of three
different kinds of corneal substitutes developed by tissue engi-
neering.
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Materials and Methods: Primary cultures of human corneal
keratocytes were established from small biopsies of the scleral
limbus, and partial human cornea substitutes were developed by
using artificial stromas made of agarose, collagen or fibrin with
human keratocytes imersed within. Viscosimetric and oscillo-
metric measures were obtained by using a Bohlin CS10 rheometer
in a plate-plate configuration. The yield stress point of each bio-
material and the biomechanical properties of the different corneal
substitutes were determined.
Results and Discussion: Rheological evaluation of the different
biomaterials demonstrated that the yield stress points of fibrin
(0.5698 Pa) and agarose (1.0206 Pa) were lower than that of col-
lagen (10.4210). Low shear viscosity was similar for fibrin and
agarose (Z0<10
4s1), whereas collagen hydrogels showed a h0
value of 3.8357 s1. Our analysis revealed that the rheological
properties of the different corneal substitutes were strongly de-
pendent on the biomaterial used as scaffold. In general, collagen
hydrogels were more viscous and sustained higher levels of yield
stress. All biomaterials evaluated in this work showed a visco-
elastic behavior and could, therefore, be used for the construction
of artificial corneas by tissue engineering.
Supported by PI-0132/2007 from Junta de Andalucia.
(P 344) Role of NEU3 Sialidases Into the Muscle Differentia-
tion Process
Ivan Carubelli1, Nadia Papini2, Bruno Venerando2
1IRCCS Policlinico San Donato, Italy.
2Department of Chemistry, Biochemistry and Medical Bio-
technology, University of Milan, Italy.
Introduction: Sialidases influence cellular activity by removing
terminal sialic acid from glycoproteins and glycolipids. Four ge-
netically-distinct sialidases (Neu1-4) have been identified in
mammalian cells. The intricate mechanisms regulating myoblast
differentiation are still under investigation. Along this line, a few
reports suggest the involvement of sialidases in muscle differen-
tiation. However, while down-regulation of Neu2 (the cytosolic
sialidase) has been shown to inhibit myotube formation [1],
nothing has been reported about the role of Neu3 (the plasma-
membrane sialidase) in this process.
Methods: The role of Neu3 sialidase has been studied in muscle
differentiation by stably overexpressing it in C2C2 cells. The effect
of Neu3 overexpression was studied by looking at muscle differ-
entiation markers and ganglioside pattern.
Gangliosides are major regulatory molecules present in the cell
membrane and are potential substrates for both Neu1 (the lyso-
somal sialidase) and Neu3.
Results: The main ganglioside in this cell is GM3 and the over-
expression of sialidase caused a decrease in GM3 content. Neu3
overexpressing cells also formed hyperthrophic myotubes and
showed a delay in proliferation towards terminal differentiation.
Conclusion: Since the overexpression of Neu3 in C2C12 cells
caused an increase in GM3 levels sialidases may influence cellular
pathways by modulating the GM3 content.
1Fanzani, A., Giuliani, R., Colombo, F., Zizioli, D., Presta, M., Preti, A.,
Marchesini, S. (2003) Overexpression of cytosolic sialidase Neu2 induces
myoblast differentiation in C2C12 cells. FEBS Lett 547, 183–8.
(P 345) Scaffold Properties and Interaction with Cells In-
vestigated By Magnetic Resonance Methods
H. Nitzsche1, A. Noack1, A. Lochmann1, C. Oliveira1, A. Besh-
eer1, H. Metz1, A. Bernstein2, G. Hause3, T. Groth1, K. Ma¨der1
1Institute of Pharmacy, Pharmaceutics and Biopharmaceutics Di-
vision, Martin Luther University Halle-Wittenberg, Wolfgang-
Langenbeck-Straße 4, 06120 Halle, Germany.
2Laboratory of Experimental Orthopedics, Department of Ortho-
pedics, Martin Luther University Halle-Wittenberg, Magdeburger
Straße 22, 06097 Halle, Germany.
3Biocenter of the University, Microscopy Unit, Martin Luther
University Halle-Wittenberg, Weinberg 22, 06120 Halle, Ger-
many.
Many properties of scaffolds have to be considered to ensure their
suitability for tissue engineering approaches. The majority is
usually investigated by techniques which are associated with a
destruction of the sample. The non-invasive analytical tools of
magnetic resonance imaging (MRI) and electron paramagnetic
resonance spectroscopy (EPR) are used to avoid scaffold damages.
Scaffolds composed of hydroxyapatite, collagen and chitosan
have been produced and some crucial properties have been char-
acterized using these techniques. For example, the pore size is
typically measured microscopically in dry state. During incubation
in culture medium or body fluids, some scaffold materials are in a
swollen state. So the actual space for diffusion processes can differ
between scaffolds of the same measured pore size but different
materials. This issue has been visualized non-invasively by MRI
and the Gd-DTPA contrast agent. Additionally, the channels for
mass transfer can be narrowed by cells growing on the surface. The
observed hindered diffusion leads to insufficient supply of oxygen
and nutrients inside the scaffold, delimiting the growth of cells to
the surface. Concerning this matter, also the pH of the aqueous
medium inside the scaffold is important, especially in the face of
acidic degradation products arising from common scaffold mate-
rials. Information about pH and oxygen concentration inside the
scaffold has been obtained non-invasively by EPR.
Furthermore, the seeding of magnetite loaded osteoblasts on the
scaffolds has been followed by the new method of benchtop-MRI.
The results have been compared with histological cuttings stained
by Prussian blue and nuclear fast red.
(P 346) Scaffolds Designed and Fabricated with Elastic Bio-
materials Applying CAD-CAM Technique
M. Enamul Hoque1, W. Feng2, Y.S. Wong2, D.W. Hutmacher3,
S. Li4, M-H Huang4, M.Vert4, P.J. Ba´rtolo5
1School of Mechanical Engineering, University of Nottingham
Malaysia Campus.
2Department of Mechanical Engineering, National University of
Singapore.
3Department of Regenerative Medicine, Queensland University of
Technology, Australia.
4Research Center for Artificial Biopolymers, University Mon-
tpellier 1, France.
5Department of Mechanical Engineering, Leiria Polytechnic In-
stitute, Portugal.
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Rapid prototyping (RP) technique is increasingly recognized to be
an efficient process to develop scaffolds for tissue engineering
applications. Scaffolds are fabricated according to user-defined
architecture and customized shape through layer-by-layer deposi-
tion of material utilizing profound advantages of CAD-CAM
techniques. An in-house built desktop robot based rapid proto-
typing (DRBRP) system was employed to manufacture scaffolds
using two polymers (PCL & PCL-PEG) and three architectural
patterns. Results from ultra pycnometer, micro-CT and SEM were
used to evaluate the scaffold morphology that evidenced well-
customized scaffold structure in terms of pore shape, size and
interconnectivity. The in vitro cell culture study using rabbit
smooth muscle cells, demonstrated bioactivity of both PCL and
PCL-PEG scaffolds for cell attachment and proliferation. How-
ever, the PCL-PEG copolymer scaffolds showed overall better
performance than the PCL homopolymer scaffold that was re-
flected by the DNA quantification assay. The reported results
demonstrate an encouraging suitability of the developed scaffolds
for tissue engineering applications.
(P 347) Self-Assembling Peptide Hydrogels: Directing Cell
Behaviour By Chemical Composition.
V. Jayawarna1, S.M. Richardson1, J. Gough1, R. Ulijn1
1The University of Manchester, UK.
Over recent years, there has been a growing interest in the design of
self-assembly systems using aromatic short peptide derivatives for
biomedical applications including 3D cell culture. We previously
demonstrated that these peptides derivatives self-assemble into
stiff nano structural hydrogels with tunable properties( Jayawarna
V., et al., Adv.Mater.18(2006).
These materials have already shown to be successful in cell
culture of chondrocytes, they have not been tested for other cell
types. Initial testing of the Fmoc-Phe-Phe-OH with skin cells such
as human dermal fibroblasts and Mouse 3T3 cells highlighted some
limitations and some development areas in terms of long term gel
performance, stability and applications. The objective of this paper
therefore is to investigate the design and the development potential
of a series of peptide hydrogel systems of different chemical com-
positions were achieved through mixing Fmoc-Phe-Phe-OH with
positively changed (Lysine), uncharged/polar (Serine) and nega-
tively charged (Glutamic acid) Fmoc amino acids. The propensity of
these hydrogel systems to promote proliferation, survival and pro-
liferation of chondrocytes, 3T3 andHDF cells have also been tested.
In addition methods were developed to form gels rapidly upon ex-
pose to culture media for both 2D and 3D cell culture applications.
Hydrogels were characterised using FTIR and TEM. The results
suggest that these peptide systems undergo spontaneous assembly
into nanofibre scaffolds by mainly adopting an antiparallel b-sheet
conformation. Both 2D and 3D cell culture analysis shows that
these new hydrogels give rise to improved culturing of different
cell types with respect to the Fmoc-Phe-Phe-OH hydrogel. Spe-
cifically, Fmoc-Phe-Phe-OHþFmoc-Serine is
(P 348) Si and Ti-Containing Glasses as Bone Cement Fillers:
a Bioactivity and Biocompatibility Study
P. P. Lopes1, B. J. M. Leite Ferreira1, R. N. Correia1, M. H. R.
Fernandes2, M. H. V. Fernandes1
1CICECO, Department of Ceramics and Glass Engineering, Uni-
versity of Aveiro.
2Faculty of Dental Medicine, University of Porto.
The main condition for a synthetic material to form a stable bond
with the bone is the precipitation of an apatite layer on its surface,
assumed to be responsible for its bioactivity[1].It is well known
that some Si-based glasses exhibit high level of bioactivity but it
has also been reported that Ti-containing glasses can induce the
surface precipitation of calcium-phosphates.In both cases the for-
mation of OH groups in physiological medium is the key of the
observed behaviour[2]. In the present study, PMMA- co-EHA
composites filled with glass particles of the Ca-P-Ti (CTi) and Ca-
P-Mg-Si (CSi) systems were developed and compared in terms of
their in vitro behaviour both in accellular and in cellular me-
dia.Accellular tests were carried out in SBF, for periods up to 21
days at 37 8C.Surface modifications were followed by SEM-EDS
and FTIR, and ICP was used to assess the variation of ionic con-
centration in the fluid. After 3 days of soaking, both composites
showed the presence of Ca-P precipitates with average Ca/P atomic
ratio of 1.53 in the layer covering CSi and 1.06 in CTi.Compat-
ibility evaluation was performed with MG63 osteoblast-like cells
up to 21 days and was followed by confocal microscopy.The ob-
served behaviour of CSi and CTi composites was explained in
terms of the differences found in accelular media. The results
showed that the glass composition was decisive to explain the
in vitro behaviour of the composites, being SiO2-based glass much
more effective than the TiO2-based glass.
1H.Takadama,et al. J.Am.Ceram.Soc.2002:85;1933–1936.
2T.Kokubo, Acta Mater. 1998:46;2519–2527.
(P 349) Silica Based Nanomaterials: Characterisation and
In Vitro Studies using Osteoprogenitor Cells
A. Dı´az-Cuenca1, L. Santos-Ruiz2, J. Becerra2
1Instituto de Ciencia de Materiales de Sevilla (Centro Mixto
CSIC-Universidad de Sevilla), Centro de Investigaciones Cientı´-
ficas Isla de la Cartuja, Avda. Americo Vespucio no. 49, 41092
Sevilla, Spain.
2Laboratorio de Bioingenierı´a y Regeneracio´n Tisular (LABRET).
Departamento de Biologı´a Celular, Gene´tica y Fisiologı´a, Fa-
cultad de Ciencias, Campus Universitario Teatinos, Universidad
de Ma´laga, 29071, Ma´laga, Spain.
This work studies the potential of mesostructured powder materials
based on the organised SBA-15 type silica in tissue engineering
applications. A bare SBA-15 silica material and a SBA-15 based
composite containing HA nanoparticles have been investigated.
The first part of this paper is focussed in the characterisation of the
microstructure and the textural properties of the materials with
special emphasis on the influence of conventional sterilisation
treatments on their final properties. The second part of the paper
reports in vitro cell biocompatibility studies. Cell culture studies
were carried out using the mouse osteoblastic cell line MC3T3-E1
as well as adult bone marrow mesenchymal stromal cells from rat
and human species. The three cell-types were shown to attach to
the materials and to form three-dimensional (3D) cell-material
aggregates. These initial small aggregates were observed to coa-
lesce and growth in size with culture time by the joining of smaller
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units. Preliminary results also indicate that the HA-SBA-15 ma-
terial can support the expression of an early bone differentiation
marker. In summary, our results show that both SBA-15 and HA-
SBA-15 materials can be easily sterilised with conventional tech-
niques preserving their textural properties, and that they support
cell attachment and proliferation.
(P 350) Spinal Injury Repair: Novel Injectable Fibronectin
Scaffolds
A. Alovskaya1, R.A. Porter1, V.R. King2, J.V. Priestley2,
R.A. Brown1
1UCL Tissue Repair & Engineering Centre, Institute of Ortho-
paedics & Musculoskeletal Science, Stanmore, Middx, HA7 4LP,
UK.
2Neuroscience Centre, Institute of Cell & Molecular Science,
Queen Mary University of London, London, E1 2AT, UK.
Spinal cord degeneration following crush injury presents major
clinical problems. Repair strategies involving surgical intervention
risk further damage to remaining functional neurones and forma-
tion of fibrous scar tissue.
A biomaterial scaffold that could be injected as a liquid and
solidify in situ offers a minimally invasive alternative to surgery. It
could also act as a carrier for transport of cells and bioactive
molecules to the injury site.
Previous studies have shown that fibronectin materials im-
planted into spinal injury sites had a positive effect on neuronal
regeneration. This study describes materials produced from highly
concentrated viscous solutions of fibronectin (FN) that were
stimulated to form a gel within seconds on contact with metal
ions.
Fibronectin pellets were dissolved in 6M urea and a range of
metal salts were added including copper, zinc, silver, magne-
sium, calcium and manganese at different concentrations (1uM-
100mM). Gel formation was measured by the change in turbidity
at 450 nm.
The addition of copper, zinc or silver to the fibronectin solution
initiated gel formation within seconds and the rate of polymeri-
sation was dependent on metal ion concentration (100uM-
100mM). Polymerisation did not occur in the presence of calcium,
magnesium or manganese salts. Analysis of the ultrastructure of
the gels by electron microscopy revealed variations in the porosity,
fibre diameter and general architecture of ZnFN, AgFN and AgFN
gels.
In conclusion, fibronectin gels are important injectables for
promoting spinal regeneration and zinc and silver produce rapid
aggregation.
We are grateful for funding from the BBSRC (BB/C513893/1)
(P 351) Study of Novel Nanofiber Mats Obtained By Electro-
spinning Ternary Blends Containing Chitosan, Cellulose
Acetate and Poly(Ethylene Oxide)
R. Vidinha1,2, C. Henriques1,2, J.P. Borges1,3,2, J.C. Silva1,2
1Physics Department.
2Faculty of Science and Technology, New University of Lisbon.
3Materials Science Department, CENIMAT/I3N.
The aim of our work is the production of biodegradable polymeric
scaffolds to be used in skin regeneration. We produced nonwoven
highly porous membranes electrospinning solutions containing
chitosan, cellulose acetate (CA) and poly(ethylene oxide) (PEO)
in 85 w/w% aqueous acetic acid. The rationale behind this novel
ternary blend approach is: the bioactivity and wound healing
properties of chitosan, which is, however, difficult to electrospin;
the easy processability of PEO, which has the handicap of being
water soluble; the biocompatibility and water insolubility of CA,
which helps preserve the structural integrity of the scaffolds. The
rheologic and electrochemical properties of the solution determine
its electrospinnability and, together with the processing condi-
tions, the morphology of the fibers. We considered six solutions
with a total polymer concentration of 6 w/w%, equal parts of PEO
and CA and chitosan concentrations ranging from 0 to 5 w/w%.
Shear viscosities, surface tensions and conductivities of the so-
lutions were measured. For the blend containing 3 w/w% chitosan
the influence of solution feed rate, applied high voltage and tip to
collector distance on fiber morphology was studied. The same
processing parameters were used for the 5 chitosan-containning
blends in order to evaluate the influence of composition on
morphology, mechanical properties (tensile tests) and structural
stability of the scaffolds in phosphate buffer saline (PBS) solu-
tions. Morphological studies were based on SEM images which
revealed fiber diameters decreasing with chitosan content.
Young’s modulus and ultimate tensile strength increased with
chitosan content. Structural stability improves with chitosan
content.
(P 352) Surface Activated Microparticulate for Bone Tissue
Engineering
H.-W. Kim1
1Department of Biomaterials Science, School of Dentistry, Dan-
kook University, Korea.
Spherical microparticulates are useful in delivery of proteins and
cells. Many polymeric materials, however, are hydrophobic and
lack of cell binding sites, thus the potential for cell delivery and tis-
sue engineering scaffold has been limited. Herein, the surface of
degradable polymeric (PL-DLA) microspheres was activated by
immobilizing lab-designed fibronectin (FN) residue for use as bone
tissue engineering matrix.
Bone marrow derived stem cells(BMSCs)were isolated from
adult rat and cultivated upon the microspherical scaffold with
varying cell densities. BMSCs were shown to adhere well and
populate actively on the FN-activated microparticulates, even
forming a thick cell layer at high loading density (>300000),
whereas poor cell adhesion and growth were noticed on the FN-
free microspheres. The cell sheet exhibited differentiation potential
into bone forming cells with significant level of alkaline phos-
phatase expression. Moreover, the cells at day 14 started to form
discrete mineralized nodules and the nodule formation was sig-
nificantly enhanced at day 28. BMSCs loaded at low density
(<50000), however, showed low level of mineral formation even
at day 28. Based on the current study, the FN peptide was useful to
direct BMSCs adhesion and population onto spherical scaffold.
The FN-activated polymeric microsphere is considered useful in
stem cell delivery and tissue engineering.
POSTER PRESENTATIONS 909
(P 353) Surface Characterization of Biologic Scaffolds Com-
posed of Extracellular Matrix
B. N. Brown1,2, C. A. Barnes3, T. L. Sellaro1,2, R. Michel3,4, D. O.
Freytes1,2, T. W. Gilbert2,5, D. G. Castner3,4, B. D. Ratner3,4, S. F.
Badylak1,2,5
1Department of Bioengineering, University of Pittsburgh.
2McGowan Institute for Regenerative Medicine, University of
Pittsburgh.
3Department of Chemical Engineering, University of Washington.
4Department of Bioengineering, University of Washington.
5Department of Surgery, University of Pittsburgh.
Biologic scaffolds composed of extracellular matrix (ECM) have
been shown to modulate the mammalian host tissue response from
scar tissue formation to a more constructive remodeling response.
The mechanisms underlying this altered response are poorly
understood. As the surface of an ECM scaffold is the first site of
host-scaffold ‘‘interaction’’, it likely plays a significant role in
determining both the initial host response and downstream tissue-
remodeling events.
The present study investigated the surface properties of ECM
scaffolds derived from porcine small intestine (SIS-ECM), urinary
bladder (UBM-ECM), and liver (L-ECM). Immunohistochemistry,
electron microscopy, and time of flight secondary ion mass spec-
troscopy (ToF-SIMS) were used to examine surface characteris-
tics. Cell culture studies were performed to determine the effects of
the differences in ECM surface properties upon growth patterns of
NIH 3T3 fibroblasts, human microvascular endothelial cells, and
hepatic sinusoidal endothelial cells.
The immunohistochemical and SEM results demonstrated that
surface composition and ultrastructure of an ECM scaffold are
dependent on the organ from which it is derived. SIS-ECM and
UBM-ECM, but not L-ECM scaffolds display a distinct ‘‘sided-
ness’’ (abluminal/luminal). ToF-SIMS was used to further eluci-
date differences in scaffold surface characteristics. Cell culture
studies showed that differences in scaffold ultrastructure, compo-
sition, and ‘‘sidedness’’ have an effect upon growth patterns and
maintenance of phenotype in vitro.
We conclude that the tissue source of a biologic scaffold com-
posed of ECM has a distinct effect upon both the surface charac-
teristics and the host-scaffold interaction associated with the
scaffold, which in turn likely affect downstream remodeling
events.
(P 354) Surface Functionalization of Starch/Polycaprolactone
Fiber Meshes for Bone Guide Regeneration
P.M. Lo´pez-Pe´rez1,2, P. Sol1,2, I. Pashkuleva1,2, R.L. Reis1,2
13B’s Research Group—Biomaterials, Biodegradables and Bio-
mimetics, Dept. of Polymer Engineering, University of Minho,
Campus de Gualtar, 4710-057 Braga, Portugal.
2IBB—Institute for Biotechnology and Bioengineering, PT Gov-
ernment Associated Laboratory, Braga, Portugal.
Surface design of biomedical devices is crucial for their accepta-
tion or rejection by the body. One of the most versatile and ef-
fective tools to tailor surface chemistry and properties of solids is
polymer grafting. This work describes the modification of starch/
polycaprolactone scaffolds by surface grafting of sulfonic and
phosphonic groups and the effect of those groups on osteoblast-like
cells behaviour on a preliminary base.
Scaffolds with porosity of about 68%were obtained from a blend
of starch with polycaprolactone (30/70wt-%) by a fiber-bonding
process. Oxygen plasma treatment was applied on the produced
scaffolds in order to create highly reactive, free radicals on their
surface. The pre-activated scaffolds were subsequently immersed
in monomer (vinyl phosphonic acid (VPA) or vinyl sulfonic acid
(VSA) solution. The successful grafting was confirmed by X-Ray
Photoelectron Spectroscopy. Scanning Electron Microscopy was
used to evaluate the possible effect of the plasma activation and
grafting process on the surface morphology. It was demonstrated
that none of the applied processes affect the scaffold/fiber texture.
Direct contact assays with osteoblastic cells (SaOs-2) were
performed in order to evaluate the effect of the modification on
their behavior. Cells were seeded onto the materials and incubated
for 2 weeks. Cells viability, morphology and proliferation were
also evaluated after different culture periods. The performed tests
revealed that the presence of sulfonic and phosphonic groups in-
creased significantly the proliferation and viability of SaOs-2
compared to untreated scaffolds. From both studied monomers, the
scaffolds modified via VPA grafting performed better than the
VSA grafted ones.
(P 355) Synthesis and In Vivo Characterization of Injectable
and Biodegradable Polyurethane Scaffolds in a Wound Heal-
ing Model
A.E. Hafeman1, K.J. Zienkiewicz1, B. Li1, J.M. Davidson2,3,
S.A. Guelcher1
1Department of Chemical Engineering, Vanderbilt University.
2Department of Pathology, Vanderbilt University School of
Medicine.
3Research Service, VA Tennessee Valley Healthcare System.
Limited availability of autograft tissue for burns and wound
healing has generated a need for improved synthetic biomaterials.
Polyurethane (PUR) scaffolds exhibit beneficial properties for
wound healing, as they support cellular proliferation and new tis-
sue formation both in vitro and in vivo. We synthesized injectable,
porous, PUR scaffolds from lysine triisocyanate (LTI) and hex-
amethylene diisocyanate trimer (HDIt) with polyester triols of two
different compositions and mass and containing 0, 30, and 50%
MW-600 poly(ethylene glycol). We evaluated the effects of these
compositional variables on PUR physical, mechanical, and bio-
logical properties. Foams showed regular pore structures, with an
average porosity of 92 vol-%. The polyol composition and PEG
content affected the mechanical properties of the foam, while the
isocyanate and PEG contents influenced their in vivo behavior. LTI
foams degraded faster than HDIt foams in vivo, probably due to
enzymatic degradation of lysines in LTI, although this difference
was minimized with PEG plus HDIt. These tunable differences in
the physical and mechanical characteristics of scaffolds can be
applied to both bone fracture and soft tissue wound healing ap-
plications. Wound healing experiments with pre-formed PUR
scaffolds showed that biodegradation occurred over 2–3 weeks
while supporting cellular infiltration and connective tissue for-
mation with minimal inflammation. Infiltration and organization
could be augmented by sustained release of morphogens from
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PUR. The injectable aspect may be particularly favorable for ob-
taining close conformation of the PUR scaffold to complex wound
cavities. Supported by NIBIB/NIA/NIAMS, the Department of
Defense, and the Department of Veterans Affairs.
(P 356) The Angiogenic Potential of Three-Dimensional
Macroporous Ceramic Scaffolds using the Chorioallantoic
Membrane Assay (CAM)
S. Teixeira1,2, W. Petersen3, J. de Boer4, M.P. Ferraz1,5, F.J.
Monteiro1,2
1INEB—Instituto de Engenharia Biome´dica,Divisa˜o de Bioma-
teriais; Universidade do Porto, Rua do Campo Alegre, 823, 4150-
180 Porto, Portugal.
2Universidade do Porto, Faculdade de Engenharia, Departamento
de Engenharia Metalu´rgica e de Materiais, Rua Dr. Roberto Frias,
Porto, Portugal.
3Department of Biophysical Engineering, University of Twente,
Postbus 217, 7500 AE Enschede, The Netherlands.
4Department of Tissue Regeneration, Institute for Biomedical
Technology, University of Twente, Postbus 217, 7500 AE En-
schede, The Netherlands.
5Faculdade de Cieˆncias da Sau´de da Universidade Fernando
Pessoa, Rua Carlos da Maia, 296, 4200-150 Porto, Portugal.
When designing biomaterials for tissue engineering, namely for
repair of critical size defects, there is the need to accelerate the
remodelling process. A well vascularised network is essential for
nutrient transport and cell delivery, thus contributing for bone
formation. Angiogenesis, the process responsible for the growth of
new blood vessels from pre-existing ones, should be considered as
an important parameter. One of the most well accepted models, the
chick embryo chorioallantoic membrane assay (CAM), was used to
evaluate the angiogenic potential of 3D macroporous scaffolds
based on hydroxyapatite and collagen type I.
The scaffolds were produced using the replication method.
Polyurethane sponges were used as a template and impregnated
with a ceramic slurry composed by hydroxyapatite (HA), water and
surfactant. After sintering, collagen was incorporated. To increase
the resistance, collagen was crosslinked by EDC/NHS conjugation
method and heparin was added. Fertilized eggs were incubated and
after 3 days, 3ml of albumin were removed from the obtuse end of
the egg. A window was cut, being the egg viability determined.
The window was sealed and the eggs placed in the incubator.
Scaffolds (loaded with 25 ng of VEGF) and controls were placed
on the CAM on day 7, sealed and returned to the incubator. Images
were captured on day 10 and blood vessels were counted. The
VEGF loaded scaffolds performed better than the scaffolds alone,
as expected. The later are characterized by a non-organized blood
vessel network whereas VEGF loaded possess a structured and
similar network to the control samples.
(P 357) The Bioengineered Renal Tubule
J.M. Boomker1, P.Y.W. Dankers1,2, E. Wisse3, A. Huizinga—van
der Vlag1, F.M.M. Smets4, E.W. Meijer3, A.W. Bosman2, M.C.
Harmsen1, M.J.A. van Luyn1
1University Medical Center Groningen, Dept. of Pathology &
Medical Biology, Stem Cells & Tissue Engineering Group, Uni-
versity of Groningen, Groningen, The Netherlands.
2SupraPolix Research Center, Eindhoven, The Netherlands.
3Lab. of Macromolecular and Organic Chemistry, Eindhoven
University of Technology, Eindhoven, The Netherlands.
4Lab. of Pathology, Foundation of Collaborating Hospitals of
Eastern Groningen, Winschoten, The Netherlands.
Introduction: Bioengineered renal tubules can be used to support
endocrine and metabolic renal functions in chronic kidney patients.
However, proliferating renal tubule epithelial cells rapidly loose
their differentiated phenotype during culture. Our goal is to
maintain highly differentiated primary human tubule epithelial
cells (PTECs) by culturing the cells on a synthetic scaffold under
perfusion conditions. We evaluated the viability and phenotype of
PTECs that were cultured on microporous polycarbonate filters
and on electrospun supramolecular ureido-pyrimidinone (UPy)-
modified polycaprolactone meshes in a commercial perfusion
culture system for 7 days.
Results and Discussion: Although cells remained viable on both
materials throughout the culture period, PTECs that were cultured
on the electrospun meshes had a more differentiated phenotype
with maintained gene expression of SGLT-1, PEPT-1, OAT-3,
NaPi and AQP-1 genes. Perfusion culture did not modulate the
gene transcription profile of these cells. However, perfusion culture
improved the integrity of the monolayer on electrospun supramo-
lecular polycaprolactone material as demonstrated by electron
microscopy. In these samples also enhanced activity of the brush
border enzyme alanine aminopeptidase was seen, whereas the ac-
tivity of other brush border enzymes remained low.
Conclusion: We conclude that electrospun supramolecular UPy-
modified polycaprolactone meshes are very suitable substrates for
renal epithelial cell monolayers and that perfusion culture can
further improve the quality of the monolayer. Work is in progress
to investigate the effect of long-term perfusion culture, as well as
the use of bioactive culture substrates, on renal epithelial cell vi-
ability and function.
(P 358) The Effect of BMP7 Overexpression in Dediffer-
entiating Human Chondrocytes
G.C. Schueller1,2, W. Schlegel2,3, C. Albrecht2,3, S. Marlovits2,3,
H. Redl1,2, M. van Griensven1,2
1Ludwig Boltzmann Institute for Experimental and Clinical
Traumatology, Vienna,.
2Cluster for Tissue Regeneration, Vienna, Austria.
3Dept. Trauma Surgery, Medical University, Vienna, Austria.
Purpose: The state of the art in cartilage tissue engineering tech-
niques is the autologous chondrocyte transplantation. This method
employs cultivation of chondrocytes with a continuous dediffer-
entiation to fibroblastic phenotype. Evidence of decreased but
potentially important BMP7 expression in cultivated chondrocytes
led us to overexpress BMP7 by transfection.
Material and Methods: Human chondrocytes were isolated from
femur heads, obtained from total joint replacement, and cultivated
in a 2D environment. For BMP7 overexpression a construct with a
CMV promoter and the BMP7-cDNA was cloned. The isolated
cells were transfected by magnetofection with the plasmid at day 1
and compared to an untransfected control group. The ratio of
Collagen Type II and Type I was measured by quantitative PCR as
a differentiation index.
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As further controls cells were transfected with plasmids over-
expressing GFP or DSRed, with the empty vector, and the reagent
without a plasmid.
Results: The BMP7 construct was shown to be transfected with
approximately 30% efficiency and low toxicity. The translation
to the protein was shown by Western Blot and quantified by
ELISA. The group of transfected cells showed a significantly higher
Col II/I index, implicating a more chondrogenic phenotype, com-
pared to the control group in a dose dependent manner. The pro-
liferation rate was slightly reduced compared to the controls. The
unspecific plasmids had a minimal influence on the index as well.
In conclusion, BMP7 transfection improved differentiation without
much effect on proliferation.
This work was supported by the European projects
Hippocrates (NMP3-CT-2003-505758) and Expertissues (NMP-
CT-2004-500283)
(P 359) The Effect of Carbon Nanotubes on Mesenchymal
Stem Cells in a 3D Environment
S.E.P. New1, A.H. Chester1, S. Sharma1, L. Safinia1, A.E.G.
Cass1, M.S.P. Schaffer1, M.H. Yacoub1, P.M. Taylor1
1Imperial College London.
Carbon nanotubes (CNTs) offer the potential to increase the intrinsic
mechanical properties of biological scaffolds used in tissue engi-
neering. Little is known as to the effect of CNTs on cells that may be
used to seed such scaffolds. This study analyses the suitability of
CNTs in tissue engineering using mesenchymal stem cells (MSCs).
Collagen gels with or without 2% CNT solution were seeded
with hTert4 MSCs. After 7 and 14 days, the cell viability was
measured using the MTT assay (Promega). The effect of me-
chanical stretch on MSC morphology while seeded in a collagen
gel containing 2% CNT solution was examined using the Flex-
ercell Tissue Train Culture system.
Viability of cells in collagen gels with and without CNTs was
comparable after 7 days (0.68 0.04 in the absence of CNTs,
0.67 0.04 in the presence of CNTs; values represent optical
density). However, after 14 days the number of viable cells in
collagen gels with CNTs was reduced to 44.9% (1.30 0.15 in the
absence of CNTs, 0.59 0.06 in the presence of CNTs; p< 0.05).
Both the stretched and non-stretched MSCs with or without CNTs
adopted a spindle shaped morphology. There was little difference
in cell morphology between the stretched and non-stretched, or
between those with and without CNTs. However the CNTs were
seen to align along the extensions of the cells.
These findings demonstrate that CNTs have no detrimental ef-
fects on MSCs and that further work is required to develop this
novel and exciting strategy to enhance the integrity of tissue en-
gineered constructs.
(P 360) The Effect of Chemotherapeutic Agents on the Pro-
liferation and Osteogenesis of Human Bone Marrow Stromal
Cells
J. Cheah1, P. Kalia1, M.J. Coathup1, G.W. Blunn1
1Centre for Biomedical Engineering, Institute of Orthopaedics and
Musculo-Skeletal Science, University College London, Royal
National Orthopaedic Hospital, Brockley Hill, Stanmore, Mid-
dlesex HA7 4LP, United Kingdom.
The administration of chemotherapeutic agents during cancer
therapy may lead to osteopathy and the failure of endoprosthetic
replacements. This study investigated the effects of chemothera-
peutic agents specific to osteosarcoma on human bone marrow
stromal cell (hBMSC) proliferation in vitro.
HBMSCs were exposed to individual chemotherapeutic agents at
a range of doses, after which cell proliferation was measured. These
results were compared to primary hBMSCs pre-cultured with os-
teogenic supplements (OG) and a human osteosarcoma (HOS) cell
line. Cell proliferation was also measured after HBMSCs and
hBMSCs pre-cultured with OGwere exposed to three agents at their
clinical doses, either individually or in combination.
A significant dose-dependent effect upon cell proliferation of
hBMSCs, hBMSCs with OG and HOS cells was observed with
cisplatin (CDP) and doxorubicin (ADM), with maximal doses
leading to a significant reduction in proliferation (p< 0.05). No
dose-dependent effects were found when cells were exposed to
methotrexate (MTX). When cells were exposed to a combination
of MTX, ADM and CDP at clinical doses, a synergistic effect on
cell proliferation was not observed.
In summary, individual chemotherapeutic agents significantly
altered the cell proliferation of hBMSCs in vitro. Interestingly, the
use of combined chemotherapy on cells did not amplify the ob-
served effects of individual agents. These results suggest that os-
teopathy and osteopenia in patients receiving chemotherapy may
be related to a reduction of the osteoblast precursor cell pool.
(P 361) The Effect of Human Knee Meniscus Preservation on
Viability of Isolated Chondrocytes
R. Joachimiak1, A. Kaznica1, T. Drewa1, T. Rawo2, K. Slynarski3,
J. Deszczynski2
1Department of Tissue Engineering, Chair of Medical Biology,
Medical College, Nicolaus Copernicus Univeristy, Bydgoszcz,
Poland.
2Department of Orhopedic Surgery and Rehabilitation, 2nd
Medical Faculty of Warsaw Medical University, Warsaw, Poland.
3Department of Orthopedic Surgery, Otwock, Poland.
Background: The meniscus plays an important role in the knee
joint stability. Meniscal fibrocartilage, like articular hyaline carti-
lage, has limited healing capabilities. Tissue engineering could be
an alternative and promising option for the treatment of meniscus
defects. The aim of this study was to check how the time of me-
niscus preservation influences on cell viability within meniscus
tissue.
Methods: Human menisci were harvested 24-hours postmortem
(n¼ 6). To check how the time of meniscus preservation influences
on cell viability, we performed 2 experiments.
In first experiment half of each sample was immediately enzy-
matically digested for 12h with collagenase II to obtain a single
cell suspension. The second experiment considered viability of
isolated chondrocytes from the second half of meniscus after 14-
day preservation in CO2 incubator in 378C. Cells from both ex-
perimental groups were counted and viability checked using trypan
blue exclusion test.
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Results: No bacterial or fungal contaminations were found after
2 weeks of incubation. Number of cells isolated immediately
and after 14 days were comparable. Number of viable isolated
chondrocytes after 1 day postmortem and 14-day storage were
3.5104 8.0104 and 2.7104 6.0104, respectively.
Conclusion: Two weeks of preservation of the menisci does not
influence on human chondrocyte viability. It seems that meniscus
after 2 week of preservation in CO2 incubator can serve as a whole
graft in surgery or as a donor tissue for isolation the chondrocytes
for tissue engineering purposes.
(P 362) The Effect of Hypoxia on Cultured Mucosal Sub-
stitutes
H. Rakhorst1, W. Tra1, S. Posthumus-van Sluis1, S. Perez1,
S. Hovius1, H. van Neck1, A. el Ghalbzouri2, S. Hofer1
1Erasmus MC.
2Leiden University Medical Centre, dept of Dermatology.
Cultured mucosal substitutes (CMS) have been developed for
clinical use to replace keratinizing skin. Upon transplantation of
CMS, a period of hypoxia occurs as vasculature invades the a-
vascular dermis. This makes the CMS fragile and susceptible to
e.g. infection.
The effect of hypoxia on epidermal morphology, proliferation
and differentiation was studied using reconstructed mucosal sub-
stitutes as a three-dimensional model. Hypoxia was shown using a
pimonidazole staining after 24 up to 72 hours in hypoxic culture
using 1.5% oxygen. CMS were stained for the differentiation
marker cytokeratin 10 (K10) and the integrin subunit b1. Epi-
dermal proliferation was examined by a Ki-67 staining. Finally, the
secretion of VEGF was examined by ELISA
The results show that hypoxia disturbed epidermal architecture
and decreased b1 integrin expression in basal keratinocytes, while
the differentiation program (K10 expression) was altered as well.
In addition, mitotic indices decreased while apoptotic cells were
not observed after hypoxic treatment. Finally, a transient upregu-
lation of VEGF secretion was observed the first 48 hours.
In conclusion hypoxia delays differentiation, reduces prolifera-
tion, and decreases metabolic activitity.
(P 363) The Effect of MMPs and Pathogenic Micro-Organisms
on Porcine Collagen Biomaterials
L.E. de Castro Bra´s; 1, P.D. Sibbons1
1Northwick Park Institute for Medical Research.
Introduction: Tissue repair is a complex process which may be
compromised by infection. Biomaterials such as Permacol (cross-
linked acellular dermal collagen) are used to facilitate the natural
wound healing process. Permacol is cross-linked for durability
and performance in complicated wounds. Cross-linking increases
resistance to proteolytic enzymes released during infection which
degrade components of the ECM such as collagen and elastin.
Permacol was incubated with micro-organisms commonly iso-
lated from infected wounds to assess potential performance in in-
fected sites. Permacol and process intermediates were tested for
resistance to neutrophils elastase and MMP-8 released as a result of
infection.
Methods: Permacol was incubated with Staphylococcus au-
reus, Pseudomonas aeruginosa, Escherichia coli or Candida albi-
cans. Samples were taken at different time-points and CFU counted.
Permacol, non-crosslinked acellular collagen and untreated col-
lagen were digested with neutrophils elastase and MMP-8. Histo-
pathology and percentage of dry-weight loss were calculated for all
samples.
Results: Permacol had no significant influence on the micro-
organisms growth. High levels of micro-organisms were observed
coating the Permacol but cellular infiltration was minimal. Fol-
lowing enzymatic digestion percentage of dry-weight loss in-
creased with incubation time in all matrices tested. Permacol
showed higher resistance to enzyme digestion compared to the
other matrices. In all experiments collagen was naturally bire-
fringent and non-degraded before and after treatments.
Discussion: Permacol was not degraded by any of the micro-
organisms tested suggesting resistance to bacterial proteases. Non-
crosslinked matrices were more vulnerable to enzymatic digestion,
therefore these data suggest that crosslinking of porcine collagen
materials confers resistance to neutrophils elastase and MMP-8.
(P 364) The Effect of PMA, IFN-g and PHA-P on Macro-
phages and T-Lymphocytes Activation Evaluated by FACS
S. C. P. Cachinho1, J. A. Hunt1
1Department of Clinical Engineering, University of Liverpool,
Duncan Building, Daulby Street, Liverpool L69 3GA, UK.
Materials are not biologically inert and may induce immune re-
sponses, both nonspecific and specific, contributing to the failure of
the implant or treatment. The potential for host specific immune
responses has been focus of attention as a result of the advances
made in the incorporation of proteins and cells in medical thera-
pies. The nature of this reaction depends on the type, size, con-
centration and duration of material exposure and the surface
characteristics of the implant. Immediately cells of the immune
system accumulate at the site of implantation and a sequence of
events targeted against the material take place. In the absence of
infection Macrophages and T-lymphocytes are the most persistent
in the material tissue interface and surrounding tissue. Upon acti-
vation, cells secrete many inflammatory cytokines including, IL-1,
IL-2, IL-4, INF-gamma and TNF-alpha, ICAM-1 and the expres-
sion of major histocompatibility complex (MHC-I and MHC-
II), CD4 and CD8, molecules implicated in specific immune re-
sponses.
The aim of this research was to determine the activation of
macrophages and lymphocytes to find out the critical stimuli that
contribute to implant failure by inducing an immune response.
Different stimulatory agents have been applied: PMA, INF-gamma
and PHA-P, to establish the elements of these cells material in-
teractions that can be objectively determined in vitro. The ex-
pression of activation markers on the cell surface was determined
by FACS. On the basis of these results and due to their different
mechanisms of activation all agents can be used as factors to study
the immune response of biomaterials.
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(P 365) The Effect of Pore Size on Osteoblast Activity in
Collagen-Glycosaminoglycan Scaffolds
C.M. Murphy 1,2, M.G. Haugh 1,2, F.J. O’Brien 1,2
1Department of Anatomy, Royal College of Surgeons in Ireland,
Dublin..
2Trinity Centre for Bioengineering, Trinity College, Dublin..
The mean pore size is an essential aspect of scaffolds for tissue-
engineering. Previous studies (1) investigating tissue regeneration
on collagen-glycosaminoglycan (CG) scaffolds hypothesised that
there is a critical range of pore sizes for optimal cellular activity. A
more recent study showed that pore size and specific surface area
significantly affected osteoblast attachment, indicating there may
be different optimal pore sizes for different cell types (2). This
study aimed to determine the optimal pore size for osteoblast at-
tachment and proliferation using a range of CG scaffolds produced
in our laboratory (3).
The freeze-drying fabrication process of the CG scaffolds was
varied to produce scaffolds with mean pore sizes ranging from 21–
183 mm (3). These scaffolds were seeded with osteoblasts and as-
sessed 24 h, 48 h and 7 days post-seeding for cellular activity
(alamarBlueTM), cell density (Hoechst 33258) and cell distribu-
tion (routine histology).
Results show that pore size has a significant effect on cellular
activity within a construct and the optimal pore size for osteoblasts
appears to be approximately 150 mm. Cell number decreases above
and below this level indicating that there is a critical range for
optimal cell activity. Future work will expand this study to compare
optimal pore size for both osteoblasts and mesenchymal stem cells.
Acknowledgements: Science Foundation Ireland & Integra Life
Sciences
1Yannas IV, (et al), Clin Mater 1992; 9(3–4): 179.
2O’Brien FJ, (et al), Biomaterials 2005; 26: 433–41.
3Haugh MG, (et al), 2007; 4th International Conference on Lyophilisation
and Freeze Drying, Dublin,
(P 366) The Effect of Shear Stress on Cell Docking Inside Mi-
crofluidic Systems: Computational and Experimental Analysis
M. Cioffi1, M. Moretti2,3, A. Manbachi3,4, B.G. Chung3,5,
A. Khademhosseini3,5, G. Dubini1
1LaBS, Department of Structural Engineering, Politecnico di
Milano, Italy.
2I.R.C.C.S. Galeazzi Orthopaedic Institute, Milano, Italy.
3Harvard-MIT Division of Health Sciences and Technology,
Massachusetts Institute of Technology, Cambridge, MA, USA.
4IBBME, University of Toronto, Toronto, Canada.
5Center for Biomedical Engineering, Department of Medicine,
Brigham and Womens’ Hospital, Harvard Medical School, MA,
USA.
Microfluidic devices are enabling platforms that can be useful to
control and test the cellular microenvironment to study high-
throughput drug screening and cell biology. The aim of this study is
to correlate computationally predicted shear stress at the base of
microwells inside microfluidic devices with experimental cell
docking within the microwells. Briefly, microchannels with 20 cy-
lindrical microwells, 150mm in diameter and either 20 or 80mm
deep were studied. NIH 3T3 mouse fibroblasts were seeded and
medium was infused at an average inlet velocity of 2.31104m/s.
Computational models of microchannels were built by means of
finite-element code Comsol Multiphysics, with and without mod-
elling the cells presence (15mm cell diameter). Flow within the
80mm deep microwells was found to be subject to major recircula-
tion areas near the well base, where the wall shear stresses were low.
(P 367) The Effect on the Manufacturing Method of PLGA
Scaffold for the Osteogenic Differentiation of Bone Marrow
Stem Cells
J.H. Choi11, J.W. So1, M.O. Baek1, J.Y. Lim1, S.H. Jung1, H.H.
Hong1, G.S. Khang1, M.S. Kim2, H.B. Lee2
1BK-21 Polymer BIN Fusion Research Team Chonbuk Nat’l
Univ.
2Nano-biomaterials Laboratory, Korea Research Institute of
Chemical Technology.
A key component in tissue engineering for bone regeneration is the
scaffold that serves as a template for cell interaction and the for-
mation of bone-extracellular matrix to provide structural support to
the newly formed tissue. In this study, three types of PLGA scaf-
folds were prepared and confirmed effect on method of fabrication
for bone tissue engineering applications.
We fabricated prepared scaffolds by solvent casting/salt-
leaching, ice particle-leaching and gas-forming/salt-leaching
method. Proliferation of BMSCs in PLGA scaffolds manufactured
by various methods was analyzed using MTT assay. Also, we have
characterized the osteogenic potential of BMSCs in scaffolds by
ALP, RT-PCR and histology for osteogenic phenotype.
The biological activity and ALP activity of BMSCs in the
scaffolds was the highest in the scaffolds using solvent casting/salt-
leaching method. In RT-PCR results, specific gene, ALP and os-
teocalcin, related with osteoblast expressed in the all type of
scaffolds. BMSCs in scaffolds were stimulated by osteogenic
medium and characterized by Masson’s trichrome and von Kossa
staining. We could observe collagen and calcification over broad
region in solvent casting/salt-leaching scaffolds.
We fabricated three types of scaffolds by mean of the
manufacturing method for osteogenesis confirmation. Results from
this preliminary work showed that solvent casting/salt-leaching
method provided highly porous structure with good interconnec-
tions between each pore, which can support the structure of cell
proliferation and differentiation. We concluded the manufacture
method of scaffold affect to differentiation of BMSCs and solvent
casting/salt-leaching is useful for osteogenesis of BMSCs.
Acknowledgements: This research was supported by KMOHW
(0405-BO01-0204-0006) and SCRC (SC3100).
(P 368) The Effects of Double-Layered Electrospun Poly
(P-Dioxanone)-Hybrid-Poly (Lactide-Co-Glycolide) Nerve Con-
duit and Adhesion Molecule on Peripheral Nerve Regeneration
in Rats
Nara Kang1, Jungsub Shin1, Hyonseok Jang2, Pill-Hoon Choung3
1Ewha Womans University School of Medicine Department of
Oral and Maxillofacial Surgery.
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The effects of a double-layered electrospun PDS-hybrid-PLGA
nerve conduit and a heparin binding peptide (Hep12) on re-
generating nerve in PC 12 cells and the rat sciatic nerve were
investigated.
Materials and Methods: 1. Fabrication of electrospun nerve
conduit All samples were made with 10/90 poly (lactide-co-
glycolide) (PLGA), poly (p-dioxanone) (PDS), and poly
(p-dioxanone)-hybrid-poly (lactide-co-glycolide)(PDS-hybrid-
PLGA) using electrospinning technique. 2. In vitro adhesion of
PC12 cells on different type of nerve conduits and a heparin
binding peptide-12 (Hep12). 3. In vivo implantation of different
type of nerve conduits and a heparin binding peptide-12 in rat
sciatic nerve. After the sciatic functional index (SFI) was calcu-
lated at the end of 8 and 12 weeks, the innervated tissues of sciatic
nerve were examined using light microscope and TEM. The axonal
density and thickness of myelinated nerve were measured using
image analyzer. The results obtained from the samples were ana-
lyzed by Krusal-Wallis with Dunn’s post test.
Results: 1. Nerve conduit with 1–8 mm sized pore was biode-
gradable intercommunicated multi-porous structure and double-
layered structure reinforced the mechanical properties for nerve
conduit. 2. PDS-hybrid-PLGA nerve conduits coated with Hep12
improved PC12 cell attachment and infiltration. 3. Walking-track
analysis showed functional recovery in PDS-hybrid-PLGA/Hep12
superior to autograft in 12 weeks 4. In 8, 12 weeks, PLGA/Hep12
and PDS-hybrid-PLGA/Hep12 shows the similar thickness to au-
tograft and PLGA/Hep12 and PDS-hybrid-PLGA/Hep12 in 8, 12
weeks show the similar axonal density to autograft.
Conclusion: Double-layered electrospun nerve conduit com-
bined with adhesion peptide has great potential in peripheral nerve
regeneration without growth.
(P 369) The Effects of Granulocyte-Colony Stimulating Factor
(G-CSF) on the Isolation of Peripheral Blood-Derived Stro-
mal-Like Cells
P. Kalia1, T.K. Singhrao1, Coathup, M.J.1, Gibson, S.J.1,
G.W. Blunn1
1Centre for Biomedical Engineering, Institute of Orthopaedics,
University College London.
Hematopoietic stem cell (HSC) mobilization can be induced using
granulocyte colony stimulating factors (G-CSF). Direct interac-
tions between HSCs and bone marrow stromal cells (BMSCs) exist
in the bone marrow stroma, which may be disrupted after G-CSF
administration. We thus hypothesised that G-CSF would increase
the mobilization of peripheral blood stromal-like cells, which could
be isolated, expanded, and characterised similarly to BMSCs. Six
sheep were given 5 mg/kg Neupogen? (G-CSF) for five days. Blood
samples were taken before G-CSF was given, and 4, 12, 24, and 2
weeks after the last G-CSF dose, for cell culture and hematology.
Fibroblastic colony forming units (CFU-F) were counted after 7
and 14 days in culture. FACS analysis and cell differentiation was
also performed. No CFU-F formation was observed in blood
samples taken pre-treatment. After G-CSF treatment, CFU-Fs were
observed in blood samples taken 4, 12, and 336 hours post-G-CSF.
Expanded cells were fibroblastic in morphology, and positive for
CD14, CD54, and CD164, and negative for CD45, CD73, CD105,
and CD106. Upon treatment with osteogenic, adipogenic, or
chondrogenic supplements, cells were positive for Von Kossa, Oil
Red ‘O’ stain, or Alcian Blue stain, respectively. PBSCs can be
isolated after G-CSF administration and may be an important
source of cells with multipotent characteristics.
(P 370) The Experimental Study on Constructing the Tissue
Engineered Myocardium-Like Tissue In Vitro with Bone Me-
senchymal Stem Cells of Infant
Wanhong Xing1, Zhiwei Xu2, Zhaohui Lu2, Jie Ma1, Guangwei
Guo1, Baoping Li1
1Cardiothoracic surgery department, the second hospital of Shanxi
medical university, Taiyuan, China..
2Cardiothoracic surgery department, Shanghai Children Medical
Center Affiliated Shanghai Jiao tong University School of Medi-
cine, Shanghai, China..
In this paper, we report on engineering 3-D myocardium¨Clike
tissue constructs in vitro with bone mesenchymal stem cells
(BMSCs) of infant. Bone marrow was obtained from the sternal
marrow cavum outflow of infant with congenital heart dis-
ease(CHD) undergoing cardiac operation. BMSCs were obtained
by density gradient centrifugation. The Changes of their shapes,
anchoring rate, clone formation rate, the surface markers and ul-
trastructure were observed. The cells during the second passage
period were induced in dulbecco’s minimum essential medium
(DMEM) with 10umol/L 5-Azacytidine(5-Aza) for 24 hours. After
having been cultured for two weeks in vitro, phenotype and mor-
phology of induced cells were examined by immunocytochemistry
and transmission electron microscope(TEM). When the induced
BMSCS had been cultured into filled, the cells were planted in the
scaffold of poly-lactic-co-glycolic acid(PLGA) in the density of
5.5 106cells/cm2. The cell-scaffold complex had been cultured in
the shake cultivation for 1 week, then the complex had been
planted in the dorse of the nude mouse. When the experiment had
been finished, the histology, immunology, real time PCR and so on
were done. The data suggested that BMSCs of infant with con-
genital heart disease have the property of the stable growth and the
rapid proliferation. Results of mmunocytochemistry showed that
BMSCs induced by 5-Aza after two weeks expressed cardiac re-
lated protein, such as a-actin, Desmin, cTni and Cx-43.The
transparent myofilaments could be observed in the induced cells by
TEM. The engineered myocardium¨Clike tissue constructed by
BMSCs of infant and the scaffold of PLGA had the auto-myo-
cardial property.
(P 371) The First Trial Use of Tissue-Engineering Design on
Basis of Autogenous Multipotential Stromal Cells of Adipose
Tissue for Sinus-Lifting and Compensate for a Deficiency
Tissues Alveolar Septum
Alekseeva I.S.1, Volkov A.V.2, Arutunyan I.V.2, Rzhaninova
A.A.2, Goldshtein D.V.2, Kulakov A.A1
1FSI SRIS and MFS Rusmedtechnology.
2Cc ReMeTex.
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The cells technology allows to receive natural equivalents of bone
tissue—tissue-engineering design on basis of multipotential stro-
mal cells (MMSC).The marrow or adipose tissue can be used as a
source of MMSC. Cell culture MMSC was received and described
according with the passport of the culture of standard proceeding.
Demineralized bone matrix in the form of blocks or chips was used
as a scaffold. The selection of 3D structure was determined ac-
cording to clinic problem. Patient 1. Transplantation construction
was executed in the area of AS after ablation ‘‘BioOss’’. The im-
provement of bone tissue and increase of width AS was detected
after 1 and 3months. Patient 2. The extraction of 14,15 at the
inspection perforation of the bottom maxillary of sinuse, the ab-
sence of bone wall from the vestibular surface. On the spiral
computer tomography (SCT) it was revealed, that the thickness and
the width of AS amount 0.61 cm. and 0.59 cm. agreeably. The sinus
lift operation with transplantation construction was made in area
bottom sinus as well as increase of width of the alveolar septum.
After 3months treatment it was determined by SCT that the height
of the alveolar septum amount 2.4 cm. and width 1.0 cm. Patient 3.
The transplantation construction in alveolar socket, extraction 18
at operation instant. The complete regeneration of the cortical plate
in the area of extraction of 18 was revealed after 3months by SCT.
After histological study of tissue revealed by reclaim every patients
was detected the forming new bone tissue.
(P 372) The Immune Suppressive Effect of Human Adipose
Derived Stem Cells
H.H. Ahn1, I.W. Lee1
1Department of Neurosurgery, Catholic University of Korea.
Adult stem cells are differentiated into multiple lineages and have
less ethical controversies than embryonic stem cells. This character
makes bone marrow derived stem cells (BMSCs) used in thera-
peutic cell sources. However researches with BMSCs have pa-
tient’s pain and low number of cells. In this study, we focused on
adipose derived stem cells (ADSCs) for the alternative source of
BMSCs in cell therapy and verified the immune suppressive effect
of ADSCs for applying to cell transplantation. We obtained adi-
pose tissue from donors, isolated and cultured ADSCs. We have
examined phenotype of the human ADSCs by the FACS analysis
and differentiated into multi-lineages. Immune suppressive prop-
erties of ADSCs were analyzed by mixed lymphocyte culture and
lymphocyte proliferation response to non specific stimulators. The
immune suppressive effect of ADSCs was compared with BMSCs.
Both ADSCs and BMSCs were obtained from 3 different donors
and the mixture was applied.
The results showed that cultured human ADSCs have mesen-
chymal surface markers and differentiation potency. ADSCs did
not arise in vitro immune response to the lymphocyte stimulation,
moreover suppressed the proliferation in mixed lymphocyte reac-
tion. ADSCs also suppressed lymphocyte proliferation to the non
specific stimulator such as PHA, Con A and IL-2. The suppressive
effect of ADSCs mixture from multi-donors was stronger than
ADSCs from single donor. These findings support that ADSCs
have the similar properties of BMSCs and immune suppressive
properties. Therefore ADSCs could be an alternative cell source of
BMSCs for using allogeneic stem cell therapy.
(P 373) The Implementation of Control Cells in Experiments
on the Immunomodulatory Properties of Mesenchymal Stem
Cells– a Technical Note
B. Kronsteiner1,2, S. Neussl1,2, A. Peterbauer1,2, M.v. Griens-
ven2,3, H. Redl2,3, C. Gabriel1,2, S. Wolbank1,2
1Red Cross Blood Transfusion Service of Upper Austria, Linz,
Austria.
2Austrian Cluster for Tissue Regeneration.
3Ludwig Boltzmann Institute for Experimental and Clinical
Traumatology, AUVA Research Center, Linz/Vienna, Austria.
It is widely recognized that mesenchymal stem cells (MSCs) from
various sources such as bone marrow, adipose tissue or amnion
possess suppressive activity on peripheral blood mononuclear cell
(PBMC) proliferation in vitro.
The purpose of this work was to select suitable primary human
cells which can be used as negative control for immunomodulatory
experiments and to ensure that the effect of MSCs on PBMCs is a
specific property of stem cells.
Human fibroblasts and human epithelial kidney cells (HEKCs)
among others were tested in parallel to adipose-derived stem cells
(ASCs) in a 6 day co-culture with stimulated and unstimulated
PBMCs. PBMC proliferation was detected by two different
methods, namely BrdU ELISA and [3H]-thymidine incorporation
assay. Furthermore a cytotoxicity assay was performed by co-
culturing PBMCs with ASCs or HEKCs as targets.
Both evaluated detection methods using either BrdU or [3H]-
thymidine showed similar results in immunomodulatory experi-
ments. It has been found that fibroblasts possess the potential to
suppress proliferation of stimulated PBMCs, which is in consis-
tency with the literature. Surprisingly suppression of PBMC pro-
liferation was also detected to a certain degree when stimulating
them in the presence of HEKCs. In contrast to ASCs, HEKCs were
able to elicit an alloreaction in co-culture with PBMCs. A func-
tional cytotoxicity assay revealed that HEKCs are lysed by cyto-
toxic cells whereas ASCs are mostly unaffected.
Overall, these findings provide evidence that HEKCs can be
applied as control cells in functional assays but not in co-culture
experiments measuring proliferation through BrdU or [3H]-
thymidine.
Acknowledgments: EXPERTISSUES (NMP3-CT-2004-
500283)
(P 374) The Importance of Multislice CT-Exam in the 3D
Evaluation of Human In Vivo Metallic Implants
S. Brad1, G. Miclaus1, H. Ples1
1The Imagistic Diagnostic Center Neuromed.
The study points out the importance of Multislice CT-scan exam in
the evaluation of the metallic human in vivo implants materials
with a special value in the diagnostic assessment of pathology
associated with their use.
We retrospectively reviewed the Multislice CT-scan imaging
studies of 122 patients with metallic implants examined between
January 2007 and December 2007 at The Imagistic Diagnostic
Centre Neuromed Timisoara using a 64 Somatom Sensation.
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The 64 Multislice CT-scan exams allow the visualization of the
integrity of the metallic prosthetic devices and osteosynthesis
materials, as well as their disfunctionalities, without being ob-
structed by metallic artifacts (major inconvenient in classic CT).
Also, a special interest was to detect the subtle local pathology
associated with their use.
We evaluated the permeability and side effects of intraventricular
shunts for hydrocephalia in 17%. The good location and efficiency
of arterial aneurisms vascular therapeutically clips were checked in
10%. Dental implants with regional tissular involvement were as-
sessed in 10%. Cardiac metallic valves prosthesis, coronary and
peripheracally endolumenal arteries stents with their specific mor-
phology, functionality parameters and local tissular side effects
were revealed in 42%. The topography, anatomic alignment and
local side effects of osteosynthesis materials were evaluated in 18%.
Hip metallic prosthetic devices integrity and regional secondary
reactive and pathologically deviations were detected in 3%.
The Multislice CT-scan examination represents the election
method in current practice for the 3D evaluation of the metallic
human in vivo implants materials with special abilities in the de-
tection and characterization of the local tissular side effects.
(P 375) The Interaction Between Nanofibers Mesh Covered
Scaffolds and Chondrocytes
E. Kijen˜ska1, T. Ciach2, W. Swieszkowski1, W. Tomaszewski3,
Y. T. Konttinen4, D.W. Hutmacher5, K.J. Kurzydlowski1
1Faculty of Materials Science and Engineering, Warsaw Uni-
versity of Technology, Poland.
2Faculty of Cemical and Process Engineering, Warsaw University
of Technology, Poland.
3Institute of Biopolymers and Chemical Fibers, Lodz, Poland.
4Biomedicum Helsinki, Helsinki, Finland.
5Institute of Health and Biomedical Innovation, Queensland
University of Technology, Australia.
The replacement of cartilage tissue or nonunion bone defects caused
by injury, infection or resection, became one of the most significant
problems for todays tissue engineering. Scaffolds covered with
nanofibers seem to be a promising solution for these problems. One
of the best methods for making nanofibers is electrospinning.
Electrospinning is a fabrication process that uses an electric field to
control the deposition of polymer fibers onto a target.
The aim of the study was to investigate the influence of nanofi-
bers made by electrospinning method, covering the 3D micropo-
rous structures (scaffolds) on the colonization and differentiation of
chondrocytes cells. Scaffolds were made of microfibers with use of
rapid prototyping method.
Various parameters of electrospinning process (applied voltage,
solution flow, thickness of needle) and different types of polymers
(PLLA, PDLLA), solution contents were studied to fabricate na-
nofibers. The choosing of optimum parameters allowed for ob-
taining fibers with diameters of tens to hundreds nanometers. The
selected nanofibers were directly electrospun on the scaffolds.
The nanofibers meshes with different density were generated on
the scaffold surfaces. The influence of fibers diameter as well as
fiber mesh density on cellular behavior was investigated. Me-
senchymal stromal cells isolated from lipoaspirate differentiated in
3–4 weeks to collagen type II and aggrecan producing chon-
drocytes/cartilage when grown as pellets on these nanofibers, dri-
ven by transforming growth factor-beta3. Thus, nanofibers can be
used as a growth platform for such cells during chondrogenesis.
(P 376) The Migration Behaviour of Chondrocytes is Affected
by the Three Dimensional Environment. Implications for One
Stage Cartilage Repair Procedures.
S. Concaro1,2, C. Lo¨nnqvist2, P. Gatenholm2, M. Brittberg1,2,
A. Lindahl1
1Department of Regenerative Medicine. Gothenburg University,
Sweden.
2Department of Biopolymer Technology, Chalmers University of
Technology Sweden.
Introduction: Materials with good biomimetic properties may fa-
cilitate the initial fases of regeneration. Migration is a complex
process that is important during development and tissue repair. The
aim of this study was to evaluate the biomimetic properties of
different materials.
Methods: Cartilage from young pigs was obtained after eutha-
nasia. The cartilage was minced using a scalpel. Similar amount of
cartilage was combined with Hyaff 11 scaffolds (Hyaff 1112,
37mg 2,41)without coating or gel coated with Puramatrix  or
Cartipatch. The constructs were cultured with proliferative me-
dia for 21 days. After this period the media was changed to a
chondrocyte differentiation. The number of migrated chondrocytes
was determined by measuring the amount of DNA in the different
groups. The chonrocyte differentiation was assessed with the
quantification of glycosaminoglycans (GAG) and the presence of
collagen type II.
Results: Cells migrated and populated the constructs in all
groups. Puramatrix had a significantly higher number of cells after
33 days (p¼ 0.0143). All the groups evidenced collagen produc-
tion. Collagen type II was only present in the puramatrix group.
The amount of GAG was significantly higher in the puramatrix
group. (p¼ 0.00270).
Conclusion: The different three dimensional and chemical
properties of materials affect important processes that are involved
in tissue repair. Puramatrix evidenced to elicit better migration and
differentiation capacity in pig chondrocytes
(P 377) The Morphology of ß-TCP- Based Biomaterials In-
fluences Their Bioactivity In Vivo
S. Ghanaati1, C. Orth1, C.J. Kirkpatrick1
1Institute of Pathology, Johannes Gutenberg University of Mainz,
Germany.
Introduction: This study was undertaken to analyse the bioactivity
of ß-tricalcium phosphate (TCP)-based biomaterials of different
granulate shape and size by characterizing the cells involved in
their degradation.
Materials and Methods: Using a modified subcutaneous implan-
tationmodel of Hafemann et al. 2007, 120 female 5-week-oldWistar
rats were randomly divided into 6 groups of 20 animals each. The
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animals received polygonal splint granulates of different sizes as
follows: Group 1) 500–1000mm, 2) 150–500mm and 3) 63–250mm.
Alternatively, the animals received spherical granulates of different
sizes as follows: 4) 500–1000mm and 5) 50–150mm). Group 6 was a
sham group (i.e., operation without biomaterial implantation). All
biomaterials were kindly provided by Curasan AG, Germany. The
biomaterials were explanted for further histological, histochemical
and immunohistochemical analysis at 3, 10, 15, 30, or 60 days after
implantation (4 animals per indicated time point).
Results: All ß-TCP based biomaterials showed a distinctive
vascularisation and degradation 60 days after implantation. The
inflammatory response, however, depended on shape and size of
the biomaterials. Already at day 10 after implantation polygonal
splint granulates of medium size showed the highest presence of
TRAP-positive osteoclast-like cells, while few (group 4) or no
(group 5) osteoclasts were detectable around spherical granulates
at the same time point.
Conclusion: This in vivo study shows that not only the compo-
sition of a biomaterial, i.e. b-TCP, but its shape and size may have
a profound influence on its bioactivity and on its potential to
stimulate the local/peripheral pluripotent cells to differentiate to
osteoclasts.
(P 378) The Presence of Chitosan at the Surface Influences the
Interaction of Biomolecules and Cells with Chitosan-Poly
(Bultylene Succinate) Blend
D. F. Coutinho1,2,3, I. H. Pashkuleva1,2,3, C. M. Alves1,2,3, A. P.
Marques1,2,3, N. M. Neves1,2,3, R. L. Reis1,2,3
13B’s Research Group—Biomaterials, Biodegradables and Bio-
mimetics, Campus Gualtar, 4710-057 Braga, Portugal.
2Department of Polymer Engineering, University of Minho,
Campus Azure´m, 4800-058 Guimara˜es, Portugal.
3IBB—Institute for Biotechnology and Bioengineering, PT Gov-
ernment Associated Laboratory, Braga, Portugal.
Chitosan blends with synthetic biodegradable biomaterials have
been proposed for various biomedical applications. However, there
are still missing details about the main surface characteristics that
may benefit from the blending of these two types of materials.
Hence, this work aims at characterising the surface properties of
those materials and at illustrating how these properties outline the
interaction with proteins involved in cell adhesion and conse-
quently with osteoblast-like cells. Etching by polishing or by
plasma was performed to compare the composition of the surface
with that of the bulk. The characterization of the unmodified and
modified surfaces was carried out by optical microscopy, scanning
electron microscopy, Fourier Transform Infrared spectroscopy,
X-Ray photoelectron spectroscopy, contact angle measurements
and surface energy calculations. The adsorption of human serum
albumin and human plasma fibronectin onto the different surfaces
was quantified by coupling an indirect method with a colorimetric
assay. A preferential adsorption of albumin over fibronectin was
registered. Furthermore, the presence of chitosan at the surface of
the materials enhanced the protein adsorption. The in-vitro bio-
logical performance of the studied materials was further investi-
gated by a direct contact assay with osteoblast-like cells (SaOs-2).
The cell culture results revealed a positive influence of chitosan
over SaOs-2 morphology and activity, while a higher proliferation
rate was promoted by the synthetic component. This work further
confirmed the interest of combining synthetic and natural poly-
mers, showing a distinctive advantage of using chitosan, within
this strategy, to tailor the surface properties of a biomaterial thus
improving its biological behaviour.
(P 379) The Use of Bone Tissue Engineered Grafts for 3D
Composition in Stimulation of Osteogenesis in Rat Mandible
V. S. Melikhova1, A.A. Orlov2, I. N. Saburina1, N. I. Novikova3,
A. N. Murashev3, A. A. Pulin1, V. S. Repin1
1Institute of General Pathology and Pathophysiology, Moscow.
2Dentistry Clinics Dental Academy, Moscow.
3Branch of the Shemyakin-Ovchinnikov Institute of Bioorganic
Chemistry, Pushino.
Congenital anomalies, trauma, and diseases affect bone structure
and mineral density and can lead to the lost of bone tissue. Prop-
erties of stem cells together with tissue engineering approaches can
be used to overcome bone degeneration and its loss in dentistry,
plastic surgery and orthopedics.
We have investigated the efficacy of b-tricalcium phosphate
(ChronOs, Synthes GmbH, Switzerland) together with stromal
cells (SC) from adipose tissue on osteogenesis after osteoabrasion
on rat mandibles. All grafts were autologous. There were 24 ani-
mals in experimental group and 12 animals in control group. Ex-
perimental animals were grafted either with a graft of b-tricalcium
phosphate with SVC or with b-tricalcium phosphate only. Animals
were sacrificed on 7, 21, 40 and 120 days after osteoabrasion and
simultaneous grafting of mandible.
The highly porous matrices support the induction of osteo-
genic differentiation of stem cells as well as progenitors from
periosteum, confirmed by positive staining with monoclonal anti-
bodies to osteocalcin and Von Kossa staining. Stromal cells
also posses angiogenic potential and stimulate vasculogenesis in
a graft, though, newly formed tubules mostly originate from
host vessels. These structures are positively stained for CD 31 and
von Willebrandt factor. Were found regions of osteogenesis on
terms of 21–120 days and strong vasculature of grafts, seeded with
SCs.
We assume, that the scaffold create and maintain a space that
facilitates progenitor cell survival, proliferation and stimulates
osteogenic differentiation of host progenitor cells. SVC stimulate
the formation of new vascular net, that provides newly-formed
bone with nutrition and oxygen supply.
(P 380) The Use of Carbon Textile Matrixes for Study of
Implanted Cell Localization
O. Toporova 1,2, O.Deryabina1,2, T. Gulko1,2, D. Pykhtyeyev3,
O. Kholodkova3, T. Ruban1,2, O. Sukhorada1,2, V. Kordium1,2
1Institute of Molecular Biology and Genetics of National Acad-
emy of Sciences of Ukraine, Kyiv, Ukraine.
2Institute of Genetic and Regenerative Medicine of Medical
Academy of Sciences of Ukraine, Kyiv, Ukraine.
3Odessa State Medical University, Odessa, Ukraine.
Objective: There are two approaches for the introduction of the
eukaryotic cells that are widely used to solve the practical prob-
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lems of the regenerative medicine, namely in suspension or at-
tached to the scaffold. During the formation of future tissue, the
attachment is achieved by growing of the cells into 3D matrix. And
in that case one can compare cells not in free (in direct introduc-
tion) and attached form, but free and those that has formed the
precursor of the tissue.The aim of our work was to investigate the
fate of the cells, which are introduced in suspension or in attached
to two-dimensional matrix form into the lesion focus of organ-
ism of experimental animals. Cell delivery systems include non-
biodegradable matrix having different chemical composition
physically associated with viable cells. The material has been in-
troduced into abdominal cavity in order to avoid quick active
washing out and in the same time to exclude the ‘‘forced’’ at-
tachment, as it takes place during introduction into dense tissues,
where the introduced cells are actively pressed to the resident cells.
Material and methods: For cell immobilization we have used non-
biodegradable matrixes: carbon textile, cellulose membrane (pore
size up to 20 mm) and silicon polymers. Matrixes-carriers for the
transplanted cell culture were made in the form of sponges, gauzes,
globules and fibers. The murine cell sublines of two different
morphological species: epithelial-like and fibroblast-like, were
used. After cultivation immobilized-cell matrixes were implanted
intraperitonealy into male mice of C57BL/6J line.. The morphol-
ogy and functional state analysis of
(P 381) The Validation of a Novel Compression Bioreactor to
Ensure the Accurate Application of Loading Regimes
K. Hampson1, J.H. Kuiper1,2, A.J. El Haj1
1Institute of Science & Technology in Medicine, Keele Uni-
versity.
2Robert Jones & Agnes Hunt Hospital, Oswestry.
Bioreactors enable the application of reproducible and accurate
mechanical loading regimes to cell-seeded constructs (De´marteau
et al. 2003). One of the most important aspects of bioreactor design
to ensure that the application of the required forces is accurate and
reproducible is the validation stage. A novel multi-construct ro-
tating bioreactor was designed to investigate the effects of com-
pression on cell-seeded PLLA scaffolds in vitro. This bioreactor
underwent extensive validation to determine the amount of error in
the system and therefore the actual amount of compression being
applied to the cell-seeded constructs. This included characterisa-
tion of the base of the bioreactor chamber, confirmation of contact
between the constructs and the loading plate, analysis of the
movement of the loading plate and determination of the average
amount of strain being applied, at different positions, across the
surface of the loading plate. The scaffolds were also mechanically
tested to ensure they had suitable mechanical properties to support
the application of the required loading regimes. The validation of
this bioreactor demonstrated that it was capable of accurately
compressing numerous constructs. This bioreactor was then used
to apply 2% compression to PLLA scaffolds seeded with mesen-
chymal stem cells which induced the chondrogenic differentia-
tion of these cells. These experiments produced reproducible
quantitative PCR and biochemical assay data from each of the
cell-seeded constructs (n¼ 5) which shows the importance of the
validation stage of bioreactor design in generating high quality
data.
(P 382) Thermal, Mechanical and Biological Properties of
PLA Fibers
G.M. Kerch1, Y. Bayon2, V. Kasyanov1, P. Gravagna2,
G. Clermont 3
1Riga Stradins University, Latvia.
2Sofradim , France.
3Biomatech , France.
Multifilament (filament diameter 18 mm) and monofilament (di-
ameter 150 mm) PLA yarns used as reinforcing components of
tissue engineering (TE) scaffolds displayed different mechanical
and thermal behavior according to their sourcing.
Melting of multifilament PLA fibers in the temperature interval
142–1758C with peak at 1628C correlated with lower biodegra-
dation rate and higher mechanical properties after aging in saline
compared to PLA monofilament fibers melting in the temperature
interval 91–1578C with the peak at 1508C.
Distinct thermodynamic and mechanical properties were ob-
served for multifilament and monofilament PLA fibers. Moderate
decrease of melting enthalpy for multifilament fibers and drastic
decrease of melting enthalpy for monofilament fibers was observed
in DSC profile in second heating. Crystallization peak was absent
in DSC profile for monofilament fibers and clearly detected for
multifilament fibers in second heating. Crystallization peak for
monofilament fibers appears on the second scan of DSC profile and
melting enthalpy increased during aging from month 3 to month 6
from 4.9 J/g to 20.1 J/g due to intensification of chemicrystalli-
zation process. Sharp decrease of mechanical properties for
monofilament fibers and slight changes for multifilament fibers
were observed after 3months storage in saline.
Animal tests (full thickness abdominal wall defect in rats)
confirmed fast degrading properties of PLA monofilaments, with
lower melting temperatures and lower crystallinity.
The selection and combination of PLA fibers for TE scaffolds
have a major impact for successful clinical indications.
(P 383) Three-Dimensional System (Bioreactor-Biomaterial)
to Engineer Ligament Tissue
S. Scaglione1,2, B. Zerega1, A. Cavaliere2, S. De Faveri2,
C. Ilengo1, R. Quarto1,3
1Stem Cell Laboratory, Advanced Biotechnology Center, Genova,
Italy.
2Department of Communication, Computer and System Sciences,
University of Genova, Italy.
3Department of Chemical and Food and Pharmaceutical Tech-
nologies, University of Genova, Italy.
A simple and compact bioreactor system has been planned and
developed to engineer ligament grafts, under monitored biome-
chanical stimuli. Partial or complete damage to ligaments is fre-
quent especially in young/sportive people; the possibility to
regenerate/substitute damaged ligaments becomes thus crucial.
Therefore, we have developed a 3D bioreactor system able to cul-
ture cells onto biomimetic substrates under controlled biome-
chanical conditions.
Gelatin-based fibers with proper bulk properties have been de-
veloped and tested as ligament substitutes. Scaffolds were placed
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within a cylindric culture chamber, clumped at the extremity, and
exposed to torsion/strain, through a stepper-motor connected to the
chamber, reproducing the physiological ligament stresses. Adult
stem and/or skin-fibroblast cells were seeded onto the scaffolds and
cultured within the bioreactor under different experimental con-
ditions (w/o AA, w/o TGF-beta). Cells proliferation and matrix
deposition has been evaluated.
The 3D bioreactor system has been validated in terms of sterility,
experimental reproducibility and ease to use. The developed biore-
actor is based on the concept of controlled alternating torsions of
scaffolds embedded incell suspension/culturemedium.Gelatin based
grafts with different compositions and architectures have been de-
veloped and tested in terms of cells adhesion, proliferation andmatrix
production under different chemical-physical stimuli conditions.
In conclusion, we have developed and validated a simple
(bioreactor-biomaterial) system to engineer ligament grafts, for a
clinical use. Particular attention was focused on the production of a
simple, efficient and low-cost 3D system.
(P 384) Tibial Defect Reconstruction using Hydroxyapatite
Scaffold Seeded with Expanded Stem Cells
R.F. Tatu1, G. Tanasie1, C. Tatu1, C. Bunu1, D. Puscasiu1,
S. Anghel2, R. Brediceanu2, C. Cebzan1
1University of Medicine and Pharmacy Timisoara.
2County Hospital Timisoara.
Introduction: Critical long bone defects can not heal spontaneously
and a replacement technique is needed.
Material and Method: A 6 cm. tibial defect of a 24 years old
male, result of a complicated open fracture, had to be recon-
structed. Because of the comminution of the homolateral fibula and
the refuse of the patient to harvest the contra lateral fibula for a
pediculated bone graft, another reconstruction method was needed.
Classic reconstruction methods (calcium sulfate pellets, autologus
bone marrow and iliac crest bone graft) failed.
A tissue engineering approach was then used by obtaining a three
dimensional construct made of a porous hydroxyapatite ceramic
scaffold, seeded with culture expanded stem cells isolated from the
patients own bone marrow. The resulting living structure was im-
planted in the diaphyseal defect. By plating the fibula using long
fibulo-tibial screws, internal bone stabilization was secured.
Results: The surgical wound healed without complications. The
patient was monitored by x-rays and periodical clinical examina-
tion. Callus formation was observed at the bone-scaffold interface
at 80 days after the operation when the patient was allowed to a
partial limb bearing. Now, at 120 postoperative days, using a cane,
he is walking without having pain and on x-ray examination peri-
implant bone formation is detectable.
Discussion: Although the described defect can not be considered
healed yet, the clinical and radiological evolution of the lesion is
promising. The use of expanded autologus stem cells seeded on
porous ceramic scaffolds could represent a progress in critical long
bone defects reconstruction.
(P 385) Tissue Engineered Bowel using Biologically Derived
De-Cellularised Scaffold.
T. Ansari1, D.A.J. Lloyd2, A. Nowocin1, P.D. Sibbons1,
A.R. Boccaccini3, S. Gabe2
1Dept. Surgical Research, NPIMR, Harrow.
2St Mark’s Hospital, Harrow.
3Dept. Materials, Imperial College, London.
Short bowel syndrome is characterised by a severe reduction in the
amount of functional intestine available as an absorptive surface.
Attempts to lengthen the intestine by interposition of artificial tu-
bular scaffolds juxtaposed between healthy tissue has shown lim-
ited success mainly because while neo-intestine can be induced to
grow, it rarely survives for long and therefore does not achieve
absorptive status.
Using a completely novel approach, lengths of adult rat colon
were harvested, de-cellularised such that they retained all the nor-
mal features of bowel except for the cells (therefore totally non-
immunogenic) and cross linked for stability, implanted into Lewis
rats followed by seeding with crypt cells. Using this methodology it
has been possible to produce neo-intestine mucosa consisting of
crypts, goblets cells, active enteroendocrine Paneth cells (a marker
of functioning mucosa which has not been successfully achieved
previously) and, uniquely, sub-mucosa, all of which is appropriately
vascularised. In order to strengthen the de-cellularised bowel which
is less robust than normal bowel until it has re-cellularised with the
host cells, attempts are currently underway to temporarily strengthen
the scaffold using poly 3-hydroxybutyrate (P3HB), a biological
polymer which is known to be non-toxic and biocompatible.
A significant advantage of this approach is that the associated
blood vessels can also be de-cellularised while still attached to the
intestine. They can then be reconnected when the bowel is im-
planted and we have evidence that these vessels will re-cellularise
appropriately to form functioning blood supply such that the im-
planted intestine is immediately re-vascularised.
(P 386) Tissue Engineering and Fetal Therapy: the Moral,
Social, and Political Implications
H.C.M.L. Rodrigues1,2, M.A. Verkerk1, P. P. van den Berg2
1Expertise Center of Ethics of Care (EEZ), University Medical
Center Groningen, Netherlands.
2Department of Obstetrics and Gynaecology, University Medical
Center Groningen, Netherlands.
The clinical application of scientific knowledge is not morally
neutral. This is especially true when advanced therapy medicinal
products (e.g., tissue-engineered products TEPs) and innovative
therapies (e.g., fetal therapy FT) are at stake.
Our task within EuroSTEc is to analyze the moral-legal impli-
cations of FT with use of tissue-engineered products.
In this context, we assume, as fundamental premise, that the
clinical use of soft tissue engineering for prenatal surgical cor-
rection of congenital defects is neither immediately justified nor
straightforwardly desirable.
Apart from legal, political and market concerns about safety,
production, availability, and commercialization, the availability of
tissue engineered products and its use in FT for correction of birth
defects raises unique ethical questions:
What are the necessary and sufficient conditions for the re-
sponsible application of TEPs in FT? Do women have a special
duty to have surgery on behalf of their fetuses? Should research on
innovative therapies for relatively rare conditions be a funding
priority? Or should resources be committed to research and treat-
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ment of diseases affecting a larger number of patients? In which
way does tissue engineering for prenatal correction of congenital
defects influences citizen’s views about the body and its bound-
aries?
Few has been written about the ethical, social, and political
impact of this new—in the minds of most people, still part of a
science fiction book—medical possibility.
We offer an overview of the complex moral issues researchers,
legislators and politicians will have to keep in mind when trying to
regulate TEPs application in FT
(P 387) Tissue Engineering for Diaphragmatic Replacement
with Collagen Matrices. Prelimenary Result
R.H.J. Verstegen1, M. Milczarek1, L. Ennen2, T. Hafmans3,
T. Kuppevelt3, W. Daamen3, R. Dekhuijzen2, W. Feitz4, I. de
Blaauw1, R. Wijnen1
1Department of Pediatric Surgery.
2Department of Pulmonology.
3Department of Biochemistry.
4Department of Urology.
Introduction: Diaphragmatic reconstruction with tissue engineer-
ing is a viable and potentially improved alternative for diaphrag-
matic replacement in the neonatal period as was shown in previous
studies.
The aim of this pilot experiment was to study the feasability of
reconstructive surgery with tissue engineering of the diaphragma
with special interest in the ingrowth of muscle cells in the grafts in
a rat model.
Materials and methods: For this pilot we used 10 Wistar rats.
Under anaesthesia the right hemidiaphragm was exposed and 1/3
was resected. In the defect a collagen matrix, size of approximately
15mm 20mm, was implanted.
Four weeks after matrix implementation the rats were harvested.
Results: Surgery was performed on 10 rats (60% overall survival
rate).
Histological examination showed high cell density and organi-
zation in the implants. Cell alignment in comparison with the
collagen fibres within the construct was seen. The grafts showed
fine muscle cells ingrowth from the margins of the grafts.
Discussion: We succeeded in the development of a rat model for
reconstructive surgery of the diaphragmatic hernia with tissue
engineering. Moreover, we observed ingrowth of muscle cells into
the scaffolds.
In future studies we will study the effect of growth factors and
GAGs on the speed of regeneration of the diaphragm. Finding a
scaffold with the least side effects (ie reherniation), allowing the
fastest muscle cells and nerves ingrowth and uncompromised
function of the diaphragm is crucial. This study is part of the
Eurostec program, a soft tissue engineering program for congenital
anomalies.
(P 388) Tissue Engineering of Functional Salivary Gland for
Replacement
A. Joraku1, C. Sullivan1, J.J. Yoo1, A. Atala1
1Wake Forest Institute for Regenerative Medicine, Wake Forest
University Health Sciences, Winston-Salem, NC 27157.
Objectives: The treatment of conditions that lead to salivary hy-
pofunction, such as radiation induced xerostomia, is currently
limited to the administration of saliva substitutes and sialogogues.
The transient effect of these medications necessitates frequent
administration and systemic side effects may be intolerable. The
creation of implantable, functional salivary gland tissue from au-
tologous glandular cells would provide a physiologic solution to
this problem. We investigated the feasibility of engineering such
tissue in vivo.
Methods: Primary human submandibular gland cells were
grown, expanded and seeded on biodegradable polymer scaffolds.
A total of 48 scaffolds with cells and 16 control polymers without
cells were implanted subcutaneously in athymic mice. The im-
plants were retrieved 2, 4 and 8 weeks after the implantation for
phenotypic and functional analyses.
Results: Human salivary gland epithelial cells retained their
phenotypic and functional characteristics at all culture stages.
Histologically, formation of acinar gland-like structures was ob-
served within the engineered tissue by 4 weeks after implantation.
Immunocytochemical and Western blot analyses of the implanted
tissues demonstrated the expression of human a-amylase, cyto-
keratins AE1/AE3, and aquaporin-5. RT-PCR analyses confirmed
the expression of human a-amylase mRNA. The retrieved tissues
demonstrated the production of human a-amylase over time using
a biochemical amylase detection system.
Conclusions: Primary human salivary glandular cells seeded on
polymers are able to form functional tissues in vivo. The en-
gineered tissues, composed of glandular epithelial cells, produce
amylase and possess water channel proteins. This autologous cell-
based system may provide a new treatment modality for patients
suffering from inadequate salivary secretion.
(P 389) Tissue Engineering the Tumor Microenvironment:
Synergy Between Biophysical and Biochemical Cues in Tumor
Invasion
A.C. Shieh1, M.A. Swartz1
1Institute of Bioengineering, Ecole Polytechnique Federale de
Lausanne.
Stromal fibroblasts can regulate the biophysical tumor microen-
vironment through matrix contraction, matrix remodeling, and
altered interstitial flow, which redistributes biochemical gradients
and has been implicated in breast cancer metastasis. Fibroblasts
also communicate with the tumor via biochemical signals to pro-
mote cell growth and migration. To examine the interplay between
the biophysical environment, fibroblasts, and the tumor in metas-
tasis and invasion, we developed a novel in vitro model of the
tumor microenvironment, incorporating breast cancer cells, fibro-
blasts, a 3-D collagen matrix, and interstitial flow. We have shown
that interstitial flow and tumor-fibroblast interactions synergisti-
cally promote matrix remodeling of the tumor microenviron-
ment. Confocal reflectance microscopy revealed marked changes
in the collagen matrix density and morphology. The apparent
permeability of the matrix increased 6.5-fold with interstitial
flow and co-cultured tumor cells and fibroblasts, while flow alone
(with a single cell type) only resulted in a 1.8 to 2.2-fold in-
crease. This suggests that the biophysical environment plays a
crucial role in modulating the effects of biochemical crosstalk
between tumor cells and fibroblasts, leading to marked changes
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in the structural and functional properties of the ECM. These
differences may lead to a more tumor-permissive matrix, by fa-
cilitating migration, providing pro-invasive signals, and increas-
ing interstitial flow to drive autologous chemotaxis by tumor
cells. The implications of this work are two-fold: (1) we have
established a novel model for the human cancer microenvironment,
and (2) we have demonstrated that interstitial flow plays an im-
portant role in tumor microenvironment, which in turn governs
cancer invasion.
(P 390) Tissue Engineering using Electrospun Functionaliz-
able Scaffolds
F. Spano1, M. Liley1, C. Hinderling1, H. Sigrist2
1Centre Suisse d’Electronique et de Microtechnique, CSEM SA,
Neuchaˆtel, Switzerland.
2Arrayon Biotechnology, Neuchaˆtel, Switzerland.
Electrospinning is a flexible and effective technique for the fab-
rication of polymer nanofibers. Various polymers have been suc-
cessfully electrospun into ultrafine fibers in recent years: mostly in
solvent solution and some in melt form. There is strong medical
interest in the generation of scaffold materials for tissue regener-
ation and 2D and 3D cell culturing. Electrospun nanofibrous ma-
terials could act as three dimensional scaffolds for the directed
growth of cells, e. g. in nerve regeneration and nerve guiding. Such
material can be produced by electrospinning in the form of aligned
nanofibers. The key property that differentiates the envisioned
material from existing systems is that it mimics the extracellular
matrix (ECM) and offers a simple way to control structural
alignment and promote target cell binding. The native ECM pro-
vides more than just a mechanical support for cells, it also serves as
a substrate to display specific ligands and factors that control cell
adhesion, migration and regulate cell proliferation and function 4.
This requires the introduction of biological guidance cues for the
controlled growth of cells on aligned electrospun nanofibers.
Electrospun functionalizable materials for medical applications
will be further investigated as ECM mimicking scaffold substrates
for nerve guiding and regeneration.
(P 391) Towards a Functional Multi–Cell Co-Culture Model
Starting From a Single Human Progenitor Cell Source
A. Papadimitropoulos1, A. Scherberich1, A.M. Mu¨ller1, A. Brac-
cini1, I. Martin1
1Tissue Engineering Laboratory, ICSF, University Hospital,
Basel, Switzerland.
The scope of this project is to generate a 3D osteoblast-osteoclast-
endothelial cell co-culture system, as an in vitro model, studying
the effect of specific biochemical and biomechanical factors on
bone remodelling process. Here, we investigated the feasibility to
derive the three cell lineages starting from a single source of hu-
man progenitor cells, in monolayer cultures.
Human bone marrow(BM) and adipose tissue(AT) cells were
cultured in presence of different cytokines and oxygen percentages
for up to 4 weeks. Cell phenotypes were assessed by cytofluori-
metric and Tartrate Resistant Acid Phosphatase (TRAP) assays.
We first aimed at maintaining the endothelial and mesenchymal
populations and at generating an increased number of osteoclastic
cells, by expanding the fraction of monocytic cells with macro-
phage colony stimulating factor and subsequently inducing their
differentiation with the receptor activator for NKkB ligand. A co-
culture of endothelial lineage cells (5.7% of CD34/CD31þ) with
mesenchymal cells (55.7% of CD105þ) and pre-osteoclasts (3.7%
of CD14/Vitronectinþ) was only obtained from AT, whereas BM
yielded a lower fraction of per-osteoclasts and absence of endo-
thelial cells. Medium supplementation with FGF-2 supported
mesenchymal cell proliferation, but eliminated the presence of
TRAPþ, CD14/Vitronectinþ cells. Lowered oxygen levels, re-
duced only the endothelial-lineage cells to 1.7%.
The study indicates that AT progenitor cells can be manipulated
appropriately to establish a co-culture of mesenchymal, osteo-
clastic and endothelial lineage cells. Ongoing experiments will
investigate whether osteoblastic differentiation of mesenchymal
cells and their production of paracrine signals are able to replace
the soluble factors used to stimulate osteoclastic differentiation of
monocytic precursors.
(P 392) Towards Functionalisation of Collagenous Nano-
and Micro- Fibrous Structures
D.I. Zeugolis1, L. Yao1, A. Pandit1
1National Centre for Biomedical Engineering Science, National
University of Ireland, Galway, Ireland.
Type I collagen accounts for up to 70–90% of the collagen found in
the body and is present in the form of elongated fibres in tissues
such as nerves, skin, tendon and cornea. In vitro, under appropriate
conditions, extracted forms of collagen spontaneously self-
assemble to form fibres that are indistinguishable from those oc-
curring in vivo. However, the natural cross-linking pathway (lysyl
oxidase mediated) does not occur in vitro and consequently such
structures lack sufficient strength. Although a number of different
chemical cross-linking approaches have been introduced, none of
them provides a potential for additional functionalisation. Towards
this goal in this study a PAMAM dendrimeric system was inves-
tigated to develop a multi-functional cross-linking method. The
influence of the novel dendrimeric cross-linking approach was
evaluated through thermal, mechanical and neuronal cellular via-
bility analysis of the produced fibrous collagen scaffolds. Differ-
ential Scanning Calorimetry investigation indicated an elevated
denaturation temperature over non-cross-linked or mild cross-
linked (water soluble carbodiimide) scaffolds (p< 0.05). Simi-
larly, extension to failure mechanical testing made apparent that
the produced scaffolds were characterised by increased tensile
strength over their non-cross-linked counterparts (p< 0.05). Bio-
logical evaluation of the cross-linked scaffolds exhibited superior
neuronal cell cytocompatibility over the one obtained from con-
ventional cross-linking approaches (water soluble carbodiimide).
Neuronal cells differentiated and exhibited normal cellular mor-
phology as evidenced by SEM and Rhodamine-Phalloidin staining.
In addition, neuronal cells aligned in the direction of the oriented
fibres. These results demonstrate the feasibility of dendrimeric
systems as a novel cross-linking approach to stabilise and conse-
quently functionalise fibrous collagenous structures.
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(P 393) Towards Improved Neovascularization–Endothelial
Progenitor Cells and PLA/Bioactive Glass Composite with
Angiogenic-Inducing Properties
A. Aguirre1,2, L. Ma´rquez2, M. Navarro1,2,3, J.A. Planell1,2,3,
E. Engel1,2,3
1Institute for Bioengineering of Catalonia, Baldiri Reixac 13,
Barcelona, Spain.
2Dpt. of Materials Science, Technical University of Catalonia
(UPC), Av. Diagonal 647 ETSEIB, Barcelona, Spain.
3CIBER-BBN, Barcelona, Spain.
Vascularization is crucial process for the success of tissue en-
gineered constructs. Without a proper vascular network, implants,
both in vivo and in vitro, suffer from hypoxia, lack of nutrients and
accumulation of waste products that ultimately result in cell death.
This problem can be circumvented by promoting enhanced blood
vessel ingrowth into the implant. To this end, we created an in vitro
system using Endothelial Progenitor Cells (EPCs) and a PLA/
calcium phosphate glass composite (PLA/G5) developed in our
group for bone regeneration (Charles-Harris et al, 2005). These
scaffolds show a high porosity (95%) and a pore size larger than
500 um with very open interconnected porosity. We expected G5
particles to introduce bioactivity in the composite, improving bone
and vascular tissue regeneration. EPCs are stem cells that can be
isolated from bone marrow. They show expression of several en-
dothelial and stem cell markers (CD31, CD34, VEGFR-2, vWF)
and have strong vasculogenic properties. Our results showed that
proliferation-measured by the WST-1 method was increased
compared to controls. Acridine Orange staining for live/dead cells
showed good viability, with no observable apoptotic or necrotic
cells. After 3 days, cells assembled into long tube-like structures
with sprouts delving deeper into the material. We decided to test its
possible angiogenic properties by comparing cells seeded in PLA/
G5 and in angiogenic conditions. Tubule density quantification
results demonstrated a strong induction of angiogenesis on PLA/
G5 discs. Our next steps are to establish co-cultures of EPCs-MSCs
for bone and vessel regeneration and measuring differentiation by
qRT-PCR.
(P 394) Towards In Situ Tissue Repair in Osteoarthritis: Dif-
ferentiation and Migration Potential of Patient-Derived
Mesenchymal Stem Cells
J. Eder1,2, T. Dehne1, C. Perka3, J. Ringe1, M. Sittinger1
1Tissue Engineering Laboratory and Berlin-Brandenburg Center
for Regenerative Therapies, Department of Rheumatology and
Clinical Immunology, Charite´-Universita¨tsmedizin Berlin, Tu-
cholskystr. 2, 10117 Berlin, Germany.
2Department of Medical and Pharmaceutical Biotechnology, IMC
University of Applied Sciences Krems, Piaristengasse 1, 3500
Krems, Austria.
3Musculoskeletal Research Centre Berlin, Charite´-
Universita¨tsmedizin Berlin, Schumannstr. 20/21, 10117 Berlin,
Germany.
In situ cartilage tissue engineering represents an alternative ap-
proach to treat degenerated articular cartilage in osteoarthritis. The
concept aims to recruit mesenchymal stem cells from bone marrow
by means of chemotactic agents to the defect padded with bio-
materials. Present there cells are induced to proliferate and dif-
ferentiate to restore articular surface. It was the aim of this study to
investigate the differentiation potential as well as the chemokine
guided migration potential of human mesenchymal stem cells de-
rived from patients with osteoarthritis.
Cells were isolated from femoral heads derived from patients
undergoing total hip athroplasty, expanded, checked for standard
surface marker profile and differentiated towards osteogenic,
chondrogenic and adipogenic lineage using standard differentia-
tion assays. A 96-well plate chemotaxis assay was used to inves-
tigate the migratory response to a set of chemokines. Finally gene
expression of the isolated cells during chondrogenic differentiation
in fibrin-PGLA biomaterial constructs was analyzed using micro-
arrays.
FACS analysis revealed a typical mesenchymal stem cell sur-
face marker profile (CD44þ, CD73þ, CD90þ, CD105þ,
CD166þ, CD14-, CD34-, CD45-). In multilineage differentiation
assays histochemistry confirmed chondrogenic, adipogenic and
osteogenic potential of the isolated cell populations by formation
of collagen type II, lipid vacuoles and calcium deposits, respec-
tively. Chemotaxis experiments could demonstrate migratory re-
sponse to CCL25. Cells maintained in 3D culture showed proper
viability over six weeks, expression profiling supported chondro-
genic potential as typical markers were clearly up-regulated
(COL2A1, COMP, ACAN, etc.).
To conclude, human mesenchymal stem cells from patients with
OA showed feasibility for in situ tissue engineering.
(P 395) Transport of Small Anionic and Neutral Solutes
Through Chitosan Membranes: Dependence on Crosslinking
and Chelation of Divalent Cations
R.M.P. da Silva1,2, S.G. Caridade1,2, J. San Roma´n3, J.F. Mano1,2,
R.L. Reis1,2
13B’s Research Group, Biomaterials, Biodegradables, Biomi-
metics, Department of Polymer Engineering, University of Minho.
2IBB, Institute for Biotechnology and Bioengineering, PT Gov
Associated Lab, Braga, Portugal.
3Department of Biomaterials, Instituto de ciencia y technologia de
polimeros, CSIC, Madrid, Spain.
Chitosan membranes were prepared by solvent casting and cross-
linked with glutaraldehyde at several ratios under homogenous
conditions. The crosslinking degree varying from 0 to 20% is de-
fined as the ratio between the total aldehyde groups and the amine
groups of chitosan. Permeability experiments were conducted us-
ing a side-by-side diffusion cell to determine the flux of small
molecules of similar size, but holding different chemical moieties,
either ionised (benzoic acid, salicylic acid and phthalic acid) or
neutral (2-phenylethanol) at physiological pH. The permeability of
the different model molecules revealed to be dependent on the
affinity of those structurally similar molecules to chitosan, i.e.,
related to the partition coefficient determined in an independent
experiment. The permeability of the salicylate anion was enhanced
by the presence of metal cations commonly present in biological
fluids, such as calcium and magnesium, but remained unchanged
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for the neutral 2-phenylethanol. This effect was explained by the
chelation of metal cations on the amine groups of chitosan, which
increased the partition coefficient. The crosslinking degree was
also correlated with the permeability and partition coefficient. The
change in the permeation properties of chitosan to anionic solutes
in the presence of these metallic cations is an important result
and should be taken into consideration in the in vitro predictions of
the drug release from chitosan based controlled drug release sys-
tems.
(P 396) Treatment of Diabetic Foot Trophic Lesions using a
Tissue-Engineered Dermal Graft
S. Llames1,2, E. Garcia-Perez1, V. Garcia3, M. Pevida1,
L. Camblor4, J.M. Llaneza4, R. Martinez1, P. Can˜al1, F. Menendez-
Tevar1, A. Meana1,2
1Centro de Sangre y Tejidos.
2Ciberer U714.
3Fundacio´n In-Clı´nica.
4Hospital Central de Asturias.
Introduction: Treatment of diabetic foot ulcers includes necrotic
tissue debridement, infection control, mechanic discharge and
whenever possible, revascularization of the lesion. Nevertheless
there are not many therapies that improve tissue regeneration and
wound healing. The use of tissue-enginneered constructs could
help to regenerate these lesions.
Aim of Study: The aim of this study is to assess the effects of the
transplant of an artificial, tissue-engineered dermis in the healing
of surgical injuries of diabetic foot.
M&M: Artificial Dermis: Fibroblasts were obtained from skin
biopsies of tissue donors from our bank. The artificial dermis was
made by mixing cultured fibroblasts and donors plasma. This
mixture was clotted by adding CaCl2.
Patients: 15 diabetic patients (bearing open injuries that did not
ameliorate for the past 4 weeks) were included in the study. One
dermal graft was transplanted on the wound bed once a week until
wound healing or, if adverse events appeared, suppression of the
treatment.
Results: 15 patients were treated. Wound healing was achieved
in 80% cases. The mean period of wound closure was 7 weeks. The
mean hospitalisation period was 2.5 weeks. Neither reject signs nor
secondary complications were observed.
Conclusion: The treatment of post-surgical wounds in the dia-
betic foot using an artificial dermis is a reliable and secure pro-
cedure.
(P 397) Umbilical Cord Derived Progenitor Cells as a Potential
Source for Autologous Cell Harvesting
S. G. Thompson1, J. A. Hunt1, F. Pu1, N. P. Rhodes1
1UK Centre for Tissue Engineering, University of Liverpool,
Clinical Engineering, Liverpool, L69 3GA, UK.
Umbilical cords have been identified as a potential niche for har-
vesting numerous multipotential progenitor cells. Contemporary
isolation protocols generate heterogeneous cell populations con-
stituting numerous stem and progenitor cell populations each
exhibiting shifting degrees of multipotentiality. Homogeneously
isolating each subpopulation and gauging therapeutic potential may
highlight umbilical cord as a potential cell source for clinical ap-
plications. Furthermore, utilisation of autologous cells overcomes
immune compromises associated with tissue engineering.
Wharton’s jelly was circumspectly dissected from washed cords
and plated into 6 well plates with basal media. Undifferentiated
confluent cells were removed and analysed by flow cytometry.
Cells were cultured in media known to cause lineage differentia-
tion along adipogenic, chondrogenic, osteogenic and neurogenic
pathways. Phenotyping by immunostaining, histological staining
and western blotting for proteins associated with the desired line-
age was carried out at 7, 14, 21 and 28 days.
Undifferentiated cells expressed the MSCmarkers CD29, CD90,
CD105, CD146 and CD166 as observed by flow cytometry. Ex-
pression of the ES markers CD9, CD30, CD56 and CD135 suggest
the presence of cells with increased plasticity. Further analysis of
the undifferentiated population demonstrated expression of STRO-
1 and the stem cell proliferation marker Nucleostemin within
subsets of the population. Cells introduced into adipogenic,
chondrogenic, osteogenic and neurogenic differentiation medias
exhibited differentiation towards the desired lineage, as confirmed
by morphological examination, immunostaining and western
blotting.
It is therefore concluded that umbilical cord tissue is a good
source of progenitor cells with multipotentiality.
(P 398) Umbilical Cord-Derived Stem Cell as a Hepatic Cell
Source for Regenerative Medicine
H.H. Yoon1, B.Y. Jung1, K.Y. Song2, Y.J. Kim3, J.K. Park1
1Dongguk University.
2Chung-Ang University School of Medicine.
3Lifecord Inc..
There are some intrahepatic liver stem cells, such as oval cells in
relation to liver regeneration. However, recently it has been re-
ported that extrahepatic liver stem cells exist in bone marrow and
contribute to liver regeneration. Many researchers have investi-
gated which cell can differentiate into hepatocyte and contribute to
liver. Until now their potential is yet controversial. Besides HSC,
there are many origins of MSC, bone marrow (BM), adipose tissue
(AT), cord blood, and cord Wharton’s jelly (UC).
Moreover, it is reported that BM-, AT-, UC-MSCs can differ-
entiate into hepatocyte in vitro or after in vivo transplantation. We
have focused on UC-MSC as a stem cell source, because UC-MSC
can be easily isolated and cultured from generally discarded cord
tissue without any ethical problem.
So we confirmed whether the isolated cell from cord by our
protocol is one of MSCs or not using FACS and differentiation
analysis. After that, we checked which condition can improve the
differentiation of UC-MSC into hepatocyte. In addition to in vitro
experiment, we transplanted UC-MSCs into rats with liver fail-
ure induced by bile duct ligation, carbon tetrachloride intoxification.
As results, UC-MSCs could differentiate into hepatocytes ex-
pressing not only hepatocyte lineage markers (albumin, CK8,
CK18) but also liver-specific functions (albumin and urea syn-
theses, cytochrome P450 activities) in vitro. In conclusion, UC-
MSCs will be a good stem cell source not only for hepatic cell
therapy but also for bioartificial liver system in the field of re-
generative medicine.
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(P 399) Use of Human Synovial Fluid-Derived Stem Cells for
Cartilage Tissue Engineering
A.Crawford1, EA. Jones2, J. Mundy1, A. English2, K. Henshaw2,
D. Corscadden2, P. Emery2, D McGonagle2
1Centre for Biomaterials and Tissue Engineering, School of Clin-
ical Dentistry, University of Sheffield, Sheffield S10 2TA, UK.
2Rheumatology Research, University of Leeds, St James Hospital,
Leeds, LS9 7TF. UK.
Introduction: Mesenchymal stem cells (MSCs) are a potentially
useful for cartilage tissue engineering due to their proliferative
capacity and chondrogenic potential under appropriate differenti-
ation signals. We recently described the presence of MSCs in
human and bovine synovial fluids (SF) and shown that bovine SF-
MSCs could form a cartilage tissue with hyaline characteristics1.
The aim of this study was to characterize MSCs in human synovial
fluid and investigate whether they could form a hyaline-like car-
tilage on polyglycolic acid (PGA) scaffolds.
Methods: SF and matched articular cartilage were obtained from
patients undergoing joint replacement. SF-MSCs were isolated,
grown for at least 24 population doublings, characterized for
multipotential differentiation in classical in vitro assays or seeded
directly onto PGA scaffolds. Chondrocytes were isolated from
macroscopically normal, articular cartilage and used as a com-
parator. Constructs were cultured in classical chondrogenic me-
dium and after incubation, they were mounted in OCT, and frozen
sections taken for analysis of the extracellular matrix for collagen
types I and II, proteoglycan and alkaline phosphatase.
Results and Conclusions: SF-derived MSCs readily seeded
(96%) onto the PGA scaffolds. Immunohistochemical and histo-
chemical localisation of matrix components indicated all con-
structs produced extracellular matrix with hyaline characteristics
which was positive for deposition of collagen II and proteoglycan.
We suggest that synovial fluid represents a potentially attractive
source of chondrogenic cells which may have utility for cartilage
repair therapies in trauma and arthritis.
Acknowledgements: Presenting author funded by EX-
PERTISSUES [NOE:FP6/500283].
1Crawford A et al Tissue Engineering 2007;13:1745.
(P 400) Use of Pancreas-Derived Stem Cells to Improve Vas-
cularization in Skin Tissue Engineering
J.T. Egan˜a1,2,3, S. Danner4, M. Kremer1, D.H. Rapoport 4,
S. Lavandero3, C. Kruse4, H.G. Machens1,2
1Dept. Plastic and Hand Surgery, University of Lu¨beck, Lu¨beck,
Germany.
2Dept. Plastic and Hand Surgery, Technical University of Munich,
Munich, Germany.
3FONDAP Center for Molecular Studies of the Cell, Faculty of
Chemical & Pharmaceutical Sciences, University of Chile, San-
tiago, Chile.
4Fraunhofer-institute of Biomedical Engineering, Group of Cell
Differentiation and Cell Technology, Lu¨beck, Germany.
Clinical success in skin tissue engineering requires improvements in
the vascularization capacity of scaffolds for dermal regeneration
(SDR). Several efforts have been done in this field including cellular
and acellular technologies. In this work we combined the use of
GFPþ Pancreas-derived stem cells (PSCs) with a commercially
available SDR (Integra matrix, IM). 1 million cells were seeded and
cultured in a 15mm SDR. Cell viability, proliferation and cytokine
release from matrices containing cells was assayed in vitro. In vivo,
scaffolds containing cells were used to induce dermal regeneration in
a 15mm full skin defect model. After three weeks of in vivo re-
generation tissues were harvested and vascularization analyses were
performed. Results showed that after seeding, PSCs can survive and
proliferate in IM, releasing significant amounts of cytokines. In vivo,
the presence of PSCs significantly enhance the vascularization levels
compared than empty scaffolds (p< 0.05). Presence of PSCs in the
tissue in regeneration was confirmed by detection of GFPþ cells in
thewound area. These results suggest that combined use of PdSC and
SDR could be a rational way to improve vascularization in scaffold-
dependent dermal regeneration. However, further studies must be
performed in order to analyze the cellular andmolecularmechanisms
involved in the contribution of PSCs and its possible physiological
role in wound healing and tissue regeneration.
(P 401) USING Cells as Micro Factories for ECM Polymer
Hybrid Material Production
C. Aulin1, F. Foroughi2, R. Brown2, J. Hilborn1
1Uppsala University, Sweden.
2University College London, UK.
Scaffold design should aim at creating structures which can guide
cells into forming new, functional tissue. This puts high demands
on the scaffold, which should ideally act as a temporary support
that degrades as new tissue is formed. By combining the possi-
bilities of tailoring polymers into desired shape and mechanics
with the ability of the natural ECM to remodel, self organize and
store growth factors, hybrid scaffolds enjoying the advantages of
both materials could be produced.
In this study, the concept of in situ deposition of ECM by cells
onto compliant, knitted polymer supports creating in vitro pro-
duced ECM polymer hybrid materials for tissue engineering was
demonstrated. Specifically, human dermal fibroblasts were grown
on a compliant poly(ethyleneterephtalate) (PET) support.
Fibroblasts are cells responsible for synthesis and maintaining
the ECM of many tissues. When exposed to forces, fibroblasts are
known to respond with expression and remodeling of ECM pro-
teins, in particular collagen type I. To increase the collagen de-
position on the polymer support, the fibroblasts were cultured in a
bioreactor with a pulsating flow and the deposited collagen was
compared to static culture conditions.
By culturing the cells under dynamic conditions a 6 fold increase
in collagen deposition could be detected compared to static culture.
After two weeks of dynamic culture, scanning electron micro-
graphs showed bundles of ECM fibers bridging between polymer
filaments and anchoring cells to the scaffold. Histology of the so
formed hybrid materials showed an even distribution of cells in the
scaffold, surrounded by matrix-like structure.
(P 402) Validation of Mechanical Test Rig to Determine the
Crush Strength of CaP Ceramics
P.J. Walsh1,2, R, Craig 1
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1Biomedical & Mechanical Engineering, NUI, Galway, Ireland.
2School of Mechanical & Aerospace Engineering, Queens Uni-
versity, Belfast, UK.
New research is moving towards the development of algae derived
CaP ceramics, as it provides a replenishable source material. The
processing techniques used in the conversion process of algae to CaP
ceramics can compromise the mechanical integrity of the material.
However, there are currently no standard tests available or compar-
ative data in the literature to quantity the change in mechanical
properties of the resultant CaP bone filler. Some studies in the liter-
ature have applied ASTM C1161 test standard to determine the
flexural strength and modulus of coral derived CaP ceramics.
However, the granular sizes of the alga after heat treatment are too
small to apply this technique. The aim of this study was to establish a
protocol to quantify the mechanical properties of porous granular
materials. Commercially available CaP filler material was used to
validate the mechanical test rig designed. The rig was attached to a
Universal Test Machine (Lloyds EZL6000K) compression tester.
The compression test results were compared to the change in specific
surface areameasuredbygasporosimetry.After the rigwasvalidated,
it was used to quantify the change in mechanical strength of algae
after different heat treatments. It found that a decrease in mechanical
strength was directly proportional to an increase in heat treatment.
The study concluded that the mechanical test rig was a reproducible
miniature specimen test method that can be used to quantify the
mechanical properties of any CaP ceramics with no size limitations.
(P 403) Variations in Essential Ion Concentration Across
Batches of Foetal Calf Serum May Influence the Expression of
Key Adhesion and Regulatory Molecules of Human Umbilical
Vein Endothelial Cells.
N.Bryan,1, K.D. Andrews.1, M.J. Loughran.1, N.P. Rhodes.1,
J.A. Hunt.1
1University of Liverpool.
Contemporary in vitro cell culture techniques rely heavily on the
inclusion of foetal calf serum (FCS). The composition of this un-
defined mixture of proteins, growth factors and other endogenous
regulatory factors fluctuate dramatically, depending on coarse
physiological factors of the donor animal. In this study the varia-
tion in elemental composition of FCS across donors has been
considered and it hypothesised that deviations in elemental com-
position of sera could influence cell fate and function at a similar
magnitude to protein composition.
Elemental composition of FCS from five donors was quanti-
fied using inductively coupled plasma mass spectrometry (ICP-MS).
Primary human umbilical vein endothelial cells (HUVECs) were
systematically cultured using DMEM basal media with 20% foetal
calf serum from each of the five donors until confluencey was
reached. Expression of surface markers was characterised using
immunohistochemistry in conjunction with flow cytometry.
Throughout the five sera significant differences in the elemental
composition encompassing a wide range of regulatory ions was
identified. In addition to this, across the five donors, statistical
variation was observed in a number of molecules critical for cellular
adhesion including PECAM-1, ICAM-1 and VCAM-1 and also
Von Willeband factor, an indicator of endothelial cell phenotype.
The efficiency of a multitude of enzymes and other key cell
signalling pathways is mediated by cofactorial ions within the cell.
Elemental analysis of FCS revealed substantial differences in the
concentrations of several essential regulatory ions. These sera also
demonstrated the capacity to influence cellular phenotype, adhe-
sion and behaviour.
(P 404) Vascular Development in Microtissues using the
Hedgehog Signalling
N.C. Rivron1, J. Rouwkema1, N.M.S. Bettahalli2, D. Stamatialis2,
M. Wessling2, C.A. van Blitterswijk 1
1Department of Tissue Regeneration, Twente University, En-
schede, The Netherlands.
2Department of Membrane technologies, Twente University, En-
schede, The Netherlands.
Introduction: In in vitro-generated tissues, the development of a
vascular system is crucial to rapidly enhance perfusion and sur-
vival after implantation [1] and promote pattern formation and
tissue development [2]. The hedgehog signalling was lately shown
to be essential for endothelial tube formation during embryonic
vasculogenesis [3]. We are investigating the use of this signalling
pathway in promoting vascular development in 3D microtissues.
Results and discussion: The co-culture of human mesenchymal
progenitor cells (hMPC) and human endothelial cells (hUVEC)
results in the formation of a primitive vascular network [4]. Sonic
hedgehog, a morphogen from the hedgehog family, induced further
in vitro vascular development including the formation of lumens
and tubes in a dose dependent manner. The cellular mechanism is
under current investigation and suggests that both hMPC and
hUVEC are stimulated and promote tubulogenesis.
Conclusion: This study shows the possibility to use the hedge-
hog signalling to promote vascular development in vitro. The
prevascularized microtissues should prove useful to investigate
tubulogenesis and as blocks to built vascularized tissues in a bot-
tom-up approach.
1Levenberg. Engineering vascularized skeletal muscle tissue. Nature bio-
technology 2005.
2Red-Horse. Endothelium microenvironment interactions in the develop-
ing embryo and in the adult. Developmental cell 2007.
3Vokes. Hedgehog signaling is essential for endothelial tube formation
during vasculogenesis. Development (Cambridge, England) 2004.
4Rouwkema J, de Boer J, Van Blitterswijk CA. Endothelial cells assemble
into a 3-dimensional prevascular network in a bone tissue engineering
construct. Tissue engineering 2006 Sep;12(9):2685–2693.
(P 405) In Vitro and In Vivo Effect of Platelet Lysate on Os-
teogenic and Chondrogenic Differentiation of Human Bone
Marrow Stromal Cells
S. Zaky1, A. Ottonello1, R. Cancedda1, M. Mastrogiacomo1
1Universita’ di Genova & Istituto Nazionale per la Ricerca sul
Cancro, Genova, Italy.
The heterogeneous population of cells residing in bone marrow,
Bone Marrow Stromal Cells, has been a source of osteoprogenitor
cells for bone tissue engineering. This process implies the inter-
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action between the cells and growth factors, normally derived from
activated blood platelets, in the healing microenvironment. Since,
by its turn, the platelet rich plasma offers a concentrate of these
‘‘favorable’’ growth factors.In this study we evaluated the effects of
Platelet Lysate (PL; the growth factor concentrate derived from
PRP) on the proliferation and the differentiation of human BMSC.
The effect of Pl on BMSC proliferation was investigated taking
advantage of the MTT assay and counting the number of cell
doublings. BMSC were cultured in presence or absence of PL with
and without the supplement of 10% Fetal Calf Serum (FCS) in the
culture medium. The highest level of proliferation was observed in
presence of PLwithout FCS supplement and the induction was dose
dependent. In this culture condition we observed a high level of
expression of mesenchymal and osteogenic markers. The PL
treatment resulted in an increased calcium deposition when cul-
tured cells in an osteogenic medium in vitro and in a bone tissue
formation when seeded on a porous ceramic scaffold and subcu-
taneously implanted in an immunodeficient mouse. Interestingly,
the cells differentiated in chondrocytes when cultured in a three-
dimensional system under chondrogenic conditions. We conclude
that the PL from human source can substitute the serum from an-
imal source to support the culture of hBMSC before in vivo im-
plantation for tissue engineering.
(P 406) Measurement of Strain Produced by a Pulsatile Flow
Bioreactor
F. Foroughi1, R.A. Brown1
1UCL Institue of Orthopaedics.
Pulsatile bioreactors are used in tissue engineering to simulate a
vascular environment for cells grown in vitro. We characterised
fluid flow and quantified strain on a tube where cylindrical scaf-
folds are mounted. Strain was quantified by measuring tube wall
displacement using a travelling microscope. The tube was pulsed
using a 3-roller peristaltic pump and pulsing measured with 1, 2 or
4 bioreactors. Flow through the system was either unconstrained or
constrained by tying off the outflow.
Initially strain was measured for an unconstrained tube. Strain
increased from 0.64% (120 rpm) to 2.16% (330 rpm), though such
unconstrained measurements were difficult as total strain was so
small. When the tube outflow was constricted to maximise back
pressure, gross movement of the whole tube was reduced and this
was replaced by pulsing of the tube walls in a sine wave pattern of
variable amplitude. The constrained system strain was inversely
proportional to frequency, decreasing from 50.5% (60 rpm) to 40%
(240 rpm). Strain was measured for both 2 and 4 bioreactors in
parallel. For these configurations the inverse strain:frequency re-
lationship remained but the strain for each comparable frequency
decreased with increasing bioreactor number (i.e. 1, 2, 4 bioreac-
tors: 50.5%, 12.6%, 12.1% strain respectively). The results show
that greater strains were generated by using constrained flow to
enhance back pressure rather than the conventional free-flow
configuration. Moreover the whole-tube displacement observed
when unconstrained, may give the wrong impression of straining
the scaffolds, though this will mix the medium.
Framework 6 EU funding: 3G-SCAFF
(P 407) Poly(trimethylene carbonate)-Based Porous Tubular
Structures for Tissue Engineering of Small Diameter Blood
Vessels
Y. Song1, M. Kamphuis1, Z. Zhang1, I. Vermes1, A.A. Poot,1
D.W. Grijpma1, J. Feijen1
1Institute for Biomedical Technology (BMTI) and Department of
Polymer Chemistry and Biomaterials, University of Twente, P.O.
Box 217, 7500 AE Enschede, The Netherlands.
For tissue engineering of small-diameter blood vessels, biode-
gradable, flexible and elastic porous tubular structures are most
suited. In this study, we prepared crosslinked porous tubular
structures from poly(trimethylene carbonate) (PTMC), in which
smooth muscle cells (SMCs) were seeded and cultured in a pul-
satile bioreactor mimicking the physiological conditions.
PTMC was synthesized and porous tubular structures were
prepared by dipping coating, cross-linking by g-irradiation, and
leaching. SMCs were seeded into the porous structures by perfu-
sion and then the constructs were cultured in a pulsatile bioreactor
system. The morphologies, mechnical properties were analyzed
and SMCs attachment and proliferation were evaluated by histol-
ogy studies and CyQuant.
Flexible tubular structures were obtained by dip coating with
3mm inner diameter and 1mm wall thickness. The porosity of the
structures in wet state reached 85 vol% and the pore sizes were 60-
150 mm. PTMC tubular structures showed comparable tensile
strength and higher elongation compared with natural blood ves-
sels.A pulsatile bioreactor system mimicking the conditions in vivo
(dynamic pressure 70 mmHg, 75 beats/min) was successfully built.
Experiements showed 7-day dilation was < 10% and variation of
diameter at each pulse was < 1%. SMCs were homogeneously
seeded in the porous scaffolds by perfusion. SMCs proliferate well
to form confluent cell layer during a time period of up to 14 days,
leading to constructs with even better mechanical performance.
PTMC Porous tubular structures were prepared with good mi-
crostructures, elasticity and biocompatibility. SMCs were seeded
and proliferated well in pulsatile bioreactor system and significant
improvement of mechnical strength was observed.
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